ï»¿abstract_number,date,position,poster_id,presenter,row,sector,session,title,co_authors
"794","12/04 12:00","1","P0001","Sireethorn NIMITVILAI","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Statins under-prescription in people with HIV in Thailand","S. Nimitvilai|W. Thammaprasert|U. Poonwiwatchaikarn"
"1081","12/04 12:00","3","P0003","Jose Ignacio MATEO GONZALEZ","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","NAFLD and hepatitis B status as predictors of liver fibrosis in PLWH who switch to LA-ART","J. Mateo-Gonzalez|M. Plaza-De-La-Torre|D. Martinez-Perez|J. Martinez-Andres|E. Ballester-Belda|V. Abril-Lopez-De-Medrano|M. Garcia-Rodriguez|C. Ricart-Olmos|M. Garcia-Deltoro"
"1085","12/04 12:00","4","P0004","Prakash GOSAIN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Development of engineered nanocarrier for controlled delivery of a protease inhibitor","P. Gosain|M. Bhargava"
"1723","12/04 12:00","6","P0006","Seyed Aria NEJADGHADERI","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Three decades of HIV/AIDS in Iran: epidemiological trends, socioeconomic impacts, and risk factors","S. Nejadghaderi|M. Bastan|M. Abdi|A. Iranpour|H. Sharifi"
"1846","12/04 12:00","7","P0007","Honey Jane BLANCO-LIMOS","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Incidence density and risk factors of hepatitis B and/or hepatitis C co-infection among newly enrolled HIV patients in a tertiary government hospital treatment hub","L. Avecilla|H. Blanco-Limos"
"1924","12/04 12:00","8","P0008","Paula SUANZES","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","CMV disease predictors and CMV viremia impact on immune reconstitution in advanced HIV infection","P. Suanzes|A. Gonzalez-Amezcua|A. Curran|M. Marcos|P. Domingo|R. Paredes|M. Saumoy|C. Manzardo|E. Bonfill|N. Climent|M. Plana|V. Falco|F. Torres|J. Miro"
"2055","12/04 12:00","9","P0009","Seyed Aria NEJADGHADERI","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","A nationwide survey on self-perception of HIV acquisition risk among people in prisons in Iran","Z. Abdolahinia|S. Nejadghaderi|S. Mehmandoost|A. Haghdoost|A. Iranpour|M. Karamouzian|H. Sharifi"
"2170","12/04 12:00","10","P0010","Milosz PARCZEWSKI","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Influence of immune exhaustion receptors PD-1 and PD-1L on immune reconstitution in ART-treated patients living with HIV","B. Aksak-Was|K. Skonieczna-Zydecka|M. Parczewski|R. Hrynkiewicz|F. Lewandowski|K. Serwin|K. Mielczak|F. Lenkiewicz|P. Niedzwiedzka-Rystwej"
"2210","12/04 12:00","11","P0011","Masa JOVANOVIC","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Treatment and follow-up of HIV-infected patients diagnosed during the COVID-19 pandemic","M. Jovanovic|K. Jovcic|A. Despotovic|D. Salemovic|D. Jevtovic"
"2505","12/04 12:00","12","P0012","Marta ILLESCAS-LÓPEZ","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Whole-genome sequencing: new strategies for managing HIV","M. Illescas-Lopez|L. Perez-Rodriguez|L. Aguilera-Muros|L. Chaves-Blanco|F. Garcia"
"2525","12/04 12:00","13","P0013","Lucia PEREZ RODRIGUEZ","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Resistance to integrase inhibitors in HIV patients with therapeutic failure: striving for ""zero resistance""","L. Perez-Rodriguez|M. Illescas-Lopez|L. Aguilera-Muros|A. De Salazar|F. Garcia"
"2655","12/04 12:00","14","P0014","Gonçalo QUEIRÓS","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Genetic diversity in the capsid protein-coding region of HIV-1 circulating in Angola: implications for primary resistance to the novel capsid inhibitor lenacapavir","G. Queiros|L. Yefimenko|F. Pereira|J. Piedade"
"3099","12/04 12:00","15","P0015","Shodok PROMSANJAN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Assessing the prevalence of latent tuberculosis infection among people living with HIV with viral suppression and CD4+ T cell counts = 200 cells/μl in Thailand","S. Promsanjan|C. Ungthammakhun|D. Changpradub|V. Vasikasin|W. Nasomsong"
"3289","12/04 12:00","16","P0016","Jacopo POLVERE","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Phenotypic modulation of RBD-specific B cells in people living with HIV upon booster vaccinations with SARS-CoV-2 mRNA vaccines","J. Polvere|F. Panza|S. Lucchesi|G. Montesi|I. Rancan|F. Fiorino|G. Pastore|M. Fabbiani|M. Tumbarello|F. Montagnani|D. Medaglini|A. Ciabattini"
"3350","12/04 12:00","17","P0017","Fatma Nisa BALLI TURHAN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Medication optimisation in older people living with HIV: a multidisciplinary approach","M. Halil|S. Unal|K. Demirkan|F. Balli Turhan|E. Kara|Z. Sahiner|C. Balci|M. Sönmezer|A. Inkaya"
"3451","12/04 12:00","18","P0018","Andrea DE VITO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Long-acting CAB + RPV: safety, efficacy, and discontinuation risks in ODOACRE cohort","A. Ciccullo|M. Mazzitelli|V. Iannone|A. Cervo|M. Fabbiani|M. Cossu|D. Leoni|G. Baldin|F. Romani|S. Antinori|A. Cattelan|C. Mussini|S. Di Giambenedetto|G. Madeddu|A. De Vito|A. Colpani|A. Giacomelli"
"3636","12/04 12:00","19","P0019","Luca MADDALONI","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","NGF levels differ by CD4+ T cell count and change after treatment in PLWH","L. Maddaloni|P. Rosso|E. Fico|L. Santinelli|G. Bugani|A. Lazzaro|L. Battistini|M. Fiore|G. Ferraguti|C. Mastroianni|G. d' Ettorre"
"3937","12/04 12:00","20","P0020","Paloma MUÑOZ","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Identification of APOBEC mutations and their impact on HIV drug resistance using next-generation sequencing (NGS)","P. Munoz-Baez|L. Chaves|A. De Salazar|M. Illescas|R. Delgado|A. Iborra|J. Galán|R. Carracedo-Monter|M. Sigcha|F. Pulido|L. Martinez Garcia|S. Pereira|C. Lopez-Causape|A. Aguilera|F. Garcia"
"4081","12/04 12:00","21","P0021","Philipp MATHÉ","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Analysis of the effect of high-sensitive CRP on bone density in people living with HIV","P. Mathé|H. Ingenstau|K. Laubner|S. Usadel|S. Rieg|J. Seufert|M. Muller"
"4662","12/04 12:00","22","P0022","Dominik BURSA","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Gender defines factors related to linkage to HIV care and early antiretroviral therapy—The Go Holistic Go Beyond project","C. Oprea|D. Gökengin|N. Yancheva-Petrova|S. Antoniak|L. Sojak|V. Saveski|D. Jilich|B. Lakatos|M. Bociaga-Jasik|B. Rozplochowski|J. Ranin|J. Kowalska|I. Gmizic|D. Bursa"
"4776","12/04 12:00","23","P0023","Brian HO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Enhanced clearance of broadly neutralising HIV-1 Antibody VRC07-523-LS under Viremia: influences on trial design and analysis","B. Ho|C. Venuto|T. Wood|G. Morse|R. Cha|M. Caskey|K. Bar|L. Gama|Q. Ma|N. Smith"
"5112","12/04 12:00","24","P0024","Jorge CISCAR SORIANO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Clinical impact of integrase inhibitor resistance: a growing challenge for the future?","J. Ciscar-Soriano|M. Gomez-Ruiz|A. Valentin-Martin|A. Hernández-Cabezas|M. Montero-Alonso|J. Lopez-Hontangas"
"5258","12/04 12:00","25","P0025","Martin OBERMEIER","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Evaluation of the new DxI 9000 anti-HIV antibody and antigen combo assay","A. Ismail|B. Wolter|J. Geisler|R. Ehret|M. Obermeier"
"5347","12/04 12:00","26","P0026","Jeppe Terpager CHRISTIANSEN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Cytomegalovirus IgG concentration is associated with reduced lung function in well-treated persons with HIV","J. Christiansen|A. Roed|N. Arentoft|T. Benfield|M. Suarez-Zdunek|S. Ostrowski|N. Kirkby|K. Kunisaki|A. Knudsen|M. Gelpi|S. Nielsen"
"5358","12/04 12:00","27","P0027","Francesco ROMANO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Mental health in PLWH: psychopathological variables and personality traits in patients compared with non-clinical subjects in Italy","F. Romano|I. Getuli|M. Ridolfi|F. Alessi|A. Lazzaro|L. Santinelli|C. Mastroianni|L. Tarsitani|G. D'ettorre"
"5514","12/04 12:00","28","P0028","Filip GLAVAC","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Significant mortality reduction of severe Pneumocystis jirovecii pneumonia in people living with HIV treated in the intensive care unit, Croatia, 2002-2023","F. Glavac|L. Dragosevic|J. Begovac|M. Kutlesa|A. Atelj|M. Vargovic|S. Zekan|M. Santini"
"5648","12/04 12:00","29","P0029","Ana Sofia GIL VIEIRA DA SILVA","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Evaluation of HIV Ag/Ab combo, HBsAg and anti-HCV serological assays on a new-to-market, high throughput analyser for emergency department opt-out testing in a high prevalence population as part of the United Kingdom screening programme","A. Gil Vieira Da Silva|D. Lee|T. Ngee Keong|M. Habibi|C. Pope|D. Andrew"
"5929","12/04 12:00","31","P0031","Öznur GÜNES","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Analysis of resistance profiles in relation to subtypes and immune markers in newly diagnosed HIV patients","Ö. Gunes|D. Sevgi|M. Yaman|M. Öcal|E. Aktas|M. Bulut"
"6065","12/04 12:00","32","P0032","Pious APPIAH","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Understanding the evolution of HIV-1 in Ghana: subtype distribution and drug resistance challenges","P. Appiah|M. Adusei-Poku|B. Musah Obeng|R. Osei-Yeboah|S. Agyemang|G. Gbassana|L. Mac-Ankrah|I. Jamfaru|M. Seshie|I. Sraku|S. Ankamah|K. Duedu|K. Sagoe"
"6148","12/04 12:00","33","P0033","Francisco ARNAIZ DE LAS REVILLAS ALMAJANO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Safety and efficacy of long-acting HIV treatment in real life at a tertiary care hospital","R. Parra Farinas|C. Arminanzas|M. Gutierrez Cuadra|C. Secada Gomez|N. Rojas|A. Illarro Uranga|C. Gonzalez Rico|C. Farinas Alvarez|F. Arnaiz De Las Revillas"
"6254","12/04 12:00","34","P0034","Francisco MERCA","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Evaluating HIV-1 protease drug binding affinity: structural prediction with AlphaFold2 and AutoDock Vina","F. Merca|A. Abecasis|P. Libin"
"6788","12/04 12:00","35","P0035","Gaurav KAUSHIK","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Toll-like receptors (TLRs) polymorphism in HIV-I infected patients with and without tuberculosis (TB) co-infection","G. Kaushik|R. Vashishtha|S. Sharma"
"6839","12/04 12:00","36","P0036","Vera ALLERHEILIGEN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Generic HIV-1 Viral Load Ver 2.0: a dual target quantitative assay for HIV-1","M. Vinay|M. Lereau-Bernier|T. Dupinay|M. Liess|M. Rothmund|D. Aberle|M. Mönnich|V. Allerheiligen"
"7049","12/04 12:00","37","P0037","Adriana Violeta TOPAN","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Measles seroprevalence in people living with human immunodeficiency virus in northern Transylvania, Romania","A. Topan|C. Jianu|I. Filipescu|M. Lupse|V. Briciu|M. Flonta|M. Flonta"
"7124","12/04 12:00","38","P0038","Filip GLAVAC","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Clinical characteristics and treatment outcomes in critically ill people living with HIV: a single-centre study from an infectious disease intensive care unit, 2002-2023","M. Santini|F. Glavac|L. Dragosevic|M. Kutlesa|S. Zekan|J. Begovac"
"7170","12/04 12:00","39","P0039","Alfonso CABELLO","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Acceptability and feasibility interventions measures (AIM & FIM) of the implementation of long-acting cabotegravir plus rilpivirine (CAB LA + RPV LA) administration out of HIV units: the IMADART study","A. Cabello|I. Carrillo|A. Al-Hayani|M. Lopez De Las Heras|C. Algar|I. Burillo|B. Álvarez-Álvarez|L. Prieto-Pérez|I. Mahillo-Fernández|M. Bonilla|L. Garcia-Jimenez|J. Caraballo|M. Espáris|B. Gallego|J. Bécares|M. Gorgolas"
"7393","12/04 12:00","40","P0040","Alessandra D'AURIA","1","B","01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Longitudinal study of type I interferon neutralising antibodies in people living with HIV","A. D'auria|F. Frasca|F. Matteo|C. Roberta|M. Luca|B. Ginevra|M. Ivano|F. Caterina|C. Giancarlo|M. Claudio Maria|A. Guido|T. Ombretta|D. Gabriella|S. Carolina"
"164","12/04 12:00","42","P0042","Hugh WATSON","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Hepatitis delta virus prevalence in the European Union estimated with novel methodology","A. Nizzardo|L. Nidiaci|E. Liusina|H. Watson|J. Alexander"
"236","12/04 12:00","43","P0043","Bouchra BELEFQUIH","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Comparative analysis of HBsAg and anti-HCV testing: dried blood spots vs whole blood","R. Bennai|N. Touyar|H. Kabbaj|B. Belefquih"
"699","12/04 12:00","44","P0044","Felipe PÉREZ-GARCÍA","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Prevalence and risk factors of active hepatitis C infection in migrants between 2019-2023 in Madrid, Spain","F. Perez-Garcia|P. Ryan|J. Valencia|I. Martinez|S. Resino|M. Quero-Delgado|G. Cuevas|S. Manzano|D. Sepúlveda-Crespo"
"818","12/04 12:00","45","P0045","Felipe PÉREZ-GARCÍA","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Opportunistic diagnosis of hepatitis C virus infection by hypertransaminasemia: a one-year, single-centre, prospective study","F. Perez-Garcia|J. Sánchez-Fuertes|A. Gomez Herrera|H. Bermúdez-Marval|T. Costales Lucia|A. Rojas-Diaz|T. Arroyo Serrano|R. Pérez-Tanoira|M. Barrionuevo González|M. Ruiz-Álvarez|J. Cuadros-González"
"1257","12/04 12:00","47","P0047","Saurabh BHARGAVA","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Development and characterisation of surface modified chitosan nanoparticles for selective targeting of lamivudine to hepatocyte","S. Bhargava"
"1520","12/04 12:00","48","P0048","Eldor URINOV","1","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Genotypic variations of hepatitis delta virus among chronic hepatitis patients in Uzbekistan","E. Urinov|T. Dolimov|L. Tuychiev"
"1732","12/04 12:00","1","P0049","Krispin HAJKOWICZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology and testing of hepatitis delta virus infection in Australia","K. Hajkowicz|B. Graves|N. Smoll|S. Bonanzinga|J. O'keefe|D. Chibo|J. Robson|E. Raby|N. Joshi Rai|M. O'sullivan|P. Harris|K. Jackson"
"1755","12/04 12:00","2","P0050","Marie Louise SLOTT JENSEN","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Diagnostic value of consecutive samples for anti-HEV IgG analyses","M. Slott Jensen|K. Franck"
"2137","12/04 12:00","3","P0051","Emma Ann DAVIES","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Whole genome sequencing of hepatitis C virus from dried blood spots by hybrid capture for genotype and antiviral resistance determination","E. Davies|C. Phillips|N. Machin|S. Kaur|D. Hand|B. Brown|R. Manu"
"2148","12/04 12:00","4","P0052","Felipe PÉREZ-GARCÍA","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Validation of a new molecular assay for the quantification of hepatitis D RNA in EDTA-plasma and serum samples","F. Perez-Garcia|A. Virseda-Berdices|C. Pita-Martinez|M. Munoz Monte|D. Sepúlveda-Crespo|H. Codina|J. Cuadros-González|I. Martinez|S. Resino|R. Alonso|S. Rodrigo|L. Mesones"
"2280","12/04 12:00","5","P0053","Samia BENADDA","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Treat and Follow-Up: Recontamination by Hepatitis C Virus After Effective Treatment","S. Benadda|A. Zertal|H. Agsous|F. Zmit|N. Belabes|N. Achour|H. Ziane"
"2514","12/04 12:00","6","P0054","Marta ILLESCAS-LÓPEZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Optimising molecular diagnosis of hepatitis delta","M. Illescas-Lopez|L. Perez-Rodriguez|A. Alberola|A. De Salazar|F. Garcia"
"2516","12/04 12:00","7","P0055","Anny CAMELO","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Relink-C study in Almería, Spain: opportunistic rescue of patients with HCV infection lost to follow-up in the healthcare system","T. Cabezas|A. Porcel|M. Rodriguez|J. Vega|M. Casado|J. Escalante|A. Camelo"
"2538","12/04 12:00","8","P0056","Robert EHRET","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","HDV full genome sequencing and genotype determination in a Berlin cohort","D. Guapiessi|Ö. Yildirim|M. Prentice|R. Ehret|M. Obermeier"
"2539","12/04 12:00","9","P0057","Lucia RIOS-MUÑOZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Neurological injury associated with rat hepatitis E virus infection","L. Rios-Munoz|M. Gallo-Marin|E. Aguera|A. Pérez|J. Caballero-Gomez|J. Caballero Villarraso|D. Corona-Mata|M. Casares-Jimenez|M. Frias|I. Perez-Valero|A. Rivero-Juárez|A. Rivero"
"2546","12/04 12:00","10","P0058","Lucia RIOS-MUÑOZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Febrile syndrome without a focus linked to rat hepatitis E infection","L. Rios-Munoz|M. Gallo-Marin|A. Pérez|J. Caballero-Gomez|D. Corona-Mata|M. Casares-Jimenez|M. Frias|A. Carrasco|P. Lopez-Lopez|C. Ferreira|I. Perez-Valero|A. Rivero-Juárez|A. Rivero"
"2605","12/04 12:00","11","P0059","Wanessa CLEMENTE","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Y.E.L.L.O.W. score (yellow fever end-stage liver and organ worsening score)","C. Viera|B. Couto|W. Clemente"
"2804","12/04 12:00","12","P0060","Muhammet KIPLAPINAR","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Redetermination Anti-HCV Levels (S/Co) Based on Correlation with HCV-RNA for Diagnosing Hepatitis C Virus (HCV) Infection","M. Kiplapinar|P. Erbay Dundar|S. Kurutepe|S. Akcali"
"2813","12/04 12:00","13","P0061","Ana ALBEROLA ROMANO","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology of the hepatitis delta virus in Spain through whole genome sequencing","A. Alberola Romano|A. De Salazar|L. Chaves-Blanco|M. Illescas-Lopez|A. Fuentes|A. Iborra|A. De La Iglesia|C. Freyre|M. Odero|I. Viciana|M. Pena|F. Fernández Sánchez|E. Ramirez De Arellano|F. Garcia"
"2883","12/04 12:00","14","P0062","Alberto VAZQUEZ BLANQUIÑO","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","""ProLink"" HCV study: optimising the HCV elimination cascade to re-engage the unreached","A. Vazquez Blanquino|A. Fuentes|L. Aguilera-Muros|L. Perez Rodriguez|M. Illescas-Lopez|L. Chaves-Blanco|F. Garcia"
"2978","12/04 12:00","15","P0063","Lorenzo SALMONI","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Characterisation of a cohort of liver transplant patients for HBV and/or HBV/HDV related complications: results of a Campania multicentre study","G. Stornaiuolo|L. Salmoni|A. Russo|D. Angrisani|A. Santonicola|G. Valente|F. Longobardi|F. Morisco|M. Persico|M. Stanzione|C. Sagnelli|M. Pisaturo|N. Coppola"
"3309","12/04 12:00","16","P0064","Erika ASPERGES","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Finite NA therapy in chronic hepatits B: a retrospective study on safety and prevalence of HBsAg-HBsAb seroconversion","E. Asperges|V. Zuccaro|E. Segalini|M. Calia|G. Nava|L. Maiocchi|P. Sacchi|R. Bruno"
"3345","12/04 12:00","17","P0065","Javier CABALLERO GÓMEZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Surveillance of ratHEV in extensively raised pigs in Spain","J. Caballero-Gomez|A. Rivero|I. Garcia-Bocanegra|D. Cano-Terriza|M. Casares-Jiménez|S. Jiménez-Ruiz|M. Risalde|L. Rios-Munoz|A. Rivero-Juárez"
"3373","12/04 12:00","18","P0066","Helena GARCIA LOPEZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Enhancing HDV detection: prevalence and diagnostic advances in northern Spain","H. Garcia-Lopez|S. Algarate|J. Bueno|R. Benito|E. Alvarado|S. Arnal|M. Riesgo Magana|C. Zumeta|M. Sarvisé|A. Achkir"
"3385","12/04 12:00","19","P0067","Kristian PAVOL","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Hepatitis C screening and treatment in the largest mariginalised Roma community with risky behavior","P. Kristian|I. Hockicková|D. Hudackova|F. Lami|J. Hockicko"
"3580","12/04 12:00","20","P0068","Sara ARNABOLDI","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Hepatitis E virus in northern Italy: focus on wild fauna for a One Health approach","S. Arnaboldi|F. Righi|A. Scarazzato|E. Pavoni|V. Filipello|D. Lelli|T. Trogu|A. Lavazza|S. Bonardi|A. Bianchi|B. Bertasi"
"3674","12/04 12:00","21","P0069","Laura GRUMIRO","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Performance evaluation of chemiluminescence anti-HCV assay","L. Grumiro|S. Semprini|E. Vecchio Nepita|M. Brandolini|C. Colosimo|L. Dionisi|M. Guerra|A. Marzucco|M. Montanari|G. Dirani|S. Zannoli|A. De Pascali|M. Cricca|V. Sambri"
"3870","12/04 12:00","22","P0070","Shreya PANI","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Novel S/Co ratios for predicting HCV RNA positivity in cancer patients: a study from a tertiary care cancer centre in India","S. Pani|G. Salunke|P. Samant|S. Biswas"
"4385","12/04 12:00","23","P0071","Anny CAMELO","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Missed opportunities for diagnosing HCV infection in patients identified by an emergency department screening strategy","T. Jordan|J. Escalante|A. Duarte|T. Cabezas|M. Rodriguez|A. Carrodeguas|J. González|J. Vega|M. Casado|A. Camelo"
"4420","12/04 12:00","24","P0072","Imran HASANOGLU","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Characterising HBV reactivation in non-liver solid organ transplant recipients: clinical insights from a multicentre study","I. Hasanoglu|M. Hallemoglu Topcu|V. Avkan-Oguz|H. Arslan|Y. Tezer Tekçe|M. Çeli?k|T. Yamazhan|E. Tanyel|T. Arslan Gulen|B. Tatar|E. Ates|S. Altunisik Toplu|S. Sayin Kutlu|A. Mete|E. Olcucuoglu|F. Celik Basaran|Y. Deligoz Bildaci|O. Acet|M. Dilek|E. Akpinar|A. Uslu|A. Safak|T. Piskin|B. Dursun"
"4906","12/04 12:00","25","P0073","Mini P SINGH","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Screening for Y93H resistance associated substitution in chronic HCV patients presenting to a tertiary care hospital of north India","M. P. Singh|S. K.|P. Kanta|K. Goyal|A. Duseja|M. Thungapathra|R. Ratho"
"5197","12/04 12:00","26","P0074","Ingrid ALBRECHT-WALZ","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Refining diagnostics: a novel chemiluminescence assay for improved sensitivity and precision in HEV detection","I. Albrecht Walz|F. Struck|E. Staschik|T. Luttich|S. Barabas|F. Schwarzmann|E. Soutschek"
"5271","12/04 12:00","27","P0075","Martin OBERMEIER","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Evaluation of the new DxI 9000 ACCESS anti-HCV assay","A. Ismail|B. Wolter|J. Geisler|R. Ehret|M. Obermeier"
"5288","12/04 12:00","28","P0076","Martin OBERMEIER","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Evaluation of the new DxI 9000 ACCESS HBsAg assay","A. Ismail|B. Wolter|J. Geisler|R. Ehret|M. Obermeier"
"5391","12/04 12:00","30","P0078","Tsung-Yu TSAI","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Acute HCV infection diagnosed by hepatitis C virus core antigen among people with HIV: an exploratory systematic review and meta-analysis","T. Tsai|G. Chen|H. Sun|C. Hung"
"5773","12/04 12:00","31","P0079","Oluwabukolami LANLOYE","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Influence of education level on the choice of hepatitis C virus self-testing: findings from Unitaid-funded STAR project in Nasarawa state, Nigeria","O. Lanloye|V. Adepoju|A. Oniyire|C. Umebido|H. Nwabueze|M. Strachan|K. Grabbe"
"5920","12/04 12:00","32","P0080","Gamze SANLIDAG ISBILEN","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Bone metabolism and management of bone diseases in patients with chronic hepatitis B","G. Sanlidag Isbilen|E. Cinar|D. Kaya|A. Parmaksizoglu Aydin|M. Tasbakan|T. Yamazhan"
"6379","12/04 12:00","33","P0081","Sumit Kumar RAWAT","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Outcomes of mitigating hepatitis B mother-to-child transmission through early detection and prophylaxis; a prospective study at a tertiary care centre","S. Rawat|V. Chouhan|R. Sharma"
"7144","12/04 12:00","34","P0082","Mafalda BRITES DE ARAÚJO LUCAS","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Molecular surveillance of hepatitis A virus in Portugal, 2015 to 2024: high-impact value for outbreak case detection","M. Lucas|E. Rosendal|S. Lino|R. Garrote|M. Garcia|E. Soares Dos Santos|R. De Sousa"
"7202","12/04 12:00","35","P0083","Harrison NWABUEZE","2","B","01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Sex and age differences in the hepatitis C virus continuum of care among people living with HIV and key populations in Nasarawa state, Nigeria","H. Nwabueze|V. Adepoju|A. Oniyire|C. Umebido|O. Lanloye|M. Strachan|K. Grabbe"
"273","12/04 12:00","36","P0084","Jon SALMANTON-GARCIA","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory viruses in patients with haematological malignancy in Boreal autumn/winter 2023-2024","J. Salmanton-Garcia|F. Marchesi|M. Navrátil|K. Puikovics|M. Del Principe|M. Criscuolo|Y. Bilgin|N. Fracchiolla|A. Vena|A. Romano|I. Falces-Romero|N. Sgherza|I. Heras-Fernando|M. Biernat|M. Delia|P. Musto|D. Leotta|O. Cornely|L. Pagano"
"329","12/04 12:00","37","P0085","Soumyadip CHATTERJI","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Change in the epidemiology of influenza infection among cancer patients in the post-COVID era: insights from India","S. Chatterji|V. Franchi|P. Das|S. Bhattacharya"
"581","12/04 12:00","38","P0086","Karin GRIMM","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The BEready pilot study: a population-based cohort to assess transmission of respiratory viral infections within households","K. Grimm|E. Hodel|L. Gasser|S. Wegmuller|S. Schuller|U. Magyar|F. Iff|E. Lim|L. Furrer|P. Bittel|N. Low|G. Wandeler|C. Hirzel"
"661","12/04 12:00","39","P0087","Tobias TUCHSCHERER","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Management of respiratory infections in primary care (RespiCare): a cluster-randomised, controlled crossover study with molecular point-of-care testing","A. Schrimpf|A. Bräsigk|T. Deutsch|S. Lippmann|M. Bleckwenn|T. Tuchscherer"
"669","12/04 12:00","40","P0088","Kübra AYKAC","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Hospitalisation due to influenza infection in children: a multicentre nationwide study","K. Aykac|H. Yakin Topcu|E. Dogan Ickin|G. Uluisik|O. Demir|M. Genceli|O. Metin Akcan|N. Mete Atasever|S. Ayper|E. Sahin Izci|N. Dalgic|E. Cakmak Taskin|F. Aksoy|E. Ciftci|C. Solmaz|M. Hacimustafaoglu|S. Kanik-Yuksek|A. Ozkaya-Parlakay|S. Ozen|H. Konca|P. Bayraktar|N. Coskun|S. Kus|A. Kara Aksay|D. Buyuktas Aytac|G. Akkoc|C. Ozlu|S. Kilic Kaya|E. Disci|S. Ilbay|L. Guder|G. Alkan|B. Ozyalvac|M. Emiroglu|D. Sener Okur|A. Bostan|G. Mardinoglu|O. Kilic|A. Telefon|M. Kilic Cil|P. Essizoglu|U. Celik|G. Ozgul Postuk|Z. Gayretli Aydin|G. Toy Usta|K. Celikkan|H. Karaoglu Asrak|M. Bicen|M. Asena|G. Avcu|C. Ekemen|A. Cakil Guzin|E. Karadag Oncel|S. Bayturan Sen|H. Sinav Utku|S. Oncel|M. Iseri Nepesov|O. Erdede|P. Kacar|M. Gulderen|A. Ozer|O. Kilicaslan|A. Karbuz|O. Cakici|E. Avci|B. Yasar|Z. Umit|N. Erdem|S. Sahinkaya|E. Gudeloglu|M. Sinanoglu|D. Ilhan|S. Kara|Y. Ekemen Keles|E. Kiymet|N. Gokay|E. Yesil|N. Kuyucu|B. Cura Yayla|H. Avci|A. Cengiz|Y. Ozsurekci"
"748","12/04 12:00","41","P0089","Gustavo SAINT-PIERRE CONTRERAS","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Characterization of adenovirus at the species level and association with the severity of acute respiratory infection in a Chilean paediatric population, 2022-2023","G. Saint-Pierre|L. Lizama|D. Vargas|D. Benadof|S. Ampuero"
"865","12/04 12:00","42","P0090","Joost VANHOMMERIG","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus (RSV) incidence estimates in primary care among adults aged 50 years and older in the Netherlands","J. Vanhommerig|C. Laarman|J. Van Summeren|M. Hooiveld|A. Meijer|A. Teirlinck|F. Stelma"
"997","12/04 12:00","43","P0091","David FISMAN","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Association between seasonal respiratory virus activity and invasive pneumococcal disease in central Ontario, Canada","A. Simmons|I. Berry|S. Buchan|A. Tuite|D. Fisman"
"1006","12/04 12:00","44","P0092","Boutheina EL KISSI","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Demographic, clinical and molecular epidemiology of respiratory syncytial virus infection in infants in central Tunisia","O. Kallala|B. El Kissi|W. Tombari|A. Dogui|J. Chemli|A. Trabelsi"
"1014","12/04 12:00","45","P0093","Amandine CAILLAULT","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Molecular characterisation of RSV infections in elderly patients during the 2023/2024 season","A. Caillault|L. Softic|P. Bay|A. Ly|A. Soulier|G. Melica|C. Rodriguez|N. De Prost|J. Pawlotsky|S. Fourati"
"1179","12/04 12:00","46","P0094","Yu LUO","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Diagnostic efficacy of different tests for influenza and their impact on clinical decision-making","Y. Luo|B. Hu"
"1185","12/04 12:00","47","P0095","Sunjoo KIM","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Analysis of myxovirus resistance protein A for diagnosis of respiratory viral infections","W. Choi|S. Kim"
"1356","12/04 12:00","48","P0096","Mieke SOENS","2","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Six-month persistence and safety of mRNA-based influenza or multicomponent influenza/COVID-19 vaccines versus licensed comparators in adults aged ≥18 years","M. Soens|D. Hsu|J. Cardona|L. Sher|K. Steil|A. Rudman Spergel|A. Figueroa|S. Osibajo|A. Buchanan|R. Chen|W. Deng|I. Wu|E. Du|B. Girard|A. Avanesov|B. Callendret|R. Nachbagauer|H. Zhou|R. Das|E. Wilson|L. Kostanyan"
"1370","12/04 12:00","1","P0097","Roberto FLORES","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The cost-effectiveness of influenza vaccination for adults aged 50 years or older in Spain","A. Perez-Rubio|R. Flores|J. Ruiz-Aragon|S. Marquez-Pelaez|J. Sanchez-Alvarez|P. Alvarez|A. Osorio-Muriel|J. Mould-Quevedo"
"1386","12/04 12:00","2","P0098","Susanna BERGBRANT","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Patients at risk of developing severe influenza-associated illness can be recognised at the emergency department using basic clinical assessment","S. Bergbrant|N. Sundell|J. Westin|M. Wahllöf|L. Gustavsson"
"1513","12/04 12:00","4","P0100","Jana ZITHA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Severe acute respiratory infection (SARI) due to RSV in Wales: burden, symptoms and clinical risks in sentinel emergency departments","J. Zitha|P. Kalapotharakou|T. Jones|A. Couzens|H. Rafferty|R. Heyburn|T. Bridges|C. Williams|J. Evans|C. Johnson|C. Moore|S. Cottrell"
"1567","12/04 12:00","5","P0101","Haryoug POO","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","A low pathogenic avian influenza A/Mallard/South Korea/KNU2019-34/2019 (H1N1) virus has the potential to increase the mammalian pathogenicity","H. Poo|J. Kim|J. Yang"
"1575","12/04 12:00","6","P0102","Zih-Syuan YANG","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Comparative analysis of galectin-3-mediated inflammasome activation in human and avian influenza A virus infections","Z. Yang|Y. Tung|S. Wang"
"1590","12/04 12:00","7","P0103","Manuel GIL MOSQUERA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Development of a predictive severity scale for respiratory syncytial virus associated acute respiratory infection in adults at the emergency department","M. Gil Mosquera|R. Gomez Guerra|M. Fernandez Ruiz|A. Mata|E. Sanz|F. Lopez-Medrano|R. San Juan|L. Castro-Arias|J. Origuen|J. Aguado"
"1640","12/04 12:00","8","P0104","Elena PARIANI","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Monitoring the transmission and health care burden of respiratory viruses in emergency departments, Lombardy (northern Italy), 2023-2024","V. Navobi Porrello|F. Morani|S. Villa|F. Scovenna|M. Maffeo|G. Del Castillo|L. Vezzosi|F. Baldanti|D. Cereda|S. Buoro|S. Merler|P. Poletti|E. Pariani"
"1654","12/04 12:00","9","P0105","Sven REISTER","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Adaptation of commercial syndromic device for quantification of viral influenza A load in clinical samples","S. Jiménez-Guzmán|L. Penarrubia|S. Reister|D. Lueerssen|F. Van Deursen"
"1665","12/04 12:00","10","P0106","Veronik HUTSE","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Wastewater-based epidemiology of respiratory viruses: integration to conventional surveillance systems in Belgium","V. Hutse|H. Maloux|A. Meyers|M. Lesenfants|B. Verhaegen|J. Linussio|L. Van Poelvoorde|N. Roosens|P. Delputte|K. Van Hoorde|K. Blot|R. Janssens"
"1666","12/04 12:00","11","P0107","Sven REISTER","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Efficacy of syndromic IVD devices in identifying influenza A strains for pandemic preparedness","L. Penarrubia|S. Jiménez-Guzmán|R. Porco|C. Congost-Teixidor|G. Pueyo|C. Camprubi-Font|M. Cardenosa|M. Contreras|S. Reister|A. Mayorgas|D. Lueerssen|F. Van Deursen|M. Schwemmle|K. Ciminski"
"1691","12/04 12:00","12","P0108","Jingyi LIANG","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","A deep learning model leveraging environmental information improves the forecasting accuracy of respiratory syncytial virus with seasonal patterns","J. Liang|S. Luz|Y. Li|H. Nair"
"1704","12/04 12:00","13","P0109","Saverio CAINI","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","A comparative study of methods for estimating the timing of RSV epidemics: an analysis within the GERi (Global epidemiology of RSV in hospitalised and community care) study","L. Staadegaard|M. Del Riccio|S. Heemskerk|M. Duckers|R. Fasce|P. Bustos|S. Huang|C. Cohen|J. Moyes|S. Monge|I. Martinez Pino|M. Bangert|R. Kramer|F. Stelma|J. Van Summeren|S. Caini"
"1877","12/04 12:00","14","P0110","John WOODSIDE","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Characterisation of respiratory pathogen coinfection in the bivalent RSVpreF pivotal RENOIR efficacy study","E. Walsh|J. Woodside|G. Pérez Marc|D. Eiras|Q. Jiang|L. Chen|C. Llapur|Y. Fukushima|M. Rämet|L. Bont|N. Hussen|T. Mikati|M. Patton|A. Zareba|K. Ilangovan|M. Lino|E. Kalinina|K. Schneider|D. Cooper|K. Swanson|A. Anderson|A. Gurtman|I. Munjal"
"1913","12/04 12:00","15","P0111","Krispin HAJKOWICZ","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The pandemic respiratory virus epidemiological surveillance trial (PREVENT)-metagenomics study: total RNASeq enhances community-based respiratory virus surveillance in the Australian flutracking network","K. Hajkowicz|E. Holmes|C. Esneau|K. Lowry|N. Niessen|N. Bartlett|M. Petrone|D. Boettiger|J. Davis"
"1921","12/04 12:00","16","P0112","Krispin HAJKOWICZ","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus burden of disease and molecular epidemiology in adults 50 years of age and older in Queensland, Australia: interim results from the 2024 season","K. Hajkowicz|K. Lowry|D. Lindsay|H. Peach|C. Lau"
"1970","12/04 12:00","17","P0113","Lisa Steen DUUS","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Effects of high-dose vs standard-dose quadrivalent influenza vaccine among patients with chronic lung disease: a prespecified secondary analysis of the DANFLU-1 trial","L. Duus|N. Johansen|D. Modin|K. Janstrup|A. Jensen|J. Nealon|S. Samson|R. Harris|M. Loiacono|C. Larsen|N. Landler|B. Claggett|S. Solomon|M. Landray|G. Gislason|L. Køber|P. Sivapalan|J. Jensen|T. Biering-Sørensen"
"2015","12/04 12:00","18","P0114","Diana TASHER","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Burden of RSV hospitalisations among high-risk vs low-risk children in the second year of life: insights from a multicentre retrospective study","K. Armoni Domany|A. Mandelberg|B. Nitzan|G. Inbal|M. Kamal|G. Michal|R. Mika|B. Moria|P. Dario|M. Merav|N. Elias|M. Orli|S. Rachel|S. Michal|S. Zohar|S. Shereen|G. Aharona|T. Diana"
"2064","12/04 12:00","19","P0115","Oguzhan ACET","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Burden and outcomes of RSV in adults aged 60 and older: a tertiary care analysis","O. Acet|S. Dirik|A. Kaya|G. Vatansever|A. Parmaksizoglu Aydin|C. Çiçek|M. Tasbakan"
"2119","12/04 12:00","20","P0116","Teena MATHEW","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Clinical characteristics and outcomes in hospitalised older adults with community onset or nosocomial respiratory syncytial virus infection (RSV) in Auckland","T. Mathew|S. Cherukuri|M. Rogers|H. Bhally"
"2238","12/04 12:00","21","P0117","Anna CREUS-COSTA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The age factor in viral codetections: insights from a multicentric study on paediatric respiratory infections","A. Creus-Costa|L. Geronès|C. Andrés|A. Perramon-Malavez|E. Lera-Carballo|A. Vidal-Moreso|Z. Lobato|B. Pujol-Soler|I. González|N. Lopez|M. Ruiz-Garcia|S. Flores|N. Rius|N. Visa-Rene|J. Balcells|P. Soler-Palacin|C. Prats|A. Anton|A. Mejias|J. Vila|A. Soriano-Arandes"
"2250","12/04 12:00","22","P0118","Anna CREUS-COSTA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","From primary care to hospitalisation: understanding the burden of the 2024 enterovirus D68 outbreak in Catalonia","A. Creus-Costa|L. Minguell|C. Andrés|C. Martin-Anson|E. Gladwin|A. González-Sánchez|I. Prats-Méndez|P. Nadal-Baron|P. Soler-Palacin|A. Anton|A. Soriano-Arandes|J. Vila"
"2308","12/04 12:00","23","P0119","Fei CHEN","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Detection of various respiratory viruses based on MALDI-TOF MS","D. Zhou|Z. Li|C. Li|F. Chen|G. Fu|Y. Zhang|M. Liu|G. Zhao|Z. Zang"
"2335","12/04 12:00","24","P0120","Wilhelmine MEERAUS","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Real-world effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines in children: a systematic literature review (SLR) and network meta-analysis (NMA)","A. Stuurman|J. Enxing|A. Gutierrez|C. Grey|I. Sepulveda-Pachon|E. Ubamadu|C. Barker|A. Bandell|W. Meeraus"
"2341","12/04 12:00","25","P0121","Cristina ANDRÉS","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Post-COVID-19 trends: enterovirus D68's seasonal reappearance and its public health relevance","C. Andrés|J. Vila|A. Creus-Costa|M. Pinana|A. González-Sánchez|I. Prats-Méndez|E. Lopez-Gonzalez|C. Gutiérrez|C. Casan|L. Calatayud|M. De Manuel-Rimbau|P. Nadal-Baron|M. Arnedo-Munoz|N. Saubi|J. Esperalba|A. Rando-Segura|M. Valverde|A. Canals Quintan|M. Martin|M. Piquer|K. Garcia-Comunas|E. Dima|A. Soriano-Arandes|N. Larrosa|T. Pumarola|A. Anton"
"2351","12/04 12:00","26","P0122","Carla TALARICO","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Similar proportions and temporal patterns of influenza, RSV and hMPV among ESKD patients tested between 2020 and 2023","S. Aggarwal|S. Mallipattu|C. Ferreira|L. Glasser|J. Dusendang|Y. Koren|S. Venkatesan|C. Talarico|D. Varghese"
"2518","12/04 12:00","27","P0123","Elke LOOTS","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Prevalence and determinants of respiratory virus screening and isolation among hospitalised patients","E. Loots|E. Bernaert|E. Van Den Brande|R. Naesens"
"2549","12/04 12:00","28","P0124","Federico MARTINÓN-TORRES","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Effectiveness of universal prophylaxis with nirsevimab for prevention of infant hospitalisations due to respiratory syncytial virus : full 2023-24 season analysis of the NIRSE-GAL study https://www.nirsegal.es/","N. Mallah|J. Pardo-Seco|O. Perez-Martinez|M. Santiago-Pérez|M. Otero-Barros|N. Suárez-Gaiche|R. Kramer|J. Jin|L. Platero-Alonso|R. Alvárez-Gil|O. Ces-Ozores|V. Nartallo-Penas|S. Mirás-Carballal|M. Pineiro-Sotelo|J. González-Pérez|C. Rodriguez-Tenreiro-Sanchez|I. Rivero-Calle|Á. Manzanares-Casteleiro|C. Durán-Parrondo|F. Martinon-Torres"
"2568","12/04 12:00","29","P0125","Dong WEI","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Age-related asymptomatic rhinovirus infections contribute to the sustained prevalence of rhinovirus in adults and are not mitigated by non-pharmaceutical interventions","D. Wei|W. Tan|W. Ma|Z. Yang|X. Zhang"
"2601","12/04 12:00","30","P0126","Kate DINGLE","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Sequence independent amplification and sequencing of respiratory viruses direct from clinical sample","K. Dingle|K. Hopkins|N. Sanderson|M. Parker|M. Colpus|D. Anderton|K. Allen|A. Walker|N. Stoesser|D. Eyre|B. Young"
"2645","12/04 12:00","31","P0127","Diana PEREZ-SANJOSE","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Investigating Cas13d activity in RNA cleavage against influenza virus","D. Perez-Sanjose|J. Eiros Bouza|I. Sanz-Munoz|M. De La Fuente"
"2659","12/04 12:00","32","P0128","Amy SPALLONE","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Outcomes of respiratory syncytial virus infections among cancer patients during the two recent respiratory viral seasons, 2022-2024","A. Spallone|T. Shafat|V. Lopez|J. Jackson|G. Angelidakis|S. Trager|L. Yaghi|R. Chemaly"
"2683","12/04 12:00","33","P0129","Fábio REIS","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Influenza-related mortality among hospitalised adults in a Portuguese hospital during the 2023-2024 influenza season: are the elderly more vulnerable?","F. Reis|E. Pena|C. Bacelar|T. Alexandre|C. Azeredo|S. Araújo|C. Batista|C. Soeiro|F. Duarte|M. Gonçalves|S. Jordao|R. Correia Abreu"
"2755","12/04 12:00","34","P0130","Tiago P. RODRIGUES","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology and seasonality of human coronaviruses in Portugal since the COVID-19 pandemic","T. P. Rodrigues|N. Verdasca|R. Guiomar|L. Gomes|C. Henriques|D. Dias|M. Lança|A. Rodrigues|P. P. Rodrigues"
"2769","12/04 12:00","35","P0131","Alejandro ORRICO-SÁNCHEZ","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Shifting viral landscapes: severe disease and mortality due to respiratory infections among older adults in the VALSARI study from Valencia, Spain, 2014-2023","A. Mira-Iglesias|T. Herring|F. Ben Hammou|C. Munoz-Quiles|M. Lopez-Lacort|X. Lopez-Labrador|J. Diez-Domingo|L. Carty|S. Taylor|A. Orrico-Sánchez"
"2777","12/04 12:00","36","P0132","Alejandro ORRICO-SÁNCHEZ","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus (RSV)-associated hospitalisations and clinical progression in adolescents and adults in Valencia, Spain, 2014/2015–2019/2020: the VALSARI study","A. Mira-Iglesias|T. Herring|F. Ben Hammou|C. Munoz-Quiles|M. Lopez-Lacort|X. Lopez-Labrador|J. Diez-Domingo|L. Carty|S. Taylor|A. Orrico-Sánchez"
"2798","12/04 12:00","37","P0133","Benjamin DAVIDO","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus vs influenza virus infection: mortality and morbidity comparison over two epidemic seasons before the pandemic in adults aged =50 years","B. Lemarie|E. Gault|D. Annane|S. Beaune|J. Dumoulin|P. De Truchis|A. Saleh-Mghir|B. Davido"
"2976","12/04 12:00","38","P0134","Hebe Noemi VAZQUEZ","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Prevention and control of influenza: available tools in seven Latin American countries","H. Vazquez|E. Baumeister|A. Ceballos|R. Kfouri|J. Labarca|N. Sandoval|M. Thormann|L. Soler|F. Fidec"
"2995","12/04 12:00","39","P0135","Elen VINK","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The epidemiology of severe acute respiratory tract infections in Glasgow, UK: 2023-24","E. Vink|M. Murphy|R. Gunson|A. Macconnachie|D. Lowe|A. Ho"
"3027","12/04 12:00","40","P0136","Xin WANG","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Between-region and serotype variations in seasonality of human parainfluenza viruses, and influence of climate factors: a global systematic analysis","J. Chen|S. Deng|X. Xu|S. Chen|Y. Li|X. Wang"
"3106","12/04 12:00","41","P0137","Pei Min THONG","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Post-acute sequelae after non-COVID-19 community-acquired pneumonia as an underappreciated problem: findings from a prospective study in Singapore","D. Ng|P. Thong|P. Tambyah|T. Yeo"
"3154","12/04 12:00","42","P0138","Sarra SAYARI","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology of respiratory pathogens in children with severe acute respiratory infection: a Tunisian three years survey","S. Sayari|L. Kanzari|S. Abid|H. El Ghord|L. Charaa|I. Landolsi|A. Ferjani|K. Mnif|C. Zedini|I. Boutiba Ben-Boubaker"
"3229","12/04 12:00","43","P0139","Alessandro MANCON","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Human metapneumovirus in Italian adults over 50 years: epidemiology and molecular evolution, 2022-2024","A. Mancon|L. Pellegrinelli|G. Romano|E. Vian|V. Biscaro|G. Piccirilli|T. Lazzarotto|S. Uceda Renteria|A. Callegaro|E. Pagani|E. Masi|G. Ferrari|C. Galli|F. Centrone|M. Chironna|C. Tiberio|E. Falco|V. Micheli|F. Novazzi|N. Mancini|T. Allice|F. Cerutti|E. Pomari|C. Castilletti|E. Lalle|F. Maggi|M. Fracella|P. Ravanini|G. Faolotto|R. Schiavo|G. Lo Cascio|C. Acciarri|S. Menzo|F. Baldanti|G. Antonelli|A. Pierangeli|E. Pariani|A. Piralla"
"3246","12/04 12:00","44","P0140","Andrea BRAMBILLA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Public health impact of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus among patients with chronic obstructive pulmonary disease in Italy","A. Brambilla|A. Puggina|F. Rumi|E. Zarkadoulas|M. Cirillo|G. Lorenzini|F. Di Marco|G. Calabro"
"3263","12/04 12:00","45","P0141","Federico MARTINÓN-TORRES","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Operational framework and feasibility of the GALFLU study: a pragmatic randomised controlled trial evaluating high-dose vs standard-dose influenza vaccination in the elderly population","N. Mallah|J. Pardo-Seco|S. Mirás-Carballal|M. Pineiro-Sotelo|M. Cribeiro-González|M. Conde-Pájaro|J. González-Pérez|C. Rodriguez-Tenreiro-Sanchez|I. Rivero-Calle|R. Harris|M. Loiacono|R. Van Aalst|M. Farre|C. Salamand|C. Durán-Parrondo|F. Martinon-Torres"
"3272","12/04 12:00","46","P0142","Laura CIUFFREDA","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","A bench-to-data analysis workflow for the sequencing of RSV whole genomes using short- and long-read technologies","A. Gomez Del Rosario|A. Munoz Barrera|J. Alcoba Florez|H. Gil Campesino|D. Garcia Martinez De Artola|N. Rodriguez Garcia|R. González-Montelongo|J. Lorenzo-Salazar|C. Flores|L. Ciuffreda"
"3275","12/04 12:00","47","P0143","Anne Marie REIMER JENSEN","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Relative effectiveness of high-dose vsstandard-dose quadrivalent influenza vaccine in patients with hypertension: a secondary analysis of the DANFLU-1 trial","A. Langhoff|N. Johansen|K. Janstrup|K. Bartholdy|C. Espersen|J. Nealon|S. Samson|R. Harris|M. Loiacono|C. Larsen|A. Jensen|N. Landler|B. Claggett|S. Solomon|J. Jensen|T. Biering-Sørensen|M. Landray|G. Gislason|L. Køber|P. Sivapalan"
"3343","12/04 12:00","48","P0144","Marco DEL RICCIO","3","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","How has the disappearance of influenza B/Yamagata altered the proportion of Influenza A and B cases? Exploring post-COVID pandemic surveillance data","M. Del Riccio|P. Zanobini|J. Van Summeren|K. Van Der Velden|S. Caini|A. Timen"
"3380","12/04 12:00","1","P0145","Karin VELTHOVE","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Burden of disease (BoD), healthcare resource use (HCRU) and costs of respiratory syncytial virus (RSV) among adults in the Netherlands in 2021-2023: a real-world retrospective observational study of five hospitals","M. Goeijenbier|D. Ong|A. Bruns|T. Pliakas|M. Van Den Berge|J. Den Hollander|B. Langeveld|M. Hemels|J. Tjhie|E. Jaarsma|K. Velthove|A. Marijam|R. Reeves"
"3399","12/04 12:00","2","P0146","Henar ALONSO-EZCURRA","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Comprehensive clinical validation of a novel real-time PCR assay for the detection of respiratory viruses in simulated human-like clinical samples","E. Franco|L. Iguacel|H. Alonso"
"3468","12/04 12:00","3","P0147","Nino SAGIRIDZE","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Phyloepidemiology of influenza A/H3N2 and A/H1N1 viruses circulating in Georgia","N. Sagiridze|A. Machablishvili|M. Gavashelidze|L. Sabadze|M. Pantsulaia|G. Brachveli"
"3482","12/04 12:00","4","P0148","Andrea STRENG","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Prospective surveillance of acute lower respiratory tract infection due to RSV and other respiratory viruses in outpatient infants under two years of age in Würzburg (Germany) since November 2022","A. Streng|K. Hecker|H. Bethe|G. Engels|K. Knies|C. Krempl|B. Weissbrich|J. Liese"
"3579","12/04 12:00","5","P0149","Miriam LATORRE-MILLÁN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","SARS-CoV-2 phylogenetics in a Spanish cohort of hospital healthcare workers, 2021-2024","D. Bádenas-Alzugaray|A. Tristancho-Baro|A. Milagro|N. Martinez|B. Gilaberte|L. Clusa|A. Rezusta|M. Latorre-Millán"
"3619","12/04 12:00","6","P0150","Niklas ANDREEN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Hospital disease burden of respiratory syncytial virus in adults 2021-2023 compared to influenza and COVID-19 using rapid PCR testing","N. Andreen|J. Westin|L. Vanfleteren|M. Lindh|L. Gustavsson|L. Andersson"
"3693","12/04 12:00","7","P0151","Alejandro ORRICO-SÁNCHEZ","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Impact of respiratory syncytial virus hospitalisation on quality of life in the Valencia region of Spain ageing population","A. Mira-Iglesias|F. Ben Hammou|C. Fernandez-Garcia|J. Diez-Domingo|A. Orrico-Sánchez"
"3751","12/04 12:00","8","P0152","Sarah FOULKES","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","How did respiratory viruses impact UK healthcare workers over winter 2023/24","S. Foulkes|K. Munro|D. Sparkes|J. Khawam|S. Russell|C. Brown|A. Atti|J. Islam|S. Hopkins|V. Hall"
"3868","12/04 12:00","9","P0153","Harald ROUHA","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Clinical burden of respiratory syncytial virus among adults hospitalised with acute respiratory infections in Austria","M. Fonseca|T. Pliakas|H. Rouha|S. Tobudic|L. Schubert|M. Kubala|H. Akpo|L. Ludikhuyze|T. Jans|A. Marijam|R. Reeves|S. Winkler"
"3987","12/04 12:00","10","P0154","Pinar ULUPINAR","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","The mitochondrial carrier homolog 2 is involved in down-regulation of influenza A virus replication","P. Ulupinar|K. Turan"
"4139","12/04 12:00","11","P0155","Nimisha RIKHI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","An unconjugated composite peptide vaccine comprising epitopes from SARS-CoV-2 RNA polymerase and influenza heamagglutinin, neuraminidase, and matrix generates broadly reactive and durable antibodies to coronavirus and influenza virus","N. Rikhi|C. Sei|K. Kroscher|K. Muema|A. Assiaw-Dufu|R. Schuman|G. Fischer"
"4150","12/04 12:00","12","P0156","Clarisse DEMONT","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Burden of chronic medical conditions that are risk factors for severe RSV among adults aged 18-59 years in the United States","E. Wilker|M. Jiang|B. Francis|M. Del Pilar Martin Matos|G. Zheng|M. Wang|L. Li|G. Goodhue|G. Parinaz|C. Demont"
"4151","12/04 12:00","13","P0157","Kristoffer SKAARUP","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Cardiac impairment during influenza flu heart: a prospective cohort study of hospitalised patients with influenza infection","F. Davidovski|K. Skaarup|L. Nielsen|J. Jensen|T. Biering-Sørensen|E. Durukan|E. Rastoder|M. Dons|M. Sengeløv|J. Borchsenius|B. Rasborg"
"4252","12/04 12:00","14","P0158","Merve MERT VAHABI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Thromboembolic complications in viral respiratory tract infections: insights into the role of clinical and biochemical coagulation parameters","M. Mert Vahabi|S. Dirik|C. Çiçek|H. Pullukçu"
"4344","12/04 12:00","15","P0159","Elisa BARBIERI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Quality of life in the toddler population (9-36 months of age) experiencing RSV infection in the 2023-2024 winter season in Italy–the EVOLUTE study","E. Barbieri|R. Boracchini|V. Bonsembiante|A. Scamarcia|L. Bertizzolo|M. Borchiellini|S. Parisi|A. Cantarutti|L. Cantarutti|C. Giaquinto"
"4522","12/04 12:00","16","P0160","Jennie KWON","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Duration of recommended and reported isolation for seasonal influenza: updates from the 2023-24 influenza season","C. O'neil|E. White|S. Jonathan|K. Vu|J. King|E. Anderson|C. Vargas|S. House|R. Presti|S. Fritz|F. Yerbic|T. Curley|B. Schibley-Laird|R. Goodridge|Y. Zhu|T. Scott|O. Abrams|S. Swan|D. Liu|S. Mclaren|E. Sano|L. Wang|J. Biddle|L. Bristol|A. Mellis|M. Stockwell|H. Talbot|C. Grijalva|J. Kwon"
"4550","12/04 12:00","17","P0161","Claudia ALTERI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Genomic epidemiology of respiratory syncytial virus circulating in Lombardy in 2023-2024 and variability in binding sites of monoclonal antibodies and small-molecule inhibitors","S. Uceda Renteria|C. Galli|G. Ferrari|M. Cossu|A. Lombardi|C. Tagliabue|G. Galli|E. Furchi|L. Pellegrinelli|G. Romano|P. Bono|V. Svicher|S. Bosis|A. Callegaro|A. Gori|A. Bandera|A. Piralla|E. Pariani|C. Alteri"
"4577","12/04 12:00","18","P0162","Tommaso MORELLI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Prolonged fatigue post-hospitalisation: novel insights across a broad range of respiratory viral infections","T. Morelli|M. Purcell|A. Mohammed|P. Lee|N. Greening|M. Pavitt|J. Myerson|S. Marciniak|C. Daneshvar|M. Crooks|S. Siddiqui|T. Clark|A. Freeman|T. Wilkinson"
"4583","12/04 12:00","19","P0163","Michael BURROWS","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Impact of rapid viral screening on influenza management: less haste, more waste","M. Burrows|S. Hughes"
"4599","12/04 12:00","20","P0164","Dragana DIMITRIJEVIC","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Facing the future of influenza surveillance: integrated surveillance for respiratory viruses in Serbia","D. Dimitrijevic|V. Jovanovic|M. Milinkovic|J. Protic|E. Grego|S. Maris"
"4626","12/04 12:00","21","P0165","Samuel GOODFELLOW","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Impact of multiplexed respiratory panel on the diagnosis and management of respiratory infections in the emergency department","S. Goodfellow|C. Costales|J. Dien Bard|D. Liu"
"4872","12/04 12:00","22","P0166","Oliver DAMM","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Burden of medically-attended respiratory syncytial virus (RSV) disease in German infants: a seven-season analysis using claims data","O. Damm|M. Wick|J. Witte|M. Batram|A. Wulfing|S. Soudani|M. Bangert|R. Kramer"
"4874","12/04 12:00","23","P0167","Alexander DOMNICH","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Unveiling an optimal case definition and the natural history of RSV infection in adult outpatients aged ≥50 years","A. Domnich|F. Lapi|A. Orsi|P. Lai|L. Pestarino|P. Brasesco|M. Vicentini|A. Puggina|A. Marijam|C. Trombetta|G. Garzillo|G. Guarona|F. Stefanelli|V. Ricucci|D. Panatto|G. Icardi"
"4935","12/04 12:00","24","P0168","Ivan SANZ-MUÑOZ","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Overview of NA inhibitors mutations during the last 15 years in Spain","I. Sanz-Munoz|A. Martin-Toribio|M. Toquero-Asensio|A. Garcia-Concejo|I. Arroyo-Hernántes|J. Sanchez-Martinez|C. Rodriguez-Crespo|S. Rojo-Rello|M. Dominguez-Gil|M. Hernández-Pérez|J. Eiros Bouza"
"4975","12/04 12:00","25","P0169","Anna SSENTONGO","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Paediatric patients with respiratory syncytial virus (RSV) are at greater risk of ICU admission when co-infections are present","D. Rabago|A. Ssentongo"
"5095","12/04 12:00","26","P0170","Kristine Lilhammer KARLSEN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Bacterial co-infections and antibiotic use in adult patients hospitalised with respiratory syncytial virus compared to patients with influenza A or B, and their relation to mortality: a multicentre cohort study","K. Karlsen|C. Clausen|T. Benfield|T. Fischer|Z. Harboe|C. Østergaard|O. Rezahosseini|M. Eiberg|L. Nielsen|J. Holler|C. Roed|A. Sejdic|R. Kahiyah|B. Lindegaard|A. Egeskov-Cavling|N. Hayder|A. Alkarawi"
"5178","12/04 12:00","27","P0171","Fredrik DYRKELL","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Identifying low-frequency mutations in influenza","I. Gold Rodal|F. Dyrkell|O. Aspelin"
"5327","12/04 12:00","28","P0172","Yi-Ting CHEN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiological shifts in paediatric respiratory infections: pre- and post-COVID-19 pandemic","Y. Chen|S. Ho|S. Chang"
"5345","12/04 12:00","29","P0173","Benjamin DAVIDO","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus vs parainfluenza and human metapneumovirus infections: mortality and morbidity comparison over two epidemic seasons before the pandemic","B. Lemarie|E. Gault|D. Annane|S. Beaune|J. Dumoulin|P. De Truchis|A. Saleh-Mghir|B. Davido"
"5406","12/04 12:00","30","P0174","Edward CARR","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Serological influenza responses over the 2023-24 winter: the SIREN study","L. Adams|P. Stevenson-Leggett|N. Lewis|R. Harvey|E. Carr|A. Atti|S. Foulkes|D. Blick|J. Islam|A. Otter|S. Hopkins|M. Wu|V. Hall"
"5456","12/04 12:00","31","P0175","Giulia BRIGADOI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Changing epidemiology: impact of the COVID-19 pandemic on bacterial and viral infections in children","G. Brigadoi|E. Gres|A. Zin|G. Francaviglia|E. Levinte|L. Chiusaroli|S. Rossin|D. Chiariotti|G. Ferraris|E. Barbieri|C. Liberati|C. Giaquinto|S. Bressan|D. Donà"
"5471","12/04 12:00","32","P0176","Frederikke LOMHOLT","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Mortality among adults aged 50+ years admitted with COVID-19, influenza A or respiratory syncytial virus (RSV) in Denmark, 2022-2024","F. Lomholt|P. Valentiner-Branth|K. Fuursted|H. Slotved|T. Benfield|L. Vestergaard|S. Bolette"
"5505","12/04 12:00","33","P0177","Nabila SHAIKH","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Symptomology of influenza-like illness reported during home self-collected swab testing: a systematic review","N. Shaikh|E. Dueger|R. Harris"
"5529","12/04 12:00","34","P0178","Timo FROYEN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Comparing viral loads in nasopharyngeal swabs and bronchoalveolar lavages after normalisation of multiplex real-time PCR data","T. Froyen|J. Dingemans|S. Martens|B. Van Meensel|R. Cartuyvels|K. Magerman"
"5691","12/04 12:00","35","P0179","Meng-Shuan LIN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Unveiling the dynamics of respiratory infections through multiplex PCR testing after the COVID-19 pandemic in Taiwan","H. Chen|S. Ho|S. Chang|M. Lin|J. Chen|Y. Chen|K. Weng"
"5771","12/04 12:00","36","P0180","Frederik VERELST","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Impact of respiratory syncytial virus (RSV) disease on health-related quality of life (HRQoL) among European older adults: combined results over three RSV seasons","R. Prato|M. Terns|D. Mcnally|B. Kirsch|P. Joosten|S. Gawade|S. Matthews|E. Cabrera|D. Curran|E. Biundo|F. Verelst"
"5857","12/04 12:00","37","P0181","Kuganya NIRMALARAJAH","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Assay development and pipeline considerations for amplicon-based respiratory syncytial virus whole genome sequencing in a clinical setting","K. Nirmalarajah|P. Aftanas|H. Wong|C. Sjaarda|W. Yim|N. Waglechner|C. Vermeiren|F. Maguire|A. Mcgeer|P. Sheth|K. Katz|R. Kozak|V. Duvvuri|S. Mubareka"
"5885","12/04 12:00","38","P0182","Gabriella TERHES","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Molecular epidemiology of paediatric respiratory syncytial virus infection in Hungary","H. Juhász|K. Burián|G. Terhes"
"5890","12/04 12:00","39","P0183","Liem Binh LUONG","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Characterisation of hMPV and RSV hospitalisations in the French national hospital claims database during the 2022-2023 season","L. Luong Nguyen|N. Capit|L. Majed|A. Anchim|E. Degand|C. Artaud|C. Wang|S. Taylor|C. Bignon-Favary|S. Larrieu|C. Marant-Micallef|Y. Caillé|M. Lachâtre|S. Fourati"
"5946","12/04 12:00","40","P0184","Christine HAGEMANN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Vakzimeter FLU: real-time in-season monitoring of adult influenza vaccination rates in Germany","C. Hagemann|C. Hartmann|L. Steffan|A. Bietz|P. Sandow"
"6001","12/04 12:00","41","P0185","Laura PELLEGRINELLI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiological and molecular characteristic of enteroviruses identified in influenza-like illness cases in Lombardy (northern Italy), January 2022-October 2024","L. Pellegrinelli|C. Galli|L. Sandri|L. Crottogini|S. Binda|D. Cereda|E. Pariani|C. Paduraru|V. Primache|A. Seiti|E. Matteucci|L. Vezzosi|G. Del Castillo"
"6156","12/04 12:00","42","P0186","Anne Marie REIMER JENSEN","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Relative effectiveness of high-dose vs standard-dose influenza vaccine in immunocompromised individuals: a posthoc analysis of the DANFLU-1 trial","N. Landler|J. Nealon|S. Samson|R. Harris|M. Loiacono|C. Larsen|B. Claggett|S. Solomon|M. Landray|G. Gislason|L. Køber|P. Sivapalan|J. Jensen|T. Biering-Sørensen|A. Reimer Jensen|N. Johansen|D. Modin|K. Janstrup|C. Espersen|K. Bartholdy"
"6180","12/04 12:00","43","P0187","Tarja SORSA-LESLIE","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Optimising respiratory syncytial virus (RSV) antibody pair selection for enhanced diagnostic accuracy and speed","T. Sorsa-Leslie|K. Grönholm|A. Moore|M. Mattila|L. Vaahtoranta|S. Suutari"
"6211","12/04 12:00","44","P0188","Douglas DREVETS","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","IFN-β administration results in mixed alterations in brain functions in elderly mice during influenza A virus infection","W. Wu|J. Alexander|Y. Song|J. Booth|J. Metcalf|D. Drevets"
"6221","12/04 12:00","45","P0189","Paloma GONÇALVES","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Broad-spectrum antiviral activity of spiro-beta-lactams: targeting SARS-CoV-2, influenza, and HIV through ferroptosis induction","P. Gonçalves|C. Rocha|V. Correia|L. Santos|H. Rebelo-De-Andrade|I. Bártolo|I. Lopes|N. Alves|A. Alves|A. Alves De Matos|S. Pöhlmann|T. Pinho Melo|N. Taveira"
"6326","12/04 12:00","46","P0190","Ruchita CHHABRA","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Spectrum of respiratory viruses in in-patients with severe acute respiratory infection in north India: insights from a two-year analysis","R. Chhabra|F. Verma|M. Chhabra|N. Duggal|N. Bhatia"
"6393","12/04 12:00","47","P0191","Benoit VISSEAUX","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","RELAB 2023-24: compared community epidemiologies of RSV, influenza and SARS-CoV-2 in France","B. Visseaux|V. Enouf|V. Vieillefond|S. Haim-Boukobza|J. Giannoli|A. Jacques|M. Nunes|C. Abou Chakra|B. Lina|L. Josset|M. Rameix-Welti|A. Bal|J. Casalegno"
"6421","12/04 12:00","48","P0192","Vincenzo PAOLOZZI","4","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology and burden of the human metapneumovirus among Italian inpatient and outpatient adults","V. Paolozzi|M. Scarpaleggia|M. Pagnucco|L. Inglese|C. Fraccalvieri|M. Lucente|M. Ogliastro|A. Orsi|B. Bruzzone|A. Domnich"
"6429","12/04 12:00","1","P0193","Ira PRAHARAJ","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Trends in the circulation of influenza A/B viruses, SARS CoV2 and respiratory syncytial virus in Indian settings, 2023-2024: emerging spectre of a tridemic?","S. Subhadra|S. Panda|J. Sabat|S. Priyadarshini|D. Rhetso|R. Priyadarshini|N. Manisha|S. Pati|I. Praharaj"
"6444","12/04 12:00","2","P0194","Victor Daniel MIRON","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Factors influencing hospital stay length and acute respiratory failure in influenza patients","O. Sandulescu|V. Miron|A. Streinu-Cercel|A. Draganescu|A. Streinu-Cercel"
"6517","12/04 12:00","3","P0195","Doaa AMIN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Can unsupervised machine learning predict outbreaks of respiratory tract infections in acute Irish hospitals (2016-2021)?","D. Amin|A. Vellinga"
"6526","12/04 12:00","4","P0196","Tu-Hsuan CHANG","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology of five respiratory viruses circulating in Taiwan, 2015-2023: a multicentre retrospective study","H. Ya-Li|C. Wan-Chen|F. Chi-Tai|H. Shu-Yuan|L. Tai-Fen|H. Yu-Tsung|C. Luan-Yin|T. Chang"
"6619","12/04 12:00","5","P0197","Nicolas NOULIN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Cold perception as a key endpoint in human challenge trials with respiratory viruses","A. Mann|B. Löndt|N. Noulin|A. Tyler|V. Parker|M. Bevan|I. Goncalves Silva|F. Rodrigues|J. Mori|K. Eze|K. Keun|M. Kalinova|A. Catchpole"
"6623","12/04 12:00","6","P0198","Nicolas NOULIN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Assessing immunomodulators in human challenge studies: insights from wild-type influenza infections in healthy adults and rhinovirus infections in patients with asthma","M. Bevan|V. Parker|B. Löndt|N. Noulin|M. Kalinova|A. Catchpole|A. Mann"
"6701","12/04 12:00","7","P0199","Simon DE LUSIGNAN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Association of virology swab positivity in adults aged =40 years with computerised medical record reported acute respiratory infection (ARI) subgroups: observational study of ARI (ObservatARI)","J. Ordonez-Mena|J. Radin|U. Hoang|A. Araujo|O. Balogh|A. Eltayeb|T. Lu|E. Enesca|E. Button|X. Gu|J. Gavin|X. Fan|S. De Lusignan|M. Zambon"
"6797","12/04 12:00","8","P0200","Yanxia SUN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Pathogen characteristics of respiratory infections in the season after the COVID-19 pandemic: evidence from direct-to-consumer testing-based surveillance, China, 2023-2024","L. Feng|Y. Sun"
"6811","12/04 12:00","9","P0201","Nicolas NOULIN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Isolation, production and validation of the first GMP RSV-B virus for use in controlled human infection studies","N. Noulin|A. Mann|B. Löndt|J. Mori|L. Calvo-Bado|F. Mackenzie|P. Griffin|C. Mencarelli|M. Kalinova|A. Catchpole"
"6840","12/04 12:00","10","P0202","Md Golam Dostogir HARUN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Influenza vaccination rates among healthcare workers and key factors influencing vaccination in Bangladesh","G. Harun|A. Hassan"
"6889","12/04 12:00","11","P0203","Maeve Louise FARRELL","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Surveillance of influenza A in red foxes and seals in Ireland","M. Farrell|C. Byrne|A. Vale|M. Byrnes|L. Garza Cuartero|G. Barry"
"6918","12/04 12:00","12","P0204","Luna COLAGROSSI","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Molecular characterisation of human adenovirus genotypes in paediatric patients","L. Forque|R. Scutari|M. Mastropaolo|V. Fox|P. Merli|V. Fini|A. Granaglia|V. Di Maio|G. Linardos|L. Coltella|S. Ranno|C. Russo|C. Perno|L. Colagrossi|A. Villani"
"7016","12/04 12:00","13","P0205","Julie BORCHSENIUS","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","High-dose vs standard-dose influenza vaccine in patients with chronic inflammatory disease: a secondary analysis of the DANFLU-1 trial","J. Borchsenius|N. Johansen|C. Espersen|K. Janstrup|G. Gislason|L. Køber|P. Sivapalan|J. Jensen|T. Biering-Sørensen|K. Bartholdy|J. Nealon|S. Samson|R. Harris|M. Loiacono|C. Larsen|A. Jensen|N. Landler|B. Claggett|S. Solomon|M. Landray"
"7102","12/04 12:00","14","P0206","Matteo RICCÒ","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Respiratory syncytial virus infection and heart disease: a systematic review and pooled analysis of clinical features","M. Ricco|P. Manzoni|S. Corrado|C. Nobili"
"7259","12/04 12:00","15","P0207","Jasper CHAN","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Elucidating the novel role of cholesterol consensus motif in coronavirus infections","J. Chan|B. Hu|S. Yuan|H. Chu|T. Yuen|H. Shuai"
"7295","12/04 12:00","16","P0208","Lakshmi Jyothi TADI","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Surveillance for respiratory viruses through DHR-ICMR VRDL network","L. Tadi|R. Narang|R. Sundaramurthy|A. Raut|M. Shaik"
"7448","12/04 12:00","17","P0209","Susan GOULD","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Air and surface sampling to investigate bovine coronavirus shedding around calves","S. Gould|J. Urbaniec|N. Noyes|P. Davies|J. Neary"
"7570","12/04 12:00","18","P0210","Anastasia COUZENS","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Evidence of oseltamivir-resistant influenza A virus transmission","A. Couzens|T. Jones|K. Pheasant|H. Rafferty|J. Evans|S. Cottrell|S. Corden|T. Connor|C. Moore"
"7620","12/04 12:00","19","P0211","Lucia MARTINEZ-HERNANDEZ","5","B","01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Epidemiology of respiratory syncytial virus among childrens and adults in a third-level care hospital in Mexico City","L. Martinez-Hernandez|J. Franco-Rodriguez|E. Ogazon Del Toro|S. Choi|M. Casillas-Casillas|C. Lopez-Enriquez|J. Donis-Hernandez"
"481","12/04 12:00","20","P0212","Kathryn KITRINOS","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Preclinical profile of ABI-5366, a novel potent HSV helicase-primase inhibitor, with potential for weekly or monthly oral dosing for the treatment of recurrent genital herpes","M. Shen|C. Li|Z. Zong|H. Contreras|R. Yan|M. Perron|W. Delaney|K. Kitrinos"
"560","12/04 12:00","21","P0213","Emily RAYENS","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Adjuvanted recombinant zoster vaccine is associated with lower risk of herpes zoster ophthalmicus, acute myocardial infarction, and stroke in adults aged ≥50 years","E. Rayens|L. Sy|L. Qian|J. Wu|B. Ackerson|Y. Luo|C. Zheng|Y. Cheng|L. Vega Daily|J. Song|H. Takhar|J. Ku|R. Cohen|H. Yun|D. Oraichi|H. Seifert|H. Tseng"
"1002","12/04 12:00","22","P0214","Jason DEER","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Estimating genital herpes prevalence and treatment patterns among US healthcare-engaged individuals: insights from claims data","C. Johnston|L. Liu|M. Seo|K. Kitrinos|A. Gaggar|J. Deer"
"1007","12/04 12:00","23","P0215","Preeti PANCHOLI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Comparison of rapid multiplexed real-time PCR platform with laboratory real-time PCR platform for detection of HSV-1, HSV-2, and VZV in lesion swab specimens","P. Pancholi|C. Plummer|K. Knecht|S. Reddy|K. King"
"1972","12/04 12:00","24","P0216","Rym TOUATI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Comparison of two commercial real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in nasopharyngeal carcinoma (NPC) patients","R. Touati|S. Gourari"
"2262","12/04 12:00","25","P0217","Katrina FERNANDES","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Varicella zoster virus central nervous system infections: a multi-site retrospective review of clinical features, treatments, and outcomes in an Australian setting","E. Schembri|K. Fernandes|G. Webb|P. Kelley|S. Guy"
"2629","12/04 12:00","26","P0218","Charles WILLIAMS","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Modelling the public health impact of herpes zoster vaccination in adults aged ≥ 50 Years via increased recombinant zoster vaccine uptake worldwide","N. Giannelos|D. Curran|S. Matthews|J. Carrico|A. Cunningham|C. Williams"
"3284","12/04 12:00","27","P0219","Sophie ALAIN","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Leveraging French compassionate programme data in refractory CMV to further describe maribavir effectiveness and resistance profile","S. Alain|M. Maric|F. Vuotto|C. Cordonnier|P. Gatault|F. Saliba|V. Bunel-Gourdy|C. Lefevre|N. Kamar"
"3319","12/04 12:00","28","P0220","Johan GULDBÆK","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Distribution of ganciclovir in the porcine central nervous system","J. Guldbaek|T. Mariager|M. Dreyer Nielsen|J. Holmen Terkelsen|R. Nau|C. Reidies Bjarkam|H. Nielsen|J. Bodilsen"
"3462","12/04 12:00","29","P0221","Xiaohui Chen NIELSEN","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Concordance of a multiplex PCR assay with HSV1-2 and VZV-specific PCR in diagnosing central nervous system infections","K. Thomsen|R. Johansen|R. Dessau|J. Engberg|X. Nielsen"
"3752","12/04 12:00","30","P0222","Tatjana SCHWARZ","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Enhancing EBV diagnostics: T-cell-based assay for accurate immune monitoring in patients with multiple sclerosis","T. Schwarz|M. Schmidt|L. Popp|F. Pache|C. Otto|K. Ruprecht|V. Corman"
"4023","12/04 12:00","31","P0223","Alice NAVA","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","CMV RNA: a new marker for monitoring CMV in HCT with LTV prophylaxis","A. Nava|G. Travi|D. Vanni|F. Peracchi|M. Soldarini|F. Crippa|G. Grillo|C. Vismara|R. Cairoli|M. Puoti|D. Fanti"
"4213","12/04 12:00","32","P0224","Siwar FRIGUI EP OUESLATI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Targeted screening for congenital cytomegalovirus infection in a high seroprevalence country","N. Ben Nejma|S. Frigui|Y. Chebbi|E. Ben Hamida|W. Achour"
"4972","12/04 12:00",,"P0225","Vani ANGRA",,,"01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Role of human herpesvirus 6 in unexplained infertility: among Indian women in a tertiary care hospital of north India","V. Angra|P. Sharma|B. Joshi|S. Gainder|N. Gupta|S. Sethi|A. Ghosh|K. Goyal|M. Singh"
"4536","12/04 12:00","34","P0226","Noelia PARAJÓ-PAZOS","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Genital ulcer etiology in northwest Spain: from 2019 to 2024","J. Colon-Perez|M. Trevino-Castellano|J. Costa-Alcalde|A. Molares-Vila|R. Carracedo-Montero|S. Pereira-Pardo|A. Amado-Fondo|N. Parajo-Pazos"
"4925","12/04 12:00","35","P0227","Martina GASSNER","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Reactivation of Ebstein-Barr virus among ARDS patients: do acute changes in the immune system play a role?","M. Gassner|C. Spies"
"5159","12/04 12:00","36","P0228","Matteo RINALDI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Predictors of CMV-colitis in patients with moderate to severe ulcerative colitis needing hospitalisation: interim analysis from a prospective study","M. Rinaldi|L. Melotti|M. Salice|N. Dussias|N. Vanigli|C. Calabrese|E. Scaioli|L. Gabrielli|G. Lazzarotto|F. Rosini|P. Viale|F. Rizzello|P. Gionchetti|M. Giannella"
"5248","12/04 12:00","37","P0229","Mads Frederik EIBERG","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","The risk of vascular events following herpes zoster: a matched cohort study","M. Eiberg|O. Rezahosseini|M. Andersen|C. Torp-Pedersen|C. Roed|C. Klint Johannesen|A. Egeskov-Cavling|T. Kølsen Fischer|K. Rostgaard|H. Hjalgrim|Z. Harboe"
"5486","12/04 12:00","38","P0230","Abda MAHMOOD","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Incidence rates of herpes zoster in immunocompromised adults aged 18 years or older in England: a large retrospective cohort study using data from the clinical practice research datalink, 2012-2019","A. Mahmood|M. Nishimwe|Y. Vekria|M. Hunjan|D. Oraichi|S. Hagenaars|K. Keapoletswe|B. Chengat Prakashbabu|S. Paparrodopoulos|S. Stavrev|S. Lay-Flurrie|H. Parry|I. Posiuniene|S. Farrow|b. Guimicheva|A. Marijam"
"5561","12/04 12:00","39","P0231","Fanny VUOTTO","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Real-life drug-drug interactions between immunosuppressive treatments and letermovir in solid organ transplant recipients","F. Moreau|N. Simon|S. Belaiche|G. Saltiel|F. Vuotto"
"5604","12/04 12:00","40","P0232","Daniela HUZLY","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Newer is not always better: evaluation of the new version of LIAISON VZV IgG CLIA","D. Steinmann|D. Huzly"
"5854","12/04 12:00","41","P0233","Sara PEDRON","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Burden of herpes zoster in immunocompromised adults aged 18 years or older: a retrospective analysis of German claims data","L. Hasemann|M. Batram|J. Witte|D. Bettenworth|R. Voll|C. Rieger|E. Wolf|C. Wendtner|S. Esser|M. Nishimwe|J. Hain|A. Mahmood|M. Waize|P. Marijic|S. Pedron"
"5980","12/04 12:00","42","P0234","Filip STEVANOVSKI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Trends in herpes simplex virus type 1 and type 2 seroprevalence in Croatia","F. Stevanovski|K. Bodulic|N. Cetinic Balent|O. Dakovic Rode"
"6286","12/04 12:00","43","P0235","Federica DOMINELLI","5","B","01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Characterisation of humoral and T-cell specific response to EBV, CMV and VZV in people with MS under DMT","F. Dominelli|M. Zingaropoli|P. Pasculli|M. Antonacci|Y. Fosso Ngangue|F. Ciccone|R. Campagna|G. Ferrazzano|A. Collura|M. Guardiani|E. Tortellini|O. Turriziani|M. Lichtner|A. Conte|C. Mastroianni|M. Ciardi"
"187","12/04 12:00","44","P0236","Garvita MATHUR","5","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Role of genetic determinants in pathogenesis and evolution of chikungunya virus","G. Mathur|S. Chaudhary|S. Mahilkar|S. Sunil"
"492","12/04 12:00","45","P0237","Thomas LEINEWEBER KRISTENSEN","5","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Beyond familiar threats: numerous RNA virus families display pandemic potential","T. Kristensen|C. Ilsby|C. Jensen|A. Høgh|J. Lisby|U. Schneider"
"573","12/04 12:00","46","P0238","Alfonso J. RODRIGUEZ-MORALES","5","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","A critical analysis of dengue epidemic in Venezuela, 2024","A. Rodriguez-Morales|D. Bonilla-Aldana|J. Cardona-Ospina|R. Moghnieh|R. Husni"
"637","12/04 12:00","47","P0239","Arash LETAFATI","5","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","RAB3GAP2 dysregulation in adult T-cell leukemia/lymphoma (ATLL) compared to acute lymphoblastic leukemia (ALL)","A. Letafati|S. Mozhgani"
"869","12/04 12:00","48","P0240","Alfonso J. RODRIGUEZ-MORALES","5","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Mpox among Venezuelan migrants in a hospital of Pereira, Colombia, 2022-2024","A. Gaviria|L. Echeverri-Catano|J. Gaviria|A. Rodriguez-Morales|J. Grajales-Aguirre"
"1180","12/04 12:00","2","P0242","Kyaw Zwa THANT","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Correlation between building features and prevalence of Aedes aegypti mosquitoes in Singapore","K. Thant|A. Tan|S. Joyce|S. Kumar"
"1347","12/04 12:00","3","P0243","Olga STUKOLOVA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Febrile illness of vector-borne and zoonotic origin in Ho Chi Minh city, Vietnam: not just dengue is in there","O. Stukolova|M. Luong|M. Sokolova|E. Raduk|L. Karan"
"1577","12/04 12:00","4","P0244","Sheng-Fan WANG","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Retrospective molecular epidemiological survey of an unexpected dengue outbreak in Taiwan, 2023","S. Wang|C. Tsui|S. Mahmoud|Z. Yang|Y. Hsu|Y. Chen|C. Lin"
"1599","12/04 12:00","5","P0245","Yun Tzu HSU","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Expression of Galectin-3 ameliorates dengue virus infection","Y. Hsu|C. Tsui|S. Wang|Y. Lee"
"1615","12/04 12:00","6","P0246","Fabiana NUCCETELLI","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Attitudes and knowledge of the adult population on arboviral diseases","F. Nuccetelli|V. Gabellone|S. Ciampini|L. Biasio|P. Lopalco"
"1801","12/04 12:00","7","P0247","Alexandra BYLINA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Clinical features of measles during the 2023-2024 outbreak in Minsk, Belarus","A. Bylina|M. Salavey|I. Karpov"
"1862","12/04 12:00","8","P0248","Emilie MAYER","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Tick-borne encephalitis virus (TBEV) is one the three leading causes of meningoencephalitis/encephalitis in Saint-Etienne area, France","A. Frésard|O. Bousetta-Charfi|F. Rousset|F. Ballereau|A. Gagneux-Brunon|J. Camdessanché|A. Velay|E. Botelho-Nevers|E. Mayer|S. Pillet|C. Cazorla|M. Detoc|M. Lutz|A. Carricajo|L. Pezzi|N. Ayhan"
"1886","12/04 12:00","9","P0249","Rachna BHAT","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Role of biomarkers in predicting mortality in patients with flaviviral disease endemic to south India: a prospective observational study","R. Bhat|V. Pothumarthy|P. Tirlangi|P. Ravindra|N. Gupta"
"2087","12/04 12:00","10","P0250","Alfonso J. RODRIGUEZ-MORALES","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Dengue epidemiology in the elderly population of a municipality in Bolívar, Colombia, 2018-2024","W. Villamil-Gomez|E. Ojeda-Martinez|Z. Alfonso-Tellez|Y. Pinillo-Patino|J. Hernández-Ovalle|C. Luna|A. Rodriguez-Morales|J. Dias-Gomez"
"2189","12/04 12:00","11","P0251","Iris CAZALI","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Impact of dengue fever on maternal and fetal outcomes: a cross-sectional study in Guatemala","I. Cazali|B. Batz|K. Juarez|D. Erdmenger|I. Hernandez"
"2207","12/04 12:00","12","P0252","Arsilda GJATAJ","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Return of WNV infection in Vlora","A. Gjataj|A. Harxhi|N. Como|S. Bino"
"2286","12/04 12:00","13","P0253","Rafael ROCHA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Seroprevalence of toscana virus in blood donors in mainland Portugal","R. Rocha|E. Kurum|N. Ayhan|R. Charrel|C. Maia"
"2460","12/04 12:00","14","P0254","Yoshito HOMMA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","CT-detected lymphadenopathy and prognostic markers in severe fever with thrombocytopaenia syndrome: a retrospective study","Y. Homma|T. Katsuta|T. Inoue"
"2472","12/04 12:00","15","P0255","Chizaram ONYEAGHALA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Epidemiology, clinical presentation, and outcome of human mpox in Rivers state Nigeria during the 2022-23 outbreak: an observational retrospective study","C. Onyeaghala|A. Somiari|U. Ichichiek|J. Ogan|O. Ehiakhamen|B. Otike-Odibi|O. Maduka|D. Alasia"
"2498","12/04 12:00","16","P0256","Antonio RIVERO-JUAREZ","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Differences in the clinical profile between ratHEV and HEV","M. Casares|D. Corona|A. Carrasco|A. Pérez|A. Fuentes|C. Freyre|B. Becerril|F. Franco-Álvarez De Luna|I. Viciana|M. Dominguez|A. Rivero|A. Rivero-Juárez"
"2677","12/04 12:00","17","P0257","Luca ZWEERS","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","A stepwise approach to developing practical guidance for healthcare professionals to safely meet the needs of patients and relatives during admission to a high-level isolation unit","L. Zweers|M. Tingen-Wieland|C. Swaan|A. Tostmann|A. Timen|C. Rovers"
"2722","12/04 12:00","18","P0258","Massimo CRAPIS","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Monocyte CD169 (mCD169) expression in peripheral blood in patients with symptomatic arbovirosis: a retrospective series in the emergency department","G. Del Fabro|S. Venturini|I. Bramuzzo|A. Callegari|G. Basaglia|M. Avolio|D. Villalta|P. Doretto|M. Crapis"
"2877","12/04 12:00","19","P0259","Irvine MANGAWA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","???Survivors of an outbreak: exploring the patient experience of a specialised regional infectious diseases centre virtual ward during the mpox outbreak of 2022","I. Mangawa|A. Beech|D. Obeng|A. Uriel|N. Jacobs"
"2929","12/04 12:00","20","P0260","Nicole BARP","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Clinical-laboratory features of the abortive form of tick-borne encephalitis virus infection in Italy: a 25-year retrospective observational study","N. Barp|V. Mondardini|R. Scaggiante|M. Lanzafame|A. Delama|M. Giordani|M. Crapis|G. Del Fabro|V. Borgo|F. Raumer|M. Albertini|F. Casari|E. Ghidoni|M. Visicaro|A. Soffritti|F. Romani|E. Martini|L. Gozzi|M. Battistel|F. Migliore|C. Mussini|E. Franceschini"
"2936","12/04 12:00","21","P0261","Nicole BARP","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Clinical-laboratory features of tick-borne encephalitis virus infection in children and adolescents in Italy: a 25-year retrospective observational study","N. Barp|V. Mondardini|R. Scaggiante|M. Lanzafame|A. Delama|M. Giordani|M. Crapis|G. Del Fabro|V. Borgo|F. Raumer|M. Albertini|F. Casari|E. Ghidoni|M. Visicaro|A. Soffritti|F. Romani|E. Martini|L. Gozzi|M. Battistel|F. Migliore|C. Mussini|E. Franceschini"
"2996","12/04 12:00","22","P0262","Katherine LAU","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Enhancing mpox diagnostics: insights from an external quality assessment programme","K. Lau|T. Theis|W. Rawlinson"
"3119","12/04 12:00","25","P0265","Jue Tao LIM","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Risk of cardiovascular complications during acute dengue infection: a population-based cohort study","W. Tan|J. Lim|I. Wee"
"3205","12/04 12:00","26","P0266","Özge EREN KORKMAZ","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","West Nile virus in European countries between 2018 and 2024: trends in case fatality rate and incidence over time","Ö. Eren-Korkmaz"
"3225","12/04 12:00","27","P0267","Mikita SALAVEI","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Clinical spectrum and diagnostic challenges of tick-borne encephalitis in Belarus: a retrospective analysis of 190 cases","M. Salavei|V. Shcherba|Y. Kamarova|E. Nekrasova|A. Bylina"
"3326","12/04 12:00","28","P0268","Luca ZWEERS","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Developing an evidence-based at-home specimen collection procedure for patients suspected of a high-consequence infectious disease","L. Zweers|M. Tingen-Wieland|M. Mccall|A. De Raad|C. Swaan|A. Tostmann|A. Timen|C. Rovers"
"3477","12/04 12:00","29","P0269","Vittorio SAMBRI","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","The next frontier in Toscana virus (TOSV) genome analysis: development of a novel amplicon-based whole genome sequencing technology","M. Brandolini|G. Dirani|S. Zannoli|A. Lapusneanu|M. Guerra|A. De Pascali|L. Ingletto|L. Dionisi|C. Colosimo|M. Cricca|A. Scagliarini|V. Sambri"
"3616","12/04 12:00","30","P0270","Luca RUOTOLO","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Phylogenetic analysis of the autochthonous dengue cases emerged in Emilia-Romagna region, in Italy, during arbovirus surveillance in 2024","L. Ruotolo|B. Mola|T. Lazzarotto|G. Rossini"
"3625","12/04 12:00","31","P0271","James BEVAN","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Viral haemorrhagic fever: auditing emergency care for at-risk patients at university college London hospital","J. Bevan|R. Hammond|V. Johnston"
"3734","12/04 12:00","32","P0272","Alessandra Mistral DE PASCALI","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Dengue seroprevalence in healthy blood donors in Romagna (Emilia-Romagna region, Italy)","A. De Pascali|M. Brandolini|L. Grumiro|G. Dirani|R. Biguzzi|R. Chicchi|L. Dionisi|L. Ingletto|G. Gatti|C. Colosimo|M. Guerra|S. Zannoli|M. Montanari|A. Marzucco|M. Cricca|A. Scagliarini|S. Semprini|V. Sambri"
"3807","12/04 12:00","33","P0273","Qiangru HUANG","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Unraveling global mpox cross-border transmission patterns and risks: a comprehensive analysis","Q. Huang|W. Yang|Z. Li"
"3823","12/04 12:00","34","P0274","Shanghavie LOGANATHAN","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Ethical drug development for global health: an interdisciplinary analysis for the current dengue emergency","S. Loganathan|M. Parker|X. Chan|T. Johnson|E. Jamrozik"
"3890","12/04 12:00","35","P0275","Guang ZHU","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Mediating analysis of IPA in the association between steroid therapy and mortality risk in patients with SFTS","G. Zhu|S. Li|Y. Xiong|N. Geng|X. Bai|W. Ni|C. Wu|J. Li"
"4159","12/04 12:00","36","P0276","Özlem ALHAN","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","West Nile virus infections in Turkey","O. Alhan|A. Batirel|M. Aydin|H. Hazir Konya|U. Kayabas|M. Kuskucu|Ö. Ergonul"
"4321","12/04 12:00","37","P0277","Agnieszka KOLAKOWSKA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Increasing incidence of neurological infections of unknown etiology in upper Corsica: a matter of arboviruses?","A. Kolakowska|A. Maka|H. Dolfi-Fiette|N. Flatischler|M. Hypolite|S. Lecollinet|A. Chéret"
"4443","12/04 12:00","39","P0279","Jens WARNECKE","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Detection of anti-oropouche virus-specific IgM in a patient panel from a zika virus epidemic area in 2015 / 2016","J. Klemens|J. Warnecke|J. Bothfur|A. Schulz|O. Klemens"
"4480","12/04 12:00","40","P0280","Ibuchukwu ORABUEZE","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Prevalence, haematological profile, and risk factors of dengue fever in under-five children with acute febrile illness in Nigeria","I. Orabueze|J. Shaibu|I. Nwafia|S. Ebede|A. Ike|I. Ezeonu|R. Audu|U. Ozumba"
"4555","12/04 12:00","41","P0281","Da Young KIM","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Comparative analysis of clinical features between patients with severe fever with thrombocytopenia syndrome and haemorrhagic fever with renal syndrome in Korea","K. Da Young|S. Jun-Won|Y. Na Ra|K. Choon-Mee|K. Dong-Min"
"4560","12/04 12:00","42","P0282","Jeferson MANOEL TEIXEIRA","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Genetic variants of the rabies virus and prevention of diagnostic errors","K. Cristina Santos De Almeida|A. Paz Suarez|L. Vicente Ferreira|L. Dias Sabino Mota|I. Talacimon Barbosa|J. Manoel Teixeira"
"4689","12/04 12:00","43","P0283","Ut Man CHAN","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Comparison of assays for assessing the humoral immune response to monkeypox virus in HIV and non-HIV individuals following two doses of the MVA vaccine","U. Chan|T. Chao|W. Liu|C. Hung|S. Chang"
"4781","12/04 12:00","44","P0284","Hon Kiu Estie SHUN","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Exploring transmission routes of rat hepatitis E from a One Health perspective","H. Shun|S. Ho|S. Wu|Z. Li|S. Sridhar"
"5050","12/04 12:00","45","P0285","Mert KUSKUCU","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Investigation of Crimean-Congo haemorrhagic fever virus in patient room air samples","M. Kuskucu|R. Inan Sarikaya|S. Yalcin|T. Barlas|Ö. Ergonul"
"5150","12/04 12:00","46","P0286","Nipun RATHNAYAKE","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Seroprevalence of hantavirus exposure among healthy individuals in the Ampara district of Sri Lanka","R. Vijeyakumaran|N. Rathnayake|P. Senarathne|D. Muthusinghe|S. Urata|V. Francis|K. Yoshimatsu|N. Dissanayake|C. Gamage"
"5181","12/04 12:00","47","P0287","Ling-Li HUANG","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Epidemiological overview of ICU-diagnosed dengue fever cases at Hargeisa group hospital, Somaliland (January-October 2024)","L. Huang|Y. Su"
"5343","12/04 12:00","48","P0288","Jo Yi CHOW","6","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Assessing the direct and spillover protective efficacies of Wolbachia-mediated introgression to combat dengue","J. Chow|S. Bansal|B. Dickens|P. Ma|A. Hoffmann|Y. Cheong|N. Ahmad|J. Lim"
"5365","12/04 12:00","1","P0289","Sara CHANDY","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Shifting pattern of circulating dengue serotypes and their associated severity in children: a report from south India","S. Chandy|A. Manoharan|R. Chandra|G. Vankayala|R. Banda|N. Suryanarayana"
"5570","12/04 12:00","2","P0290","Manel BEN SELMA","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Neurologic manifestations and outcome of West Nile virus infection","M. Ben Selma|N. Ben Lasfar|M. Abid|H. Knani|F. Bellazreg|W. Hachfi"
"5656","12/04 12:00","3","P0291","Majid ALSHAMRANI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Modes of transmission of mpox by virus clade and geographic distribution: a systematic review","M. Alshamrani|A. El-Sead|S. Alfayez|A. Kholoud|M. Al Zunitan|M. Abalkhail|F. Farahat|F. Othman|W. Nasser|S. Nazeer|M. Al Ahmadi|H. Hamilton|G. Satta|A. Baller|V. Willet|H. Mahamed|T. Fletcher|T. Okwor|G. Gordon"
"5753","12/04 12:00","4","P0292","Aiman EL-SEAD","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Secondary infection rates after mpox exposure in multiple settings: a systematic review","A. El-Sead|M. Alshamrani|S. Al Fayez|K. Ameer|H. Hamilton|G. Satta|H. Mahamed|A. Baller|V. Willet|G. Guyatt|F. Othman"
"6343","12/04 12:00","5","P0293","Simone MALAGÒ","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Molecular characterization of Tick-borne encephalitis cases in north-eastern Italy","S. Malago|A. Mori|A. Matucci|S. Accordini|R. Passarelli Mantovani|N. Gianesini|P. Sponga|F. Perandin|F. Formenti|S. Scarso|A. Ragusa|L. Moro|F. Gobbi|C. Piubelli|C. Castilletti"
"6410","12/04 12:00","6","P0294","Arnaud CHALIN","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Antibody generation and development of a rapid test for the diagnosis of infection caused by the monkeypox virus","A. Chalin|F. Gallais|O. Ferraris|L. Niol|S. Debroas|A. Nouvel|L. Bellanger"
"6598","12/04 12:00","7","P0295","Anna PAPA-KONIDARI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","First usutu virus infection in an asymptomatic blood donor in Greece","A. Papa-Konidari|K. Tsioka|S. Pappa|V. Bakaloudi"
"6611","12/04 12:00","8","P0296","Margherita Eleonora PIERUZZI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Confirmed dengue cases in returning travellers in Milan, Italy: clinical and microbiological features from 2018 to 2024","M. Pieruzzi|A. Behring|S. Caronni|A. Poloni|D. Mileto|A. Mancon|A. Rizzo|A. Giacomelli|S. Antinori"
"6635","12/04 12:00","9","P0297","Jue Tao LIM","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Integrating spatial-environmental models to evaluate Wolbachia-mediated intervention efficacy on dengue transmission","L. Ponce|J. Lim"
"6665","12/04 12:00","10","P0298","Olalekan John OKESANYA","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Addressing the emerging threat of oropouche virus: implications and public health responses for healthcare systems","O. Okesanya|M. Ahmed|B. Ukoaka|D. Lucero Prisno Iii"
"6724","12/04 12:00","11","P0299","Nurcan BAYKAM","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Promising results with anakinra in severe cases of Crimean-Congo haemorrhagic fever","D. Yapar|O. Akdogan|A. Kocagul Celikbas|N. Baykam"
"6934","12/04 12:00","13","P0301","Emanuele NICASTRI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Clinical characteristics of Marburg virus disease: a systematic review of the literature","R. Pisapia|F. Fusco|L. Scorzolini|E. Nicastri|L. Fontana"
"6981","12/04 12:00","14","P0302","Anna PAPA-KONIDARI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Detection of West Nile virus, Usutu virus and phleboviruses in Culex spp. mosquitoes in Central Macedonia, Greece, 2024","K. Tsioka|S. Pappa|K. Stoikou|S. Gewehr|S. Kalaitzopoulou|S. Mourelatos|A. Papa-Konidari"
"7118","12/04 12:00","15","P0303","Gvantsa CHANTURIA","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Whole-genome sequencing based phylogenetic analysis of CCHFV strains isolated in Georgia (2013–2023)","M. Pantsulaia|G. Brachveli|A. Papkiauri|S. Javashvili|N. Mamuchishvili|P. Imnadze|G. Chanturia|G. Tomashvili"
"7120","12/04 12:00","16","P0304","Federica FRASCA","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Exploring the anti-interferon autoantibodies in mosquito-borne viral infections","F. Frasca|A. D'auria|M. Fracella|M. Compri|E. Diani|G. Bugani|L. Maddaloni|E. Coratti|F. Carletti|G. D'ettorre|G. Antonelli|M. Cusi|G. Matusali|D. Gibellini|C. Scagnolari"
"7181","12/04 12:00","17","P0305","Juliana MUNIZ","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Association of sonographic findings with severity of dengue fever: a systematic review and meta-analysis","J. Muniz|A. Oesir Goncalves Neto|V. Santos Silva|V. Vaz"
"7326","12/04 12:00","18","P0306","Chizaram ONYEAGHALA","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Seroprevalence of dengue IgG antibodies among adult community residents in Enugu, south-east Nigeria: a cross-sectional survey","C. Onyeaghala|N. Chika-Igwenyi|C. Ugweu|I. Orabueze|E. Odeh|U. Unigwe"
"7363","12/04 12:00","19","P0307","Nadja HEDRICH","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","West Nile human infections in Europe from 2000–2023","P. Schlagenhauf|N. Hedrich|M. Bekker-Nielsen Dunbar"
"7388","12/04 12:00","20","P0308","Matteo RICCÒ","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Did Marburg virus disease clinical features change overtime? A systematic review and meta-analysis,1967-2024","M. Ricco|C. Nobili|S. Corrado|P. Manzoni"
"7490","12/04 12:00","21","P0309","Carolina VENERI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Wastewater monitoring of dengue virus RNA during a local outbreak in central Italy, August-October 2024","C. Veneri|P. Mancini|G. Bonanno Ferraro|A. Franco|M. Iaconelli|D. Brandtner|L. Lucentini|G. Venturi|G. Marsili|M. Del Manso|C. Sacco|A. Bella|F. Riccardo|P. Pezzotti|L. Bolognini|S. Magi|E. Ballarini|A. Grucci|E. Suffredini|G. La Rosa"
"7504","12/04 12:00","22","P0310","Alice SCHARMELI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Target identified: a comparison of Brazilian and Singaporean dengue control ecosystems to aid antiviral target product profile development","A. Scharmeli|B. Choy|T. Thein|A. Siqueira|Y. Leo|X. Chan"
"7624","12/04 12:00","23","P0311","Hannachi HANNACHI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","West Nile virus infection investigation at the clinical virology laboratory, Pasteur Institute of Tunis","Y. Chaari|F. Wasfi|H. Hannachi|I. Chakroun|A. Sadraoui|H. Touzi|N. Hogga|Z. Meddeb|H. Triki"
"7639","12/04 12:00","24","P0312","Umair HUSSAINI","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","whole-genome sequencing of MERS-CoV: comparison of amplicon-based approaches and short read and long read sequencing platforms","T. Talts|M. Patel|U. Hussaini|B. Kele|M. Zambon"
"7656","12/04 12:00","25","P0313","Carlos STARLING","7","B","01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Dengue incidence in 26 cities affected by a tailing dam rupture at the Córrego do Feijão mine in Brumadinho/ Brazil: a ten-year ecological study.","G. Fernandes|C. Mota Filho|A. Martins Vaz|B. Lopes|W. Oliveira|M. Castro|C. Starling"
"1485","12/04 12:00","26","P0314","Ulrich EIGNER","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","High percent of co-detections of viral versus bacterial gastrointestinal pathogens in stool samples calls for a different approach in analysis of molecular testing results","M. Kolb|J. Koeffer|U. Betz|C. Eckel|J. Feenstra|C. Ulekleiv|M. Singh|C. Wang|U. Eigner"
"1923","12/04 12:00","27","P0315","Julia ALCOBA FLÓREZ","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Gene promoter methylation as a progression biomarker of HPV-associated precancerous lesions in young women","B. Pino Calm|C. Mateo Leon|A. Gomez De La Rosa|J. Alcoba Florez"
"2181","12/04 12:00","28","P0316","Oscar Enrique TORRES MONTAGUTH","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Hybridisation-capture approaches for the diagnosis and surveillance of viruses using real-time sequencing","O. Torres Montaguth|S. Buddle|L. Forrest|T. Brooks|R. Williams|S. Morfopoulou|J. Breuer|H. Tutill|C. Williams"
"2362","12/04 12:00","29","P0317","Bhoomika RAJYAGURU","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Bridging diagnostic gaps and strengthening vaccination strategies in mumps control: a tertiary care experience in western India","B. Rajyaguru|A. Agarwal|A. Padhi|A. Chaudhary|S. Vaidya"
"2376","12/04 12:00","30","P0318","Jens WARNECKE","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Detection of immune response to rubella antigen using an anti-rubella IgM ELISA and a newly designed anti-rubella IgG ELISA","S. Benning|C. Messing|A. Schulz|J. Klemens|J. Warnecke|O. Klemens"
"2548","12/04 12:00","31","P0319","Robert EHRET","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Ongoing MPXV infections in the Berlin MSM cohort: multiplex PCR for differentiation between MPXV Clade I; Ib and Clade II","R. Ehret|M. Prentice|E. Ahmed|M. Obermeier"
"2639","12/04 12:00","32","P0320","Lucie MANGIN","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","A lyophilised and deployable real time RT-PCR assay for the detection of viral RNA","L. Mangin|R. Charrel|B. Coutard|L. Falgous|L. Pezzi|L. Thirion|M. Sergent|L. Doumbia|O. Koita|X. De Lamballerie"
"3094","12/04 12:00","33","P0321","Volker STRENGER","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Determination of measles-virus-IgG titre in blood drawn by finger prick","V. Strenger|C. Koidl|C. Zurl|M. Gaggl"
"3125","12/04 12:00","34","P0322","Suyeon JO","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Evaluation of Torque teno virus DNA as an immunological marker through correlation with clinical parameters and survival in paediatric haematopoietic stem cell transplantation patients","S. Jo|H. Lee|I. Kim|S. Oh"
"3420","12/04 12:00","35","P0323","Chiara SENTI","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","In vitro validation of a preservative media for circulating cell-free HPV-DNA stabilisation in artificial human plasma samples","C. Senti|I. Triva|M. Ibrahim Hamoude|C. Sabelli"
"3893","12/04 12:00","36","P0324","Tarteel HASSAN","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Molecular identification of enterovirus 71 and coxsackie A16 among paediatric patients with aseptic meningitis in Khartoum state, Sudan","T. Hassan|H. Osman|K. Enan"
"4857","12/04 12:00","37","P0325","Henar ALONSO-EZCURRA","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Evaluating the impact of EDTA K2 vs. EDTA K3 on viral load quantification using real-time PCR assays","E. Franco|E. Teresa|M. Lopez|F. Navarro|S. Lucea|H. Alonso"
"4930","12/04 12:00","38","P0326","Gnana Soundari PALANI","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Genomic characterisation of JC virus in progressive multifocal leukoencephalopathy","P. Gnanasoundari|T. Surbhi|K. Dhanya|M. Ashwini|S. Reeta"
"5009","12/04 12:00","39","P0327","Eleni VAGDATLI","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Increased detection of human parvovirus B19 on a tertiary care Greek hospital","A. Karyoti|K. Tsioni|K. Bani|S. Mallini|M. Papadopoulou|E. Vagdatli"
"5234","12/04 12:00","40","P0328","Run HUANG","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Diagnostic accuracy of MxA protein as a biomarker for acute viral infections: a multi-centre validation study","B. Tan|T. Ma|Y. Li|H. Deng|R. Huang|F. Lu"
"5463","12/04 12:00","41","P0329","Jean-Christophe PETER","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","New raw materials for serology immunoassay quality controls","C. Vauloup-Fellous|S. Hantz|C. Torlotin|A. Menuet|P. Monsbrot|J. Peter"
"5682","12/04 12:00","42","P0330","Heidi BERGHALL","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Neither nor or norovirus GI/GII? Good consensus in international EQA pilot study for norovirus antigen detection","H. Berghall|K. Luiro|K. Virtanen|J. Pelanti"
"5872","12/04 12:00","43","P0331","Maria Del Carmen NIETO TOBOSO","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Emergence of Enterovirus D68 infection in northern of Spain","M. Nieto Toboso|E. Ugalde Zárraga|M. Urrutikoetxea-Gutierrez|M. Gurruchaga Yanes|M. Cabrerizo Sanz|J. Diaz De Tuesta Del Arco"
"5877","12/04 12:00","44","P0332","Martine ALTIDOR","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","On the hotline: the imported fever service response to the mpox Clade I outbreak","M. Altidor|S. Kate|S. Poole|A. Thompson|B. Hack|A. Belfield|U. Helen|T. Samuels|C. Houlihan|T. Rampling|C. Warrell|C. Petridou|T. Brooks|J. Owen|J. Furneaux|N. Gordon"
"6236","12/04 12:00","45","P0333","Martin KAMMEL","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Evaluation of INSTAND EQA samples for virus genome detection: target values by dPCR results instead of consensus values?","M. Kammel|A. Zimmermann|M. Obermeier|A. Schubert|E. Valiente|S. Falak|E. Niemann|K. Allers|H. Zeichhardt|A. Martin"
"6404","12/04 12:00","46","P0334","Nadia WOHLWEND","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Accelerating dengue detection: comparing the performance of rapid tests and ELISA for NS1, IgG, and IgM antibodies","D. Hilti|F. Wehrli|R. Wampfler|L. Rumèbe|P. Landolt|T. Lung|S. Bigler|L. Risch|M. Risch|N. Wohlwend"
"6418","12/04 12:00","47","P0335","Karolína TOMCÍKOVÁ","7","B","01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Next-generation sequencing method for analysis of multi-infections and antibiotic resistance markers in self-collected swabs from HPV positive women","K. Tomcikova|M. Majdan|L. Jakubcová|V. Chebenová|L. Reizigová|A. Dobias|M. Kasny|M. Jurenova|N. Tomko|E. Hladikova|I. Mertová|A. Marecek Patlevicova|M. Gazdarica|J. Sokolová"
"238","12/04 12:00","48","P0336","Dilsah BASKOL ELIK","7","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Measles seroprevalence of medicine faculty student","D. Baskol Elik|M. Özkara|P. Kiran|I. Sahin|H. Erdem|M. Isikgoz Tasbakan"
"269","12/04 12:00","1","P0337","Hyun Soo KIM","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Epidemiology of human sapovirus in Korea: impact of COVID-19","S. Lee|Y. Jeon|H. Kim|D. Whang|J. Kim|H. Kim"
"537","12/04 12:00","2","P0338","Daniela JAVORSKÁ","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Parvovirus B19 on the rise in 2024: a multifaceted pathogen with varied clinical manifestations","D. Javorská|I. Hockicková|M. Novotny|Z. Paralicova|J. Hockicko|Z. Váczy|D. Semenovová"
"638","12/04 12:00","3","P0339","Arash LETAFATI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Declining trend of HTLV-1 among organ/tissue donors in Iranian population","A. Letafati"
"795","12/04 12:00","4","P0340","Anna SMIELEWSKA","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Parvovirus: a growing problem?","J. York|B. Sultan|M. Atkin|A. Smielewska|C. Donaldson|F. Kempson|C. Perry"
"957","12/04 12:00","5","P0341","Pattara KHAMRIN","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Molecular epidemiology of human rotavirus in post-vaccination era in Chiang Mai, Thailand","P. Khamrin|N. Jampanil|K. Kumthip|N. Maneekarn"
"959","12/04 12:00","6","P0342","Kattareeya KUMTHIP","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Molecular epidemiology of classic and novel human astroviruses in paediatric patients with acute gastroenteritis in Thailand","K. Kumthip|P. Khamrin|N. Maneekarn"
"1563","12/04 12:00","7","P0343","Amir ABOOFAZELI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","An in-depth review of epidemiologic, clinical, and laboratory characteristics in women with cervical abnormalities: insights from a leading referral centre","A. Aboofazeli|Z. Sadeghi|S. Jazayeri"
"1754","12/04 12:00","8","P0344","Dharam Veer SINGH","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Etiologic involvement of enterovirus and human boca virus in acute flaccid paralysis cases in India","D. Singh|R. Gupta|S. Yadav|V. Patel|A. Garg"
"2283","12/04 12:00","9","P0345","Federico FALLETTA","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Prevalence of anti-parvovirus B19 IgG and IgM antibodies in a local population from 2019 to 2024","L. Mule'|F. Falletta|V. Iacolino|D. Schifaudo|L. Graci|B. Turchio|I. Brusca|G. Mancuso"
"2410","12/04 12:00","10","P0346","Edita GREGO","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Prevalence and genotype distribution of high-risk HPV genotypes by the RT-PCR method among women in Serbia in a two-year period, 2022-2024","E. Grego|M. Ivanovic|N. Simic|J. Ivanovic|M. Cabrilo|H. Gospodinovic|L. Pavlovic|V. Jovanovic|S. Jovanovic"
"2880","12/04 12:00","11","P0347","Gustavo Adolfo MÉNDEZ","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Hospitalised dengue patients: insights from Argentina's 2023-2024 outbreak","J. Salmanton-Garcia|C. Niveyro|P. Villalba Apestegui|V. Martin|L. Company Kec|M. Tomasino|A. Jara|O. Cornely|G. Méndez"
"3389","12/04 12:00","12","P0348","Muhamed SKOMORAC","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Spreading and epidemiological characteristics of measles in the area of Zenica-Doboj Canton, Bosnia-Herzegovina","M. Skomorac|A. Terzimehic|E. Terzic|A. Kozica|E. Kuduzovic|I. Kovac|L. Ljevakovic|N. Hasanica|S. Begagic|A. Ibrahimagic"
"3681","12/04 12:00","13","P0349","Marta BERNAT","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Increase in parvovirus B19 cases in Barcelona: comparative analysis from 2019 to 2024","M. Bernat-Sole|J. Rovira-Plujà|P. Nadal-Baron|A. Rando-Segura|M. Arnedo-Munoz|M. Sanchez-Durán|N. Maiz|A. Soriano-Arandes|J. Vila|M. Alvarez De Toledo-Lopez-Herrera|J. Burgos|S. Català Altarriba|A. Aymar Torné|A. Anton|J. Esperalba"
"3848","12/04 12:00","14","P0350","Dee DAVIS","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Clinical significance of torque teno virus (TTV) in CSF samples/TTV dynamics in paediatric population","D. Davis|J. Brown"
"4619","12/04 12:00","15","P0351","Mark A SCHMIDT","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Incidence and severity of sporadic, medically attended norovirus infection in the United States, 2023-2024","M. Schmidt|H. Groom|L. Tsaknaridis|M. Slaughter|J. Dickerson|A. Ojebode|L. Morrow|R. Evans|S. Vertrees|J. Donald|M. O'keeffe-Rosetti|W. Wu|K. Carlson|C. Crocker|E. Viscidi"
"4809","12/04 12:00","16","P0352","Harpreet SINGH","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Clinical, laboratory profile and outcome of expanded dengue syndrome and its correlation with virus specific serotype at a tertiary care hospital in north India","H. Singh|A. Gaud|I. Bora|D. Dhibar|V. Suri|A. Bhalla|R. Ratho"
"5177","12/04 12:00","17","P0353","Francesco ROMANO","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Sexual behaviour and age related incidence of sexually transmitted infections among MSM and transgender women using daily and event-driven pre-exposure prophylaxis (PrEP): two-year follow-up","F. Romano|M. Ridolfi|F. Alessi|A. Lazzaro|C. Mastroianni|G. D'ettorre|E. Bogliolo"
"5315","12/04 12:00","18","P0354","Siham AZROU","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Screening for human papillomavirus in women over 30 years of age at the mother and child laboratory of a west Algiers hospital","S. Azrou|H. Kriter|F. Djennane"
"5318","12/04 12:00","19","P0355","Clara FAPPANI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","The landscape of human papillomavirus types among women screened for cervical cancer in a rural healthcare facility in Eswatini","C. Fappani|M. Gori|D. Colzani|L. Tieghi|A. Amendola|E. Tanzi|S. Villa|S. Baldi|P. Angelone|M. Raviglione|B. Nhleko|T. Motsa|X. Dlamini|G. Maphalala|G. Buthelezi"
"5378","12/04 12:00","20","P0356","Xuewei ZHOU","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Adeno-associated virus (AAV2) is a common finding in adenovirus infections in children and adults","G. Berger|L. Gard|D. De Voogd|G. Duursma|E. Boerma|C. Van Leer|X. Zhou"
"5394","12/04 12:00","21","P0357","Federica SALARI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Prevalence and distribution of vaccine-preventable HPV genotypes in unvaccinated PrEP users","A. Rizzo|D. Moschese|F. Salari|G. Carrozzo|S. Reato|D. Mileto|A. Giacomelli|A. Dolci|A. Lombardi"
"5410","12/04 12:00","22","P0358","Maria ALBERTUZ CRESPO","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Increased circulation of human parvovirus B19 during spring of 2024 in Madrid, Spain","M. Albertuz-Crespo|M. Cárdenas-Isasi|M. Cabello|B. Romero|L. Martinez-Garcia|J. Galán|M. Rodriguez-Dominguez"
"5496","12/04 12:00","23","P0359","Özlem YILDIRIM","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Sequencing of MPXV positive samples in Berlin 2022 to 2024","M. Lautner|R. Ehret|Ö. Yildirim|M. Obermeier"
"5500","12/04 12:00","24","P0360","Flora Marzia LIOTTI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Compelling increase in parvovirus B19 infections: analysis of diagnostic trends, 2019–2024","F. Liotti|S. Marchetti|S. D'onghia|R. Santangelo|B. Posteraro|M. Sanguinetti|S. Galuppi|C. Marturano|C. Rocchetti|M. Volpe"
"5550","12/04 12:00","25","P0361","Kyoko YOKOTA","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Colonoscopic observations in asymptomatic norovirus infection: insights from a small-scale study at a single Japanese centre","K. Yokota|S. Yamagata-Uyama|K. Yamamoto|M. Saito|D. Kobayashi"
"5702","12/04 12:00","26","P0362","Pamela MANCINI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Comprehensive identification of respiratory viruses in wastewater using a broad-spectrum respiratory virus manel and whole genome sequencing","P. Mancini|D. Brandtner|C. Veneri|G. Bonanno Ferraro|M. Iaconelli|E. Suffredini|G. La Rosa"
"5776","12/04 12:00","27","P0363","Selma HABIBOVIC","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Vaccine hesitancy and measles resurgence: lessons from Novi Pazar","S. Habibovic|I. Corovic|B. Simovic Markovic|S. Ljajic|M. Dudic|A. Jovanovic|S. Ribis"
"5790","12/04 12:00","28","P0364","Silvia BIANCHI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Phylogenetic analysis of human parvovirus B19, northern Italy, 2017-2024","C. Fappani|M. Gori|S. Bianchi|D. Colzani|C. Golti|L. Tieghi|P. Pasutto|M. Canuti|A. Amendola"
"6025","12/04 12:00","29","P0365","Ioannis DANIIL","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Coxsackieviruses type B infections: the effect of COVID-19 pandemic","F. Mitropoulou|I. Daniil|C. Louka|K. Sklavounou|N. Rekleiti|V. Papadouli|V. Mamali|O. Zarkotou"
"6214","12/04 12:00","30","P0366","Priscila TRINDADE","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Rotavirus A outbreak predominantly affecting adults in Santa Maria, southern Brazil","B. Casarin|B. Piccoli|A. Daneli|A. Haisi|J. Kuhns|R. Marchesan|J. Araújo Jr|M. Lobato|A. Schwarzbold|P. Trindade"
"6835","12/04 12:00","31","P0367","Xiaolei LI","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","A large outbreak of acute hemorrhagic conjunctivitis in Yunnan, China in 2023","X. Li|L. Zhou"
"6957","12/04 12:00","33","P0369","Na LIU","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Serotype distribution of enterovirus associated with hand, foot, and mouth disease in China based on laboratory surveillance, 2012-2023","N. Liu|T. Ji|D. Yan|Q. Yang|J. Xiao"
"7076","12/04 12:00","34","P0370","Alpana MOHTA","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Hand, foot, and mouth disease amid COVID-19: an overlapping epidemic within a pandemic","A. Mohta"
"7265","12/04 12:00","35","P0371","Keun Hwa LEE","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Different genotypic distributions of hantaan virus causing human infections on Jeju island, South Korea","S. Heo|M. Kim|S. Kang|E. Bae|J. Yoo|Y. Song|M. Wiley|A. Letizia|K. Lee"
"7438","12/04 12:00","36","P0372","Tianjiao TIANJIAO","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","An outbreak caused by imported sub-genotype B5 of EV-A71 reveals multiple recombination pattern in China","J. Tianjiao|Y. Lan"
"7515","12/04 12:00","37","P0373","Koenraad VAN HOORDE","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Improved surveillance of viral gastroenteritis after implementation of wastewater surveillance in Belgium","B. Verhaegen|R. Janssens|H. Maloux|V. Hutse|M. Lesenfants|K. Van Hoorde"
"7559","12/04 12:00","38","P0374","Giada GARZILLO","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Resurgence of measles: new evidence of viral circulation in Liguria, northern Italy, 2024","G. Garzillo|M. Scarpaleggia|C. Trombetta|L. Inglese|N. Randazzo|S. Ferrari|V. Chessa|R. Qosja|V. Ricucci|B. Bruzzone"
"7690","12/04 12:00","39","P0375","Amparo FERNÁNDEZ-RODRÍGUEZ","8","B","01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Viral myocarditis manifesting as sudden death in infants and children: an ESGFOR approach from symptoms to autopsy","M. Fernandez Rodriguez|D. Callon|L. Andreoletti|M. Cohen"
"401","12/04 12:00","40","P0376","Carlo FERRAZZANO","8","B","01h. Antiviral drugs, treatment, susceptibility/resistance (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Investigation of the HPV 53 E2 protein as a potential treatment for cervical cancer","C. Ferrazzano|I. Hampson|O. Anthony"
"1163","12/04 12:00","41","P0377","Houda HADDAD","8","B","01h. Antiviral drugs, treatment, susceptibility/resistance (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Evaluation of the antiviral activity of new dermaseptin analogs against zika virus","H. Haddad"
"1892","12/04 12:00","42","P0378","Xicheng SUN","8","B","01h. Antiviral drugs, treatment, susceptibility/resistance (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Discovery of PROTAC compounds as potent viral protease degraders and inhibitors against Corona viruses","C. Mason|H. Liu|T. Hoang|H. Li|S. Samrat|T. Jarvis|U. Ochsner|X. Sun"
"2492","12/04 12:00","43","P0379","Javier MARTÍN-ESCOLANO","8","B","01h. Antiviral drugs, treatment, susceptibility/resistance (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge","J. Martin-Escolano|J. Li|M. Carretero-Ledesma|S. Herrera-Espejo|J. Xu|H. Chen|C. Diaz-Navarro|J. Pachon|J. Sánchez-Céspedes|J. Zhou|M. Pachon-Ibanez"
"1473","12/04 12:00","44","P0380","Simone LEONI","8","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Exploring the pathogenesis of TBE in an infant rat model","S. Leoni|D. Grandgirard|R. Dijkman|S. Leib|M. Erhardt"
"2473","12/04 12:00","45","P0381","Gulfaraz KHAN","8","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Impact of the route of EBV transmission on viral infection and reactivation in the rabbit model","M. Al Ameri|P. Philip|A. Rasheed|L. Alkhyeli|G. Khan"
"2861","12/04 12:00","46","P0382","Ondrej CINEK","8","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Gut virome composition modifies the risk of subsequent coeliac disease in two European birth cohorts","O. Cinek|K. Chuda|G. Tapia|K. Hubackova|S. Shah|J. Thorsen|U. Boulund|L. Stene|K. Stordal|J. Laiho|S. Virtanen|J. Lehtonen|H. Hyoty|J. Toppari|R. Veijola"
"3200","12/04 12:00","47","P0383","Virginia LOTTI","8","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Preliminary analysis of viral infection in human organoids from different GI tracts: SARS-CoV-2 and beyond","V. Lotti|R. Latorre|C. Mortali|C. Sorio|D. Gibellini|V. Corbo|A. Lagni|R. Cecchetto|E. Diani"
"5414","12/04 12:00","48","P0384","Anupriya M G","8","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","A genetically encoded BRET-based SARS-CoV-2 main protease activity sensor","A. M. Geethakumari|W. S. Ahmed|S. Rasool|A. Fatima|N. Uddin|M. Aouida|K. H. Biswas"
"5736","12/04 12:00","1","P0385","Nicolas NOULIN","9","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Advancing vaccine and treatment development, state-of-the-art human challenge trial facility","B. Löndt|A. Collyer|A. Mann|N. Noulin|A. French|A. Catchpole"
"6588","12/04 12:00","2","P0386","Maria DOLCI","9","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Expression of human endogenous retroviruses in clinical samples of patients with colorectal cancer","P. Tebaldi|L. Signorini|E. Calvo-Alvarez|A. Gianatti|A. Lucianetti|C. Scagnolari|S. Delbue|M. Dolci|F. Frosio|A. D'auria"
"6925","12/04 12:00","3","P0387","Lucia SIGNORINI","9","B","01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Study of the endothelial response to SARS-CoV-2 in vitro infection of human lung microvascular endothelial cells","L. Signorini|F. Novazzi|S. D'alessandro|S. Boutahar|N. Basilico|F. Perego|M. Dolci|F. Drago|N. Mancini|S. Delbue"
"125","12/04 12:00","4","P0388","Jeonghyun CHANG","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Clinical performance evaluation of GeneFinder COVID-19/Flu antigen test and SGTi-flexM COVID-19 & flu A/B Ag for diagnosis of SARS-CoV-2, influenza A and influenza B infection","J. Chang|S. Shin|D. Whang|T. Um|C. Cho"
"137","12/04 12:00","5","P0389","Murat KARAMESE","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients","M. Karamese|A. Gumus|E. Atalay|E. Tutuncu"
"234","12/04 12:00","6","P0390","Juana CLAUS","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity","J. Claus|J. Top|F. Paganelli|T. Ten Doesschate|N. Paternotte|M. Youngapelian|R. Schuurman|R. Willems|H. Leavis|J. Van De Wijgert"
"304","12/04 12:00","7","P0391","Gulbanu SHAIMERDENOVA","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","THE EFFECT of pregnancy on the severity of the course of COVID-19: an analysis of clinical data","G. Shaimerdenova"
"314","12/04 12:00","8","P0392","Luka Svitek","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Correlation between urinary neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in hospitalised COVID-19 patients","L. Svitek|S. Mandic|B. Grubisic|M. Zlosa"
"324","12/04 12:00","9","P0393","Ishikawa KAZUHIRO","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Deterioration of swallowing function among patients with COVID-19: propensity score-matched cohort study","I. Kazuhiro|D. Kobayashi|N. Mori"
"332","12/04 12:00","10","P0394","Manuela DI FUSCO","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Health-related quality of life, work productivity and activity levels in younger and older adults with acute COVID-19","M. Di Fusco|J. Cappelleri|L. Lupton|M. Moran|L. Puzniak|S. Lopez|M. Gavaghan|A. Yehoshua|X. Sun"
"399","12/04 12:00","11","P0395","Eveline Katharina OTTE IM KAMPE","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Cost-effectiveness of oral nirmatrelvir/ritonavir for high-risk severe COVID-19 patients in Germany","E. Otte Im Kampe|C. Schmalhofer|D. Eheberg|H. Sandhu|M. Maier|A. Perschke|T. Mugwagwa|E. Fröling|A. Kisser"
"524","12/04 12:00","12","P0396","Sanskruti SHAH","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Acceptance of booster dose of COVID-19 vaccine: a community based study","S. Shah|S. Vachhani|S. Vasaya|S. Purohit|U. Prajapati"
"525","12/04 12:00","13","P0397","Muhammad Ismail BIN ABDUL MALEK","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Utility of population-wide digital contact tracing in estimating vaccine effectiveness in a real-world pandemic setting","W. Chan|L. Wee|M. Bin Abdul Malek|C. Chiew|Z. Ho|B. Ong|D. Heng|V. Lee|D. Lye|K. Tan"
"552","12/04 12:00","14","P0398","Maria Giulia CAPONCELLO","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Differential long-term serological responses to SARS-CoV-2 vaccination in patients with solid and heamatologic malignancies","M. Caponcello|C. Zamagni|A. Ardizzoni|F. Lo Bianco|M. Nannini|N. Caroccia|S. Cataudella|A. Vatteroni|M. Krampera|Z. Palacios-Baena|P. Olivares Navarro|H. Manuel|H. Jan|M. Garcia Sanchez|A. Hidalgo|I. Hrom|S. Kumar-Singh|N. Palazon Carrion|A. Rodriguez Fernandez|C. Simio|J. Rodriguez Bano|A. De Giglio|M. Giannella|E. Tacconelli"
"636","12/04 12:00","15","P0399","David FISMAN","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV-2 infection in Ontario, Canada","D. Fisman|A. Simmons|T. Ashleigh"
"648","12/04 12:00","16","P0400","Veronica OBER","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Immune disturbances in individuals with post-COVID syndrome (PCS) are not characterised by enhanced SARS-CoV2-specific immunity","V. Ober|F. Völk|J. Roider|E. Gruener|J. Sbierski-Kind|S. Feldmann|H. Stubbe|K. Adorjan|R. Stirner|G. Reiling|U. Seybold|J. Bogner"
"662","12/04 12:00","17","P0401","An Ting TAY","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Remdesivir and risk of multi-systemic long-term sequelae following COVID-19 hospitalisation","J. Lim|C. Chiew|B. Young|D. Lye|A. Tay|K. Tan|L. Wee"
"670","12/04 12:00","18","P0402","Maria DIOVERTI","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Protracted COVID-19 in immunocompromised hosts: a multicentre retrospective cohort study","S. Koo|I. Gonzalez-Bocco|R. Razonable|Z. El Boghdadly|N. Marschalk|S. Hammond|A. Apostolopoulou|C. Liu|E. Sanchez|J. Nelson|Z. Raglow|D. Kaul|M. Maccort|D. Sow|R. Frierson|A. Franceschi|E. Morell|J. Evans|T. Liang|R. Avery|G. Haidar|M. Dioverti"
"710","12/04 12:00","19","P0403","Guido GRANATA","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The evolving challenge of appropriate antibiotics use in hospitalised COVID-19 patients: a systematic literature review","G. Granata|S. Cicalini"
"740","12/04 12:00","20","P0404","Sarang YOON","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Preliminary safety and effectiveness estimate of 2023-2024 COVID-19 vaccines (XBB.1.5) in preventing symptomatic infections in US adults","S. Yoon|M. Thiese|A. Phillips|G. Ellsworth|D. Chen|F. Yan|Y. Zhang|S. Ball|E. Rowley|S. Battan-Wraith|R. Fink|A. Yates|S. Toback|L. Dunkle|M. Rousculp|H. Zhao"
"771","12/04 12:00","21","P0405","Thu-Trang VU","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of SARS-CoV-2 infection and long COVID on health-related quality of life among school-aged children in Vietnam","T. Vu|F. Vogt|C. Nguyen|Q. Pham|A. Hoang|T. Nguyen|D. Ngu|T. Vu"
"880","12/04 12:00","22","P0406","Mary Ngongang KAMENI","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Human ACE2 and TMPRSS2 polymorphisms for predicting susceptibility to tuberculosis and COVID-19 co-infection in Cameroonian cohort","M. Kameni|E. Tchoupe|S. Kamdem|P. Masumbe"
"1126","12/04 12:00","23","P0407","Elda DE VITA","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Role of frailty index-laboratory (FI-LAB) to predict COVID-19 mortality: a cross-sectional study","E. De Vita|N. Veronese|G. Guido|L. Frallonardo|S. Cotugno|G. Manco Cesari|M. Cibelli|A. Vigna|D. Capruzzi|M. Fiorella|C. Santoro|G. Brindicci|F. Di Gennaro|A. Saracino"
"1197","12/04 12:00","24","P0408","Keiko BABA","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Phenotyping and genotyping analysis using baseline swab samples in ensitrelvir clinical studies","A. Yamamoto|H. Nobori|H. Sakaguchi|T. Imamura|K. Fukao|K. Baba|J. Li|A. Greninger"
"1241","12/04 12:00","25","P0409","Guillermo RODRIGUEZ-NAVA","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Bayesian estimation of counterfactual mortality reduction following COVID-19 vaccine introduction in the United States, 2020–2023","G. Rodriguez-Nava"
"1258","12/04 12:00","26","P0410","Joanne LACY","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Variable selection for prediction models of Omicron infection: insights from two population-based cohort studies","J. Lacy|D. Menges|T. Ballouz|A. Frei|C. Pellaton|C. Fenwick|G. Pantaleo|M. Puhan"
"1333","12/04 12:00","27","P0411","Antonella SANCHEZ ZERILLO","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Breast milk secretory IgA against SARS-CoV-2 S antigen: a comparative study between pandemic and post-pandemic periods in Peru","A. Sanchez|G. Toscano|D. Durand|S. Bellomo|T. Ochoa"
"1371","12/04 12:00","28","P0412","Spyros CHALKIAS","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Clinical evaluation of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine","S. Chalkias|P. Dennis|D. Petersen|K. Radhakrishnan|L. Vaughan|R. Handforth|A. Rossi|R. Wahid|D. Edwards|J. Feng|W. Deng|H. Zhou|E. De Windt|V. Urdaneta|B. Girard|S. Faust|S. Walsh|C. Cosgrove|R. Das"
"1378","12/04 12:00","29","P0413","Christina GRASSI","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants aged ≥12 years","C. Grassi|J. Feng|R. Wahid|B. Kandinov|S. Goel|D. Wang|K. Sellers|A. Dixit|O. Kogawara|R. Das|S. Chalkias"
"1406","12/04 12:00","30","P0414","Minkyeong LEE","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The impact of convalescent immune reactions on long-term pulmonary sequelae in mild to moderate COVID-19 patients during active treatment era","M. Lee|D. Shin|H. Oh|S. Park|B. Park|C. Jeong|S. Lee|J. Kim"
"1425","12/04 12:00","31","P0415","Alain AMSTUTZ","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","JAK inhibitors in adults hospitalised due to COVID-19: individual participant data meta-analysis","A. Amstutz|S. Schandelmaier|T. Agoritsas|K. Tomashek|J. Arribas|Y. Yazdanpanah|K. Lacombe|M. Hites|F. Ader|E. Tacconelli|D. Costagliola|C. Rueegg|I. Olsen|M. Trøseid|M. Briel"
"1441","12/04 12:00","32","P0416","Marvin WEISS","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Benefits and risks of systematic screening for SARS-CoV-2 in asymptomatic hospitalised patients","S. Tschudin-Sutter|K. Leuzinger|M. Weiss|P. Urwyler|M. Von Rotz|R. Kuhl|S. Kuster|I. Vock|L. Aguilar-Bultet|C. Bagutti|K. Rentsch"
"1476","12/04 12:00","33","P0417","Irini ZOGRAFAKI","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Post pandemic burden of COVID-19 in ix European countries: a national surveillance analysis for 2023-2024 fall-winter season","I. Zografaki|R. Sini De Almeida|E. Froeling|D. Malhotra|D. Curcio|C. Reynard|K. Dragsbaek Moller|A. Boukhlal|A. Lopez|A. Pagliaro"
"1479","12/04 12:00","34","P0418","Lauren RODRIGUEZ","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Viral resistance analyses from the obeldesivir OAKTREE study in low-risk nonhospitalised patients with COVID-19","L. Rodriguez|Y. Hu|J. Li|D. Han|N. Peinovich|C. Martinez|P. Ho|J. Perry|R. Martin|O. Ogbuagu|A. Lichtman|J. Llewellyn|C. Hedskog"
"1564","12/04 12:00","35","P0419","David Chien LYE","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Risk of long-term complications following steroid treatment for COVID-19 in hospitalised Singaporean adults: a retrospective cohort study","L. Wee|E. Loy|J. Lim|A. Tay|C. Chiew|B. Young|D. Lye|K. Tan"
"1614","12/04 12:00","37","P0421","Javier MARTÍN-ESCOLANO","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Factors associated with the development of SARS-CoV-2 RNAemia at COVID-19 diagnosis","J. Martin-Escolano|A. Ruiz-Molina|J. Rodriguez-Bano|J. Cisneros|B. Gutiérrez-Gutiérrez|R. Alvarez-Marin|M. Aguilar-Guisado|S. Salto-Alejandre|E. Cordero|J. Pachon|J. Sánchez-Céspedes|G. Abelenda-Alonso|G. Euba|Z. Palacios-Baena|F. Arnaiz De Las Revillas|J. Alba|A. Rombauts|R. Rodriguez-Alvarez|N. Maldonado|C. González-Rico|S. Santibanez|M. Carretero-Ledesma|L. Merino|J. Carratalà|A. Goikoetxea-Agirre|M. Fernandez-Martinez|J. Oteo|C. Farinas|C. Rodriguez-Urbistondo|C. Infante-Dominguez"
"1626","12/04 12:00","38","P0422","Saeed SHAMS","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Investigating the prevalence of Streptococcus pneumoniae co-infection in patients with COVID-19 in the world: a meta-analysis study and systematic review","A. Hamta|S. Shams"
"1627","12/04 12:00","39","P0423","Mark BERRY","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Early vs late vs no remdesivir initiation in patients with immunocompromising conditions hospitalised with COVID-19","E. Lee|V. Shvachko|C. Nielson|K. Hurwitz|N. Rathnayaka|R. Faller|M. Abdelghany|M. Brookhart|A. Chokkalingam|M. Berry"
"1632","12/04 12:00","40","P0424","Choi Young JANG","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Development of a definition of post-acute sequelae of SARS-CoV-2 (PASC) in a Korean long COVID cohort by using machine learning","M. Kim|W. Kim|J. Son|E. Chang|C. Jang|S. Kim"
"1689","12/04 12:00","41","P0425","Charlotte HEDSKOG","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Viral resistance analyses from the obeldesivir BIRCH study in high-risk nonhospitalised patients with COVID-19","C. Hedskog|L. Rodriguez|Y. Hu|J. Li|D. Han|N. Peinovich|C. Martinez|P. Ho|J. Perry|J. González Del Castillo|Y. Koullias|R. Martin|J. Llewellyn"
"1740","12/04 12:00","42","P0426","Xuan Ying POH","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Antibody persistence against omicron subvariants induced by monovalent mRNA, bivalent mRNA or nuvaxovid vaccines: final results from Phase D of the PRIBIVAC study, a randomised clinical trial","X. Poh|A. Yeoh|S. Mah|J. Chavatte|D. Lim|H. Tang|C. Tan|S. Rao|P. Chia|S. Sadarangani|Y. Chin|L. Ng|L. Renia|R. Lin|D. Lye|L. Wang|C. Tan|B. Young"
"1788","12/04 12:00","43","P0427","Karolina AKINOSOGLOU","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Correlation of immune response with COVID-19 outcomes","V. Dimakopoulou|A. De Lastic|M. Rodi|A. Mouzaki|K. Akinosoglou|D. Georgakopoulou|V. Apostolopoulos"
"1813","12/04 12:00","44","P0428","Essy MOZAFFARI","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-CoV-2 infection and hospitalisations in the omicron era: triangulation of symptom onset, positive test, and vaccination","E. Mozaffari|N. Quignot|M. Bartoletti|N. Montano|G. Pesce|G. Gusto|M. Berry|T. Oppelt|A. Kalil|P. Loubet"
"1829","12/04 12:00","45","P0429","Tadas ALCAUSKAS","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Longitudinal analysis of antibody dynamics post-COVID-19 vaccination in the context of healthcare worker-driven COVID-19 transmission","V. Gurksniene|T. Alcauskas|F. Majauskaite|L. Jancoriene|J. Urboniene"
"1851","12/04 12:00","46","P0430","Sibra R.M. SHIHAB","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Comparative subgenomic RNA expression profiles in SARS-CoV-2 variants: insights from symptomatic and asymptomatic cases in Sri Lanka","B. Iqbal|S. Shihab|A. S. Abdeen|S. Arunasalam|T. Zhang|L. Poon|M. Peiris|F. Noordeen"
"1857","12/04 12:00","47","P0431","Sibra R.M. SHIHAB","9","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Uncovering mutational drivers of enhanced transmission in the B.1.411 SARS-CoV-2 lineage in Sri Lanka","B. Iqbal|S. Shihab|S. Arunasalam|A. Abdeen|T. Zhang|L. Poon|M. Peiris|F. Noordeen"
"1986","12/04 12:00","2","P0434","Maria FERNANDEZ","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Work productivity losses after COVID-19 infection among high-risk US patients with or without treatment with nirmatrelvir/ritonavir","M. Fernandez|B. Brady|K. Evans|A. Cha-Silva|R. Shah|G. Sidhu|P. Cislo|F. Ernst|J. Cappelleri|M. Chaudhary|E. Drabo|R. Mokgokong"
"2062","12/04 12:00","3","P0435","David SMITH","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluating the efficiency of population-based infectious disease surveillance: a modelling study","D. Smith|S. Campbell|J. Robotham|S. Walker|K. Pouwels"
"2133","12/04 12:00","4","P0436","Berta PERNAS-SOUTO","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Changes in management of immunosuppressed patients with SARS-CoV-2 infection: impact on cure and mortality rates","B. Pernas|V. Balboa|F. Pena|J. Gutierrez|A. Pérez|S. Cabezal|A. Canosa|O. Porto|L. Gutierrez|E. Miguez"
"2173","12/04 12:00","5","P0437","Berta PERNAS-SOUTO","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Persistent SARS-CoV-2 infection among immunosuppressed patients: characterisation of subpopulations of lymphocytes","B. Pernas|B. Castelo|V. Balboa|D. Brandariz|F. Pena|A. Fernández|A. Alonso|R. Fernandez|J. Gutierrez|E. Miguez"
"2293","12/04 12:00","6","P0438","Yenan FENG","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020-2023","Y. Feng|S. Chen|A. Wang|Z. Zhao|C. Chen"
"2296","12/04 12:00","7","P0439","Jong Su JONG SU","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Fc-mediated effector functions in mild and severe COVID-19: focus on ADE and ADCP","K. Jong Su|C. Sungim|J. Hee Bum|K. Jisoo|K. Sung-Han|P. Seong-Yeon"
"2331","12/04 12:00","8","P0440","Cao CHEN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China","C. Chen|Y. Feng|Z. Yin|M. Pang|Q. Shi|X. Ma|X. Dong"
"2415","12/04 12:00","9","P0441","Hamidi-Fard MOJTABA","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of Lactobacillus gasseri on inflammatory responses in intestinal cells exposed to SARS-CoV-2","O. Khormaei|S. Mehrabian|M. Aghasadeghi|A. Akhavan|H. Mojtaba"
"2445","12/04 12:00","10","P0442","Sonsoles SALTO-ALEJANDRE","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Development and internal validation of a simplified scoring model with CURB-65 plus RNAemia for predicting mortality at diagnosis of SARS-CoV-2 pneumonia","S. Salto-Alejandre|C. Rodriguez-Urbistondo|J. Martin-Escolano|A. Ruiz-Molina|C. Infante-Dominguez|G. Abelenda-Alonso|M. Del Álamo|N. Maldonado|F. Arnaiz-De Las Revillas|J. Alba|A. Rombauts|R. Rodriguez-Alvarez|Z. Palacios-Baena|C. González-Rico|S. Santibanez|M. Carretero-Ledesma|L. Merino|B. Gutiérrez-Gutiérrez|M. Gozalo-Marguello|C. Farinas|J. Oteo|A. Goikoetxea-Agirre|J. Carratalà|J. Rodriguez-Bano|E. Cordero|R. Alvarez-Marin|M. Aguilar-Guisado|J. Cisneros|J. Pachon|J. Sánchez-Céspedes"
"2448","12/04 12:00","11","P0443","Georgios SCHINAS","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The impact of baricitinib on systemic inflammation in COVID-19 and its association with prolactin: an exploratory analysis of interleukin levels","G. Schinas|E. Polyzou|A. Delastic|D. Georgakopoulou|T. Karampitsakos|T. Galanis|D. Velissaris|M. Marangos|A. Tzouvelekis|A. Mouzaki|K. Akinosoglou"
"2451","12/04 12:00","12","P0444","Muhammad Ismail BIN ABDUL MALEK","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","A nationwide cohort study of delta and omicron SARS-CoV-2 outcomes in older Singaporean adults stratified by frailty","M. Bin Abdul Malek|L. Wee|X. Loy|J. Lim|W. Kwok|C. Chiew|C. Lien|B. Rosario|Y. Leong|R. Merchant|D. Lye|K. Tan"
"2502","12/04 12:00","13","P0445","Huajie XU","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-CoV-2 infection and different-term thrombotic outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study","H. Xu|C. Zhixue|B. Hu"
"2510","12/04 12:00","14","P0446","Mohammadreza SHAFIEI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Efficacy of HMG-CoA reductase inhibitors in hospitalisation and mortality of COVID-19 patients: a meta-analysis of randomised control trials","M. Shafiei|M. Keykhah"
"2536","12/04 12:00","15","P0447","Dominik DIETLER","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Trends in type 1 diabetes incidence between 2007 and 2023 and its association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years in Sweden","D. Dietler|J. Björk|E. Palmkvist|A. Carlsson"
"2541","12/04 12:00","16","P0448","Sam MATTHEWS","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","A validated threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19 enabling rapid development for future SARS-CoV-2 variants","R. Edge|S. Matthews|J. Pura|B. Ahani|A. Aksyuk|L. Clegg|M. Esser|L. Chang|I. Hirsch|T. Villafana|J. Perez|O. Stepanov|K. Streicher|T. White|T. Cohen|D. Follmann|P. Gilbert|S. Seegobin"
"2587","12/04 12:00","17","P0449","Ana ATTI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Characterisation of serological response against SARS-CoV-2 throughout the pandemic within the UK-based SIREN study","A. Atti|E. Carr|F. Insalata|A. Otter|S. Foulkes|M. Wu|R. Beale|A. Charlett|S. Hopkins|V. Hall"
"2591","12/04 12:00","18","P0450","Chiara SINISCALCHI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","MicroRNAs in SARS-CoV-2 infection: analysis of immunocompromised and non-immunocompromised patients","C. Siniscalchi|A. Di Fraia|M. Starace|C. Minichini|F. Fusco|S. Imbriani|C. Ricozzi|K. Gjeloshi|R. Astorri|A. Russo|C. Sagnelli|M. Pisaturo|N. Coppola"
"2626","12/04 12:00","19","P0451","Ruth MOKGOKONG","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Development of the long COVID/post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument","D. Chandler|S. Tatlock|B. Abramoff|C. Bramson|J. Cappelleri|A. Chohan|M. Harrington|H. Jamal|J. Lusk|I. Mazar|R. Paredes|A. Ustianowski|E. Weinstein|R. Mokgokong"
"2682","12/04 12:00","20","P0452","Sonia LEWYCKA","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of the COVID-19 pandemic on healthcare seeking and antibiotic prescribing for acute respiratory infection in primary care centres in Nam Dinh province, Vietnam: analysis of routinely collected electronic prescription data","S. Trinh|J. Chan|T. Vu|N. Do|M. Vu|Y. Nguyen|T. Vu|T. Nguyen|Q. Pham|D. Dang|H. Tran|T. Nguyen|H. Cao|D. Amin|T. Nguyen|T. Kesteman|J. Nuil|M. Chambers|T. Vu|H. Doorn|S. Lewycka"
"2699","12/04 12:00","21","P0453","Matthew ROUSCULP","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Relative effectiveness of COVID-19 vaccinations in immunocompromised individuals: a real-world study in South Korea","E. Gwak|S. Choe|M. Gschwend|J. Fix|M. Vadivale|M. Rousculp|Y. Choe"
"2726","12/04 12:00","22","P0454","Yi-Tsung LIN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Clinical outcomes of immunocompromised patients using tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan","Y. Wang|S. Liu|C. Chuang|C. Juan|Y. Lin|S. Chou|Y. Ho"
"2825","12/04 12:00","23","P0455","Violeta BRICIU","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Inflammatory biomarkers in hospitalised COVID-19 patients during different pandemic waves as predictors for outcome","V. Briciu|D. Leucuta|M. Muntean|C. Cismaru|A. Radulescu|L. Herbel|A. Topan|M. Horvat|M. Flonta|M. Calin|R. Dobrota|M. Lupse"
"2987","12/04 12:00","24","P0456","Malwina MEJER","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of remdesivir in Portugal: enhancing healthcare capacity and outcomes in COVID-19","M. Mejer|L. Kilsdal|N. Siersbaek|J. Wahl"
"3015","12/04 12:00","25","P0457","Zhonghao WANG","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Increased MP/CP co-infection in COVID-19-positive kidney transplant recipients","Z. Wang"
"3044","12/04 12:00","26","P0458","Shinya TSUZUKI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of long COVID on health-related quality-of-life among Japanese adults: findings of CARE Japan study","S. Sultana|A. Yusuke|S. Tsuzuki|O. Norio|M. Nobuaki|I. Haruhiko|O. Anna|I. Shinichiro"
"3139","12/04 12:00","27","P0459","Zhangfan FU","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Exploring the role of LAMP1 (CD107a) and PDCD1 high Tfh cells in COVID-19 immunopathogenesis and vaccine response","Z. Fu|J. Guo|J. Ai"
"3187","12/04 12:00","28","P0460","Julien AUCLAIRE","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-Cov-2 evolution in patients with prolonged viral shedding","J. Auclaire|N. Dossou|I. Gaubert|E. Leperchois|J. Hamel|A. Vabret|S. Corbert|B. Leterrier|M. Ar Gouilh"
"3271","12/04 12:00","29","P0461","Ana ATTI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Estimating population protection against emerging SARS-CoV-2 variants: a risk assessment utilising convalescent sera before the roll-out of XBB-lineage vaccines","A. England|J. Sung|S. Foulkes|J. Islam|A. Otter|K. Thomas|B. Hallis|S. Charlton|S. Hopkins|V. Hall|A. Atti"
"3315","12/04 12:00","30","P0462","Daniel PAN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Understanding COVID-19 mitigation behaviours during the pandemic: comprehensive analysis from 12,626 healthcare workers","C. Martin|J. Nazareth|A. O'reilly|M. Gogoi|L. Bryant|A. Masood|J. Choi|L. Pi|L. Gray|M. Barer|D. Hollingsworth|L. Nellums|K. Woolf|M. Pareek|D. Pan"
"3352","12/04 12:00","31","P0463","Pamela HAWN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Structure of VYD2311 & in vitro neutralisation against a panel of contemporary SARS-CoV-2 variants","D. Chupp|B. Williams|A. Kreher|J. Hourican|C. Powers|R. Martin|B. West|P. Hawn|F. Gao|R. Allen"
"3410","12/04 12:00","32","P0464","Sarah FOULKES","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Healthcare worker attitudes to lateral flow device testing and sick leave for influenza-like illness in the UK: a hypothetical scenario-based study","K. Munro|Q. Bustamante|L. Findlater|D. Sparkes|J. Rubin|A. Atti|S. Foulkes|S. Hopkins|V. Hall|J. Islam"
"3442","12/04 12:00","33","P0465","Emmanouil STYLIANAKIS","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Molecular pathways affected by anakinra treatment in patients with severe COVID-19: analysis of the SAVE-MORE trial","E. Stylianakis|G. Poulakou|S. Metallidis|H. Milionis|N. Keur|E. Taddei|G. Adamis|G. Dalekos|P. Panagopoulos|M. Netea|E. Giamarellos-Bourboulis|V. Kumar"
"3623","12/04 12:00","34","P0466","Craig WILLIAMS","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Non-invasive COVID-19 detection using FTIR spectroscopy and machine learning on nasopharyngeal and salivary samples","C. Williams|C. Meza|A. Segura|I. Rehman|G. Rozada"
"3629","12/04 12:00","35","P0467","Cindy M. LIU","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The nasal microbiome modulates risk for COVID-19 infection","D. Park|M. Aziz|J. Salazar|T. Pham|S. Nelson|J. Villani|N. Weber|L. Price|B. Hungate|C. Liu"
"3649","12/04 12:00","36","P0468","Basant Mahmoud ABDELHAMID","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Screening of COVID-19 antibodies in recovered healthcare workers after thee months and after six months","B. Abdelhamid|M. Gaafar"
"3706","12/04 12:00","37","P0469","Chloe DAVISON","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The effect of immunomodulatory therapy on the incidence of secondary bacterial and fungal infections of hospitalised COVID-19 patients in England, January 2020 – August 2023: a case-control study","C. Davison|R. Hope|C. Brown|L. Turtle|A. Ho|S. Gerver"
"3741","12/04 12:00","39","P0471","Nicole VAN DEN BRAAK","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Mental well-being and resilience during a pandemic: co-creating with students","S. Janssen|K. Verschueren|I. Bastiaanssen|G. Nagelhout|J. Nooij|N. Van Den Braak|E. Schrauwen"
"3757","12/04 12:00","40","P0472","Yong Yi TAN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Risk of multi-systemic long-term sequelae following COVID-19 in older adults, stratified by frailty: a population-based cohort study","Y. Tan|E. Loy|J. Lim|C. Chiew|D. Chien|K. Tan|L. Wee"
"3759","12/04 12:00","41","P0473","Luca MADDALONI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Different innate immune response in SARS-CoV-2 vaccinated and unvaccinated individuals with COVID-19","L. Maddaloni|G. Bugani|L. Santinelli|C. Mastroianni|G. Antonelli|C. Scagnolari|G. D'ettorre"
"3780","12/04 12:00","42","P0474","Irina LUT","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluating blood sampling strategies in large-scale multi-site cohort studies: insights from the SIREN study","I. Lut|N. Hettiarachchi|D. Blick|A. Otter|S. Foulkes|J. Islam|S. Hopkins|V. Hall|A. Atti"
"3842","12/04 12:00","43","P0475","Janice TAN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Risk of new-incident mental health diagnoses during COVID-19 and post-SARS-CoV-2 infection amongst children and young adults in Singapore: a retrospective cohort study","L. Wee|J. Lim|J. Tan|A. Yap|C. Chiew|T. Goh|S. Ong|C. Lim|D. Fung|D. Lye|K. Tan"
"3921","12/04 12:00","44","P0476","Janice TAN","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Long-term multi-systemic sequelae following hospitalisation for respiratory syncytial virus vs omicron SARS-CoV-2/influenza in Singaporean adults and children","L. Wee|R. Ho|J. Lim|J. Tan|C. Chiew|D. Lye|K. Tan"
"3998","12/04 12:00","45","P0477","Irini ZOGRAFAKI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Understanding winter and summer surges of COVID-19 in the post pandemic period: a multinational analysis of surveillance data for 2023-2024","I. Zografaki|C. Reynard|J. Spinardi|S. Lopez|M. Mc Colgan|R. Sini De Almeida|D. Malhotra|D. Curcio"
"4025","12/04 12:00","46","P0478","Tanu BANSAL","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Analysing adaptive immune responses to BBV152 (Covaxin) and ChAdOx1 nCoV-19 (Covishield)","T. Bansal|T. Choudhury|H. Bhakhri|S. Reddipalli|K. Luthra|J. Kumar"
"4051","12/04 12:00","47","P0479","Arianna LIPPI","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Longitudinal humoral response to SARS-CoV-2 mRNA vaccines and boosters in heart and lung transplant patients","A. Lippi|C. Coppola|S. Costagli|F. Pierguidi|G. Montesi|M. Fabbiani|M. Zanchi|S. Bernazzali|D. Bennett|S. Lucchesi|J. Polvere|D. Medaglini|M. Tumbarello|A. Ciabattini|F. Montagnani"
"4056","12/04 12:00","48","P0480","Priscila TRINDADE","10","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Retrospective analysis of SARS-CoV-2 omicron variant prevalence over two years in southern Brazil","B. Piccoli|T. Y. Castro|B. Casarin|L. Tessele|A. Daneli|A. Seerig|A. Vieira|V. Santos|J. Kuhns|R. Marchesan|A. Schwarzbold|P. Trindade"
"4097","12/04 12:00","1","P0481","Manuel KRONE","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Association of AB0 blood type with humoral immune responses to SARS-CoV-2 vaccination and infection","J. Mees|I. Wagenhäuser|J. Reusch|T. Schmer|N. Schossee|A. Gabel|N. Petri|M. Krone|J. Kossler"
"4135","12/04 12:00","2","P0482","Phillip SWANSON","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Low dosage of a novel SARS-COV-2 mRNA VLP vaccine elicits equivalent cell-mediated immunity to a licensed mRNA vaccine","P. Swanson|M. Padilla|N. Battaglia|M. Powell|A. Pack|R. Cimbro|A. Stanley|T. Roe|T. Oyedele|S. Cromer Berman|L. Chang"
"4163","12/04 12:00","3","P0483","Juliane MEES","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Dynamics of cellular and humoral immune responses in healthcare workers following a fourth COVID-19 vaccination","J. Mees|J. Rätz|I. Wagenhäuser|J. Reusch|A. Gabel|N. Petri|B. Weissbrich|K. Knies|L. Dölken|N. Beyersdorf|M. Krone"
"4211","12/04 12:00","4","P0484","Imran HASANOGLU","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Short-term challenges, long-term consequences: a comprehensive study of COVID-19 in solid organ transplant recipients","G. Cinar|G. Okut|T. Yanik Yalcin|A. Mete|K. Memikoglu|A. Altunsoy|B. Tatar|T. Yamazhan|D. Seyman|K. Ozden|E. Oruc|Y. Tezer Tekçe|O. Eren Kutsoylu|K. Hizel|Y. Uygun Kizmaz|S. Arslan Ozel|O. Ozgen Top|S. Alkan|V. Avkan-Oguz|N. Altin|E. Tatar|O. Kirimker|E. Karakaya|A. Bulut|E. Olcucuoglu|D. Turan Gokce|C. Tugmen|B. Kenanoglu|A. Aslaner|G. Ozturk|S. Cetinkunar|T. Egeli|E. Ok|A. Halis|B. Voyvoda|O. Helvaci|H. Kurt|H. Sahin|H. Arslan|A. Dalkiran Baydar|I. Hasanoglu|A. Ari"
"4224","12/04 12:00","5","P0485","Julia DEICHMANN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Antibody kinetics and duration of protection against SARS-CoV-2 following vaccination","J. Deichmann|N. Barda|M. Canetti|Y. Peretz|Y. Ottolenghi|Y. Lustig|G. Regev-Yochay|M. Lipsitch"
"4467","12/04 12:00","6","P0486","Orla HILTON","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Characterisation of young vs older stroke in hospitalised patients with COVID-19 infection: a UK based, multicentred, case-control study","O. Hilton|S. Ray|G. Wood|B. Michael|C. Dunai|F. Egbe|J. Jones|A. Ross Russell|J. Grixti|D. Kell"
"4515","12/04 12:00","7","P0487","David FISMAN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Regression-based forecasting of SARS-CoV-2-related ICU admissions during the pandemic: impact of widespread vaccination","A. Tuite|A. Grima|D. Fisman|E. Lee|N. Wilson"
"4565","12/04 12:00","8","P0488","Yu-Lung HSU","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Correlation analysis of immune checkpoint molecules in children with post-acute sequelae of SARS-CoV-2 infection in Taiwan","Y. Hsu|P. Chen|L. Wu|K. Hsieh|H. Lai|H. Lin|K. Hwang|J. Wang"
"4612","12/04 12:00","9","P0489","Anastasiya SUSHKOVA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Validation and longitudinal analysis of the consensus immune dysregulation framework in a multi-cohort study of COVID-19","A. Sushkova|A. Moore|A. Ganesan|H. Zheng|J. Enriquez|S. Orde|A. Rogers|M. Shojaei|P. Khatri"
"4623","12/04 12:00","10","P0490","Tsz Kin Mark CHENG","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Chronic SARS-CoV-2 infection demonstrate immune compromisation type- and intensity-dependent viral load dynamics and adaptive evolution trajectory: results from an aggregated meta-analysis","T. Cheng|T. Bell|B. Wang|L. Tillman|O. Tam|I. Khan|A. Mendonca|K. Kamelian|R. Gupta"
"4637","12/04 12:00","11","P0491","Mi-Kyung LEE","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Both clinical status and practices affect microbiome dynamics of the upper respiratory tract during COVID-19 infection","M. Lee|J. Yun|T. Kim"
"4657","12/04 12:00","12","P0492","Genovefa PAPANICOLAOU","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Antibody responses to SARS-CoV2 among cancer patients in New York city during the 2020 wave of the COVID-19 pandemic","M. Gianniki|Y. Li|G. Papanicolaou|Y. Hinwar|K. Walsh"
"4673","12/04 12:00","13","P0493","Ana Paula BARBOZA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Artificial intelligence-enhanced nurse navigation: a new paradigm for long COVID diagnosis and care","A. Barboza|A. Luna-Muschi|R. Monteiro|A. Santos Silva|C. Salete|G. Castro|R. Carvalho|J. Santana|D. Silva|R. Silva|G. Romitelli|J. Veneziani|E. Silva|A. Barboza|R. Ribeiro|S. Costa"
"4705","12/04 12:00","14","P0494","Ana Paula BARBOZA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Nasopharyngeal microbiome evolution after SARS-CoV-2 infection: insights into long COVID progression","A. Barboza|S. Costa|N. Coimbra|J. Fonseca|L. Time|N. Scaccia"
"4744","12/04 12:00","15","P0495","Tomonori TAKANO","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Combination therapy with ensitrelvir and remdesivir reduces viral shedding duration in COVID-19 patients treated with anti-CD20 monoclonal antibodies","T. Takano|H. Aiba|H. Takemura|H. Kunishima"
"4821","12/04 12:00","16","P0496","Valente-Acosta VALENTE-ACOSTA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Epidemiology of Pseudomonas aeruginosa superinfection in critical COVID-19 patients in a tertiary-care teaching hospital in Mexico City","B. Valente-Acosta|G. Monjaras|I. Hoyo-Ulloa|F. Moreno-Sanchez"
"4862","12/04 12:00","17","P0497","Hye Hee CHA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Neutralising antibody responses against omicron variants in individuals vaccinated or unvaccinated with the bivalent BA.4/5 vaccine: a six-month prospective study","H. Cha|J. Kim|J. Kwon|J. Cha|S. Kim|C. Jang|W. Kim|J. Son|S. Lim|S. Kim"
"5015","12/04 12:00","18","P0498","Ji-Soo KWON","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Cytokine profile-based symptom clustering in patients with post-acute sequelae of COVID-19","J. Kwon|C. Jang|W. Kim|J. Son|J. Cha|E. Chang|S. Kim"
"5100","12/04 12:00","19","P0499","Anna GORSKA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","A dynamic latent transition model for predicting post-COVID condition trajectories and guiding patient management","A. Gorska|R. Gusinow|E. Gentilotti|I. Lopes-Rafegas|L. Canziani|M. Caponcello|G. De Boer|M. Di Chiara|A. Florence|K. Wold|S. Cataudella|J. Hasenauer|G. Hara|M. Giannella|L. Cedric|A. Tami|E. Tacconelli"
"5135","12/04 12:00","20","P0500","Shinichiro MORIOKA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Factors associated with silent hypoxia in patients with COVID-19","S. Morioka|M. Mori|N. Iwamoto|S. Saito|M. Hojo|K. Teruya|N. Ohmagari|T. Morita|M. Sugiyama"
"5192","12/04 12:00","21","P0501","Anna LAGNI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Different transcriptional metabolic response in SARS-CoV-2 infected CFTR-defective vs wild-type bronchial cells","A. Lagni|V. Lotti|E. Diani|R. Cecchetto|E. Tonon|C. Sorio|D. Gibellini|P. Melotti"
"5278","12/04 12:00","22","P0502","Kwok KIN ON","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Kinetics of neutralising antibodies against omicron BA.2 and BA.5 beyond the acute phase of infection in residential care homes for the elderly","K. Kin On|P. Chan|M. Edward|S. Wong|W. Wei"
"5341","12/04 12:00","23","P0503","Pierantonio GRIMALDI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Long COVID in a cohort of patients hospitalised for COVID-19","P. Grimaldi|A. Russo|L. Onorato|C. Monari|K. Gjeloshi|S. Imbriani|C. Ricozzi|F. Caruso|C. Curatolo|R. Palladino|F. Milite|C. Cacace|M. Pisaturo|N. Coppola"
"5422","12/04 12:00","24","P0504","Ashwin MAK","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Immunological imprinting by seasonal coronaviruses and previous herpesvirus infections in patients with long COVID","D. Wapperom|A. Redel|J. Koeleman|P. Smit|W. Lam-Tse|T. Van Der Poll|H. Chen|J. Den Dunnen|G. Braunstahl|D. Ong|A. Mak"
"5435","12/04 12:00","25","P0505","Siméon DE BRUIJN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Post-COVID in autumn 2023: pre- and post-infection comparison","S. De Bruijn|A. Huiberts|S. Andeweg|C. Hoeve|M. Schipper|H. De Melker|J. Van De Wijgert|S. Van Den Hof|M. Knol|C. Van Den Wijngaard"
"5549","12/04 12:00","26","P0506","Ji Soo CHOI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The effect of SARS-CoV-2 mRNA vaccination on contagiousness of individuals with breakthrough infection following vaccination: a systematic review and meta-analysis of over six million study participants","J. Choi|D. Pan|D. Barnes|M. Choi|M. Fahad|J. Nazareth|C. Martin|M. Pareek|P. Divall"
"5654","12/04 12:00","27","P0507","Merlin VAN LOENEN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Prevalence of post-COVID syndrome and its societal impact","M. Van Loenen|S. De Bruijn|L. Van Leersum-Bekebrede|I. Rahmon|S. Van Den Hof|C. Van Den Wijngaard|E. Marra"
"5661","12/04 12:00","28","P0508","David GREENWOOD","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Sequential SARS-CoV-2 antigen exposures drive durable, broad and non-waning neutralising antibodies over four years","D. Greenwood|J. Gahir|M. Shawe-Taylor|H. Townsley|M. Wu|E. Carr|D. Bauer|E. Wall"
"5667","12/04 12:00","29","P0509","Raph L. HAMERS","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Anti-SARS-CoV-2 antibody and cellular immune responses to third, fourth and fifth heterologous vaccine doses in Indonesian healthcare workers","S. Suwarti|E. Nelwan|S. Zanjabila|R. Sinto|Y. Anggraini|M. Zwedie|B. Kronsteiner|C. Tan|L. Tan|S. Dunachie|R. Hamers"
"5700","12/04 12:00","30","P0510","Anna Maria AZZINI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-CoV-2 infection management in haematological malignancy patients: the ORCHESTRA Delphi consensus","L. Canziani|A. Azzini|J. Salmanton-Garcia|A. Savoldi|M. Caponcello|Z. Pasquini|L. Pagano|O. Cornely|A. Cingolani|A. Vergori|F. Cosentino|J. Rodriguez Bano|M. Krampera|E. Tacconelli"
"5730","12/04 12:00","31","P0511","Kelvin Bryan TAN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Social support in a pandemic: impact of household situation on severity of COVID outcomes","N. Goh|A. Yap|C. Leong|K. Tan"
"5759","12/04 12:00","32","P0512","Francesca BOBBIO","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Impact of secondary infections on the outcomes of patients with SARS-CoV-2 infection and heamatological malignancies","F. Bobbio|C. Pellicano|F. Petrucci|F. Cogliati Dezza|S. Valeri|S. Covino|S. Figliomeni|A. Gigante|F. Sacco|A. Viscido|A. Iacovelli|E. Rosato|P. Palange|C. Mastroianni|A. Oliva"
"5762","12/04 12:00","33","P0513","Joshua GAHIR","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","First antigenic exposures to SARS-CoV-2 Spike inform subsequent Omicron infection risk but do not indelibly shape longitudinal neutralising immunity","D. Greenwood|J. Gahir|M. Shawe-Taylor|H. Townsley|M. Wu|E. Carr|D. Bauer|E. Wall"
"5806","12/04 12:00","34","P0514","Harriet DICKINSON","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Routinely captured measurements of vital signs within long-term care facilities indicate substantial and sustained physiological impacts associated with COVID-19 infection","H. Dickinson|R. Gupta|A. Norfolk|B. Wagner|K. Mathers|S. Davies|S. Wang|C. Anand"
"5849","12/04 12:00","35","P0515","Christian FAZEKAS","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Chronic stress prior to SARS-CoV-2 infection as predictor of ongoing symptomatic COVID-19","A. Eberl|C. Fazekas|J. Lodron|M. Rijksen|H. Kessler|T. Binz|A. Wittmann|S. Pilz|H. Sourij|B. Hanfstingl|F. Matzer|A. Avian|N. Goswsmi|E. Stelzl|C. Vögel|K. Voyko|A. Groselj-Strele"
"6120","12/04 12:00","36","P0516","Sándor MAHIEU","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Assessing the impact of public health policies affecting indoor SARS-CoV-2 transmission: a retrospective analysis in Amsterdam","S. Mahieu|Z. Fang|Q. Bosch|Ten|J. Bosdriesz"
"6130","12/04 12:00","37","P0517","Alessandra D'ABRAMO","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluation of SARS-CoV-2 spike mutations in immunocompromised and immunocompetent patients before and after SARS-CoV-2 treatment","A. D'abramo|S. Vita|M. Rueca|A. Nappo|F. Smoquina|A. Bettini|L. Fabeni|G. Maffongelli|A. Corpolongo|G. Berno|C. Gruber|F. Maggi|E. Nicastri"
"6151","12/04 12:00","38","P0518","Santiago MELÓN GARCÍA","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","New circulating variants of SARS-CoV-2 in Asturias during the post-COVID era","J. Gonzalez-Alba|S. Rojo-Alba|Z. Perez-Martinez|E. Rodrigo Arrazola|J. Boga|C. Ochoa Varela|F. Abreu Salinas|S. Melon Garcia|M. Alvarez-Arguelles"
"6186","12/04 12:00","39","P0519","Elisa GENTILOTTI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Functional measurements of muscle strength and assessment of sarcopenia to evaluate post-COVID chronic fatigue","E. Gentilotti|A. Gorska|P. De Nardo|F. Cioli Puviani|D. Fasan|G. Maccarrone|G. Vantini|G. Stabile|S. Zambaldo|E. Zoico|M. Zamboni|E. Tacconelli"
"6201","12/04 12:00","40","P0520","Sarah FOULKES","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluating the feasibility of SARS-CoV-2 and influenza genomic sequencing from lateral flow devices: a pilot study within the UK SIREN cohort","K. Munro|Q. Bustamante|M. Cairns|S. Foulkes|K. Lewandowski|K. Rogers-Broadway|C. Ryan|D. Williamson|R. Vipond|S. Hopkins|S. Pullan|A. Atti|J. Islam|V. Hall"
"6222","12/04 12:00","41","P0521","Jo Yi CHOW","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluating quasi-experimental approaches for estimating vaccine effectiveness: an empirical and simulated COVID-19 study","J. Chow|J. Lim"
"6250","12/04 12:00","42","P0522","Peter MORTENSEN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Forecasting the impact of declining COVID-19 vaccination rates: scenario analysis using machine learning-enabled susceptible-infected-recovered models in England","P. Mortensen|S. Rautenbach|M. Gallotta|N. Sharapova|I. Takkides|M. Wright|M. Linley"
"6263","12/04 12:00","43","P0523","Hannah HAMILTON HURWITZ","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","From evaluation to action: applying WHO IPC COVID-19 outcomes/impact evaluation findings to current public health emergency responses","H. Hamilton Hurwitz|V. Willet|N. Femi|W. Joanna|A. Baller|E. Clery"
"6434","12/04 12:00","44","P0524","Michele ANTONACCI","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-CoV-2 vaccination influence in development of long-COVID clinical phenotypes","P. Pasculli|M. Antonacci|M. Zingaropoli|F. Dominelli|F. Ciccone|F. Pandolfi|Y. Fosso Ngangue|G. Masci|R. Campagna|F. Iafrate|V. Panebianco|C. Catalano|T. Ombretta|G. Galardo|P. Palange|C. Mastroianni|M. Ciardi"
"6472","12/04 12:00","45","P0525","Saikhuan TOWACHIRAPORN","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The association between COVID-19 vaccination with the prevalence of post-COVID conditions in Thai patients with mild COVID-19","S. Towachiraporn|H. Thongwitokomarn|P. Salee"
"6499","12/04 12:00","47","P0527","Sándor MAHIEU","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The impact of non-pharmaceutical interventions implemented during the COVID-19 pandemic on the number of close contacts of SARS-CoV-2 cases in the Netherlands","A. Bellaar|S. Mahieu|E. Boogert|Den|S. Campman|N. Dukers-Muijrers|E. Fanoy|H. Götz|I. Goverse|J. Heijne|S. Hof|Van Den|I. Joore|T. Leenstra|M. Petrignani|S. Raven|K. Wevers-De Boer|M. Schim-Van Der Loeff|J. Bosdriesz"
"6541","12/04 12:00","48","P0528","Carsten VAN ROSSUM","11","B","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Spatio-temporal modelling of inequalities in the 2020-2021 COVID-19 pandemic waves in the Netherlands using reported SARS-CoV-2 infections and hospitalisations","C. Van Rossum|D. Drenth|C. Bussemakers|J. Backer|I. Veldhuijzen|A. Tostmann|F. Giardina"
"6569","12/04 12:00","1","P0529","Kees C. VAN DEN WIJNGAARD","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Prospective one-year post-acute sequelae of COVID-19 in youth","A. Tulen|S. De Bruijn|T. Van Der Maaden|E. Mutubuki|A. Van Hoek|S. Van Den Hof|E. Franz|K. Van Den Wijngaard|M. Schipper|J. Rodenburg|H. Boshuizen|M. Luijten|L. Haverman|E. Sanders|H. Knoop"
"6607","12/04 12:00","2","P0530","Thibault KERDILES","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Higher SARS-CoV-2 viral load and delayed viral clearance in patients with autoantibodies neutralizing type I interferons","T. Kerdiles|A. Gervais|L. Bizien|P. Bastard|A. Puel|G. Lingas|C. Massonnaud|F. Mentré|M. Bouscambert|N. Peiffer-Smadja|J. Guedj|L. Abel|J. Casanova|M. Hites|F. Ader|J. Bertrand|A. Cobat"
"6618","12/04 12:00","3","P0531","Lyudmila NIAZYAN","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Features of long COVID-19 in the Armenian population","L. Niazyan|M. Simonyan|G. Asatryan|A. Tadevosyan"
"6657","12/04 12:00","4","P0532","Mohamed Hamouda Elsayed Ahmed Ali ELKASABY","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Platelet-rich plasma therapy for resistant post-COVID-19 olfactory dysfunction: a systematic review and meta-analysis of placebo-controlled studies","M. Elkasaby|A. Elkoumi|O. Elkoumi"
"6678","12/04 12:00","5","P0533","Hanieh RADKHAH","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Brachial neuritis as a side effect of COVID-19 vaccine: a systematic review on reported cases","H. Radkhah"
"6682","12/04 12:00","6","P0534","Hanieh RADKHAH","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Ophthalmoplegia following oculomotor, trochlear, or abducens nerves disorder after COVID-19 vaccination: a systematic review of reported cases","H. Radkhah"
"6862","12/04 12:00","8","P0536","Romina QUERCIA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Assessing the synergistic effect of NMV-r and acquired immunity in reducing severe COVID-19","W. Bao|W. Wisemandle|H. Leister-Tebbe|R. Quercia|J. Hammond"
"6865","12/04 12:00","9","P0537","Patricia BRUIJNING-VERHAGEN","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Viral co-infection reduces SARS-CoV-2 illness severity in community, but not in healthcare cohorts: a meta-analysis of 11 prospective studies","M. De Hoog|E. Hauser-Westrhenen|D. Eggink|H. Goossens|S. Van Lelyveld|S. Euser|M. De Jong|P. Bruijning-Verhgane|R. Schuurman|A. Van Der Velden|M. Van Houten|J. Wildenbeest|M. Bonten|L. Duijts|J. Van de Wijgert"
"6897","12/04 12:00","10","P0538","Nelly Daniela ZURITA CRUZ","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evaluation of digital PCR technique for the study of SARS-CoV-2 viremia as a predictor of poor clinical evolution","N. Zurita|L. Fontán|E. Roy|L. Sevillano|E. Lomas|L. Cardenoso Domingo"
"6928","12/04 12:00","11","P0539","Dimosthenis CHOCHLAKIS","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Challenges on the implementation of wastewater as a prediction tool: the paradigm of SARS-CoV-2","D. Chochlakis|G. Tzedakis|A. Kokkinomagoula|M. Malliarou|A. Ntoula|A. Koutsolioutsou|V. Sakkalis|A. Psaroulaki"
"6953","12/04 12:00","12","P0540","André ALMEIDA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Long-term exposure to air pollution and serum levels of inflammatory markers in acute severe COVID-19: an ICU based multicentric study","A. Almeida|J. Monjardino|R. Pereira|S. Rodrigues|J. Cidade|S. Rodeia|H. Tente|A. Abecasis|T. Mertens"
"7041","12/04 12:00","13","P0541","Sonia QURESHI","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Long term impact on lung function of patients with moderate and severe COVID-19: a prospective cohort study","S. Qureshi|N. Nasir|N. Rashid|N. Ahmad|Z. Haq|F. Qamar"
"7084","12/04 12:00","14","P0542","Alpana MOHTA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Mucocutaneous adverse events following COVID-19 vaccination- a clinico-histopathological correlation study","A. Mohta"
"7179","12/04 12:00","15","P0543","Lourdes MATEU PROUNONOSA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The consequences of reinfections in long COVID patients","C. Lopez-Rodriguez|C. Loste|G. Llados|J. Santos|F. Munoz-Lopez|A. Chamorro|C. Herrero|A. Garcia|E. Caballero|C. Amarilla|J. Munoz-Moreno|A. Prats|C. Rodriguez Fumaz|R. Paredes|M. Massanella|L. Mateu"
"7193","12/04 12:00","16","P0544","Philipp WÖHLER","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","The role of leptin on macrophage function in patients with COVID-19","P. Wöhler|R. Vollenberg|F. Krus|A. Keimburg|A. Kretschmer|C. Do|F. Dewald|A. Simonis|S. Theobald|R. Hanssen|J. Rybniker|F. Klein|K. Peiffer|C. Lehmann|J. Trebicka|P. Tepasse|J. Fischer"
"7220","12/04 12:00","17","P0545","Ha LE THANH","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Risk and resilience for depression, anxiety, and stress among healthcare workers and health-related staff in Indonesia, Nepal, and Vietnam during COVID-19: a multi-site cross-sectional study","L. Ha|L. Chang|T. Thao|K. Aria|I. Jennifer|C. Mary|L. Sonia"
"7251","12/04 12:00","18","P0546","Patricia MARTELETO SCANAVEZ","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","SARS-CoV-2 reinfections in a large cohort study: results from the UnCoVER-Brazil project","P. Scanavez|Y. Oliveira|M. Sawan|R. Monteiro|S. Baroni|A. Yamamoto|L. Colli|F. Carvalho|B. Fonseca|F. Bellissimo-Rodrigues|P. Capretz Agy|R. Santana"
"7486","12/04 12:00","19","P0547","Anil BOZDOGAN","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Graphene biosensors: bridging basic science and applied diagnostics for viral infections","A. Bozdogan|A. Herdina|R. Strassl"
"7549","12/04 12:00","20","P0548","Elisa GENTILOTTI","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Post-COVID condition in vulnerable populations: the ORCHESTRA Delphi consensus on prevention, diagnosis and management","E. Gentilotti|A. Azzini|L. Canziani|M. Caponcello|A. Savoldi|P. De Nardo|Z. Palacios-Baena|B. Tazza|N. Carroccia|A. Tavelli|A. D'arminio Monforte|M. Giannella|J. Rodriguez Bano|E. Tacconelli"
"7600","12/04 12:00","21","P0549","Dalia RAÏCH-REGUÉ","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Humoral immunity after PHH-1V COVID-19 booster vaccination in adults with immunosuppressive conditions","R. Dalia|A. Ester|P. Edwards|B. Rytis|T. Benjamin|A. Yovaninna|B. Susana|C. Jorge|F. Laura|G. Julia|M. Beatriz|B. Julià|I. Nuria"
"7633","12/04 12:00","22","P0550","Elisa GENTILOTTI","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Evolution of determinants and severity of post-COVID Condition across 24 months: the ORCHESTRA long-term sequelae extended follow up","E. Gentilotti|A. Gorska|L. Canziani|A. Visentin|R. Gusinow|M. Caponcello|M. Di Chiara|A. Florence|S. Cataudella|J. Hasenauer|G. Levy Hara|I. Lopes-Rafegas|K. Wold|A. Tami|M. Giannella|C. Laouenan|J. Rodriguez Bano|E. Tacconelli"
"7680","12/04 12:00","23","P0551","Samya DA SILVA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Challenges in the diagnosis of SARS-CoV-2 infection in the nervous system","S. Da Silva|M. Cabral-Castro|C. Gonçalves|D. Mariani|O. Ferreira|A. Tanuri|M. Puccioni-Sohler"
"7681","12/04 12:00","24","P0552","Samya DA SILVA","9","A","01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Challenges in the diagnosis of SARS-CoV-2 infection in the nervous system","S. Da Silva|M. Cabral-Castro|C. Gonçalves|D. Mariani|O. Ferreira|A. Tanuri|M. Puccioni-Sohler"
"571","12/04 12:00","1","P2731","Teresa NASCIMENTO","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Unveiling the skin mycobiome: fungal diversity in intensive care patients","T. Nascimento|J. Inácio|D. Guerreiro|L. Proença|P. Patricio|C. Toscano|H. Barroso"
"992","12/04 12:00","2","P2732","Gargi RAI","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Integrative transcriptome profiling and flow cytometric analysis of Th1/Th17 cell dynamics in chronic dermatophytosis","G. Rai|S. Das|P. Singh"
"3954","12/04 12:00","3","P2733","Bram SPRUIJTENBURG","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Impact of loss of heterozygosity in diploid fungi on outbreak detection","B. Spruijtenburg|J. Rhodes|J. Buil|A. Prigitano|A. Tortorano|E. De Carolis|M. Sanguinetti|M. Ilkit|A. Arastehfar|C. Lass-Flörl|J. Meis|T. De Groot|E. Meijer"
"5962","12/04 12:00","4","P2734","Silvia ANCONA","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Planktonic and sessile Candida albicans cells release extracellular vesicles carrying the virulence factor Eno1p","S. Ancona|F. Triva|E. Ottaviano|C. Bernardelli|A. Villa|E. Lesma|E. Borghi"
"6158","12/04 12:00","5","P2735","Haseen AHMAD","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","In vitro evaluation of thermal stress on the biofilm formation by a neurotropic fungus, Cladophialophora bantiana","H. Ahmad|H. Kaur|P. Salunke|D. Chatterjee|A. Takkar|A. Ghosh|S. Rudramurthy"
"6751","12/04 12:00","7","P2737","Ming Horng TSAI","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","The influence of biofilm forming abilities and fluconazole trailing effect of clinical candida albicans isolates on the outcomes of children with Candida bloodstream infections","M. Tsai|J. Hsu|S. Chu"
"6926","12/04 12:00","8","P2738","Thomas TAYNTON","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Longitudinal analysis of the mycobiome in acute leukaemia using metagenomic long-read sequencing","T. Taynton|G. Barlow|D. Allsup|M. Hardman"
"7192","12/04 12:00","9","P2739","Justyna KARKOWSKA-KULETA","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Impact of extracellular vesicles from various species of Candida fungi on the cross-species adhesion to human epithelial cells","J. Karkowska-Kuleta|Z. Majerz|K. Kulig|K. Kowalik|M. Rapala-Kozik"
"7203","12/04 12:00","10","P2740","Vanessa MEZA-PEREZ","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Rapid onset cardiac pathology caused by a virulent and antifungal-resistant Candida auris outbreak lineage isolate","V. Meza-Perez|T. Simmons|S. Jones|L. Doorley|A. Iverson|C. Johnson|A. Mcknight|S. Wilde|L. Janke|J. Rosch|J. Rybak"
"7237","12/04 12:00","11","P2741","Jack MCHUGH","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Serum cytokine profiles in patients with candidaemia","J. Mchugh|J. Bjerke|E. Nadarevic|P. Vergidis"
"7371","12/04 12:00","12","P2742","Alberto PAGOTTO","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Candidemia's silent weapon: biofilm's role and the race against time in candidemia outcomes","F. Dellai|F. Sbrana|A. Ripoli|D. Casagrande Pierantoni|A. Pagotto|D. D'elia|M. Geminiani|S. Giuliano|G. Cardinali|C. Tascini"
"7375","12/04 12:00","13","P2743","Dorota SATALA","1","A","06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Nakaseomyces glabratus yapsins are involved in antimicrobial peptides degradation and fungal biofilm detachment","D. Satala|M. Rapala-Kozik"
"189","12/04 12:00","14","P2744","Sandhya NAGARAKANTI","1","A","06b. Fungal disease epidemiology","Cavitary pneumonia unveiled: tracing causes in the arid landscapes of southern Arizona, United States","R. El Kurdi|K. Nayar|M. Gotway|J. Blair|S. Nagarakanti"
"277","12/04 12:00","15","P2745","Jon SALMANTON-GARCIA","1","A","06b. Fungal disease epidemiology","Strengthening fungal infection diagnosis and treatment: an in-depth analysis of capabilities in Honduras","B. Ortiz|D. Varela|G. Fontecha|K. Torres|O. Cornely|J. Salmanton-Garcia"
"286","12/04 12:00","16","P2746","Tshiama Miriam MWAMBA","1","A","06b. Fungal disease epidemiology","Distribution of Candida species colonising skin of inpatients in Southern Africa","T. Mwamba|S. Nzimande|R. Mpembe|R. Mashau|T. Maphanga|S. Naicker|S. Jallow|N. Francisco|G. Kwenda|A. Nhantumbo|S. Massora|T. Gatonye|J. Strysko|E. Jantjies|T. Mashe|A. Juru-Chibango|S. Kwenda|C. Maluleka|N. Govender"
"350","12/04 12:00","17","P2747","Jing LIN","1","A","06b. Fungal disease epidemiology","Prediction of in-hospital mortality and persistence by biofilm phenotype in patients with Candida glabarata bloodstream infections and screening of related biofilm genes","J. Lin|Z. Liu"
"496","12/04 12:00","18","P2748","Aliyavong THAMMAVONG","1","A","06b. Fungal disease epidemiology","Invasive fungal diseases among COVID-19 patients at a tertiary university hospital in Thailand","A. Thammavong|M. Chayakulkeeree|T. Naorungroj|T. Viarasilpa|R. Ratanarat"
"565","12/04 12:00","19","P2749","Eun Jeong WON","1","A","06b. Fungal disease epidemiology","Characterisation of cryptococcal isolates and clinical outcomes in HIV-negative Korean patients with cryptococcosis: a four-year multicentre study","B. Park|E. Suh|Y. Choi|T. Kim|E. Won|H. Sung|M. Kim"
"634","12/04 12:00","20","P2750","Dimitrios KOUROUPIS","1","A","06b. Fungal disease epidemiology","Changing epidemiology of Candida spp. isolated from patients with candidemia in a tertiary hospital in northern Greece: appearance of Candida auris","A. Pyrpasopoulou|C. Zarras|E. Mouloudi|G. Vakalis|A. Ftergioti|D. Kouroupis|A. Papathanasiou|E. Iosifidis|S. Goumperi|A. Geladari|C. Antachopoulos|E. Roilides"
"806","12/04 12:00","21","P2751","Ilias MASOURIS","1","A","06b. Fungal disease epidemiology","Clinical, diagnostic and therapeutic characterstics of CNS fungal infections: insights from a single-centre reptrospective study","I. Masouris|M. Klein|U. Koedel|H. Pfister|J. Stemmler|C. Schichor"
"861","12/04 12:00","22","P2752","Maddalen GURRUTXAGA OLANO","1","A","06b. Fungal disease epidemiology","Epidemiological analysis of candidaemias in a Spanish tertiary hospital during a five-year period","M. Gurrutxaga Olano|C. Garcia Escudero Corcuera|A. Sanchez Diaz|I. Alejo Cancho|S. Hernáez-Crespo|C. Gomez Gonzalez|J. Arribas|M. Lecaroz Agara|M. Gomez Ruiz De Arbulo|M. Fernández Torres|A. Canút Blasco"
"884","12/04 12:00","23","P2753","Muammer ÇELIK","1","A","06b. Fungal disease epidemiology","Candida infective endocarditis: clinical insights and outcomes","M. Çeli?k|E. Saricaoglu|A. Batirel|N. Sari|S. Simsek Yavuz|Ö. Kurt Azap|S. Velioglu Ocalmaz|Y. Uygun Kizmaz|D. Berzeg Deniz"
"931","12/04 12:00","24","P2754","Akshatha RAVINDRA","1","A","06b. Fungal disease epidemiology","Disseminated histoplasmosis in non-endemic area: comparative analysis of clinical features, risk factors, and outcome of histoplasmosis in HIV-positive and HIV-negative cohorts in western India","A. Ravindra|D. Kumar|D. Shankar Meena|G. Krishana Bohra|A. Gollarahalli Patel|V. Jain"
"1226","12/04 12:00","25","P2755","Yong Jun KWON","1","A","06b. Fungal disease epidemiology","Nationwide surveillance of Candida bloodstream infections in Korea: species distribution, antifungal resistance, and molecular characteristics (2022-2024)","Y. Kwon|S. Lee|S. Jeong|D. Kim|K. Shin|J. Shin|Y. Kim|H. Kim|Y. Kim|Y. Uh|N. Ryoo|J. Cho|H. Lee|S. Byun|G. Lee|S. Kim|J. Shin"
"1307","12/04 12:00","26","P2756","Melike INAN HEKIMOGLU","1","A","06b. Fungal disease epidemiology","Evaluation of EQUAL Candida score and other risk factors predicting mortality in patients with candidemia","M. Inan Hekimoglu|E. Mukime Saricaoglu|E. Gulten|I. Akdemir|G. Cinar|A. Yilmaz|D. Öcal|I. Kar|K. Memikoglu|F. Yoruk"
"1832","12/04 12:00","27","P2757","Solène LE GAL","1","A","06b. Fungal disease epidemiology","Pneumocystis primary infection in infants is a community-acquired infection: results of a single-centre prospective observational study","L. Gaitan|P. Cros|C. Hoffmann|T. Tierrie|N. Le Nan|M. Consigny|G. Nevez|S. Le Gal"
"2039","12/04 12:00","28","P2758","Harsimran KAUR","1","A","06b. Fungal disease epidemiology","Epidemiology of HIV and non-HIV cryptococcosis at a tertiary care hospital of a developing country","H. Kaur|P. Gupta|A. Chakraborty|K. Kumar|H. Singh|V. Suri|A. Takkar|R. Kanaujia|A. Ghosh|A. Chakrabarti|S. Rudramurthy"
"2143","12/04 12:00","29","P2759","Ezgi GÜLTEN","1","A","06b. Fungal disease epidemiology","Retrospective analysis of risk factors and outcomes in Candida auris and non-Candida auris candidemia in critically ill patients","E. Gulten|G. Cinar|I. Akdemir|E. Saricaoglu|A. Yilmaz|E. Saldere|F. Yoruk"
"2163","12/04 12:00","30","P2760","Lydia FINNEY","1","A","06b. Fungal disease epidemiology","The role of a fungal multidisciplinary team in diagnosing and managing respiratory fungal disease: a retrospective study at a tertiary referral centre","D. Ilangovan|N. Sultana|T. Khan|M. Coleman|L. Finney"
"2165","12/04 12:00","31","P2761","Jui ATHAVALE","1","A","06b. Fungal disease epidemiology","Comparative clinical profile of non-neutropaenic patients with Candida auris vs non-C.auris candidemia","J. Athavale|S. Sridharan|N. Sethuraman|R. Gopalakrishnan|V. Ramasubramanian|P. Nambi|V. Krishna|P. Balaguru"
"2243","12/04 12:00","32","P2762","Mohammad Taghi HEDAYATI","1","A","06b. Fungal disease epidemiology","Trichophyton indotineae, an emerging and recalcitrant dermatophytosis agent in Iran and Middle East: a two-centre study from Iran and literature review","M. Hedayati|I. Haghani|M. Abastabar|A. Rezaei-Matehkolaei|S. Seyedmousavi|H. Mohammadtaghi Fam"
"2389","12/04 12:00","33","P2763","Pankaj CHAUDHARY","1","A","06b. Fungal disease epidemiology","Burden of fungal keratitis(FK) in Sagarmatha Choudhary eye hospital (SCEH), Nepal: epidemiological and microbiological profile","P. Chaudhary"
"2572","12/04 12:00","34","P2764","Loice OMBAJO","1","A","06b. Fungal disease epidemiology","Candida auris colonisation in multiple facilities in Kenya","L. Ombajo|A. Kassim|F. Kigu|J. Nkuranga|A. Kanyua|R. Kinuthia|L. Maobe|J. Yego|C. Okoth|A. Macharia|R. Okioma|M. Atuti|E. Otieno|N. Odhiambo|V. Omodi"
"2747","12/04 12:00","35","P2765","Laura MEZZOGORI","1","A","06b. Fungal disease epidemiology","Establishing the optimal length of testing to detect Candida auris colonisation after discharge from an endemic area","L. Mezzogori|M. Bavastro|M. Bonaffini|L. Magnasco|F. Centorrino|V. Di Pilato|E. Willison|F. Portunato|D. Giacobbe|A. Vena|A. Marchese|M. Mikulska|M. Bassetti"
"2766","12/04 12:00","36","P2766","Dina Mercedes SANCHEZ DIAZ","1","A","06b. Fungal disease epidemiology","Chromoblastomycosis in Peru: an underreported infection","D. Sanchez-Diaz|N. Antunez De Mayolo|O. Chincha|B. Bustamante"
"2928","12/04 12:00","1","P2767","Ricky HUYNH-PHAN","2","A","06b. Fungal disease epidemiology","A six-year evaluation of invasive candidiasis epidemiology including emergence of Candida auris from a large, southern US metro area","J. Jo|N. Beyda|R. Huynh-Phan|T. Eubank|K. Phe|W. Musick|W. Hoffman|A. Plauche|M. Al Mohajer|K. Garey"
"2953","12/04 12:00","2","P2768","Konstantina GKARTZONIKA","2","A","06b. Fungal disease epidemiology","Candida auris in polymicrobial bloodstream infections: probably a deadlier foe compared to other Candida species?","M. Gerasimou|E. Markou|C. Kittas|E. Christaki|E. Priavali|K. Gkartzonika"
"2957","12/04 12:00","3","P2769","Anna MAVROMMATI","2","A","06b. Fungal disease epidemiology","Candidemia caused by different Candida species: a five-years retrospective study","A. Mavrommati|D. Giannousoglou|S. Savva|S. Triantafillou|M. Voutou|G. Metaxas|C. Andreopoulou|C. Bousboura|S. Karabela"
"3102","12/04 12:00","4","P2770","Yong Jun KWON","2","A","06b. Fungal disease epidemiology","Whole-genome sequencing of recently introduced Clade I Candida auris clinical isolates from hospitals in Korea","H. Yu|T. Kim|S. Jeong|D. Kim|M. Choi|Y. Kim|Y. Kwon|S. Byun|S. Kim|J. Shin"
"3209","12/04 12:00","5","P2771","Camille MARCHETTI","2","A","06b. Fungal disease epidemiology","Breakthrough invasive mold infections under posaconazole prophylaxis","C. Marchetti|E. Glampedakis|F. Lamoth|J. Stemler|L. Hänsel|S. Kuster|N. Khanna|I. Kronig|D. Neofytos|K. Boggian|O. Cornely"
"3565","12/04 12:00","6","P2772","Ana SORIANO-MARTÍN","2","A","06b. Fungal disease epidemiology","An analysis of Candida albicans and Candida parapsilosis candidaemia in the last 14-years (CANDIPAR Study)","A. Soriano-Martin|M. Machado|P. Escribano|J. Guinea|E. Bouza|P. Munoz"
"4302","12/04 12:00","7","P2773","Kalliopi AVGOULEA","2","A","06b. Fungal disease epidemiology","A retrospective study of ocular fungal infections over a two-year period in a tertiary Hellenic hospital","K. Avgoulea|A. Yiaskouri|A. Tsakalos|A. Athanasopoulou|M. Kamperogianni|M. Orfanidou|S. Arkouli"
"4308","12/04 12:00","8","P2774","Valentina ARSIC ARSENIJEVIC","2","A","06b. Fungal disease epidemiology","Candida and non- yeasts prevalence in vulvovaginal infection during pregnancy: Serbian national survey viewed through the MALDI-TOF MS analysis","V. Arsic Arsenijevic|V. Gerginic|B. Milicic|A. Jurisic|S. Otasevic|M. Randjelovic|L. Petricevic"
"4377","12/04 12:00","9","P2775","Giorgia PALLADINI","2","A","06b. Fungal disease epidemiology","Inter-hospital spread of fluconazole-resistant C. parapsilosis in northern Italy: study of clonality aspects, resistance mechanisms and their correlation with biofilm production","G. Palladini|V. Lepera|C. Cavanna|E. Iskandar|N. Ferraro|R. Schiavo|F. Baldanti|G. Lo Cascio"
"4470","12/04 12:00","10","P2776","Denise D'ELIA","2","A","06b. Fungal disease epidemiology","Long-term survival of patients undergoing myelosuppressive therapy for acute leukemia","D. D'elia|E. Kampouri|A. Guillet|F. Lamoth|D. Neofytos|P. Bochud"
"4513","12/04 12:00","11","P2777","Paula MUÑOZ-BRELL","2","A","06b. Fungal disease epidemiology","Candidemia in paediatric population: a nine-year review at a tertiary hospital","P. Munoz-Brell|J. Frasquet-Artes|J. Peman-Garcia|J. Pérez-Royo|P. Suárez-Urquiza|E. Gremaldos-Mira|M. Garrido-Jareno|J. Lopez-Hontangas|A. Ruiz-Gaitán"
"4651","12/04 12:00","12","P2778","Julian Andres HOYOS PULGARIN","2","A","06b. Fungal disease epidemiology","Factors associated with the development of esophageal candidiasis in oncological patients","J. Hoyos Pulgarin|J. Benitez Mejia|G. Moreno Gomez"
"4693","12/04 12:00","13","P2779","Jeannete ZURITA","2","A","06b. Fungal disease epidemiology","Molecular characterisation of the genotype of Candida albicans in patients with candidemia in Ecuador","J. Zurita|G. Sevillano|J. Ramirez|A. Zapata|C. Zurita-Salinas|M. Galarza|J. Navarro"
"4811","12/04 12:00","14","P2780","Mi-Kyung LEE","2","A","06b. Fungal disease epidemiology","Isolation of a novel genus in the family Myriangiales from a patients with onychomycoses using whole-genome sequencing","M. Lee|K. Choe|T. Kim"
"4887","12/04 12:00","15","P2781","Shashikala SHIVAPRAKASHA","2","A","06b. Fungal disease epidemiology","Risk stratification in candidemia: a case-control study from 2016-2023","N. Biyani|V. Nagvekar|P. Chandorkar|S. Shivaprakash"
"4893","12/04 12:00","16","P2782","Esma ERYILMAZ EREN","2","A","06b. Fungal disease epidemiology","Candidemia epidemiology and antifungal resistance during and after COVID-19 pandemic: comparison between two tertiary care hospitals in Greece and Turkey","E. Eryilmaz Eren|E. Iosifidis|H. Sav|I. Celik|E. Mouloudi|A. Pyrpasopoulou|C. Zarras|E. Roilides"
"4962","12/04 12:00","17","P2783","Twishi SHRIMALI","2","A","06b. Fungal disease epidemiology","Detection of causative agents of infectious keratitis in patients from western Rajasthan","T. Shrimali|A. Sharma|A. Ghosh|A. Morya"
"5072","12/04 12:00","18","P2784","Alexander Maximilian ALDEJOHANN","2","A","06b. Fungal disease epidemiology","Culture-positive-CAPA of three German tertiary care hospitals: incidence, management and risk factors","L. Aldejohann|J. Steinmann|T. Ruegamer|R. Martin|O. Kurzai|A. Aldejohann"
"5212","12/04 12:00","19","P2785","Valentina LEPERA","2","A","06b. Fungal disease epidemiology","Trichophyton indotineae or not-indotineae, that is the question: evaluation of Piacenza epidemiology of dermatophytes and presence of emerging species","V. Lepera|G. Palladini|G. Tocci|A. Zappavigna|C. Cordini|C. Gorrini|R. Schiavo|G. Lo Cascio"
"5218","12/04 12:00","20","P2786","Yusuf KAMESHKI","2","A","06b. Fungal disease epidemiology","Determining the significance of Candida growth in nephrostomy urine samples","Y. Kameshki|A. Marek|A. Bal"
"5335","12/04 12:00","21","P2787","Ana SORIANO-MARTÍN","2","A","06b. Fungal disease epidemiology","An analysis of risk factors associated with high mortality of candidaemia by Candida albicans compared with Candida parapsilosis (CANDIPAR study)","A. Soriano-Martin|M. Machado|P. Escribano|J. Guinea|E. Bouza|P. Munoz"
"5448","12/04 12:00","22","P2788","David KOFFI","2","A","06b. Fungal disease epidemiology","Identifying the impact of fungal exposure on TB patient outcomes in Ivory Coast","D. Koffi|B. Kouadio|F. Kouadjo|A. Toure|M. Dosso|D. Denning"
"5453","12/04 12:00","23","P2789","Elena CHARPENTIER","2","A","06b. Fungal disease epidemiology","Pneumocystis jirovecii colonisation in mothers of preterm newborns and risk of vertical transmission","E. Charpentier|E. Garcia Victori|C. Fernando|C. Serradilla Rodriguez|V. Friaza Patino|M. Salsoso Rodriguez|A. Vallejo Vaz|O. Matos|A. Pavon Delgado|E. Calderon Sandubete"
"5491","12/04 12:00","24","P2790","Laura MICHON","2","A","06b. Fungal disease epidemiology","Characteristics, treatment outcomes and Aspergillus susceptibility in chronic pulmonary aspergillosis patients treated with echinocandins","L. Michon|J. Buil|P. Verweij|B. Geurts|F. Van De Veerdonk|M. Reijers|R. Bruggemann"
"5516","12/04 12:00","25","P2791","Nkosi MBALI","2","A","06b. Fungal disease epidemiology","Pneumocystis jirovecii pneumonia in South Africa: trends and insights from 2018 to 2022","N. Mbali|K. Hoog|M. Lowe"
"5544","12/04 12:00","26","P2792","Alessandra MICOZZI","2","A","06b. Fungal disease epidemiology","Invasive aspergillosis (IA) and survival of acute myeloid leukemia (AML) patients at 12 weeks and 12 months after AML diagnosis","M. Capriata|G. Assanto|M. Bisegna|C. Minotti|G. Gentile|A. Micozzi"
"5564","12/04 12:00","27","P2793","Ines NOLL","2","A","06b. Fungal disease epidemiology","Surveillance of fungi in Germany: first results 2019-2023","I. Noll|A. Von Laer|M. Feig|M. Schneider|T. Eckmanns|A. Hoffmann"
"5621","12/04 12:00","28","P2794","Paula MUÑOZ-BRELL","2","A","06b. Fungal disease epidemiology","Corneal keratitis: a clinical and microbiological analysis of fungal and bacterial species in a tertiary hospital over 14 years","A. Ruiz-Gaitán|A. Rego Sobrido|L. Castellano Sanchez|P. Munoz-Brell|J. Peman-Garcia|P. Suárez-Urquiza|M. Moll Navarro|J. Lopez-Hontangas"
"5662","12/04 12:00","29","P2795","Anthony ANUFORO","2","A","06b. Fungal disease epidemiology","Keratomycosis in a tertiary hospital: an eight-year experience from southwest Nigeria","E. Irek|A. Anuforo|T. Obadare"
"5705","12/04 12:00","30","P2796","Sukru DIRIK","2","A","06b. Fungal disease epidemiology","Urgent consultation: evaluation of 47 invasive fungal sinusitis cases","S. Dirik|O. Acet|M. Yasar Duman|D. Metin|M. Tasbakan|B. Arda|H. Erdem"
"5801","12/04 12:00","31","P2797","Eelco F.J. MEIJER","2","A","06b. Fungal disease epidemiology","Short tandem repeat genotyping of extensive Sporothrix brasiliensis collection reveals spread is largely driven by clonal clades","B. Spruijtenburg|C. Melchior Do Prado|M. Rodrigues Trápaga|B. Jacomel F. De Souza Lima|S. Gonçalves|J. Pereira Brunelli|V. Sosa|A. Rodrigues|A. Borman|D. Wagner Santos|G. Chavez|V. Rodrigues Poester|N. Fernandez|J. Venturini|R. Cognialli|M. Orzechowski Xavier|V. Vicente|F. De Queiroz-Telles|J. Meis|T. De Groot|E. Meijer"
"5802","12/04 12:00","32","P2798","Jorge Alberto CORTES LUNA","2","A","06b. Fungal disease epidemiology","Predictors of bloodstream infection caused by Candida auris in comparison to other Candida species in adults in Colombia","J. Cortes|C. Oritz-Roa|A. Noches-Buelvas|S. Sierra-Umana|J. Rodriguez|G. Muneton-Lopez|C. Solorzano-Ramos|P. Escandon|C. Alvarez-Moreno"
"5915","12/04 12:00","33","P2799","Kemel HAMMU","2","A","06b. Fungal disease epidemiology","Impact of candidemia and septic metastases on survival in critically ill patients colonised with Candida auris: a retrospective cohort study","A. Segura|K. Hammu|J. Amigo|M. Cabanero-Navalon|A. Ruiz-Gaitán|V. Garcia-Bustos"
"6413","12/04 12:00","34","P2800","Olivier FRIEDLI","2","A","06b. Fungal disease epidemiology","Trends in invasive Candida infections in Swiss hospitals: a 15-year surveillance study (2009-2023) on species distribution, resistance, and antifungal use","O. Friedli|C. Pluss-Suard|A. Kronenberg"
"6437","12/04 12:00","35","P2801","Marie Louise JOERGENSEN","2","A","06b. Fungal disease epidemiology","The epidemiology of chronic pulmonary aspergillosis in Denmark","M. Jørgensen|M. Fally|R. Gregersen|J. Petersen|A. Victor|D. Podlekareva"
"6582","12/04 12:00","36","P2802","M.Teresa MARTIN-GOMEZ","2","A","06b. Fungal disease epidemiology","T. indotineae as an agent of dermatophytosis in Barcelona, Spain","J. Rovira-Pluja|A. Bedoya-Lourido|C. Fontalba-Matas|M. Martin-Gomez"
"6601","12/04 12:00","1","P2803","Kruthi MALUR KUMARASWAMY","3","A","06b. Fungal disease epidemiology","Candidemia and the Candida equal score: a clinical evaluation in a tertiary care hospital","K. Malur Kumaraswamy|A. Shetty|A. Sunavala|N. Shah|S. Ganta|S. Gore|A. Erande|C. Rodrigues|U. Agrawal"
"6687","12/04 12:00","3","P2805","Filipe PROHASKA BATISTA","3","A","06b. Fungal disease epidemiology","Parinaud syndrome as a clinical manifestation of Sporothrix brasiliensis more often than it should!","F. Prohaska Batista|F. Cavassin|F. Queiroz-Telles"
"6828","12/04 12:00","4","P2806","Christel MAMONA","3","A","06b. Fungal disease epidemiology","Management of Candida spp. prosthetic joint infections (PJI) according to country","M. Mcnally|R. Ho|M. Scarborough|C. Ronde Oustau|J. Lora-Tamayo|J. Barbero Allende|C. Arvieux|D. Vaznaisiène|L. Noussair|N. Rossi|A. Lemaignen|M. Costa Salles|T. Cunha Ribeiro|J. Mazet|E. Canoui|L. Escolà-Vergé|P. Thill|L. Morata|A. Soriano|G. Giordano|C. Fourcade|B. Franck|J. Hofstätter|E. Bonnet|A. Dinh|C. Mamona"
"7150","12/04 12:00","5","P2807","Paula FIGUEROA","3","A","06b. Fungal disease epidemiology","Factors associated with mortality in critically ill patients: a comparison between HIV-infected and non-immunodeficient individuals with histoplasmosis","L. González|M. Juárez|W. Bautista|P. Figueroa|E. Martinez"
"7167","12/04 12:00","6","P2808","María Paula VARGAS DURÁN","3","A","06b. Fungal disease epidemiology","Incidence of Aspergillus species isolates in samples from the lower respiratory tract in the years 2017 to 2024","M. Vargas Durán|P. Gomez Sastre|A. Arenas Martinez-Armero|M. De La Mata Fernández|N. Yuste Ángel|L. Cardenoso Domingo|A. Gutiérrez Cobos"
"7175","12/04 12:00","7","P2809","Frédégonde ABOUT","3","A","06b. Fungal disease epidemiology","International survey on the diagnosis and treatment of disseminated histoplasmosis in people living with HIV (PLHIV): the PROPULS2A study","F. About|A. Ladgham|F. Lanternier|V. Veloso|M. Demar|A. D'avila Freitas|R. De Almeida Paes|A. Adenis|M. Nacher|O. Lesens"
"7302","12/04 12:00","8","P2810","Serge DOU","3","A","06b. Fungal disease epidemiology","High prevalence of histoplasmosis among persons with advanced HIV disease in Ivory Coast, 2024","S. Dou|M. Tamboura|O. Nassoue|D. Aka|G. Adjo|E. Dannaoui|K. Adoubryn|C. D'enfert|A. Doumbia|M. Toure|M. Bougnoux"
"7330","12/04 12:00","9","P2811","Kathrin SPETTEL","3","A","06b. Fungal disease epidemiology","Global transmission of Candida auris to Austria: epidemiological, phenotypical, and phylogenetic insights","K. Spettel|F. Lötsch|R. Kriz|G. Vrioni|E. Dimitroulia|M. Loy|B. Willinger"
"7458","12/04 12:00","10","P2812","Yousra ZEKRI","3","A","06b. Fungal disease epidemiology","Otomycosis: a retrospective study","Y. Zekri|H. Naoui|B. Lmimouni|M. Ikken"
"7478","12/04 12:00","11","P2813","Joanna BRODERSEN","3","A","06b. Fungal disease epidemiology","Paediatric eumycetoma patients: a threefold neglected patient group","A. Erber|S. Regensburger|T. Weichselberger|J. Brodersen"
"7489","12/04 12:00","12","P2814","Maricela VALERIO MINERO","3","A","06b. Fungal disease epidemiology","Fungal endocarditis: experience in a tertiary hospital","M. Valerio|F. Valenzuela|M. Machado|A. Estévez|E. Reigadas|P. Garcia-Clemente|J. Guinea|P. Escribano|P. Munoz"
"7493","12/04 12:00","13","P2815","Lucia INGLESE","3","A","06b. Fungal disease epidemiology","Impact of the Candida auris management protocol on epidemiological trends: a study at IRCCS San Martino hospital","L. Inglese|M. Pagnucco|V. Paolozzi|F. Stella|D. Bellina|M. Paoletti|A. Talamini|A. Marchese|A. Morando|A. Orsi"
"7538","12/04 12:00","14","P2816","Charlotte SRIRUTTAN-NEL","3","A","06b. Fungal disease epidemiology","Rhinosporidiosis in South Africa (2012 to 2024)","C. Sriruttan-Nel"
"7553","12/04 12:00","15","P2817","Yuyan HUANG","3","A","06b. Fungal disease epidemiology","Epidemiology of Meyerozyma guilliermondii species complex isolated from invasive fungal diseases: a multicentre study in China","Y. Huang"
"7608","12/04 12:00","16","P2818","Samuel Adetona FAYEMIWO","3","A","06b. Fungal disease epidemiology","High prevalence of behaviours known to increase the risk of recurrent vulvovaginal candidiasis in Nigeria","S. Fayemiwo|L. Novak-Frazer|I. Adewole|R. Rautemaa-Richardson"
"7617","12/04 12:00","17","P2819","Anastasia SAADE-ANTYPAS","3","A","06b. Fungal disease epidemiology","Characterisation and risk factors of occupational aspergillosis: a national multicentre retrospective study using RNV3P data","A. Michel|C. Paris|J. Gangneux|A. Saade"
"7649","12/04 12:00","18","P2820","Jorge Alberto CORTES LUNA","3","A","06b. Fungal disease epidemiology","Risk factors for mortality among adult patients with bloodstream infection caused by Candida auris in Colombia","J. Cortes|C. Ortiz-Roa|S. Sierra-Umana|Y. Rodriguez|G. Muneton-Lopez|C. Solorzano-Ramos|P. Escandon|C. Alvarez-Moreno"
"7686","12/04 12:00","19","P2821","Simone NOUÉR","3","A","06b. Fungal disease epidemiology","Changes in the epidemiology of candidemia after the COVID-19 pandemic at a Brazilian","S. Nouér|M. Barreiros|K. Nathan|L. Carvao|L. Mendes|A. Castineiras|H. Reis|W. Baleta|L. Guimaraes|M. Nucci"
"213","12/04 12:00","20","P2822","Qingqing WANG","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Value of CRISPR-Cas12-based polymerase chain reaction for diagnosing invasive fungal infection and chronic fungal pneumonia","Q. Wang|Q. Miao|B. Hu"
"230","12/04 12:00","21","P2823","Eun Jeong WON","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Detection of clinically relevant Candida species from positive blood culture using an automated point-of-care assay: MoiM Dx Candida 9-plex assay","B. Park|E. Oh|E. Won|J. Kang|D. Jin|C. Yoo|J. Park|H. Sung|M. Kim"
"275","12/04 12:00","22","P2824","Jon SALMANTON-GARCIA","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Fungi under fire: addressing a Peruvian health challenge","J. Maquera-Afaray|L. Cuéllar|O. Cornely|J. Salmanton-Garcia"
"418","12/04 12:00","23","P2825","Zeqi ZHOU","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of a novel Aspergillus galactomannan chemiluminescence immunoassay for the diagnosis of invasive pulmonary aspergillosis: a multicentre controlled study","Y. Xiao|C. Wu|Y. Yuan|Y. Wang|Z. Liu|D. Zhang|G. Song|Z. Liu|H. Wang|Z. Zhou|Y. Geng|B. Shan|X. Chu|L. Gu|S. Wu|Y. Xie"
"504","12/04 12:00","24","P2826","Faezeh ROUHI","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of SYBR green real-time PCR for rapid and specific detection of Trichophyton indotineae","F. Rouhi|H. Mirhendi|S. Aboutalebian|A. Rezaei-Matehkolaei|Z. Jahanshiri|M. Shidfar|A. Chadeganipour|S. Shadzi|M. Kharazi|M. Erami"
"885","12/04 12:00","25","P2827","Andrea LANGER SERMEÑO","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Time- and temperature-dependent pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples","R. Dobias|V. Skopelidou|A. Langer Sermeno|D. Luptakova|V. Havlicek"
"921","12/04 12:00","26","P2828","Ruben MERTENS ALBUSAC","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Implementation of in-house Histoplasma antigen tesing from serum and urine samples using","I. Butler|R. Mertens"
"978","12/04 12:00","27","P2829","Robert MARKS","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","MP65/ENO1 ratio as a diagnostic marker for pathogenic Candida albicans in vulvovaginal candidiasis","Y. Cohen|R. Marks"
"1029","12/04 12:00","28","P2830","Rosalie SACHELI","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of a new commercial real-time PCR assay to detect dermatophytes in nails","R. Sacheli|E. Paris|A. Adjetey|S. Egrek|M. Hayette"
"1097","12/04 12:00","29","P2831","Renu KUMARI","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","High volume culture technique: a good alternative to conventional culture on the bronchioalveolar lavage samples in invasive pulmonary aspergillosis patients","R. Kumari|A. K. P.|I. Xess|G. Singh|T. Bordoloi|B. Rana"
"1152","12/04 12:00","30","P2832","Shima ABOUTALEBIAN","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Development and evaluation of simple molecular methods for the distinction of the newly emerging dermatophyte Trichophyton indotineae","S. Aboutalebian|H. Mirhendi|Z. Jahanshiri|M. Shidfar|M. Chadeganipour|Z. Mirhendi|M. Kharazi|M. Erami"
"1362","12/04 12:00","31","P2833","Xin SU","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Pentraxin-3 as a novel prognostic biomarker in nonneutropaenic invasive pulmonary aspergillosis patients","C. Sun|X. Cai|H. Zhong|Y. Lu|Y. Li|Y. Cai|Y. Wang|T. Zhao|M. Cao|L. Wang|C. Feng|W. Sun|C. Chen|Y. Tao|G. Ma|B. He|X. Wang|X. Lu|Y. Li|X. Su"
"1522","12/04 12:00","32","P2834","Ayse KALKANCI","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Comparative analysis of chemiluminescence immunoassay (CLIA)-based tests in the diagnosis of invasive aspergillosis in patients with heamatologic malignancies","E. Kilic|E. Sahin|O. Tunccan Guzel|S. Yildiz|Z. Ozkurt|Z. Yegin|A. Kalkanci"
"1703","12/04 12:00","33","P2835","Monique WETZELS-VRANCKEN","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Optimisation of C.auris culture: the influence of temperature, enrichment broth and chromogenic agar","J. Dirks|M. Wetzels-Vrancken|M. Claessens|S. Kurvers|E. De Brauwer"
"1784","12/04 12:00","34","P2836","Kon CHU","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Real-time application of ITS and D1-D3 nanopore amplicon metagenomic sequencing in fungal infections: enhancing fungal infection diagnostics","S. Kim|N. Kim|W. Park|C. Kang|J. Park|S. Lee|K. Jung|K. Park|S. Lee|J. Moon|K. Chu"
"1837","12/04 12:00","35","P2837","Christopher CANTRELL","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Assessment of prioritised fungal pathogen detection in aerobic blood culture system","C. Cantrell|K. Mckay|A. Parmar|A. Hutchins|C. Carvalhaes|V. Girard"
"1841","12/04 12:00","36","P2838","Ioanna MARINOU","3","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Comparison of two Aspergillus galactomannan detection tests: platelia galactomannan and virclia galactomannan mono test","I. Marinou|S. Mavrea|S. Savva|I. Dima|E. Georgakopoulou|S. Karabela"
"1991","12/04 12:00","1","P2839","Miguel FERNÁNDEZ-HUERTA","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Clinical evaluation of a novel qPCR assay for the detection of dermatophyte fungi and Candida albicans in skin and nail material","M. Fernández-Huerta|L. Beramendi|L. Argente Colás|A. Navascués-Ortega|C. Ezpeleta"
"2101","12/04 12:00","2","P2840","Jong Hee SHIN","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Usefulness of sequence-based identification methods for differentiating clade II and non-clade II Candida auris isolates from Korean hospitals","J. Shin|S. Byun|S. Lee|G. Lee|Y. Kwon|S. Kee|S. Kim|M. Shin"
"2139","12/04 12:00","3","P2841","Jannik STEMLER","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Sequential serum galactomannan as predictive response marker for invasive aspergillosis","C. Többen|O. Cornely|D. Seidel|C. Joisten|J. Cozzi|B. Hoellinger|D. Yilmaz Karapinar|D. Richter|A. Groll|G. Méndez|J. Jenks|N. Erben|L. Lopez Soria|P. Koehler|A. Apostolopoulou|D. Deeren|R. Draenert|I. Falces-Romero|J. Maquera-Afaray|L. Meintker|J. Stemler"
"2160","12/04 12:00","4","P2842","Dina OULKADI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Verification of a new enrichment broth and two chromogenic agars for the identification of Candida auris","D. Oulkadi|I. Mermans|K. Van Den Berghe|M. Vanden Driessche|T. Demuyser|V. Matheeussen|H. Jansens|S. Vandamme"
"3017","12/04 12:00","5","P2843","Tingting WANG","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Aspergillus IgG antibodies in diagnosing pulmonary aspergillosis","T. Wang"
"3036","12/04 12:00","6","P2844","Zeqi ZHOU","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Diagnostic value of combined detection of BDG assay and GM assay in invasive aspergillosis","M. Li|W. Yao|Y. Wang|Y. Zhang|H. Wang|Y. Su|Z. Zhou"
"3046","12/04 12:00","7","P2845","Zeqi ZHOU","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","A novel multiplex Aspergillus PCR assay for detection of of invasive aspergillosis","S. Li|Z. Wang|W. Yao|Y. Wang|Y. Zhang|H. Wang|Y. Su|Z. Zhou"
"3079","12/04 12:00","8","P2846","Koray DEMIR","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Accuracy and actionability of mold PCR panel on bronchoalveolar lavage for the diagnosis of invasive mold disease","K. Demir|G. Anderson|N. Banaei"
"3140","12/04 12:00","9","P2847","Zeqi ZHOU","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","A novel multiplex real-time quantitative PCR detecting system approach for detection of Candida auris","D. Jiang|S. Li|Z. Wang|W. Yao|Y. Wang|H. Wang|Y. Su|Z. Zhou|J. Guo|Y. Zhang"
"3153","12/04 12:00","10","P2848","Ana FERNÁNDEZ-CRUZ","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Prospective national multicentre study to determine the usefulness of 18-FDG-PET-TC for the management of invasive fungal infection (PETIFI project)","A. Gutiérrez-Villanueva|B. Rodriguez-Alfonso|K. Velásquez|J. Ramos-Ramos|S. Rizkallal-Monzoin|A. Avendano Pita|J. Canadas|M. Caponcello|R. Fernandez-Lopez|P. Monzo-Gallo|A. Perisinottii|A. Bergas-Farrés|J. Laporte-Amargos|V. Carrero-Vásquez|P. González-Sierra|C. Ramos-Font|A. Prolo-Acosta|S. Sanz|A. Alvarez-Uria|A. Mari-Hualde|S. Infante|A. Fernández-Cruz|Z. Palacios-Baena"
"3235","12/04 12:00","12","P2850","Hervé BOUTAL","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Efficient lateral flow assay for rapid sporothricosis diagnostic","N. Darwich|A. Vogel|M. Plaisance|M. Lujan Cuestas|S. Simon|H. Boutal"
"3237","12/04 12:00","13","P2851","Enrico FURCHI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Use of MT-PCR (multiplex tandem) in dermatomycosis diagnostic","E. Furchi|P. Bortoluzzi|A. Parisi|A. Busacca|M. Liporace|D. Consonni|L. Terranova|A. Callegaro|A. Grancini|D. Girelli"
"3393","12/04 12:00","14","P2852","Chiara SENTI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Enhancing molecular detection of Candida auris through broth media enrichment","F. Degiovanni|M. Beffa|C. Sabelli|C. Senti"
"3721","12/04 12:00","15","P2853","Elaine Cristina FRANCISCO","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Development and validation of a TaqMan-based real-time PCR assay for direct detection of Trichosporon asahii in spiked blood culture bottles","M. De Almeida|E. Francisco|F. Hagen|A. Colombo"
"3761","12/04 12:00","16","P2854","Mohammadreza SALEHI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Mycological evaluation of sinus lavage fluid in patients with heamatological malignancies and suspected invasive fungal sinusitis","M. Salehi|A. Tabari|N. Shafiee|S. Khodavaisy|F. Arbabzadeh|K. Roudini|A. Ahmadi|P. Saleh"
"3767","12/04 12:00","17","P2855","Hannah PAY","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Performance evaluation of a novel Candida auris differentiation medium","H. Pay|R. Augustine|S. Free|R. Owen|D. Crabtree|J. Stringer"
"3812","12/04 12:00","18","P2856","Animesh RAY","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Effect of galactomannan in food on serum levels in suspected IPA patients: insights from a hospital-based and mouse study","A. Ray|G. Singh|D. Mahajan"
"3865","12/04 12:00","19","P2857","Sayan MAHARATNA","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Performance of Aspergillus PCR on mini broncho-alveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis using BM-aspICU criteria: a cross-sectional diagnostic test validation study","S. Maharatna|A. Ray|G. Singh|M. Soneja|I. Xess|A. Mohan|N. Wig"
"3972","12/04 12:00","20","P2858","Jonathan BYROM","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Service evaluation of fungal antigen testing in renal transplant patients at a UK regional transplant centre","J. Byrom|R. Barton|N. Young"
"4059","12/04 12:00","21","P2859","Maria ZOLOTAREVA","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Fungal DNA-barcoding on a chip: ITS-DNA biosensors for yeast infection diagnosis","M. Zolotareva|F. Cascalheira|R. Afonso|D. Caetano|M. Teixeira"
"4100","12/04 12:00","22","P2860","Elizabeth ISKANDAR","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Enhancing the diagnosis of invasive candidiasis using Candida real-time PCR: uncovering hidden challenges","E. Iskandar|N. Ferraro|L. Dossena|S. Paolucci|C. Cavanna|F. Baldanti"
"4500","12/04 12:00","23","P2861","Saliba WEHBE","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Prognostic value of serum and bronchoalveolar lavage fluid galactomannan in invasive aspergillosis: an eight-year experience at a tertiary cancer centre","S. Wehbe|A. Chaftari|R. Hachem|H. Dagher|A. Haddad|A. Philip|Y. Jiang|R. Zakhour|P. Bakht|J. Shrestha|P. Lamie|R. Sherchan|J. Makhoul|I. Raad|P. Chaftari"
"4716","12/04 12:00","24","P2862","Claudia CASTILLO","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Results of a universal fungal PCR performed in clinical samples of patients: experience of a Chilean university centre","C. Castillo|J. Aguirre|M. Ramirez|P. Ross|O. Villarreal|P. Garcia"
"4829","12/04 12:00","25","P2863","Weili ZHANG","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","The diagnostic value of metagenomic next-generation sequencing for mucormycosis and the risk factors of poor prognosis in mucormycosis","W. Zhang|Y. Xie"
"5151","12/04 12:00","26","P2864","Ji Yeun KIM","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Comparison of clinical performances between a commercial real-time PCR kit and in-house real-time PCR assay in plasma and paraffin-embedded tissue samples for diagnosis of Aspergillosis","J. Kim|H. Jang|J. Son|S. Kim|C. Jang|J. Cha|S. Kim"
"5186","12/04 12:00","27","P2865","Truong Giang NGUYEN","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","A promising combination for fast molecular diagnosis of dermatophytosis","T. Nguyen|C. Garnaud|D. Maubon|H. Primard|F. Saragosa|I. Almahmoud|M. Robert"
"5188","12/04 12:00","28","P2866","Jean MENOTTI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of a new multiplex-tandem PCR assay for the diagnosis of superficial fungal infections of the skin, hair and nails","C. Vincent-Falquet|P. Tirard-Collet|F. Durupt|M. Hérault|C. Miossec|J. Lemoine|D. Dupont|M. Rabodonirina|M. Wallon|F. Persat|J. Menotti"
"5231","12/04 12:00","29","P2867","Giulia GATTI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","The Candida auris surveillance: why do we need to implement it? A validation study on new enrichment broth to increase the sensibility of Candida auris detection","A. Marzucco|G. Gatti|M. Montanari|C. Colosimo|L. Dionisi|L. Ingletto|G. Dirani|S. Zannoli|M. Guerra|M. Brandolini|L. Grumiro|A. De Pascali|A. Scagliarini|V. Sambri|M. Cricca"
"5465","12/04 12:00","30","P2868","Tin Long LUI","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of real-time PCR assay for detection of Candida auris in surveillance specimens on a fully automated system","T. Lui|A. Ho|J. Chan|M. Lee|W. To|K. Luk|V. Chow"
"5528","12/04 12:00","31","P2869","Cornelia LASS-FLÖRL","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Epsilometer test-based limitations in detecting anidulafungin resistance in Candida parapsilosis","R. Vahedi-Shahandashti|C. Lass-Flörl"
"5536","12/04 12:00","32","P2870","Elisa MATARAZZO","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","1,3-beta-D-glucan on ascitic fluid: possible early marker of fungal infection in patients with cirrhosis and/or acute liver failure?","E. Matarazzo|M. Merli|G. Perricone|G. Casalicchio|M. Puoti|G. Lombardi|C. Vismara"
"5829","12/04 12:00","33","P2871","Silvia BOLAÑO GARCÍA","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Prospective evaluation of a new multiplex PCR for dermatophyte detection in clinical samples from a tertiary hospital","S. Bolanos|C. Castello|S. Martinez|A. Montufo|C. Campillo-Martin|C. Rodriguez-Lucas"
"6132","12/04 12:00","34","P2872","Lara Rubbia FERREIRA","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Application of the Fourier transform-infrared (FT-IR) biotyper for Candida auris clade level differentiation","L. Ferreira|A. Borman|J. Loveridge|E. Wey|R. Gorton|P. Jones"
"6134","12/04 12:00","35","P2873","Surjo DE","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Assessing the utility of a pan-fungal (ITS2 gene) PCR assay on whole blood in the paediatric setting: five years' experience","S. De|J. Brown|L. Atkinson|D. Davis|H. Brosnan|T. Best"
"6208","12/04 12:00","36","P2874","Sandeep RAO KORDCAL","4","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Evaluation of endotracheal aspirate galactomannan antigen detection for diagnosis of invasive pulmonary aspergillosis: a diagnostic test validation study","A. Kumar|S. Rao Kordcal|I. Xess|M. Soneja|G. Singh|K. Madan|U. Baitha|R. Kumar"
"6253","12/04 12:00","1","P2875","Victor GARCIA-BUSTOS","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","External validation and refinement of a clinical predictive model of candidemia by Candida auris in critically ill patients","V. Garcia-Bustos|F. Alonso-Ecenarro|F. Puchades|M. Cabanero-Navalon|A. Ruiz-Gaitán|M. Salavert|R. Guna|C. Ferrer Gomez|V. Abril"
"6573","12/04 12:00","2","P2876","Marko ARSENIJEVIC","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Using MALDI-TOF MS for identification of dermatophyte and non-dermatophyte molds: single centre experience","M. Arsenijevic|D. Milosevic|S. Mulic|A. Roganovic|D. Dobrosavljevic Vukojevic"
"6641","12/04 12:00","3","P2877","Elaine Cristina FRANCISCO","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Microsatellite typing: validating a new tool for molecular epidemiology of Trichosporon asahii infections","E. Francisco|N. Fernandez|M. Carbia|A. Bostanaru|J. Houbraken|A. Colombo|F. Hagen"
"6837","12/04 12:00","4","P2878","Riccardo PAGGI","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Pneumocystis jirovecii pneumonia and the possible prognostic role of quantitative polymerase chain reaction: preliminary results from a retrospective multicentre study","R. Paggi|S. Biagioni|A. Melelli Roia|L. Gozzi|S. Giovannelli|R. Matteucci|A. Rocca|N. Ciccone|S. Pollini|F. Lagi|J. Mencarini|A. Moroni|G. Rossolini|A. Mencacci|A. Bartoloni"
"6967","12/04 12:00","5","P2879","Dorothy MONTGOMERY","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","QCMD Candida auris: a new EQA scheme designed in response to a serious global health threat from an emerging pathogen","D. Montgomery|A. Ricketts|L. White"
"7019","12/04 12:00","6","P2880","Enrica BONO","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Beta-d-glucan where are you? Impact of false negative BDG on antifungal treatment initiation in patients with candidemia","E. Bono|P. Valsecchi|A. Valeretto|S. Resuli|M. Corbella|C. Cavanna|E. Seminari|R. Bruno"
"7031","12/04 12:00","7","P2881","Alem ABEBE","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Candida albicans nucleic acid sample preparation in 15-seconds with Autolab HBH","A. Abebe|R. Peytavi|B. Miller|T. Heeren|K. Allen|S. Babikian|M. Petrullo"
"7186","12/04 12:00","8","P2882","Corrie BELANGER","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Integration of MALDI-TOF and ITS sanger sequencing into a streamlined pipeline for identification of fungi from clinical specimens","C. Belanger|S. Liu|H. Glassman|K. Locher|B. Velapatino|A. Lieu|M. Charles"
"7235","12/04 12:00","9","P2883","Adam STEWART","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing","A. Stewart|A. Douglas|S. Kidd|A. Morris|C. Halliday|S. Chen"
"7596","12/04 12:00","10","P2884","Priyadarshini PADAKI","5","A","06c. Diagnostic mycology (incl traditional, molecular and other methods)","Is a good KOH Calcoflour white microscopic examination sufficient for diagnosis of mucormycosis in a resource limited setting instead of an expensive real time PCR assay?","P. Padaki|J. Savio|C. B."
"115","12/04 12:00","11","P2885","Jack MCHUGH","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Declining azole susceptibility in candida parapsilosis: a ten-year analysis of US blood culture isolates, 2015-2024","J. Mchugh|S. Chesdachai|N. Wengenack|P. Vergidis"
"381","12/04 12:00","12","P2886","Teodora SHERBAN","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Resistance profiles of Candida auris strains in Cluj-Napoca, Romania: a minireview","T. Serban|M. Lupse|M. Flonta"
"649","12/04 12:00","13","P2887","Zitong PAN","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Characteristics of Candida auris colonized in different sites of the same patient","H. Li|Z. Pan|R. Chen"
"892","12/04 12:00","14","P2888","Zeqi ZHOU","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Novel rapid antifungal susceptibility testing system for yeasts based on fast cell growth","X. Wu|Y. Lin|Y. Wang|Y. Zhang|H. Wang|Y. Su|Z. Zhou"
"1005","12/04 12:00","15","P2889","Marisa WINKLER","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Echinocandin susceptibility patterns and genetic changes in nonsusceptible Candida glabrata with non-hotspot FKS alterations","M. Winkler|L. Deshpande|J. Kimbrough|M. Castanheira"
"1167","12/04 12:00","16","P2890","Eloy ORDAYA","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Antifungal susceptibility patterns and genomic mutations in Candida glabrata isolates from patients with candidemia","E. Ordaya|M. Jagannathan|J. Kaur|N. Birk|G. Suleyman|G. Alangaden"
"1244","12/04 12:00","17","P2891","Marisa WINKLER","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Activity of manogepix against a worldwide collection of yeast isolates from 2023","M. Winkler|S. Edeker|A. Klauer|P. Rhomberg|M. Castanheira"
"1369","12/04 12:00","18","P2892","Ken BABCOCK","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Rapid antifungal susceptibility testing direct from positive blood culture","H. Delaney|Z. Ruhe|J. Tedesco|K. Babcock"
"1634","12/04 12:00","19","P2893","Pilar ESCRIBANO","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Copy number variants (CNVs) at chromosome 3 as azole resistance mechanisms additional to ERG11p substitutions in azole-resistant Candida parapsilosis isolates","A. Mesquida|A. Ryam|E. Alcoceba|P. Merino Amador|F. González-Romo|T. Durán-Valle|M. Munoz-Algarra|A. Pérez-Ayala|J. Meletiadis|S. Santos Gonçalves|M. Fernández-Huerta|M. Arias-Temprano|P. Munoz|G. Butler|J. Guinea|P. Escribano"
"1698","12/04 12:00","20","P2894","Ayse KALKANCI","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Biocide, antifungal susceptibilities and virulence characteristics of Clade 1 Candida auris strains","A. Kalkanci|S. Erganis|E. Sahin|E. Kilic|S. Algin|H. Martli|B. Yavuz|A. Dogan|F. Kirca|S. Uzuntas Turan|A. Çagatan Seyer|M. Mustapha Taiwo|A. Usman|M. Yuvali|C. Ergin|B. Dinç|D. Uzun Ozsahin"
"1757","12/04 12:00","21","P2895","Hedda Luise VERHASSELT","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Trends of azole-resistant Aspergillus fumigatus susceptibility over more than one decade from a German ECMM excellence centre","H. Verhasselt|L. Thissen|U. Scharmann|S. Dittmer|P. Rath|J. Steinmann|L. Kirchhoff"
"2375","12/04 12:00","22","P2896","Fanny WEGNER","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","whole-genome sequencing of Candida glabrata and Candida albicans for detection of resistance mutations against echinocandins","F. Wegner|P. Darshini|S. Purushothaman|B. Schulthess|A. Egli"
"2422","12/04 12:00","23","P2897","Stella WOLFGRUBER","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","ECMM-Candida IV: a worldwide study on antifungal tolerance, resistance, and clinical outcomes in candidemia caused by non-albicans Candida species","S. Wolfgruber|M. Arendrup|C. Lass-Flörl|R. Vahedi-Shahandashti|P. Pappas|L. Sixto|E. Roilides|J. Prattes|S. Sedik|R. Kovács|M. Valerio|A. Pappas|J. Young|S. Cugnata|G. Desoubeaux|A. Henao-Martinez|J. Van Praet|M. Samarkos|G. Vella|R. Sprute|O. Cornely|M. Hoenigl"
"2475","12/04 12:00","24","P2898","Aakriti JAIN","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Revolutionising the fight against fungi with clinically relevant in silico tools for fungal drug resistance","A. Jain|M. Kumar"
"2517","12/04 12:00","25","P2899","Radim DOBIAS","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Antifungal susceptibility profiles of Cryptococcus neoformans isolates from Czech Republic: a 20-year surveillance study, 2002-2023","R. Dobias|P. Lyskova"
"2565","12/04 12:00","26","P2900","Mariana CASTANHEIRA","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Phylogenomics reveals patterns of azole activity against Aspergillus section Nigri clinical isolates","J. Kimbrough|M. Karr|M. Winkler|M. Castanheira"
"2735","12/04 12:00","27","P2901","Ulrike SCHARMANN","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Azole-resistant Aspergillus fumigatus in people with cystic fibrosis with lung transplantation: susceptibility patterns and molecular epidemiology","U. Scharmann|L. Kirchhoff|P. Rath|J. Steinmann|M. Welsner|L. Sedlacek"
"3029","12/04 12:00","28","P2902","Soo Bin LEE","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Fluconazole-nonsusceptible Candida tropicalis bloodstream isolates in South Korea, 2003–2024: resistance mechanisms and genetic relatedness","S. Lee|J. Shin|S. Kee|M. Shin|S. Byun|G. Lee|Y. Kwon|S. Kim"
"3428","12/04 12:00","29","P2903","Veronique SAUVONNET","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Isavuconazole MIC determination: comparative evaluation of a new gradient strip to the EUCAST E.DEF 9.4 BMD on 110 Aspergillus isolates","V. Sauvonnet|E. Escoffier|D. Halimi|C. Franceschi"
"3432","12/04 12:00","30","P2904","Lucía GÓMEZ BARRAL","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Rapid vs standard susceptibility testing to echinocandins: is RAST for antifungal agents possible?","L. Gomez Barral|B. Burgoa Rubido|I. Garcia Garcia|A. Muriel Serrano|D. González Polo|D. Vazquez Gomez|P. Hernández Calvo|J. Munoz Bellido|J. Pendones Ulerio"
"3437","12/04 12:00","31","P2905","Lisa HAHN","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","In vitro susceptibility testing of rare moulds ""RaMo Study"": an ECMM-EC/EFISG/ECMM/ISHAM initiative","L. Hahn|R. Shahandashti|S. Berger|C. Lass-Flörl"
"3630","12/04 12:00","32","P2906","Aleksandra GÓRZYNSKA","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","The susceptibility of Meyerozyma guilliermondii and Kluyveromyces marxianus to manogepix and other antifungal drugs","A. Gorzynska|D. Konarska|J. Pucek|A. Korzeniowska-Kowal|U. Nawrot"
"3656","12/04 12:00","33","P2907","Jesus GUINEA","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","National survey on azole-resistant clinical Aspergillus fumigatus collected in 2023: environmentally generated azole-resistant isolates (TR34-L98H and TR46-Y121F-T289A substitutions) are expanding across Spain","P. Escribano|J. Moraga|P. Munoz|J. Guinea|A. Gomez"
"3781","12/04 12:00","34","P2908","Carolina DO PRADO","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","New insights into antifungal susceptibility testing on Sporothrix brasiliensis","C. Do Prado|B. Spruijtenburg|J. Meis|V. Vicente|T. De Groot|E. Meijer|F. Queiroz-Telles"
"3944","12/04 12:00","35","P2909","Luis OSTROSKY-ZEICHNER","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Antifungal susceptibility testing of SCY-247 against contemporary clinical yeast isolates","C. Grimes|M. Horne|L. Ostrosky-Zeichner|K. Borroto-Esoda|D. Angulo"
"3980","12/04 12:00","36","P2910","Bram SPRUIJTENBURG","5","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Identification of antifungal resistance mechanisms in the Tardiomyces genus","B. Spruijtenburg|T. De Groot|F. Hagen|S. Rudramurthy|N. Kobayashi|J. Meis|E. Meijer"
"4950","12/04 12:00","1","P2911","Celia SÁNCHEZ-MARTÍNEZ","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","In vitro activity of rezafungin against antifungal-resistant Candida spp isolates: loss of activity against C. glabrata isolates harbouring S663 and delF659 substitutions","C. Sanchez-Martinez|P. Escribano|P. Munoz|J. Guinea"
"5094","12/04 12:00","2","P2912","Yasuhiro TSUCHIDO","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Prospective single centre surveillance of clinically isolated azole-resistant Aspergillus fumigatus in Japan","Y. Tsuchido|N. Fujimoto|S. Arasawa|Y. Tsuda|K. Shinohara|M. Yamamoto|Y. Matsumura|M. Nagao"
"5287","12/04 12:00","3","P2913","Wenjuan WU","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","In vitro activitiy of rezafungin in comparison with anidulafungin and caspofungin against invasive fungal isolates in China, 2017-2022","S. Yang|F. Wan|J. Guo|W. Wu"
"5423","12/04 12:00","4","P2914","Isaac ALONSO GARCIA","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Activity of the new antifungal oteseconazole against Pichia kudriavzevii clinical isolates from invasive fungal infections","A. Garcia-Pose|A. Mesquida|G. Báez-Barroso|C. Sanchez-Martinez|G. Bou|A. Beceiro|P. Escribano|J. Guinea|I. Alonso Garcia"
"5501","12/04 12:00","5","P2915","Pilar ESCRIBANO","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","First report of fluconazole-resistant Candida parapsilosis harbouring the G438S ERG11p substitution in a Brazilian hospital","S. Santos Gonçalves|S. Bravim Maifrede|P. Peçanha|R. Cayô Da Silva|A. Messias Rodrigues|E. Yake|P. Munoz|P. Escribano|J. Guinea"
"5670","12/04 12:00","6","P2916","Laura ALGUACIL CUÉLLAR","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Fungal colonisation, resistance, and invasive infections in spanish ICUs: findings from 22 centres","L. Alguacil Cuéllar|A. Hrynzovska|S. Cano Pascual|R. Garcia Ortega|O. Zaragoza Hernández|R. Zaragoza|C. Soriano|A. Alastruey Izquierdo"
"5768","12/04 12:00","7","P2917","Camille MARCHETTI","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Study of Tac1a and Tac1b in azole resistance in Candida auris","C. Marchetti|J. Li|C. Gibert|D. Brandalise|A. T. Coste|D. Sanglard|F. Lamoth"
"5574","12/04 12:00",,"P2918","Shyam Kumar MISHRA BAISHNAB",,,"06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","A guanidine-functionalised anthranilamide peptidomimetic RK758 targets Candidozyma auris: integrative mechanistic insights from morphology to transcriptomics","S. Mishra Baishnab|R. Kuppusamy|A. Hui|E. Wong|M. Willcox"
"5895","12/04 12:00","9","P2919","Teresa CARRASCO GIL","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Spread of Y132F fluconazole-resistant C. parapsilosis genotypes causing candidemia in patients admitted to a tertiary hospital in Genoa, Italy","T. Carrasco|A. Vena|A. Mesquida|V. Di Pilato|A. Marchese|M. Mikulska|M. Basetti|P. Munoz|J. Guinea|P. Escribano"
"5948","12/04 12:00","10","P2920","Alexandre ALANIO","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Antifungal resistance surveillance: insights from a multicentre survey","A. Alanio|M. Arendrup|P. Verweij|L. White|A. Alastruey Izquierdo"
"5954","12/04 12:00","11","P2921","Pooja SEN","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Understanding multiazole resistance in Aspergillus fumigatus: the impact of non-cyp51A mutation and efflux pump overexpression","P. Sen|P. Vijayaraghavan"
"6038","12/04 12:00","12","P2922","Lucia CERNÁKOVÁ","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Photodynamic inactivation and the paucity of the antifungal arsenal against oral fluconazole-resistant non-Candida albicans Candida species","L. Cernakova|C. Rodrigues|J. Dekkerová|H. Bujdáková"
"6041","12/04 12:00","13","P2923","Francesca TRIVA","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","P-bromodomiphen bromide potentiates conventional antifungal activity against Candida auris","F. Triva|E. Ottaviano|S. Ancona|F. Sisto|A. Artasensi|L. Fumagalli|M. Cacaci|F. Bugli|E. Borghi"
"6137","12/04 12:00","14","P2924","Jesus GUINEA","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","The new triterpenoid antifungal SCY-247 retained activity against most echinocandin- and fluconazole-resistant Candida spp isolates: reduced susceptibility in C. glabrata isolates showing substitutions at the first amino acid in hotspot 1 FKS2 gene","C. Sanchez-Martinez|P. Escribano|P. Munoz|J. Guinea"
"6461","12/04 12:00","15","P2925","Laura DOORLEY","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Unlocking the fungicidal activity of triazoles against Candida auris","L. Doorley|S. Jones|T. Simmons|V. Meza-Perez|A. Iverson|C. Johnson|A. Mcknight|S. Wilde|J. Parker|J. Miao|J. Carnahan|L. Janke|S. Kelly|B. Peters|J. Rosch|J. Rybak"
"6462","12/04 12:00","16","P2926","Erganis Sidre","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Fluconazole heteroresistance in Candida auris","E. Sahin|S. Erganis|A. Kalkanci"
"6565","12/04 12:00","17","P2927","Ayse BARIS","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Investigation of expression levels of 14-alpha lanosterol demethylase gene (ERG11) and efflux pump-encoding genes (CDR1, CDR2, and MDR1) in C. albicans isolates with decreased susceptibility to azoles from vaginal cultures","M. Alcali|P. Armutcuoglu|N. Kina|E. Aktas|Ö. Dogan|A. Baris"
"6674","12/04 12:00","18","P2928","Dylan STAATS","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Evaluation of rezafungin on the thermo scientific sensititre YeastOne panel","K. Hajek|M. Hendrix|D. Staats|S. Killian|K. Knight|D. Paisey|J. Bovill|B. Willinger|M. Ghannoum|Y. Li|P. Rhomberg|A. Klauer|M. Redell"
"6697","12/04 12:00","19","P2929","Illan LALOUM","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","In vitro antagonism between voriconazole and olorofim against 30 clinical strains of Aspergillus fumigatus","I. Laloum|A. Bidaud|P. Schwarz|M. Bougnoux|E. Dannaoui"
"6998","12/04 12:00","20","P2930","Nazaret BETANZOS GUTIERREZ","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Optimising the screening method for fluconazole-resistant Candida parapsilosis with chromogenic media","N. Betanzos|C. Mora|M. Martinez-Fernández|L. Echegoyen|N. Eguiluz|M. Villanueva|J. Del Pozo|M. Fernández-Alonso"
"7303","12/04 12:00","21","P2931","Maddalena ALBERTINI","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Antifungal susceptibility profile of Aspergillus species isolated from 2019 to 2024 in a tertiary care hospital","M. Albertini|S. Cantergiani|F. Ferrari|I. Venturelli|M. Sarti|A. Bedini|M. Meschiari|C. Mussini|E. Franceschini"
"7304","12/04 12:00","22","P2932","Kathrin SPETTEL","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Cladophialophora bantiana: first insights into susceptibility patterns and whole-genome sequencing analysis of a clinical case","K. Spettel|F. Lötsch|R. Kriz|F. Thalhammer|S. Frank|B. Willinger"
"7320","12/04 12:00","23","P2933","Richard KRIZ","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","DBRMC: database for resistance mutations in Candida","K. Spettel|R. Kriz|S. Galazka|N. Schweitzer|A. Graf|B. Willinger"
"7664","12/04 12:00","24","P2934","Elizabeth ISKANDAR","6","A","06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Effect of rezafungin against biofilm of Candida parapsilosis fluconazole-resistant isolates","A. Prigitano|M. Esposto|E. Iskandar|C. Cavanna|F. Baldanti|M. Cogliati|L. Romano"
"219","12/04 12:00","25","P2935","Yazed ALSOWAIDA","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis","Y. Alsowaida|B. Alshoumr|S. Alowais|K. Bin Saleh|A. Alshammari|K. Alshurtan|H. Wali"
"376","12/04 12:00","26","P2936","Yachna KUMARI","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","ASLdC3 elevates mitochondrial dysfunction by impeding the central carbon metabolism to inhibit yeast-to-hyphae transition in Candida albicans","Y. Kumari|M. Bhattacharyya"
"1116","12/04 12:00","27","P2937","Johan MAERTENS","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients","J. Maertens|R. Rodriguez Veiga|J. De Greef|M. Uzunov|L. Vazquez|O. Penack|A. Albasanz-Puig|M. Ngirabacu|V. Mehra|D. Teschner|L. Albert|C. Pfeifer|P. Brennan-Benson|K. Vanstraelen|E. Azoulay|R. Herbrecht|S. Fodil|A. De Voeght|K. Delavigne|T. Liebregts"
"1175","12/04 12:00","28","P2938","Dayu CHEN","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Antifungal treatment regimens as primary therapy for invasive aspergillosis: a systematic review and network meta-analysis","Q. Gu|Y. Chen|P. Ding|J. Kan|D. Chen|H. Zhang|N. Hu|J. He"
"1235","12/04 12:00","29","P2939","Craig COLEMAN","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Healthcare resource utilisation, all-cause treatment costs, and mortality in patients with malignancies that develop invasive aspergillosis","C. Coleman|B. Lovelace|B. Alexander|M. Johnson|M. Bresnik|T. Walsh"
"1294","12/04 12:00","30","P2940","Borja SUBERVIOLA","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Retrospective, multicentre study of the renal safety of liposomal amphotericin B in critically ill with invasive pulmonary aspergillosis","B. Suberviola|J. Peral|M. Asensio|C. Soriano|R. Zaragoza|L. Forcelledo|I. Seijas"
"1413","12/04 12:00","31","P2941","Giuliana BANCHE","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Azole-loaded mucosomes: a hopeful approach to fight Candida albicans in mucosal infections","N. Mandras|L. Cavallo|O. Garbero|L. Sardelli|F. Menotti|F. Longo|J. Roana|C. Pagano|S. Visentin|V. Allizond|G. Banche|E. Fassina"
"1536","12/04 12:00","32","P2942","Lucinda VAN ANGLEN","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Real-world experience with rezafungin: a novel long-acting echinocandin","K. Couch|R. Hengel|C. Weeks|L. Van Anglen|B. Metzger|J. John|Jr.|E. Young|S. Baker"
"1549","12/04 12:00","33","P2943","Kieren MARR","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Safety and pharmacokinetics of SF001, a next-generation polyene antifungal, following single and multiple doses in healthy adults","K. Marr|L. Navalta|K. Truhe|N. Nepomuceno|A. Das"
"1658","12/04 12:00","34","P2944","Laura KOVANDA","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Deciphering connections between isavuconazole (ISAV) drug exposures and responses among different infections: Mucorales","L. Kovanda|A. Desai"
"1662","12/04 12:00","35","P2945","Amit DESAI","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Deciphering connections between Isavuconazole (ISAV) drug exposures and responses among different infections: dimorphic fungi/mould/other filamentous fungi and mixed infections","L. Kovanda|A. Desai"
"1664","12/04 12:00","36","P2946","Laura KOVANDA","6","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Deciphering connections between isavuconazole (ISAV) drug exposures and responses among different infections: invasive candidiasis","L. Kovanda|A. Desai"
"1996","12/04 12:00","1","P2947","Zarifa ORTA","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Evaluation of the compliance of the antifungal treatment approach with the recommendations in current international guidelines in patients with invasive candida infection or candida colonisation","Z. Orta|S. Basaran|B. Bayraktar|A. Benli|H. Ozsut"
"2396","12/04 12:00","2","P2948","Lingai PAN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","A study on intensive care unit invasive fungal stewardship (IFS) cognition and clinical practice among ICU physicians in Sichuan province","L. Pan|R. Yue|X. Huang|C. Pan"
"2588","12/04 12:00","3","P2949","Dorian VANNESTE","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Old friends, new foes: explorative assessment of the potential drug-drug interaction between metamizole and mold-active azoles","D. Vanneste|K. Nadrah|I. De Booser|M. Gijsen|L. Katrien|J. Maertens|S. Rex|B. Morlion|B. Kokosar Ulcar|J. Urbancic|A. Matos|K. Kalan|M. Somrak|I. Spriet"
"2746","12/04 12:00","4","P2950","Sean WASSERMAN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Study design: Phase 2, multicentre, open-label, randomised, active-controlled trial to evaluate the efficacy and safety of rezafungin adjunctive therapy in HIV-associated Pneumocystis jirovecii pneumonia","S. Wasserman|C. Schutz|L. Cox|L. Pillay-Ramaya|V. Ueckermann"
"2789","12/04 12:00","5","P2951","Oliver A. CORNELY","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Clinical outcomes with rezafungin or caspofungin in adults with invasive infections due to non-albicans Candida: pooled analysis from STRIVE and ReSTORE trials (including extension phase data)","O. Cornely|A. Soriano|G. Thompson|P. Honore|S. Dickerson|J. Vazquez|M. Bassetti"
"2972","12/04 12:00","6","P2952","Navjeet NAGI","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Implementation of antifungal stewardship rounds at a large teaching hospital","N. Nagi|M. Gilchrist|D. Armstrong-James|J. Peters|F. Davies|A. Ghazy|R. Wilson|C. Eades|M. Coleman"
"3241","12/04 12:00","7","P2953","Stella WOLFGRUBER","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Availability of antifungals in low- and middle-income countries: updating the maps","S. Wolfgruber|J. Salmanton-Garcia|M. Ngouanom Kuate|M. Hoenigl|J. Pereira Brunelli"
"3321","12/04 12:00","8","P2954","Ilana REINHOLD","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","A survey on candidemia management in Germany","I. Reinhold|J. Salmanton-Garcia|J. Lecker|D. Seidel|J. Stemler|O. Cornely|R. Sprute"
"3388","12/04 12:00","9","P2955","Eelco F.J. MEIJER","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","SCY-247, a novel second-generation IV/oral triterpenoid antifungal, demonstrates in vitro activity against C. auris including the majority of strains exhibiting high MICs for echinocandins","B. Spruijtenburg|T. De Groot|K. Borroto-Esoda|S. Wring|D. Angulo|E. Meijer"
"3398","12/04 12:00","10","P2956","Emily BEHRENS","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Isavuconazole pharmacokinetics in critically ill patients with acute-on-chronic liver failure and continuous haemodialysis: an observational study","E. Behrens|J. Grensemann|V. Fuhrmann|D. Jarczak|S. Kluge|J. Martens-Lobenhoffer|S. Bode-Böger|S. Wicha"
"3556","12/04 12:00","11","P2957","Vincent ARANZANA-CLIMENT","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Manogepix and amphotericin B combination is synergistic against Candida glabrata as evidenced by a new pharmacodynamic-modelling approach","A. Baillod|V. Aranzana-Climent|J. Clarhaut|S. Marchand|K. Brunet"
"3777","12/04 12:00","12","P2958","Emma OLIOSI","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Fluconazole-resistant Candida urinary tract infections: rare but difficult to manage","E. Oliosi|C. Angebault|B. Souhail|P. Huriez|A. Fekkar|G. Thizy|M. Bougnoux|F. Botterel|B. Henry"
"3798","12/04 12:00","13","P2959","Theunis GOOSEN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Isavuconazole comparison with other azoles regarding CYP3A-based drug-drug interactions in combination with ibrutinib, venetoclax, or midostaurin","T. Goosen|X. Wu|J. Lin|N. Cheruvu|S. Raber|M. De Figueiredo|M. Varma"
"3907","12/04 12:00","14","P2960","Frédégonde ABOUT","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Antifungal alternatives to itraconazole for the treatment of histoplasmosis: a multicentre retrospective study","B. De Valence|F. About|F. Samou|G. De Moustier|I. Le Bégue De Germiny|M. Demar|A. Amadouhé Kpangon|V. Veloso|A. Adenis|O. Lesens"
"3959","12/04 12:00","15","P2961","Pelinsu ARMUTCUOGLU","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","In-vitro investigation of the gold nanoparticles efficiency in the treatment of multidrug-resistant Candida auris","P. Armutcuoglu|B. Keles|C. Gunduz|E. Sokullu|Ö. Dogan"
"4690","12/04 12:00","16","P2962","Natalia IORIO","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Cytotoxicity and antifungal activity of Felimare lajensis","G. Chianca|S. Alves|H. Povoa|R. Braga|N. Iorio"
"5052","12/04 12:00","17","P2963","Tianyan CHEN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Posaconazole tablets in preventing invasive fungal diseases in patients with end-stage liver disease","C. Yunru|S. Lei|Z. Xi|L. Xiaojing|N. Yinghua|H. Yingli|C. Tianyan"
"5653","12/04 12:00","18","P2964","Benjamin Kingsley HARLEY","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Potent and broad-spectrum antifungal activity of 6-alpha-(3'-methoxy-4'-hydroxybenzoyl)-lup-20(29)-ene-3-one, a triterpenoid from Paullinia pinnata","B. Harley|T. Asamoah|C. Amengor|D. Neglo|T. Fleischer"
"5783","12/04 12:00","19","P2965","Patrick VAN DIJCK","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris","H. Carolus|D. Sofras|G. Boccarella|S. Jacobs|V. Biriukov|L. Goossens|A. Chen|I. Vantyghem|S. Pierson|C. Lobo Romero|H. Steenackers|K. Lagrou|P. Van Den Berg|J. Berman|T. Gabaldon|P. Van Dijck"
"5819","12/04 12:00","20","P2966","Jesus GUINEA","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Assessment of in vitro activity of the new triterpenoid antifungal, SCY-247, against a collection of yeasts causing fungaemia in patients admitted to a tertiary hospital in Madrid from 2014 to 2024","P. Escribano|A. Gomez|A. Burillo|P. Munoz|J. Guinea"
"5827","12/04 12:00","21","P2967","Ashok AADITH","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Evaluation of posaconazole therapeutic drug monitoring for anti-fungal prophylaxis in patients with a heamatological malignancy: a tertiary referral centre's experience","A. Ashok|S. Fernando|S. Lee|J. Coutsouvelis|R. Pai Mangalore|C. Morrissey"
"6085","12/04 12:00","22","P2968","Dominic WICHMANN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Mold-active therapy in critically ill patients from 2008 to 2023 in a tertiary care hospital in Germany","M. Haar|K. Roedl|S. Kluge|C. Koenig|D. Wichmann"
"6741","12/04 12:00","23","P2969","Vasiliki KROUSTALI","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Clinical outcome of different treatments in patients with vulvovaginal candidiasis","V. Kroustali|E. Resoulai|M. Siopi|S. Antonopoulou|J. Meletiadis"
"6887","12/04 12:00","24","P2970","Federico FAMA","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Tolerability and pharmacological monitoring of voriconazole and isavuconazole in chronic pulmonary aspergillosis: a real-world comparison","F. Fama|C. Conflitti|A. Civati|D. Cattaneo|A. Torre|A. Gori|S. Antinori|M. Colaneri|M. Schiuma"
"6993","12/04 12:00","25","P2971","Maria-Ioanna BEREDAKI","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Fluconazole pharmacodynamics against Candidozyma auris isolates in an in vitro pharmacokinetic/pharmacodynamic model","M. Beredaki|V. Kroustali|S. Pournaras|J. Meletiadis"
"7229","12/04 12:00","26","P2972","Ippei SAKAMAKI","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Inhibition of tumor necrosis factor-alpha production by azole antifungal agents","Y. Tanaka|Y. Tanaka|H. Iwasaki|I. Sakamaki"
"7415","12/04 12:00","27","P2973","Sara COBO SACRISTÁN","7","A","06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Isavuconazole therapeutic drug monitoring and dosage adjustments","S. Cobo Sacristán|M. Santos Puig|I. Gonzalez Caballero|E. Shaw Perujo|N. Sabe Fernández|G. Abelenda-Alonso|F. Ubau Quintano|R. Granada Vicente|A. Padullés|C. Ribera-Puig"
"1759","12/04 12:00","1","P2974","Ramya MADHAVAN","1","C","07a. Fundamental parasitology","Hookworm modulated immune responses to bystander antigens among adults in endemic rural communities in southern India","P. Saravanan|A. Kumar|J. Michael|J. Walson|S. Babu|T. Nutman|S. Ajjampur|R. Ramesh|G. Israel|S. Galagan|M. Manuel|C. Syed|R. Madhavan"
"2483","12/04 12:00","2","P2975","Anja GODFREY","1","C","07a. Fundamental parasitology","Advancing blastocystis research through a One Health approach: insights from a COST action","A. Godfrey|E. Gentekaki|A. Tsaousis"
"3690","12/04 12:00","4","P2977","Jingjia ZHANG","1","C","07a. Fundamental parasitology","Bulk and single-cell transcriptome profiling revealed dynamic pathological changes of granulomatous amebic encephalitis caused by Balamuthia mandrillaris: a cohort study","J. Zhang|X. Jia|B. Yang|Q. Yang"
"4168","12/04 12:00","5","P2978","Soodeh GHADIMI","1","C","07a. Fundamental parasitology","Evaluation of natural killer cell exhaustion markers in the peripheral blood of hydatid cyst patients","S. Ghadimi|S. Ghadimi|R. Sepahvandi"
"4222","12/04 12:00","6","P2979","Sabrina EGREK","1","C","07a. Fundamental parasitology","Emsb microsatellites analysis of Echinococcus multilocularis specimens isolated from Belgian patients with alveolar echinococcosis and host animals","S. Egrek|R. Sacheli|J. Knapp|O. Detry|S. Engelskirchen|A. Linden|M. Hayette|K. El Moussaoui|P. Léonard"
"4572","12/04 12:00","7","P2980","Zhihua OU","1","C","07a. Fundamental parasitology","Spatiotemporal transcriptomic profiling reveals the dynamic immunological landscape of alveolar echinococcosis","P. Ren|Z. Ou|L. Li|F. He|J. Chen|T. Zhou|W. Jia|J. Li|H. Yan"
"4949","12/04 12:00","8","P2981","Hiroshi TACHIBANA","1","C","07a. Fundamental parasitology","Single-cell analysis of gene expression in a pathogenic strain of Entamoeba species","T. Imai|X. Cheng|H. Tachibana"
"6252","12/04 12:00","9","P2982","Mohammadreza SHAFIEI","1","C","07a. Fundamental parasitology","Evaluation of natural killer cell frequency and exhaustion markers in the peripheral blood of patients with cutaneous leishmaniasis","M. Shafiei|H. Mohammadi"
"6497","12/04 12:00","10","P2983","Settimia SBARRA","1","C","07a. Fundamental parasitology","Stage-specific immune response to AgB T-peptides in patients with cystic echinococcosis","S. Sbarra|A. Vola|F. Tamarozzi|S. Najafi-Fard1|A. Ludovisi|A. Teggi|E. Nicastri|F. Albarello|D. Goletti|L. Petrone|E. Brunetti"
"7294","12/04 12:00","11","P2984","Surachai TECHAOEI","1","C","07a. Fundamental parasitology","Prevalence of parasites in three-spot gourami (Trichopodus trichopterus) from natural water sources in Khlong 7, Thanyaburi district, Pathum Thani province","S. Techaoei|S. Sriwongpuk"
"805","12/04 12:00","12","P2985","Francesca TAMAROZZI","1","C","07b. Parasitic disease epidemiology","Presence of Wolbachia bacteria in Mansonella perstans isolates from migrants of different geographical origin: a pilot study from the ESCMID study group on clinical parasitology","E. Pomari|D. Voronin|M. Alvarez|M. Arsuaga|E. Bottieau|M. Luzon-Garcia|B. Nickel|J. Rubio|J. Salas-Coronas|F. Salvador|M. Soriano Perez|E. Sulleiro|L. Goterris|M. Van Esbroeck|J. Van Hellemond|L. Wammes|L. Zammarchi|D. Lavezari|M. Degani|S. Tais|J. Held|F. Gobbi|F. Tamarozzi"
"1105","12/04 12:00","13","P2986","Natalia OSLAJ","1","C","07b. Parasitic disease epidemiology","Recent spread and outcomes of human alveolar echinococcosis in Croatia","M. Balen Topic|K. Viskovic|M. Sviben|N. Oslaj"
"1763","12/04 12:00","14","P2987","Filip JANSÅKER","1","C","07b. Parasitic disease epidemiology","Risk factors for trichomoniasis in women: a nationwide study","C. Sundqvist|X. Li|K. Sundquist|F. Jansaker"
"1975","12/04 12:00","15","P2988","Francesca TAMAROZZI","1","C","07b. Parasitic disease epidemiology","Ultrasonographic prevalence of cystic echinococcosis in school-aged children in Chile: results of a pilot survey in the context of a developing control programme","C. Alvarez-Rojas|T. Manciulli|F. Tamarozzi|M. Spinicci"
"2102","12/04 12:00","16","P2989","Junwon SEO","1","C","07b. Parasitic disease epidemiology","Breakthrough infection with Plasmodium species in deployed military personnel who completed prophylactic antimalarial medication during their deployment period and returned home: a case-control study","J. Seo|D. Kim|N. Yun|D. Kim"
"2330","12/04 12:00","17","P2990","Pallavi MOUDGIL","1","C","07b. Parasitic disease epidemiology","Mitochondrial nad5 gene-based molecular insights into zoonotic Echinococcus granulosus sensu lato genotypes endemic in north India","P. Moudgil|A. Moudgil"
"2866","12/04 12:00","18","P2991","Maria Delmans FLORES-CHAVEZ","1","C","07b. Parasitic disease epidemiology","Neglected blood parasitic diseases and malaria in the Peruvian Amazon: molecular screening employing a new multiplex qPCR","V. Anton Berenguer|S. Otero Rodriguez|Á. Ceballos Caro|J. Ramos Rincon|J. Celis Salinas|M. Casapia Morales|R. Pérez Tanoira|J. Sánchez Canales|S. Quevedo Soriano|S. Gomez De Frutos|M. Flores Chávez|J. Rubio Munoz"
"3520","12/04 12:00","19","P2992","Eddy KYAGULANYI","1","C","07b. Parasitic disease epidemiology","Knowledge on female genital schistosomiasis among women attending public healthcare facilities in Namayingo and Mayuge Districts, Uganda","D. Abila|W. Bugosera|E. Kyagulanyi|B. Chemutai|D. Gakwerere|H. Wabinga"
"3765","12/04 12:00","20","P2993","Santiago RODRÍGUEZ","1","C","07b. Parasitic disease epidemiology","Clinical outcomes in chagas disease among military personnel: a retrospective observational study in Bogota, Colombia","H. Vergara-Samur|S. Rodriguez-Piragauta|J. Hoyos-Garcia|C. Gomez-Quintero"
"3782","12/04 12:00","21","P2994","Francesca TAMAROZZI","1","C","07b. Parasitic disease epidemiology","Investigating hybrid Schistosoma spp. imported infections to Europe: a cohort from the ESCMID study group on clinical parasitology","E. Pomari|B. Webster|M. Alvarez-Martinez|M. Arsuaga|E. Bottieau|D. Camprubi-Ferrer|M. Concu|R. De Miguel Buckley|R. Koelewijn|D. Marangoni|A. Marteau|N. Beatrice|C. Rothe|F. Salvador|M. Schunk|E. Sulleiro|M. Van Esbroeck|J. Van Hellemond|L. Wammes|L. Zammarchi|S. Pettene|E. Rizzi|S. Scarso|F. Gobbi|F. Tamarozzi"
"3809","12/04 12:00","22","P2995","Malika MADHAVA","1","C","07b. Parasitic disease epidemiology","Congenital toxoplasmosis screening of pregnant women in Cameroon: proposing a novel algorithm with a cost savings analysis","M. Madhava|J. Dionne|D. Ntambo"
"3971","12/04 12:00","23","P2996","Eylem AKDUR ÖZTÜRK","1","C","07b. Parasitic disease epidemiology","Comprehensive mapping of Blastocystis epidemiology and subtypes: insights from COST action CA21105 'One Health Blastocystis`","E. Akdur Ozturk|A. Figueiredo|I. Guadano-Procesi|A. Godfrey|E. Gentekaki|A. Tsaousis|D. Carmena|F. Dogruman Al"
"3973","12/04 12:00","24","P2997","Andrea POLONI","1","C","07b. Parasitic disease epidemiology","D-dimer as a marker of severe disease in imported P. falciparum malaria: a retrospective observational study","A. Poloni|M. Colaneri|A. Giacomelli|C. Arrigo|A. Dolci|S. Antinori|A. Rizzo|S. Caronni|M. Pieruzzi|A. Behring|S. Grosso"
"4273","12/04 12:00","25","P2998","Rose Chimezie IHEZIE","1","C","07b. Parasitic disease epidemiology","Risk factors for Trichuris trichuira infection in children","A. Anyasodor|R. Ihezie"
"4525","12/04 12:00","26","P2999","Arthur MAKA","1","C","07b. Parasitic disease epidemiology","Intestinal parasitic infections in upper Corsica: current epidemiology and diagnostic approach","A. Maka|A. Kolakowska|H. Fiette|N. Flatischler|E. Parisi|A. Chéret"
"4582","12/04 12:00","27","P3000","Tommaso GRITTI","1","C","07b. Parasitic disease epidemiology","Unveiling the molecular diversity of Leishmania infantum in human tegumentary leishmaniasis: evidence from Italy and Spain","T. Gritti|C. Carmen|E. Carrillo|J. Solana|M. Javier|E. Carra|M. Ortalli|M. Sara|M. Zanazzi|T. Lazzarotto|G. Rugna|S. Varani"
"5855","12/04 12:00","28","P3001","Jolana HAVLOVÁ","1","C","07b. Parasitic disease epidemiology","Prevalence and molecular typing of the parasite Dientamoeba fragilis in patients from two hospitals in the Czech Republic","J. Havlova|I. Zicklerova|P. Tumova|D. Fackova|E. Nohynkova"
"6047","12/04 12:00","29","P3002","Suryeong GO","1","C","07b. Parasitic disease epidemiology","Epidemiological investigation of a malaria outbreak in overseas deployment units in 2022","S. Go|H. Park"
"6314","12/04 12:00","31","P3004","Meriem ABDELJELIL","1","C","07b. Parasitic disease epidemiology","Visceral leishmaniasis among children and adults in a Tunisian hospital","O. Safta|M. Abdeljelil|E. Sfar|L. Saad|S. Zayeni|W. Marrakchi|F. Ben Romdhane|A. Aouam|H. Ben Brahim|S. Chouchene|A. Toumi"
"6609","12/04 12:00","32","P3005","Anil Kumar NEHRA","1","C","07b. Parasitic disease epidemiology","Unveiling Ehrlichia canis: genetic diversity, population structure, and haplotype variations of an emerging zoonotic pathogen","A. Nehra|A. Kumari|A. Moudgil|S. Vohra"
"6645","12/04 12:00","33","P3006","Sundaram PANDEY","1","C","07b. Parasitic disease epidemiology","Visceral leishmaniasis and lymphatic filariasis co-endemicity in Bihar, India","S. Pandey|E. Hasker|S. Sundar"
"6992","12/04 12:00","34","P3007","Isabel HUGHES","1","C","07b. Parasitic disease epidemiology","Optimisation of PCR-based detection of Wolbachia bacterial strains in Anopheles malaria vectors in the field","I. Hughes|J. Ball|S. Sougoufara|L. Chatterley|T. Walker"
"7142","12/04 12:00","35","P3008","Chiara FANELLI","1","C","07b. Parasitic disease epidemiology","Awareness and knowledge of human leishmaniasis in a mediterranean endemic area: a cross-sectional study from Sardinia","C. Fanelli|S. Morales|F. Zeroual|D. Pasero|I. Maida"
"433","12/04 12:00","1","P3010","Enoch ANINAGYEI","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Detecting Plasmodium falciparum histidine-rich proteins 2 and Plasmodium lactate dehydrogenase in saliva: a non-invasive means of diagnosing malaria in children","E. Aninagyei|C. Addo Boatey|J. Arthur-Asmah|G. Larbi|B. Sarfo-Bempong|O. Desmond"
"671","12/04 12:00","2","P3011","Caroline RÖNNBERG","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Establishing a diagnostic algorithm with high performance for Schistosoma serology: an approach using composite reference standard and latent class analysis ??????","C. Rönnberg|I. Bujila|S. Kuhlmann-Berenzon|G. Killander|S. Sigurdsen|T. Lier"
"1164","12/04 12:00","3","P3012","Patricia VIVAS","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Evaluation of bead beating preparation of stool samples for detection of helminths by multiplex PCR","P. Vivas|M. Amoureux|S. Ferreira|S. Boubtane|A. Imbach|S. Romand"
"1646","12/04 12:00","4","P3013","Henar ALONSO-EZCURRA","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Detecting and differentiating plasmodium species using real-time PCR in clinical samples collected over five years in a Spanish tertiary hospital","B. Dehesa-Garcia|P. Peris-Peris|A. Milagro-Beamonte|P. Abad|N. Martinez-Cameo|D. Martinez-Mateos|B. Gilaberte-Angos|L. Laborda-Balaguer|M. Alejandre-Alegre|A. Rezusta|H. Alonso-Ezcurra|P. Robres"
"1656","12/04 12:00","5","P3014","Jamie LEMON","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","A simple, extraction-free molecular assay for the diagnosis of malaria","F. Zhang|V. Streva|S. Duong|S. Juretschko|J. Lemon"
"2058","12/04 12:00","6","P3015","Varol TUNALI","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Emerging tools in parasitological diagnostics: a comparative study of AI, microscopy, and rapid antigen testing","V. Tunali|N. Turgay"
"2428","12/04 12:00","7","P3016","Lena BAUKART","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Verification of an ultra-sensitive mitochondrial cytochrome c oxidase III (cox3) gene primer for the detection of Plasmodium spp. using conventional PCR","L. Baukart|C. Hansen|H. Aftab|K. Schønning|R. Dargis"
"2959","12/04 12:00","8","P3017","Mariana RIBEIRO GONÇALVES","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Evaluation of the humoral immune response to Plasmodium vivax antigens in patients with Plasmodium vivax malaria recurrences","M. R. Goncalves|J. R. S. Alves|J. P. C. Tavares|L. Albrecht|I. S. Soares|P. A. C. Costa|A. C. G. Almeida|J. A. Leite|I. F. A. Antunes|A. P. B. Lopes|C. B. S. Rodrigues|D. G. Q. Ribeiro|V. G. G. De Siqueira|M. V. G. Vallejos|M. V. G. Lacerda|E. V. De Paula|S. C. P. Lopes|G. C. Melo|F. T. M. Costa"
"3278","12/04 12:00","9","P3018","Silje HOEGH","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","The 18S rDNA sequencing of Plasmodium species","S. Hoegh|K. Steinke|M. Rasmussen|M. Skov|S. Larsen|K. Thomsen|T. Sydenham|G. Hartmeyer"
"3330","12/04 12:00","10","P3019","Anna SMIELEWSKA","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Polymerase chain reaction for malaria diagnosis","J. York|N. Reza|L. Swithenbank|D. Carlisle|J. Booth|J. Jones|I. Slack|C. Parry|A. Smielewska"
"3464","12/04 12:00","11","P3020","Azucena RODRIGUEZ-GUARDADO","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Usefulness of molecular diagnostic techniques in imported strongyloidiasis","C. Campillo-Martin|M. Rodriguez-Perez|B. Rivaya|J. Boga|F. Vazquez|A. Rodriguez-Guardado"
"3521","12/04 12:00","12","P3021","Henar ALONSO-EZCURRA","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Advancing Chagas disease diagnosis: a real-time PCR validation for congenital and chronic infections","C. Ballart|A. Abras|H. Alonso|M. Lopez|C. Munoz|M. Gállego"
"3602","12/04 12:00","13","P3022","Henar ALONSO-EZCURRA","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Diagnostic performance of a novel real-time PCR assay for Toxoplasma gondii DNA using amniotic fluid and plasma clinical-like samples","F. Navarro|C. Escolar|H. Alonso"
"4190","12/04 12:00","15","P3024","Joao SERRA","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Comparison of the sensitivity and specificity of diagnostic tests to detect Schistosoma spp. infection in the adult population of Chókwè district in Mozambique","J. Serra|N. Ferracini|P. Ferreira|S. Belo|C. Silva|M. Sidat|C. Conceicao"
"4244","12/04 12:00","16","P3025","Allison HAAS","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Evaluation of the BioFire global fever panel compared to laboratory-developed PCR for malaria diagnostics","A. Haas|M. Couturier"
"4474","12/04 12:00","17","P3026","Didi BANG","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","LAMP for malaria diagnosis in a non-endemic country Denmark","D. Bang"
"4516","12/04 12:00","18","P3027","Pierre Martin ENGLERT","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Comparative analysis of chronic schistosomiasis cases diagnosed by microscopy or by serology only: a retrospective study in the Belgian national reference centre","P. Englert|M. Van Esbroeck|J. Verschueren|P. Soentjens|E. Bottieau|M. Hites"
"5017","12/04 12:00","19","P3028","Agnese COMELLI","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Screening and diagnosis access for neglected and tropical parasitic diseases in Italy: a national survey","A. Comelli|E. Oliva|F. Bernieri|L. Zammarchi|L. Clemente|L. Petrullo|G. Calleri|F. Bruschi|A. Raglio"
"5022","12/04 12:00","20","P3029","Gian Luca D'ALESSANDRO","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Performance of VIRapid HYDATIDOSIS test for diagnosis of cystic echinococcosis: can it be used for field screening?","A. Vola|R. Lissandrin|F. Campanini|G. D'alessandro|E. Brunetti|C. Stocchero"
"6370","12/04 12:00","21","P3030","Tommaso GRITTI","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Comparing molecular methods for the identification of Leishmania infantum in blood samples: a retrospective study of diagnostic accuracy","T. Gritti|S. Varani|B. Granozzi|S. Morselli|S. Castaldini|T. Lazzarotto|M. Ortalli"
"6536","12/04 12:00","22","P3031","Jean-Pierre GANGNEUX","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Diagnostic practices and therapeutic modalities for the management of visceral leishmaniasis: a joint ESCMID-ESGCP and LeishMan study","J. Gangneux"
"6677","12/04 12:00","23","P3032","Eylem AKDUR ÖZTÜRK","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Investigation the transmission dynamics of Cryptosporidium sp. and Giardia duodenalis in humans, animals, and the environment in rural Turkey: a One Health approach","E. Akdur Ozturk|Y. Majid Salman Al-Adilee|E. Gentekaki|A. Tsaousis|F. Dogruman Al"
"6879","12/04 12:00","24","P3033","Marie Gladys ROBERT","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Benefit of pan-nematode PCR in unusual clinical presentations of nematodosis","C. Garnaud|M. Robert|M. Raberahona|D. Bernheim|R. Siest|J. Arata-Bardet|S. Larrat|D. Maubon"
"7163","12/04 12:00","25","P3034","Anna BARBIERO","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Molecular assays on cutaneous swabs as an effective and less invasive diagnostic technique for cutaneous leishmaniasis: results from a retrospective study conducted in Italy","A. Barbiero|A. Aiello|N. Ciccone|S. Pollini|F. Malentacchi|G. Rossolini|C. Fiorelli|D. Massi|A. Bartoloni|M. Spinicci|L. Zammarchi"
"7218","12/04 12:00","26","P3035","Carlos Mauricio CULMA RAMIREZ","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Concordance between computed tomography and transfontanellar ultrasound for diagnosing central nervous system lesions in congenital toxoplasmosis","A. Romero|Y. Cedeno|J. Jovel|C. Culma"
"7470","12/04 12:00","27","P3036","Lilia KRICHENE","2","C","07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Demodex sp.: parasitological diagnosis, molecular identification and clinical expressions","L. Krichene|F. Cheikhrouhou|K. Sellami|S. Werda|S. Gargouri|F. Makni|H. Turki|A. Trigui|A. Ayadi"
"905","12/04 12:00","28","P3037","Vishal Kumar SINGH","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","The anti-Leishmanial potential of Toona ciliata leaf extract: harnessing nature's arsenal against leishmaniasis","V. Singh|A. Kumar|R. Tiwari|R. .|R. Kumar"
"1012","12/04 12:00","29","P3038","Varun BHARGAVA","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Carrier-mediated delivery of amphotericin-B through mannosylated liposomes for effective management of leishmaniasis","V. Bhargava|S. Bhargava"
"1086","12/04 12:00","30","P3039","Toshi NEMA","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Ligand conjugated carbon nanotubes for effective antileishmanial therapy","T. Nema|M. Bhargava"
"2010","12/04 12:00","31","P3040","Tito KIBONA","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Optimising deworming interventions: a study on Taenia multiceps control in rural northern Tanzanian livestock and dog populations","J. Buza|G. Shirima|T. Kibona"
"2153","12/04 12:00","32","P3041","Prasoon MADHUKAR","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Design, characterisation, and in vitro assessment of amine-functionalised graphene quantum dots conjugated with amphotericin B for visceral leishmaniasis therapy","P. Madhukar|S. Sundar"
"2240","12/04 12:00","33","P3042","Joan ROIG SANCHIS","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Long-term follow up of Chagas disease individuals treated with posaconazole and benznidazole: the CHAGASAZOL cohort","J. Roig-Sanchis|P. Bosch-Nicolau|A. Silgado|F. Salvador|A. Sánchez-Montalvá|M. Aznar|I. Oliveira|J. Espinosa-Pereiro|N. Serré-Delcor|D. Pou|J. Marinez-Camprecios|E. Sulleiro|I. Molina"
"3716","12/04 12:00","34","P3043","Hanna DE JONG","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Concentrations of artemether/lumefantrine in hair: a potential tool to retrospectively determine drug exposure following malaria treatment","J. Schnyder|H. De Jong|M. Vos-Van Der Meer|D. Van Der Laan|P. Schlagenhauf|R. Mathot|R. Van Hest|M. Grobusch"
"3837","12/04 12:00","35","P3044","Sara MORSELLI","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Screening of a chalcone-based library for anti-Leishmania activity","S. Morselli|M. Ortalli|T. Gritti|A. Garofalo|E. Roggiolani|L. Floris|C. Pierri|A. Cannarozzi|G. Castelli|F. Bruno|F. Belluti|S. Varani"
"3880","12/04 12:00","36","P3045","Sara MORSELLI","2","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Nucleo-cytoplasmic shuttling inhibitors as novel anti-Leishmania agents","S. Morselli|M. Ortalli|G. Alberoni|L. Anahita Suprani|T. Gritti|C. Pierri|G. Perrone|S. Varani|G. Alvisi"
"6096","12/04 12:00","1","P3046","Kurt ÖZGÜR","3","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Investigation of anti-leishmanial activities of Aspergillus metabolites and their effects on the pathogenesis of Leishmania virus at molecular level: in vitro studies from Turkey","I. Sertdemir|B. Kaymaz|G. Bayram Akcapinar|O. Kurt"
"6557","12/04 12:00","2","P3047","Martina BELTRAMI","3","C","07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Unveiling the veil: risk factors for Chagas disease treatment discontinuation in a non-endemic country: a retrospective cohort study","M. Beltrami|M. Navarrete-Lorite|E. Salamanca-Rivera|Á. Dominguez-Castellano|E. Ramirez De Arellano|I. Lopez-Hernandez|S. Antinori|J. Rodriguez-Bano"
"264","12/04 12:00","3","P3048","Soichi TAKEISHI","3","C","07f. Travel medicine, migrant and refugee health","The difference in seasonal variation in the number of arrival aircrafts investigated for invasive mosquitoes between airports in Japan","S. Takeishi|T. Inoue|K. Miyamura"
"509","12/04 12:00","4","P3049","Saeed AHMAD","3","C","07f. Travel medicine, migrant and refugee health","Assessing health disparities and access: a data-driven analysis of Afghan refugee health in Pakistan","S. Ahmad"
"534","12/04 12:00","5","P3050","Anatolio ALONSO CRESPO","3","C","07f. Travel medicine, migrant and refugee health","Appropriateness of malaria treatment according to WHO criteria for severe malaria in a non-endemic country","A. Alonso Crespo|A. Navarro Flores|A. Pérez De Ayala|I. Losada Galván|B. De Dios|P. Hérnandez Jiménez|J. Herrero|M. Perez-Jacoiste Asin|M. Lizasoain Hernández"
"715","12/04 12:00","6","P3051","Giovanni MORI","3","C","07f. Travel medicine, migrant and refugee health","Empowering migrants health: results from a monocentric prospective study","L. Battsti|G. Mori|L. Massimiliano|A. Castelli|D. Visentin|M. Zuccali|P. Fatehmoghadam|C. Alessio|D. Andrea|L. Emanuela"
"729","12/04 12:00","7","P3052","Paul Clemens PITZINGER","3","C","07f. Travel medicine, migrant and refugee health","Preliminary evaluation of a multiplex PCR assay for detecting protozoan and helminth infections in travelers returning to Berlin, Germany","P. Pitzinger|F. Mockenhaupt|G. Equihua Martinez|M. Nurnberg|A. Lindner|B. Kampmann"
"982","12/04 12:00","8","P3053","Bernadette WALTER","3","C","07f. Travel medicine, migrant and refugee health","A cross-sectional study on diphtheria and other wound infections among asylum seekers arriving in Baden-Wuerttemberg, Germany, August-October 2024","B. Walter|K. Luck|M. Adam|B. Winter|N. Knab|A. Kuhn|A. Welker|E. Aichinger|S. Brockmann|J. Rau"
"1385","12/04 12:00","9","P3054","Eirini ILIAKI","3","C","07f. Travel medicine, migrant and refugee health","A successful checklist order set for infectious disease screening in immigrant patients in the US","E. Iliaki|J. Cahn|A. Sundaram|L. Shipton|A. Mathews|T. Seufert|R. Osgood"
"1480","12/04 12:00","10","P3055","Martin P. GROBUSCH","3","C","07f. Travel medicine, migrant and refugee health","Burden of dengue fever in travellers from non-endemic areas: a systematic literature review","M. Grobusch|M. Diaz Menendez|E. Bittencourt De Gomensoro|C. Mächler|C. Shaw|B. Milovanovic"
"1858","12/04 12:00","13","P3058","Kieran KILLINGTON","3","C","07f. Travel medicine, migrant and refugee health","Incidence of Hymenolepis nana infection within people seeking asylum and refugees attending health screening at an integrated refugee health service (respond)","K. Killington|L. Nabarro|H. Chowdhury|P. Cinardo|K. Bowers|N. Longley|S. Eisen"
"2006","12/04 12:00","15","P3060","Maya Christina HITES","3","C","07f. Travel medicine, migrant and refugee health","Strongyloidiasis diagnosed by ELISA in Brussels: a bicentric retrospective study","J. Becu|C. Martin|S. Van Den Wijngaert|C. Truyens|D. Martiny|M. Hites"
"2059","12/04 12:00","16","P3061","Azucena RODRIGUEZ-GUARDADO","3","C","07f. Travel medicine, migrant and refugee health","Differential characteristics of imported schistosomiasis in female immigrant population","L. Anton|M. Rodriguez-Perez|E. De Andrés|J. Boga|J. Fernandez-Martinez|B. Rivaya|A. Rodriguez-Guardado"
"2127","12/04 12:00","17","P3062","Giacomo GUIDO","3","C","07f. Travel medicine, migrant and refugee health","Prevalence of neglected tropical diseases among migrants living in Europe: a systematic review and meta-analysis","G. Guido|L. Frallonardo|S. Cotugno|E. De Vita|G. Patti|L. De Santis|F. Segala|E. Nicastri|F. Gobbi|A. Morea|F. Indraccolo|D. Otranto|A. Requena-Mendez|N. Veronese|A. Saracino|F. Di Gennaro|R. Iatta"
"2868","12/04 12:00","18","P3063","Paloma MERINO AMADOR","3","C","07f. Travel medicine, migrant and refugee health","Impact of Chagas disease on quality of life in women diagnosed through neonatal screening","P. Merino Amador|F. González Romo|J. Marroyo Laso|E. Diaz Fernandez|E. Baos Munoz|A. Delgado-Iribarren"
"3395","12/04 12:00","19","P3064","Agnese COLPANI","3","C","07f. Travel medicine, migrant and refugee health","Breaking barriers to health: the urgent need for targeted screening in migrant populations","A. Colpani|A. De Vito|M. Soddu|C. Frau|B. Zauli|G. Moi|S. Masala|P. Sini|F. Angioj|R. Govoni|A. Moroni|S. Uzzau|P. Rappelli|S. Babudieri|G. Madeddu"
"3440","12/04 12:00","20","P3065","Tuomas ARO","3","C","07f. Travel medicine, migrant and refugee health","Carriage of multidrug-resistant bacteria among Ukrainian refugees","T. Aro|T. Häkkinen|V. Holmberg|M. Kajova|A. Kantele"
"3961","12/04 12:00","21","P3066","Vanessa WONG","3","C","07f. Travel medicine, migrant and refugee health","National genomic surveillance of travellers with co-infections involving typhoidal Salmonella over a 20-year period in England","V. Wong|A. Ismail Ahmed|C. Maguire|D. Powell|G. Godbole|M. Chattaway"
"4307","12/04 12:00","22","P3067","Olivier LESENS","3","C","07f. Travel medicine, migrant and refugee health","What probabilistic antibiotic therapy for skin abscess in the Amazon?","O. Lesens|K. Sylla|P. Lu|A. Mons|V. Sainterose|P. Leturnier|L. Epelboin|F. Djossou|F. About"
"4360","12/04 12:00","23","P3068","Fergal HOWLEY","3","C","07f. Travel medicine, migrant and refugee health","Describing immigrants' experiences of accessing healthcare in an Irish infectious diseases clinic","F. Howley|C. Barrett|E. De Barra|S. Mcconkey|C. Mcnally|P. Coakley"
"4519","12/04 12:00","24","P3069","Milan TROJANEK","3","C","07f. Travel medicine, migrant and refugee health","Traveller profiles and pre-travel counselling: a retrospective cross-sectional study","M. Trojánek|V. Grebenyuk|V. Jegorova|O. Beranek|D. Drazan|T. Ernestova|M. Hodik|V. Hvizdova|L. Kohout|G. Meseznikov|A. Nycova|B. Pisova|M. Roubinkova|R. Sindlerova|M. Tulach|Z. Uhrikova|M. Vidlicka|M. Stefan|F. Stejskal"
"4875","12/04 12:00","25","P3070","Pyae Linn AUNG","3","C","07f. Travel medicine, migrant and refugee health","Challenges for malaria control among Myanmar migrants in western Thailand: a qualitative study","N. Inthitanon|P. Sripoorote|J. Sattabongkot|D. M. Parker|W. Nguitragool|P. Aung"
"4968","12/04 12:00","26","P3071","Cong SHEN","3","C","07f. Travel medicine, migrant and refugee health","Dynamics and persistence of antimicrobial resistance genes and gut microbiome of healthy individuals after travel","C. Shen|M. Wu|C. Chen|Y. Xiao|S. Yu|Y. Hong"
"7660","12/04 12:00","27","P3072","Jeferson MANOEL TEIXEIRA","3","C","07f. Travel medicine, migrant and refugee health","Malaria and travel medicine: how to prevent it","I. Talacimon Barbosa|J. Teixeira Manuel"
"225","12/04 12:00","1","P3373","Yinjuan GUO","4","C","09a. Microbial pathogenesis & virulence","Sub-minimum inhibitory concentrations of rifampicin attenuate methicillin-resistant Staphylococcus aureus virulence by suppressing SaeRS two-component system and arginine biosynthesis","Y. Guo|Y. Xiao|Y. Xu|W. Han|B. Wang|F. Yu"
"253","12/04 12:00","2","P3374","Blake NEIL","4","C","09a. Microbial pathogenesis & virulence","In vivo transcriptome analysis of Aeromonas dhakensis isolated from fatal cases of multidrug-resistant bacteraemia reveals novel virulence genes","B. Neil|M. Netherland|H. Nur|A. Fnu|P. Samir|E. Hendrix|G. Cheney|P. Kilgore|J. Sha|A. Chopra"
"357","12/04 12:00","3","P3375","Yun WU","4","C","09a. Microbial pathogenesis & virulence","Klebsiella oxytoca subgroup KO5: highly resistant and superior immune evasion capability","Y. Wu|Y. Liu"
"658","12/04 12:00","4","P3376","Jiawei JIAWEI","4","C","09a. Microbial pathogenesis & virulence","Impact of insertion mutation in the accessory gene regulator agrC gene in the Staphylococcus aureus: reduced virulence and enhanced persistence capacity","J. Chen|Y. Xu"
"659","12/04 12:00","5","P3377","Jiawei JIAWEI","4","C","09a. Microbial pathogenesis & virulence","Epidemiological analysis and functional characterisation of HlyA hemolysin in Morganella morganii","J. Chen|Y. Xu|Y. Liu"
"922","12/04 12:00","6","P3378","Roberto CABRERA ORTEGA","4","C","09a. Microbial pathogenesis & virulence","Characterisation of Pseudomonas aeruginosa virulence factors and immune response during exacerbations and stable phase in bronchiectasis","R. Cabrera|N. Rovira-Ribalta|A. Motos|L. Bueno-Freire|N. Vázquez|A. Soler-Comas|V. Alcaraz-Serrano|R. Lopez-Aladid|L. Munoz|J. Vila|A. Torres|L. Fernandez-Barat"
"950","12/04 12:00","7","P3379","Jiayuan QIN","4","C","09a. Microbial pathogenesis & virulence","Preliminary investigation of how Acinetobacter baumannii enhances intracellular survival via the specific TonB-dependent transporter BauA in outer membrane vesicles","J. Qin|Y. Feng|Y. Yang|X. Lv|Z. Zong"
"1298","12/04 12:00","8","P3380","Ingrid Maria Cecilia RUBIN","4","C","09a. Microbial pathogenesis & virulence","Virulence signature of the dominating vancomycin-resistant Enterococcus faecium clones in Denmark, 2015-2023","I. Rubin|K. Karstensen|M. Lindegaard|K. Hegstad|A. Freitas|A. Hammerum|L. Roer"
"1566","12/04 12:00","9","P3381","Steven TAYLOR","4","C","09a. Microbial pathogenesis & virulence","Monoclonal lung dissemination by Pseudomonas aeruginosa precipitating bilateral lung transplantation in primary ciliary dyskinesia","S. Taylor|S. Manning|L. Papanicolas|L. Leong|I. Canoy|L. Morgan|G. Rogers"
"1749","12/04 12:00","10","P3382","Yi-Ywan Margaret CHEN","4","C","09a. Microbial pathogenesis & virulence","The impact of type IV pili-mediated twitching motility in biofilm formation by Streptococcus sanguinis","Y. Chen|Y. Lin"
"2437","12/04 12:00","11","P3383","Jale BORAL","4","C","09a. Microbial pathogenesis & virulence","Molecular epidemiology and comparative virulence patterns of Acinetobacter baumannii isolates from war-related injuries in Ukraine","J. Boral|E. Matuschek|C. Giske|C. Tellapragada|M. Magda|O. Nazarchuk|K. Riesbeck|A. Blom"
"2561","12/04 12:00","12","P3384","Franziska Dorothee SCHULER","4","C","09a. Microbial pathogenesis & virulence","Strain-dependent internalisation of S. aureus in podocytes and renal epithelial cells","F. Schuler|M. Döser|F. Schaumburg|S. Niemann"
"2586","12/04 12:00","13","P3385","Kristina NESPOROVA","4","C","09a. Microbial pathogenesis & virulence","You are not my type: large-scale bioinformatics analysis uncovers the distribution and diversity of Type VI secretion systems in Escherichia coli","K. Nesporova|S. Govers"
"2672","12/04 12:00","14","P3386","Mohammed ALOSAIMI","4","C","09a. Microbial pathogenesis & virulence","Unveiling the role of the glc locus in Campylobacter: a key to glucose metabolism, survival, and niche adaptation","M. Alosaimi|B. Djeghout|M. Sheila"
"3097","12/04 12:00","15","P3387","Cheng-Yen KAO","4","C","09a. Microbial pathogenesis & virulence","Uncovering the mechanisms behind carbapenem-resistant Escherichia coli causing recurrent and multi-site infections: adaptive genotypic and phenotypic evolution within the host","C. Kao|Y. Cheng"
"3202","12/04 12:00","16","P3388","Miquel SÁNCHEZ-OSUNA","4","C","09a. Microbial pathogenesis & virulence","High lethality of methicillin-susceptible Staphylococcus aureus ST398 in animal models","M. Sánchez-Osuna|M. Bravo|M. Canas-Pacheco|A. Gomez|I. Gomez-Sanchez|P. Bierge|M. Pedrosa|M. Espasa|J. Miro|I. Gibert|O. Gasch|C. Garcia-De-La-Maria|D. Yero|O. Pich"
"3212","12/04 12:00","17","P3389","Rui WENG","4","C","09a. Microbial pathogenesis & virulence","Dynamic evolutionary strategies of clinically isolated hypervirulent carbapenem-resistant Klebsiella pneumoniae in response to drug and survival pressures within the host","Y. Yu|Y. Jiang|R. Weng|X. Wu|J. Zhu|Q. Shi|W. Huang|H. Hu|Y. Wang|J. Quan|D. Zhao|Y. Wang|X. Du"
"3306","12/04 12:00","18","P3390","Jad ATRISSI","4","C","09a. Microbial pathogenesis & virulence","Resistance and persistence: a reciprocal driving force of survivability in uropathogenic E. coli?","J. Atrissi|C. Culot|F. Van Bambeke"
"3312","12/04 12:00","19","P3391","Yang ZHONG","4","C","09a. Microbial pathogenesis & virulence","Carbapenem-resistant Acinetobacter baumannii causing the dual-strain persistent infection with significant loss-of-function mutations in virulence factors and the ability to form persisters under PMB-MEM combination therapy: an eight-month genetic-based ICU patient monitoring study","Y. Zhong|J. Yeo|J. Teo|A. Kwa"
"3424","12/04 12:00","20","P3392","Xingyu WU","4","C","09a. Microbial pathogenesis & virulence","A-to-I RNA editing in Klebsiella pneumoniae influences the oxidative stress tolerance","X. Wu|R. Wang|L. Jin|Q. Wang|H. Wang"
"3436","12/04 12:00","21","P3393","Van Chi THAI","4","C","09a. Microbial pathogenesis & virulence","Novel inhibitors targeting lipid A phosphoethanolamine transferase (EptA) to break beta-lactam resistance in extensively drug-resistant Neisseria gonorrhoeae","V. Thai|K. Stubbs|M. Sarkar-Tyson|C. Kahler"
"3717","12/04 12:00","22","P3394","Lucía SAIZ-ESCOBEDO","4","C","09a. Microbial pathogenesis & virulence","Genomic characterisation of a novel capsular operon in extensively drug-resistant Haemophilus parainfluenzae urogenital strains","L. Saiz-Escobedo|M. Garreta-Esteban|M. Ballestero-Tellez|M. Rajadell|I. Cadenas-Jiménez|R. Costa Primo|F. Tubau|D. Sánchez|M. Dominguez|C. Ardanuy|A. Gonzalez-Diaz|S. Marti"
"4040","12/04 12:00","23","P3395","Kerstin STRENGER","4","C","09a. Microbial pathogenesis & virulence","Investigating Staphylococcus aureus infections in human-derived musculoskeletal tissue slices: a new ex vivo approach","K. Strenger|F. Marro|L. Sauteur|B. Morin|R. Kuhl|M. Morgenstern|M. Clauss|D. Bumann|N. Khanna"
"4212","12/04 12:00","24","P3396","Helvécio CARDOSO CORRÊA PÓVOA","4","C","09a. Microbial pathogenesis & virulence","Virulence potential and characteristics of multidrug-resistant Corynebacterium amycolatum strains in mountainous region of Rio de Janeiro state","N. Povoa|P. Sonza|D. Souza|M. Fontao|E. Guedes|M. Pacheco|H. Povoa"
"4650","12/04 12:00","25","P3397","Natalia IORIO","4","C","09a. Microbial pathogenesis & virulence","Biofilm formation of lactose-pre-adapted Streptococcus mutans","A. Fabri|G. Chianca|I. Costa|A. Scarparo|H. Povoa|N. Iorio"
"4816","12/04 12:00","26","P3398","Soojin YANG","4","C","09a. Microbial pathogenesis & virulence","Potential Role of malR-malABC Operon in Enhanced Virulence of Staphylococcus pseudintermedius During Canine Otitis Externa","J. Lim|G. Lee|J. Park|S. Yang"
"4844","12/04 12:00","27","P3399","Ping LU","4","C","09a. Microbial pathogenesis & virulence","Knockout of the wza gene significantly affects capsule formation in Acinetobacter baumannii, weakening its virulence and environmental adaptability","P. Lu|Q. Luo|Y. Xiao"
"5539","12/04 12:00","28","P3400","Cansel VATANSEVER","4","C","09a. Microbial pathogenesis & virulence","Predicting high-risk clone pathogenesis in Pseudomonas aeruginosa through a random forest model of the pangenome","A. Akpinar|C. Vatansever|S. Kolsuz|F. Can"
"5795","12/04 12:00","29","P3401","Luisa Maria Vieira PEIXE","4","C","09a. Microbial pathogenesis & virulence","Bacterial fluid dynamics unmasked: how Klebsiella pneumoniae capsules rewrite virulence mechanics","M. Loiodice|P. Costa|H. Amaral|Â. Novais|L. Peixe"
"5824","12/04 12:00","30","P3402","Lijuan LUO","4","C","09a. Microbial pathogenesis & virulence","SalComSNP: an interactive platform for shortlisting key genes putatively associated with bloodstream infections of invasive non-typhoidal Salmonella","L. Luo|A. Predeus|K. Hokamp|J. Hinton"
"6003","12/04 12:00","31","P3403","Deepak KUMAR","4","C","09a. Microbial pathogenesis & virulence","Staphylococcus aureus biofilm metabolite interactome act as key modulators for host immune evasion","D. Kumar|R. Kannan|A. Tyagi|P. Joshi|M. Yadav|S. Pandey|C. Singhal|S. Gupta|J. .|S. Shamshi|S. Tanwar|N. Kumar|C. Sharma|R. Dwivedi|Y. Kumar|S. Chaudhuri"
"6101","12/04 12:00","32","P3404","Grace LEE","4","C","09a. Microbial pathogenesis & virulence","Prophage and central metabolic genome adaptations drive virulent Staphylococcal infections in the community","C. Black|W. So|R. Benavides|S. Dallas|C. Frei|G. Lee"
"6191","12/04 12:00","33","P3405","Cansel VATANSEVER","4","C","09a. Microbial pathogenesis & virulence","Molecular conservation of itaconate metabolism and type 6 secretion in the high-risk clone of Pseudomonas aeruginosa ST235","C. Vatansever|A. Akpinar|J. Boral|M. Gönen|F. Can"
"6333","12/04 12:00","34","P3406","Hyun Ah KIM","4","C","09a. Microbial pathogenesis & virulence","Compensatory mechanisms in capsule production following RmpA deletion in hypervirulent Klebsiella pneumoniae","S. Jung|M. Hyun|J. Lee|K. Lee|H. Kim"
"6378","12/04 12:00","35","P3407","Peiyao JIA","4","C","09a. Microbial pathogenesis & virulence","Plt-1 acted as a novel virulence factor by enhancing inflammation level and macrophage death in ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae","P. Jia|Q. Yang"
"6487","12/04 12:00","36","P3408","Helen KIRIKOU","4","C","09a. Microbial pathogenesis & virulence","Turicella otitidis: from an external auditory canal coloniser to a cause of severe ear infections in children, a three-year retrospective study","H. Kirikou|K. Spyridopoulou|E. Petridou|I. Marsellou|A. Simou|A. Psaraki|M. Mika|G. Paradeisis|A. Stathi|L. Zachariadou"
"6675","12/04 12:00","1","P3409","Francois LEBRETON","5","C","09a. Microbial pathogenesis & virulence","Functional genomics of hypervirulent Klebsiella pneumoniae, a step forward for accurate diagnosis","T. Russo|P. Mcgann|F. Lebreton"
"6705","12/04 12:00","2","P3410","Jordan Aston Tregurtha MATHIAS","5","C","09a. Microbial pathogenesis & virulence","Serotype O16:H5 ST131 Escherichia coli are significantly more virulent in the galleria mellonella insect model than O25:H4 ST131","J. Mathias|P. Boidya|D. Babenko|T. Fearing|R. Petit|J. Mildenberger|B. Bisha|M. Toleman|W. Martins"
"6748","12/04 12:00","3","P3411","Jordan Aston Tregurtha MATHIAS","5","C","09a. Microbial pathogenesis & virulence","""Superbugs vs bugs"": Galleria mellonella (greater wax moth) larvae as a model for the pathogenicity of Staphylococcus aureus neonatal bacteraemia","J. Mathias|D. Shelley|C. Farley|I. Boostrom|H. Abdollahian|L. Murarka|N. Roivainen|R. Zahra|K. Iregbu|A. Whitelaw|K. Le Doare|M. Sekikubo|T. Walsh|K. Sands|O. Spiller"
"6814","12/04 12:00","4","P3412","Giulia Chiara Maria PERRONE","5","C","09a. Microbial pathogenesis & virulence","Neuraminidase structural diversity across bacteria, metazoa, fungi and viruses: observations for target-based development of new selective drugs","G. Perrone|A. Francavilla|M. Volpicella|L. Guerra|A. De Grassi|C. Pierri|A. Cannarozzi"
"6944","12/04 12:00","5","P3413","Nadia AFTAB","5","C","09a. Microbial pathogenesis & virulence","Differential cultivability of isogenic Staphylococcus aureus sub-populations in diferent growth environments","N. Aftab|J. Hira|S. Høyforslett|B. Singh|J. U. Ericson|M. Johannessen|C. S. Lentz"
"7014","12/04 12:00","6","P3414","Márcia SOUSA","5","C","09a. Microbial pathogenesis & virulence","Genetic diversity and regulatory context of vaginolysin in Gardnerella species: implications for virulence and host-pathogen interactions","M. Sousa|L. Ferrador|T. Gonçalves Ribeiro|F. Grosso|L. Peixe"
"7022","12/04 12:00","7","P3415","Alice DE FRANCESCO","5","C","09a. Microbial pathogenesis & virulence","Capsular cluster expression in hypermucoviscous KPC-producing Klebsiella pneumoniae sequence type 101","A. De Francesco|R. Polani|R. Trirocco|M. Laudazzi|G. Arcari|G. Prosseda|B. Colonna|A. Carattoli"
"7197","12/04 12:00","8","P3416","Yan Corrêa RODRIGUES","5","C","09a. Microbial pathogenesis & virulence","Molecular epidemiology of Pseudomonas aeruginosa in cystic fibrosis patients: insights from the Brazilian Amazon region","M. Gouveia|E. Sarges|H. Dos Reis|D. Sardinha|P. Dos Santos|L. Ribeiro|M. Silva|M. De Melo|A. Quaresma|D. Brasiliense|L. Lima|K. Lima|Y. Rodrigues"
"7206","12/04 12:00","9","P3417","Jale BORAL","5","C","09a. Microbial pathogenesis & virulence","The role of ompW on infectivity and adherence of Acinetobacter baumannii in relation to colistin resistance","J. Boral|G. Shahrokhi|A. Baybes|E. Ural|C. Vatansever|M. Kuskucu|F. Can"
"7381","12/04 12:00","10","P3418","Martina LAUDAZZI","5","C","09a. Microbial pathogenesis & virulence","The multidrug efflux pump AcrAB contributes to the aggregative-adherence phenotype of enteroaggregative Escherichia coli","M. Laudazzi|E. Schifano|L. Altieri|F. Sivori|D. Uccelletti|E. Di Domenico|B. Colonna"
"7433","12/04 12:00","11","P3419","Sophie JARRAUD","5","C","09a. Microbial pathogenesis & virulence","Characterisation of the susceptibility and adaptive mechanisms of Legionella to serum bactericidal activity","M. Ibranosyan|C. Allam|A. Bolon|N. Vincent|O. Dubois|C. Ginevra|G. Descours|S. Jarraud"
"138","12/04 12:00","12","P3420","Murat KARAMESE","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Naringin is a possible protective agent in a rat model of polymicrobial sepsis","M. Karamese"
"140","12/04 12:00","13","P3421","Ali GÜRASLAN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The protective effects of a single dose myricetin application on CLP-induced rat sepsis model by analysing some immune mechanisms","I. Can|A. Guraslan|O. Baser|G. Yildiz|I. Topaloglu|S. Aksak Karamese|M. Karamese"
"153","12/04 12:00","14","P3422","Selina Aksak Karamese","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Two flavonoids, baicalein and naringin, are effective as anti-inflammatory and anti-oxidant agents in a rat model of polymicrobial sepsis","P. Bayram|S. Aksak Karamese|B. Ozdemir|C. Salum|M. Karamese|H. Erol"
"160","12/04 12:00","15","P3423","Gulfem Nur YILDIZ","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Investigation of the anti-inflammatory, anti-oxidant and anti-apoptotic activity of 18-beta-glycyrrhetinic-acid on the model of LPS-induced lung injury in rats","S. Aksak Karamese|V. Gelen|G. Yildiz|K. Albayrak|S. Gedikli|A. Kara|M. Karamese"
"322","12/04 12:00","16","P3424","Sucheta GULERIA","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Giardia infection is associated with alterations in the community structure of the murine gut microbiome","S. Guleria|S. Khurana|U. Dutta|A. Mewara|A. Arora"
"466","12/04 12:00","17","P3425","Jessica MCLOUGHLIN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The effect of selective estrogen receptor modulators on the clearance of Staphylococcus aureus and Pseudomonas aeruginosa by monocyte-derived macrophages","J. Mcloughlin|M. El Mohtadi"
"533","12/04 12:00","18","P3426","Ganji LEILA","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Relative abundance of bacterial phyla and diversity of pathogenic bacteria in patients with irritable bowel syndrome compared with healthy controls relative abundance of bacterial phyla and diversity of pathogenic bacteria in patients with irritable bowel syndrome compared with healthy controls","M. Alebouyeh|T. Elahe|G. Leila"
"620","12/04 12:00","19","P3427","Ali GÜRASLAN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The beneficial effects of dose-dependent umbelliferone application on CLP-induced experimental sepsis model","Y. Bati|M. Sezer|A. Yilmaz|L. Baser|A. Guraslan|M. Karamese|P. Bayram"
"851","12/04 12:00","20","P3428","Nazila KASSAIAN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","An assessment of breastmilk microbiome focusing on probiotics","E. Mohammadi|S. Ahangarzadeh|B. Vakili|P. Shoaei|A. Alibakhshi|S. Rostami|S. Arbabnia|N. Kassaian"
"936","12/04 12:00","21","P3429","Guillaume COSSON","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Escherichia coli division and nonresponse factors to antibiotic therapy in a murine model of acute prostatitis","G. Cosson|A. Amoura|S. Dion|V. De Lastours|B. Fantin|I. El Meouche|A. Lefort"
"1209","12/04 12:00","23","P3431","Sophia GOLADZE","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Evolution of phage resistance through CRISPR-Cas adaptation in the mucosal environment","S. Goladze|O. Bonnardel|D. Patricio|G. Magno De Freitas Almeida|L. Sundberg"
"1306","12/04 12:00","24","P3432","Oana DUMITRESCU","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Autologous host-pathogen pairing enhances early immune responses and bacterial control in tuberculosis in vitro granuloma model","C. Genestet|C. Bourg|E. Hodille|O. Bahuaud|F. Ader|O. Dumitrescu"
"1445","12/04 12:00","25","P3433","Lucia ARMAN FERNANDEZ","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Identification of anti-CRISPR (Acr genes) proteins harbored in Pseudomonas aeruginosa clinical strains","L. Armán|L. Fernandez-Garcia|C. Lopez-Causape|L. Blasco|M. Lopez|I. Bleriot|C. Ortiz-Cartagena|C. Ibarguren|A. Barrio-Pujante|R. Canton|A. Oliver|M. Tomás"
"1672","12/04 12:00","26","P3434","Zhangfan FU","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Pulmonary microbiota analysis and host gene expression: a diagnostic model for distinguishing respiratory colonisation and pneumonia","Z. Fu|Y. Sun|J. Ai|N. Jiang|J. Jin|W. Zhang"
"2357","12/04 12:00","27","P3435","Nidhi KAMBOJ","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Breaking new ground: human intestinal organoids reveal Shigella's invasive strategies","N. Kamboj|N. Taneja|B. Mohan|S. B. Lal"
"2402","12/04 12:00","28","P3436","Daniel PARK","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Post-coital dynamics of the male and female genital microbiome","D. Park|A. Mohammadi|S. Nelson|J. Salazar|S. Bagherichimeh|A. Onos|J. Villani|A. Fazel|E. Tevlin|S. Huibner|W. Tharao|R. Kaul|C. Liu"
"2524","12/04 12:00","29","P3437","Elisa RUBIO GARCÍA","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Blastocystis sp. relationship with gut microbiota composition in healthy donors from a microbiota transplant centre","J. Iglesies-Torrent|E. Mangas|A. Maughelli|J. Barrachina|R. Albarracin|C. Casals-Pascual|A. Aira|E. Rubio Garcia"
"2598","12/04 12:00","30","P3438","Joke BASTIAENSSEN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Interactions between respiratory viruses, airway microbiome and immune response during pulmonary exacerbations in children with cystic fibrosis","J. Bastiaenssen|E. Cauwenberghs|N. Jouret|P. Delputte|S. Verhulst|S. Lebeer|I. De Boeck|I. Spacova|K. Van Hoorenbeeck"
"2640","12/04 12:00","31","P3439","Jessica MCLOUGHLIN","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Androgen receptor blockade induces the phagocytosis of wound associated bacteria by monocyte-derived macrophages","A. Belboul|J. Mcloughlin|M. El Mohtadi"
"3096","12/04 12:00","32","P3440","Jinhan YU","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Clinical infection patterns and pulmonary tropism of Yarrowia lipolytica in murine models","J. Yu|Y. Zhao|Y. Xu"
"3166","12/04 12:00","33","P3441","Kan YU","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Interactions between Dolosigranulum pigrum and Corynebacterium species, health-associated bacterial commensals of the human nasopharynx","K. Yu|E. Chua|R. Bahal|M. Nicol"
"3332","12/04 12:00","34","P3442","Isabell RAMMING","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","DPP4 activity and translocation of membrane vesicles of Enterococcus faecium","I. Ramming|V. Rauschenberger|C. Hildbrand|P. Burkard|N. Wagner|S. Kampmeier"
"3484","12/04 12:00","35","P3443","Dandan LI","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Phage-host interaction in Pseudomonas aeruginosa clinical isolates with functional and altered quorum sensing systems","B. Hu|N. Li|Y. Chen|Y. Yang|D. Li|D. Tan|J. Lin|X. Gao|R. Bao|C. Zhou|S. Wang"
"3786","12/04 12:00","36","P3444","Miguel BLANCO FUERTES","5","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Oral microbiome landscape under household quarantine measures during the first wave of COVID-19 pandemic","M. Blanco-Fuertes|G. González-Colomino|A. Lluansi|D. Henares|A. Perez-Arguello|M. Cisneros|C. Launes|M. De Sevilla|P. Brotons|C. Munoz-Almagro"
"3910","12/04 12:00","1","P3445","Alex TANNER","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Interpretation of respiratory virus detection in adults hospitalised with acute respiratory infection: insights from a host response profiling study","A. Tanner|B. Dedeoglu|N. Brendish|R. Wong|K. Beard|I. Maan|T. Clark"
"3930","12/04 12:00","2","P3446","Fabio FIORINO","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Mouse model for eradication of Streptococcus pyogenes from the upper respiratory tract","F. Fiorino|E. Pettini|D. Medaglini|F. Iannelli|G. Pozzi"
"4076","12/04 12:00","3","P3447","Patricia ANTUNES","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Klebsiella pneumoniae diversity and lifestyle factors in the healthy gut: a role for the food chain?","L. Nova|C. Matos|B. Gonzalez|L. Peixe|A. Freitas|C. Novais|P. Antunes"
"4143","12/04 12:00","5","P3449","Vera RAUSCHENBERGER","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Membrane vesicles as potential surrogate for impaired intestine barrier","V. Rauschenberger|I. Ramming|P. Burkard|N. Wagner|S. Kampmeier"
"4260","12/04 12:00","6","P3450","Khurshida BEGUM","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Microbiome bacterial DNA quantity is unchanged during antimicrobial therapy in patients with Clostridioides difficile infection","K. Begum|M. Alam|T. Eubank|K. Garey"
"4343","12/04 12:00","7","P3451","Lima Rodriguez OLALLA","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Fecal microbiota features and pathways potentially associated with spontaneous clearance of carbapenem-resistant Enterobacterales colonization","O. Lima|S. Perez-Castro|C. Davina Nunez|M. Represa|P. Rubinan Iglesias|M. Avila-Nunez|S. Rey|J. Cabera|C. Portela|R. Longueira|M. Perez-Rodriguez"
"4736","12/04 12:00","8","P3452","Helvécio CARDOSO CORRÊA PÓVOA","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Galleria mellonela as an experimental model for the study of bacterial co-infection","P. Sonza|V. Kaufmann|M. Pacheco|M. Fontao|D. Souza|E. Guedes|N. Povoa|H. Povoa"
"4769","12/04 12:00","9","P3453","Juhi JAIN","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Peste des petits ruminats virus (PPRV) non-structural C and V proteins modulate the NF-kB signalling pathway","J. Jain|R. Kaul|R. Kaul"
"4995","12/04 12:00","11","P3455","Xingxing LI","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Study on the interaction mechanism of Paeniclostridium sordellii haemorrhagic toxin and its host","X. Li|X. Hua|L. Tao|Y. Yu"
"5061","12/04 12:00","12","P3456","Diaz BENITEZ","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Prospective case-control study on bacterial gut microbiota and invasive enterococcal disease","D. Benitez|V. Saludes|N. Mauri|A. Escalas|M. Gonzalez|L. Soler|A. Paris De Leon|O. Perez|V. Leonov|M. Quesada|A. Sales|M. De Homdedeu|C. Bracke|A. Peris|A. Romero|R. Paredes|L. Pedro-Botet|P. Cardona"
"5208","12/04 12:00","13","P3457","Aurélien PEYRON","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Staphylococcus capitis NRCS-A target tight junctions to disrupt intestinal epithelial barrier and induce bacteraemia in vivo","A. Peyron|M. Cellard-Dalud|M. Kaiboue|M. Fayolle|J. Guillemot|A. Eymaron|M. Paul|Q. Delorme|J. Josse|P. Martins-Simoes|A. Tristan|F. Laurent|P. Verhoeven|M. Butin"
"5243","12/04 12:00","14","P3458","Alaa ABOUELFETOUH","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Commensal vs clinical staphylococci, the yin and yang of bacterial interaction with the host","A. Abouelfetouh|M. Shehat|A. Sobhy|M. Alseqely|O. Attia|H. Abou-Shleib|M. Youssef"
"5262","12/04 12:00","15","P3459","Camille VILLENAVE","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Female urinary microbiota characterisation by culturomics","C. Villenave|S. Dahyot|G. Roussel|M. Pestel-Caron"
"5532","12/04 12:00","16","P3460","Mario ROMERO RIVERA","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Gastrointestinal symptomatology in Sanfilippo syndrome is related to gut microbiota metabolism","R. Barbero-Herranz|M. Garriga-Garcia|A. Moreno-Blanco|E. Palacios|R. Del Campo|J. Avendano|M. Romero Rivera"
"5562","12/04 12:00","17","P3461","Sonia PÉREZ CASTRO","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Gut microbiota in patients with metastasic prostate cancer: analysis of potential effects of androgen receptor pathway inhibitors","C. Davina Nunez|A. Bellas-Pereira|J. Cabrera-Alvargonzalez|M. Perez-Schoch|C. Muller-Arteaga|J. Sanchez-Garcia|N. Rodriguez-Costas|S. Perez-Castro|M. Carballo-Quinta|A. Freire-Rodriguez|E. Cespon-Outeda|E. Lopez-Diez"
"5674","12/04 12:00","18","P3462","Matteo Domenico MARSIGLIA","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Gut microbiota alterations in relapsing-remitting multiple sclerosis","M. Marsiglia|E. Ottaviano|E. Borghi|A. Corona|A. Zollo|A. Mingione|F. Martinelli Boneschi"
"5837","12/04 12:00","19","P3463","Astrid Christine ERBER","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The influence of time of day of vaccination and infection on immunity in rodent animal models, and translational aspects: a systematic review","M. Zeman|L. Marady|R. Gawish|I. Koneczny|A. Erber|M. Okuliarova|A. Wagner|K. Papantoniou"
"6054","12/04 12:00","20","P3464","Barbara SPELLERBERG","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Limiting the spread of nosocomial bacterial pathogens through endotracheal illumination in a long-term ventilation pig model","L. Spring|T. Merz|D. Haider|A. Hoffmann|F. Zink|B. Sicks|M. Hessling|P. Radermacher|B. Spellerberg"
"6068","12/04 12:00","21","P3465","Llorenç FERNÁNDEZ-COLL","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The secondary messenger ppGpp controls virulence and pathogenicity of adherent-invasive Escherichia coli strains through changes in gene expression","L. Fernández-Coll|M. Ramos-Corominas|Q. Bonet-Rossinyol|M. Lopez-Siles|K. Potrykus|M. Martinez-Medina"
"6244","12/04 12:00","22","P3466","Tonino ALONZI","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Peripheral CD34+ cells as a niche for Mycobacterium tuberculosis","T. Alonzi|A. Aiello|F. Repele|D. Perruzzu|A. Altera|G. Bontempi|R. Strippoli|L. Pierelli|G. Delogu|D. Goletti"
"6337","12/04 12:00","23","P3467","Luz M. TORIBIO","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Exploring residual antigen distribution and neuroinflammation in calcified neurocysticercosis","L. Toribio|L. Tello|J. Bustos|G. Arroyo|H. Garcia"
"6364","12/04 12:00","24","P3468","Csongor FREYTAG","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Dynamics of gut microbiome enterotypes in a healthy Hungarian cohort using whole-length 16S metabarcoding","C. Freytag|A. Váradi|G. Kardos|L. Laczko"
"6407","12/04 12:00","25","P3469","Maria PALS BENDIXEN","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Airway epithelial air-liquid-interface culture systems for high-resolution investigations of bacterial infection dynamics during treatment with elexacaftor/tezacaftor/ivacaftor","S. Lolle|S. Molin|H. Johansen|M. Bendixen"
"6457","12/04 12:00","26","P3470","Bijie HU","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Phage-antibiotics synergy and antagonism in Pseudomonas aeruginosa clinical isolate ZS-PA-35","Y. Yang|N. Li|D. Li|D. Tan|B. Hu"
"6553","12/04 12:00","27","P3471","Brendan KELLY","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Lung pathogens persist in the gut microbiome during critical illness","A. Mezochow|E. Wilkins|L. Cressman|B. Kelly"
"6651","12/04 12:00","28","P3472","Angela KUKA","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Exploring microbial diversity in calcific aortic valve disease","A. Kuka|C. Merla|G. Petazzoni|I. Mileto|A. Girello|P. Giordani|S. Roda|M. Corbella|P. Cambieri|E. Seminari"
"7146","12/04 12:00","29","P3473","Mariliis HINNU","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Development of a chronic wound infection model in rats for testing novel wound therapies","K. Randmäe|K. Pohako-Palu|M. Hinnu|A. Korkjas|G. Lanno|O. Gerulis|M. Putrins|I. Laidmäe|T. Tenson|K. Kogermann"
"7466","12/04 12:00","30","P3474","Monika BRZYCHCZY-WLOCH","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","The role of periodontal disease in modulating salivary microbiome in atherosclerotic cardiovascular patients","M. Brzychczy-Wloch|K. Talaga-Cwiertnia|A. Sroka-Oleksiak|B. Brzychczy-Sroka|A. Gurgul|T. Gosiewski|J. Zarzecka"
"7471","12/04 12:00","31","P3475","Dafne BONGIORNO","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Evaluation of mobilome impact in isolates of Staphylococcus aureus sequence type 8 during in vitro cellular internalisation","D. Bivona|L. Colombini|T. Mariana|S. Francesco|M. Nicolo|S. Stefani|I. Francesco|B. Dafne"
"7492","12/04 12:00","32","P3476","Alicia EYMARON","6","C","09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Live-cell confocal microscopy reveals that intracellular Staphylococcus aureus producing phenol-soluble modulins triggers an autophagic response prior to cytosol access in HeLa cells","A. Eymaron|J. Guillemot|J. Josse|F. Laurent|P. Verhoeven|K. Rodriguez|N. Prodone|E. Audoux|M. Fayolle"
"139","12/04 12:00","33","P3477","Marta DÍAZ-NAVARRO","6","C","09c. Pre-clinical biofilm studies","Assessment of the cefiderocol anti-biofilm effect against 28 clinical strains of multidrug-resistant Gram-negative bacilli","M. Diaz-Navarro|E. Cercenado|A. Visedo|M. Marin|M. Machado|Á. Irigoyen-Von-Sierakowski|B. Loeches|J. Cacho-Calvo|J. Garcia|E. Di Domenico|P. Munoz|M. Guembe"
"567","12/04 12:00","34","P3478","Marta DÍAZ-NAVARRO","6","C","09c. Pre-clinical biofilm studies","Are biomass and metabolic activity staining biofilm techniques reliable enough to be used in microbiology laboratories?","M. Diaz-Navarro|A. Crespo|P. Munoz|M. Guembe"
"1143","12/04 12:00","35","P3479","Ohiana RODRIGUEZ MEDINA","6","C","09c. Pre-clinical biofilm studies","Determination of the MBIC and MBEC of ciprofloxacin and colistin in biofilms produced by Pseudomonas aeruginosa","O. Rodriguez Medina|I. Martinez-Malaxetxebarria|A. Canút Blasco"
"1953","12/04 12:00","36","P3480","Julian AZZOUZI","6","C","09c. Pre-clinical biofilm studies","Impact of penicillin susceptibility and endocarditis source on Enterococcus faecalis biofilm production","J. Azzouzi|O. Funk|J. Cusumano|T. Inzana"
"2246","12/04 12:00","1","P3481","Giorgia FABRIZIO","7","C","09c. Pre-clinical biofilm studies","Genomic characterisation and antibiotic susceptibility of biofilm-forming Borrelia afzelii and Borrelia garinii from patients with erythema migrans","G. Fabrizio|I. Cavallo|F. Sivori|M. Truglio|D. Kovacs|M. Francalancia|G. D'agosto|E. Trento|G. Prignano|E. Ruzic-Sabljic|F. Pimpinelli|E. Di Domenico"
"2786","12/04 12:00","2","P3482","Estíbaliz TORRECILLA-SÁDABA","7","C","09c. Pre-clinical biofilm studies","Synergistic potential of rifampicin and aztreonam against Pseudomonas aeruginosa biofilm in respiratory infections","E. Torrecilla-Sádaba|L. Salar-Vidal|C. Ortega-Portas|J. Esteban|J. Aguilera-Correa"
"2833","12/04 12:00","3","P3483","Estíbaliz TORRECILLA-SÁDABA","7","C","09c. Pre-clinical biofilm studies","Evaluation of rifampicin's potential for preventing the development and treating Pseudomonas aeruginosa biofilm in respiratory infections","E. Torrecilla-Sádaba|L. Salar-Vidal|L. Trallero-Calvo|J. Esteban|J. Aguilera-Correa"
"3406","12/04 12:00","4","P3484","Alba SANCHEZ MORILLO","7","C","09c. Pre-clinical biofilm studies","Differences in pathogenic mechanisms of Gram-positive and Gram-negative strains in medical device-associated infections","A. Sánchez|F. Gomez-Bertomeu|G. Garcia-Pardo|M. Guerrero-Torres|S. Pardo-Granell|E. Pico-Plana|B. Verdu-Marti|L. Guillem|V. Francesc|A. Rull|J. Peraire"
"3434","12/04 12:00","5","P3485","Özge YETIS","7","C","09c. Pre-clinical biofilm studies","Trace/sublethal antimicrobials in hospital wastewaters act as stressors which promote enhanced biofilm-expression in Pseudomonas aeruginosa in clinical and environmental colonisation","Ö. Yetis|E. Shore|S. Ali"
"4236","12/04 12:00","6","P3486","Helvécio CARDOSO CORRÊA PÓVOA","7","C","09c. Pre-clinical biofilm studies","Evaluation of biofilm formation and the effectiveness of antimicrobial photodynamic therapy on polydioxanone yarns","N. Povoa|M. Teixeira|E. Guedes|D. Souza|P. Sonza|M. Fontao|M. Pacheco|H. Povoa"
"4238","12/04 12:00","7","P3487","Mauro Jose COSTA SALLES","7","C","09c. Pre-clinical biofilm studies","Exploring the interaction between antimicrobials and bioactive glass in the Cutibacterium acnes in vitro biofilm formation and in the Galleria mellonella in vivo model","M. Neri Lucas Kurihara|I. Frois Brasil|M. Muniz De Andrade Silva|M. Costa Salles"
"5194","12/04 12:00","9","P3489","Abebe Mekuria SHENKUTIE","7","C","09c. Pre-clinical biofilm studies","Effects of small molecules and antimicrobial peptides targeting small RNA00203: pioneering antimicrobial solutions for biofilm-producing, multidrug-resistant Acinetobacter baumannii","A. Shenkutie|P. Leung"
"5625","12/04 12:00","10","P3490","Vikas GAUTAM","7","C","09c. Pre-clinical biofilm studies","VG111 and its impact on Stenotrophomonas sepilia biofilms: unveiling a promising antibiofilm strategy","V. Gautam|S. Chakraborty|R. Rawat|N. Shekhar|L. Singhal|P. Patil"
"6877","12/04 12:00","11","P3491","Rossella MAURO","7","C","09c. Pre-clinical biofilm studies","Reduction of bacterial adhesion on wrinkled surfaces under fluid shear","L. Pellegrino|R. Rusconi|R. Mauro|C. Rocchi"
"6927","12/04 12:00","12","P3492","Jaroslava DEKKEROVÁ","7","C","09c. Pre-clinical biofilm studies","Analysis and photodynamic inactivation of biofilm of carbapenemase-resistant isolates of Klebsiella pneumoniae in a regional hospital in Slovakia","J. Dekkerová|T. Walentin|L. Cernakova|H. Bujdáková"
"7002","12/04 12:00","13","P3493","Paula EGUIZÁBAL","7","C","09c. Pre-clinical biofilm studies","Biofilm induction by glucose and/or sodium chloride in S. aureus isolates from the airways of Spanish people with cystic fibrosis","P. Eguizábal|C. Rumpf|M. Sanders|S. Deiwick|A. Lopez-Calleja|A. Arias|C. Martin-De-Vicente|I. Antonanzas-Torres|A. Rezusta|C. Torres|B. Kahl|C. Lozano"
"7088","12/04 12:00","14","P3494","Alpana MOHTA","7","C","09c. Pre-clinical biofilm studies","The role of Cutibacterium acnes in adolescent acne: a study of microbiome diversity and biofilm production","A. Mohta"
"7230","12/04 12:00","15","P3495","Paola BOCANEGRA IBARIAS","7","C","09c. Pre-clinical biofilm studies","Biofilm characterisation and antimicrobial susceptibility of Gram-positive bacteria associated with osteoarticular infections","P. Bocanegra Ibarias|A. Alanis-Valdez|S. Villarreal-Cruz|S. Flores-Trevino|A. Camacho-Ortiz|E. Perez-Alba|L. Villarreal-Trevino|J. Vazquez-Guillen"
"7241","12/04 12:00","16","P3496","Kavitha KUMAR","7","C","09c. Pre-clinical biofilm studies","Beyond resistance ? Exploring biofilm dynamics in carbapenem-resistant Acinetobacter baumannii from urinary tract infections","K. Kumar|.. Vaishnavi|V. Shamanna|G. Nagaraj|R. Kadalahalli"
"7343","12/04 12:00","17","P3497","Qingqing XU","7","C","09c. Pre-clinical biofilm studies","Activity of individual drugs against biofilm in hypervirulent Klebsiella pneumoniae","A. Alimire|Q. Xu"
"7362","12/04 12:00","18","P3498","Kelli RANDMÄE","7","C","09c. Pre-clinical biofilm studies","Efficacy testing of antimicrobial fibrous wound dressings against in vitro polybacterial biofilm","K. Randmäe|K. Lorenz|K. Pohako-Palu|L. Preem|M. Putrins|T. Tenson|K. Kogermann"
"7460","12/04 12:00","19","P3499","Joana ARAÚJO ALVES DE CAMPOS","7","C","09c. Pre-clinical biofilm studies","Exploring the biofilm-mediated resistance in polymicrobial infections involving clinically relevant pathogens","J. Freitas Da Silva|Â. S. Inácio|J. Campos|I. C Rodrigues|P. Martins Da Costa"
"969","12/04 12:00","20","P3500","Mateusz WDOWIAK","7","C","09d.?Experimental and cellular microbiology","Siderophore-PNA conjugates for antisense targeted control of bacterial pathogens","M. Wdowiak|U. Tsylents|J. Trylska|M. Wojciechowska"
"1049","12/04 12:00","21","P3501","Theresa WAGNER","7","C","09d.?Experimental and cellular microbiology","Extracellular vesicles of minimalistic bacteria as mediators of immune modulation and horizontal gene transfer","S. Torres Puig|T. Yimthin|T. Desmoulins|J. Jores|T. Wagner"
"1887","12/04 12:00","22","P3502","Emanuela PELUSO","7","C","09d.?Experimental and cellular microbiology","3D model of monoculture of lung epithelial cells with/without bacterial infection to evaluate mucosomes interaction and their antibacterial activity","E. Peluso|E. Restivo|L. Sardelli|C. Butnarasu|G. Guagliano|N. Tirelli|P. Petrini|S. Visentin|L. Visai"
"2474","12/04 12:00","23","P3503","Luís MELO","7","C","09d.?Experimental and cellular microbiology","Characterisation of a novel H. pylori bacteriophage with therapeutic potential","R. Ferreira|R. Ferreira|M. Oleastro|J. Azeredo|C. Figueiredo|L. Melo"
"3232","12/04 12:00","24","P3504","Jia Hao YEO","7","C","09d.?Experimental and cellular microbiology","Deciphering the redox environment in bacteriophage-infected bacteria by flow cytometry (FCM)","J. Yeo|S. Thong|S. Chung|A. Kwa"
"3895","12/04 12:00","25","P3505","Marina MURILLO TORRES","7","C","09d.?Experimental and cellular microbiology","Green tea antioxidant epicatechin to inhibit the SOS response and tackle antibiotic resistance dissemination","M. Murillo-Torres|S. Diaz-Diaz|E. Recacha|F. Docobo-Pérez|M. Buckner|J. Rodriguez-Martinez"
"4239","12/04 12:00","26","P3506","Mathieu GREGOIRE","7","C","09d.?Experimental and cellular microbiology","Nisin A and cefoxitin combination against staphylococcal biofilms","M. Gregoire|A. Anantharajah|F. Van Bambeke|A. Verroken|H. Rodriguez-Villalobos"
"5048","12/04 12:00","27","P3507","Claire GOURIN","7","C","09d.?Experimental and cellular microbiology","New discovery on the mode of action of letermovir and the resistance mechanism of human cytomegalovirus","C. Gourin|G. Ligat|C. Lefèvre|S. Alain|S. Hantz"
"5217","12/04 12:00","28","P3508","Julia WIDSTRÖM","7","C","09d.?Experimental and cellular microbiology","ADAR-mediated RNA editing of influenza A virus RNA is age-dependent and inversely correlates with viral load","J. Fingal|J. Widström|J. Ringlander|M. Lindh|M. Andersson|M. Wahllöf|J. Westin|G. Rydell|L. Bustamante Jaramillo|H. Kann|M. Kann"
"5876","12/04 12:00","29","P3509","Sonia PÉREZ CASTRO","7","C","09d.?Experimental and cellular microbiology","Pangenomic analysis of Haemophilus parainfluenzae reveals distinct metabolic patterns according to colonisation niche","C. Davina Nunez|A. Rincon-Quintero|C. Potel-Alvarellos|S. Pérez Castro"
"5953","12/04 12:00","30","P3510","Gulsen ULUÇAM ATAY","7","C","09d.?Experimental and cellular microbiology","Typing and whole-genome analysis of lysogenic bacteriophages isolated from carbapenem-resistant Acinetobacter baumannii strains","G. Bayramoglu|G. Uluçam Atay|A. Bozdeveci|S. Suyabatmaz|S. Alpay Karaoglu"
"7020","12/04 12:00","31","P3511","Sven HAMMERSCHMIDT","7","C","09d.?Experimental and cellular microbiology","Monoclonal antibodies for functional studies and therapeutic applications in pneumococcal infections","F. Weber|B. Köllner|F. Voss|S. Hammerschmidt"
"7389","12/04 12:00","32","P3512","Alba SOLER COMAS","7","C","09d.?Experimental and cellular microbiology","Model of activated macrophages infected with Streptococcus pneumoniae for immunomodulatory assays","A. Soler-Comas|P. Conde|N. Vázquez|R. Lopez-Aladid|R. Cabrera|A. Gabarrús|M. Camprubi-Rimblas|A. Artigas|A. Torres|L. Fernandez-Barat"
"453","12/04 12:00","33","P3513","Qingqing FANG","7","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","The establishment of a lytic phage library targeting carbapenem-resistant Klebsiella pneumoniae","F. Qingqing|H. Luo"
"548","12/04 12:00","34","P3514","Sanket KAUSHIK","7","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Penetrating the pilus biogenesis in ESKAPE pathogens through in-silico and in vitro approaches","S. Kaushik"
"1212","12/04 12:00","35","P3515","Samuele NOTARBARTOLO","7","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Unraveling the regulatory circuits underlying human memory T cell precursor differentiation for developing improved vaccine co-adjuvants","L. Montani|S. Notarbartolo|A. Bandera|A. Lanzavecchia|E. Coluccio|D. Prati"
"1554","12/04 12:00","36","P3516","Wang LIJUN","7","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Response regulator OmpR-regulated metabolite succinate suppresses mucoviscosity of hypervirulence Klebsiella pneumoniae","L. Wang|W. Gao"
"1778","12/04 12:00","1","P3517","Jean-Christophe GIARD","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Proteomic characterisation of extracellular vesicles from Enterococcus faecalis","J. Giard|O. Coulon|B. Bernay|A. Dhalluin|C. Isnard"
"2780","12/04 12:00","2","P3518","Agnes Marie FIGUEIREDO","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","A PCR-based test for classifying Staphylococcus aureus ST30 strains in phylogenetic groups","M. Esteves|C. Martini|L. Longo|A. Figueiredo|M. Carvalho|A. Viana"
"3707","12/04 12:00","3","P3519","Dominika SALAMON","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Could archaea belong to Halobacteriales and Methanosarcinales order be biomarkers of schizophrenia? Studies on a rat model","D. Salamon|A. Krawczyk|T. Kasperski|B. Zapala|T. Gosiewski"
"4015","12/04 12:00","4","P3520","Xiaolan HUANG","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","in vitro metabolic profiling of Acinetobacter baumannii in artificial urine medium and CAMHB: investigating the synergistic effects of colistin and sulbactam combination therapy","X. Huang|X. Liu|X. Bian|J. Zhang"
"4242","12/04 12:00","5","P3521","Luis Angel NUÑEZ GARCIA","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Genomic landscape of Achromobacter xylosoxidans","L. Nunez-Garcia|E. Garza-González"
"5012","12/04 12:00","6","P3522","Qiwen YANG","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Characteristics of outer membrane vesicles from Klebsiella pneumoniae: a proteomic insights","J. Xi|Q. Yang"
"5027","12/04 12:00","7","P3523","Etienne RUPPE","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Metagenomic analysis reveals enterotype-based prognostic stratification in severe COVID-19 patients","N. Maziers|F. Plaza-Onate|E. Le Chatelier|J. Patrier|F. Lamara|S. Gueye|B. Quinquis|K. Villageois-Tran|P. Wicky|J. Timsit|E. Ruppé"
"5240","12/04 12:00","8","P3524","Helena BUJDÁKOVÁ","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","The potential of using photodynamic inactivation to treat microbial infections","H. Bujdáková|M. Stefanek|K. Bilská|S. Kendra|J. Czucz Varga|L. Bugyna|B. Radochová|J. Bujdák"
"5279","12/04 12:00","9","P3525","Hongyu WANG","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Multi-omics profiling immunosuppressive status in severe pneumonia","H. Wang|B. Sun|T. Yang|J. Ai|W. Zhang"
"5803","12/04 12:00","10","P3526","Jan RYBNIKER","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Multi-OMICS techniques decipher distinct immunotypes and novel diagnostic signatures for EPTB","S. Theobald|I. Suárez|K. Dahm|D. Lange|A. Klingmuller|T. Ulas|J. Rybniker"
"6109","12/04 12:00","11","P3527","Nicolas NOULIN","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Evolution of human metapneumovirus A2 in vitro and post human challenge: tracking viral polymorphism using next-generation sequencing","N. Noulin|L. Calvo-Bado|M. Kalinova|F. Mackenzie|C. Mencarelli|P. Griffin|B. Löndt|C. Williams|R. Sunando|A. Catchpole"
"6684","12/04 12:00","12","P3528","Benedicte LANGLOIS","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Pan-genomic analyses of digestive persistent Klebsiella pneumoniae in ICU patient","B. Langlois|C. Isnard|J. Giard|C. Gakuba|D. Du Cheyron|S. Le Hello|F. Gravey"
"7436","12/04 12:00","13","P3529","Muhammad SHAFIQ","8","C","09e. Fundamental science studies using Omics (in vitro and in vivo)","Genomic characteristics of Listeria monocytogenes in clinical listeriosis: implications for pathogenicity and antibiotic resistance","M. Shafiq"
"415","12/04 12:00","15","P3531","Chenxi ZHAO","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Age-stratified analysis of the association between cytokine profiles and clinical outcomes in severe fever with thrombocytopenia syndrome","C. Zhao|Z. Ge|W. Niu|L. Lin|Z. Liu|P. Chen|Z. Chen"
"770","12/04 12:00","17","P3533","Camille ALLAM","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Alteration of transcriptional immune profile in patients with severe Legionnaires' disease","C. Albert-Vega|C. Ginevra|M. Ibranosyan|G. Descours|L. Beraud|J. Richard|L. Argaud|A. Friggeri|V. Labeye|Y. Jamilloux|N. Freymond|N. Fessy|J. Guillemot|A. Chapalain|F. Venet|G. Lina|C. Allam|W. Mouton|P. Doublet|F. Ader|S. Trouillet-Assant|S. Jarraud"
"1028","12/04 12:00","18","P3534","Praveen Kumar SINGH","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Arginase-1-mediated T cell suppression by MDSCs in dermatophytic infection: a combined transcriptomic and functional study","P. Singh|S. Das|G. Rai"
"1488","12/04 12:00","19","P3535","Jan CUPPEN","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Mitigating infectious disease by early neutrophil activation","J. Cuppen|H. Savelkoul"
"1557","12/04 12:00","20","P3536","Hui QI","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Virus and bacteria co-infection breaks the host adaptive immunity against IAV","Q. Fang|H. Qi|L. Sun|X. Guo"
"1606","12/04 12:00","21","P3537","Michiko YOSHIDA","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","FTY720-induced cryptococcosis reactivation in persistently infected mice: mechanisms uncovered","M. Yoshida|N. Nakahata|H. Sato|R. Ohagi|K. Sato|E. Kanno|H. Tanno|K. Ishii|T. Aoyagi|A. Kikuchi|K. Kawakami"
"2030","12/04 12:00","22","P3538","Anna J HENNINGSSON","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Genome-wide DNA methylation profiling in acute Lyme neuroborreliosis and over a one-year follow-up period","S. Sayyab|P. Gyllemark|M. Lager|I. Tjernberg|M. Lerm|A. Henningsson"
"2387","12/04 12:00","23","P3539","Yuhan SUN","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Impaired neutrophil respiratory burst response in elderly and infectious states","Y. Sun|W. Lin|J. Zhao|H. Cai|Z. Zhou|S. Wang|J. Jin|J. Wu"
"3230","12/04 12:00","25","P3541","Santiago LETONA","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Sepsis-induced immune dysfunction weakens tumour defense and undermines immunotherapy efficacy","S. Letona-Giménez|L. Embereck|M. Garzon-Tituana|A. Andrés-Tovar|N. Pena|Á. Abejez-Arrizabalaga|G. Pellejero-Sagastizábal|E. Morte-Romea|E. Galvez|J. Pano-Pardo|J. Pardo|M. Arias"
"3775","12/04 12:00","26","P3542","Laura Marcela PALMA MEDINA","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Differential local immune responses in Group A streptococcal necrotising soft tissue infections","L. Palma Medina|A. Bergonzini|K. Moll|P. Arnell|O. Hyldegaard|S. Skrede|M. Svensson|A. Norrby-Teglund"
"3978","12/04 12:00","27","P3543","Oluwasefunmi AKEJU","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Systemic and mucosal antibody responses to Streptococcus pneumoniae serotype 3 carriage","O. Akeju|P. Gonzalez-Dias|G. Goulart|A. Gonçalves|R. Huq|M. Farrar|R. Robinson|E. Mitsi|A. Collins|D. Ferreira|A. Howard|L. Kerruish|A. Hyder-Wright|K. Liatsikos|T. Nyazika|C. Solorzano|B. Urban|A. Pollard|D. El Safadi|K. Davies|S. Gordon"
"4153","12/04 12:00","28","P3544","Florian EDBAUER","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Micro- and nanoplastics reduce the phagocytosis of E. coli by THP-1 macrophages","F. Edbauer|J. Seele|R. Nau|H. Ludwig"
"4280","12/04 12:00","29","P3545","Kitt DOKAL","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Reduction in respiratory pathogen exposure and immunity in European children following COVID-19 non-pharmaceutical interventions: a link to the post-pandemic Group A Streptococcus outbreak","S. Channon-Wells|C. Davis|D. Estrada-Rivadeneyra|S. Hamilton|K. Huse|T. Parks|S. Sriskandan|M. Levin|K. Dokal"
"4291","12/04 12:00","30","P3546","Emmanouil STYLIANAKIS","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Molecular pathways affected by clarithromycin treatment in community-acquired pneumonia: analysis of the ACCESS trial","E. Stylianakis|S. Foutadakis|N. Antonakos|S. Doulou|G. Niotis|K. Akinosoglou|K. Iliopoulou|S. Sympardi|E. Giamarellos-Bourboulis"
"4318","12/04 12:00","31","P3547","Elisa Justine Melina RAINERI","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Exploring the antimicrobial response of MAIT cells to Staphylococcus aureus and the impact of bacterial immune evasion","E. Raineri|E. Mouchtaridi|C. Boulouis|J. Sandberg"
"5026","12/04 12:00","32","P3548","Linda PETRONE","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Therapy modulates the response to T cell epitopes over the spectrum of tuberculosis infection","L. Petrone|D. Peruzzu|A. Altera|A. Salmi|V. Vanini|G. Cuzzi|A. Coppola|V. Mellini|G. Gualano|F. Palmieri|S. Panda|B. Peters|A. Sette|C. Lindestam Arlehamn|D. Goletti"
"5089","12/04 12:00","33","P3549","Varpu RINNE","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Single-cell profiling of T-dependent immune response of Borrelia burgdorferi infection in a murine model","V. Rinne|R. Fair-Mäkelä|P. Sundqvist|A. Wierda|T. Lönnberg|J. Alinikula|A. Pietikäinen|J. Hytönen"
"5165","12/04 12:00","34","P3550","Ritirupa ROY","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Differential miRNA signatures in circulating CD4+ T cells of Indian patients with visceral leishmaniasis and post-kala-azar dermal leishmaniasis","R. Roy|C. Hudachek|S. Chauhan|S. Pandey|A. Kumar|B. Zhanbolat|M. Rai|R. Kumar|M. Wilson|S. Sundar"
"6063","12/04 12:00","35","P3551","Auliana Ratri Prabandari HIDAYAT","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Cytokine modulation of mycobacterial restriction by macrophages","A. Hidayat|M. Noursadeghi"
"6097","12/04 12:00","36","P3552","Alessandra AIELLO","8","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Patients with TB disease differ from subjects with TB infection in the ability to in vitro control mycobacterial replication","A. Aiello|S. Sbarra|A. Salmi|V. Vanini|G. Cuzzi|I. Palucci|G. Delogu|G. Gualano|F. Palmieri|D. Goletti"
"6099","12/04 12:00","1","P3553","Simon ATHLIN","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Lipopolysaccharide-induced inflammation and cardiomyocyte dysfunction in a cardiac spheroid model","G. Paramel|N. Steger|J. Thazhath-Veettil|I. Demirel|A. Sirsjö|A. Nordenskjöld|S. Athlin"
"6115","12/04 12:00","2","P3554","Vienne PINLAC","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Pre-transplant anti-cytomegalovirus immunoglobulin G titers as predictor of cytomegalovirus infection in seropositive Filipino kidney transplant recipients: a retrospective cohort study","V. Pinlac|C. Abad|M. Arakama"
"6271","12/04 12:00","3","P3555","Luz M. TORIBIO","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Antigen-specific modulation of inflammation and tissue remodelling in neurocysticercosis","L. Toribio|D. Chong|H. Garcia|J. Friedland"
"6400","12/04 12:00","4","P3556","Assaf MIZRAHI","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Can the Torque teno virus viral load predict Clostridioides difficile infection and evolution?","A. Parfut|L. Feghoul|A. Le Monnier|G. Péan De Ponfilly|J. Le Goff|A. Mizrahi"
"6476","12/04 12:00","5","P3557","Eleonora CIMINI","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","V-delta-2 T-cells response in people with mpox infection: a three-month longitudinal assessment","E. Cimini|E. Tartaglia|F. Messina|A. Coppola|V. Mazzotta|M. Tempestilli|G. Matusali|S. Notari|A. Mondi|G. Prota|A. Oliva|C. Fontana|E. Girardi|F. Maggi|A. Antinori"
"6491","12/04 12:00","6","P3558","Virginia BATIGNANI","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Engineering Klebsiella pneumoniae's outer membrane proteins as novel antigen for therapeutic purposes","V. Batignani|A. Spitaleri|R. Sorrentino|M. Toccafondi|E. Pesce|A. Lombardi|A. Maccaro|A. Bandera|R. Grifantini|D. Cirillo"
"7273","12/04 12:00","7","P3559","Ramla CUSMAN","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","The PI3K-mTOR-HIF-alpha pathway regulates fibroblast-driven tissue destruction in tuberculosis","R. Cusman|J. Kutschenreuter|S. Ratnakumar|D. Chong|J. Friedland"
"7332","12/04 12:00","8","P3560","Matteo FRACELLA","9","C","09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Co-infection with persistent HPV and Merkel cell polyomavirus enhances IFN-lambdas production in the anal mucosa of MLWH","M. Fracella|S. Passerini|F. Frasca|A. D'auria|G. Bugani|E. Cavallari|G. Ceccarelli|C. Mastroianni|G. Antonelli|A. Pierangeli|V. Pietropaolo|G. D'ettorre|C. Scagnolari"
"5357","12/04 12:00","1","P3561","Le QIN","12","B","10a. Host genetics: Susceptibility to infection & primary immunodeficiency","Metagenomic sequencing reveals differences in lung microenvironment among patients with nontuberculous Mycobacterium pulmonary disease under different immune states","L. Qin|Y. Chen|S. Luan|X. Yin|J. Pan|L. Wang|Y. Yao|C. Zhou|R. Bao|J. Shen|Q. Miao|B. Hu"
"129","12/04 12:00","2","P3562","Kentaro IWATA","12","B","10b. Infections related to solid organ transplantation","Hepatitis B crossover boosters using a different product vs the boosters using the same product for renal transplant patients: a retrospective study with Bayesian inference","S. Ikegaki|H. Miyake|Y. Hyodo|K. Iwata"
"550","12/04 12:00","3","P3563","Koh OKAMOTO","12","B","10b. Infections related to solid organ transplantation","Inpatient antimicrobial usage among solid organ transplant recipients in Japan: a ten-year nationwide database study","K. Okamoto|N. Kanda|H. Yamana|Y. Matsuo|H. Matsui|H. Yasunaga|S. Hatakeyama"
"1547","12/04 12:00","4","P3564","Milo GATTI","12","B","10b. Infections related to solid organ transplantation","Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients : an interim analysis of a three-year prospective, observational study","M. Rinaldi|C. Laici|C. Bonazzetti|L. Vizioli|S. Ambretti|M. Morelli|A. Siniscalchi|M. Giannella|P. Viale|F. Pea|M. Gatti"
"1762","12/04 12:00","5","P3565","Irene CASSANITI","12","B","10b. Infections related to solid organ transplantation","Pre-transplant lymphocyte count and HCMV-specific T-cell response as predictive markers of severe HCMV reactivations in kidney transplant recipients","I. Cassaniti|F. Zavaglio|M. Gregorini|M. Grignano|T. Rampino|D. Lilleri|F. Baldanti"
"1868","12/04 12:00","6","P3566","Laura WALTI","12","B","10b. Infections related to solid organ transplantation","Epithelial lining fluid (ELF) concentrations of beta-lactam agents in the lung allograft","L. Walti|C. Mory|S. Husain|N. El Helali|C. Ng|R. Bitterman|T. Martinu|S. Keshavjee|B. Pilmis|L. Del Sorbo"
"2028","12/04 12:00","7","P3567","Rozita KHODASHAHI","12","B","10b. Infections related to solid organ transplantation","Evaluating the efficacy of HBIG and antiviral therapy in preventing hepatitis B recurrence in liver transplant patients: a study from data registry of Montaseriyeh hospital","R. Khodashahi|M. Aliakbarian|A. Doostparast|S. Javanshir"
"2343","12/04 12:00","8","P3568","Satoshi KITAURA","12","B","10b. Infections related to solid organ transplantation","Go the extra mile: a solid organ transplant-specific antibiogram in a tertiary care centre in Japan","S. Kitaura|K. Okamoto|T. Tsutsumi|M. Hatano|M. Sato|N. Akamatsu|K. Hasegawa|D. Yamada|H. Kume|Y. Hamasaki|M. Mizoguchi|M. Ando|M. Ono|E. Amiya"
"2450","12/04 12:00","9","P3569","Mario FERNANDEZ RUIZ","12","B","10b. Infections related to solid organ transplantation","Impact of recipient age on the incidence of infection following kidney transplantation","M. Fayos|I. Rodriguez-Goncer|F. Lopez-Medrano|T. Ruiz-Merlo|H. Trujillo|N. Polanco|E. González|R. San Juan|A. Andrés|J. Aguado|M. Fernández-Ruiz"
"2589","12/04 12:00","10","P3570","Miki NAGAO","12","B","10b. Infections related to solid organ transplantation","Impact of prior mycobacterial and Aspergillus infections on post-lung transplant infections: risk factors, clinical features and prognosis","M. Nagao|Y. Tsuda|K. Shinohara|Y. Tsuchido|M. Yamamoto|Y. Matsumura"
"3095","12/04 12:00","11","P3571","Adrian Anthony ALEXANDER","12","B","10b. Infections related to solid organ transplantation","Safety of adjuvant respiratory syncytial virus vaccine in lung and allogeneic haematopoietic cell transplant recipients","A. Alexander|V. Hall|S. Humar|P. Winichakoon|R. Johnstone|M. Aversa|I. Novitzky-Basso|A. Humar|D. Kumar|J. Mattsson"
"3265","12/04 12:00","12","P3572","Tamara RUIZ MERLO","12","B","10b. Infections related to solid organ transplantation","Lifestyle habits to minimise infection risk in kidney transplant recipients: a single-centre survey","T. Ruiz-Merlo|E. González|N. Polanco|H. Trujillo|F. Lopez-Medrano|R. San Juan|I. Rodriguez-Goncer|M. Fayos|N. Redondo|A. Andrés|J. Aguado|M. Fernández-Ruiz"
"3722","12/04 12:00","13","P3573","Gonzalo ESCUDERO ARNÉS","12","B","10b. Infections related to solid organ transplantation","Vancomycin systemic absorption in lung trasplant recipients treated with inhaled vancomycin","C. Laborda|G. Escudero|I. Los-Arcos|J. Sacanell|A. Pau|Y. Villena|C. Berastegui|J. Rosado|D. Campany|J. Vima|B. Sáez|L. Domenech|M. Martin-Gomez|O. Len|J. Gavaldà|M. Culebras"
"3723","12/04 12:00","14","P3574","Mark HERRINGTON","12","B","10b. Infections related to solid organ transplantation","Evaluating maribavir use in solid organ transplant recipients: a real-world perspective","J. Sanders|M. Herrington|R. La Hoz|V. Beechar"
"3760","12/04 12:00","15","P3575","Douwe Frans POSTMA","12","B","10b. Infections related to solid organ transplantation","Invasive aspergillosis after lung transplantation: effectiveness of nebulised amphotericin-B prophylaxis and statins as preventive strategies","J. Gemert|G. Fleurke|O. Akkerman|C. Gan|W. Steenhuis|H. Kerstjens|E. Verschuuren|D. Postma"
"3952","12/04 12:00","16","P3576","Vaishnavi VELMANI","12","B","10b. Infections related to solid organ transplantation","Comprehensive insights into post-liver transplant infections: a study from a Quaternary care hospital in India","V. Velmani|B. Govindaraj|S. Malleeswaran|L. Gopal|S. Radhakrishnan|N. Nandagopal|V. Baskal|L. Muppa"
"4054","12/04 12:00","17","P3577","Alice MULÈ","12","B","10b. Infections related to solid organ transplantation","Impact of pre-transplant infection and multi-drug resistant (MDR) bacteria colonisation on in-hospital post-transplant survival in subjects with pre-transplant liver failure","A. Mulè|M. Merli|G. Perricone|F. Crippa|G. Travi|C. Oltolini|G. Cavazza|F. Peracchi|N. Bana|E. Di Gennaro|M. Grimaudo|F. Stefanini|R. De Carlis|V. Buscemi|A. Lauterio|G. Monti|L. Belli|M. Puoti"
"4198","12/04 12:00","18","P3578","Renato PASCALE","12","B","10b. Infections related to solid organ transplantation","Epidemiological burden of and risk factors for ganciclovir resistant /refractory cytomegalovirus in solid organ transplant patients and haematopoietic stem cell transplant patients: a multicentre cohort study, the ReCySOHT study: preliminary results","R. Pascale|A. Toschi|E. Franceschini|G. Piccirilli|A. Pérez Jiménez|S. Corcione|A. Mularoni|J. Torre-Cisneros|T. Lazzarotto|M. Giannella"
"4368","12/04 12:00","19","P3579","Jose Tiago SILVA","12","B","10b. Infections related to solid organ transplantation","Experience with isavuconazole in lung transplant recipients with Aspergillus infection","J. Silva|D. Sousa-Regueiro|M. Aguilar-Pérez|J. Aguado|A. Cano-Yuste|J. Torre-Cisneros|A. Monforte|O. Len|D. Brandariz|F. Lopez-Medrano|A. Gutiérrez-Villanueva|A. Fernández-Cruz"
"4499","12/04 12:00","20","P3580","Imran HASANOGLU","12","B","10b. Infections related to solid organ transplantation","Diagnostic stewardship in early postoperative kidney transplantation: the role of CRP and procalcitonin in infection prediction","G. Donertas Turan|I. Hasanoglu|A. Kaya|E. Olcucuoglu|F. Eser|B. Kayaaslan|R. Guner"
"4529","12/04 12:00","21","P3581","Regino RODRIGUEZ-ALVAREZ","12","B","10b. Infections related to solid organ transplantation","Single-centre experience with the use of letermovir for prophylaxis of cytomegalovirus in liver transplant recipients","R. Rodriguez-Alvarez|P. Salvador|E. Bereciartua|M. Senosiain|J. Goikoetxea"
"4661","12/04 12:00","22","P3582","Sunil Kumar DODANI","12","B","10b. Infections related to solid organ transplantation","Comparison of risk factors and outcome between high and low cytomegalovirus viremia in living donor R+D+ renal transplant recipients from Pakistan","A. Naseem|S. Dodani"
"5097","12/04 12:00","23","P3583","Adriana CERVO","12","B","10b. Infections related to solid organ transplantation","Kidney transplantation in people living with HIV: ten-year experience in Modena","A. Cervo|M. Albertini|I. Baldisserotto|F. Casari|E. Ghidoni|F. Romani|V. Todisco|G. Mori|E. Franceschini|G. Donati|C. Mussini|G. Guaraldi"
"5117","12/04 12:00","24","P3584","Maristela P. FREIRE","12","B","10b. Infections related to solid organ transplantation","Vancomycin-resistant Enterococcus infections after liver transplantation: clinical presentation and factors associated with mortality","L. Alves Ferreira|A. T.W. Song|N. Neves Nunes|F. Souza Spadao|L. Carneiro D Albuquerque|E. Abdala|M. P. Freire"
"5132","12/04 12:00","25","P3585","Cecilia BONAZZETTI","12","B","10b. Infections related to solid organ transplantation","HHV8-related diseases in solid organ transplantation: a case series","C. Bonazzetti|M. Rinaldi|M. Casarini|N. Alvaro|M. Morelli|G. Comai|E. Salvaterra|L. Potena|P. Viale|T. Lazzarotto|M. Giannella"
"5437","12/04 12:00","26","P3586","Andrea CONA","12","B","10b. Infections related to solid organ transplantation","Clinical impact of preservation fluid culture in solid organ transplantation: a prospective observational study","A. Cona|A. Copes|M. Campanella|D. Lo Porto|G. Mulè|E. Gervasi|F. Monaco|F. Cardinale|G. Di Martino|G. Panarello|S. Gruttadauria|A. Bertani|P. Grossi|A. Mularoni"
"5677","12/04 12:00","27","P3587","Arnau MONFORTE PALLARÈS","12","B","10b. Infections related to solid organ transplantation","Is nebulised liposomal amphotericin B universal prophylaxis in lung transplant recipients still useful? A single-centre cohort","A. Monforte|I. Los-Arcos|M. Martin-Gomez|E. Márquez-Algaba|C. Berastegui|J. Sacanell|J. Rosado|J. Gavaldà|O. Len"
"5820","12/04 12:00","28","P3588","Cecilia BONAZZETTI","12","B","10b. Infections related to solid organ transplantation","Impact of extended criteria donor transplants on infections in kidney and liver transplant recipients and marginal donor definition criteria: a systematic review","C. Bonazzetti|M. Gatti|M. Chionsini|C. Calgarini|M. Casarini|L. Ceccarelli|M. Rinaldi|P. Viale|M. Giannella"
"5965","12/04 12:00","29","P3589","Sukru DIRIK","12","B","10b. Infections related to solid organ transplantation","Infectious complications in heart transplant recipients: a focus on fungal and mycobacterial infections","S. Dirik|U. Kahraman|B. Emekdas|O. Acet|B. Sullu|C. Cavusoglu|D. Metin|M. Tasbakan"
"6531","12/04 12:00","30","P3590","Elena GHIDONI","12","B","10b. Infections related to solid organ transplantation","Post-surgical infections in liver transplantation performed using robotic surgery: preliminary results of a case-control study","E. Ghidoni|F. Casari|A. Cervo|P. Magistri|C. Guidetti|G. Guerrini|S. Di Sandro|G. Guaraldi|F. Di Benedetto|C. Mussini"
"6734","12/04 12:00","31","P3591","Giovanna MELICA","12","B","10b. Infections related to solid organ transplantation","Burden of first severe infections in kidney transplant recipients: a nationwide French cohort study","L. Hoisnard|L. Tan-Lhernould|V. Esnault|S. Gallien|P. Grimbert|M. Matignon|G. Melica"
"111","12/04 12:00","32","P3592","Taiichiro KOBAYASHI","12","B","10c. Infections related to haematopoietic stem cell transplantation","Prospective evaluation of short- and long-term immune responses to DTaP-IPV and DTaP vaccination in adult allogeneic HSCT recipients","T. Kobayashi|S. Fujiwara|A. Ide|T. Toya|N. Shingai|H. Shimizu|Y. Najima|T. Kobayashi|N. Doki|A. Jo"
"417","12/04 12:00","33","P3593","Bruno RANDI","12","B","10c. Infections related to haematopoietic stem cell transplantation","SARS-CoV-2 infection prior to hematopoietic stem cell transplantation does not increase mortality or the risk of graft-versus-host disease","B. Randi|H. Higashino|V. Ponzio|E. Abdala|T. Guimaraes|F. Vasques|C. Arrais|B. Pires|V. Rocha|S. Costa"
"452","12/04 12:00","34","P3594","Isabel Cristina RAMÍREZ-SÁNCHEZ","12","B","10c. Infections related to haematopoietic stem cell transplantation","Risk factors and a machine learning model to predict adenovirus infection in allogeneic haematopoietic stem cell transplant recipients","R. Diaz-Sanabria|J. Alza-Arcila|I. Ramirez-Sanchez"
"3143","12/04 12:00",,"P3595","Luyang CHANG",,,"10c. Infections related to haematopoietic stem cell transplantation","Safety and efficacy of contezolid in haematological patients with Gram-positive infections: a retrospective analysis","R. Mi|L. Chang|L. Chen|L. Wang|Y. Ma|J. Liu|F. Qin|T. Chen|X. Wei"
"1766","12/04 12:00","36","P3596","Sarah DRÄGER","12","B","10c. Infections related to haematopoietic stem cell transplantation","Incidence of acute kidney injury in patients treated with beta-lactam monotherapy or beta-lactam/amikacin combination therapy after autologous haematopoietic stem cell transplantation","S. Schurch|S. Dräger|S. Bausch|M. Hoffmann|N. Gurtler|C. Hirzel|J. Passweg|S. Bassetti|T. Pabst|P. Sendi|M. Osthoff"
"1944","12/04 12:00","37","P3597","Megan BIGGS","12","B","10c. Infections related to haematopoietic stem cell transplantation","Infection in VEXAS patients undergoing haematopoietic stem cell transplantation","M. Biggs|P. Crowley|M. Thoendel"
"2013","12/04 12:00","38","P3598","Fabian Armando HERRERA","12","B","10c. Infections related to haematopoietic stem cell transplantation","Antifungal prophylaxis strategies in patients with allogeneic haematopoietic stem cell transplantation: impact on empirical antifungal treatment","F. Herrera|J. Carlos|D. Torres|M. Leone|E. Temporiti|M. Querci|S. Relloso|A. Forastiero|J. Ramponi|G. Castro|P. Bonvehi"
"2081","12/04 12:00","39","P3599","Fabian Armando HERRERA","12","B","10c. Infections related to haematopoietic stem cell transplantation","Isavuconazole for invasive fungal infections in patients with haematologic malignancies and haematopoietic stem cell transplantation: data from the first multicentre Latin American study","F. Herrera|D. Torres|G. Méndez|N. Manez|R. Jordán|M. Cabral|A. Manzur|M. Alderete|N. Garcia Allende|J. Benso|C. Salgueira|H. Peretti|C. Niveyro|F. Polastirelli|J. Dapas|A. Riso Patron|V. Fernández|J. Afeltra"
"2355","12/04 12:00","40","P3600","Basem ALRADDADI","12","B","10c. Infections related to haematopoietic stem cell transplantation","Epidemiology and outcomes of carbapenem resistant Enterobacterales in immunosuppressed population","B. Alraddadi|E. Heaphy|R. Almaghrabi|S. Althawadi|A. Alshahrani|S. Almosallam|A. Alraddadi|L. Hefni|M. Bosaeed|M. Shamsan|I. Bahabri|E. Alamoudi"
"2616","12/04 12:00","41","P3601","Adriana BAQUEIRO ABAD RIBEIRO","12","B","10c. Infections related to haematopoietic stem cell transplantation","Evaluation of invasive pneumococcal diseases and vaccination adherence in patients undergoing hematopoietic stem cell transplantation","A. Baqueiro Abad Ribeiro|S. Figueiredo Costa|A. Christovam Sartori|H. Ryoiti Higashino|B. Azevedo Randi|V. Geraldo Rocha|B. Garcia Pires Da Silva"
"2842","12/04 12:00","42","P3602","Michaela STEINHILPER","12","B","10c. Infections related to haematopoietic stem cell transplantation","Assessment of T-cell-mediated, SARS-CoV-2-specific immune responses in patients after allogeneic haematopoietic stem cell transplantation: a prospective diagnostic study","M. Steinhilper|E. Hermann|D. Teschner|A. Ruckdeschel|M. Amersbach|J. Löffler|C. Blasberg|L. Hock|J. Frietsch|F. Sahiti|K. Eder|F. Kanis"
"2986","12/04 12:00","43","P3603","Ellen WALSH","12","B","10c. Infections related to haematopoietic stem cell transplantation","Cellular immune response to RSV vaccine and quadrivalent inactivated influenza vaccine in allogeneic stem cell transplant recipients in the early post-transplant period","J. Dunne|C. De Gascun|L. Bacon|D. Doherty|C. Bergin|N. Conlon|E. Walsh"
"3293","12/04 12:00","44","P3604","Chiara RODARO","12","B","10c. Infections related to haematopoietic stem cell transplantation","Ethnic disparities in response to CMV immunotherapy using intravenous CMV hyperimmune globulin in paediatric allo-HSCT recipients","N. Maximova|S. Braidotti|D. Curci|C. Rodaro|D. Zanon|A. Maestro|A. Di Paolo"
"3678","12/04 12:00","45","P3605","Satish SWAIN","12","B","10c. Infections related to haematopoietic stem cell transplantation","Tuberculosis among allogeneic bone marrow transplant recipients in India","S. Swain|P. Rupali"
"3839","12/04 12:00","46","P3606","Carlota GUDIOL","12","B","10c. Infections related to haematopoietic stem cell transplantation","Hospital-acquired and ventilator-associated bacterial pneumonia in neutropaenic cancer patients or haematopoietic stem cell transplant recipients: the CARINA study","M. Montero|F. Carmona-Torre|E. Sastre-Escola|C. Garcia Vidal|P. Munoz|A. Falco|P. Martin Davila|Z. Palacios-Baena|A. Gutiérrez-Villanueva|M. Aguilar|M. Cotarelo|R. Ponz|C. Gudiol"
"4366","12/04 12:00","47","P3607","Cristina Teresa FUENTES MORALES","12","B","10c. Infections related to haematopoietic stem cell transplantation","Toxoplasma and allogeneic stem cell transplantation","S. Munoz Criado|C. Fuentes Morales|A. Avendano Pita|D. Martin Clavo|A. Fernández Sánchez|C. Santos Marcos|R. Malaver Campos|C. Puerta Vazquez|P. Garcia Jaen|E. Zapata Tapia|E. Alejo Alonso|D. Alonso Castronuno|M. Cabreo Calvo|A. Garcia Bacelar|A. Martin Lopez|M. Baile González|A. Cabero Martinez|E. Perez Lopez|A. Cotos Suárez|J. Munoz Bellido|L. Lopez Corral|M. Vazquez Lopez"
"4659","12/04 12:00","48","P3608","Fabian Armando HERRERA","12","B","10c. Infections related to haematopoietic stem cell transplantation","Letermovir primary cytomegalovirus prophylaxis in allogeneic haematopoietic cell transplant recipients: data from the first multicentre Latin American study","F. Herrera|D. Torres|N. Manez|H. Peretti|M. Alderete|A. Laborde|L. Tula|M. Pereyra|F. Otermin|S. Garcia Rojas|M. Eusebio|F. Arguello|S. Adriani|M. Gonzalez Ibanez|N. Pozzi|R. Gago|M. Silva|R. Jordán"
"4760","12/04 12:00","1","P3609","Yu ZHANG","13","B","10c. Infections related to haematopoietic stem cell transplantation","Oral contezolid treatment for skin and soft tissue infections in paediatric patients with heamatologic disorders: a retrospective analysis of 13 cases","X. Wang|Y. Zhang|C. Wang|Q. Zhang|Y. Li|C. Yang|X. Zhou|F. Qin|T. Chen"
"5219","12/04 12:00","2","P3610","Nicoletta DI LAURIA","13","B","10c. Infections related to haematopoietic stem cell transplantation","Implementing de-escalation of antimicrobial therapy to targeted agents in haematopoietic stem cell transplantation patients with bloodstream infections","N. Di Lauria|M. Fognani|L. Graziani|M. Spinicci|E. Mantengoli|G. Corti|A. Farese|I. Cutini|C. Nozzoli|G. Rossolini|A. Bartoloni"
"6362","12/04 12:00","3","P3611","Siwar FRIGUI EP OUESLATI","13","B","10c. Infections related to haematopoietic stem cell transplantation","Changing epidemiology of febrile neutropenia in patients undergoing allogeneic haematopoietic stem cell transplantation","M. Ezzedini|Y. Chebbi|D. Belloumi|S. Frigui|T. Ben Othmen|N. Abdejlil|W. Achour"
"6816","12/04 12:00","4","P3612","Juan GEA-BANACLOCHE","13","B","10c. Infections related to haematopoietic stem cell transplantation","Toxoplasmosis after allogeneic haematopoietic cell transplantation: 17 years of experience with Toxoplasma gondii PCR","M. Czech|J. Cuellar-Rodriguez|S. Das|T. Jerussi|J. Gea-Banacloche"
"2999","12/04 12:00","5","P3613","Jennifer MAKHOUL","13","B","10d. Infections related to cell-based therapies","Cytomegalovirus infections in patients with relapsed/refractory multiple myeloma on novel therapies","S. Seif|J. Makhoul|S. Jetty|F. Khawaja|K. Patel|H. Lee|S. Thomas|L. Gensini|C. Morales De Partovi|S. Horowitz|A. Spallone|E. Ariza Heredia|R. Chemaly"
"5249","12/04 12:00","6","P3614","Gemma REYNOLDS","13","B","10d. Infections related to cell-based therapies","Longitudinal cytokine expression in CAR-T-treated aggressive-lymphoma patients","G. Reynolds|L. Williams|M. Anderson|M. Dowling|A. Minson|M. Dickinson|K. Thursky|S. Harrison|M. Slavin|M. Doerflinger|B. Teh"
"5366","12/04 12:00","7","P3615","Gemma REYNOLDS","13","B","10d. Infections related to cell-based therapies","Predicting risk of infection in CAR-T-treated lymphoma patients: utility of immune-profiling","G. Reynolds|L. Williams|M. Anderson|M. Dowling|A. Minson|M. Dickinson|K. Thursky|S. Harrison|M. Slavin|M. Doerflinger|B. Teh"
"320","12/04 12:00","8","P3616","Seohyeon IM","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Infectious risks with blinatumomab exposure in B-cell acute lymphoblastic leukemia","S. Im|I. Gonzalez-Bocco|P. Sakr|A. Franceschi|M. Diaz|S. Koo|J. Safiia"
"344","12/04 12:00","9","P3617","Nitin BANSAL","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Clinical utility of serum procalcitonin in cancer patients with suspected sepsis episode","N. Bansal"
"1104","12/04 12:00","10","P3618","Yii Ean TEH","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Tuberculosis (TB) screening and TB disease in patients on immune checkpoint inhibitors (ICIs)","Y. Teh|M. Bracchi|A. Dalla Pria|X. Yeo|B. Mora Peri|M. Mercer|T. Newsom-Davis"
"1511","12/04 12:00","11","P3619","Temitope OBADARE","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Bacterial agents and antibiotic resistance in febrile neutropenia in Africa: a systematic review and meta-analysis","T. Obadare|A. Adeyemo|N. Sule|M. Adeyemo|O. Alatise"
"1895","12/04 12:00","12","P3620","Miguel RODRÍGUEZ-FERNÁNDEZ","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Clinical impact of OXA-48-producing Enterobacterales rectal colonisation on heamatologic patients with febrile neutropaenia","M. Rodriguez-Fernandez|P. Rosales-Garcia|J. Cuevas-Corrales|P. Martinez Perez-Crespo|L. Valiente-De Santis|I. Simon-Pilo|E. Gil-Espárraga|C. Serrano Martino|A. Aller-Garcia|N. Merchante"
"1941","12/04 12:00","13","P3621","Fabian Armando HERRERA","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Bacteraemia in neutropaenic patients admitted to the intensive care unit with septic shock: aetiology, clinical characteristics, outcome and impact of multidrug resistance on mortality","F. Herrera|D. Torres|N. Suchowiercha|N. Manez|A. Laborde|M. Pereyra|L. Tula|L. Berruezo|J. Benso|A. Nenna|A. Racioppi|I. Roccia Rossi|L. Barcán|M. Gonzalez Ibanez|R. Gago|S. Lambert|A. Fernández|V. Fernández|V. Soto|M. Alderete|N. Grippo|M. Reynaldi|M. Visús|M. Pennini|N. Azula|M. Blanco|R. Carbone|M. Chaves|S. Valle|F. Pasteran|A. Corso|M. Rapoport|A. Carena"
"2020","12/04 12:00","14","P3622","Aseel ABUSARA","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Guideline adherence for vancomycin prescribing in febrile neutropaenia cases in Jordan","A. Abusara|C. Dabeet|S. Elshayib|M. Meranda|R. Najjar|Y. Mann|M. Zervos|A. Shallal|J. Jarrah|M. Veve"
"2146","12/04 12:00","15","P3623","Berta PERNAS-SOUTO","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Characterisation of infections in immunosuppressed patients with lung cancer in Northwest Spain","B. Pernas|J. Mosquera|T. Calleja|F. Busto|V. Balboa|D. Sousa|L. Ramos|M. Garcia-Campelo|E. Miguez"
"2230","12/04 12:00","16","P3624","Fabian Armando HERRERA","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Antibiotic de-escalation in neutropenic patients with Enterobacterales bacteraemia: an important antimicrobial stewardship programme strategy in the multi-drug resistant era","F. Herrera|D. Torres|L. Tula|N. Manez|A. Laborde|M. Pereyra|L. Berruezo|N. Suchowiercha|M. Alderete|M. Gonzalez Ibanez|R. Gago|A. Fernández|I. Roccia Rossi|N. Grippo|M. Blanco|M. Visús|M. Pennini|N. Azula|R. Carbone|M. Reynaldi|S. Valle|F. Pasterán|A. Corso|M. Rapoport|A. Carena"
"2309","12/04 12:00","17","P3625","Silpa JETTY","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Infectious complications in patients with relapsed and refractory multiple myeloma undergoing novel bispecific antibody therapy","S. Jetty|J. Makhoul|F. Khawaja|S. Horowitz|A. Spallone|E. Ariza Heredia|R. Chemaly|K. Patel|H. Lee|S. Thomas|L. Gensini|C. Morales De Partovi|S. Seif"
"3268","12/04 12:00","18","P3626","Aleksandra KRÓLAK","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Enterococcal bacteraemia in children undergoing anticancer therapy or haematopoietic stem cell transplantation: a multicentre nationwide survey in Poland (2014-2021)","M. Lukszo|K. Drabko|J. Zawitkowska|W. Badowska|T. Brzeski|K. Mycko|J. Peregud-Pogorzelski|P. Wawrykow|N. Irga-Jaworska|E. Bien|M. Krawczuk-Rybak|M. Plonowski|K. Kalwak|M. Salamonowicz-Bodzioch|O. Piotrowska|O. Zajac-Spychala|J. Styczynski|J. Kozuch|J. Strzemecka|K. Czyzewski|K. Jaremek|O. Grochowska|P. Zalas-Wiecek|K. Derwich|A. Mizia-Malarz|W. Stolpa|K. Baranowska|R. Chaber|W. Bal|G. Karolczyk|A. Urbanek-Dadela|T. Szczepanski|R. Tomaszewska|A. Ksiazek|P. Laguna|L. Hutnik|A. Szmydki-Baran|A. Minkowska|K. Pikora|W. Mlynarski|F. Pierlejewski|B. Dembowska-Baginska|O. Gryniewicz-Kwiatkowska|T. Ociepa|A. Krolak|H. Kluk"
"3381","12/04 12:00","19","P3627","Eduardo APARICIO-MINGUIJÓN","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Risk of infection in multiple myeloma patients receiving bispecific antibodies","E. Aparicio-Minguijon|N. Lopez-Munoz|G. Bartolomé Herguedas|A. Saez Marin|J. Boán|F. Lopez-Medrano|R. San Juan|M. Lizasoain Hernandez|J. Sánchez-Pina|M. Calbacho|J. Martinez-Lopez|J. Aguado|M. Fernández-Ruiz|I. Rodriguez-Goncer"
"4332","12/04 12:00","20","P3628","Pierre-Yves BOCHUD","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Epidemiology, risk factors and outcome of neutropaenic enterocolitis in onco-heamatological patients according to chemotherapy regimen","A. Brunel|C. Seydoux|S. Schmidt|S. Ahlyege|M. Fleury|A. Cairoli|S. Blum|O. Spertini|O. Marchetti|M. Gavillet|P. Bochud"
"4392","12/04 12:00","21","P3629","Anna Marie RUCKDESCHEL","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","NGS-based pathogen detection in bronchoalveolar lavage fluid obtained from immunocompromised patients with pulmonary infections","A. Ruckdeschel|M. Amersbach|S. Hoffmann|J. Frietsch|J. Forster|H. Einsele|D. Teschner"
"4401","12/04 12:00","22","P3630","Balint Gergely SZABO","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Comparison of virus-specific T-cell therapy and CD45RA+ T-cell-depleted donor lymphocyte infusion against COVID-19 among adult patients with hematologic malignancies","B. Szabo|B. Petrik|M. Reti|L. Gopcsa|P. Remenyi"
"4685","12/04 12:00","23","P3631","Julian Andres HOYOS PULGARIN","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Risk of infection by carbapenemase-producing Enterobacterales, associated factors, and a predictive model for its development in oncological patients","J. Hoyos Pulgarin|G. Omar Armando|G. Moreno Gomez|M. Jose William|N. Monica|P. Miguel Angel|G. Vanessa"
"4698","12/04 12:00","24","P3632","Juan Fernando CONTRERAS VALERO","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Characterisation of bacteraemia caused by Staphylococcus aureus in oncologic patients and mortality-related factors","M. Lopez|J. Contreras Valero|C. Buitrago|M. Chavarro|S. Galeano|A. Carvajal"
"5644","12/04 12:00","25","P3633","Irene CADENAS JIMÉNEZ","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Molecular epidemiology and antimicrobial resistance profiles of Pseudomonas aeruginosa causing bloodstream infections in neutropenic cancer patients","I. Cadenas-Jiménez|A. Badia|C. Lopez-Causape|M. Morosini|I. Portillo-Calderon|M. Machado|N. Larrosa|P. Martin Davila|Z. Palacios-Baena|A. Puig-Albasanz|F. Tubau|A. Oliver|S. Marti|C. Gudiol"
"5786","12/04 12:00","26","P3634","Vijeta BAJPAI BATRA","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Phenotypic and genotypic characterisation of atypical non-lactose-fermenting Escherichia coli in cancer patients: an emerging diagnostic challenge","V. Bajpai|A. Kumar|A. Mishra|P. Kumar|S. Bharti|R. Sarode|H. Pandey"
"5931","12/04 12:00","27","P3635","Juhui HAN","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Cytomegalovirus (CMV) reactivation after chimeric antigen receptor (CAR) T-cell therapy or bispecific antibodies treatment for hematologic malignancies","J. Han|S. Kim"
"6954","12/04 12:00","28","P3636","Edit ZSOLDINÉ URBÁN","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Microbiological background of medical-related osteonecrosis of the jaw bones","Z. Kövér|B. Polgár|E. Urbán"
"7623","12/04 12:00","29","P3637","Ebru ORUC","13","B","10e. Infections related to cancer treatment (incl neutropaenia)","Bloodstream infection in heamatological malignancy patients","G. Yapar Toros|H. Ertekin|S. Ceken|E. Guner|E. Oruc"
"1317","12/04 12:00","30","P3638","Takashi KURITA","13","B","10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","A proposal of the refined diagnostic criteria for invasive pulmonary aspergillosis in autoimmune inflammatory rheumatic diseases treated with immunosuppressive agents","T. Kurita|K. Okamoto|N. Sekiya|R. Hanazawa|A. Yamamoto|T. Hosoya|A. Hirakawa|S. Yasuda|Y. Gu"
"2315","12/04 12:00","31","P3639","Adam STEWART","13","B","10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","Bloodstream infection and risk for plasma cell neoplasms: a large population-based cohort study","A. Stewart|F. Edwards|K. Laupland"
"4101","12/04 12:00","32","P3640","Omid REZAHOSSEINI","13","B","10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","Temporal timing patterns of herpes zoster events in relation to diagnosis of immunocompromising conditions","O. Rezahosseini|M. Eiberg|M. Andersen|A. Egeskov-Cavling|C. Johannesen|C. Roed|C. Torp-Pedersen|T. Fischer|Z. Harboe"
"4167","12/04 12:00","33","P3641","Omid REZAHOSSEINI","13","B","10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","Timing of pneumococcal infections in adults with diseases associated with immunocompromised states: temporal patterns and implications for vaccination","O. Rezahosseini|M. Eiberg|M. Andersen|C. Roed|D. Weinberger|C. Torp-Pedersen|Z. Barrella Harboe"
"4546","12/04 12:00","34","P3642","Sarah JAWAD","13","B","10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","IL-5 inhibitors and screening for helminth infection","S. Jawad|G. Godbole|D. Armstrong-James|M. Habibi|B. Healy|I. Jones|N. Longley|D. Lowe|P. Patel|L. Nabarro"
"104","13/04 12:00","1","P0553","Sung-Woon KANG","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Impact of fluoroquinolone exposure on the diagnosis and prognosis of tuberculosis in immunocompromised patients: a propensity-score matched, competing risk analysis","S. Kang|H. Jang|E. Chang|S. Bae|J. Jung|M. Kim|Y. Chong|S. Lee|S. Choi|Y. Kim|S. Kim"
"276","13/04 12:00","2","P0554","Matthew WILLIS","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Barriers and facilitators to paediatric tuberculosis management in India: a systematic review","M. Willis|J. Van De Wetering|H. Brown|E. Barnowska|S. Stuetzle|M. Nadiruzzaman|A. Fastenau"
"408","13/04 12:00","3","P0555","Nils WETZSTEIN","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008-2023","N. Rachwal|R. Idris|V. Dreyer|E. Richter|T. Wichelhaus|S. Niemann|N. Wetzstein|U. Götsch"
"510","13/04 12:00","4","P0556","Agrim JHILTA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Inhalable statin-encapsulated gelatin microsphere as a host targeted strategy to inhibit matrix metalloproteinases in tuberculosis pathogenesis","A. Jhilta|K. Jahdav|R. Singh|S. Negi|R. Verma"
"511","13/04 12:00","5","P0557","Samarth BHAT K S","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","In-hospital and 90-day post-discharge outcomes in central nervous system tuberculosis: a prospective observational study","S. Bhat K S|D. Kumar|N. Midha|G. Bohra|M. Garg|S. Bhaskar|V. Tak|S. Tiwari|S. Kombade|D. Meena"
"564","13/04 12:00","6","P0558","Young Ah KIM","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Analysis of clinical impact of the coronavirus disease (COVID-19) pandemic on the quality of pulmonary tuberculosis management with national reimbursement data","Y. Kim|J. Lee|S. Lee"
"602","13/04 12:00","7","P0559","Huahui YANG","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Safety, tolerability and pharmacokinetics of single and multiple ascending doses and food-effect of MRX-5 tablets in healthy adult subjects","F. Kong|H. Yang|Z. Wan|C. Chang"
"646","13/04 12:00","8","P0560","Hee Joo LEE","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Whole-genome sequencing and phenotypic DST of bedaquilin, delamanid, proteomanid and linezolid in drug-resistant Mycobacterium tuberculosis in South Korea","H. Choi|Y. Kim|J. Lee|J. Kim|S. Kang|S. Yoon|Y. Kang|M. Cho|K. Choi|E. Son|J. Lee|S. Kee|H. Lee"
"647","13/04 12:00","9","P0561","Suwatchareeporn ROTCHEEWAPHAN","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Genetic diversity of Mycobacterium bovis BCG clinical isolates from immunocompromised patients with BCG infections","S. Rotcheewaphan|P. Premchaiporn|K. Wongjarit|S. Petsong|C. Srichomthong|S. Anugulruengkit|S. Payungporn|V. Shotelersuk|V. Sawaswong"
"693","13/04 12:00","10","P0562","Ashish SINHA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Assessment of isoniazid preventive therapy and barriers of implementation among contacts of pulmonary tuberculosis patients in Raipur district","A. Sinha"
"714","13/04 12:00","11","P0563","Fereshteh SHEIBANI","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Empirical anti-tuberculous medications in adults with suspected tuberculous meningitis: a retrospective cohort study in Mashhad, Iran","F. Sheybani|M. Haddad|M. Maleki Rad"
"754","13/04 12:00","12","P0564","Rohit KUMAR","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Utility of Xpert MTB/XDR in GeneXpert MTB/RIF positive extrapulmonary tuberculosis (EPTB) samples: a step towards precision in EPTB management","R. Kumar|A. Chakravarty"
"778","13/04 12:00","13","P0565","Christian KRAEF","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Risk of tuberculosis among patients with inflammatory bowel disease and inflammatory rheumatic disease treated with biological agents in Denmark: a nationwide population-based cohort study","C. Kraef|A. Østergaard|T. Lillebaek|A. Fløe|L. Larsen|A. Colic|I. Petersen|I. Johansen"
"789","13/04 12:00","14","P0566","Ana YEPES GARCIA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Characterising Mycobacterium tuberculosis resistance mechanisms to ganfeborole and monitoring drug resistance during Phase 2a clinical trial","A. Yepes Garcia|E. Lopez Roman|R. Gonzalez Del Rio|S. Penman|J. Bezuidenhout|E. Perez Herran|A. Toledo Olayaa|L. Guijarro Lopez|R. Bates|G. Maher-Edwards|D. Barros Aguirre"
"793","13/04 12:00","15","P0567","Emma Elisabeth POULSEN","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","The effect on tuberculosis on lung function: a case-control study","E. Poulsen|F. Rudolf|A. Hvass|C. Wejse"
"827","13/04 12:00","16","P0568","Srishty Sananda HOTA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Decoding isoniazid resistance: a comprehensive study of mutation patterns and diagnostic insights in tuberculosis","S. Hota|S. Kombade|N. Dutt|D. Kumar"
"831","13/04 12:00","17","P0569","Fang You YU","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Targeted next-generation sequencing: a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance","X. Wu|Y. Fangyou"
"893","13/04 12:00","19","P0571","Ashima BHASKAR","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","HDAC1 mediated acetylome landscape controls mycobacteria-specific T cell memory responses during tuberculosis","A. Bhaskar|V. Dwivedi"
"899","13/04 12:00","20","P0572","Qiaolian YI","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Direct identification of Mycobacterium tuberculosis and eight dominant non-tuberculous mycobacterial using a multiplex molecular point-of-care panel","Q. Yi|Y. Wu|Y. Xu"
"932","13/04 12:00","21","P0573","Pernille Grand MOESTRUP","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Nontuberculous mycobacterial diagnosis codes: a good proxy of NTM disease?","P. Moestrup|V. Dahl|A. Fløe|C. Wejse"
"934","13/04 12:00","22","P0574","Alberto MATTEELLI","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Treatment outcomes in patients with M. abscessus lung infection: national multicentre study of the IRENE project","V. Crosato|A. Pavesi|L. Tomasoni|S. Aliberti|A. Matteelli|F. Colombo"
"960","13/04 12:00","23","P0575","Ummu Afeera ZAINULABID","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","From fish fin injury to Mycobacteroides abscessus: precision diagnosis in a complex case using shotgun metagenomics","U. Zainulabid|M. Aziz|W. Leong|X. Chew|A. Abdul Rahman|X. Cheong|N. Kori|S. Abdullah|C. Lim|K. Khalid|E. Mohammed Rusli|P. Periyasamy"
"961","13/04 12:00","24","P0576","Sandeep RAO KORDCAL","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Tuberculosis infection and tuberculosis disease in household contacts of newly diagnosed multidrug-resistant tuberculosis patients","S. Rao Kordcal|P. Jorwal|B. Singh Kumar|S. Dhawan|M. Ahmad Khan|B. Kumar Vashishth|N. Wig|T. Maula"
"991","13/04 12:00","25","P0577","Michael PRODANUK","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Host blood biomarkers for the diagnosis of childhood tuberculosis: a systematic review and meta-analysis","M. Prodanuk|J. King|M. Ratnayake|I. Kitai|J. Cunningham|P. Piche-Renaud|M. Richard-Greenblatt|S. Morris"
"1147","13/04 12:00","26","P0578","Abhinav SENGUPTA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Complicated CNS tuberculosis: a retrospective cohort study","A. Sengupta|R. Sarmah|A. Mandal|A. Agarwal|M. Soneja|S. Kordcal|A. Ray|N. Wig"
"1173","13/04 12:00","27","P0579","Stephanie SUTJIPTO","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Longitudinal assessment of health-related quality of life in untreated Mycobacterium abscessus pulmonary disease: interim analysis from the Singapore FORMaT trial observational cohort","S. Sutjipto|I. Lee|J. Lim|S. Retnam|B. Young|Z. Au|T. Chia|P. Tambyah|L. Chai|D. Ng|K. Chew|J. Tan"
"1186","13/04 12:00","28","P0580","Miles EDWARDS","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Infliximab or inflixi-mad? Disordered approaches to pre-immunosuppressive therapy latent TB infection screening","M. Edwards|D. Hettle|D. Bruchez|A. Thompson|F. Easton|I. Heys"
"1194","13/04 12:00","29","P0581","Nikhil BHALLA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Pangenome and CNV analysis of clinical Mycobacterium tuberculosis isolates identifies perturbations in phage immunity genes linked to drug resistance and lineage types","N. Bhalla|A. Behera|A. Gupta|R. Nanda"
"1236","13/04 12:00","32","P0584","Victor NÆSTHOLT DAHL","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mortality and causes of death in patients with Mycobacterium avium complex isolates through 28 years","A. Pedersen|I. Johansen|R. Ibsen|A. Fløe|A. Løkke|O. Hilberg|A. Andersen|C. Wejse|T. Lillebaek|V. Dahl"
"1283","13/04 12:00","33","P0585","Hyeyoung LEE","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Platelets at tuberculomas worsen CNS-TB by inducing PAD-driven NETs and PI3K/Akt-driven MMP-1 release: data from human, murine and 3D cellular models","H. Lee|F. Loh|P. Thong|X. Poh|T. Teo|T. Hu|H. Chong|B. Chen|S. Fong|W. Teo|M. Lee|C. Tan|C. Ding|J. Tay|A. Vallejo|T. Yeo|L. Teck|C. Ong"
"1287","13/04 12:00","34","P0586","Shasank Sekhar SWAIN","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Development of potential and cost-effective isoniazid-phytochemical hybrid drugs using an integrated combinatorial approach against Mycobacterium tuberculosis","S. Swain"
"1311","13/04 12:00","35","P0587","Edith MACHOWSKI","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Characterisation of mycobacteriophage BluSpix and Mycobacterium smegmatis phage-resistant strain Nigel","E. Machowski|C. Madhav|B. Kana|F. Wells|P. Mpangase"
"1376","13/04 12:00","36","P0588","Tânia SILVA","1","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Accelerating Mycobacterium abscessus drug discovery with novel double-reporter strains","C. Bento|G. Oliveira|K. Van Calster|A. Pombinho|R. Reis|L. De Vooght|A. Maia|P. Cos|M. Gomes|T. Silva"
"1395","13/04 12:00","1","P0589","Peize ZHANG","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Early bactericidal activity of contezolid in patients with drug-resistant tuberculosis","P. Zhang|T. Chen|S. Zhan|H. Qin|D. Li|Q. Gao|Z. Chen|L. Yang|F. Shen|H. Lu|G. Deng|L. Yang|F. Shen|H. Lu|G. Deng"
"1437","13/04 12:00","2","P0590","Johanna ÅHSBERG","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of the Xpert MTB/RIF Ultra assay to detect tuberculosis in concentrated urine from inpatients with advanced HIV in Ghana","J. Ahsberg|S. Bjerrum|P. Asare|S. Osei-Wusu|T. Afum|F. Sorvor|Y. Adusi-Poku|M. Lartey|D. Yeboah-Manu|J. Opintan|I. Johansen"
"1503","13/04 12:00","3","P0591","Pradnya Laxman SAMANT","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Prevalence of tuberculosis in cancer patients: a single centre experience from India","P. Samant|S. Biswas|G. Salunke|P. Dixit"
"1633","13/04 12:00","5","P0593","Marta POZUELO TORRES","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluating the intracellular activity of a phage combination targeting Mycobacterium tuberculosis","M. Pozuelo Torres|J. Van Ingen|S. Larsen|C. Guerrero-Bustamante|A. Diacon|G. Hatfull|R. Coler|S. Janssen"
"1643","13/04 12:00","6","P0594","Salim AGSOUS","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","GenoMAB: a genomic pipeline for Mycobacterium abscessus antimicrobial resistance","S. Agsous|K. La|P. Baylac|Z. Awad|F. Mougari|C. Allam|E. Cambau"
"1702","13/04 12:00","7","P0595","Gerasimos Socrates CHRISTODOULATOS","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Advantages of fluorescence staining technique in the diagnosis of tuberculosis as an alternative to Ziehl-Neelsen: a comparative study in a tertiary Greek hospital","K. Stamoulos|G. Christodoulatos|A. Velentza|P. Dimolianis|E. Sirmou|E. Liakou|K. Mari|K. Belechri|P. Kaskaveli|G. Gkolias|S. Kogiou|M. Martsoukou|M. Kechagia"
"1705","13/04 12:00","8","P0596","Madeline SANDERS","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","In vitro activity of imipenem/relebactam alone and in combination against cystic fibrosis isolates of Mycobacterium abscessus","M. Sanders|A. Shinde|P. Beringer|S. Kim|E. Quach"
"1738","13/04 12:00","9","P0597","Kan YU","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Clinical Mycobacterium tuberculosis isolates exhibit a molecular clock rate below 1 SNP per genome per year","W. Jun-Li|C. Ya-Li|G. Cui-Ping|Y. Kan|W. Mao-Shui"
"1771","13/04 12:00","10","P0598","Frieder PFÄFFLIN","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mycobacterium chelonae infective endocarditis: data from the MYBACH registry","F. Pfäfflin|J. Kikhney|I. Friesen|T. Christ|M. Stegemann|N. Menner|K. Sarbandi|F. Klefisch|L. Sander|A. Moter|D. Von Schöning"
"1774","13/04 12:00","12","P0600","Yi Hao WONG","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Pro-angiogenic growth factors and matrix metalloproteinases are key drivers of dysregulated angiogenesis in tuberculosis with diabetes mellitus","F. Loh|Y. Wong|C. Bai|H. Chong|T. Hu|P. Thong|A. Chang|H. Lee|C. Choong|L. Galamay|P. Yang|A. Lim|S. Mok|S. Kao|C. Ong"
"1828","13/04 12:00","13","P0601","Amina ZAFFAGNINI","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","How to manage drug-sensitive tuberculosis when rifampicin cannot be used? A survey by the study group on Mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine","A. Zaffagnini|N. Riccardi|A. Matteelli|A. Calcagno|N. Coppola|E. Pontali|J. Mencarini|M. Trezzi|C. Monari|L. Surace|R. Parrella"
"1843","13/04 12:00","14","P0602","Philip FOWLER","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Rapidly and reproducibly building a catalogue of resistance-associated variants using 46,800 M. tuberculosis samples with genomes and DST data","P. Fowler|D. Adlard|J. Westhead|H. Thai|M. Colpus|R. Turner|T. Peto|D. Crook"
"1879","13/04 12:00","15","P0603","Giulia GATTI","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Definition of SNPs limit range for unknown non-tuberculous Mycobacteria genomic investigation","G. Gatti|L. Ingletto|G. Dirani|S. Zannoli|F. Taddei|C. Colosimo|L. Dionisi|A. Marzucco|M. Montanari|M. Brandolini|M. Guerra|L. Grumiro|A. De Pascali|A. Scagliarini|M. Cricca|V. Sambri"
"1945","13/04 12:00","16","P0604","Jung-Ah KIM","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of bioline TB Ag MPT64 for detecting Mycobacterium tuberculosis complex in acid-fast bacilli-positive cultures","J. Kim|T. Kim|I. Yoo|H. Yu|H. Huh"
"1960","13/04 12:00","17","P0605","Wenting JIN","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance in paucibacillary clinical samples","W. Jin|Y. Wang|J. Chen|B. Hu"
"1999","13/04 12:00","18","P0606","Nezihat Desen BÜYÜKSOY","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Comparison of three different protocols for identification of nontuberculous mycobacteria species from liquid media by matrix-assisted laser desorption/ionisation-time-of-flight mass spectrometry","N. Buyuksoy|O. Appak|C. Biçmen|N. Esen"
"2005","13/04 12:00","19","P0607","Carlo PALLOTTO","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Treatment of latent tuberculosis infection: obstacles to reach the goal: the TIBER study, preliminary results","C. Pallotto|E. Svizzeretto|C. Papalini|G. Genga|A. Tommasi|D. Francisci"
"2096","13/04 12:00","20","P0608","Atish MOHAPATRA","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Development and validation of a novel scoring system to differentiate between tuberculous and non-tuberculous pleural effusion","A. Mohapatra|U. Gaikwad|R. Ganga|P. Sharma"
"2178","13/04 12:00","21","P0609","Lorenzo GUGLIELMETTI","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","EndTB-Q trial for pre-XDR-TB: impact of baseline tuberculosis disease extent on efficacy of a shortened, stratified-medicine treatment strategy","L. Guglielmetti|M. Gouillou|A. Abubakirov|U. Khan|L. Lecca|D. Luong|S. Panda|S. Patil|N. Salahuddin|M. Tamirat|C. Mitnick"
"2334","13/04 12:00","22","P0610","Yinjuan GUO","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Molecular characteristics and drug susceptibility of aminoglycosides in multidrug-resistant tuberculosis","G. Yinjuan|Y. Fangyou"
"2429","13/04 12:00","24","P0612","Marina VICENTE CIURANS","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Phenotypic and genotypic antimicrobial susceptibility testing of Mycobacterium avium complex and Mycobacterium kansasii","M. Vicente-Ciurans|J. Rodriguez-Ochoa|M. Mena|M. Vivas|M. Tortola-Fernandez"
"2484","13/04 12:00","25","P0613","Emma CARTER","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","TBM PR-IRIS: a UK wide retrospective cohort study of paradoxical reaction in central nervous system tuberculosis","C. Fernandez|C. Walsh|S. O'riordan|P. Lillie|P. Mcgann|M. Mugglestone|F. Mcgill|E. Carter"
"2488","13/04 12:00","26","P0614","Anqi LI","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","LeuRS-targeting prodrug, MRX-5, expresses anti-Mycobacterium abscessus activity","A. Li|S. He|B. Li|H. Chu"
"2550","13/04 12:00","27","P0615","Ulrich EIGNER","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of the clinical performance of an enzyme-linked immunosorbent assay and an immunochromatographic lateral flow assay for the detection of Mycobacterium tuberculosis infection in human plasma samples","C. Eckel|J. Köffer|U. Betz|U. Eigner"
"2615","13/04 12:00","28","P0616","Sara BATISTA ARNAU","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Study of the antimicrobial and antibiofilm activity of eugenol, gallic acid and ellagic acid in Mycobacterium avium complex clinical isolates","S. Batista|m. Fernandez-Pittol|L. San Nicolás|D. Matinez|G. Tudo|J. González-Martin|E. Garcia Losilla|M. Espasa|S. Narváez"
"2654","13/04 12:00","29","P0617","Sheri M SALEEB","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Accelerated and refined genomic analysis, coupled with epidemiological interventions, to optimise tuberculosis transmission control","S. M. Saleeb|S. Buenestado-Serrano|M. Martinez-Lirola|S. Vallejo-Godoy|F. Escabias-Machuca|M. Herranz|M. Lopez-Llaria|T. Cabezas Fernández|G. Bernal|L. Wang|P. Munoz|B. Santiago|L. Pérez-Lago|D. Garcia De Viedma|P. Barroso-Garcia"
"2697","13/04 12:00","30","P0618","Anat ARBEL","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Treatment outcomes in Mycobacterium simiae pulmonary disease: a retrospective multicentre cohort study","A. Arbel|R. Najjar-Debbiny|R. Cohen|R. Abu Riya|M. Dekel|A. Adler|I. Fuchs|F. Frost|Y. Maor|S. Perl|G. Rahav|M. Shteinberg"
"2781","13/04 12:00","31","P0619","Tim DOYLE","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","The microbiological and clinical complexity of infections in patients with treatment-refractory Mycobacterium avium complex lung disease","T. Doyle|J. Doyle|T. Keepers-White|S. Prior|M. Castanheira"
"3141","13/04 12:00","32","P0620","Edoardo SCARPA","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Chronic mycobacteria infection triggers macrophage senescence","E. Scarpa|D. Oliveri|G. Moschetti|A. Griego|A. Vianello|D. Rondelli|B. Antinori|N. Lorè|D. Cirillo|L. Rizzello"
"3192","13/04 12:00","33","P0621","Florah WETENDE","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Investigation into comorbidities and mortality in clinically diagnosed tuberculosis patients in Kilifi county, Kenya","F. Wetende|O. Abdullahi|S. Masha|M. Ngari|P. Ingosi|D. Saga"
"3336","13/04 12:00","34","P0622","Andreas ARNHOLDT PEDERSEN","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Species-specific mortality and causes of death in patients with the most common nontuberculous mycobacterial pulmonary isolates in Denmark, 1991-2018","A. Pedersen|V. Dahl|T. Lillebaek|C. Wejse|A. Andersen|R. Ibsen|A. Fløe|A. Løkke|O. Hilberg|I. Johansen"
"3340","13/04 12:00","35","P0623","Nalan SÜRÜCÜOGLU","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","The evaluation of cross-resistance to rifabutin and accompanying mutations by DNA sequence analysis in rifampicin-resistant Mycobacterium tuberculosis complex strains","N. Surucuoglu|S. Surucuoglu|N. Ozkutuk"
"3401","13/04 12:00","36","P0624","Dan ZHOU","2","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of four matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry systems for identification of non-tuberculous Mycobacteria","Y. Xiao|D. Zhou"
"3415","13/04 12:00","1","P0625","Shima MAHMOUDI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","In silico analysis of phase-specific antigens for the diagnosis and progression prediction of tuberculosis","S. Mahmoudi|S. Ali Khan|A. Gora"
"3429","13/04 12:00","2","P0626","Gabriel S. OLIVEIRA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Using QSAR models to refine antimicrobial peptides against Mycobacterium abscessus","G. Oliveira|M. Gomes|S. Sousa|T. Silva"
"3490","13/04 12:00","3","P0627","Thanakorn VONGJARUDECH","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Relative bioavailability of rifapentine and isoniazid when crushed in adults with tuberculosis infection: RPT CRUSH","T. Vongjarudech|S. Janssen|M. Karlsson|C. Upton|A. Garcia-Prats|A. Diacon|T. Sachs|N. Salazar-Austin|A. Hesseling|E. Svensson"
"3534","13/04 12:00","4","P0628","Diego RONDELLI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Precision medicine in tuberculosis: utilising photoactivatable bedaquiline for controlled therapy","D. Rondelli|A. Griego|S. Muzzioli|E. Armano|A. Giraudo|B. Antinori|G. Moschetti|E. Scarpa|A. Spitaleri|L. Rizzello|M. Pallavicini|C. Bolchi"
"3576","13/04 12:00","5","P0629","Johanna ÅHSBERG","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of the diagnostic accuracy of the Xpert MTB/RIF ultra assay for detecting Mycobacterium tuberculosis complex in routine samples in Denmark, 2020-2023","J. Ahsberg|D. Bek Folkvardsen|E. Svensson|T. Lillebaek"
"3677","13/04 12:00","6","P0630","Manoj MANDAL","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Chitosan-particle-based cystatin F RNA silencing as a therapeutic strategy to improve the control of intracellular Mycobacterium tuberculosis","M. Mandal|D. Pires|A. Matos|H. Florindo|E. Anes"
"3715","13/04 12:00","7","P0631","Vera RIBEIRO","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","A comparative study of Mycobacteria species identification with immunoblot (subjective method) and liquidArray (automatic identification)","V. Ribeiro|M. Martins|A. Silva|A. Ferreira|E. Costa"
"3840","13/04 12:00","8","P0632","Giorgia MOSCHETTI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mechanisms of immune evasion by Mycobacterium abscessus in human primary macrophages","G. Moschetti|G. Morales-Artavia|L. Calo|D. Oliveri|I. Muzzolini|B. Antinori|A. Griego|M. Albanese|S. Abrignani|J. Geginat|E. Scarpa|L. Rizzello"
"3856","13/04 12:00","9","P0633","Alice NAVA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Comparison between two different sequencing platform for whole-genome sequencing of Mycobacterium tuberculosis complex","A. Coviello|A. Nava|E. Franchetti|A. Corbetta|S. Mari|S. De Giorgi|S. Renica|S. Torri|C. Vismara|D. Fanti"
"3943","13/04 12:00","10","P0634","Alice NAVA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mycobacterium tuberculosis complex genotipic resistance: targeted next generation sequence vs whole-genome sequence","F. Borreca|F. Stasi|S. Mari|N. Lo Re|E. Mancinelli|S. Torri|S. De Giorgi|A. Nava|C. Vismara|D. Fanti"
"3984","13/04 12:00","11","P0635","Adrián SÁNCHEZ-MONTALVÁ","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Preliminary results from Phase 2b multicentre, randomised, open clinical trial in people with drug susceptible pulmonary tuberculosis using optimised dose rifampicin, optimised dose moxifloxacin and linezolid (RML TB trial)","E. Juan|T. Maria Teresa|C. Xavier|M. Joan Pau|P. Virginia|N. Enrique|G. Jesús|D. Alberto|G. Veronica|M. Marta|R. Ramon|A. Luis|S. Francisco|A. Maria Luisa|M. Joan|S. Núria|S. Adrián"
"3994","13/04 12:00","12","P0636","Van-Dong NGUYEN","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Clofazimine vs rifamycin in treating Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis","V. Nguyen|J. Dai|M. Lee|C. Lee"
"3997","13/04 12:00","13","P0637","Dennis MUJUNI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Drug resistance and genotypic profiling of Mycobacterium tuberculosis strains in Uganda","D. Mujuni"
"4008","13/04 12:00","14","P0638","Katarzyna KANIA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Comparative analysis of molecular and culture-based methods for detection and drug resistance assessment of Mycobacterium tuberculosis in extrapulmonary specimens","K. Kania|K. Wojcik|K. Drozdz|K. Klesiewicz"
"4037","13/04 12:00","15","P0639","Stavroula ANTONOPOULOU","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Trends in isolation frequency of nontuberculous mycobacteria at the national reference laboratory of Mycobacteria, in Athens, Greece, 2015-2023","M. Giannakaki|S. Antonopoulou|P. Rodopoulou|P. Lagiou|D. Paraskevis|P. Ioannidis|D. Papaventsis|A. Mavrommati|S. Karabela"
"4186","13/04 12:00","16","P0640","Bettina SCHULTHESS","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Characterisation of clinical Mycobacterium kansasii complex isolates in routine diagnostics","J. Caro|F. Kaelin|B. Schulthess|T. Roloff|P. Sander"
"4253","13/04 12:00","17","P0641","Aidan BAKER JOHAL","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Leprosy is evading eradication: epidemiology and pathogenesis in 2024","A. Baker Johal"
"4336","13/04 12:00","18","P0642","Sandra RAJME","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Extrapulmonary and disseminated tuberculosis in non-immunocompromised patients: a retrospective cohort study","S. Rajme-Lopez|B. Aceves-Sánchez|S. Guadarrama-Torres|L. González-Vázquez|O. Lazcano-Delgadillo|R. Nares-Lopez|Z. Segura-Ortiz|K. Tepo-Ponce|B. Chávez-Mazari|M. González-Lara|A. Ponce-De-Leon"
"4354","13/04 12:00","19","P0643","Laura Anne HUGHES","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Disseminated pneumonia associated with achalasia and a Mycobacterium fortuitum group species: phylogenetic characterisation and ESX-complex analysis","L. Hughes|L. Gard|M. Fliss|E. Bathoorn"
"4497","13/04 12:00","20","P0644","Drieda ZACE","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Characteristics of tuberculosis in migrants and native population: a retrospective study in an Italian hospital","L. Coppola|M. Compagno|L. Campogiani|M. Iannetta|L. Sarmati|D. Zaçe|B. Rossi|G. Alessio|A. Cekrezi|G. Muratore|L. Alborghetti"
"4600","13/04 12:00","21","P0645","Brenda ACEVES SÁNCHEZ","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Non-tuberculous mycobacterial skin and soft tissue infections following cosmetic procedures: a multicentric cohort","B. Aceves-Sánchez|S. Rajme-Lopez|J. Hernández-Carlsen|L. Arizmendi-Ocampo|L. Cano-Aguilar|L. Lopez-Jimenez|O. Munoz-Morales|B. Chávez-Mazari|M. González-Lara|J. Bobadilla-Del-Valle|D. Aguilar-Zapata|A. Macias-Hernandez|A. Ponce-De-Leon"
"4629","13/04 12:00","22","P0646","Joana BATISTA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Tuberculous meningitis: a ten-year retrospective study regarding treatment and outcomes","J. Batista|M. Alves|J. Oliveira|P. Pacheco"
"4710","13/04 12:00","23","P0647","Peize ZHANG","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Contezolid in tuberculosis therapy: a retrospective analysis of real-world practice in China","K. Pang|X. Li|L. Yang|Y. Wang|H. Qin|Y. Wu|P. Zhang"
"4789","13/04 12:00","24","P0648","Jae Hyeon PARK","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Increasing non-tuberculous mycobacteria recovery rate and regional difference of mycobacterial species over 11 Years in a Korean tertiary care hospital","J. Park|J. Lee|M. Seong|T. Kim"
"4868","13/04 12:00","25","P0649","Anushika SONI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of rifampicin resistance burden in pulmonary and extrapulmonary tuberculosis at a paediatric tertiary care facility in northern India","A. Soni|S. Nandwani|A. Hazarika|N. Perween|D. Singh"
"4894","13/04 12:00","26","P0650","Sidhartha GIRI","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Seasonality of tuberculosis at a capital city in eastern India during 2016 to 2024","S. Giri|S. Rout|S. Kumar|T. Mohanty|J. Turuk|S. Pati"
"4916","13/04 12:00","27","P0651","Bettina SCHULTHESS","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Impact of the new WHO critical concentration for rifampicin for diagnosis of rifampicin resistance of Mycobacterium tuberculosis in a low TB prevalence area","R. Steiger|P. Sander|B. Schulthess|F. Kaelin|T. Roloff"
"4933","13/04 12:00","28","P0652","Tao CHEN","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","In vitro drug susceptibility of rifampicin-resistant and rifampicin-susceptible Mycobacterium tuberculosis in Shanghai, China","J. Li|T. Chen|H. Zhang|C. Yu|L. Wang|Y. Zhang|Y. Jiang|X. Shen"
"4969","13/04 12:00","29","P0653","Rong BAO","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Species identification and antimicrobial susceptibility of Mycobacterium abscessus complex clinical isolates from a general hospital","W. Guo|R. Bao|Y. Chen|J. Shen|B. Hu"
"4977","13/04 12:00","30","P0654","Himanshi KHERA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","A study to evaluate the efficacy, safety, pharmacokinetics-pharmacodynamics of bedaquiline based regimen in multibacillary leprosy not responding to WHO-multidrug therapy (WHO-MDT)","H. Khera|T. Narang|S. Chhabra|S. Malhotra|V. Kumar|A. Khan|K. Sahay|V. Suri|S. Dogra|N. Shafiq"
"4990","13/04 12:00","31","P0655","Wenjuan NIE","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Distribution of contezolid concentrations at lesion sites in bone and joint tuberculosis patients","W. Nie|N. Chu"
"4996","13/04 12:00","32","P0656","Diksha CHHABRA","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Screening of Mycobacterium tuberculosis in medicolegal autopsy cases in a tertiary care centre in central India","D. Chhabra|A. Arora|K. Maurya|U. Khurana"
"5005","13/04 12:00","33","P0657","Yumeng YAO","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Microbiological and clinical characteristics of extrapulmonary nontuberculous mycobacterial disease in a Chinese general hospital, a ten-year retrospective study","Y. Yao|R. Bao|J. Pan|M. Wang|H. Mi|Q. Miao|C. Zhou|B. Hu|Y. Chen"
"5033","13/04 12:00","34","P0658","Saskia JANSSEN-LE ROUX","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Non-tuberculous mycobacterial disease at a tertiary care centre in high tuberculosis and HIV burden setting: a retrospective study","S. Janssen|Z. Ismail|T. Lovelock|S. Hugo|M. Van Schalkwijk|A. Parker|B. Allwood|C. Koegelenberg|J. Van Ingen|A. Van Laarhoven|T. Mabuka|H. Prozesky|J. Taljaard"
"5082","13/04 12:00","35","P0659","Martina DI GIUSEPPE","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","CXCL-9 and CXCL-10 as potential biomarkers for tuberculosis severity in children","M. Di Giuseppe|S. Chiurchiù|L. Cursi|G. Prencipe|L. Romani|M. De Luca|C. Tripiciano|S. Mercadante|G. Lorenzetti|L. Lancella|V. Francesco|F. Calo Carducci"
"5098","13/04 12:00","36","P0660","Marianne ANTAR","3","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mapping tuberculosis diversity in Lebanon: a pioneering baseline study using whole genome sequencing","J. Najjar|M. Antar|Z. Awad|K. La|N. Godron|C. Allam|F. Mougari|M. Abifadel|H. Yaacoub|L. Raskine|C. Sola|E. Cambau"
"5210","13/04 12:00","1","P0661","Sidhartha GIRI","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Pulmonary and extrapulmonary tuberculosis at an urban setting in eastern India during 2016 to 2023","S. Giri|S. Rout|S. Kumar|T. Mohanty|J. Turuk|S. Pati"
"5337","13/04 12:00","2","P0662","Alice AXINDER","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Time to positivity correlates with treatment initiation and disease severity in patients with Mycobacterium avium-complex in sputum culture","A. Axinder|T. Sunnerhagen|J. Walles"
"5373","13/04 12:00","3","P0663","Jeremy WESTHEAD","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Detection of cross-border M. tuberculosis clusters using an online cloud genetics processing platform","J. Westhead|R. Spies|M. Colpus|M. Brouard|T. Peto|D. Crook|R. Turner|P. Fowler"
"5527","13/04 12:00","4","P0664","Muhammad Asif SYED","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Predictors of multidrug-resistant tuberculosis in rural district of Pakistan: a case-control study, 2024","M. Syed"
"5571","13/04 12:00","5","P0665","Oguzhan ACET","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","The role of lipid biomarkers in inflammatory and mortality in tuberculosis patients","O. Acet|K. Bagir|M. Tasbakan|M. Tasbakan|T. Yamazhan|C. Cavusoglu"
"5615","13/04 12:00","6","P0666","Kusum SHARMA","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Defining drug resistance beyond rifampicin: evaluation of Xpert MTB/XDR assay directly from cerebrospinal fluid (CSF) samples in patients of tuberculous meningitis (TBM)","K. Sharma|A. Sharma|M. Modi|A. Sharma"
"5633","13/04 12:00","7","P0667","Ananya SHARMA","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of Mycobacterium tuberculosis derived cell-free DNA (CF-DNA) based multi-targeted real-time PCR (MRTPCR) from cerebrospinal fluid (CSF) samples for diagnosis of tuberculous meningitis (TBM)","K. Sharma|A. Sharma|M. Modi|A. Sharma"
"5645","13/04 12:00","8","P0668","Daragh MCGEE","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Initiation and completion of latent tuberculosis treatment in healthcare workers across two hospital sites in Ireland","D. Mcgee|C. Anderson|A. Hehir|L. Dolan|M. Coleman|N. Noonan|C. Fleming|C. Bergin|L. Townsend"
"5709","13/04 12:00","9","P0669","Chiara SEPULCRI","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Routine investigations for tuberculosis on bronchoalveolar fluid lavage in a low-incidence setting: is it worth it?","C. Sepulcri|R. Barbieri|L. Crupi|M. Bonaffini|E. Delfino|E. Tagliabue|A. Di Biagio|E. Barisione|A. Marchese|M. Bassetti"
"5716","13/04 12:00","10","P0670","Franziska Maria KANIS","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Performance of a novel dual marker RT-qPCR-based whole-blood test for improved detection of M. tuberculosis infection","J. Meier|S. Möbus|F. Heigl|L. Deml|F. Kanis|S. Barabas|H. Niller|K. Avsar|M. Heiss-Neumann|D. Teschner|S. Blaas|E. Soutschek"
"5743","13/04 12:00","11","P0671","Raja IDRIS","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Preliminary results from Europe-wide survey “EURO-SURVERY TB” on adjunctive surgical treatment of pulmonary tuberculosis","R. Idris|A. Bertani|L. Guglielmetti|S. Tunesi|N. Wetzstein"
"5758","13/04 12:00","13","P0673","Henar ALONSO-EZCURRA","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Unmasking hidden coinfections: a breakthrough real-time PCR approach for detecting and differentiating tuberculosis and Mycobacterial strains","E. Teresa|E. Rodrigo|C. Escolar|H. Alonso"
"5792","13/04 12:00","14","P0674","Marc GORDO-BASTÉ","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of trace result from Xpert MTB/RIF ultra in a low-burden tuberculosis area","S. Pérez-Recio|N. Sabé Fernández|V. Pomar|M. Garrigo|M. Gordo-Basté|C. Medina|E. Garcia-Losilla|Y. González-Atencia|L. Fernández-Delgado|F. Alcaide"
"5812","13/04 12:00","15","P0675","Adlard ADLARD","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Improved prediction of bedaquiline resistance from genetic data using automatically-built catalogues","D. Adlard|J. Knaggs|T. Peto|D. Crook|S. Omar|P. Fowler"
"5823","13/04 12:00","16","P0676","Taniela MARLI BES","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Efficacy of rifapentine plus moxifloxacin vs standard of care for pulmonary tuberculosis: a systematic review and meta-analysis","C. Rocha Dantas|T. Areas Lisboa Netto|B. Dellatorre Diniz|M. Fonseca Loureiro Caldeira De Freitas|P. Odutola|T. Marli Bes"
"5864","13/04 12:00","17","P0677","Sandra PÉREZ-RECIO","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Secular trends in clinical features and outcomes of peritoneal tuberculosis","S. Pérez-Recio|E. Noguera-Gras|M. Santin|M. Grijota-Camino|N. Sabé Fernández"
"5866","13/04 12:00","18","P0678","Rym ABID","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Extrapulmonary tuberculosis: still a persistent issue!","R. Abid|S. Hannachi|Z. Denden|R. Battikh"
"6168","13/04 12:00","19","P0679","Elisa PETRUCCIOLI","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Modulation of RISK-3 signature in patients at different tuberculosis (TB) stages enrolled in a low-TB endemic country","E. Petruccioli|T. Alonzi|A. Altera|F. Repele|G. Cuzzi|G. Gualano|F. Palmieri|D. Goletti"
"6226","13/04 12:00","20","P0680","Francesca CATANIA","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Comparison of high-frequency ultrasound and contrast computed tomography for detection of spleen micro-abscesses in disseminated mycobacterial infections","F. Taccari|G. Cicchetti|F. Catania|I. Friscia|T. Heller|T. Kumwenda|C. Wallrauch|I. Palucci|M. Sali|E. Visconti|G. Scoppettuolo|A. Cingolani|S. Di Giambenedetto|G. Baldin|E. Tamburrini|P. Del Giacomo|R. Murri|C. Torti"
"6233","13/04 12:00","21","P0681","Sara CALDRER","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Non-tuberculous and tuberculous Mycobacteria prevalence and drug resistance in Italian and foreign subjects","S. Caldrer|E. Pomari|A. Carrara|A. Ragusa|L. Nicolini|P. Rodari|A. Angheben|F. Perandin|F. Gobbi"
"6355","13/04 12:00","22","P0682","Sara MAGALHÃES","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Diagnostic utility of blood cultures and myelocultures for non-tuberculous mycobacteria infections: a retrospective study in a Portuguese tertiary hospital","S. Magalhaes|V. Mendes|R. Pinto|C. Gonçalves|J. Novoa|S. Betkova|S. Lino|H. Choon|M. Manata|F. Maltez"
"6450","13/04 12:00","23","P0683","Luca ROSSI","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Crossroads of care: TB trends among Italians and migrants in a tertiary hospital in northern Italy","B. Rossi|A. Franzelli|L. Rossi|G. Maifredi|M. Gulletta|A. Matteelli"
"6468","13/04 12:00","24","P0684","Yumeng YAO","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Clinical significance of nontuberculous mycobacteria isolates in a Chinese general hospital","Y. Yao|R. Bao|J. Pan|X. Gao|W. Jin|Y. Ma|B. Hu"
"6478","13/04 12:00","25","P0685","Arthur LEMSON","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluating the performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease","A. Lemson|E. Van De Pol|J. Van Ingen|W. Hoefsloot"
"6513","13/04 12:00","26","P0686","Arthur LEMSON","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?","A. Lemson|E. Van De Pol|J. Van Ingen|W. Hoefsloot"
"6546","13/04 12:00","27","P0687","Ronald OLUM","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Tuberculosis infection progression among pregnant women with HIV at high risk of tuberculosis: a sentinel screening study at three Ugandan health facilities","R. Olum|D. Sitende|P. Ssekamate|D. Kibirige|A. Kyazze|A. Tugume|F. Bongomin|J. Baluku|S. Cose|I. Andia-Biraro"
"6602","13/04 12:00","28","P0688","Awilly CHOFLE","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Management of mycobacterial infections: experience with amikacin use in OPAT at NHS GGC","A. Chofle|C. Summerhill|R. Seaton"
"6703","13/04 12:00","29","P0689","Theo FOUCHET","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of clinical performances of the PATHFAST TB Lam Ag assay, a new diagnostic test for tuberculosis","T. Fouchet|F. Mougari|Z. Awad|C. Allam|A. Hartmann|M. Rochelet|E. Cambau"
"6714","13/04 12:00","30","P0690","Olivier BAHUAUD","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Early acquisition of long-term memory and decline of cytotoxic CD8+ T-cells subpopulations in blood as biomarkers of tuberculosis treatment efficacy in human","O. Bahuaud|R. Bayaa|T. Andrieu|C. Genestet|E. Hodille|J. Hoffmann|O. Dumitrescu|F. Ader"
"6785","13/04 12:00","32","P0692","Ole SKOUVIG PEDERSEN","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Predicting development of tuberculosis disease by stratifying T-SPOT.TB results: a retrospective cohort study of diagnostic accuracy among 8,544 individuals","O. Skouvig Pedersen|S. Sperling|A. Koch|T. Lillebaek|V. Dahl|A. Fløe"
"6804","13/04 12:00","34","P0694","Sarah ALAM","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Assessment of demographic characteristics, clinical profiles, laboratory findings, and outcome of CNS tuberculosis among paediatric patients in a tertiary care hospital in Bangladesh","S. Alam|Y. Chowdhury|S. Sumi|M. Yusuf|A. Moureen"
"6851","13/04 12:00","35","P0695","Vijeta PATIAL","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of Truenat drug chips directly from clinical samples for detection of XDR, pre-XDR, and MDR in patients of extrapulmonary tuberculosis(EPTB) from north India","V. Patial|K. Sharma|A. Sharma|M. Modi"
"6937","13/04 12:00","36","P0696","Kathya SUASTE","4","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Epidemiological profile and clinical presentation of cutaneous tuberculosis: systematic review","K. Suaste|J. Acosta|A. Cruz|A. Gomez"
"6940","13/04 12:00","1","P0697","Ingrid VAN WEERDENBURG","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","No evidence of nation-specific ecotypes for Mycobacterium avium in Northern Europe","I. Van Weerdenburg|V. Dahl|A. Norman|P. Koopman|J. Van Ingen|T. Lillebaek"
"6982","13/04 12:00","2","P0698","Marina TADOLINI","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Asymptomatic tuberculosis: a new challenge","M. Tadolini|B. Granozzi|F. Bisognin|M. Zagarrigo|M. Giacomini|P. Dal Monte"
"7025","13/04 12:00","3","P0699","Emmanuel LAFONT","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration for bladder cancer: a decade nationwide French study","T. Guilhou|A. Lillo Lelouet|F. Schlemmer|M. Reveillon|F. Audenet|A. Le Breton|C. Verdet|C. Charlier|E. Canoui|D. Malandain|F. Roborel de Climens|M. Dubert|C. Chollet|A. Masson Lecomte|Y. Neuzillet|L. Chouchana|E. Ewig|E. Lafont|L. Levi"
"7033","13/04 12:00","4","P0700","Marina TADOLINI","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Inpatient versus outpatient pulmonary tuberculosis management in Italy: a nationwide survey","C. Monari|L. Saderi|N. Riccardi|A. Pontarelli|D. Buonsenso|E. Falbo|F. Saluzzo|E. Pontali|J. Mencarini|M. Trezzi|A. Calcagno|G. Besozzi|L. Codecasa|M. Tadolini"
"7042","13/04 12:00","5","P0701","Héctor MORENO","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Rapid detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis using the Xpert MTB/XDR assay in a low TB and low MDR-TB prevalence setting","H. Moreno|G. Gonzalez|C. Von Garnier|J. Mazza Stalder|G. Greub|O. Opota"
"7070","13/04 12:00","6","P0702","Alejandra ARENAS","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Increased isolation of Mycobacterium lentiflavum along the years: is it the new Mycobacterium avium?","A. Arenas Martinez-Armero|P. Gomez|E. Lozano Vilches|D. Mistek|L. Cardenoso Domingo|D. Domingo"
"7139","13/04 12:00","7","P0703","Onya OPOTA","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","TBSure: survey of paediatric TB management practices in the Europe region","A. Uka|D. Podlekareva|D. Cirillo|L. Guglielmetti|P. Crisinel|O. Opota|F. Mechai"
"7188","13/04 12:00","9","P0705","Billie VELAPATIÑO","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Mycobacterium tuberculosis DNA detection in formalin-fixed paraffin-embedded tissue using digital PCR: a proof-of-concept study","B. Velapatino|K. Locher|C. Belanger|M. Charles"
"7211","13/04 12:00","10","P0706","Arjan VAN LAARHOVEN","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Adjuvant use of TNF-alpha antagonists for TB meningitis: RNA signalling and clinical experience","P. Widya Andini|S. Dian|K. Van Abeelen|E. Ardiansyah|R. Estiasari|K. Maharani|T. Setiabudiwan|D. Imran|A. Ganiem|A. Van Laarhoven|R. Van Crevel"
"7274","13/04 12:00","11","P0707","Anvita GUPTA MALHOTRA","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Comparative evaluation of Xpert, Xpert Ultra, and Truenat for the diagnosis of tuberculous meningitis in central India","A. Gupta Malhotra|J. Singh|L. Lokhande|S. Vishwakarma|P. Soni|A. Maurya|A. Khurana|A. Agrawal|S. Singh"
"7277","13/04 12:00","12","P0708","Akiko TAKAKI","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Evaluation of comprehensive drug resistance prediction using nanopore targeted NGS reagent with MDR-TB isolates in Japan","A. Takaki|K. Chikamatsu|Y. Igarashi|A. Aono|Y. Shimomura|M. Hosoya|Y. Morishige|K. Natsume|Y. Murase|S. Mitarai"
"7300","13/04 12:00","13","P0709","Xenia Emilie Sinding IVERSEN","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Epidemiology of non-tuberculous Mycobacteria in Denmark: seven decades of clinical occurrence","X. Iversen|A. Norman|D. Folkvardsen|E. Rasmussen|E. Svensson|L. Rigouts|C. Meehan|L. Jelsbak|T. Lillebaek"
"7309","13/04 12:00","14","P0710","Marianne ANTAR","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Clinical management of trace results in a rapid molecular TB diagnostic assay among presumptive cases in Lebanon, a low-TB burden country","M. Antar|S. Abou Ismail|A. Farhat|H. Yaacoub|L. Raskine|J. Najjar|M. Abifadel"
"7334","13/04 12:00","15","P0711",,"5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Assessment of in vitro efficacy of three-antibiotics combinations against Mycobacterium abscessus","J. Charles|L. Prouvensier|J. Clarhaut|S. Marchand|N. Gregoire|J. Buyck"
"7402","13/04 12:00","17","P0713","Andre DOI","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Molecular diagnosis of mycobacteria: identification of tuberculous and non-tuberculous species in 733 clinical samples","R. Ruiz|R. Petroni|A. Portello|C. Cazarini|R. Santana|D. Campos|M. Martino|A. Doi"
"7475","13/04 12:00","18","P0714","Federica SORELLA","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","A new multiplex real-time PCR test for the diagnosis of TB and NTM patients","F. Sorella|F. Bisognin|G. Germinario|V. Ferraro|P. Caiazza|P. Dal Monte|C. Crovara Pesce|T. Ferniani"
"7477","13/04 12:00","19","P0715","Olha KONSTANTYNOVSKA","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Delayed TB diagnostics and treatment in Ukraine due to the war and preceding COVID-19 epidemics","O. Konstantynovska|T. Liadova|S. Samchenko|P. Brännberg|T. Synenko|I. Molina|O. Volobuieva|O. Tolstopiatov|O. Rzhepishevska"
"7573","13/04 12:00","21","P0717","Julie CHARLES","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Assessment of in vitro efficacy of three-antibiotics combinations against Mycobacterium abscessus","J. Charles|L. Prouvensier|J. Clarhaut|S. Marchand|N. Gregoire|J. Buyck"
"7591","13/04 12:00","22","P0718","Hanen BEN HMIDA","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Hepatic adverse reactions in anti-tuberculosis treatment","H. Ben Hmida|A. Bouabdallah|R. Sallami|H. Ghorbel|L. Zrelli|H. Azzouzi|M. Gargouri"
"7659","13/04 12:00","23","P0719","Susan Shin-Jung LEE","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Safety and efficacy of four-month short course regimen in low risk active tuberculosis-a multicentre randomised controlled trial","J. Feng|C. Shu|S. Lin|C. Sheu|C. Liu|S. Lee"
"7671","13/04 12:00","24","P0720","Fang XU","5","A","02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Identification of differentially expressed transcriptional profiling from active tuberculosis infection to healthy children","F. Xu|L. Su"
"402","13/04 12:00","25","P0721","Tiara Joy FOO","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Risk factors for mortality in Elizabethkingia spp. bloodstream infections","M. Koh|T. Foo|K. Chew|L. Lum|N. Smitasin|D. Allen|J. Ngiam"
"404","13/04 12:00","26","P0722","Ka Lip CHEW","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Levofloxacin minimum inhibitory concentration greater than 2 mg/L correlates with adverse outcomes in levofloxacin-treated patients with Stenotrophomonas maltophilia bacteraemia","M. Koh|J. Ngiam|L. Lum|N. Smitasin|D. Allen|K. Chew"
"591","13/04 12:00","27","P0723","Dimitrios KOUROUPIS","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Pancreatic stone protein levels accurately predict severity in sepsis of various causes earlier than other biomarkers","D. Kouroupis|C. Zarras|T. Koufakis|M. Terzaki|P. Pateinakis|A. Halvantzis|K. Mpani|A. Issa|P. Soukiouroglou|A. Sarvani|A. Pyrpasopoulou|M. Doumas|E. Vagdatli"
"631","13/04 12:00","28","P0724","Juliana BECKER","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Infective endocarditis: clinical profile and prognosis of patients admitted to a university hospital in San Paulo, Brazil","V. Ambrosio Moises|D. Barbosa|J. Barros Becker"
"688","13/04 12:00","29","P0725","Yusuke WATANABE","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The clinical characteristics and prognosis of Staphylococcus argenteus bacteraemia as analysed by massively parallel sequencing in Japan","Y. Watanabe|Y. Miura|K. Komori|T. Yamaguchi|I. Nakamura"
"690","13/04 12:00","30","P0726","Lulu GONG","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The impact of rapid microbiology identification report and dual AST cards on the antibiotic therapy and economics of hospitalised bloodstream infection patients","Y. Jinxi|L. Jin|X. Yijun|Y. Shuangshuang|L. Jing|L. Tao|X. Ning|Z. Hong|G. Stanley"
"800","13/04 12:00","31","P0727","Dang Hai PHAM","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Predictive utility of the lactate-to-albumin ratio in 28-day mortality among septic shock patients in Vietnam","H. Pham Dang"
"912","13/04 12:00","32","P0728","Miguel Ángel VERDEJO GÓMEZ","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Alpha-toxin production by Staphylococcus aureus is not associated with thrombocytopenia or clinical outcome in bacteremic patients","M. Verdejo|D. Malano-Barletta|J. Boán|K. Galevski|M. Mozaffari|C. Pitart|M. Espasa|L. Morata|A. Soriano|A. Kaasch"
"915","13/04 12:00","33","P0729","Theevasha GOVENDER","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Comparative genomics between Staphylococcus aureus isolates from patients with bacteraemia and infective endocarditis from public hospitals in Gauteng","L. Spaltman|T. Hamiwe|T. Govender|V. Ueckermann|A. Bosch|M. Ehlers"
"938","13/04 12:00","34","P0730","Amelia ANDREWS","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Association of individual-level amoxicillin prescribing in primary care on Escherichia coli bacteraemia in older adults in England, 2018-2021","A. Andrews|S. Gerver|B. Muller-Pebody|R. Hope|S. Hopkins|S. Walker"
"1068","13/04 12:00","36","P0732","Torgny SUNNERHAGEN","5","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Bloodstream infection with Aerococcus vs Escherichia and Enterococcus: does species matter?","J. Walles|M. Inghammar|S. Skovbjerg|B. Nilson|B. Herrmann|M. Sundqvist|M. Rasmussen|T. Sunnerhagen"
"1093","13/04 12:00","1","P0733","Biniyam Tedla MAMO","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Gram-negative sepsis, antimicrobial drug susceptibility, and treatment outcomes at two NICU in Addis Ababa, Ethiopia","B. Mamo|Z. Bonger|F. Senbato|T. Eguale|K. Akililu|S. Welelaw|E. Zeleke|A. Demtse|T. Assefa|R. Yirgu|Z. Mekuria|J. Balada-Llasat|S. Wang"
"1141","13/04 12:00","2","P0734","Vettakkara Kandy Muhammed NIYAS","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Antimicrobial resistance genes profile and 28-day mortality in Enterobacterales bacteraemia: a retrospective study from a tertiary care centre in Kerala, India","S. Syamaladevi Amma|V. Niyas|R. Ananthanarayanan"
"1154","13/04 12:00","3","P0735","Agnes MEYBECK","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Impact of duration of antibiotic treatment for ESBL-producing Enterobacteriaceae bacteraemia in critically patients on in-ICU mortality: a French multicentric retrospective observational cohort","C. Le Berre|M. Houard|M. Degrendel|L. Benetazzo|A. Vachee|H. Georges|F. Wallet|P. Patoz|P. Bortolotti|S. Nseir|P. Delannoy|A. Meybeck"
"1196","13/04 12:00","4","P0736","Jingxing XIE","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The clinical and economic effects of rapid antimicrobial susceptibility testing report and the dual susceptibility cards on adult ICU patients with bloodstream infection","Y. Feng|Y. Xu|K. Shao|L. Xu|C. Shi|P. Ma|S. Gong|R. Xie"
"1251","13/04 12:00","5","P0737","Sean Wei Xiang ONG","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","BALANCE+ platform trial for Gram-negative bloodstream infections: vanguard phase","N. Daneman|J. Johnstone|T. Lee|D. Macfadden|E. Mcdonald|S. Morpeth|S. Ong|D. Paterson|R. Pinto|A. Rishu|B. Rogers|D. Yahav|B. Coburn|P. Daley|P. Das|K. Fiest|A. Findlater|M. Fralick|C. Kandel|J. Powis|R. Somayaji|R. Fowler"
"1276","13/04 12:00","6","P0738","Marta HERNÁNDEZ-MENESES","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Delphi consensus document on treatment and follow-up of vascular graft/endograft infection","I. Kouijzer|M. Hernández-Meneses|L. Rezzonico|F. Olearo|A. Raglio|A. Ravindra|A. Russo|E. Giannitsioti|M. Papadimitriou-Olivgeris|B. Hasse"
"1297","13/04 12:00","7","P0739","Andrea MAZZELLA","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Trends in bloodstream infections in critical care: incidence, antimicrobial resistance and mortality (English national surveillance, 2017-2023)","A. Mazzella|O. Conroy|H. Choi|J. Elmes|M. Wilson|D. Chudasama|S. Gerver|M. Mihalkova|A. Rhodes|P. Wilson|N. Brown|J. Islam|R. Hope"
"1407","13/04 12:00","8","P0740","Yongseop LEE","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Incidence, outcomes and risk factors for mortality of patients with sepsis in Korea: a nationwide cohort study","Y. Lee|D. Lee|J. Seong|J. Lee|J. Kim|J. Ahn|S. Jeong|J. Choi|H. Choi|N. Ku"
"1409","13/04 12:00","9","P0741","Alfred Lok Hang LEE","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The genotypic and phenotypic continuum of hypervirulence in Klebsiella pneumoniae invasive infection in an endemic region","A. Lee|C. Li|P. Yip|W. Lee|L. Ho|M. Ip"
"1410","13/04 12:00","10","P0742","Qixia LUO","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China: population superseding and toxification","Q. Luo|P. Lu|M. Chang|H. Zhu|Y. Xiao"
"1422","13/04 12:00","11","P0743","Sowmya PR","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Genomic diversity of bloodstream infections caused by typhoidal and non-typhoidal Salmonella enterica serovars in India","S. Pr|V. Shamanna|G. Nagaraj|R. Kl"
"1431","13/04 12:00","12","P0744","Shun KOSAKA","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Overuse of blood cultures and its associated factors: a single-centre retrospective study","S. Kosaka|K. Okamoto|K. Imada|Y. Tagashira|N. Sekiya|K. Takahashi|Y. Gu"
"1500","13/04 12:00","13","P0745","Tsung-Hua WU","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Emergence, adaptation and genomic insights into human variant of methicillin-resistant Staphylococcus aureus clonal complex 398 in Taiwan","T. Wu|Y. Wu|Y. Fang|C. Lee|Y. Chen"
"1613","13/04 12:00","14","P0746","Arneet ARORA","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Point-of-care testing of procalcitonin serum level: a rapid approach to diagnose sepsis post mortem","A. Arora|A. Chandran|S. Khadanga"
"1661","13/04 12:00","15","P0747","Harshitha GK","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The resistance phenotype and molecular epidemiology of Klebsiella pneumoniae causing bloodstream infections in Indian population: a multicentric retrospective study","H. Gk"
"1676","13/04 12:00","16","P0748","Rhoda Cheuk-Ying LEUNG","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Utilising rapid next generation metagenomic sequencing for pathogen identification and antimicrobial resistance characterisation in bloodstream infections: a preliminary study","R. Leung|A. Chu|W. Chan|F. Pak|B. Chan|K. To"
"1833","13/04 12:00","17","P0749","Huseyin BILGIN","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Positron emission tomography/computed tomography utilisation in infective endocarditis: a retrospective audit","H. Bilgin|S. Duckett|F. Yazdani"
"1853","13/04 12:00","18","P0750","Myo Maung Maung SWE","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Evaluating the impact of delayed concordant empirical antibiotics treatment on 30-day mortality in patients with Enterobacterales bloodstream infection in low- and middle-income country settings","M. Swe|A. Aiken|M. Sharland|B. Cooper|C. Lim"
"1884","13/04 12:00","19","P0751","Mario KAROLYI","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Linezolid vs high dose daptomycin for the treatment of vancomycin-susceptible Enterococcus faecium blood stream infections: a retrospective observational study","M. Karolyi|A. Karsten|D. Stahl|E. Pawelka|S. Omid|A. Kuran|M. Naegeli|T. Seitz|C. Wenisch|A. Zoufaly"
"1912","13/04 12:00","20","P0752","Roberta MONARDO","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A descriptive study of patients treated with monotherapy for Stenotrophomonas maltophilia bloodstream infections","R. Monardo|R. Shields|A. Yogo|I. Machuca|P. Ross|W. Walaiporn|D. Mokrani|K. Wolfe|D. Van Duin|J. Pogue|L. Hojat|M. Ripa|H. Henderson|T. Khuu|C. Gudiol|G. Tiseo|G. Rao|M. Mojica|R. Bonomo|M. Falcone"
"1917","13/04 12:00","21","P0753","Ali ALTHUBYANI","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Combination therapy vsmonotherapy for persistent MRSA bacteraemia: a retrospective cohort study","A. Althubyani|T. Morrisette|S. Magrath|T. Thomas|D. Holger"
"1985","13/04 12:00","23","P0755","Martha KESTLER HERNANDEZ","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Aging and infective endocarditis: outcomes and challenges in the elderly population","M. Kestler|G. Fajardo|C. Huerta|A. Burillo|P. Munoz|J. Serra|E. Bouza"
"1998","13/04 12:00","24","P0756","Suhail Hassan JALAL","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Artificial intelligence assisted management impact on clinical outcomes of sepsis in a tertiary care setting","S. Jalal|D. Sureshkumar|R. Murali|R. Dharan|S. Sathyanarayan"
"2012","13/04 12:00","25","P0757","Elisavet STAVROPOULOU","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Should antimicrobial treatment be initiated immediately after blood culture collection among all patients with suspicion of infective endocarditis?","E. Stavropoulou|N. Fourré|V. Zimmermann|N. Ianculescu|G. Tzimas|P. Tozzi|M. Kirsch|P. Monney|L. Senn|B. Guery|M. Papadimitriou-Olivgeris"
"2049","13/04 12:00","26","P0758","Connor PROSTY","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Cefazolin vs antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","C. Prosty|D. Noutsios|T. Lee|N. Daneman|J. Davis|E. Mcdonald|S. Tong|S. Ong"
"2061","13/04 12:00","27","P0759","Virgile ZIMMERMANN","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Evaluation of the NOVA and DENOVA scores and the different versions of Duke criteria for the diagnosis of infective endocarditis among patients with enterococcal bacteremia","V. Zimmermann|N. Fourré|N. Ianculescu|G. Tzimas|P. Tozzi|M. Kirsch|P. Monney|L. Senn|B. Guery|M. Papadimitriou-Olivgeris"
"2076","13/04 12:00","28","P0760","Cristiane LAMAS","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Repeat PET/CT in the follow up of unoperated patients with prosthetic valve endocarditis","C. Lamas|M. Philip|T. Runet|L. Tessonnier|M. Correia|S. Hubert|F. Arregle|J. Casalta|G. Habib|F. Gouriet"
"2149","13/04 12:00","29","P0761","Cinzia TAVANO","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Role of CBC positional parameters in defining sepsis and bacteremia","C. Tavano|A. Frigeri|S. Bianco|L. Pangaro|G. Caffiero|S. Daffara|L. Soattini|L. Cianci|P. Micaela"
"2231","13/04 12:00","30","P0762","Marek Stefan","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Severe invasive Streptococcus pyogenes infections in children and adults: are they the same?","M. Stefan|M. Brajerová|S. Prasad|E. Bébrová|J. Berousek|P. Pavlicek|J. Pozniak|S. Jarosciakova|O. Nyc|M. Trojánek|P. Drevinek|M. Krutova"
"2239","13/04 12:00","31","P0763","Sophie FOX","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Injecting drug use related septic thrombophlebitis: a retrospective review","S. Fox|C. Macleod|N. Rae|J. Nagy|S. Suttie"
"2260","13/04 12:00","32","P0764","Marwa ALLAM","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The antimicrobial resistance patterns and epidemiology of community onset bloodstream infections among children in Liverpool city region","M. Allam|M. Talamentes|E. Carrol|C. Parry"
"2266","13/04 12:00","33","P0765","Carlos KIFFER","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Bloodstream infections burden and trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden on public healthcare data, 2013-2022","É. Carmo|B. Franzon|A. Aquino|M. Otani|P. Charf|C. Wagner|A. Marinonio|A. Colombo|C. Kiffer"
"2269","13/04 12:00","34","P0766","José Miguel ORTEGA FUENZALIDA","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Microbiological profile of infective endocarditis episodes in two high-complexity hospitals in Chile, 2012-2022","J. Ortega Fuenzalida|M. Rau Moreno|D. Collao Torrealba|C. San Martin Ojeda|I. Ceron Araya|K. Villalobos Gallardo"
"2304","13/04 12:00","35","P0767","Genevieve MCKEW","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Dual beta-lactam synergy in Enterococcus faecalis infective endocarditis and its relationship with penicillin/ceftriaxone treatment outcomes","A. Gregson|S. Rizzo|J. Purani|E. Martinez|S. Mamoottil Sudeep|G. Coombs|S. Mowlaboccus|I. Sandaradura|G. Mckew"
"2317","13/04 12:00","36","P0768","Ummu Afeera ZAINULABID","6","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Correlation of pancreatic stone protein (PSP) with septic shock, SOFA, and APACHE scores: an emerging biomarker for disease severity","U. Zainulabid|N. Danapaul|N. Kori|C. Lau|B. Mat Nor|N. Ramly|K. Mansor|X. Cheong|M. Baharuddin|W. Meor Jamaludin|M. Ismail|M. Mohd Junit|M. Yuhana|R. Ramli|N. Kamarudin|P. Periyasamy|M. Mohd Ibrahim"
"2322","13/04 12:00","1","P0769","Kathryn WILKS","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The complexity of prescribing for sepsis: is it in the diagnosis of source of infection?","K. Wilks|D. Mason"
"2326","13/04 12:00","2","P0770","Christopher LAI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Infective endocarditis prediction score for non-pyogenes and non-pneumococcal streptococcal bacteremia","C. Lai Koon Chi|M. Chan|L. Lee|C. Lui|M. Ip"
"2366","13/04 12:00","3","P0771","Qi ZHAO","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Reporting MIC results within 48 hours reduced antibiotic use and costs for patients with bloodstream infection in the intensive care unit","Q. Zhao"
"2374","13/04 12:00","4","P0772","Jing Heng TOH","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","In vitro antibiotic combination testing-guided therapy vs standard care for the treatment of difficult-to-treat resistant pseudomonal infections","J. Teo|J. Toh|T. Lim|W. Lee|S. Chung|Y. Tan|A. Kwa"
"2392","13/04 12:00","5","P0773","Sylvain MEYLAN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","An AI-driven learning health system to improve sepsis quality of care","J. Despraz|R. Matusiak|S. Nektarijevic|V. Rossetti|R. Akrour|F. Bastardot|A. Junger|A. Konasch|E. Gauthiez|O. Pignolet|S. Pepe|I. Lehn|M. Roth|J. Chiche|D. Kaufmann|T. Calandra|J. Raisaro|S. Meylan"
"2417","13/04 12:00","6","P0774","Bryan TAN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Improved immunodeficiency detection in patients with invasive airway pathogens: a prospective cohort study","B. Tan|M. Metlapalli|M. Liu|D. Kotsanas|E. Smith|S. Ojaimi"
"2442","13/04 12:00","7","P0775","Samar AKBI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Is the early versus late-onset neonatal sepsis paradigm relevant in middle-income settings? An Algerian hospital experience","F. Henniche|F. Yamouni|D. Bensersa|N. Aggoune|A. Zerouki|S. Akbi"
"2459","13/04 12:00","8","P0776","Rita NG","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Epidemiology and risk factors for mortality of Escherichia coli bloodstream infections in Hong Kong","W. Ng|L. Yang|M. Ip"
"2648","13/04 12:00","9","P0777","Ping LU","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Epidemiology of Acinetobacter baumannii from bloodstream infections in China over the past decade","P. Lu|Q. Luo|M. Chang|H. Zhu|Y. Xiao"
"2741","13/04 12:00","10","P0778","Cristiane LAMAS","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A multicentre international study on Staphylococcus lugdunensis infective endocarditis","M. De La Chapelle|C. Selton-Suty|B. Hoen|M. Erpeldening|P. Tattevin|A. Le Bot|N. Fernandez-Hidalgo|M. Villa|C. Tribouilloy|E. Pluquet|V. Dubee|P. Danneels|M. Hannan|G. Dornikova|E. Durante-Mangoni|L. Bertolino|R. Siciliano|A. De Oliveira|M. Correia|F. Gouriet|C. Lamas|G. Habib|M. Philip|N. Issa|B. Lefèvre"
"2788","13/04 12:00","11","P0779","Leo HUANG","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Investigating the role of Streptococcus dysgalactiae bloodstream infections in Scotland, 2014-2023","L. Huang|A. Smith|C. Douglas|G. Pauparyte"
"2800","13/04 12:00","12","P0780","Elena RUBIO-MARTÍN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Bacteraemias of unknown origin: description and prognostic analysis","M. Mantecon Vallejo|A. Plata|P. Retamar-Gentil|I. Lopez-Hernandez|J. Rodriguez-Bano|A. Jordano Jiménez|L. Lopez-Cortes|P. Martinez Perez-Crespo|M. Perez-Rodriguez|A. Goikoetxea-Agirre|E. Rubio-Martin|E. Leon|J. Caston|A. Bahamonde Carrasco|M. Farinas"
"2887","13/04 12:00","13","P0781","Patricio FAVIER","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Gianella risk score in the carbapenemase´s jungle: performance in mix-carbapenemase setting ??????","P. Favier|C. Raffo|D. Torres|J. Sanz-Caballer|J. Peman-Garcia|P. Suárez-Urquiza|J. Lopez-Hontangas|E. González-Barberá"
"2924","13/04 12:00","14","P0782","Gavin DEAS","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Risk of endocarditis strongly relates to Streptococcal species and should influence management: focus on the 'small five'","G. Deas|T. Lee|P. Williams|F. Hamilton"
"3024","13/04 12:00","15","P0783","Erlinda R ULLOA","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Synergistic killing of methicillin-resistant Staphylococcus aureus with ceftaroline or vancomycin combined with carbapenems","W. Rose|G. Sakoulas|E. Ulloa|G. Pérez-Parra|A. Khetarpal|I. Alvarado|V. Nizet|A. Jankeel"
"3063","13/04 12:00","16","P0784","Sulagna BASU","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Type I CRISPR-Cas system in neonatal septicaemic Klebsiella pneumoniae: exploring the association with multidrug-resistant bacteria","A. Rao|D. Roy|S. Naha|T. Kazi|D. Ghosh|S. Basu"
"3064","13/04 12:00","17","P0785","Deepak KUMAR","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Utility of various clinical scores to predict infective endocarditis in patients with Staphylococcus aureus bacteraemia","D. Kumar|N. Kaur|T. Kanagiri|N. Tr|Y. Khatod|B. Kumar|D. Meena|N. Midha|R. Choudhary|V. Tak|G. Bohra"
"3100","13/04 12:00","18","P0786","Tsai-Wen WAN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Genomic population structure and adhesion-related virulence factors of invasive nontypeable Haemophilus influenzae isolates","T. Wan|Y. Huang|J. Lai|H. Chiu"
"3226","13/04 12:00","20","P0788","Miguel Angel CONSUEGRA PEREZ","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Risk of infective endocarditis in oncohaematological patients with Enterococcus faecalis bloodstream infection","M. Consuegra Perez|S. Grillo|A. Rombauts|M. Rivera Martinez|A. Falco-Roget|A. Albasanz-Puig|B. Vinado-Perez|N. Fernandez-Hidalgo|L. Camps-Relats|A. Bergas|J. Laporte-Amargos|J. Lopez-Contreras|L. Escolà-Vergé"
"3254","13/04 12:00","21","P0789","Hamad ABDEL HADI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Epidemiology, phenotypic and genotypic evaluation of carbapenem-resistant Enterobacterales bacteraemia in Qatar","H. Abdelhadi|C. Tsui|F. Eltayeb|S. Dargham|B. Samuel|S. Skariah|A. Sultan"
"3291","13/04 12:00","22","P0790","Katharina LAST","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Effects of biological sex on mortality and complications in infective endocarditis patients: preliminary results from the multicentre DERIVE cohort study in Germany","K. Last|C. Papan|S. Becker|S. Röttgen|J. Camp|S. Rieg|M. Wolkewitz|N. Jung|K. Schmidt-Hellerau"
"3378","13/04 12:00","23","P0791","Alba SANCHEZ MORILLO","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Important plasma lipid changes related to sepsis progression","A. Sánchez|T. Sans|S. Espineira|I. Samarra|G. Masdeu Eixarch|F. Vidal|J. Peraire|A. Rull"
"3439","13/04 12:00","24","P0792","Diksha GAKHAR","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","In quest of determining an effective antimicrobial peptide against uropathogenic Escherichia coli in silico and in vitro validation","D. Gakhar|H. Singh|G. Choudhary|D. Makkar|B. Medhi|N. Taneja|A. Rakha"
"3446","13/04 12:00","25","P0793","Emma RENNEL-DICKENS","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Rapid AST enables treatment optimisation over 32-h earlier than standard of care for BSI patients: interim results of the LIFETIMES study","E. Rennel-Dickens|P. Bernaschi|M. Antonelli|F. Ippolita Calo Carducci|V. Brisigotti|C. Chilleri|V. Cortazzo|G. De Angelis|M. Del Carmen Pereyra Boza|E. De Robertis|A. Mencacci|C. Federico Perno|F. Picciafuochi|S. Romagnoli|G. Maria Rossolini|M. Sanguinetti|B. Viaggi|F. Allegrucci"
"3567","13/04 12:00","26","P0794","Laura DIONISI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Performance evaluation of an automated microbial detection system for diagnosing bloodstream infections","L. Dionisi|C. Colosimo|M. Guerra|G. Gatti|L. Ingletto|A. Marzucco|M. Maria Sofia|L. Grumiro|M. Brandolini|G. Dirani|S. Zannoli|A. De Pascali|A. Scagliarini|M. Cricca|V. Sambri"
"3570","13/04 12:00","27","P0795","Hanife Nur KARAKOC","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Antimicrobial lock therapy in the treatment of catheter-related bacteraemia in heamodialysis patients","F. Aksoy|H. Karakoç Parlayan|M. Agirman|G. Yilmaz"
"3611","13/04 12:00","28","P0796","Emilie Marie Juelstorp PEDERSEN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Myocardial infarction and new-onset heart failure following bacteremia: general and pathogen-specific associated risk in a nationwide Danish nested case-control study","E. Pedersen|G. Egelund|N. Lohse|E. Fosbøl|L. Køber|M. Voldstedlund|C. Torp-Pedersen|B. Lindegaard|A. Jensen"
"3645","13/04 12:00","29","P0797","Jana EPPRECHT","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","No gender disparities in surgical treatment of infective endocarditis: a Swiss multicentre study","J. Epprecht|B. Siedentop|M. Papadimitriou-Olivgeris|M. Frank|B. Ledergerber|B. Hasse|M. Van Hemelrijck|O. Dzemali|P. Monney|G. Tzimas|P. Tozzi|M. Kirsch"
"3705","13/04 12:00","30","P0798","Calvin MAN","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Staphylococcus aureus bacteraemia time to positivity for risk of infectious endocarditis and mortality","C. Man|R. Bentvelsen"
"3756","13/04 12:00","31","P0799","Maria MAZZITELLI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Predictors of mortality of Enterococcus faecium bacteraemia: results from a five-year retrospective study at Padua university hospital","M. Mazzitelli|A. Maraolo|U. Barbieri|V. Scaglione|F. Giovagnorio|L. Sasset|S. Lo Menzo|I. Castagliuolo|P. Burra|L. Furian|F. Nalesso|P. Navalesi|T. Ivo|P. Simioni|C. Annamaria"
"3785","13/04 12:00","32","P0800","Yifan ZENG","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The role of CD4+ T cells in the acute course of sepsis","Y. Zeng|B. Ruan"
"3792","13/04 12:00","33","P0801","Miia SAUKKOSAARI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Streptococcus dysgalactiae subsp. equisimilis bacteraemia, emm types and clinical characteristics: a four-year prospective study","M. Saukkosaari|J. Aittoniemi|R. Huttunen|H. Hyyryläinen|T. Seiskari|T. Luukkaala|S. Rantala"
"3824","13/04 12:00","34","P0802","Camilla GENOVESE","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Impact of nuclear imaging in the management of infections in critically ill patients","C. Genovese|B. Mahida|F. Rouzet|J. Timsit|M. Thy|E. De Montmollin|R. Sonneville|L. Bouadma"
"3825","13/04 12:00","35","P0803","Pietro VALSECCHI","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Navigating troubled waters: a systematic review of reported cases of prosthetic valve endocarditis treated with suppressive antimicrobial treatment","P. Valsecchi|M. Calia|P. Giordani|C. Giuliani|A. Arcuri|V. Scotti|E. Seminari|R. Bruno"
"3835","13/04 12:00","36","P0804","Benedetta ANDRIOLO","7","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Staphylococcal endocarditis treatment, clinical practice vs guidelines: the experience from Agostino Gemelli university hospital, Rome","B. Andriolo|G. Leanza|F. Frondizi|L. Vahedi|F. Catania|F. Sangiorgi|B. Liguoro|M. Chiuchiarelli|G. Oliva|P. Veltri|F. Giovannenze|E. Taddei|G. Scoppettuolo|C. Torti"
"3993","13/04 12:00","1","P0805","Luca MARTINI","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Ampicillin and ceftobiprole: a potent duo against Enterococcus faecalis infective endocarditis","L. Martini|S. Giuliano|J. Angelini|D. Pecori|P. Della Siega|C. Tascini"
"4014","13/04 12:00","2","P0806","Ranganathan Natarajan IYER","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Carbapenamase gene detection and synergy testing: role in management of blood stream infections due to carbapenem resistant Enterobacterales","A. Ranganathan|R. Iyer|S. Deshpande"
"4107","13/04 12:00","3","P0807","Marie-Liesse ETIENNE","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Carbapenem tolerance in Enterobacter bugandensis in neonatal sepsis","M. Etienne|M. Aubourg|L. Augusto|P. Tissières|F. Doucet-Populaire|N. Bourgeois-Nicolaos"
"4108","13/04 12:00","4","P0808","Cristiane LAMAS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Splenic embolism and infective endocarditis: on radiology and histopathology","N. Feijoo|T. De Almeida|M. De Carvalho|G. Pompeo|R. Garrido|G. Barbosa|B. Zappa|W. Golebiovski|C. Weksler|M. Correia|C. Lamas"
"4121","13/04 12:00","5","P0809","Laura SERRANO MARTÍN","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Predictive power of LIAISON MeMed VB for bacteraemia in adult patients seen in emergency deparments due to infections","L. Serrano Martin|J. Cabanas Morafraile|E. De Rafael González|E. Heredero Ga?lvez|A. Julián-Jiménez"
"4165","13/04 12:00","6","P0810","Beatrice LIGUORO","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Challenges in the diagnosis and management of negative blood culture infective endocarditis: insights from a retrospective cohort study","B. Liguoro|F. Giovannenze|G. Leanza|F. Frondizi|M. Chiuchiarelli|G. Oliva|L. Vahedi|P. Veltri|M. Cassano|E. Taddei|G. Scoppettuolo|C. Torti"
"4193","13/04 12:00","7","P0811","Daniel HORNUSS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Diagnosis and severity prediction of bacterial infections and sepsis using a 29-gene host-response test from whole blood","D. Hornuss|O. Liesenfeld|P. Mathé|S. Rieg"
"4228","13/04 12:00","8","P0812","Marta VECCHI","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A prospective cohort study on the performance of chatbot artificial intelligence in infective endocarditis management compared to infectious diseases consultation","L. Denti|L. Rezzonico|C. Oltolini|M. Vecchi|G. Bonalumi|M. Ripa|M. Bartoletti|R. Murri|M. Merli|G. Travi|F. Crippa|S. Capitanio|A. Cannata|R. Tortorella|F. Spano|C. Vismara|A. Moreo|M. Moioli|M. Puoti|N. Bana"
"4234","13/04 12:00","9","P0813","Sara KAMEL REY","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Outpatient parenteral antimicrobial therapy (OPAT): a four years review in a tertiary care hospital in Belgium","S. Kamel Rey|E. Larranaga Lapique|O. Mukangenzi|S. Chennoufi|Z. Khalil|A. Vervacke|J. Steens|M. Hites|O. Vosters"
"4250","13/04 12:00","10","P0814","Layla VAHEDI","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Long-acting antibiotics as sequential therapy for infective endocarditis caused by Gram-positive bacteria: a propensity score-weighted cohort study","L. Vahedi|H. Morrone|G. Leanza|F. Frondizi|M. Chiuchiarelli|B. Andriolo|F. Giovannenze|E. Taddei|V. Pierangelo|M. Cassano|G. Scoppettuolo|C. Torti"
"4266","13/04 12:00","11","P0815","Christina BAHRS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical outcomes of penicillin-based therapy compared to alternative enterococcal treatment in patients with vancomycin-susceptible enterococcal bacteremia: a retrospective cohort study","T. Landrock|S. Glöckner|S. Hagel|M. Pletz|C. Bahrs"
"4276","13/04 12:00","12","P0816","Anna WIJEN","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Evaluation of a point-of-care sepsis risk prediction test in ICU patients: comparison with standard scores, biomarkers, and physician judgement","A. Wijen|C. Von Wintersdorff|R. Driessen|D. Bergmans|P. Savelkoul"
"4322","13/04 12:00","13","P0817","Maricela VALERIO MINERO","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Infective endocarditis in patients with intracardiac devices","M. Valerio|I. Fernandez-Lopez|D. Monzon|A. Alvarez-Uria|M. Machado|M. Marin|L. Alcalá|M. Kestler|S. De La Villa|A. Estévez|A. Delgado|A. Pedraz|G. Cuerpo|M. Martinez-Selles|E. Bouza|P. Munoz"
"4369","13/04 12:00","14","P0818","Alessandra IMENEO","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Long-term suppressive antimicrobial therapy in infective endocarditis: a ten-year retrospective study on 52 patients with prosthetic valve infections at Tor Vergata university hospital","A. Imeneo|G. Alessio|L. Ferrari|T. Mulas|M. Iannetta|V. Malagnino|L. Sarmati"
"4371","13/04 12:00","15","P0819","Felicia RUFFIN","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Symptom duration and outcomes among patients with Staphylococcus aureus bloodstream infections","F. Ruffin|V. Fowler|J. Thaden"
"4402","13/04 12:00","16","P0820","Alexandre ZIDOUH","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A retrospective study: Enterobacter spp. bloodstream infection in a tertiary hospital in Balearics Islands, Spain","A. Zidouh Jimenez|C. Garcia Borreda|H. Vilchez Rueda|E. Ruiz De Gopegui Bordes|M. Colomar Ferra|J. Ayestaran Rota|A. Oliver Palomo|M. Riera Jaume"
"4436","13/04 12:00","17","P0821","Annelies MONDELAERS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Towards a Belgian national sepsis action plan: Be-SNAP","A. Mondelaers|F. Van De Voorde|I. Malfait|K. Dewitte|J. Dewaele|H. Peperstraete|P. Van De Voorde|E. Vlieghe"
"4451","13/04 12:00","18","P0822","Lal Sude GÜCER","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","The impact of antibiotic resistance on 30-day fatality in BSI: a prospective cohort study","L. Gucer|F. Pinarlik|R. Farzana|N. Ataç|Z. Genç|B. Madran|O. Usta|I. Bulbul|F. Sahin|B. Erturk Sengel|E. Tukenmez Tigen|A. Ilki|N. Sari|Ö. Kurt Azap|F. Can|T. Walsh|Ö. Ergonul"
"4455","13/04 12:00","19","P0823","Matteo MORRA","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Accurate long-term mortality prediction after BSI Using BLOOMY scores: a validation study in a challenging MDR environment","F. Cioli Puviani|F. Pezzini|M. Morra|R. Scardellato|C. Konishi De Toffoli|M. Fezzi|S. Zenere|E. Piccinno|A. Mazzariol|D. Girelli|E. Tacconelli|A. Azzini"
"4472","13/04 12:00","20","P0824","María Alexandra CAÑAS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","In vitro study on the efficacy of oral antibiotic combinations for oral outpatient treatment of infective endocarditis caused by Staphylococcus aureus, Staphylococcus epidermidis, and Enterococcus faecalis","M. Canas-Pacheco|J. Garcia-Gonzalez|G. Cuervo|M. Hernández-Meneses|C. Falces|A. Perissinotti|B. Vidal|J. Tolosana|E. Sandoval|J. Llopis|A. Moreno|J. Miro|C. Garcia De La Maria"
"4545","13/04 12:00","21","P0825","Emilio Felipe HUAIER ARRIAZU","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Ceftazidime/avibactam plus aztreonam vs comparators in metallo-beta-lactamase-producing Enterobacterales: a multicentre target trial emulation","M. Castro|V. Stanek|M. Sanchez|E. Huaier Arriazu|W. Cornistein|E. Cunto|P. Novelli Poisson|M. Boutet|D. Ávila Poletti|M. Beloso|A. Amato|V. Chediack|E. Diaz Lobo|J. Coduri|Y. Andrade Pino|L. Ibanez|A. Gira|C. Domingez|A. Rodriguez|V. Rucci|M. Lagostena|M. Arias|M. Galati|R. Cabrera|D. Violi|V. Tissera|C. Taffarel|O. Garcia Messina|M. Garcia|Y. Cortez Aguayo|M. Branez Merida|M. Gutierrez|S. Arias|E. D'urbano|S. Moreno|M. Barnes|F. Masa|D. Ivulich|J. Salcedo|M. Gomez|N. Carrizo|S. Kriger|E. Ruiz|P. Escobar|A. Romani|M. Mirofsky|L. Duarte Sotelo|L. Camera|J. Pollan|M. Vaena|I. Huespe"
"4563","13/04 12:00","22","P0826","Sunish SHAH","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia","S. Shah|L. Clarke|K. Shutt|B. Smith|R. Shields"
"4589","13/04 12:00","23","P0827","Fereshteh SHEIBANI","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Impact of neurological complications on infective endocarditis outcomes","M. Shirazinia|F. Babaee|M. Haddad|F. Sheybani"
"4601","13/04 12:00","24","P0828","Yi-Tsung LIN","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Carbapenems vs non-carbapenems as definitive treatment for hypervirulent Klebsiella pneumoniae bacteraemia in Taiwan","C. Juan|C. Chuang|S. Chou|S. Liu|Y. Ho|Y. Lin|L. Chen"
"4686","13/04 12:00","25","P0829","Xinlei XU","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Diagnostic performance and prognostic assessment of ddPCR in patients with sepsis","W. Zhang|X. Xu|H. Zhang|K. Lin|J. Ai"
"4699","13/04 12:00","26","P0830","Myeong Hee KIM","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Comparative evaluation of the utility of serum amyloid A, C-reactive protein, procalcitonin, and precepsin as diagnostic markers for sepsis","M. Kim|S. Kang|W. Lee|M. Lee"
"4739","13/04 12:00","27","P0831","Tomonori TAKANO","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Revised VIRSTA score for infective endocarditis focusing on persistent fever","T. Takano|H. Aiba|H. Kunishima"
"4835","13/04 12:00","28","P0832","Sofia MOLINA GARCIA","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Bacteraemia due to Lactobacillus species: a Mayo Clinic experience from 2012 to 2024","S. Molina Garcia|M. Thoendel|O. Abu Saleh"
"4876","13/04 12:00","29","P0833","Qiwen YANG","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A nationwide genomic surveillance study of Gram-negative bacteria causing community and hospital-acquired bloodstream infections in China","J. Xi|X. Jia|Q. Yang"
"4942","13/04 12:00","30","P0834","Miguel Angel CONSUEGRA PEREZ","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical features and outcomes of patients with infective endocarditis and intracardiac abscess compared to patients without intracardiac complications","M. Consuegra Perez|L. Escolà-Vergé|C. Fernández De Vinzenzi|A. Gutiérrez Baena|A. Arias Costa|M. Rivera Martinez|M. Tauron Ferrer|J. Lopez-Contreras|S. Grillo"
"4997","13/04 12:00","31","P0835","Omar Fernando MENDOZA-VÁZQUEZ","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","In-hospital mortality associated with bacteraemia caused by Escherichia coli and Klebsiella spp. with priority resistances","A. Acosta-Ruiz|A. González-Cardel|B. Lopez-Luis|O. Mendoza-Vázquez"
"4999","13/04 12:00","32","P0836","Christian FINI","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Enhanced sepsis management with a novel multiplex real-time PCR system","M. Favaro|C. Fini|M. Capannari|P. Ivano|V. Antonella"
"5029","13/04 12:00","33","P0837","Kathryn WILKS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Herding cats with WISCAs: using weighted incidence syndromic combined antibiograms to inform community-acquired sepsis guideline development","K. Wilks|D. Mason"
"5043","13/04 12:00","34","P0838","Annette WESTGEEST","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","When staph won't budge: how the world tackles persistent Staphylococcus aureus bacteraemia","A. Westgeest|M. Lambregts|E. Schippers|M. De Boer|V. Fowler"
"5045","13/04 12:00","35","P0839","Kathryn WILKS","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Novel sepsis guideline adherence and useability: impact of a WISCA-derived local sepsis guideline for Queensland, Australia","K. Wilks|D. Mason|D. Abbot"
"5069","13/04 12:00","36","P0840","Dasa STUPICA","8","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Prevalence and clinical presentation of prosthetic osteoarticular material infections in patients with Staphylococcus aureus bacteraemia","D. Stupica|J. Gulin|I. Velimirovic|S. Collinet-Adler"
"5078","13/04 12:00","1","P0841","Chiara SEPULCRI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Who is the true bad bug? Post COVID-19 increase in incidence of MSSA bacteraemia associated with high mortality in older adults","M. Muccio|G. Cenderello|M. Berruti|G. Malerba|A. Parisini|S. Boni|G. Carrega|C. Russo Artimagnella|G. Cattardico|M. Mirabella|L. Magnasco|E. Delfino|F. Toscanini|S. Dettori|C. Dentone|A. Vena|F. Portunato|D. Giacobbe|F. Mina|N. Ullah|M. Bassetti|M. Mikulska|F. Briano|C. Lorusso|A. Calzi|G. Brucci|C. Sepulcri"
"5175","13/04 12:00","2","P0842","Annamária MACHÁCKOVÁ","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Sequencing for pathogen detection in valve tissue in clinical diagnostics of infective endocarditis","A. Machackova|M. Vanerkova|K. Fiedorová|H. Obrucova|T. Freiberger"
"5215","13/04 12:00","3","P0843","Elif Mukime SARICAOGLU","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Non-device-associated right-sided infective endocarditis: bridging gaps in epidemiology and clinical insights","K. Turkiye Endocarditis Group|E. Saricaoglu|Y. Tezer Tekçe|D. Sayman|M. Aslan|S. Simsek Yavuz|O. Azap"
"5276","13/04 12:00","4","P0844","Pietro VALSECCHI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Cardiac CT scan in infective endocarditis: correlation with transoesophageal findings and feasibility of coronary artery evaluation","P. Valsecchi|K. Ellena|A. D'onorio De Meo|A. Valentini|R. Cattaneo|C. Volpe|F. Amoroso|C. Klersy|G. Magrini|L. De Luca|S. Pelenghi|L. Preda|R. Bruno|E. Seminari"
"5344","13/04 12:00","5","P0845","Federica MALERBA","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical impact and therapeutic management of Enterococcus faecium bloodstream infections: a systematic review and meta-analysis","F. Malerba|M. Rinaldi|I. Rancan|M. Gatti|B. Tazza|C. Campoli|C. Bonazzetti|B. Profiti|N. Caroccia|P. Viale|M. Giannella"
"5359","13/04 12:00","6","P0846","Maia DE LUCA","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Genetic characterisation of Enterobacter cloacae strains causing paediatric sepsis","M. De Luca|C. Tripiciano|G. Vrenna|V. Fox|S. Raimondi|L. Romani|L. Lancella|P. Bernaschi|S. Mercadante|G. Lorenzetti|F. Pagano"
"5360","13/04 12:00","7","P0847","Sara Palma GULLÌ","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Predictive factors of early and late mortality and evaluation of therapeutic efficacy in patients with bacteraemia associated with MDR Acinetobacter baumannii: the ITACA (ITalian Advances on Carbapenem-resistant Acinetobacter) study","A. Russo|S. Gulli|A. Vena|S. Corcione|R. Serraino|F. Serapide|M. Bassetti|C. Torti|E. Trecarichi"
"5393","13/04 12:00","8","P0848","Sunish SHAH","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.","C. Hausberger|R. Shields|L. Clarke|S. Shah"
"5450","13/04 12:00","9","P0849","Victoria ALLEN","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Rising rates of sepsis in England: an ecological study","V. Allen|M. Russell|M. Adas|A. Goodman|M. Mcphail|S. Norton|J. Galloway"
"5460","13/04 12:00","10","P0850","Agnese COMELLI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","High antimicrobial resistance among invasive non-typhoidal Salmonella in hospitalised patients with advanced-HIV disease: a prospective study in Kinshasa, DRC","C. Langendorf|A. Comelli|C. Bossard|F. Nackers|M. Berghmans|G. Molay|F. Gordillo Gomez|A. Dicko|E. Bangwen|F. Mangana|R. Burton|G. Mucinya Lumowo|P. Isaakidis|T. Kalwangila|A. Kilundu|R. Ngantsui Beni"
"5489","13/04 12:00","11","P0851","Kate DRUMMOND","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Adherence to Duke-ISCVID and ESC guidelines for infective endocarditis: insights from a three-year retrospective study","K. Drummond|S. Fernando|A. Koshy|O. Smibert"
"5494","13/04 12:00","12","P0852","Shincy METTINGAL RAMAKRISHNAN","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Serotype V dominance and emerging resistance in Indian Streptococcus agalactiae: genomic insights and antibiotic profiling","S. Mettingal Ramakrishnan|N. Geetha|S. Varun|K. Ravikumar"
"5538","13/04 12:00","13","P0853","Agnese COMELLI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Community and hospital-acquired invasive bacterial infections in hospitalised patients with advanced-HIV disease: a prospective study in Kinshasa, DRC","C. Langendorf|C. Bossard|F. Nackers|A. Comelli|M. Berghmans|G. Molay|F. Gordillo Gomez|A. Dicko|E. Bangwen|F. Mangana|R. Burton|G. Mucinya Lumowo|P. Isaakidis|T. Kalwangila|A. Kilundu|R. Ngantsui Beni"
"5608","13/04 12:00","14","P0854","Linda BUSSINI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Long-term antibiotic therapy in non-surgical prosthetic valve endocarditis: a retrospective international multi-centre study (L-TAPE study)","L. Bussini|A. Pozzi|E. Barone|A. Grechi|R. Pascale|L. Bertolino|A. Saracino|P. Munoz|A. Vena|D. Vaznaisiène|M. Muratori|A. Bandera|C. Bea Serrano|P. Bonfanti|I. Lopez Montesinos|I. Gentile|E. Gervasi|G. Pagani|S. Corcione|M. Giannella|P. Viale|M. Bartoletti|D. Podestà|D. Bavaro|A. Belati|L. Diella|D. Pocaterra|D. Barbanotti|P. Morelli|N. Caroccia|M. Papadimitriou-Olivgeris|P. Monney|R. Dworakowski|S. Watson|M. Bach|C. Torti|E. Seminari"
"5704","13/04 12:00","15","P0855","Fabian PATAUNER","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Hypolipidemia, a novel potential predictor of mortality in infective endocarditis","F. Patauner|R. Gallo|L. Bertolino|A. Peluso|I. Cafarella|E. Tricarico|F. Luciano|E. Durante-Mangoni"
"5740","13/04 12:00","16","P0856","Sebastian SCHÖNHERR","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Sepsis in children with burn injuries: preliminary findings from a prospective observational study from Malawi","P. Kamanga|F. Malengenya|H. Chadwala|W. Lungu|T. Maida|A. Von Braun|E. Jingini|S. Schönherr"
"5828","13/04 12:00","17","P0857","Michael THY","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical characteristics of endocarditis patients with negative valve culture but positive 16S RNA: a cohort study","A. Carriere|G. Suc|N. Grall|M. Para|J. Timsit|L. Deconinck|C. Amaris Hobson|X. Duval|B. Iung|L. Armand-Lefevre|N. Peiffer-Smadja|S. Provenchère|C. De Tymowski|M. Thy"
"5879","13/04 12:00","18","P0858","Laura-Georgiana TIRLESCU","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical utility of negative predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swabs in infective endocarditis: is there a step forward to antimicrobial stewardship goals?","L. Tirlescu|R. Matoru|M. Gorea|C. Niculae"
"5904","13/04 12:00","19","P0859","Mark A SCHMIDT","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Validating code-based algorithms to detect invasive Escherichia coli disease in US healthcare records: impact of incorporating microbiology culture data in the case definition","M. Schmidt|M. Blum|C. Onwuchekwa|J. Poolman|T. Verstraeten|J. Geurtsen"
"5933","13/04 12:00","20","P0860","Annika MEINEN","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Sepsis in Germany: an estimation of incidence using two extrapolation approaches","A. Meinen|A. Dörre|K. Schussel|I. Noll|T. Eckmanns|S. Haller"
"5940","13/04 12:00","21","P0861","Imran HASANOGLU","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Time efficiency in tailoring antimicrobial treatment: a propensity score-matched comparison of sepsis panel-guided and blood culture-guided therapy","I. Hasanoglu|R. Guner|F. Aslan|M. Korkmaz|A. Kaya|B. Kayaaslan|F. Eser|F. Horan|M. Meral|B. Dinç"
"5959","13/04 12:00","22","P0862","Michael THY","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Role of nuclear imaging techniques in the diagnosis and management of infective endocarditis in critically ill patients","C. Genovese|B. Mahida|F. Rouzet|L. Deconinck|C. Amaris Hobson|N. Grall|B. Iung|X. Duval|M. Para|N. Peiffer-Smadja|R. Sonneville|E. De Montmollin|L. Bouadma|J. Timsit|M. Thy"
"6034","13/04 12:00","23","P0863","James HARTLEY","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Campylobacter bacteraemia: ten years of experience in a large teaching hospital","J. Hartley|J. Odone|R. Dellar|D. Salih|T. Gouliouris"
"6093","13/04 12:00","24","P0864","Gamze SANLIDAG ISBILEN","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Evaluation of septic shock patients in a tertiar-care educational university hospital: a series of 2314 cases","G. Sanlidag Isbilen|D. Akyol Seyhan|M. Vahabi Mert|B. Kenanoglu|C. Tol|D. Baskol Elik|O. Acet|S. Ketentzi|N. Yalcin|A. Kaya|S. Dirik|C. Bulut Avsar|M. Özkara|A. Önal|U. Önal|D. Kaya|D. Akdag|M. Ceylan|G. Guliyeva|M. Demir Gorur|S. Uysal|D. Yaman|B. Sullu|A. Parmaksizoglu Aydin|F. Arikan|S. Istek|H. Sipahi|S. Aydemir|M. Tasbakan|B. Arda|O. Sipahi"
"6162","13/04 12:00","25","P0865","Jorge CALDERON PARRA","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Risk factors and prognostic influence of carbapenem-resistance in Klebsiella spp. bloodstream infections: experience from a tertiary hospital","J. Calderon-Parra|A. Visedo-Colino|M. Carretero-Henriquez|A. Gutiérrez-Villanueva|I. Diego-Yague|A. Rojo-Reyes|G. Escudero-Lopez|E. Suances-Martin|M. Murga De La Fuente|E. Exposito-Palomo|I. Sanchez-Romero|A. Ramos-Martinez"
"6179","13/04 12:00","26","P0866","Keegan John HOOG","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Burkholderia sepsis in Bangladesh: clinical impact, diagnostic challenges, and molecular epidemiology","K. Hoog|C. Abdellaoui|M. Haque|S. Bin Shahid|N. Haque|M. Rahman|M. Sultana|J. Joyee|A. Sharmin|M. Kabir|R. Rony|A. Monir|T. Mallik Rifa|R. Tanvir Ahmed|C. Zerin Tasnia|A. Shamima|P. Sahanaz|T. Walsh|R. Farzana"
"6225","13/04 12:00","27","P0867","Angela NOVAIS","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Robust, rapid and cost-effective diagnosis of bloodstream infections by FT-IR spectroscopy directly from blood culture bottles","A. Gonçalves|V. Alves|M. Read|S. Saha|K. Holt|L. Peixe|Â. Novais"
"6248","13/04 12:00","28","P0868","Gustavo Adolfo MÉNDEZ","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Ceftazidime/avibactam in real-world clinical practice","G. Méndez|C. Niveyro|V. Martin|P. Villalba Apestegui|L. Company Kec|M. Tomasino|R. Solari Maidana|M. Lopez|C. Villalba|J. Salmanton-Garcia"
"6353","13/04 12:00","29","P0869","Dorottya NAGY","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Molecular epidemiological study of Escherichia coli bloodstream infection-causing isolates across England using nanopore long read-only sequencing: an interim analysis of the NEKSUS study","D. Nagy|P. Valentina|G. Rodger|K. Hopkins|R. Moran|S. Hopkins|D. Crook|A. Walker|J. Robotham|K. Hopkins|A. Ledda|D. Williams|R. Hope|C. Brown|N. Stoesser|S. Lipworth|C. Jones"
"6366","13/04 12:00","30","P0870","Jordan Aston Tregurtha MATHIAS","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","High carriage of known sepsis causing ExPEC Escherichia coli are the cause of high rates of bacteraemia in Wyoming","B. Bisha|M. Toleman|D. Babenko|T. Fearing|R. Petit|J. Mildenberger|P. Boidya|J. Mathias"
"6403","13/04 12:00","31","P0871","Giulia LORENZETTI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical features and antimicrobial susceptibility profiles of Gram-negative bloodstream infections in paediatric ICU patients","G. Lorenzetti|C. Tripiciano|M. Di Giuseppe|S. Mercadante|M. De Luca|L. Romani|L. Cursi|L. Lancella|P. Bernaschi|V. Cortazzo|C. Perno|M. Pereyra Boza|C. Cecchetti|L. Di Chiara|D. Perrotta|R. Bianchi|F. Calo Carducci|A. Dotta"
"6409","13/04 12:00","32","P0872","Anandakrishnan NANDAKUMAR","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Validation of Pro-SOFA and Pro-SAPS models incorporating biomarkers PCT, NLR, and CRP in a new patient cohort","G. Jayasree Sudhakaran|G. Gutjahr|M. Moni|D. T. Sathyapalan|A. Nandakumar|S. Sudeep|A. Lakshmi"
"6480","13/04 12:00","33","P0873","Amelieke Johanna Hendrina CREMERS","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Sex-specific performance of SIRS, qSOFA, CURB-65, DS-CRB-65 and PSI in predicting mortality from pneumococcal bacteraemia","C. Burke|J. Gisolf|W. Albrich|A. Cremers"
"6580","13/04 12:00","34","P0874","Marisa ZENAIDE RIBEIRO GOMES","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Predictive factors for sepsis by or associated with Stenotrophomonas maltophilia complex (SMC) in adult critically ill patients in Rio de Janeiro: prospective, nested case-case-control study","T. Pavoni Gomes Chagas|M. Zenaide Ribeiro Gomes|R. Amorim Silveira Verduc|A. Monteiro De Barros Titonelli|L. Vellozo Dos Reis|I. Ribeiro Gomes De Queiroz Crespo|R. De Assis Coco|E. Martins De Lima|D. Quintanilha Braga|N. Dias Lourenço|D. Souza Beck|L. Henrique Zanata Pinheiro|P. Aquen Cid|J. Silva Tonhá|V. Pinson Ruggi Dutra|L. Sênos De Mello|M. Marçal Castro|In Memoriam|M. Cassiano Da Silva|A. Aparecida Da Silva Machado|L. Silva De Sousa|M. Lopes Secundo Dias|T. Medeiros Tozo|Y. Rodrigues Mathuiy|L. Lameirao Pinto De Abreu Rosas|P. Cesar Mendes Barros|J. Oliveira Da Silva|P. Pinho Da Silva|C. Souza Bandeira|D. Gomes Ambrozino Pereira|B. Hasselmann Fernandes De Oliveira|M. Zenaide De Oliveira Alves|R. Queiroz Santos|J. Aurélio Marques|C. Santos Rodrigues|S. Dos Santos Gomes Junior|C. Raymundo|G. Fontes Marcelino|E. Almeida Ribeiro De Castro"
"6679","13/04 12:00","36","P0876","Gloria SANGALETTI","9","A","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Double-valve infective endocarditis: real-life experience in a tertiary hospital in Italy","G. Sangaletti|S. Lerta|V. Villano|F. Puci|E. Kushta|P. Totaro|F. Amoroso|P. Valsecchi|R. Bruno|E. Seminari"
"6749","13/04 12:00","1","P0877","Philip NWAJIOBI-PRINCEWILL","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Pantoea spp bacteraemia in national hospital Abuja","P. Nwajiobi-Princewill|S. Sonibare|N. Medugu|K. Iregbu"
"6752","13/04 12:00","2","P0878","Maricela VALERIO MINERO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Endocarditis due to Gram-negative bacilli and its comparison with endocarditis due to other microorganisms","M. Valerio|C. Mora|A. Alvarez-Uria|M. Machado|M. Kestler|S. De La Villa|A. Estévez|I. Fernandez-Lopez|A. Delgado|A. Mansilla|D. Monzon|A. Pedraz|G. Cuerpo|H. Rodriguez-Abella|M. Marin|L. Alcalá|M. Martinez-Selles|E. Bouza|P. Munoz"
"6767","13/04 12:00","3","P0879","Karen Viviana CABEZAS MARQUEZ","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Short antibiotic treatment for uncomplicated Gram-negative bacilli bacteraemia: real-world experience in a single centre","K. Cabezas Marquez|E. Huaier Arriazu|F. Arguello|N. Manez|M. Indo|M. Visus|M. Sanchez|C. Nemirovsky"
"6805","13/04 12:00","4","P0880","Jorge CALDERON PARRA","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Definition of early prosthetic valve endocarditis","J. Calderon-Parra|C. Farinas|J. Miro|M. Goenaga-Sánchez|J. Goikoetxea|A. Alarcon|A. Plata|A. Ramos-Martinez|G. Cuervo|F. Escrihuela|P. Munoz|Á. Pedraz|M. Rodriguez Esteban|R. Rodriguez"
"6822","13/04 12:00","5","P0881","Mustafa DENIZ","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical spectrum of Enterococcal endocarditis: key findings from a multicentre study","M. Deniz|Y. Tezer Tekçe|B. Kayaaslan|C. Ayaz|S. Simsek Yavuz|Ö. Kurt Azap|D. Berzeg Deniz|E. Saricaoglu"
"6858","13/04 12:00","6","P0882","James STIMSON","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","A metric to measure mortality due to antibiotic-resistant bacteraemia in the UK using public health data","J. Stimson|B. Cooper|K. Pouwels|R. Hope|S. Evans|J. Robotham"
"6985","13/04 12:00","7","P0883","Nuran SARI","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Infective endocarditis in immunocompromised patients: pathogens, complications, and outcomes","N. Sari|S. Basaran|Y. Tezer Tekçe|C. Ayaz|Y. Uygun Kizmaz|E. Saricaoglu|D. Berzeg Deniz|S. Simsek Yavuz|Ö. Kurt Azap|K. Teg"
"6994","13/04 12:00","8","P0884","Miguel SUAREZ ROBLES","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Sepsis code programme: outcomes after two years of implementation in a tertiary hospital","M. Suarez-Robles|M. Corbacho-Loarte|R. Escudero|C. Cano De Luque|D. Gayoso Cantero|M. Nebot|E. Cadenas Carmona|J. Lopez Mogollon|F. Higaldo|S. Diz|N. Martinez|A. Lietor Villajos|A. Azzam Lopez|P. Cobeta Orduna|A. Mira|M. Lopez Olivencia|J. Marquez|A. Halperin|M. Cárdenas-Isasi|J. Saez|M. Menacho Roman|J. Cobos Alonso|A. Sanjuan Benito|A. Gomis|M. Rivilla|P. Martin Davila|J. Fortun Abete|V. Pintado|C. Suarez-Carantona|M. Najarro|E. Perez|P. Gallego|M. Ferro|A. Carrasquel|C. Benitez Gimenez|T. Bravo Acosta|A. Santos Polo|M. Mediavilla|M. Rivilla|P. Martin Davila|J. Fortun Abete|V. Pintado|J. Cobo Reinoso|F. Gioia"
"7059","13/04 12:00","9","P0885","Sandra SCHÜTZE","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Body temperature and serum levels of C-reactive protein and procalcitonin in hospitalised geriatric patients with bacteriaemia","O. Habich|R. D`cruz|H. Hölting|S. Schutze"
"7075","13/04 12:00","10","P0886","Nuran SARI","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","How does infective endocarditis due to non-HACEK Gram-negative bacilli progress?","N. Sari|Y. Tezer Tekçe|S. Basaran|C. Ayaz|Y. Uygun Kizmaz|E. Saricaoglu|D. Berzeg Deniz|S. Simsek Yavuz|Ö. Kurt Azap|T. Klimik"
"7089","13/04 12:00","11","P0887","Brice ANDRIAMIRADO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Evaluation of the role of geriatrician in the endocarditis team","B. Andriamirado|A. Zeggay|I. Gueit|A. Savoure|J. Burdeau|F. Roca|D. Lesage|L. Zmuda"
"7157","13/04 12:00","12","P0888","Oren TURGMAN","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Modified PRIEST score for predicting adverse outcome in emergency room patients with suspected infection","O. Turgman|C. Boelens|M. Schinkel|J. Wiersinga|T. Van Der Poll"
"7173","13/04 12:00","13","P0889","Christian Jay DOMINGO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Restrictive versus liberal fluid management in adult patients with septic shock: a systematic review and meta-analysis","C. Domingo|E. Tablante|A. Masbang"
"7245","13/04 12:00","14","P0890","Carlos TARRAZO TARRAZO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Implementation of bedside consultation for Staphylococcus aureus bacteraemia: a pre-post intervention study","C. Tarrazo Tarrazo|J. Valdés Bécares"
"7341","13/04 12:00","15","P0891","Inacio MANDOMANDO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Exploring the virulence potential of Escherichia coli of ST131 fimH27 subclone causing infantile bacteraemia in Mozambican children","M. Garrine|J. Neves|M. Andrade|A. Messa Jr.|N. Boisen|I. Couto|S. Costa|I. Mandomando"
"7394","13/04 12:00","16","P0892","Domingo FERNANDEZ VECILLA","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Hypervirulent Klebsiella pneumoniae (HvKp) causing bacteraemia in a tertiary referral hospital","D. Fernández Vecilla|J. Rodriguez Grande|N. Fraile Valcárcel|S. Garcia Fernandez|M. Siller Ruiz|M. Roiz Mesones|J. Calvo Montes|A. Ocampo Sosa"
"7395","13/04 12:00","17","P0893","Lena Vania MANHIQUE-COUTINHO","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Neonatal sepsis in quaternary unit in south of Mozambique: preliminary result/study","L. Manhique-Coutinho|C. Isabel|V. Joyce|M. Inacio|S. Paque|M. Eugénio|C. Sofia Santos|S. Jeronimo"
"7548","13/04 12:00","18","P0894","Islam GHAZI","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Clinical outcomes of cefepime dosing in patients with Pseudomonas infections undergoing renal replacement therapies","I. Ghazi|E. Abidi|K. Al Zaman|M. Ghosn|R. El Lababidi|M. Mooty|A. Malik|A. Alshamsi|A. Almeheiri|J. Mallat|D. Alrahmany|W. El Nekidy"
"7551","13/04 12:00","19","P0895","Azmi RAHMAN","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Isolated spikes in temperature and leucocyte count do not predict positive blood cultures in the intensive care setting","A. Rahman|A. Walden|S. Iyer"
"7625","13/04 12:00","20","P0896","Gerardo Antonio MUÑETON-LÓPEZ","1","B","02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Impact of antimicrobial dose adjustment timing in patients with Gram-negative bacilli bacteraemia and reduced glomerular filtration rate","G. Muneton-Lopez|J. Mendoza|L. Hoyos-Moreno|J. Quiroz-Chavez|H. Vergara-Samur"
"439","13/04 12:00","21","P0897","Lilia POTTER-SCHWARTZ","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Amoxicillin is non-inferior to other antibiotics as treatment of CAP in adults and children: results of a systematic review and meta-analysis of 44 trials","L. Potter-Schwartz|M. Maung Maung Swe|B. Cooper|M. Sharland|C. Lim"
"544","13/04 12:00","22","P0898","Fabian REICHEL","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Burden and risk factors of 30-day readmissions and mortality after CAP hospitalisation: a population-based cohort study","F. Reichel|F. Tesch|S. Berger|M. Seifert|D. Koschel|J. Schmitt|M. Kolditz"
"576","13/04 12:00","23","P0899","Alfonso J. RODRIGUEZ-MORALES","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","A critical analysis of the trends in low immunisation coverage of under-one-year-old against diphtheria, tetanus, and pertussis in Venezuela, 1995-2023","A. Rodriguez-Morales|J. Cardona-Ospina|R. Moghnieh|R. Husni|G. Camacho-Moreno|C. Torres-Martinez|J. Brea|R. Ulloa-Gutierrez"
"785","13/04 12:00","24","P0900","Yinjuan GUO","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Immunoglobulin M of respiratory viral and atypical pathogens among adults with respiratory tract infections in Shanghai, China","Y. Guo|H. Wang|F. Yu"
"971","13/04 12:00","25","P0901","Andres BLANCO-DI MATTEO","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Comparative outcomes of severe pneumonia: home vs conventional hospitalisation","A. Blanco-Di Matteo|N. Fernández Hortaleza|M. Bonilla Hernández|R. Rodil Fraile|M. Ruiz Castellano"
"1269","13/04 12:00","26","P0902","Jingwen AI","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Pathogen distribution and Pneumococcus disease burden of clinical diagnosed pneumonia among children, a multi-centre case-control study","J. Ai|H. Zhang|Y. Zhang|T. Zhou|W. Zhang|X. Liang|W. Wang|M. Zeng|Y. Qu|H. Li"
"1595","13/04 12:00","27","P0903","Richa RAO","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Comparison of microbial diversity in upper and lower respiratory tracts of children using 16S metagenomics sequencing","R. Rao|J. Mathew|P. Bhatia"
"1620","13/04 12:00","28","P0904","Karl HAGMAN","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Characteristics, epidemiology and treatment of adults hospitalised for Mycoplasma pneumoniae pneumonia","K. Hagman|A. Nilsson|M. Hedenstierna|J. Ursing"
"2050","13/04 12:00","29","P0905","Pullagura GOKUL RAJ","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Post-pandemic shifts in Streptococcus pneumoniae serotypes causing invasive pneumococcal disease (IPD) among US and Canadian children","P. Gokul Raj|S. Torres-Florez|A. Grajales Beltran|B. Althouse|M. Tort|A. Cane"
"2056","13/04 12:00","30","P0906","Genady DROZDINSKY","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Doxycycline in the treatment of outpatient community-acquired pneumonia: propensity matched control cohort study","A. Ness|G. Drozdinsky|M. Shahar|S. Kushnir|J. Bishara|N. Eliakim-Raz"
"2265","13/04 12:00","31","P0907","Carlos KIFFER","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Pneumonia burden and temporal trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden based on public healthcare system secondary data 2013-2022","É. Carmo|P. Charf|C. Wagner|M. Otani|B. Franzon|A. Aquino|A. Marinonio|A. Colombo|C. Kiffer"
"2267","13/04 12:00","32","P0908","Carlos KIFFER","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Pneumonia related antimicrobial resistance burden in hospitalised patients over ten years: a national bottom-up initiative for disease and AMR burden on public healthcare data 2013-2022","P. Charf|É. Carmo|C. Wagner|B. Franzon|A. Aquino|A. Marinonio|A. Colombo|C. Kiffer"
"2377","13/04 12:00","33","P0909","Weiwei JIAO","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Whole-genome analysis unveils genetic factors driving the Mycoplasma pneumoniae outbreak among children post-COVID-19 in China","W. Jiao|J. Wang|C. Li|P. Wang|J. Bi|A. Shen|F. Chen"
"2441","13/04 12:00","34","P0910","Pei Min THONG","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Sputum yields higher viral detection than oropharyngeal swabs in non-COVID-19 community-acquired pneumonia","P. Thong|B. Young|D. Ng|S. Ooi|F. Khan|P. Tambyah|T. Yeo"
"2617","13/04 12:00","35","P0911","Teppo SALMINEN","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Automated lateral flow immunoassay based on upconverting nanoparticles for serological point-of-care diagnosis of pertussis","T. Salminen|K. Korpi|T. Laaksoaho|V. Saramäki|J. Pyylampi"
"2689","13/04 12:00","36","P0912","Lin SUN","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Integrated study of respiratory microbiota and host response in children with macrolide-unresponsive Mycoplasma pneumoniae pneumonia","L. Sun|P. Zhang|F. Liu"
"2799","13/04 12:00","37","P0913","Zsófia SZOJKA","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Monitoring genomic evolution of Bordetella pertussis patient isolates in Austria before and after the COVID-19 pandemic","Z. Szojka|M. Cardoso|A. Stöger|A. Reich|E. Mustafa-Korninger|A. Wojna|G. Wagner|M. Hell|W. Ruppitsch|J. Bender|A. Cabal Rosel"
"2963","13/04 12:00","38","P0914","Sandra DEVATINE","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Impact of shortages of amoxicillin and amoxicillin/clavulanate on the outcome of bacterial sinusitis in adults: a French retrospective, single-centre study","S. Devatine|C. Maubaret|F. Chatelet|B. Verillaud|A. Munier|N. Leclerc De Sablon|D. Lebeaux|S. Atallah"
"3203","13/04 12:00","39","P0915","Sang Bong HAN","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Reemergence of Bordetella parapertussis and Bordetella pertussis after COVID-19 pandemic in Korea","S. Han|M. Koo|S. Yoo|J. Son"
"3458","13/04 12:00","40","P0916","Muhamed SKOMORAC","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Epidemiological features of pertussis in the Zenica-Doboj canton, Bosnia-Herzegovina","M. Skomorac|E. Terzic|A. Terzimehic|E. Kuduzovic|A. Kozica|I. Kovac|N. Hasanica|S. Begagic|A. Ibrahimagic"
"3553","13/04 12:00","41","P0917","Donia BOUZID","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Impact of a multimodal algorithm on antibiotic use for acute community-acquired pneumonia in the emergency department: a quasi-experimental time series study","D. Bouzid|S. Tubiana|T. Coralie|G. Laura|S. Robin|C. Choquet|M. Debray|A. Gaudemer|X. Duval|X. Lescure|N. Peiffer-Smadja|E. Casalino|D. Descamps|Q. Le Hingrat|P. Loubet"
"3608","13/04 12:00","42","P0918","Johannes FORSTER","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","The role of viridans Streptococci and anaerobic bacteria of the oral cavity in children with parapneumonic pleural effusions/empyema: nationwide hospital surveillance (Germany, 2010/11-2022/23)","P. Reuter-Weissenberger|C. Bauer|S. Blomenkamp|C. Schoen|J. Forster|A. Streng|J. Liese"
"3635","13/04 12:00","43","P0919","Núria BORRELL-SOLÉ","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Outbreak of pneumococcal pneumonia among vaccinated patients in a mental health facility","N. Borrell-Solé|S. Minguell|A. Martinez|P. Ciruela|D. Henares|D. Litt|S. Eletu|E. Besso|R. Rosich|C. Munoz-Almagro"
"3680","13/04 12:00","44","P0920","Henar ALONSO-EZCURRA","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Revolutionising respiratory pathogen detection: evaluation of a multiplex real-time PCR assay for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis","E. Teresa|H. Alonso|D. Morales-Jadan|M. Garcia Bereguiain"
"3720","13/04 12:00","45","P0921","Hanne-Dorthe EMBORG","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Mycoplasma pneumoniae significantly contributes to the burden of hospitalisations due to respiratory infections in Denmark","H. Emborg|S. Uldum|K. Møller|A. Breschel|I. Moustsen-Helms|T. Dalby|S. Gubbels|B. Søborg|F. Lomholt"
"3820","13/04 12:00","46","P0922","Eleana TSOUMANI","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","An estimation of costs associated with lower-tract respiratory infections in older adults in Sweden","E. Tsoumani|D. Alexander|J. Pan|C. Perera|R. Hughes|S. Salomonsson|A. Abbadi|D. Vetrano|A. Fox"
"3884","13/04 12:00","47","P0923","Panoraia KALAPOTHARAKOU","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","The largest epidemic of Mycoplasma pneumoniae in more than ten years in Wales: an epidemiological summary, symptoms and risks","P. Kalapotharakou|J. Zitha|T. Bridges|A. Couzens|R. Heyburn|T. Jones|C. Moore|M. Perry|H. Rafferty|K. Pheasant|C. Williams|J. Evans|S. Cottrell"
"4264","13/04 12:00","48","P0924","Ilona ZHYGALOVA ZHYGALOVA","1","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Clinical impact of combined treatment of beta-lactam with azithromycin in hospitalised community-acquired pneumonia","I. Zhygalova Zhygalova|I. Blanco Lopez|S. Dopazo Sotillo|U. Carreira Sampayo|P. Rubinan Iglesias|A. Sousa Dominguez|A. Pérez-Landeiro|M. Perez-Rodriguez"
"4311","13/04 12:00","1","P0925","Lisa WASSERSTROM","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Increasing numbers of Legionnaires' disease cases caused by Legionella longbeachae during 2024 in Sweden, Scotland, Denmark and Finland","E. Touriki|C. Schönning|J. Brynedal Öckinger|A. Iversen|D. Lindsay|S. Mentula|P. Airaksinen|T. Miller|E. Savonen|J. Ikonen|M. Niittynen|V. Drasar|C. Eves|J. Sørensen|C. Kjelsø|S. Uldum|A. Vatland Krøvel|H. Lund|H. K. Epstein|L. Wasserstrom"
"4390","13/04 12:00","2","P0926","Katarina MONDRUP FUNCH","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Risk of infection in pregnant women with and without chronic respiratory diseases, and association with adverse pregnancy outcomes","K. Funch|L. Ryom|M. Korslund Wiinblad Crusell|E. Moseholm|N. Weis"
"4396","13/04 12:00","3","P0927","Mary Paz ROCHE MATHEUS","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Post-pandemic trends and clinical features of severe community-acquired pneumonia (CAP) due to Streptococcus pyogenes: a retrospective study in a tertiary care centre","M. Roche Matheus|J. Aragon Diez|M. Gurruchaga Yanes|M. Larrauri Garcia|M. Unzaga Baranano|M. Cano Garcia|C. Aspichueta Vivanco|J. Diaz De Tuesta Del Arco"
"4510","13/04 12:00","4","P0928","Catalina MEDINA GOMEZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Pneumococcal colonisation in adult patients with acute respiratory infection","C. Medina-Gomez|R. Espana-Bonilla|L. Fernández-Delgado|G. Abelenda-Alonso|M. Gasa|J. Niubo|M. Dominguez|L. Calatayud|C. Ardanuy"
"4533","13/04 12:00","5","P0929","Julien OPPLIGER","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Diagnostic performance of short-trained emergency department physicians for pneumonia using lung ultrasound","J. Oppliger|T. Brahier|C. Bessat|R. Bingisser|M. Schwendiger|T. Bulaty|F. Graulich|Y. Fournier|V. Della Santa|M. Pfeil|D. Schwab|J. Leuppi|N. Geigy|S. Steuer|F. Roos|M. Christ|A. Sirova|T. Espejo|H. Riedel|A. Atzl|F. Napieralski|W. Albrich|O. Hugli|E. Garcia|N. Boillat-Blanco"
"4630","13/04 12:00","6","P0930","Yasmine CHELBI","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Current epidemiological profile of pertussis diagnosed in children in Tunis, Tunisia","Y. Chelbi|K. Meftah|S. Mhimdi|F. Aloui|A. Bouafsoun|H. Smaoui"
"4644","13/04 12:00","7","P0931","Sara SIERRA ALCAÑIZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Characterisation and analysis of a whooping cough outbreak in Albacete, Castilla-La Mancha, Spain","S. Sierra Alcaniz|P. Robles Dominguez|L. Robles Fonseca|P. Martin Bazarra|R. Abad Torreblanca|E. Escribano Garaizábal|E. De La Hoz Sereno|C. Sainz De Baranda Camino"
"4700","13/04 12:00","8","P0932","Chorong HAHM","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Changes in the prevalence of bacteria detected in respiratory infections and antibiotic resistance before and after the COVID-19 pandemic in Korea","C. Hahm"
"4940","13/04 12:00","9","P0933","Zeinab MOHSENIPOUR","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Predatory bacteria to combat respiratory infections: friend or foe?","Z. Mohsenipour|M. Feizabadi|F. Kianian|B. Jahanbin|H. Abtahi|M. Edalatifard|P. Arazi"
"4978","13/04 12:00","10","P0934","Sonsoles SALTO-ALEJANDRE","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Identification of clinical phenotypes in community-acquired pneumonia","B. Gutiérrez-Gutiérrez|S. Salto-Alejandre|J. Pachon|J. Rodriguez-Bano|J. Sánchez Céspedes"
"5106","13/04 12:00","11","P0935","Katarina HEDIN","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Penicillin V as first-line treatment for pneumonia in outpatient care: a register-based study of treatment failures","O. Cronberg|A. Beckman|S. Carlsson|K. Ekblom|A. Moberg|M. Tyrstrup|K. Hedin"
"5180","13/04 12:00","12","P0936","José Luis CARRIÓN FRÍAS","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Insight into the microbiological diagnosis of Streptococcus pneumoniae in pleural fluid in paediatric population with complicated pneumonia: a decade-long study","J. Carrion|M. Castano-Amores|F. Del Nogal|E. Viedma|M. Meléndez|J. Villa|R. Recio|P. Branas|I. Munoz-Gallego"
"5467","13/04 12:00","13","P0937","Irene CADENAS JIMÉNEZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Persistence of Haemophilus influenzae and Pseudomonas aeruginosa strains in bronchiectasis patients: a longitudinal study","I. Cadenas-Jiménez|P. Camps-Massa|Y. Benaali-Bakkar|F. Gonçalves-Carvalho|L. Rodriguez|A. Adrià|S. Lucia|C. Sara|O. Antonio|D. Maria Angeles|S. Salud|T. Fe|G. Aida|A. Carmen|M. Alicia|M. Sara"
"5557","13/04 12:00","14","P0938","Shiyu HUANG","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Post COVID-19 disruption of the respiratory microbiome modulates Mycoplasma pneumoniae infections: a multi-centre retrospective investigation study","S. Huang|Q. Cao"
"5577","13/04 12:00","15","P0939","Akhila M M","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Immunogenicity insights: comparing pneumococcal antibody levels in healthy and diabetic Indian adults","A. M. M.|S. M. R.|V. Govidan|R. Kl"
"5589","13/04 12:00","16","P0940","María Soledad ZAPICO GONZÁLEZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Whooping cough outbreak during 2024 in the fourth healthcare area in Asturias (north of Spain): epidemiological analysis","S. Bolanos|M. Sánchez Araujo|A. Fernandez Ibanez|M. Zapico González|S. Rojo Alba|E. Rodrigo Arrazola"
"5649","13/04 12:00","17","P0941","Katarina HEDIN","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Incidence of respiratory tract infections and complications in Sweden 2014-2023; developing a surveillance framework to evaluate antibiotic stewardship interventions","K. Hedin|M. Almstedt|T. Cars|A. Fasten|A. Hahlin|A. Olsson|C. Ahren|T. Tängdén"
"5694","13/04 12:00","18","P0942","Andrea STRENG","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Comparison of Streptococcus pneumoniae serotypes between children with paediatric parapneumonic pleural effusions/empyema and other invasive pneumococcal diseases: results from two nationwide surveillance systems, Germany, 2010/11-2023/24","A. Streng|A. Itzek|J. Forster|S. Blomenkamp|C. Schoen|J. Liese|M. Van Der Linden"
"5791","13/04 12:00","19","P0943","Sadjia MAHRANE","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Re-emergence of diphtheria in Algeria","S. Mahrane|A. Nait Kaci|S. Hasnaoui|F. Djedjig|S. Bouheraoua|H. Tali Maamar"
"6152","13/04 12:00","20","P0944","Maria Del Carmen PEREYRA BOZA","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Epidemiology of Mycoplasma pneumoniae infections in paediatric patients: trends and positivity rates from 2017 to 2024","V. Cortazzo|V. Di Maio|M. Pisani|M. Bianchi|M. Pereyra Boza|E. Chaiter|B. Lucignano|G. Vrenna|M. Rossitto|M. Agosta|S. Ranno|L. Coltella|G. Linardos|L. Colagrossi|S. Cristaldi|C. Russo|P. Bernaschi|A. Villani|C. Perno"
"6327","13/04 12:00","21","P0945","Preudtipong NOOPETCH","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Mortality in community-acquired pneumonia patients with and without microbial detection: a hospitalised cohort study","P. Noopetch"
"6341","13/04 12:00","22","P0946","Benoit VISSEAUX","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Whooping cough: the summer B. pertussis epidemic increase in France driven by young vaccine-targeted populations","S. Trombert-Paolantoni|B. Visseaux|M. Roussel|E. Hedbaut|V. Coyaud|L. Verdurme|C. Dhumieres"
"6376","13/04 12:00","23","P0947","Revathy ARUSHOTHY","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Pneumococcal carriage and capsular serotype prevalence among healthy children attending childcare centres in Klang valley, Malaysia: a pre-vaccination retrospective analysis","R. Arushothy|C. Tan|N. Nor Amdan|K. Chua|R. Hashim"
"6514","13/04 12:00","24","P0948","Sara CALVO-SILVERIA","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Interactions between SARS-CoV-2 and S. pneumoniae in adults: from colonisation to disease","L. Fernández-Delgado|S. Calvo-Silveria|A. Gonzalez-Diaz|R. Espana-Bonilla|S. Marti|L. Calatayud|J. Niubo|M. Dominguez|J. Càmara|C. Ardanuy"
"6537","13/04 12:00","25","P0949","Ridwanul AMIN","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Hospitalisation rates, disease burden, and aetiology for community-acquired pneumonia before, during and after the COVID-19 pandemic: a register-based cohort study among adults in Stockholm county, Sweden","R. Amin|P. Eriksson|P. Hedberg|P. Nauclér"
"6821","13/04 12:00","26","P0950","Mario RAMIREZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Non-invasive pneumococcal disease in Portugal: serotype distribution, comparison with invasive pneumococcal disease and potential vaccine coverage, 2023-2024","R. Nina-Cunha|A. Guerreiro-Nunes|J. Gomes-Silva|C. Silva-Costa|M. Ramirez|J. Melo-Cristino"
"6859","13/04 12:00","28","P0952","Patricia NADAL-BARON","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Neurological manifestations associated with Mycoplasma pneumoniae infection in adult patients","E. Márquez-Algaba|B. Boy|A. Vilaseca|P. Nadal-Baron|J. Burgos|H. Arino|A. Zabalza|X. Montalban"
"6868","13/04 12:00","29","P0953","Lucía TEJEDOR CANTERO","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","The atypical return of Mycoplasma pneumoniae in a tertiary hospital","L. Tejedor Cantero|S. Rojo Rello|V. Cerpa Almenara|N. González Espinosa|J. Guevara Osorio|M. Uruena Garcia|B. Requejo Baruque|J. Gutiérrez Ballesteros|B. González Fernández|M. Garcinuno Perez|I. Lopez Mestanza|J. Eiros Bouza"
"6906","13/04 12:00","30","P0954","Juan Pablo RODRIGUEZ-RUIZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Detection of respiratory pathogens in the nasopharynx of children hospitalised with severe pneumonia in sub-Saharan Africa","J. Rodriguez-Ruiz|K. Loens|V. Musiime|M. Clements|A. Walker|J. Bielicki|M. Sharland|S. Malhotra-Kumar"
"6917","13/04 12:00","31","P0955","Gülsüm Iclal BAYHAN","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Clinical and antibiotic resistance patterns in paediatric pneumococcal infections: a retrospective analysis from a tertiary care centre","E. Tekgul|G. Bayhan|G. Cinel"
"7006","13/04 12:00","32","P0956","Esther DE LA HOZ SERENO","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Mycoplasma pneumoniae infection in the paediatric population at a tertiary care hospital","E. De La Hoz Sereno|E. Simarro Cordoba|S. Sierra Alcaniz|L. Robles Fonseca|C. Sainz De Baranda Camino"
"7055","13/04 12:00","33","P0957","Romy RIEGER","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Active nationwide surveillance of invasive pneumococcal disease (IPD) to enable choice of extended-spectrum PCV for elderlies in Israel","R. Rieger|D. Yahav|I. Margalit|H. Azulay|M. Bitan|A. Attamana|Y. Schindler|H. Abu Zayyad|R. Dagan|G. Regev-Yochay"
"7153","13/04 12:00","34","P0958","Isabel Cristina LÓPEZ MESTANZA","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Epidemiology of whooping cough in a Spanish tertiary hospital beyond COVID-19","I. Lopez Mestanza|S. Rojo Rello|M. Miguel Gomez|V. Cerpa Almenara|L. Tejedor Cantero|N. González Espinosa|G. March Rosello|M. Garcinuno Perez|J. Gutiérrez Ballesteros|J. Guevara Osorio|J. Eiros Bouza"
"7200","13/04 12:00","35","P0959","Dariane PEREIRA","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Resurgence of pertussis in southern Brazil: a two-year analysis of increasing Bordetella pertussis cases","B. Kappaun|W. Matos|L. Costa|L. Antochevis|A. Hellwig|G. Rodrigues|L. Giordani|P. Barth|F. De Paris|M. Ritter|E. Costabeber|D. Menezes|C. Soares|R. Paiva|D. Pereira"
"7324","13/04 12:00","36","P0960","Juan Pablo RODRIGUEZ-RUIZ","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","The gastrointestinal resistome and microbiota of children hospitalised with severe pneumonia in sub-Saharan Africa in the PediCAP trial","J. Rodriguez-Ruiz|S. Hiel|V. Musiime|M. Clements|A. Walker|J. Bielicki|M. Sharland|S. Malhotra-Kumar"
"7531","13/04 12:00","37","P0961","Tian-Chi ZHOU","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Risk factors influencing the carriage of Streptococcus pneumoniae among children","T. Zhou|J. Ai|Y. Zhang|Y. Qu|W. Zhang"
"7668","13/04 12:00","38","P0962","Zurva ASHRAF","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Re-emergence of diphtheria in Pakistan: a call for reinforced immunisation efforts to prevent future outbreaks","Z. Ashraf|M. Salman|L. riaz|A. zaman"
"7683","13/04 12:00","39","P0963","Laura DIAB CASARES","2","B","02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Study of S. pneumoniae serotypes and their associations with clinical factors/mortality and antimicrobial resistance in the Comunidad Valenciana","L. Diab Casares|M. Guna Serrano|N. Tormo Palop|C. Gimeno Cardona|A. Gil"
"142","13/04 12:00","40","P0964","Mohsen ROKNI","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Comparison of the high-dose dual treatment with standard quadruple treatment methods containing bismuth subcitrate as the first line of treatment in eradicating Helicobacter pylori infection","S. Nikpour|M. Salehi|M. Abbasy|A. Ghahremani|S. Abasi|M. Rokni"
"398","13/04 12:00","41","P0965","Amani ALFADHLI","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Salmonella enterica serotypes causing infection in Kuwait during 2018-2021, determined by multi-locus sequence typing and whole-genome sequencing","A. Alfadhli|W. Jamal|M. Albert"
"467","13/04 12:00","42","P0966","Christopher SMITH","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Symptom profiles and stool shedding dynamics from a first-in-human Salmonella paratyphi murium-controlled human infection model","C. Smith|R. Varro|A. Rydlova|E. Smith|M. Gordon|J. Hinton|X. Liu|Y. Ni|R. Choy|C. Chiu|G. Cooke|M. Gibani"
"747","13/04 12:00","43","P0967","Anna JONES","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Diagnostic stewardship for paediatric diarrhea: a qualitative study of parent and provider perspectives","A. Jones|A. Mangadu|S. Dallas|O. Hanson|K. Arn|P. Gesteland|J. Szymczak|A. Pavia|D. Leung|M. Watt"
"1349","13/04 12:00","44","P0968","Harpreet KAUR","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Enteroaggregative Escherichia coli: from a diarrhoeal pathogen to a superbug uropathogen?","H. Kaur|V. Modgil|N. Chaudhary|B. Mohan|N. Taneja"
"1363","13/04 12:00","45","P0969","Neelam TANEJA","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","I am here if you want to detect me, i am important too: campylobacteriosis in India","N. Taneja|J. Mahindroo|C. Narayan|B. Mohan"
"2168","13/04 12:00","46","P0970","Dietmar PFEIFFER","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Identification of potentially new anti-infectives against Helicobacter pylori by repurposing FDA-approved drugs","D. Pfeiffer|T. Burrell|R. Mejias-Luque|M. Gerhard"
"2628","13/04 12:00","47","P0971","Geoffrey ROSSI","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Short-course vs long-course antibiotic therapy for pyogenic liver abscess: a retrospective cohort study","M. Beydon|Y. Nguyen|O. Roux|S. Dokmak|F. Bert|M. Ronot|C. Pouchelon|A. Hamon|A. Sokal|V. Zarrouk|V. Delastours|B. Fantin|A. Lefort|G. Rossi"
"3001","13/04 12:00","48","P0972","Wania FREITAS","2","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Global warming can exacerbate the infectious diseases occurrence: an analysis of Brazilian typhoid fever cases over 17 years, 2007-2024","W. Freitas|Y. Costa|I. Albuquerque|R. Fleury|M. Alves"
"3149","13/04 12:00","1","P0973","Hyun Ah KIM","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Clinical and microbiological differences in Klebsiella pneumoniae liver abscess by metastatic spread","M. Hyun|J. Lee|H. Kim"
"3640","13/04 12:00","3","P0975","Joseph THOMPSON","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Audit of enteric fever management in Manchester, UK: opportunities for antimicrobial stewardship due to high rates of ceftriaxone susceptibility","J. Thompson|S. Ladha|N. Shafiq|T. Lamb"
"3672","13/04 12:00","4","P0976","Philippe LEHOURS","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Description of the first two human cases of infection with Helicobacter zhangjianzhongii, a new Helicobacter closely related to Helicobacter canis","W. Sahel|Q. Jehanne|L. Benejat|A. Ducournau|J. Aptel|M. Levast|M. Jauvain|P. Lehours"
"4012","13/04 12:00","6","P0978","Irene MILETO","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Salmonella typing: from serum agglutination to WGS","I. Mileto|G. Grassia|G. Romano|S. Gaiarsa|J. Bagnarino|M. Corbella|A. Piralla|P. Cambieri|V. Monzillo|F. Baldanti"
"4268","13/04 12:00","7","P0979","Sofia NARVÁEZ MORALES","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Prevalence of campylobacteriosis and antimicrobial resistance in Vallès Occidental: a three-year descriptive study","S. Narváez|M. Jiménez|M. Ballestero-Téllez|G. Santillana|J. Pérez"
"4687","13/04 12:00","8","P0980","Koh SHINOHARA","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Clinical characteristics of campylobacteriosis in immunocompromised patients in comparison with immunocompetent patients","Y. Tsuda|Y. Tsuchido|M. Yamamoto|Y. Matsumura|M. Nagao|K. Shinohara"
"4762","13/04 12:00","9","P0981","Aadhil AHAMED","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Evaluating the awareness of campylobacteriosis among adults in Sri Lanka","A. S. Abdeen|N. Ruwanpathiranage"
"4896","13/04 12:00","10","P0982","Verena ZERBATO","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Campylobacter bacteraemia outcomes: a systematic review with meta-analysis","V. Zerbato|S. Crocè|R. Luzzati|A. Maraolo|C. Fanelli|L. Fusaro|A. Botan|L. Principe|D. Toc|S. Di Bella|S. Guicciardi|R. Baldan"
"5259","13/04 12:00","11","P0983","Mohammad Ridhuan MOHD ALI","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Genomic and epidemiological insights into Campylobacter fetus subsp. testudinum B1200: analysis of two clinical isolates with divergent outcomes","M. Mohd Ali|J. Mohamed Zahidi|N. Abd Hazis|K. Kubota|H. Walpola|F. Ambrosio|R. Hashim"
"5427","13/04 12:00","12","P0984","Nayna BABAR","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","A species-specific PCR approach to enhance probiotic studies exploring Christensenella minuta","N. Babar|A. Váradi|C. Freytag|L. Laczko|G. Kardos|K. Szarka|E. Fidrus"
"5581","13/04 12:00","13","P0985","Priscilla PASUTTO","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","A retrospective study of Salmonella enterica in Lombardy (northern Italy) drew attention back to invasive serotypes","P. Pasutto|M. Gori|C. Fappani|D. Colzani|M. Pontello|A. Amendola|E. Tanzi|S. Bianchi"
"6015","13/04 12:00","14","P0986","Marcos HERNANDO GOZALO","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","A two-year longitudinal study of the epidemiology of Escherichia coli enteritis in a Spanish secondary hospital","C. Rescalvo-Casas|M. Hernando Gozalo|H. Bermúdez-Marval|L. Seijas-Pereda|C. Garcia-Bertolin|G. Sánchez-De Luis|T. Costales Lucia|R. Pérez-Tanoira|J. Cuadros-González"
"6375","13/04 12:00","15","P0987","Beidi ZHU","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","The application value of mNGS and etiologic features in liver abscess with underlying intra-abdominal risk factors","B. Zhu|Q. Miao|B. Hu"
"6895","13/04 12:00","17","P0989","Yaren BUYUKCOLAK CEBECI","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","The role of H. pylori virulence factors triggering pyroptosis in gastritis and ulcer pathology","Y. Buyukcolak Cebeci|E. Timucin|S. Akcelik Deveci|N. Mansur Ozen|T. Aydinlar|A. Tiftikci|S. Oktem Okullu"
"6975","13/04 12:00","18","P0990","Tadesse EGUALE","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Management of diarrhea among patients attending public health centre and private clinics in Addis Ababa, Ethiopia","A. Leta|D. Wolde|M. Legesse|G. Medhin|E. Tigabu|T. Eguale"
"7032","13/04 12:00","19","P0991","Ramón VELA FERNANDEZ","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Application of whole-genome sequencing and bioinformatics in the epidemiological surveillance of non-typhoidal Salmonella enterica at the clinical level","R. Vela-Fernández|P. Fernández-Palacios|T. Trujillo-Soto|C. Sánchez Casimiro-Soriguer|E. Jurado-Tarifa|F. Galán-Sánchez|M. Rodriguez-Iglesias"
"7328","13/04 12:00","20","P0992","Laura ANDRÉS ESLAVA","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Enteric pathogens in flood-affected populations: insights from the Valencia flood event","L. Andrés Eslava|V. Artal Munoz|C. Salvador Garcia|L. Sempere Mira|N. Talon Costa|P. Floria Vaquero|L. Suarez Lopez|V. Nova Marqués|C. Gimeno Cardona"
"7428","13/04 12:00","21","P0993","Alimatou HEMA","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Prevalence and drug-resistance patterns of enterotoxigenic Escherichia coli among children with diarrhea in Ouagadougou, Burkina Faso","A. Héma|R. Kaboré|I. Tondé|M. Tamboura|M. Sanou"
"7463","13/04 12:00","22","P0994","Alejandra ARENAS","3","B","02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Helicobacter pullorum isolated from stool culture in a tertiary hospital in Madrid","P. Lauria De Oliveira|A. Arenas Martinez-Armero|P. Gomez Sastre|E. Lozano Vilches|R. Arroyo Rodrigues|L. Cardenoso Domingo|T. Alarcon Cavero"
"135","13/04 12:00","23","P0995","Carl LLOR","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Exposure to continuous suppressive antibiotic therapy in women with recurrent urinary tract infections and the severity of infectious complications: a population-based cohort study","D. Ochai|A. Moragas|R. Morros|S. Fernandez-Garcia|M. Giner-Soriano|C. Llor"
"170","13/04 12:00","24","P0996","Debby BEN-DAVID","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Improving urine culture appropriateness and reducing unnecessary testing through education and feedback in a hospital setting","G. Frankfurter|Y. Cohen|I. Zohar|Y. Maor|D. Ben-David"
"412","13/04 12:00","25","P0997","Maxime VALLÉE","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Diagnosis and management with urinary behavioral therapy of recurrent acute bacterial cystitis in women: preliminary results of the URICA study","T. Maurice|O. Lemetayer|C. Bonduelle|A. Sotto|M. Vallée"
"561","13/04 12:00","26","P0998","Loreto SANGORRIN-LAPIEZA","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Trends and clinical characteristics of anorectal Chlamydia trachomatis infections: a comparative analysis of lymphogranuloma venereum (LGV) and non-LGV serovars","L. Sangorrin-Lapieza|P. Lopez-Roa"
"590","13/04 12:00","27","P0999","Merel E.P. WILMSEN","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Breaking the cycle: barriers to UTI prevention in primary care","M. Wilmsen|L. Van Gestel|M. De Boer|A. Koucher|M. Aantjes|L. Van Bodegom-Vos|R. Vos|T. Bonten|S. Geerlings|L. Visser|M. Lambregts|M. Sijbom"
"640","13/04 12:00","28","P1000","Arash LETAFATI","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Chlamydia trachomatis prevalence in patients suspected with keratitis: unravelling insights among diverse eye specimen type","A. Letafati"
"820","13/04 12:00","29","P1001","Jorge-Alfredo PEREZ-GARCÍA","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Causative microorganisms of sexually transmitted infections in a STI clinic during the year 2024","J. Perez-Garcia|M. Escobar|B. Baza|I. Diaz|E. Orviz|M. Vera|R. Linares|T. Puerta|I. Armenteros|M. Sanchez|L. Dans|S. Fernandez|N. Fernandez|R. Mayorga|B. Tena|M. González|R. Sánchez|P. Fernández|J. Del Romero|A. Delgado-Iribarren"
"1015","13/04 12:00","30","P1002","Deepak KOCHER","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","The O25b-ST131 pandemic uropathogenic E. coli in India: examining antibiotic resistance, virulence, and phylogenetic distribution in community-acquired UTIs","D. Kocher|S. Mohapatra|S. Pundir|B. Das|B. Dhawan|S. Sood|H. Gautam|B. Nayak|A. Kapil|M. Kalaivani|P. Hari"
"1133","13/04 12:00","31","P1003","Jose BAEZA ROS","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Infections caused by Mycoplasma genitalium: an emerging pathogen","J. Baeza Ros|A. Moreno Docon|G. Valero Chazarra|E. Aguilar Monino"
"1301","13/04 12:00","32","P1004","Franziska Dorothee SCHULER","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","What is the most effective culture-based detection approach for Streptococcus agalactiae colonisation in pregnant women?","S. Schoeler|T. Theiler|M. Möllers|I. Olaru|F. Schuler|F. Schaumburg"
"1504","13/04 12:00","33","P1005","David VALTIERRA","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Establishment and validation of a lower genital tract Neisseria gonorrhoeae infection in ovariectomised mice","D. Valtierra|M. Pulse|P. Nguyen|K. Peterson|L. Beeman|W. Weiss|A. Ogbonna|M. Espinoza-Sauceda"
"1631","13/04 12:00","34","P1006","Ashim Kumar DUBEY","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Understanding polymicrobial UTIs : results from a retrospective study and prospective sample collection indicate significant differences in urinary microbial composition and AMR patterns by sample type","A. Dubey|J. Reyes|C. Rhiner|K. Drescher|J. Dunkel|J. Mckinney|A. Egli"
"1651","13/04 12:00","35","P1007","Meghan LUCK","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Treatment failure in patients with uncomplicated urinary tract infection in the United States: a latent class cluster analysis","D. Fromer|J. Ellis|D. Proco|R. Chang|M. Mahendran|M. Pinaire|M. Piplani|M. Duh|M. Luck"
"1710","13/04 12:00","36","P1008","Azucena RODRIGUEZ-GUARDADO","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Does age influence the effectiveness of OPAT programmes?","A. Licetti|S. Santos|I. Bayon|R. Pampin|S. Tembras|P. Garcia|A. Rodriguez-Guardado"
"1745","13/04 12:00","37","P1009","Jeong Woo LEE","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","A multicentre, observational study on efficacy and safety of six-month long-term therapy with Uro-Vaxom in patients with recurrent urinary tract infection","L. Jeong Woo|J. Hae Do|L. Joo Yong|C. Hoon|K. Tae Hyoung"
"1769","13/04 12:00","38","P1010","Ngai Sze WONG","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Multi-anatomic site prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection among male in HIV care","N. Wong|B. Wong|D. Chan|D. Cheung|H. To|S. Chung|M. Ip|S. Lee"
"1875","13/04 12:00","39","P1011","Alicia BORONAT MUÑOZ","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Is Haemophilus sp. a pathogenic species to consider in the clinical entity of urethritis?","A. Boronat Munoz|M. Ballestero-Téllez|M. Ribas Oriol|P. Moreno Ocana|R. Sánchez Ubeda|C. Berrar Colmenero|R. Rubio Casino|M. Guiu Rajadell|P. Pérez Jove"
"1894","13/04 12:00","40","P1012","Fiona MURPHY","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Epidemiological profile of Neisseria gonorrhoeae in the west of Ireland","F. Murphy|C. Coleman|S. Connolly|J. Freeman|P. Cremin|C. Fleming"
"2074","13/04 12:00","41","P1013","Oguzhan ACET","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Pelvic inflammatory disease in hospitalised patients: a retrospective single-centre analysis in developing country","O. Acet|S. Dirik|A. Kaya|N. Yalcin|O. Sipahi|B. Arda|M. Tasbakan|E. Bolat|S. Aydemir|I. Hortu|M. Kanat|H. Erdem"
"2268","13/04 12:00","42","P1014","Carlos KIFFER","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Urinary tract infection burden and trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden on public healthcare data, 2013-2022","É. Carmo|C. Wagner|B. Franzon|A. Aquino|M. Otani|P. Charf|A. Marinonio|A. Colombo|C. Kiffer"
"2273","13/04 12:00","43","P1015","Carlos KIFFER","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Urinary tract infection related antimicrobial resistance burden in hospitalised patients over 10 years: a national bottom-up initiative for disease and AMR burden on public healthcare data 2013-2022.","C. Wagner|É. Carmo|B. Franzon|P. Charf|A. Aquino|M. Otani|A. Marinonio|A. Colombo|C. Kiffer"
"2290","13/04 12:00","44","P1016","Wayne LEUNG","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Ocular syphilis frequently presents without known sexual risk factors: the importance of ophthalmology screening","W. Leung|E. Shojae|T. Sheidow|L. Bursztyn|M. Devlin|M. Silverman|R. Reza"
"2661","13/04 12:00","45","P1017","Shruptha KUMARI","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Microbiome analysis of cervical cancer identified Stenotrophomonas as a potential pathogen involved in tumor progression","S. Kumari|P. Jayarama|S. Kapaettu|J. Poyya"
"2679","13/04 12:00","46","P1018","Maria Lucia GALLO VAULET","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Surveillance of STIs in symptomatic male patients attending the STI clinic of the university hospital in Buenos Aires, Argentina: high prevalence of extragenital infections","M. Gallo Vaulet|C. Vay|A. Melgar|M. Rodriguez Fermepin|A. Famiglietti|M. Losada|L. Caceres|D. Sosa|A. Toledano|S. Garcia"
"2696","13/04 12:00","47","P1019","Bastian DIRK","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","""Ex vivo-response"" to antibiotic therapy in urinary tract infection: early treatment response detected by monitoring bacterial counts in consecutive urines","B. Dirk|H. Swilem|M. Holz|B. Schönbeck|L. Von Muller"
"2878","13/04 12:00","48","P1020","Murat Hakan KIR","3","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Investigation of individuals diagnosed with ocular syphilis, with and without HIV","M. Kir|Z. Abdullayeva|A. Benli|S. Basaran|S. Simsek Yavuz|A. Cagatay|O. Oncul|H. Ozsut"
"2884","13/04 12:00","1","P1021","Sofie Skovmand RASMUSSEN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","In vitro activity of thiamphenicol against drug-susceptible and -resistant strains of Mycoplasma genitalium","S. Skovmand|C. Nørgaard|K. Salado-Rasmussen|J. Jensen"
"2922","13/04 12:00","2","P1022","Miriam LATORRE-MILLÁN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Prevalence of sexually transmitted infections in women infected with human papilloma virus","N. Burillo|M. Ariza|A. Milagro|A. Tristancho-Baro|P. Abad|L. Baquedano|A. Borque|A. Rezusta|M. Latorre-Millán"
"2932","13/04 12:00","3","P1023","Ilaria DE LUCA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Empirical ESBL vs NON-ESBL therapy in a cohort of patients admitted to the emergency department for urinary tract infections: the UTILY study, a multicentre prospective study","I. De Luca|L. Onorato|E. Allegorico|M. Macera|C. Monari|B. Migliaccio|C. Nasta|M. Florio|R. Sciorio|F. Numis|G. Guiotto|M. Giordano|R. Raucci|F. Dello Vicario|R. Nasti|A. Voza|N. Coppola"
"2938","13/04 12:00","4","P1024","Tadhg SULLIVAN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Adjunctive treatment with doxycycline for the treatment of Mycoplasma genitalium infection: a systematic review","T. Sullivan|K. Jackson"
"3016","13/04 12:00","5","P1025","Bruna DA SILVA MIRANDA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","TechTrials' Brazilian public health documentation of urinary tract infection during COVID-19 pandemic","B. Da Silva Miranda|C. Peçaibes De Oliveira|S. Figueiredo Costa|E. Cerdeira Sabino|D. Valverde|E. Da Motta Pacheco Alves De Araujo"
"3164","13/04 12:00","6","P1026","Sevinc ALIYEVA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Effect of E.coli on plasma NTproBNP levels in patients cardiosclerosis after myocardial infarction","S. Aliyeva|A. Hajiyev|G. Dadashova|Z. Rakhmanov|S. Hajizada"
"3181","13/04 12:00","7","P1027","Alanna FARRELL-FOSTER","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Patient characteristics and clinical outcomes among patients with complicated urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacterales: a US cohort study","R. Shields|M. Drysdale|R. Chang|L. Yu|M. DerSarkissian|M. Pinaire|Z. Chen|M. Duh|J. Ellis|A. Farrell-Foster|F. Mitrani-Gold"
"3206","13/04 12:00","8","P1028","Rui ZHANG","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Varied community burden of Chlamydia trachomatis and Neisseria gonorrhoeae infections by anatomic site in men who have sex with men: a longitudinal study","R. Zhang|N. Wong|D. Chan|S. Chung|T. Kwan|K. Lee|C. Kwan|S. Lee"
"3297","13/04 12:00","9","P1029","Tina TRIGLAV","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","A brief look at the genome of Treponema pallidum in clinical samples from Slovenian patients","K. Strasek Smrdel|A. Celar Sturm|V. Cvitkovic Spik|T. Triglav"
"3644","13/04 12:00","10","P1030","Sebastiaan MOGGRE","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Scoping review of reported outcomes in clinical trials on complicated urinary tract infections","S. Moggre|K. Romijnders|A. Reuland|M. Bonten|T. Ten Doesschate"
"3683","13/04 12:00","11","P1031","Eleni POLYZOU","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Impact of bacteraemia on clinical outcomes and costs in urinary tract infections: a retrospective study","E. Polyzou|S. Tsoupra|M. Gavatha|G. Schinas|A. De Lastic|K. Skintzi|V. Niarou|K. Akinosoglou"
"3737","13/04 12:00","12","P1032","Markus HELL","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Chronic bacterial prostatitis a neglected disease: reevaluation of pathogen spectrum and new treatment options","M. Hell|S. Maiburger|I. Schwingenschlögel"
"3802","13/04 12:00","13","P1033","Sydney NELSON","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Designing and validating real-time PCR assays for Prevotella bivia, Peptostreptococcus anaerobius, and Dialister micraerophilus, three genital anaerobic bacteria associated with HIV acquisition","S. Nelson|M. Spyers-Duran|M. Aziz|D. Marcone|R. Kaul|R. Galiwango|R. Yee|C. Liu"
"3818","13/04 12:00","14","P1034","Aida RAMIREZ MARINERO","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Feasibility of pooling urogenital and extragenital specimens for sexual transmitted infections (STI) screening in asymptomatic individuals","M. González Soler|S. Molinos Abos|N. Romani Rodes|P. Pillado Alonso|N. Ladines Reyes|P. Nef Rabadán|P. Cardona|A. Ramirez Marinero"
"3891","13/04 12:00","15","P1035","Juan Carlos GARCÍA-BETANCUR","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Population structure of CTX-M-producing uropathogenic Escherichia coli recovered from patients with complicated urinary tract infection (cUTI) in a high complexity hospital in Bogota (Colombia)","E. De La Cadena|J. Garcia-Betancur|B. Castro-Cardozo|N. Restrepo-Arbeláez|P. Christian José|M. Claudia Paola|M. Luis Alfonso|Z. Camilo|V. Maria Virginia"
"4240","13/04 12:00","16","P1036","Loris MOCIBOB","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","High prevalence and incidence of bacterial sexually transmitted infections among HIV pre-exposure prophylaxis users in Croatia, 2018-2022","N. Sarac|L. Mocibob|S. Zidovec Lepej|J. Begovac"
"4254","13/04 12:00","17","P1037","Javeria PERVAIZ","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Immunosuppressive macrolides inhibit transcription factors and epithelial-mesenchymal transition (EMT) related parameters induced by Chlamydia trachomatis infection in conjunctival epithelial cells","J. Pervaiz|I. Ghanem|E. Awad|T. Barisani-Asenbauer"
"4406","13/04 12:00","18","P1038","Chiara MACI","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","The controversial significance of Stenotrophomonas maltophilia isolation in urine samples: insights from a 15-year single-centre experience","C. Maci|R. Monardo|E. Scifo|S. Carletti|C. Tassandin|P. Scarpellini|A. Castagna|M. Ripa"
"4479","13/04 12:00","19","P1039","Alicia GALAR","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Could second and third trimester urine culture increase the detection of Group B Streptococcus (GBS) colonisation in pregnancy?","S. De La Villa|A. Alvarez-Uria|C. Vinuela|S. Lizarraga|E. Bouza|P. Munoz|A. Galar"
"4564","13/04 12:00","20","P1040","Carla MIMOSO SANTOS","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Antimicrobial prophilaxis in endourological procedures: early results and challenges","A. Rodrigues|F. Gonçalves|G. Domingos|I. Sousa|S. Pereira|C. Mimoso Santos|M. Fernandes"
"4714","13/04 12:00","21","P1041","Asma NASEEM","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Microbiology and risk factors for bacteremic urinary tract infection: insights from the largest urological centre in Pakistan","A. Naseem|S. Dodani"
"4724","13/04 12:00","22","P1042","Steven ARONIN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Impact of age on antibiotic resistance and efficacy of antibiotics for women with uncomplicated urinary tract infection","S. Aronin|S. Puttagunta|J. Gupta|M. Dunne"
"4902","13/04 12:00","23","P1043","Dongheui AN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","The prevalence of sexually transmitted infection pathogens in a Korean single-commercial laboratory over the last three years","D. An|M. Kim|S. Lee|Y. Sohn"
"5108","13/04 12:00","24","P1044","Ana MORAGAS MORENO","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Validity of leukocyte esterase and/or nitrite results for the diagnosis of bacteriuria in older individuals: a systematic review and meta-analysis","A. Moragas|A. Garcia-Sangenis|R. Monfà|C. Llor"
"5398","13/04 12:00","25","P1045","Elena ADDIS","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Heterogeneity in assessing the burden of urinary tract infections: a literature review and recommendations","E. Addis|J. Garlasco|M. Pezzani|O. Awwad|D. Ortiz Quiroga|K. Odoj|C. Magnabosco|F. Manco|F. Arieti|E. Tacconelli"
"5503","13/04 12:00","26","P1046","Carl LLOR","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Utilisation of a simplified and practical algorithm to assess potentially unnecessary antibiotic use for suspected urinary tract infections in nursing homes","A. Moragas|M. Elistratova|L. Vallejo-Torres|B. Gonzalez Lopez-Valcarcel|J. Nygaard Jensen|M. Theut|V. Antsupova|M. Pledjrup Hansen|J. Olsen|J. Lykkegaard|A. Bálint|H. Glasova|J. Glasa|G. Tsoulchai|. Anastasaki|C. Lionis|A. Kowalczyk|D. Petek|N. Sodja|L. Jaruseviciene|R. Radzeviciene|G. Ruppe|A. Garcia-Sangenis|R. Monfà|C. Llor"
"5530","13/04 12:00","27","P1047","Marta LERATE ALBA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Distribution of human papillomavirus genotypes in endocervical exudates from women, Malaga, Spain, 2021-2024","F. Chamizo-Lopez|M. Lerate-Alba|A. Borrego-Alcaide|A. Fernández-Sánchez|B. Palop-Borrás|M. Pérez-Ruiz"
"5727","13/04 12:00","28","P1048","Jan ZÁVORA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Cumulative antibiograms can support adequate management of urinary tract infections if done properly","J. Závora|G. Kroneislová|M. Matouskova|V. Adámková"
"5760","13/04 12:00","29","P1049","Vicens DIAZ BRITO FERNANDEZ","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Individualised autovaccine therapy significantly reduces recurrence and improves quality of life in women with recurrent urinary tract infections (rUTI), regardless of non-modifiable risk factors (nmRF).","V. Diaz-Brito|M. Sanmarti|A. Cardenas|A. González-Cuevas|M. Guerrero|A. Capella|E. Martinez-Franco|M. Margarit|A. Agud|J. Bastaros|F. Medina|E. Moreno|M. Alvarez|S. Balsells|E. Esteve-Palau"
"5782","13/04 12:00","30","P1050","Patricia GARCIA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Sexually transmitted infections and their impact on bacterial vaginosis: findings from a one-year review","P. Garcia|J. Niubo|J. Ayats|L. Calatayud|S. Maestre|C. Rodriguez|C. Arin|N. Prim|M. Dominguez|D. Sánchez"
"5816","13/04 12:00","31","P1051","Neva BRACCIALARGHE","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Screening for sexually transmitted infections in a cohort of people living with HIV: a retrospective analysis of a single centre in 2023","N. Braccialarghe|D. Zaçe|R. Cavasio|V. D'aquila|I. Fato|G. Alessio|V. Tatou Metsanou|L. Ansaldo|D. Checchi|M. Compagno|E. Teti|L. Sarmati"
"5825","13/04 12:00","32","P1052","Cansel VATANSEVER","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","A multi-centre retrospective study on urinary tract infections from patients in Turkey reveals alarming antibiotic resistance levels","A. Akpinar|G. Karahan|S. Aydemir|D. Öcal|C. Vatansever|J. Boral|S. Kolsuz|Ö. Ergonul|H. Tokucoglu|E. Uzunoglu|E. Aktas|B. Otlu|I. Kaleli|O. Azap|S. Aksaray|F. Can"
"5924","13/04 12:00","33","P1053","Bilge MAZLUMOGLU","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Investigation of Streptococcus agalactiae colonisation in pregnancy by culture and molecular methods","B. Mazlumoglu|L. Genç|S. Birol Ince|S. Pelit|E. Aktas|E. Tanriverdi"
"6131","13/04 12:00","34","P1054","Valentina IMPERADORI","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Performance evaluation of a boric acid-free device designed for pre-analytics in urine culture testing for UTIs","V. Imperadori|M. Beffa"
"6173","13/04 12:00","35","P1055","Valentina IMPERADORI","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Evaluating a boric acid-free device designed for UTIs pre-analytics in urine molecular and antigenic testing","V. Imperadori|M. Beffa"
"6336","13/04 12:00","36","P1056","Julia ALCOBA FLÓREZ","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Actively looking for cases of lymphogranuloma venereum in the southern Tenerife population","B. Pino Calm|D. Garcia Martinez De Artola|E. Canton-Benito|J. Alcoba Florez"
"6486","13/04 12:00","37","P1057","Jeferson MANOEL TEIXEIRA","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Vulnerability of people living whith autism: the urgency of inclusive sexual education","L. Ferreira|I. Talacimon Barbosa|R. Mendes De Oliveira|A. Suarez Paz|L. Martins Da Silva|J. Manoel Teixeira"
"6832","13/04 12:00","38","P1058","Erik SENNEBY","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Streptococcus dysgalactiae as the cause of peripartum infections: a population-based cohort study with a phylogenetic analysis of hospital clusters","M. Rasmussen|E. Senneby|M. Dooley|O. Gunnarsson|A. Carblom|A. Petersson"
"6890","13/04 12:00","39","P1059","Gülsah GELISIGÜZEL","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Prospective evaluation of ESBL risk factors and empirical treatment based on culture result suitability of community-acquired pyelonephritis","G. Gelisiguzel|S. Altun Demircan|M. Aysin|E. Kaya Kilic|S. Yagci|S. Kinikli|R. Berkem"
"6910","13/04 12:00","40","P1060","María DE LA MATA FERNÁNDEZ","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Aerococcus spp., emerging pathogens isolated from a Spanish tertiary care hospital","M. De La Mata Fernández|N. Yuste Ángel|P. Lauria De Oliveira|V. Garcia Artiaga|L. Cardenoso Domingo|M. Diez Aguilar"
"6974","13/04 12:00","41","P1061","Ayla YARCI CARRION","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Exudative sexually transmitted infections among PrEP-users, people living with HIV and general population: a retrospective observational study","A. Yarci Carrion|I. Fradejas Villajos|M. Grados Sánchez|A. Ortega Fernández|J. Valverde Cánovas|C. Campelo Gutiérrez|M. Goyanes Galán|J. Losa Garcia"
"7029","13/04 12:00","42","P1062","Digbijay KUNWAR","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Antibiotic class comparisons for acute pyelonephritis: a systematic review of randomised, controlled trials","D. Kunwar|I. Zahavi|J. Olchowski|H. Dallashi|M. Paul"
"7165","13/04 12:00","43","P1063","Rachele PINCINO","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Temporal trends of sexually transmitted infections from 2018 to 2023 in two community hospitals in Liguria","R. Pincino|M. Berruti|N. Forni|K. Sciolé|S. Tita Farinella|D. Laurenda|M. Migliorati|G. Malerba|D. Picicco|M. Dotta|P. Dusi|G. Cenderello"
"7287","13/04 12:00","44","P1064","Naruemit SAYABOVORN","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Five-Year Review of Diagnostic Practices and Antibiotic Prescribing Patterns for Acute Cystitis: Insights from a University Hospital in Thailand","N. Sayabovorn|P. Ariyakunaphan|C. Kositamongkol|P. Phisalprapa|T. Chaisathaphol"
"7307","13/04 12:00","45","P1065","Mikel URRUTIKOETXEA-GUTIERREZ","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","LGV are we trying too hard?","M. Almela-Ferrer|M. Barberá-Gracia|M. Lopez De Munain|J. Diaz De Tuesta Del Arco|M. Urrutikoetxea-Gutierrez|Y. Casado Alonso|L. Hernández Ragpa"
"7308","13/04 12:00","46","P1066","Jaya PRASANTHI","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Optimising diagnostic and antibiotic stewardship with BLADDER score","S. Jaya Prasanthi|M. Mubeen|I. Dhinakaran|N. Tamilmani"
"7340","13/04 12:00","47","P1067","María Del Rosario ALMELA FERRER","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Molecular surveillance of Neisseria gonorrhoeae in north Spain","M. Almela Ferrer|M. Nieto Toboso|M. Urrutikoetxea Gutiérrez|E. Ugalde Zárraga|M. Imaz Pérez|L. Hernández Ragpa|M. Lopez De Munain|J. Diaz De Tuesta Del Arco|M. Basaras Ibarzabal|R. Cisterna Cancer"
"7396","13/04 12:00","48","P1068","Marta ROLO","4","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Prevalence of Streptococcus agalactiae colonisation in the general female population and description of its phenotypic resistance profile","L. Romero-Oraá|M. Rolo|A. Garcia|B. González-Blanco|N. Navarrete-Ferrero|E. Echeverria-Moran|M. Garcia-Sanchez|M. Sánchez-Megia|L. Hernández-Arévalo|V. Ballesteros-Pena|S. Utrilla-Plazuelo|P. Romero-Amenta|C. Martin-Higuera"
"7494","13/04 12:00","1","P1069",,"5","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Risk factors for ciprofloxacin-resistant and ESBL-producing E. coli or Klebsiella spp. in patients with urinary tract infections: implications for empirical treatment","J. Lundvik|H. Montelin|T. Tängdén"
"7589","13/04 12:00","2","P1070","Kaitlyn O'BRIEN","5","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","A single-centre outpatient parenteral antimicrobial therapy (OPAT) management experience for severe pelvic inflammatory disease in Ireland","K. O'brien|A. Delmonte Sen|A. O'neill|S. Waqas|P. Govender|M. Brassil|A. Demaio|S. Maher"
"7593","13/04 12:00","3","P1071","Skander CHAABOUNI","5","B","02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Streptococcus agalactiae carriage among women living in Tunis, Tunisia over a period of ten years","S. Chaabouni|A. Zarrouk|S. Bouras|I. Kraiem|H. Hannachi"
"850","13/04 12:00","4","P1072","Sidrah ASGHAR","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Assessment of topical phage therapy for Pseudomonas aeruginosa burn wound infection","S. Asghar|A. Ahmed"
"928","13/04 12:00","5","P1073","Martin LLEWELYN","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","External validation of the baseline recurrence risk in cellulitis (BRRISC) score and the additional impact of incorporating acute clinical response","A. Walker|E. Cross|G. Hayward|M. Llewelyn"
"1004","13/04 12:00","6","P1074","Alberto PAGOTTO","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Blood ozonisation as a complementary treatment in infective chronic wound healing: a single centre experience","A. Pagotto|C. Turco|M. Floreani|E. Vlad|I. Floreani|A. De Vitis|M. Tondolo|L. Ditaranto|E. Cossaro|F. Dellai|D. D'elia|C. Tascini"
"1065","13/04 12:00","7","P1075","Simon JAMARD","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Streptococcus agalactiae, a frequent but not so well-known cause of bone and joint infections","S. Jamard|M. Lartigue|A. Lemaignen|G. Le Moal|C. Plouzeau Jayle|P. Abgueguen|R. Chenouard"
"1747","13/04 12:00","8","P1076","Sreethish SASI","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Emerging insights into Corynebacterium kroppenstedtii associated breast abscesses: a retrospective study","S. Sasi|M. Hamed|H. Abdelhadi|W. Goravey|E. Ibrahim|F. Abid|S. Doiphode|G. Wilson|A. Kashaf|M. Al-Maslamani|A. Al-Khal"
"1765","13/04 12:00","9","P1077","Filip JANSÅKER","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Risk factors for erysipelas and cellulitis: a national cohort study","P. Forsberg|X. Li|K. Sundquist|F. Jansaker"
"1905","13/04 12:00","10","P1078","Marta GONZÁLEZ-SANZ","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Diagnostic value of CT-guided percutaneous needle biopsy and/or aspiration in suspected spondylodiscitis cases: five-year audit at Ramón y Cajal University Hospital","C. Jimenez Dominguez|J. Cobos Alonso|J. Cobo Reinoso|D. Gijon Cordero|M. González-Sanz|E. Navas Elorza|P. Martin Davila|F. Dronda Nunez|J. Fortun Abete|C. Quereda Rodriguez-Navarro|V. Pintado|R. Escudero-Sánchez|F. Gioia|M. Gomez Bermejo"
"2278","13/04 12:00","11","P1079","Karolina DYDAK","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","In vitro evaluation of the antibacterial activity of hypochlorite products","K. Dydak|D. Konarska|M. Kajstura|A. Junka"
"2354","13/04 12:00","12","P1080","Nicolas MASSIE","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","A retrospective review of granulomatous mastitis over four years in a large district general hospital serving a diverse patient population: largest UK dataset","N. Massie|S. Thaw|S. Ananth|R. Perry-Thomas|H. Navalan|T. Swaine|S. Ranasinghe|A. Whittington"
"2432","13/04 12:00","13","P1081","Ulrika SNYGG-MARTIN","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Dramatic upsurge of invasive Group A streptococcal infections during 2023-2024 among younger patients without comorbidities in western Sweden","U. Snygg-Martin|P. Söderlund|J. Westin"
"2580","13/04 12:00","14","P1082","Anna NANAVA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Effectiveness of phage therapy for treatment of acute vs chronic wounds","A. Nanava|M. Kutateladze|C. Hulseberg|K. Hourihan|L. Nadareishvili|N. Pruidze|M. Dadiani|N. Trapaidze|T. Musich"
"2610","13/04 12:00","15","P1083","Mei YANG","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Improved peroxidase-like activity and photothermal/photodynamic effect of MAX phase with copper single-atom sites for facilitating diabetic wound repair","M. Yang|Z. Shuairu|Y. Binwu"
"2660","13/04 12:00","16","P1084","Mei YANG","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Improved peroxidase-like activity and photothermal/photodynamic effect of MAX phase with copper single-atom sites for facilitating diabetic wound repair","M. Yang|Z. Shuairu|Y. Binwu"
"2772","13/04 12:00","17","P1085","Estíbaliz TORRECILLA-SÁDABA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Evaluation of the antibiotic treatment against a polymicrobial biofilm made of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus","E. Torrecilla-Sádaba|L. Salar-Vidal|M. Cano-Fernández|J. Esteban|J. Aguilera-Correa"
"2801","13/04 12:00","18","P1086","Léna SANDJAKIAN","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Patients' characteristics, treatment and prognosis of Enterobacter cloacae osteomyelitis: about 146 patients","L. Sandjakian|H. Durox|E. Denes|N. Hidri"
"2855","13/04 12:00","19","P1087","Ander URIBARRI","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Low-grade infections as a potential cause of arthrofibrosis following total knee arthroplasty","A. Uribarri|L. Henriquez|I. Beguiristain|I. Sancho|C. Ezpeleta|M. Portillo"
"2974","13/04 12:00","20","P1088","Jun Jie TAN","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Optimising regimen of co-amoxiclav (ORCA): the safety and efficacy of intravenous co-amoxiclav at higher dosing frequency in patients with diabetic foot infection","J. Tan|F. Liu|P. Zhou|A. Kwa"
"3070","13/04 12:00","21","P1089","Rita IGWILO-ALANEME","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Culture-negative native vertebral osteomyelitis: ten-year retrospective analysis at the Mayo clinic","R. Igwilo-Alaneme|S. El-Zein|R. Khodadadi|F. Petri|O. Mahmoud|E. Berbari"
"3407","13/04 12:00","22","P1090","Diana CAIEIRO","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","High prevalence of pathogenic methicillin-susceptible Staphylococcus aureus ST398-MSSA among atopic dermatitis patients in Portugal","D. Caieiro|N. A. Faria|M. Araújo|M. Gonçalo|L. Ramos|M. Miragaia"
"3585","13/04 12:00","23","P1091","Samuel MOODY","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","The role of antimicrobial prophylaxis in the treatment of snakebite: a systematic review","S. Moody|A. Beech|E. Harriss|T. Lamb"
"3861","13/04 12:00","24","P1092","Sean VAN HELDEN","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Clinical efficacy and safety of omadacycline in the treatment of enterococcal infections","S. Van Helden|M. Al Musawa|A. El-Ghali|M. Mahoney|K. Molina|M. Salam|M. Saeedi|B. Chen|S. Butt|E. Sinclair|M. Veve|A. Webb|M. Rybak"
"4173","13/04 12:00","25","P1093","Ander URIBARRI","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Prevalence of PVL toxin in S. aureus isolated from patients with invasive infections in a tertiary hospital in Navarra","A. Uribarri|M. Olazabal|L. Argente|A. Navascues|C. Ezpeleta|A. Aguinaga"
"4441","13/04 12:00","26","P1094","Szofia HAJÓSI-KALCAKOSZ","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Clinical characteristics and follow-up of children with primary haematogenous osteomyelitis and septic arthritis: a single-centre experience from Hungary","S. Hajosi-Kalcakosz|E. Varga|D. Ori|C. Raskai|B. Zsigmond|B. Visy|F. Fekete|A. Horvath|O. Dobay|B. Szabo"
"4456","13/04 12:00","27","P1095","Mohammed AL MUSAWA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Omadacycline for skin and soft tissue infections: a multicentre retrospective analysis of efficacy and safety in real-world clinical practice","M. Al Musawa|A. Banks|K. Raja|M. Saeedi|M. Mahoney|K. Molina|M. Salam|E. Sinclair|T. Eubank|M. Campion|S. Van Helden|M. Rybak"
"4605","13/04 12:00","28","P1096","Yan FENG","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Clinical epidemiology, risk factors, and outcomes of carbapenem-resistant Klebsiella pneumoniae wound infection","Y. Feng"
"4808","13/04 12:00","29","P1097","David Eduardo JUÁREZ HINOJOS","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Clonal persistence of methicillin-susceptible Staphylococcus aureus ST672 in paediatric patients with invasive infections: genomic insights into virulence and resistance","D. Juárez Hinojos|N. Aguilar Gomez|R. Bautista Hernández|M. Aguilera Arreola|J. Merida Vieyra|A. Aquino Andrade"
"5200","13/04 12:00","30","P1098","Alessandra GIARDINA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Anti-virulence activity of dalbavancin against clinical isolates of Staphylococcus aures: a comparison with ""gold standard"" antibiotics in paediatric infections","A. Giardina|P. Conti|S. Fortuna|M. Calvo|G. Migliorisi|M. Perez|D. Bongiorno|F. Campanile|S. Stefani"
"5522","13/04 12:00","31","P1099","Renáta KARPÍSKOVÁ","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Prevalence and characterisation of PVL-positive MRSA isolates in Moravian region, Czech Republic, 2021-2024","R. Karpiskova|I. Kolackova|K. Brodikova|K. Fiserova"
"5556","13/04 12:00","32","P1100","Azzam SALEH-MGHIR","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Comparative efficacies of amoxicillin/clavulanate acid, oxacillin alone or in combination with rifampin against experimental methicillin-susceptible Staphylococcus aureus (MSSA) joint prosthesis infection in rabbit","A. Saleh-Mghir|B. Davido|L. Gatin|A. Crémieux"
"5599","13/04 12:00","33","P1101","Rafael BRULL TUMA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Epidemiology and microbiological patterns of fracture related infections among different regions in Brazil: observational and multicentre cohort study","R. Brull Tuma|I. Santos Oliveira|I. Marcelino Santos|M. Muniz De Andrade Silva|L. Batista Campos|J. Santos Machado|C. Cunha|T. Durigon|J. Arruda De Matos|C. Salume Xavier|R. Esteves Santos Pires|T. De Oliveira Campos|T. Cunha Ribeiro|R. Peixoto Vargas|E. Cezar|G. Waldolato|R. Mafaciolli|H. Andreolla|G. Yoshiyasu|R. Bernardelli Gonçalves|M. Ezequiel Guerra|C. Riche|M. Costa Salles|M. Neri Lucas Kurihara|F. Baldy Dos Reis|C. Finelli"
"5637","13/04 12:00","34","P1102","Michael THY","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Comparative analysis of community-acquired and hospital-acquired necrotising soft-tissue infections in critically ill patients: a ten-year retrospective study","M. Thy|E. Atchade|B. Lortat-Jacob|S. Jean-Baptiste|P. Tashk|A. Snauwaert|L. Ribeiro|M. Ben Rehouma|P. Montravers|S. Tanaka"
"5869","13/04 12:00","35","P1103","Simran THADANI","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Outpatient management of complex bone and joint infections in a virtual hospital setting","S. Thadani|O. Bannister|S. Iyer|S. Nahas|A. Walden"
"5998","13/04 12:00","36","P1104","Sathyavani SUBBARAO","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Ceftazidime±ciprofloxacin twice-daily has better outcomes to piperacillin-tazobactam infusion for necrotising otitis externa: a retrospective study","V. Subbarao|P. Allebone-Salt|T. Hettiaratchy|C. Hemsley|V. Alexander|M. Laundy"
"6262","13/04 12:00","37","P1105","Cansu TOL","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Vessels, nerves, and vision: the overlooked trio in diabetic foot infections","C. Tol|O. Acet|N. Yalcin|A. Parmaksizoglu Aydin|G. Unal Kocabas|A. Ozturk|M. Isikgoz Tasbakan"
"6311","13/04 12:00","38","P1106","Layan AKKIELAH","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","The role of dalbavancin in managing acute bacterial skin and skin structure infection with treatment noncompliance","L. Akkiela|W. Leung|R. Shahmirzadi|M. Silverman"
"6402","13/04 12:00","39","P1107","Filippo BARRECA","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Use of dalbavancin as an alternative therapy for osteomyelitis, spondylodiscitis and prosthetic joint infections: a retrospective single-centre study","F. Barreca|V. Malagnino|L. Ferrari|T. Mulas|D. Zaçe|M. Compagno|M. Iannetta|L. Sarmati"
"6620","13/04 12:00","40","P1108","Nisarg SHAH","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Skull base osteomyelitis (SBO): an observational study","N. Shah|A. Sunavala|K. M. K.|A. Shetty|M. Kirtane|A. Sharma|S. Varty|K. Ajbani|S. Gore|S. Ganta|U. Agrawal"
"7518","13/04 12:00","41","P1109","Simran THADANI","5","B","02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Outpatient management of complex bone and joint infections in a virtual hospital setting","S. Thadani|O. Bannister|S. Iyer|S. Nahas|A. Walden"
"443","13/04 12:00","42","P1110","Ayesha SAMREEN","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Streptococcus pneumoniae meningitis: clinical review and antimicrobial susceptibility trends over 13 years (2012-2024), a tertiary centre experience in the United States","A. Samreen|P. Mira|D. Kind|N. Ranganath|O. Abu Saleh"
"497","13/04 12:00","43","P1111","Cong Hieu TRUONG","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Hospital-based surveillance of paediatric pneumococcal meningitis in southern Vietnam: clinical features and antibiotic resistance patterns (2012-2023)","C. Truong|V. Nguyen|N. Speybroeck"
"713","13/04 12:00","44","P1112","Fereshteh SHEIBANI","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Neurobrucellosis: a retrospective cohort study in Mashhad, Iran","F. Sheybani|M. Haddad|F. Arazi"
"759","13/04 12:00","45","P1113","Amille Joy TY-LUISTRO","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","In-hospital clinical outcomes of adult tetanus patients admitted at a tertiary government hospital","A. Ty-Luistro|M. Arguelles"
"843","13/04 12:00","46","P1114","Edwin SNG","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Comparing the radiological features of infective ring-enhancing brain lesions: a four-year retrospective study in a tertiary referral centre in Singapore","E. Sng|C. Chan|E. Conceicao|M. Wong|L. Chan"
"1166","13/04 12:00","47","P1115","Vishal VARGHESE","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","A retrospective study of intracranial abscess and implications of early oral antibiotic switch","V. Varghese|N. Mahobia"
"2896","13/04 12:00","48","P1116","James BEVAN","5","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Exploring the relationship between environmental change and meningitis risk in Angola","J. Bevan|C. Trotter|N. Francisco"
"3355","13/04 12:00","1","P1117","Maria De Las Huertas GARCIA ATIENZA","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Trends in primary meningitis: a 14-year retrospective study at hospital universitario Nuestra Senora de la Candelaria, Tenerife","M. Garcia Atienza|I. Gutiérrez González|C. Mateo Leon"
"3572","13/04 12:00","2","P1118","Sara CALVO-SILVERIA","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Pneumococcal meningitis in adults: a 33-year analysis of serotype distribution and antimicrobial resistance","S. Calvo-Silveria|A. Gonzalez-Diaz|L. Guillem|D. Berbel|F. Tubau|J. Linares|P. Viladrich|R. Espana-Bonilla|S. Marti|J. Càmara|C. Cabellos|C. Ardanuy"
"3638","13/04 12:00","3","P1119","Steven Lukas STAAL","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Screening for neuronal auto-antibodies in adults after community-acquired bacterial meningitis","S. Staal|L. Ter Horst|J. Brenner|D. Van De Beek|M. Titulaer|M. Brouwer"
"5118","13/04 12:00","4","P1120","Evelien Hendrika Gerarda Maria DROST","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Community-acquired bacterial meningitis in adults in the Netherlands: outcome and neurological sequelae","E. Drost|E. Schepers|M. Brouwer|D. Van De Beek"
"5154","13/04 12:00","5","P1121","Eva Nadine SCHEPERS","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Visual impairment in community acquired bacterial meningitis","E. Schepers|E. Drost|M. Brouwer|D. Van De Beek"
"6306","13/04 12:00","6","P1122","Sylviane DEFRES","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Changing aetiology and outcomes of brain abscesses in a UK tertiary neurological centre","N. Scott|B. John|S. Larkin|D. Lawson|C. Burness|R. Siripurapu|T. Sewedy|C. Parry|S. Defres|T. Hughes|O. Hilton|T. Flamini|V. Owen|S. Krishna|F. Mcgill"
"6465","13/04 12:00","7","P1123","Béla KÁDÁR","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Clinical and microbiological characteristics of invasive pneumococcal diseases in a Hungarian tertiary care institute: 20 years and counting","B. Kádár|T. Erdosi"
"7423","13/04 12:00","8","P1124","Khaoula MEFTAH","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Characterisation of paediatric pneumococcal meningitis before and after introduction of 10-valent pneumococcal conjugate vaccine in Tunisia, 2016-2022","K. Meftah|S. Mhimdi|A. Blaiech|A. Bouafsoun|A. Miraoui|E. Jbebli|I. Trabelsi|N. Missaoui|R. Guedri|K. Menif|M. Khemiri|K. Boussetta|S. Boukthir|Z. Fitouri|H. Smaoui"
"7461","13/04 12:00","9","P1125","Adeel SHAH","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","The spectrum of CNS infections at a teaching hospital in Kenya","A. Shah|A. Rodney|M. Wangui"
"7658","13/04 12:00","10","P1126","Leandro Andrés ESCOBAR-HERRERA","6","B","02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Origins of S. epidermidis strains causing endophthalmitis","S. Sagerfors|L. Escobar-Herrera|T. Johannesen|M. Stegger|B. Söderquist"
"345","13/04 12:00","11","P1127","András ZÓKA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","A novel approach for utilising IgG avidity in Lyme serology","A. Zoka|M. Gönczi|R. Steinhauser|Z. Odor|G. Beko"
"349","13/04 12:00","12","P1128","Reyhan BALKAYA DEMIRTAS","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","The role of serology in the diagnosis of Brucella endocarditis: a literature search","R. Balkaya Demirtas|G. Metan"
"643","13/04 12:00","13","P1129","Roman CHLIBEK","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Prevalence of Borrelia burgdorferi sensu lato infection in the Czech Republic","R. Chlibek|J. Smetana|K. Kybicová|M. Malikova|F. Angulo|A. Loew-Baselli|Y. Tan|A. Ondrejicek|G. Brestrich|A. Pilz|J. Moisi|J. Stark"
"677","13/04 12:00","14","P1130","Tristan LEAROYD","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","112 year global analysis of human botulinum toxin serotyping","T. Learoyd|J. Pittman"
"720","13/04 12:00","15","P1131","Petek KONYA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Comparison of different treatments and durations for brucellosis: a randomised study","E. Kosar|P. Konya|M. Gurbuz|N. Demirturk|N. Demirturk|M. Gurbuz"
"752","13/04 12:00","16","P1132","Supta Rani SARKER","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Dengue mortality in southeast Asia region: exploring regional trends and disparities","S. Sarker|S. Sumon"
"811","13/04 12:00","17","P1133","Holly YU","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Claims-based algorithm to classify Lyme disease manifestations","H. Yu|R. Fee|B. Campfield|L. Gould|A. Mercadante|B. Chastek|M. Johnson|J. Halperin"
"814","13/04 12:00","18","P1134","Ahad AL BALUSHI","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","The epidemiology of brucellosis in Oman: a seven-year retrospective analysis, 2017-2023","A. Al Balushi|A. Al Wahaibi|A. Al Rashdi|A. Al Jardani|A. Al Maani|N. Al Balushi|I. Al Wahaibi"
"1010","13/04 12:00","19","P1135","Mercedes GARCIA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Q fever in Majorca, Spain","M. Garcia-Gasalla|S. Pineki|J. Murillas|R. Rowena|P. Fraile-Ribot|M. Martin-Pena|A. Villoslada|M. Fernandez-Baca"
"1253","13/04 12:00","20","P1136","Karla Therese L. SY","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Background incidence rates of health outcomes for Lyme disease vaccine safety monitoring in hospitalised and outpatient German populations","K. Sy|J. Dreyfus|C. Bengtsson|B. Correia|R. Figueiredo|J. Stark|M. Zawora|M. Riddle|J. Maguire|J. Groark|Q. Jiang|C. Ianos|J. Turrado|H. Svanström|S. Bailey|M. Dekoven|S. Kelly|S. Dombrowski|S. Munnangi"
"1296","13/04 12:00","21","P1137","Arvind Krishna DEVARAJ","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Epidemiology and clinical outcomes of scrub typhus in rural and urban settings: a hospital-based study from south India","N. Raju C.|A. Devaraj|M. Alagesan|M. Sarikonda|N. Veerappan"
"1380","13/04 12:00","22","P1138","Wania FREITAS","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Foodborne botulism in Brazil: analysis of cases over the last 17 years (2007-2024) and occurrence of an outbreak related to the consumption of chicken mortadella at popular fairs","W. Freitas|R. Fleury|Y. Costa|C. Gouvea|M. Sousa|M. Alves"
"1388","13/04 12:00","23","P1139","Helmi ERNANDES","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Spinal brucellosis: the great mimicker","H. Ernandes|S. Kaoual|S. Benzarti|A. Bellaaj|S. Sallem|I. Kooli|S. Besbes"
"1512","13/04 12:00","24","P1140","Liliana FRANCO MOREIRA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Epidemiological and clinical outcomes of human monocytic ehrlichiosis (HME) presenting to a single centre university hospital in the state of Florida, USA","L. Franco Moreira|N. Beatty"
"1514","13/04 12:00","25","P1141","Yupin SUPUTAMONGKOL","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Scrub typhus trend in northeastern Thailand, 2011-2023","Y. Suputamongkol|E. Wongsawat|S. Silpasakorn"
"1560","13/04 12:00","26","P1142","Olena ZUBACH","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Influence of different Leptospira serovars on lung damage in leptospirosis","O. Zubach|A. Zadorozhnyi|I. Ben|A. Zinchuk"
"1596","13/04 12:00","27","P1143","Olga STUKOLOVA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Development and validation of the microarray for the detection of IgG against Bacillus anthracis, Yersinia pestis and Francisella tularensis","M. Sokolova|A. Cherkashina|E. Solovyeva|M. Polygalova|O. Stukolova"
"1645","13/04 12:00","28","P1144","Kurosh SARBANDI","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Diagnosis and visualisation of biofilms in Bartonella quintana endocarditis","K. Sarbandi|J. Kikhney|L. Kursawe|D. Von Schöning|I. Moter|F. Klefisch|A. Friedrichs|W. Eichinger|V. Falk|A. Moter"
"1797","13/04 12:00","29","P1145","Shigetoshi SAKABE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Comparison of gene detection rates in whole blood, eschar, and erythematous skin samples by polymerase chain reaction in Japanese spotted fever cases","S. Sakabe|R. Koike|H. Tanaka|H. Toyoshima|D. Goto|T. Sekoguchi|T. Nakagawa|N. Yamazoe|H. Kusuhara|A. Kobayashi"
"1934","13/04 12:00","30","P1146","Ameeka THOMPSON","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Epidemiology of leptospirosis in the United Kingdom","J. Warner|A. Thompson|C. Houlihan|J. Olver|J. Osborne|T. Brooks"
"2004","13/04 12:00","31","P1147","Özlem ALHAN","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Challenges in case management of brucellosis: prospective study from an endemic region","O. Alhan|B. Coker"
"2122","13/04 12:00","32","P1148","Mathilde ZENOU","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Epidemiological evolution of leptospirosis in French Guiana: a descriptive and comparative analysis of 2016-2022 cases with 2007-2014","M. Zenou|P. Bourhy|M. Demar|P. Abboud|F. Djossou|A. Kpangon|H. Kallel|J. Carod|C. Prince|S. Trombert-Paolantoni|A. Barbry|M. Picardeau|L. Epelboin|P. Le Turnier"
"2424","13/04 12:00","33","P1149","Victoria DOLANGE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Development of monoclonal antibodies and immunoassays targeting VlsE to improve Lyme disease diagnosis","V. Dolange|J. Denis|E. Yang|E. Fissier|S. Simon|N. Morel"
"3081","13/04 12:00","34","P1150","Nipun RATHNAYAKE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Detection of Leptospira licerasiae, a P2 sub-clade species, in febrile patients, rodents, and livestock in Sri Lanka","N. Rathnayake|P. Senarathne|U. Karunadasa|R. Vijeyakumaran|D. Muthusinghe|K. Yoshimatsu|S. Urata|N. Dissanayake|N. Koizumi|C. Gamage"
"3170","13/04 12:00","35","P1151","Franc STRLE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Clinical data on symptomatic cutaneous reinfections due to Borrelia burgdorferi sensu lato in Europe: erythema migrans from reinfection differs from primary erythema migrans","A. Kastrin|K. Strle|G. Wormser|F. Strle|K. Ogrinc|V. Maraspin|S. Lotric-Furlan|T. Rojko|E. Ruzic-Sabljic|P. Bogovic"
"3317","13/04 12:00","36","P1152","Andres SUAREZ-IBARRA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","High seroprevalence of Coxiella burnetii among blood donors in Mallorca: implications for diagnostics and surveillance","A. Suarez-Ibarra|L. Canals-Ferrer|C. Iglesias-Escobar|M. Garcia-Gasalla|P. Fraile-Ribot"
"3526","13/04 12:00","37","P1153","Emanuela OLIVIERI","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Neoehrlichia mikurensis and Borrelia miyamotoi: emerging and neglected pathogens in northern Italy","E. Olivieri|S. Rigamonti|N. Vicari|G. Maioli|A. Bianchi|I. Bertoletti|I. Karaman|A. Grassi|P. Prati"
"3773","13/04 12:00","38","P1154","Alessandra Mistral DE PASCALI","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Molecular detection of Borrelia burgdorferi in off-season questing ticks: impact of environmental and climatic variables","A. De Pascali|L. Dionisi|B. Vandelli|C. Valenti|M. Brandolini|L. Ingletto|G. Gatti|C. Colosimo|M. Guerra|G. Dirani|S. Zannoli|L. Grumiro|M. Montanari|A. Marzucco|M. Cricca|R. Cazzolla Gatti|A. Scagliarini|V. Sambri"
"3854","13/04 12:00","39","P1155","Pablo PILLADO ALONSO","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Evaluating the value of serological follow-up in managing Q fever infections","P. Pillado Alonso|G. Fernández-Rivas|L. Mateu|N. Ladines Reyes|M. Campos-Ruiz|E. Saya Amaro|N. Sopena"
"3889","13/04 12:00","40","P1156","Ilari KUUKKANEN","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Metabolomic profiling of cerebrospinal fluid in Lyme neuroborreliosis: a diagnostic insight","I. Kuukkanen|T. Rissanen|A. Pietikäinen|J. Hytönen|M. Karonen|S. Hurme"
"4219","13/04 12:00","41","P1157","Pierre BOYER","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","TIck-borne lymphadenopathy in northeastern France: human and vector clinical-epidemiological study","J. Kotzyba|E. Baux|Y. Hansmann|P. Boyer|B. Jaulhac|M. Martinot|B. Martha|C. Kaeuffer|T. Bonijoly|F. Bani-Sadr|A. Legoff|F. Hoefler|M. Blot|L. Bourdellon|L. Zilliox|N. Boulanger|B. Lefèvre"
"4383","13/04 12:00","42","P1158","Holly YU","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","The burden of Lyme disease (BOLD) study in Europe: PTLD in six European countries and an examination of its criteria","A. Mercadante|H. Yu|K. Halsby|A. Loew-Baselli|Y. Tan|F. Angulo|E. Begier|M. Dzingina|J. Berglund|V. Cibik|K. Mehltretter|A. Moniuszko-Malinowska|M. Pavlasek|F. Strle|D. Zakova|J. Stark"
"4607","13/04 12:00","43","P1159","Helvécio CARDOSO CORRÊA PÓVOA","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Comparative evaluation of the infectious potential of zoonotic and human atypical enteropathogenic Escherichia coli (aEPEC) strains using in vivo infection models","N. Povoa|V. Kaufmann|P. Sonza|M. Pacheco|D. Souza|M. Fontao|E. Guedes|H. Povoa"
"4617","13/04 12:00","44","P1160","Anna LEE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Seroprevalence of Bartonella henselae IgG among the healthy population in Korea and associated risk factors","U. Kim|J. Kim|C. Nahm|S. Baik|J. Jang|A. Lee"
"4903","13/04 12:00","45","P1161","Jintao HE","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Epidemiological and clinical characteristics of psittacosis using cgMLST by capture sequencing: a multicentre, genome-based study in China","J. He|Y. Yu|H. Zhou|L. Xi"
"4991","13/04 12:00","46","P1162","Gang WANG","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Sitafloxacin monotherapy vs standard rifampicin-doxycycline dual therapy for uncomplicated brucellosis: a multicentre, open-label, randomised, non-inferiority trial","W. Gang|X. Nannan"
"5157","13/04 12:00","47","P1163","Guanmin YUAN","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Functional characterisation of CD57+ OMP-specific CD8+ T cells in acute and chronic brucellosis","G. Yuan|H. Wang|J. Ai|W. Zhang"
"5328","13/04 12:00","48","P1164","Ehsan GHASEMIAN","6","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Tick-borne pathogens in Switzerland: surveillance of Rickettsia, Anaplasma, Coxiella, and Chlamydiae in Ixodes ricinus","E. Ghasemian|S. Hälg|R. Ackermann-Gäumann|P. Muller|F. Tagini|C. Beuret|S. Abey|R. Lienhard|A. Croxatto|W. Tischhauser|O. Opota|G. Greub"
"5361","13/04 12:00","1","P1165","Henar ALONSO-EZCURRA","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Clinical evaluation of a novel real-time PCR assay for Leptospira DNA detection: advancing leptospirosis diagnosis","D. Paredes|A. Rodriguez-Pazmino|E. Carvajal|S. Orlando|H. Alonso|M. Garcia Bereguiain"
"5492","13/04 12:00","2","P1166","Klaudia Maria Svirlochova","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Changing incidence of human granulocytic anaplasmosis in Slovakia, Central Europe","B. Vichova|D. Zubrikova|L. Vargová|M. Stanko|V. Blazekova|K. Svirlochova|J. Hockicko|M. Novotny"
"5805","13/04 12:00","3","P1167","Nathalie WEISS","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Quality assessment of the diagnostic testing for Q fever: lessons from five years of external quality control in medical laboratories","N. Weiss|U. Reischl|I. Schellenberg|D. Frangoulidis|K. Hunfeld|C. Dintsios|S. Fischer"
"6447","13/04 12:00","6","P1170","Debora Stefany FERNANDES GUEDES","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Bacterial genera identified by metagenomics in ticks collected from a Brazilian university","D. Fernandes Guedes|G. Montenegro De Campos|A. Sarana Da Silva|F. Anibal|S. Slavov|F. Carvalho"
"6521","13/04 12:00","7","P1171","Yaroslava BURMA","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Clinical and epidemiological characteristics of leptospirosis in the Kharkiv region, Ukraine in 2022-2024","Y. Burma|A. Sokhan|K. Yurko|D. Kukhar"
"6795","13/04 12:00","8","P1172","Ayse Nur CEYLAN","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Evaluation of human brucellosis patients with and without decreasing serum agglutination test titers","A. Benli|A. Ceylan"
"7095","13/04 12:00","9","P1173","Meriem ABDELJELIL","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","A case series of rickettsial infections","I. Bartegi|M. Abdeljelil|W. Marrakchi|L. Saad|F. Ben Romdhane|A. Aouam|H. Ben Brahim|A. Toumi"
"7268","13/04 12:00","10","P1174","Debora Stefany FERNANDES GUEDES","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Identification of Coxiella species by metagenomics in in ticks collected from a Brazilian university","D. Fernandes Guedes|G. Montenegro De Campos|L. Barci|A. Sarana Da Silva|B. Begalli|I. Moreira|P. Araujo|F. Carvallho|S. Slavov|F. Anibal"
"7467","13/04 12:00","11","P1175","Maria Grazia CARIGLIA","7","B","02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Rickettsiosis by Rickettsia aeschlimannii from Hyalomma marginatum tick bite in a cattle breeder (southern Italy)","M. Cafiero|M. Cariglia|C. Nardella La Porta|D. Raele"
"471","13/04 12:00","12","P1176","M. John ALBERT","7","B","02i. Other intracellular or rare bacteria","Enteropathogenic Providencia alcalifaciens: a subgroup of P. alcalifaciens that causes diarrhea","M. Albert"
"1967","13/04 12:00","15","P1179","Prithvishree RAVINDRA","7","B","02i. Other intracellular or rare bacteria","Low counts predict mortality in melioidosis: a retrospective cohort study","P. Ravindra|P. Tirlangi|R. Bhat|C. Mukhopadhyay|N. Gupta"
"3258","13/04 12:00","16","P1180","Julia RZASKA","7","B","02i. Other intracellular or rare bacteria","Characterisation of an emerging pathogen Pantoea dispersa causing neonatal sepsis in a tertiary healthcare facility in Pakistan","J. Rzaska|A. Cooke|R. Zahra|E. Rashid|S. Naqvi|J. Zafar|S. Riaz|T. Walsh|K. Sands|K. Thomson|B. Hassan"
"4232","13/04 12:00","17","P1181","Ayush GUPTA","7","B","02i. Other intracellular or rare bacteria","Melioidosis in India: emerging or neglected?","A. Gupta|M. Dadheech|F. Siddiqui|S. Purwar|N. Kaore|S. Khadanga"
"4543","13/04 12:00","18","P1182","Ellen SUGRUE","7","B","02i. Other intracellular or rare bacteria","Retrospective review of patients with clinically significant Fusobacterium gonidiaformans infection","E. Sugrue|J. Anderson|O. Moncayo-Nieto|C. Mackintosh|L. Tysall|S. Dewar"
"6469","13/04 12:00","19","P1183","Nadim CASSIR","7","B","02i. Other intracellular or rare bacteria","Emergence of cases of neurolisteriosis in a single centre: insights into genomic analysis","A. Stheme De Jubecourt|M. Beye|C. Mortier|F. Gouriet|N. Cassir"
"7036","13/04 12:00","20","P1184","Zara Ahmad KHAN","7","B","02i. Other intracellular or rare bacteria","Survival mechanism of pancreatic tumor bacteria and their ability to metabolise chemotherapy drugs","Z. Khan|M. Sobkowiak|M. Ghorbani|P. Tajpara|K. Almanei|A. Halimi|Z. Ateeb|V. Özenci|R. Heuchel|M. Löhr|M. Sällberg Chen"
"220","13/04 12:00","25","P2314","Lavanya KHULLAR","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Metformin attenuates quorum sensing-regulated virulence factors in Pseudomonas aeruginosa: novel aspects of a multifaceted drug","L. Khullar|J. Chadha|S. Chhibber|K. Harjai"
"422","13/04 12:00","26","P2315","Katharina RICHTER","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Treating infected wounds with plasma-activated water in vivo in mice","A. Abdo|H. Nguyen|G. Neville|T. Schmitt-John|A. Ogunniyi|Z. Kopecki|K. Richter"
"449","13/04 12:00","27","P2316","Wen WANG","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Benzoxaborole leucyl-tRNA synthetase inhibitor MRX-5: preclinical pharmacokinetics and in vitro drug-drug interaction","Z. Li|H. Yuan|W. Wang"
"450","13/04 12:00","28","P2317","Wen WANG","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","GLP 13-week repeat-dose toxicology studies of MRX-5 in sprague dawley rats and beagle dogs","Z. Li|H. Yuan|W. Wang"
"738","13/04 12:00","29","P2318","Antoine CULOT","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophage genome annotation: comparing automatic and manual approaches","A. Culot|G. Abriat|K. Furlong"
"813","13/04 12:00","30","P2319","Yuqing ZHOU","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Efficacy, safety and caecal microbiome analysis of nitroxoline for preventing Salmonella infection in chickens","Y. Zhou|M. Trush|L. Ibbotson|A. Lankapalli|A. Farley|H. Song|C. Wu|J. Shen|C. Schofield|T. Walsh"
"985","13/04 12:00","31","P2320","Farras Daffa IMTIYAZ","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Enhancing colistin efficacy against multidrug-resistant Klebsiella pneumoniae using farnesol-loaded lipid nanoparticles","S. Marchand|J. Buyck|F. Tewes|C. Faivre|M. Collot|N. Anton|T. Henry|L. Dortet|R. Bonnin|F. Imtiyaz"
"1013","13/04 12:00","32","P2321","Maria Soledad RAMIREZ","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Overcoming bacterial defense mechanisms: strategic considerations for effective bacteriophage therapy against Acinetobacter baumannii","L. Sanhueza Salas|C. Quiroga|M. Ramirez"
"1071","13/04 12:00","33","P2322","Ruxandra CALIN","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Evaluating phage therapy for multidrug-resistant Klebsiella pneumoniae UTI","R. Calin|C. Eckert|J. Gedeon|R. Tournebize|M. Ingersoll"
"1088","13/04 12:00","34","P2323","Bruce BLOUGH","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Chemistry centre for combating antibiotic resistant bacteria (CC4CARB)","B. Blough|C. Jin|E. Pauli"
"1096","13/04 12:00","35","P2324","Jie ZHANG","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro susceptibility studies of several novel antimicrobial drugs against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates","J. Zhang|Y. Li|Y. Li"
"1117","13/04 12:00","36","P2325","Samir MOUSSA","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vivo and in vitro activity of durlobactam vs Enterobacterales","S. Moussa|S. Mcleod|N. Carter|A. Miller|J. O'donnell"
"1211","13/04 12:00","37","P2326","Jose GUTIERREZ-FERNANDEZ","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Cefepime/enmetazobactam as a carbapenem-sparing alternative: activity against extended-spectrum beta-lactamase-producing Enterobacteriaceae, with or without carbapenemases","J. Gutierrez-Fernandez|L. Castellano-Sanchez|M. Aguilera-Franco|M. Albendin-Moreno|J. Navarro-Mari|A. Abreu-Garcia"
"1230","13/04 12:00","38","P2327","Stephen HAWSER","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Susceptibility of a worldwide collection of 12,613 Enterobacterales isolated during 2021-2023 to the novel combination therapy aztreonam/nacubactam","S. Hawser|N. Kothari|F. Monti|A. Shimizu|H. Okade"
"1231","13/04 12:00","39","P2328","Stephen HAWSER","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Activity of the novel combination therapies cefepime/nacubactam against 12,613 clinical isolates of Enterobacterales collected worldwide during 2021-2023","S. Hawser|N. Kothari|F. Monti|A. Shimizu|H. Okade"
"1248","13/04 12:00","40","P2329","Semra TASDURMAZLI","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophage-derived endolysin as a therapeutic protein candidate: in vitro activity, stability, and in vivo efficacy in an MRSA-induced skin wound model","S. Tasdurmazli|I. Cinar|M. Karamese|S. Aksak Karamese|E. Cadirci|L. Melo|T. Ozbek"
"1275","13/04 12:00","41","P2330","Kaixi ZHANG","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Conjugated oligoelectrolytes: a novel antibiotic platform with activity against nontuberculous mycobacteria","K. Zhang|A. Moreland|G. Bazan"
"1435","13/04 12:00","42","P2331","Michelle OUTEDA GARCÍA","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Enhanced antimicrobial activity of the novel polymyxin analogue SPR206 compared to colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii","M. Outeda-Garcia|J. Vázquez-Ucha|G. Bou|A. Beceiro|P. Guijarro-Sánchez|C. Lasarte-Monterrubio|R. Maceiras|A. Rodriguez-Coello|A. Garcia-Pose|J. Arca-Suárez"
"1450","13/04 12:00","43","P2332","Clara IBARGUREN QUILES","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage tail like bacteriocins or tailocins as antimicrobial agents against Pseudomonas aeruginosa clinical strains","C. Ibarguren|L. Blasco|C. Lopez-Causape|I. Bleriot|L. Fernandez-Garcia|C. Ortiz-Cartagena|L. Armán|A. Barrio-Pujante|R. Canton|A. Oliver|M. Tomás"
"1515","13/04 12:00","44","P2333","Mark ESTABROOK","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","The in vitro activity of aztreonam-avibactam against Enterobacterales isolates positive for metallo-beta-lactamases or serine-carbapenemases by commonly used in vitro diagnostic kits","M. Estabrook|C. Streit|A. Townsend|G. Stone|E. Utt|S. Kamat|D. Sahm"
"1579","13/04 12:00","45","P2334","Alina Karoline NUSSBAUMER-PRÖLL","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Effect of cefepime/enmetazobactam (FEP-META) versus ceftazidime/avibactam (CAZ-AVI) in combination with aztreonam (ATM) against clinical isolates resistant to different β-lactamase classes","S. Eberl|M. Zeitlinger|A. Nussbaumer-Pröll"
"1602","13/04 12:00","46","P2335","Isidro GARCÍA-MENIÑO","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Ready-to-eat food samples as sources of promising bacteriophages for the treatment of multidrug-resistant Klebsiellae including ST147-KL64 and the hypervirulent clone ST23-KL57","I. Garcia-Menino|J. Hammerl"
"1617","13/04 12:00","47","P2336","Khadijah DASHTI","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Identification of antibiotic-producing Pseudomonas guguanensis from seawater in Kuwait","K. Dashti|N. Almaraghi|L. Vali|H. Abul|H. Ebrahim|A. Dashti"
"1695","13/04 12:00","48","P2337","Victoria KLEIN","7","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Using marine sponge-derived pyrrole-imidazole alkaloids to combat antibiotic resistance","V. Klein|J. Piotrowski|C. Bewley"
"1731","13/04 12:00","1","P2338","Hao-Chieh CHIU","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Synergistic antibacterial activity of SC5005 and DHA against multidrug-resistant Mycobacterium abscessus without detectable resistance","M. Kuo|H. Yeo|C. Shu|H. Chiu"
"1786","13/04 12:00","2","P2339","Marie ATTWOOD","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Antibacterial-bacteriophage interactions: evaluation of E. coli kill kinetics using a combination of meropenem plus an E. coli phage cocktail","M. Attwood|P. Griffin|P. Smorowinski|A. Noel|M. Haines|A. Millard|M. Clokie|A. Macgowan"
"1821","13/04 12:00","3","P2340","Isabelle ERBETTI","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Assessment of zosurabalpin activity in combination with other antibiotics","I. Erbetti|D. Sabatini|C. Zampaloni|S. Louvel"
"1872","13/04 12:00","4","P2341","Nicole E. SCANGARELLA-OMAN","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro activity of gepotidacin against baseline uropathogens including drug-resistant phenotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections","D. Butler|J. Breton|D. Brown|C. Kasapidis|A. Sheets|N. Scangarella-Oman"
"1888","13/04 12:00","5","P2342","Javier CASADO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","N-(4-chlorophenyl)-5-nitro-3-thiophenecarboxamide: a novel, narrow-spectrum antimicrobial agent targeting Helicobacter pylori","J. Casado|I. Olivan-Muro|M. Fillat|Á. Lanas|A. González"
"2085","13/04 12:00","6","P2343","Kaja TURZANSKA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Singlet-oxygen producing BODIPYs for topical treatment of wound infections: an in vitro light activated antibacterial study","K. Turzanska|S. O'sullivan|L. Tabrizi|M. Pryce|D. Fitzgerald Hughes"
"2124","13/04 12:00","7","P2344","Haiqing CHU","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","DDD02049209, a lysyl-tRNA synthetase inhibitor, is active against M. avium in vitro","J. Li|J. Fan|Y. Jia|R. Li|B. Li|H. Chu"
"2155","13/04 12:00","8","P2345","Saeed SHAMS","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Anti-bacterial and anti-inflammatory activity of chitosan nanoparticles as carrier for supernatant of mesenchymal stem cells in a cholera mouse model","M. Saberpour|B. Bakhshi|S. Najar-Peeraye|S. Shams"
"2480","13/04 12:00","9","P2346","Ana BARBARIC","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","The antimicrobial potential with detailed chemical characterisation of linden honeydew honey from Bosnia and Herzegovina","A. Barbaric|L. Saftic Martinovic|D. Milincic D.|M. Pesic B.|L. Juretic|D. Petrovic|H. Brekalo|I. Gobin"
"2507","13/04 12:00","10","P2347","Fabrice PIROT","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage-embedded hydrogel: an emerging personalised therapy for antimicrobial-resistant Staphylococcus aureus skin infections","B. Lapras|Y. Pryyatselyuk|A. Von Kanel|V. Lequeux|M. Medina|C. Merienne|C. Marchand|F. Laurent|F. Pirot"
"2604","13/04 12:00","11","P2348","Claudia ALDEIA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage therapy induces colonisation resistance for an OXA-48 Salmonella Kentucky ST198 during in vivo Zoophobas morio larvae gut colonisation","C. Aldeia|E. Campos-Madueno|A. Endimiani"
"2637","13/04 12:00","12","P2349","Amol SHINDIKAR","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Potent in vitro activity of novel beta-lactam/ beta-lactam enhancer cefepime/zidebactam against K. pneumoniae and P. aeruginosa, enriched with carbapenem resistance collected from four tertiary-care hospitals in India","M. Radhakrishnan|H. Periasamy|Y. Deogirikar|A. Deshmukh|A. Nikalje|P. Suryawanshi|S. Kulkarni|A. Shindikar"
"2770","13/04 12:00","13","P2350","Mariana CASTANHEIRA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Antimicrobial activity of zosurabalpin against a diverse collection of aerobic and anaerobic bacterial and yeast isolates","J. Maher|B. Roth|M. Castanheira|C. Zampaloni|S. Louvel|A. Watson"
"2971","13/04 12:00","14","P2351","Alena SIVÁKOVÁ","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Enhancement of mupirocin anti-staphylococcal decolonisation therapy by combination with phages","A. Siváková|T. Botka|L. Vacek|Z. Svagerova|E. Kucerova|L. Hermanová|M. Osowski|K. Rovnakova|P. Petras|D. Polastik Kleknerova|M. Dvorackova|F. Ruzicka|J. Tkadlec|J. Vrbsky"
"3105","13/04 12:00","15","P2352","Kunal MADHAV","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Assessment of antibacterial and wound healing potential of bacteriogenic silver nanoparticles (BSNP) synthesised by Klebsiella pneumoniae","K. Madhav"
"3188","13/04 12:00","16","P2353","Jia Hao YEO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Immune monitoring by flow cytometry (FCM) in patient undergoing phage therapy (PT).","J. Yeo|Z. Chong|S. Thong|S. Chung|A. Kwa"
"3247","13/04 12:00","17","P2354","Shuhua THONG","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophage (phage) cocktail resuscitates antibiotics for management of multidrug-resistant Pseudomonas aeruginosa (PAE) infections","S. Thong|N. Begam|T. Aung|W. Moreira|S. Chung|A. Kwa"
"3260","13/04 12:00","18","P2355","Laia FERNANDEZ-BARAT","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Impact of engineered Mycoplasma pneumoniae on P. aeruginosa biofilms and respiratory microbiota during experimental ventilator-associated pneumonia","A. Soler-Comas|G. Macip|K. Kiarostami|A. Motos|B. Llonch|N. Vázquez-Burgos|R. Cabrera|F. Galli|I. Rodriguez Arce|C. Segura|L. Serrano|A. Torres|L. Fernandez-Barat"
"3261","13/04 12:00","19","P2356","Jorge ARCA-SUÁREZ","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Disarming carbapenemase-producing Acinetobacter baumannii: high potency of the novel therapeutic combination of meropenem with the diazabyciclooctane beta-lactamase inhibitor ANT3310","S. Rodriguez-Pallares|M. Outeda-Garcia|A. Rodriguez-Coello|L. González-Pinto|L. Sanchez-Pena|T. Blanco-Martin|J. Vázquez-Ucha|G. Bou|A. Beceiro|J. Arca-Suárez"
"3310","13/04 12:00","20","P2357","Anthony VOCAT","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Exploring nanomotion technology for phage therapy: a novel diagnostic tool to combat antimicrobial resistance","A. Vocat|A. Luraschi-Eggemann|G. Jozwiak|J. Dolezel|Z. Azizi|S. Vasantham|S. Gutierrez|D. Cichocka|A. Sturm|G. Resch"
"3320","13/04 12:00","21","P2358","Yang ZHONG","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Comprehensive bacteriophage sequencing analysis pipeline empowers insights into host specificity for treating multidrug-resistant Pseudomonas aeruginosa","Y. Zhong|M. Koh|W. Moreira|J. Teo|R. Ong|A. Kwa"
"3374","13/04 12:00","22","P2359","Alastair CLEMENTS","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Optimising combination antibiotic-phage therapies against MRSA: an interdisciplinary approach","A. Clements|J. Lindsay|G. Knight|Q. Leclerc|N. Ince|J. Wildfire"
"3382","13/04 12:00","23","P2360","Loris RIZZELLO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophages-derived endolysins for next tuberculosis stewardship","B. Antinori|G. Moschetti|I. Muzzolini|E. Scarpa|L. Rizzello|A. Griego"
"3426","13/04 12:00","24","P2361","Elisa CIORATA MIHALCEA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Impact of bacterial inoculum on the activity of cefepime and cefepime/enmetazobactam against AmpC-hyperproducing Enterobacter spp","E. Ciorata Mihalcea|Á. Rodriguez-Villodres|C. Soto-Gallego|J. Ortiz De La Rosa|M. Rodriguez-Rodriguez|J. Lepe"
"3430","13/04 12:00","25","P2362","Lucía SÁNCHEZ-PEÑA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Universal beta-lactamase coverage and potent antimicrobial activity of xeruborbactam plus meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new beta-lactam/beta-lactamase inhibitor combinations","L. Sanchez-Pena|S. Rodriguez-Pallares|T. Blanco-Martin|P. Aja-Macaya|L. González-Pinto|J. Vázquez-Ucha|A. Beceiro|L. Lopez-Cerero|L. Martinez-Martinez|L. Poirel|G. Bou|J. Arca-Suárez"
"3516","13/04 12:00","26","P2363","Miriam LATORRE-MILLÁN","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Olive leaf extract as an antimicrobial agent against Staphylococcus aureus and its resistant strains: in vitro results","C. Guerrero-Diaz|R. Fernandez-Simon|M. Lezaún-Andreu|B. Lambán-Per|M. Asensio|N. Del Villar|R. Martinez-Beamonte|A. Rezusta|Y. Gilaberte|L. Clusa|M. Latorre-Millán|A. Milagro|A. Tristancho-Baro"
"3518","13/04 12:00","27","P2364","Shuhua THONG","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro anti-bacterial activity of bacteriophages (phages) to guide treatment against refractory Pseudomonas aeruginosa (PAE) infection","S. Thong|N. Begam|E. Tan|N. Abdul Muthalib|A. Lee|W. Moreira|T. Aung|S. Chung|A. Kwa"
"3538","13/04 12:00","28","P2365","Shuhua THONG","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Jumbo bacteriophages demonstrate indirect anti-bacterial effects against carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates","N. Begam|Y. Zhong|J. Teo|S. Chung|A. Kwa|S. Thong"
"3627","13/04 12:00","29","P2366","Susanne PAUKNER","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Antibacterial in vitro activity of the novel epimutilins AR-7731, AR-7732, AR-10058, and AR-9842 against MDR and pre-XDR Mycobacterium tuberculosis","S. Paukner|U. Schlosser|G. Gassner|J. Bleier|C. Zerbe|F. Heger"
"3632","13/04 12:00","30","P2367","Thuy TRAN THI DIEU","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Investigating probiotic lactobacilli and their bacteriocin-like inhibitory substances (BLISs) as potential therapeutic agents for vaginal infections","T. Tran|C. Kao"
"3633","13/04 12:00","31","P2368","Carl Jay BREGENTE","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Evaluating the efficacy of lytic bacteriophages against multidrug-resistant Enterobacter cloacae strains","C. Bregente|T. Thuy|C. Kao"
"3642","13/04 12:00","32","P2369","Antonio DIGIANDOMENICO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","A bispecific monoclonal antibody targeting Psl and PcrV enhances bronchiectasis atient neutrophil-mediated killing of Pseudomonas aeruginosa","M. Long|A. Gilmour|M. Crichton|H. Lind|A. Digiandomenico|P. Warrener|A. Lidwell|M. Kehl|D. Tabor|V. Gopalakrishnan|S. Rosengren|W. Brailsford|B. Sellman|R. Hughes|E. Mcintosh|Y. Giam|J. Chalmers"
"3660","13/04 12:00","33","P2370","Inés BADO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Presence of antiphage defense mechanisms in carbapenemase-producing strains isolated from blood cultures in Uruguay","R. Papa-Ezdra|M. Outeda|V. Seija|R. Vignoli|I. Bado|N. Cordeiro|F. Ferreira|S. Munilla"
"3687","13/04 12:00","34","P2371","Kristiana AVAD","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Structural determinants of inhibitor selectivity towards Enoyl ACP Reductase, FabK","K. Avad|O. Alaidi|F. Pavel|D. Doran|D. Sun|H. Kirk"
"3813","13/04 12:00","36","P2373","Viviane Cássia OLIVEIRA","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Dynamics of phage sensitivity in multidrug-resistant and non-resistant Pseudomonas aeruginosa: implications for phage therapy","V. Oliveira|R. Cabrera|A. Planchart|A. Rocha|E. Watanabe|M. Ferrer|A. Torres|L. Fernandez-Barat"
"3843","13/04 12:00","37","P2374","Núria MARTÍN-VILARDELL","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","The activity of a new bicyclic peptide against colistin-resistant Pseudomonas aeruginosa biofilms","N. Martin-Vilardell|D. Higazy|C. Ballesté-Delpierre|J. Vila|O. Ciofu|N. Høiby"
"3844","13/04 12:00","38","P2375","Yun WU","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro activity of a novel synthetic macrocyclic peptide, BRII-693, against carbapenem-resistant A. baumannii and P. aeruginosa isolates from China","P. Gu|W. Yun"
"3929","13/04 12:00","39","P2376","Sean VAN HELDEN","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Impact of Pseudomonas aeruginosa biofilm composition on bacteriophage activity: overcoming barriers","S. Van Helden|M. Rybak|C. Bleick|S. Lehman|R. Bonomo|J. Alexander"
"3936","13/04 12:00","40","P2377","Antonio DIGIANDOMENICO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Broad coverage of antibiotic-resistant Klebsiella pneumoniae by multi-specific antibodies against the lipopolysaccharide O-antigen","A. Hatke|L. Xuiling|S. Frey|C. Caceres|M. Doyle|A. Smith|P. Warrener|T. Warren|Z. Britton|M. Ford|E. Minton|B. Sellman|Y. Mazor|T. Christine|D. Antonio"
"4016","13/04 12:00","41","P2378","Clement MARLAT","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro efficacy of cefepime/enmetazobactam against AmpC beta-lactamase-producing Enterobacterales","C. Marlat|M. Giry|C. Baulier|M. Etienne|F. Lamoureux|F. Gravey|J. Giard|K. Alexandre"
"4281","13/04 12:00","43","P2380","Anne SANTERRE HENRIKSEN","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro activity of cefepime/enmetazobactam and comparators against ESBL and plasmid-AmpC-producing Enterobacterales","R. Canton|S. Hawser|J. Quevedo|N. Dunkel|A. Santerre Henriksen"
"4282","13/04 12:00","44","P2381","Bianca-Maria TIHAUAN","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Beyond the surface: how the transdermal delivery of cannabidiol can unlock new antimicrobial sustained effects","B. Tihauan|C. Iliescu|F. Iliescu|G. Gradisteanu-Pircalabioru"
"4452","13/04 12:00","45","P2382","Callan BLEICK","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Go big or go home? Efficacy of two- vs three-phage cocktail targeting DNS-MRSA","C. Bleick|R. Richa|A. Hassan|S. Lehman|M. Rybak"
"4476","13/04 12:00","46","P2383","Giulia TOCCACIELI","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Evaluation of inhibition of biofilm production after treatment with the combination of phage PSE1720 and meropenem, in Pseudomonas aeruginosa strains isolated from people with cystic fibrosis","A. Ciaramelletti|F. Tolio|A. Bertoncelli|A. Mazzariol|G. Toccacieli"
"4587","13/04 12:00","47","P2384","Favour Okwukweka NWAJIOBI","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Wound healing potentials of crude bacteriocins from Lactobacillus rhamnosus and Lactobacillus fermentum isolated from decaying fruit using albino mice model","F. Nwajiobi|C. Anyamene"
"4734","13/04 12:00","48","P2385","Natalia IORIO","8","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro effectiveness of endodontic triple antibiotic associated with daptomycin","S. Azevedo|G. Chianca|B. Thurler|R. Chamon|H. Povoa|L. Antunes|N. Iorio"
"4815","13/04 12:00","1","P2386","Thet Tun AUNG","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Novel bacteriophage therapy for multi-drug resistant methicillin-resistant Staphylococcus aureus (MRSA) infectious keratitis","T. Aung|J. Ang|Y. Tan|Z. Loh|M. Muthu|D. Tan|J. Mehta|R. Lakshminarayanan"
"4883","13/04 12:00","2","P2387","Naveenkumar C N","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","FNDR-20364: a novel topical antibiotic for skin infections caused by Gram-positive bacteria","B. Piplani|C. Naveenkumar|K. Bharathkumar|V. Ramya|P. Kaur|S. Shanmugam S.|R. Mohan|R. Shandil|S. Narayanan"
"4915","13/04 12:00","3","P2388","Nouha BENTEBBAL","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Unraveling novel approaches to manage biofilm-associated infection","N. Bentebbal|M. Alsharqi|L. Mohamed|A. Senok|R. Nassar"
"4928","13/04 12:00","4","P2389","Paschalis PARANOS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage heteroresistance in multidrug-resistant Klebsiella pneumoniae clinical isolates","P. Paranos|S. Pournaras|J. Meletiadis"
"4967","13/04 12:00","5","P2390","Paschalis PARANOS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Comparative assessment of interactions between phages and antibacterial agents inhibiting DNA and protein synthesis against Gram-negative clinical isolates","P. Paranos|M. Siopi|S. Pournaras|J. Meletiadis"
"5076","13/04 12:00","6","P2391","Paschalis PARANOS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Antibacterial susceptibility testing of bacteriophages against Gram-negative pathogens","P. Paranos|S. Pournaras|J. Meletiadis"
"5123","13/04 12:00","7","P2392","Veronika SMITH","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Metallo-beta-lactamase inhibitor APC148: impact of choice of Mueller-Hinton broth brand on results from antimicrobial susceptibility testing","V. Smith|P. Rongved|O. Økstad"
"5124","13/04 12:00","8","P2393","Matthieu DEGREZE","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Potential of phage training to extend the host spectrum of anti-Staphylococcus aureus phages","M. Degreze|M. Medina|F. Laumay|L. Blazère|E. Helluin|C. Kolenda|F. Laurent"
"5139","13/04 12:00","9","P2394","Jyothi EMBEKKAT KAVIYIL","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Effect of GCurNPs on biofilm formation and quorum sensing genes of Pseudomonas aeruginosa","J. Embekkat Kaviyil|G. Ramesh|K. Raja|R. Joseph"
"5164","13/04 12:00","10","P2395","Balint KINTSES","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Genomic surveillance as a scalable framework for phage therapy against critically resistant bacterial pathogens","B. Kintses"
"5176","13/04 12:00","11","P2396","Stefano STRACQUADANIO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Kill two strains with one phage: broadening the host range of an Italian Acinetobacter baumannii bacteriophage","A. Nicolosi|G. Bonanno Ferraro|D. Brandtner|C. Veneri|M. Marchetti|G. La Rosa|S. Stefani|S. Stracquadanio"
"5179","13/04 12:00","12","P2397","Maryam AL SHARQI","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Enhancing the efficacy of phytic acid as an antimicrobial agent","M. Al Sharqi|R. Nassar|M. Nassar|A. Senok|S. Al Heialy"
"5308","13/04 12:00","13","P2398","Yang ZHONG","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage-antibiotic synergy induces genomic restructuring in multidrug-resistant Pseudomonas aeruginosa to mitigate resistance and virulence","Y. Zhong|S. Thong|Y. Liu|J. Teo|A. Kwa"
"5322","13/04 12:00","14","P2399","Andrej TRAUNER","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Effect of zosurabalpin, a pathogen-focused antibiotic, on the gut microbiome of healthy participants","E. Galvez|P. Scepanovic|M. Anliker-Ort|A. Zipperer|P. Misson|C. Heer|L. Proctor|A. Trauner|R. Deurloo|C. Zampaloni|A. Guenther"
"5330","13/04 12:00","15","P2400","Anissa BENKHALED","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Assessing the therapeutic potential of an apramycin-gallium combination for treating Acinetobacter baumannii lung infections","A. Benkhaled|S. Marchand|F. Tewes"
"5370","13/04 12:00","16","P2401","Raquel Lobato ALMEIDA","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","A novel class of antibiotics against multidrug-resistant Klebsiella pneumoniae","R. Almeida|N. Faria|B. Royo|O. Lenis-Rojas|M. Miragaia"
"5432","13/04 12:00","17","P2402","Michael SHEHAT","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Eco-friendly resveratrol nano-capsules to combat virulence of methicillin-resistant Staphylococcus aureus","M. Shehat|G. Dogheim|D. Mahdy|H. Barakat|A. Abouelfetouh|A. Ramadan"
"5455","13/04 12:00","18","P2403","Karolina KLESIEWICZ","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","PZ-2645 as a potential agent against biofilm-forming vancomycin-resistant Enterococci (VRE)","K. Klesiewicz|V. Canale|K. Piska|P. Krzyzek|P. Zajdel|E. Karczewska"
"5480","13/04 12:00","19","P2404","Regis TOURNEBIZE","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Activity of bacteriophages targeting Klebsiella pneumoniae","V. Fontaine|R. Calin|T. Strowig|V. Lannoy|L. Osbelt|A. Otwinowska|G. Majkowska-Skrobek|S. Wurtzer|L. Moulin|A. Aubry|A. Bleibtreu|J. Gedeon|E. Capton|Z. Drulis-Kawa|C. Eckert|R. Tournebize"
"5594","13/04 12:00","20","P2405","Balaji VEERARAGHAVAN","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.","B. Veeraraghavan|E. Shin|Y. Bakthavatchalam|A. Manesh|D. Dubey|C. Tascini|T. Magdalena A.|H. Andrea M.|J. Michael R.|B. Robert A."
"5602","13/04 12:00","21","P2406",,"9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophage isolation and characterisation against multidrug-resistant Stenotrophomonas maltophilia","E. Szoták|Z. Halász|N. Babar|L. Laczko|G. Kardos|K. Szarka"
"5672","13/04 12:00","22","P2407","Balaji VEERARAGHAVAN","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","?????In vitro activity of once-daily, investigational combination, ertapenem/zidebactam (WCK 6777) against cefiderocol non-susceptible E. coli harbouring NDM and PBP3 insertions","B. Veeraraghavan|R. Puthan|Y. Bakthavatchalam|D. S.|A. S.|S. K.|P. B.|P. B.|K. Walia|R. Soman|R. V.|A. Egli"
"5678","13/04 12:00","23","P2408","Roberto RILO-ANTELO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Influence of outer membrane permeability and KPC amino acid variation on the activity of cefepime/enmetazobactam against KPC-producing Enterobacterales showing ceftazidime/avibactam resistance","R. Rilo-Antelo|S. Rodriguez-Pallares|C. Riazzo|C. Elias-Lopez|T. Blanco-Martin|L. Sanchez-Pena|L. González-Pinto|J. Vázquez-Ucha|A. Beceiro|L. Lopez-Cerero|L. Martinez-Martinez|G. Bou|J. Arca-Suárez|E. Recacha"
"5831","13/04 12:00","24","P2409","Naouel KLIBI","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Study of antibacterial activity of aromatic plants extracts on multiresistant bacteria of avian origin","M. Ben Tekfa|O. Chabbar|S. Gharbi|H. Ouzari|N. Klibi"
"5903","13/04 12:00","25","P2410","Sara BOLOGNINI","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Selection of Pseudomonas aeruginosa phages and improvement of their lytic activity for a therapeutic approach in lung infection","S. Bolognini|C. Ferretti|E. Trovato|N. Poma|L. Rindi|A. Tavanti|M. Di Luca"
"5909","13/04 12:00","26","P2411","Charalampos MYSTAKELIS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Susceptibility patterns of Pseudomonas aeruginosa isolates exhibiting difficult-to-treat resistance against available and upcoming beta-lactam agents","H. Mystakelis|Y. Bergman|E. Jacobs|A. Mathers|R. Shields|P. Simner|P. Tamma"
"6045","13/04 12:00","27","P2412","Oksana GERULIS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Probiotics-loaded electrospun matrices: an innovative approach for enhanced wound healing","O. Gerulis|M. Putrins|T. Tenson|K. Kogermann"
"6086","13/04 12:00","28","P2413","Dilip DUBEY","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Cefepime/zidebactam: a novel beta-lactam-enhancer mechanism based triple action BCH-DBO antibiotic","D. Dubey|N. Bano|M. Roy"
"6171","13/04 12:00","29","P2414","Marija MILJKOVIC","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro activity of a BV500 lead compound against M. abscessus and other NTMs","M. Miljkovic|L. Hofmann|M. Appertet|B. Schellhorn|A. Michelotti|A. Dreneau|G. Caron|V. Le Moigne|I. Hermann|C. Poignon|J. Schill|L. Munch|K. Antraygues|M. Maingot|J. Herrmann|A. Aubry|N. Veziris|N. Willand|V. Trebosc|M. Bandera|N. Khan|S. Lociuro"
"6277","13/04 12:00","30","P2415","Paschalis PARANOS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Multiplicity of infection ratios for determining phage activity","P. Paranos|S. Pournaras|J. Meletiadis"
"6284","13/04 12:00","31","P2416","Patricia BARTSCH","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Activity of cefepime/enmetazobactam in highly resistant Gram-negative bacteria in a tertiary care setting in Germany","P. Bartsch|S. Weisselberg|L. Brakert|M. Savickis|P. Haffke|H. Rohde|M. Aepfelbacher"
"6292","13/04 12:00","32","P2417","Samantha DONNELLAN","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Efficacy of solid drug nanoparticles against MRSA: a promising approach to combat AMR","S. Donnellan|U. Bah|N. Wheelhouse|S. Dancer"
"6293","13/04 12:00","33","P2418","Eunjeong SHIN","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Novel C5-alpha-substituted carbapenems targeting Mycobacterium abscessus: enhanced peptidoglycan protein binding and reduced BlaMab hydrolysis","E. Shin|P. Quan|M. Khan|J. Cox|K. Dousa|M. Nantongo|S. Holland|E. Rubin|K. Barry|R. Bonomo|J. Buynak"
"6297","13/04 12:00","34","P2419","Adriana SILVA","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","New potential antibacterial agents using natural product extracts against important foodborne pathogens","A. Silva|V. Silva|G. Igrejas|P. Valentao|V. Falco|P. Poeta"
"6310","13/04 12:00","35","P2420","Ana Carolina RAMOS DA SILVA","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","In vitro activity of aztreonam/durlobactam against MbetaL-producing Enterobacterales strains","A. Ramos|W. Martins|E. C. C. M. Moura|T. R. Walsh|A. J. M. Farley|C. J. Schofield"
"6331","13/04 12:00","36","P2421","Andrea GARCÍA NAVARRO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophage EC10P1 re-sensitises multidrug-resistant Escherichia coli 456 to aztreonam/avibactam","A. Garcia Navarro|S. Patpatia|H. Thalén|C. Tellapragada|C. Giske|A. Örmälä-Tiznado"
"6349","13/04 12:00","37","P2422","Rafael GOMES VON BOROWSKI","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Monitoring of PHAXIAM's phage spectrum of activity on clinical strains (PST CE-IVD)","A. Bernon|M. Thépaut|R. Gomes Von Borowski"
"6483","13/04 12:00","38","P2423","Callan BLEICK","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Does order of administration matter? Bacteriophage antibiotic combinations against DNS-MRSA isolates","C. Bleick|S. Van Helden|S. Lehman|M. Rybak"
"6525","13/04 12:00","39","P2424","Anni-Maria ÖRMÄLÄ-TIZNADO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Bacteriophages against pulmonary infection and colonisation of the gut by multidrug-resistant Klebsiella pneumoniae in murine models","A. Örmälä-Tiznado|S. Patpatia|A. Garcia Navarro|E. Loo|C. Giske|J. Bengoechea|C. Frantzen"
"6628","13/04 12:00","40","P2425","Stefan MILENKOVIC","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Decoding the MIC-permeability relationship in Escherichia coli using advanced statistical machine learning approaches","M. Ceccarelli|S. Milenkovic|M. Scorciapino|F. Angius|S. Puxeddu|S. Boi"
"6658","13/04 12:00","41","P2426","Elisa D'ALIESIO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Isolation and characterisation of bacteriophages against carbapenemase-resistant strains of Acinetobacter baumannii (CR-Ab)","E. D'aliesio|C. Luceri|M. Miele|D. Nashon|I. Farrotti|M. De Leon|D. Tomolillo|L. Martellone|A. Oliva|C. Mastroianni"
"6755","13/04 12:00","42","P2427","Souad LOQMAN","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","New approach for high eradication of multidrug-resistant bacteria by biosynthesised copper oxide nanoparticle ST@CuONPs using Streptomyces thinghirensis sp. nov","S. Loqman|A. Loqman|A. Outzourhit|Y. Ouhdouch|J. Rolain|J. Renault"
"6919","13/04 12:00","43","P2428","Elisa RESTIVO","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage display-derived neutralising monoclonal antibody as possible vaccine against Staphylococcus aureus collagen adhesin CNA","E. Restivo|F. Bertoglio|F. Azzali|M. Pedotti|L. Simonelli|M. Höök|L. Varani|M. Hust|L. Visai"
"7087","13/04 12:00","44","P2429","Angel MAGAÑA","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Inhibition of gene expression by multiple mechanisms using locked-nucleic acid gapmers","A. Magana|K. Phan|M. Ramirez|M. Tolmasky"
"7093","13/04 12:00","45","P2430","Anna DE FILIPPIS","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","The anti-virulence and immunomodulatory potential of the peptide oreoch-1 against enteroinvasive E. coli infection","F. Palma|A. Chianese|R. Della Marca|A. Monti|N. Doti|C. Zannella|M. Galdiero|A. De Filippis"
"7147","13/04 12:00","46","P2431","Rizka JARIAH","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Phage therapy and antibiotics combination as the best standard treatment for Klebsiella??????: urinary tract infections","R. Jariah|J. Schofield|M. Clokie|M. Haines"
"7191","13/04 12:00","47","P2432","Sibel Dosler","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Sustained antimicrobial activities of antibiotic and metal nanoparticles loaded biopolymers","C. Özkanca|I. Esenturk Guzel|O. Tosyali|O. Karal Yilmaz|A. Bal Ozturk|S. Dosler"
"7310","13/04 12:00","48","P2433","Caterina FERRETTI","9","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Italian compassionate phage therapy pipeline: in vitro evaluation of bacteriophages to treat an Acinetobacter baumannii prosthetic joint infection","C. Ferretti|N. Cesta|L. Rindi|S. Bolognini|A. Bonacorsi|M. Di Luca"
"7318","13/04 12:00","1","P2434","Theresa HERMANN","10","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Novel 1,3,4-oxadiazole derivatives as promising antibacterial agents","T. Hermann|R. Weis"
"7627","13/04 12:00","2","P2435","Jabir ALI","10","B","05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Biological role of prolyl hydroxylation in Pseudomonas aeruginosa","J. Ali|F. Alshref|M. Allen|L. Wilson|G. Siegwart|C. Schofield"
"259","13/04 12:00","3","P2436","Yixuan LI","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A comparative pharmacodynamic evaluation of epithelial lining fluid exposures of piperacillin/tazobactam achieved by intermittent, extended, and continuous infusion regimens against Pseudomonas aeruginosa clinical isolates in an in vitro hollow-fibre infection model","Y. Li|J. Roberts|G. Assefa|F. Sime"
"360","13/04 12:00","4","P2437","Raja IDRIS","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis","R. Idris|A. Dayani|A. Groh|A. Mohr|J. Koepsell|A. Zielbauer|E. Herrmann|M. Vehreschild|T. Wichelhaus|N. Wetzstein"
"374","13/04 12:00","5","P2438","Johannes STARP","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Ten years of susceptibility testing of linezolid in a tertiary care hospital: model-informed precision dosing as a strategy for rising resistance","J. Starp|A. Leonhardt|J. Jung|M. Paal|M. Zoller|C. Scharf|S. Wicha|U. Liebchen"
"462","13/04 12:00","6","P2439","Soma HERBERS-BAHMANY","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Quantification of ceftazidime in vitreous humor using ultra-performance convergence chromatography-tandem mass spectrometry","S. Herbers-Bahmany|M. Manzulli|K. Faridpooya|S. Van Romunde|R. Ramautar|R. Flint"
"597","13/04 12:00","7","P2440","Justin SHIAU","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Urinary KIM-1 and vancomycin exposure in children with sepsis-induced MODS","J. Shiau|V. Amajor|J. Rhodes|A. Bwint|A. Sharova|J. Hensley|A. Pai|B. Wen|A. Zuppa|M. Hall|K. Downes|M. Scheetz"
"650","13/04 12:00","8","P2441","Soma HERBERS-BAHMANY","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Quantification of vancomycin and clindamycin in synovial tissue and bone using ultra-performance liquid chromatography-tandem mass spectrometry","A. Holst|S. Herbers-Bahmany|A. Van Dorp|J. Van Oldenrijk|K. Bos|W. Veltman|N. Kops|B. De Winter|B. Koch"
"1282","13/04 12:00","9","P2442","Yalew WALE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacodynamic evaluation of short vs long durations of amikacin combined with meropenem against meropenem-resistant Pseudomonas aeruginosa in hollow fibre infection model","Y. Wale|J. Roberts|G. Assefa|F. Sime"
"1398","13/04 12:00","10","P2443","Yukihiro HAMADA","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Optimisation of cefepime dosing regimen for Pseudomonas aeruginosa infection in Japanese patients using Monte Carlo simulation with pharmacokinetic/pharmacodynamic analysis for efficacy and safety","F. Ebihara|T. Maruyama|H. Kasai|N. Matsunaga|Y. Hamada"
"1446","13/04 12:00","11","P2444","Kévin ALEXANDRE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Effect of pH on the bacteriostatic and bactericidal activities of delafloxacin against Escherichia coli isogenic strains harboring diverse chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms","K. Alexandre|C. Saúco-Carballo|M. Murillo-Torres|F. Docobo-Pérez|J. Rodriguez|A. Pascual Hernandez"
"1468","13/04 12:00","12","P2445","Saskia Eliena ZIECK","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetic/pharmacodynamic target attainment of cefuroxime in adult patients on general wards with different degrees of renal function: a prospective observational cohort study","S. Zieck|S. De Vroom|F. Mulder|G. Van Twillert|R. Mathôt|S. Geerlings|R. Van Hest"
"1487","13/04 12:00","13","P2446","Magali VIDAL","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Amoxicillin blood concentration in high-dose intravenous amoxicillin: look beyond the numbers","M. Clément|F. Anglade|L. Gibold|C. Dubray|B. Pereira|A. Tournadre|G. Clerfond|C. Dupuis|X. Moisset|M. André|E. Geoffroy|D. Richard|M. Vidal|C. Durand|D. Martineau"
"1523","13/04 12:00","14","P2447","Brian VANSCOY","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics/pharmacodynamics of ANT3310, in combination with meropenem, against carbapenem-resistant Enterobacterales using a neutropaenic murine acute pyelonephritis model","M. Zalacain|A. Llanos|A. Ledoux|P. Ambrose|B. Vanscoy|A. Seyfried|M. Nasham|C. Vincent|C. Rubino|S. Bhavnani"
"1527","13/04 12:00","15","P2448","Brian VANSCOY","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Characterisation of pharmacokinetics/pharmacodynamics for efficacy of CZ-02-833 against Escherichia coli in a one-compartment in vitro infection model","B. Vanscoy|H. Conde|C. Vincent|C. Rubino|S. Bhavnani|P. Ambrose|C. Testa"
"1539","13/04 12:00","16","P2449","Marc SCHEETZ","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Lessons from a large multi-national database of children: standard paediatric dosing for vancomycin results in unacceptable exposure variability","M. Scheetz|S. Roy|P. Sabourenkov|J. Shiau"
"1544","13/04 12:00","17","P2450","Hailan WU","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Penetration of contezolid into bone tissues and body fluids in patients undergoing artificial hip or knee replacement surgery","F. Yin|H. Wu|Y. Chen|M. Chen|B. Guo|H. Wang|Y. Cao|T. Chen|J. Zhang"
"1772","13/04 12:00","18","P2451","Carina MATIAS","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Development of a murine pneumonia model with methicillin-resistant Staphylococcus aureus (MRSA) to evaluate antibiotic treatments","C. Matias|D. Vera-Yunca|L. E. Friberg|C. Vingsbo Lundberg"
"1831","13/04 12:00","19","P2452","Elena SOTO","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Clinical, microbiological, and pharmacokinetic/pharmacodynamic (PK/PD) target attainment analyses to support EUCAST aztreonam/avibactam minimum inhibitory concentration (MIC) breakpoints against Enterobacterales","S. Raber|R. Xie|J. Chow|H. Rogers|E. Soto|F. Arhin|G. Stone|H. Leister-Tebbe"
"2299","13/04 12:00","20","P2453","Daniel J.G. THIRION","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Piperacillin in adults 75-year-old and over should be monitored as exposure is two times above the expected levels","D. Thirion|M. El-Hassani|J. Verdon|E. Mcdonald|C. Desforges|A. Marsot"
"2327","13/04 12:00","21","P2454","Hailan WU","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics of contezolid in plasma and pulmonary epithelial lining fluid of patients with community-acquired pneumonia","H. Wu|Z. Cheng|F. Ding|J. Hua|H. Wang|X. Meng|Y. Cao|J. Zhang|J. Zhang|T. Chen"
"2400","13/04 12:00","22","P2455","Layios NATHALIE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Early beta-lactam target attainment in critically ill patients: a three-year retrospective cohort study using therapeutic drug monitoring","N. Layios|A. Pochon|M. Thys|N. Maes|C. Meex"
"2446","13/04 12:00","23","P2456","Romain AUBRY","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","PKPD modelling of ceftazidime/avibactam and colistin against five KPC-producing Klebsiella pneumoniae","R. Aubry|L. Friberg|L. Allander|P. Lagerbäck|T. Tängdén"
"2469","13/04 12:00","24","P2457","Marie ATTWOOD","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Antibacterial effect of BV100 plus polymyxin B, at simulated human drug exposures, against Acinetobacter baumannii in an in vitro infection model","M. Attwood|P. Griffin|A. Noel|B. Schellhorn|V. Trebosc|G. Dale|A. Macgowan"
"2620","13/04 12:00","25","P2458","Kristina SHAPOSHNIKOVA","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Effectiveness of meropenem/avibactam combination in suppressing emergence of meropenem-resistant carbapenemase-producing Klebsiella pneumoniae: predictive potential of a pharmacokinetically-based approach to MIC determination","K. Shaposhnikova|E. Strukova|M. Golikova|S. Zinner"
"2725","13/04 12:00","26","P2459","Reya SHAH","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Comparing the impact of renal replacement therapy on clarithromycin pharmacokinetic exposure in critically unwell adults using population pharmacokinetic analysis","R. Shah|K. Kipper|E. Baker|C. Barker|I. Oldfield|B. Philips|A. Johnston|A. Rhodes|M. Sharland|J. Standing|D. Lonsdale"
"2743","13/04 12:00","27","P2460","Kristina SHAPOSHNIKOVA","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Aztreonam combined with avibactam against Klebsiella pneumoniae: a pharmacokinetically-based approach to MIC determination to improve the prediction of efficacy","K. Alieva|M. Golikova|K. Shaposhnikova|S. Zinner"
"2771","13/04 12:00","28","P2461","Carlos SAÚCO CARBALLO","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacodynamic optimisation of temocillin treatment against CTX-M-15-producing K. pneumoniae isolates in a hollow-fiber infection model","J. Rodriguez-Ochoa|C. Saúco Carballo|V. Merino-Bohorquez|A. Velázquez-Escudero|J. Rodriguez-Bano|J. Rodriguez-Martinez|Á. Pascual|F. Docobo-Pérez"
"2809","13/04 12:00","29","P2462","Sonia LUQUE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Predictive score for selecting patients candidate to linezolid therapeutic drug monitoring and need for dosage individualisation","D. Fresán|L. Sorli Redo|A. Benitez-Cano|R. Munoz|I. Subirana|J. Barcelo-Vidal|M. Montero|T. Baciu|E. Padilla|J. Horcajada|S. Grau|S. Luque|M. Comas"
"2834","13/04 12:00","30","P2463","Keely MORRIS","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetics of vancomycin in critically ill adult patients undergoing continuous renal replacement therapy","A. Hopkins|K. Morris|S. Tamirisa|H. Robinson|S. Rizwan|G. Severance|A. Yassin|A. Farkas"
"2876","13/04 12:00","31","P2464","Hiie SOEORG","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetic model averaging for a priori dose optimisation of meropenem and piperacillin in intensive care patients","H. Soeorg|H. Laas|T. Metsvaht"
"2950","13/04 12:00","32","P2465","Zong Heng SHI","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Evaluating the clinical impact of targeting lower versus higher serum vancomycin trough: a retrospective study using a desirability of outcome ranking (DOOR) analysis","Z. Shi|S. Ong|L. Palmay|N. Ma|M. Granger|P. Lam|M. Elligsen"
"2991","13/04 12:00","33","P2466","Antonio ARRIETA","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Determining the appropriateness of standard cefepime dosing in septic paediatric cancer patients: a pilot study","A. Arrieta|S. Osborne|A. Lee|T. Tran|C. Enriquez|D. Nieves"
"3011","13/04 12:00","34","P2467","Vasin VASIKASIN","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Development of a quantitative lateral flow assay for meropenem: a proof-of-concept study for point-of-care therapeutic drug monitoring","V. Vasikasin|A. Riezk|R. Wilson|T. Rawson|A. Cass|A. Holmes"
"3255","13/04 12:00","35","P2468","Pippa GRIFFIN","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Antibacterial effect of zosurabalpin using simulated human doses against carbapenem resistant Acinetobacter baumannii studied in an in vitro model of infection","P. Griffin|M. Attwood|A. Noel|C. Bissantz|C. Zampaloni|P. Misson|P. Dzgiel|A. Macgowan"
"3318","13/04 12:00","36","P2469","Agata SOLTYSINSKA","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A draft EUCAST rationale for antimicrobial susceptibility testing and treatment of ESBL infections with cefepime/sulbactam","A. Soltysinska|H. Soeorg|J. Readman|J. Standing|D. Wareham"
"3368","13/04 12:00","37","P2470","Yan CHEN","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Checkerboard coupling PopPK/PD: a rapid optimising solution for drug combination efficacy","Y. Li|Y. Chen"
"3387","13/04 12:00","38","P2471","Bjørg BOLSTAD","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Safety and pharmacokinetics of single ascending doses of APC148, a zinc-chelating MBL-inhibitor, in healthy volunteers","B. Bolstad|R. Hovland|J. Bylund|E. Rein-Hedin|S. Kuusk|P. Rongved"
"3390","13/04 12:00","39","P2472","Vasin VASIKASIN","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Lateral flow assay innovation for vancomycin: advancing point-of-care therapeutic drug monitoring","A. Riezk|V. Vasikasin|D. Lalwani Shahani|R. Wilson|T. Rawson|A. Cass|A. Holmes"
"3479","13/04 12:00","40","P2473","Simone ZONNENBERG","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Clinical evaluation of PK/PD target attainment for meropenem therapy: a retrospective observational study","S. Zonnenberg|L. De Jong|M. Kuindersma|B. Hafkamp|E. Van Kan|E. Olyslager|R. Zuidema|S. Wilkes"
"3555","13/04 12:00","41","P2474","Antonia LEONHARDT","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","External evaluation of popPK models for model-informed precision dosing of oral linezolid therapy administered to hospitalised patients","A. Leonhardt|J. Starp|M. Zoller|C. Scharf|J. Zander|J. Ermtraud|A. Kunzelmann|C. König|J. Grensemann|L. Reiter|C. Lau|D. Marriott|S. Stocker|S. Wicha|U. Liebchen|M. Paal|S. Greppmair|L. Schatz"
"3557","13/04 12:00","42","P2475","Jaap MOUTON","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Optimised target recommendations against systemic infections in ICU settings caused by Gram-positive cocci: lessons from a hollow-fibre infection model","J. Raaijmakers|J. Mouton|R. Bruggemann|C. Van Hasselt|N. Jager|S. Tandar|J. Van Ingen"
"3612","13/04 12:00","43","P2476","Taeeun KIM","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Adjunctive antimicrobial effect of ticagrelor at conventional antiplatelet dosages against methicillin-resistant Staphylococcus aureus in vitro and in vivo models","T. Kim|Y. Hong|E. Jeon|J. Jung|M. Kim|H. Sung|M. Kim|S. Kim|S. Choi|S. Lee|Y. Kim|Y. Chong"
"3646","13/04 12:00","44","P2477","Christina KÖNIG","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetics (PK) of posaconazole in critically ill patients","C. Koenig|S. Kluge|M. Goepfert|D. Wichmann"
"3652","13/04 12:00","45","P2478","Joerg STEINMANN","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Inadequate linezolid plasma concentrations in critical ill patients with extracorporeal membrane oxygenation (ECMO): results from 53 patients","R. Hoehl|F. Rasshofer|F. Soergel|M. Kinzig|R. Bertram|J. Steinmann"
"3691","13/04 12:00","46","P2479","Cindy FEVRE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Complementary killing activities of pbunavirus LS1 and bruynoghevirus LUZ24 phages on planktonic and biofilm of Pseudomonas aeruginosa","M. Billaud|C. Plantady|E. Ollivier|J. Lossouarn|E. Moncaut|J. Deschamps|R. Briandet|A. Cleret|C. Fevre|G. Demarre|M. Petit"
"3694","13/04 12:00","47","P2480","Nattapat SANGKAKUL","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetics and Monte Carlo simulations of ceftriaxone to optimise dosage regimen in patients with sepsis","S. Nattapat|S. Chusri|P. Siripaitoon|N. Kositpantawong|S. Kanchanasuwan|S. Chittrakarn|B. Charoenmark|M. Jullangkoon|B. Apinya"
"3764","13/04 12:00","48","P2481","Beatriz ESTEBAN-CARTELLE","10","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Stability of ceftobiprole medocaril in portable elastomeric infusion devices","B. Esteban-Cartelle|B. Anaya|C. Perez Menendez-Conde|N. Vicente-Oliveros|D. Serrano|A. Alvarez-Diaz|J. Fortun Abete|P. Martin Davila"
"3789","13/04 12:00","1","P2482","Mathilde BERGHMANS","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","The use of vancomycin with drug trough monitoring in methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis: a retrospective cohort study in Gaza","M. Berghmans|R. Aqel|K. Al Sedawi|A. Alhenawi|H. Salama|S. Safi|J. Younis|R. Kanapathipillai|M. Khalife|R. Malaeb|P. Garcia-Vello|A. Elmanama|K. Moussally"
"3821","13/04 12:00","3","P2484","Jun Jie TAN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Meropenem levels in critically ill patients on continuous veno-venous hemodiafiltration (CVVHDF): exploration of variables and their influence on dose requirements","J. Tan|N. Chua|K. Goh|T. Lim|W. Lee|A. Kwa"
"3892","13/04 12:00","4","P2485","Emily JAIME","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacodynamic target attainment of commercially available fixed-dose daptomycin preparations in hospitalised patients with blood stream infections caused by Staphylococcus aureus","E. Jaime|S. Tamirisa|G. Severance|A. Yassin|A. Hopkins|A. Farkas"
"3927","13/04 12:00","5","P2486","Thomas NGUYEN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Unraveling phage pharmacodynamics against KPC-5 Pseudomonas in the hollow fiber infection model","T. Nguyen|J. Sanborn|A. Frymoyer|G. Suh|P. Bollyky|D. Roach|N. Smith"
"3988","13/04 12:00","6","P2487","Hanna Kadri LAAS","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Clinical trial ProVanc evaluating individualised model selection and dosing tool for vancomycin: safety review","H. Laas|T. Metsvaht|K. Tamme|J. Karjagin|H. Soeorg"
"4001","13/04 12:00","7","P2488","Jane FREEMAN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Aztreonam/avibactam is more sparing to the gut microbiome than ceftazidime/avibactam with aztreonam in a human in vitro gut model","C. Normington|J. Bromley|C. Chogogudza|E. Clark|K. Bentley|K. Kaur|W. Spittle|D. Ewin|M. Wilcox|K. Davies|J. Freeman"
"4125","13/04 12:00","8","P2489","Theis MARIAGER","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Induction of Meningeal Inflammation via Intraventricular Lipopolysaccharide Inoculation in a Porcine Model","T. Mariager|J. Guldbaek|J. Terkelsen|M. Nielsen|C. Bjarkam|M. Ettrup|H. Nielsen|J. Bodilsen"
"4131","13/04 12:00","9","P2490","Michel PIEREN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Determination of the pharmacodynamic targets of BV100 in the neutropaenic murine lung infection model","M. Pieren|A. Muller|M. Pulse|W. Weiss|W. De Jong|V. Trebosc|F. Jung|S. Van Den Berg|G. Dale"
"4178","13/04 12:00","10","P2491","Michel PIEREN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Determination of the pharmacodynamic targets of BV100 in the neutropaenic murine thigh infection model","M. Pieren|A. Muller|M. Pulse|W. Weiss|W. De Jong|V. Trebosc|F. Jung|S. Van Den Berg|G. Dale"
"4195","13/04 12:00","11","P2492","Harivenkatesh NATARAJAN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics of vancomycin in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: a comparison between AUC and trough level monitoring for optimising vancomycin dose","H. Natarajan|N. Krishnapa|S. Sistla|S. Sistla|.. Vivekanandan|.. Girish"
"4196","13/04 12:00","12","P2493","Anouk Edwina MULLER","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Sub-MIC exposure linked in vivo pharmacokinetic/pharmacodynamic targets (PDTs) of beta-lactam enhancer zidebactam in presence of cefepime against carbapenem-resistant Acinetobacter baumannii (CRAB)","A. Muller|V. Zope|R. Chavan|S. Takalkar|K. Umarkar|P. Tayde|M. Tellis|H. Periasamy|S. Bhagwat|M. Patel"
"4251","13/04 12:00","13","P2494","Ronaldo MORALES JUNIOR","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Identifying predictors of cefepime pharmacokinetics in bone marrow transplant recipients","R. Morales Junior|H. Hambrick|T. Mizuno|S. Benoit|E. Schuler|G. Klink|S. Tang Girdwood"
"4289","13/04 12:00","14","P2495","Anouk Edwina MULLER","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Phase 1, randomised, double-blind, placebo-controlled, single-dose study to evaluate the pharmacokinetics of cefepime/zidebactam (WCK 5222) in healthy adult Chinese subjects","R. Gutte|L. Llorens|A. Patel|P. Iwanowski|R. Chavan|R. Yeole|A. Muller"
"4419","13/04 12:00","15","P2496","Maria Bech Damsgaard NIELSEN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Cefepime/enmetazobactam for Gram-negative PJIs? A porcine study evaluating target tissue concentrations following intermittent short-term infusion and continuous infusion of a novel antibiotic combination","M. Nielsen|M. Mikkelsen|H. Ramussen|M. Hvistendahl|C. Lutzhoft|J. Slater|N. Jørgensen|A. Soriano|M. Stilling|M. Bue"
"4469","13/04 12:00","16","P2497","Bonniface OBURA","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics of intrapartum benzylpenicillin: insights into candidate regimens to prevent early onset neonatal Group B Streptococcus disease","B. Obura|A. Jimenez-Valverde|J. Unsworth|C. Waitt|S. Das|W. Hope|K. Navaratnam"
"4498","13/04 12:00","17","P2498","Giorgia MENEGATTI","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Real-world evidence: cefiderocol therapeutic drug monitoring in critically ill, obese patients in NDM infections","G. Menegatti|A. Manca|J. Cusato|C. Grosso|S. Corcione|J. Mula|S. Scabini|A. De Nicolo|F. De Rosa|A. D'avolio"
"4541","13/04 12:00","18","P2499","Sebastian HERREN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Phage K exposure generates phage K neutralising activity in a rabbit septic arthritis model","S. Herren|M. Karau|C. Koscianski|D. Granger|R. Patel"
"4602","13/04 12:00","19","P2500","Thomas LODISE","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A Phase 1, randomised, double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacokinetics (PK) of intravenous ertapenem (ERT) with zidebactam (ZID) in combination (WCK 6777) in healthy adult subjects","T. Lodise|R. Chavan|A. Patel|R. Yeole|S. Bhagwat|M. Patel|G. Saviolakis|M. Kankam|K. Gu|V. Ghazaryan|R. Bonomo|A. Jaunarajs|E. Hammett|H. Howell"
"4665","13/04 12:00","20","P2501","Stephanie SUPPARITSCH","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Efficacy of ceftazidime/avibactam against ten clinical isolates of Pseudomonas aeruginosa in peritoneal dialysis fluid","S. Supparitsch|A. Vychytil|M. Zeitlinger|A. Nussbaumer-Pröll"
"4668","13/04 12:00","21","P2502","Alexander LEPAK","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Development of a novel complicated urinary tract infection (cUTI) mouse model utilising heamatogenous pyelonephritis in neutropenic thigh-infected mice","A. Lepak|R. Jones|R. Zarnowski|D. Andes"
"4696","13/04 12:00","22","P2503","Helmi SULAIMAN","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Do current piperacillin-tazobactam dosing regimens achieve optimal epithelial lining fluid (ELF) concentrations in intensive care unit (ICU) patients with pneumonia?","X. Liu|S. Hasan|M. Mohamad|J. Lefrant|C. Roger|L. Muller|J. Dhanani|C. Fourie|L. Ling|W. Wong|M. Abdul-Aziz|J. Roberts|H. Sulaiman|J. De Waele|D. Marjanovic|S. Wallis|C. Landersdorfer|J. Lipman|A. Andrew"
"4733","13/04 12:00","23","P2504","Marta ZURAWSKA","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Piperacillin population pharmacokinetic/pharmacodynamic target attainment with continuous infusion dosing in patients admitted to the ICU with hospital-acquired pneumonia","S. Nozick|A. Misharin|R. Wunderink|N. Rhodes|M. Zurawska|A. Valadez|E. Harlan|M. Scheetz|M. Neely|P. Yarnold|M. Kang|H. Donnelly|F. Martinez|E. Korth|R. Medernach|A. Hauser|E. Ozer|E. Diaz"
"4793","13/04 12:00","24","P2505","Mikaela WALKER","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Fosfomycin and ceftazidime/avibactam combination as a possible treatment for blaIMP-4 harbouring Escherichia coli: a hollow fibre infection model evaluation","M. Walker|S. Wallis|J. Roberts|Y. Li|S. Naicker|B. Forde|F. Sime"
"4839","13/04 12:00","25","P2506","Adrian VALADEZ","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMO","A. Valadez|M. Zurawska|E. Harlan|M. Neely|M. Scheetz|P. Yarnold|M. Kang|H. Donnelly|K. Dedicatoria|R. Medernach|S. Nozick|A. Hauser|E. Ozer|E. Diaz|A. Misharin|R. Wunderink|N. Rhodes|E. Korth|F. Martinez"
"4918","13/04 12:00","26","P2507","Rekha PAI MANGALORE","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A beta-lactam antibiotic dose adaptation feasibility randomised controlled trial utilising therapeutic drug monitoring (ADAPT-TDM study)","R. Pai Mangalore|M. Chai|J. Pope|S. Lee|A. Padiglione|A. Diehl|L. Roberts|K. Sim|P. Rawson-Harris|S. Wicha|H. Schneider|T. Peel|A. Jenney|D. Ayton|A. Peleg|A. Udy"
"4981","13/04 12:00","28","P2509","Birgit KOCH","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Leveraging clinical data to enhance the performance evaluation of ceftriaxone population pharmacokinetic models in children","S. Schouwenburg|T. Preijers|A. Abdulla|E. Wildschut|B. Koch|M. De Hoog"
"4998","13/04 12:00","29","P2510","Birgit KOCH","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Prediction of vancomycin area-under-the-curve using trough concentrations only: performance evaluation of paediatric population pharmacokinetic models","S. Schouwenburg|T. Preijers|R. Flint|E. Wildschut|B. Koch|B. De Winter|A. Abdulla"
"5013","13/04 12:00","30","P2511","Arnaud DE CLERCQ","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics and target attainment of teicoplanin: a systematic review","A. De Clercq|J. Mouton|P. De Paepe|M. Petrovic|T. Desmet|R. Bruggemann|J. Schouten|N. Jager|P. De Cock"
"5014","13/04 12:00","31","P2512","Julia LAPORTE-AMARGOS","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetics and optimised initial dosing of piperacillin in in haematologic patients with febrile neutropenia","M. Ulldemolins|J. Laporte-Amargos|R. Rigo-Bonin|F. Carmona-Torre|M. Huguet|P. Puerta|M. Arnan|A. Torrent|C. Garcia-Vidal|A. Sureda|J. Del Pozo|A. Bergas|E. Sastre-Escola|J. Carratalà|C. Gudiol"
"5085","13/04 12:00","32","P2513","Birgit KOCH","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A pooled population pharmacokinetic study of intravenous cefuroxime in neonates and infants: renal function dependent underexposure","S. Schouwenburg|T. Preijers|S. Hartman|S. De Wildt|M. De Hoog|B. Koch|A. Abdulla|E. Wildschut"
"5104","13/04 12:00","33","P2514","Valentin AL JALALI","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Distribution of ampicillin and sulbactam into the cerebrospinal fluid of children and adolescents with brain tumors","V. Al Jalali|H. Schned|T. Pecho|C. Dorn|I. Minichmayr|M. Zeitlinger|A. Peyrl|C. Lier"
"5138","13/04 12:00","34","P2515","Adela BENITEZ-CANO MARTINEZ","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetic/pharmacodynamic target attainment of continuous infusion of ceftazidime and avibactam in plasma and epithelial lining fluid in critically ill patients with nosocomial pneumonia","A. Benitez-Cano Martinez|I. Ramos|R. Adalia|J. Gomez-Junyent|M. Montero|T. Baciu|V. Vega Toribio|V. Curull|A. Sánchez|R. Chalela|E. Navarrete|M. De Antonio|S. Grau|J. Horcajada|S. Luque|L. Sorli Redo"
"5272","13/04 12:00","35","P2516","Matteo MORRA","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","External validation of vancomycin population pharmacokinetics models in hospitalised patients with bloodstream infections","M. Morra|E. Carrara|E. Tacconelli|A. Azzini"
"5281","13/04 12:00","36","P2517","Valentin AL JALALI","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics and safety of BV100 in epithelial lining fluid and plasma","C. Kemmer|V. Al Jalali|L. Husband|T. Armengol|M. Davila|P. Delique|S. Ravalli|A. Jorda|F. Bergmann|L. Pracher|M. Prager|M. Jackwerth|S. Eberl|A. Leutzendorff|E. Lackner|M. Zeitlinger|G. Dale|A. Nussbaumer-Pröll"
"5291","13/04 12:00","37","P2518","Lisa LEYENBERGER","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Intense care medicine-optimised dosing nomograms for beta-lactams administered by continuous infusion","L. Leyenberger|R. Garreau|A. Friggeri|S. Goutelle"
"5508","13/04 12:00","38","P2519","Iain ABBOTT","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Urinary pharmacodynamic profiling of oral amoxicillin-clavulanate in a bladder infection model","C. Anderson|C. Landersdorfer|J. Meletiadis|A. Peleg|I. Abbott"
"5554","13/04 12:00","39","P2520","Mariana ANDRADE","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Evaluation of candidate drugs for repurposing in a Galleria mellonella staphylococcal infection model","M. Andrade|J. Neves|M. Bento|J. Marques|S. Seabra|M. Viveiros|L. Rodrigues|A. Armada|H. Silveira|I. Couto|S. Costa"
"5565","13/04 12:00","40","P2521","Fernando DOCOBO PÉREZ","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Population pharmacokinetic/pharmacodynamic analysis of intravenous temocillin for the treatment of 3rd generation cephalosporin-resistant Escherichia coli bacteraemia (ASTARTE study)","F. Docobo-Pérez|V. Merino-Bohorquez|M. Tirado|B. Gallego Mesa|N. Zuabi Garcia|A. Alemán|L. Cubero|L. Barrera Pulido|F. Cogliati Dezza|V. Palomo Jiménez|J. Rodriguez Bano"
"5640","13/04 12:00","41","P2522","Akim CHAYEM","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Focus on enmetazobactam chemical stability in association with cefepime for prolonged infusions, in syringe and elastomeric diffusers","A. Chayem|J. Quevedo|N. Jemmely|E. D´huart"
"5669","13/04 12:00","42","P2523","Clara BERARDI","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Cefiderocol: stability study in elastomeric device at 32°C","C. Berardi|E. D'huart|C. Marquet|N. Sobalak|A. Charmillon|J. Vigneron|B. Demoré"
"5752","13/04 12:00","43","P2524","Giorgia MENEGATTI","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetics and intra-individual variability of multidose oritavancin in real-life use","G. Menegatti|A. De Nicolo|S. Corcione|F. De Rosa|M. Cotrufo|C. Tascini|A. D'avolio"
"5896","13/04 12:00","44","P2525","Marion GIRY","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Effect of augmented renal clearance on in vitro bactericidal activity of cefepime/nemetazobactam against ESBL-producing Escherichia coli evaluated via a mechanism-based modelling","M. Giry|C. Marlat|C. Baulier|F. Lamoureux|F. Gravey|M. Etienne|K. Alexandre"
"6154","13/04 12:00","45","P2526","Marion GIRY","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Efficacy of different piperacillin/tazobactam (TZP) - amikacin (AMK) regimens against ESBL Escherichia coli in a hollow fiber infection model (HFIM) simulating sepsis augmented renal clearance","M. Giry|C. Marlat|C. Baulier|F. Lamoureux|A. Ganem|D. Diagouraga|F. Docobo-Pérez|M. Etienne|F. Gravey|K. Alexandre"
"6193","13/04 12:00","46","P2527","Jennie VAN DYK","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Clavulanate pharmacokinetics in severe paediatric community-acquired pneumonia: findings from PediCAP-A and -B","J. Van Dyk"
"6200","13/04 12:00","47","P2528","Birgit KOCH","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Unraveling the bone pharmacokinetics of cefuroxime in periprosthetic joint infection","G. De Waard|E. Veltman|J. Van Oldenrijk|K. Bos|B. Koch"
"6342","13/04 12:00","48","P2529","Lynn MIESEL","11","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","A murine disease model of Pseudomonas aeruginosa lung infection for drug candidate characterisation","L. Miesel|J. Chia|Y. Lee|C. Chiang|Y. Huang|W. Liao|J. Chien|Y. Yeh|H. Lee|M. Hsieh|K. Lin|C. Shen"
"6813","13/04 12:00","1","P2530","Thi Van Anh NGUYEN","12","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Understanding meropenem disposition in critically ill children: a population PK analysis","A. Nguyen|E. Dhont|E. Beel|N. Verougstraete|V. Stove|S. Vanhaesebrouck|D. Vens|P. De Paepe|P. A. De Cock"
"6825","13/04 12:00","2","P2531","Paschalis PARANOS","12","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","PK/PD of colistin in combination with bacteriophages against carbapenemase-producing Klebsiella pneumoniae clinical isolates","P. Paranos|S. Pournaras|J. Meletiadis"
"6883","13/04 12:00","3","P2532","Andre WIERINGA","12","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Predicting ciprofloxacin target non-attainment in critically ill patients at treatment initiation: development and external validation of two novel (machine learning) models","A. Wieringa|A. Egberts|R. Gangapersad|R. Van Hest|E. Wils|B. Koch|A. Abdulla"
"7216","13/04 12:00","4","P2533","Oscar DELLA PASQUA","12","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Dealing with the myth of 40% T>MIC for amoxicillin clavulanate: a hollow-fiber study using clinically relevant concentrations","F. Sanz Garcia|S. Moreira|S. Ramon-Garcia|A. Lucia|M. Martinez-Martinez|F. Romano|P. Nijhara|K. Langfeld|O. Della Pasqua"
"7610","13/04 12:00","5","P2534","Islam GHAZI","12","B","05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Pharmacokinetic analysis of ceftazidime/avibactam dosing in patients utilising renal replacement therapy","I. Ghazi|E. Abidi|L. Ali|W. Rabbah|D. Alrahmany|W. El Nekidy"
"810","13/04 12:00","7","P2536","Maria MAZZITELLI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Clinical, microbiological and laboratory predictors of on- and off-label dalbavancin treatment failure","M. Mazzitelli|D. Mengato|V. Scaglione|E. Giunco|E. Barzizza|L. Salmaso|S. Cavinato|A. Sattin|M. Trevenzoli|F. Venturini|A. Cattelan"
"901","13/04 12:00","8","P2537","Jonas HINK","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","A Phase 1, randomised, double-blind, first-in-human, dose-escalation study investigating the safety, recovery, and pharmacodynamics of a novel CRISPR-Cas therapeutic (SNIPR001)","A. Petersen|E. Van Der Helm|C. Grøndahl|M. Petersen|S. Semsey|A. De Santiago Torio|I. Turcu|F. Smrekar|Y. Taur|M. Satlin|M. Sommer|B. Damholt|M. Grove|J. Hink|T. Marotte-Hurbon|J. Söderqvist|A. Troy|M. Zdravkovic|L. Bayer|K. Brunner|T. Bryde|J. Clube|Y. Gencay|A. Gram|J. Krause Haaber|B. Hallström|D. Jasinskyte|R. Pascal"
"1089","13/04 12:00","9","P2538","Lauren FORTIER","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Impact of hypoalbuminemia on outcomes of ertapenem","J. Ventres|L. Fortier|A. Brotherton|B. Velikaneye|E. O'neill|C. Cunha"
"1350","13/04 12:00","10","P2539","Emanuele PALOMBA","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Efficacy and safety of monoclonal antibodies for prevention and treatment of multidrug-resistant organisms' infections: a scoping review","M. Piscaglia|G. Scaglione|C. Genovese|F. Borgonovo|F. Brivio|F. Rampichini|R. Grifantini|A. Bandera|A. Gori|M. Colaneri|E. Palomba"
"1418","13/04 12:00","11","P2540","Ines Maria BLERIOT RIAL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Studies in vitro and in vivo of phage therapy medical products (PTMPs) targeting clinical strains of Klebsiella pneumoniae belonging to the clone ST512","I. Bleriot|L. Blasco|P. Fernandez-Grela|L. Fernandez-Garcia|L. Armán|C. Ibarguren|C. Ortiz-Cartagena|A. Barrio-Pujante|J. Pano-Pardo|J. Oteo-Iglesias|M. Tomás"
"1430","13/04 12:00","12","P2541","Harpreet KAUR","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Reviving old drugs: targeting FliN of uropathogenic Escherichia coli to treat urinary tract infections","H. Kaur|N. Taneja"
"1477","13/04 12:00","13","P2542","Stefano VERARDI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Cefiderocol treatment in patients with Gram-negative bacterial infections: European results of the global retrospective observational PROVE study","J. Asensio|A. Bleibtreu|E. Durante-Mangoni|D. Wichmann|D. Wareham|O. Cornely|S. Nguyen|S. Verardi|A. Karas"
"1657","13/04 12:00","14","P2543","Jazmin DIAZ-REGAÑON","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Design of a Phase 3b, open-label, single-arm study evaluating clinical symptom improvement with gepotidacin in participants with uncomplicated urinary tract infection (uUTI)","J. Diaz-Reganon|M. Ramirez|D. Powell|R. Banerjee|S. Janmohamed|A. Mulgirigama"
"1878","13/04 12:00","15","P2544","Nicole E. SCANGARELLA-OMAN","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Gepotidacin and nitrofurantoin efficacy by baseline uropathogen drug-resistant phenotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections","D. Butler|J. Breton|D. Brown|C. Kasapidis|A. Sheets|N. Scangarella-Oman|C. Perry|J. Dennison|C. Huang|H. Millns|S. Janmohamed"
"1898","13/04 12:00","16","P2545","Michael HUBAND","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Preliminary zosurabalpin (5µg) disk diffusion quality control ranges using clinical and laboratory standards institute M23 criteria","M. Huband|Y. Edah|T. Andrej|M. Castanheira"
"2162","13/04 12:00","17","P2546","Amani PATEL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Off-label use of oritavancin: a case series on clinical efficacy, bed day savings, and cost benefits","A. Patel|A. Walden|A. Okoibhole|S. Iyer"
"2405","13/04 12:00","18","P2547","Yang LIU","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Clinical application of customised and non-customised bacteriophage therapy in patients with persistent and difficult-to-treat bacterial infections: systematic review and meta-analysis","Y. Liu|S. Thong|W. Moreira|J. Yeo|Y. Zhong|Z. Chong|T. Wong|S. Chung|A. Kwa"
"2668","13/04 12:00","19","P2548","Gabriela ABELENDA-ALONSO","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Real-life experience with cefiderocol treatment of multidrug-resistant Gram-negative infections","L. Garcia-Carnero|G. Abelenda-Alonso|M. Santos-Puig|A. Padullés|C. Ribera-Puig|F. Tubau|R. Costa-Primo|V. Gumucio|R. Granada Vicente|E. Santafosta|A. Blanco-Arevalo|M. Puig-Asensio|E. Shaw|J. Carratalà|A. Lamiel|C. Gudiol"
"2759","13/04 12:00","20","P2549","Bernd NEUMANN","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Efficacy of aztreonam/avibactam, ceftazidime-avibactam, and cefiderocol against multidrug-resistant and putative-hypervirulent Klebsiella pneumoniae isolates","B. Neumann|S. Wilhelm|A. Lang|A. Rath|B. Kieninger|W. Schneider-Brachert|J. Steinmann"
"2850","13/04 12:00","21","P2550","Anouk Edwina MULLER","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Efficacy and safety of oral nafithromycin as a three- and five-day treatment regimen compared with moxifloxacin in adult patients with community-acquired bacterial pneumonia (CABP): a global Phase 2 randomised trial","A. Patel|L. Llorens|P. Iwanowski|R. Gutte|R. Chavan|S. Palwe|J. Prashant|H. Periasamy|M. Patel|S. Bhagwat|A. Muller"
"2874","13/04 12:00","22","P2551","Simon TIBERI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Ganfeborole in combination with novel antitubercular agent BTZ-043 administered for 14-days to participants with rifampicin-susceptible pulmonary tuberculosis: interim analysis results","S. Tiberi|S. Daware|A. Diacon|M. Hoelscher|G. Maher-Edwards|K. Fletcher|V. De Jager|S. Penman|K. Rolfe|R. Sharma|L. Iavarone|S. Lavezzi|J. Dreisbach|C. Upton|D. Barros Aguirre"
"2921","13/04 12:00","23","P2552","Taylor MORRISETTE","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Real-world, multicentre experience with ceftazidime/avibactam in the paediatric population","T. Morrisette|C. Lockowitz|V. Yuenger|D. Holger|A. Althubyani|B. Santevecchi|V. Venugopalan|A. Gainey|K. Mediwala Hornback|S. Thacker"
"2941","13/04 12:00","24","P2553","Emre YUCEL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Preliminary findings from a systematic literature review: bactericidal research on multi-drug resistant Pseudomonas aeruginosa (MDR-PsA) infections of Gram-negative using high-level therapeutics (BRIGHT)","H. Collings|A. Deepak|T. Waldenberg|E. Yucel|T. Lodise"
"3038","13/04 12:00","25","P2554","Krit THIRAPANMETHEE","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Polycationic PEI-based nanoparticles enhance antimicrobial delivery against multidrug-resistant Acinetobacter baumannii","K. Thirapanmethee|P. Khuntayaporn|T. Audshasai|N. Santhiyothin|P. Danpornprasert|S. Visansirikul|M. Chomnawang"
"3098","13/04 12:00","26","P2555","Haritha MADIGUBBA","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Bacteriological profile, antimicrobial susceptibility, and treatment outcomes of multidrug-resistant Gram-negative infections using a novel antibiotic combination ceftriaxone/sulbactam+EDTA","H. Madigubba|G. Jagathkar"
"3486","13/04 12:00","27","P2556","Magnus UNEMO","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Evidence of reinfection and no emergence of resistance following a single oral 3g dose of zoliflodacin demonstrated by whole-genome sequencing (WGS) in a global Phase 3 randomised controlled trial (RCT) for treatment of uncomplicated gonorrhoea","M. Unemo|D. Golparian|V. Elango|L. Piddock|S. Srinivasan|P. Bradford|S. Mcleod|S. Moussa|E. Hook Iii|A. Luckey"
"3502","13/04 12:00","28","P2557","Tanel TENSON","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Antibacterial compounds against non-growing and intracellular bacteria","N. Kaldalu|N. Berzins|S. Berglund Fick|A. Sharma|N. Andersson|J. Aedla|M. Hinnu|A. Puhar|V. Hauryliuk|T. Tenson"
"3771","13/04 12:00","29","P2558","Juan Luis QUEVEDO MARIN","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Microbiological outcome of eradication of cefepime/enmetazobactam vs piperacillin/tazobactam against most common Enterobacterales at test of cure; a posthoc analysis from the ALLIUM Phase 3 trial","J. Quevedo|N. Dunkel|P. Velicitat|S. Cure"
"3876","13/04 12:00","30","P2559","Emre YUCEL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Systematic review of the efficacy and safety of ceftolozane/tazobactam (C/T) for the treatment of complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI): ZEBRA","C. Cameron|S. Bagga|M. Korei|H. Esam|B. Mangla|C. Gulea|E. Yucel"
"4085","13/04 12:00","31","P2560","Emre YUCEL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Systematic literature review of efficacy and safety of ceftolozane/tazobactam (C/T) for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP): INSIGHT","C. Gulea|S. Bagga|M. Korei|N. Sharma|V. Sharma|C. Cameron|E. Yucel"
"4105","13/04 12:00","32","P2561","Emre YUCEL","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections: A Systematic Literature Review of Clinical Trials: RESOLVE","C. Gulea|S. Bagga|V. Khurana|P. Das|A. Goswami|C. Cameron|E. Yucel"
"4112","13/04 12:00","33","P2562","Michele SPINICCI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Single-centre real-life experience with imipenem/cilastatin/relebactam use at a tertiary care hospital in Italy, June 2022-November 2024","M. Spinicci|T. Giani|R. Antonello|N. Di Lauria|L. Graziani|G. Corti|A. Farese|L. Zammarchi|M. Angileri|M. Cecchi|A. Bartoloni|G. Rossolini"
"4229","13/04 12:00","34","P2563","Anne SANTERRE HENRIKSEN","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Outcomes by MIC values for patients infected with Enterobacterales treated with cefepime/enmetazobactam or piperacillin/tazobactam for complicated urinary tract infections in the phase 3 ALLIUM trial","M. Karolyi|P. Velicitat|J. Quevedo|N. Dunkel|A. Santerre Henriksen"
"4319","13/04 12:00","35","P2564","Luca MEZZADRI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Ceftazidime/avibactam plus aztreonam vs cefiderocol in the treatment of infections caused by metallo-beta-lactamase-producing microorganisms: real-world data from the Italian cohort SUSANA","L. Mezzadri|E. Ricci|M. Merli|N. Corti|M. Faltoni|A. Bandera|P. Maggi|M. Bartoletti|A. Mastroianni|S. Rusconi|M. Carleo|G. Cenderello|L. Bisi|G. Madeddu|P. Bonfanti"
"4403","13/04 12:00","36","P2565","Eugenia MAGRINI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Ceftaroline for the treatment of Staphylococcus aureus infections: a systematic review with Bayesian meta-analysis","E. Magrini|E. Rando|F. Sangiorgi|F. Catania|E. Matteini|M. Chiuchiarelli|F. Salvati|M. Fantoni|R. Murri|C. Torti"
"4855","13/04 12:00","37","P2566","Pooja SACHDEVA","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Bacteriophage therapy: an effective approach against multidrug-resistant Acinetobacter baumannii","P. Sachdeva|G. Nath|U. Jain"
"5734","13/04 12:00","38","P2567","Matteo FALTONI","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Comparison of meropenem/vaborbactam vs ceftazidime/avibactam in the treatment of KPC-producing Klebsiella pneumoniae infections","M. Faltoni|E. Ricci|L. Mezzadri|N. Corti|L. Bisi|M. Fois|G. Madeddu|F. Colucci|P. Maggi|M. Pontolillo|K. Falasca|A. Bandera|A. Maccaro|M. Berruti|D. Mondatore|L. Bussini|S. Greco|A. Mastroianni|F. Baragli|L. Attala|A. Pandolfo|G. De Socio|G. Angioni|M. Merli|M. Rossi|P. Bonfanti"
"5873","13/04 12:00","39","P2568","Marija MILJKOVIC","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Rifabutin exerts potent intracellular and biofilm eradication activity against Acinetobacter baumannii","V. Trebosc|M. Miljkovic|B. Schellhorn|M. Appertet|J. Schill|L. Munch|M. Gitzinger|S. Lociuro|F. Jung|M. Pieren|C. Kemmer|G. Dale"
"6103","13/04 12:00","40","P2569","Gabriele Maria LEANZA","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Real-world vs trial populations. a comparison between the clinical characteristics and outcome of the REACT-MDR and five pathogen-focused randomised clinical trials populations","G. Leanza|E. Rando|A. Tarik Aslan|F. Sangiorgi|B. Andriolo|E. Magrini|B. Fiori|G. De Pascale|M. Antonelli|P. Harris|D. Paterson|R. Murri|C. Torti"
"6671","13/04 12:00","41","P2570","Sarah ALGHANEM","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Colistin prescribing and outcomes in Kuwait public hospitals","S. Alghanem|W. Al-Fouzan|M. Soliman|E. Alroomi|S. Alajmi|T. Mahmoud|J. Yagan"
"7412","13/04 12:00","42","P2571","Nuria TORMO","12","B","05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Three-year retrospective analysis of the use of cefiderocol in a Spanish tertiary hospital","L. Andrés|N. Tormo|V. Abril|M. Ortega|L. Sempere|V. Lobo|C. Ferrer|M. Melero|C. Gimeno Cardona"
"199","13/04 12:00","43","P2572","Gaurav SALUNKE","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","In vitro susceptibility of NDM-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae to cefepime/zidebactam from a tertiary-care cancer hospital","G. Salunke|S. Biswas|J. Sinol"
"281","13/04 12:00","44","P2573","Matin MD ABDUL","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Availability and quality of selected essential antibiotics circulating in Bangladesh: a cross-sectional study","M. Abdul"
"292","13/04 12:00","45","P2574","Evelyn SHAW PERUJO","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Effect of including infectious disease experts in the primary care antibiotic stewardship team on prescribing for upper respiratory tract infections: the IDASP study","N. Santos-Erice|M. Ronda|A. Padullés|P. Simonet|G. Rodriguez|C. Estrada|A. Lérida|S. Cobo|F. Tubau|L. Gardenes|R. Freixedas|M. Lopez|J. Carratalà|M. Puig-Asensio|E. Shaw"
"310","13/04 12:00","46","P2575","Shakil A. SHAKAR","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","We removed all urine dipstick tests from our regional hospital in north Denmark","S. Shakar|C. Holm|V. Pedersen"
"352","13/04 12:00","47","P2576","Sriram RADHAKRISHNAN","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Unveiling the DOOR for optimising antimicrobial stewardship in Escherichia coli and Klebsiella pneumoniae bloodstream infections in India","S. Radhakrishnan|R. S. K.|D. S.|G. Mohanta|S. Swaminathan|N. Niranjan"
"358","13/04 12:00","48","P2577","Kittiya JANTARATHANEEWAT","12","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The impact of a multidisciplinary team featuring a clinical pharmacist on adherence to recommended antimicrobial therapy in neurosurgical units in Thailand","K. Jantarathaneewat|P. Rukskul|P. Yodwisithsak|W. Kaewwichai|B. Camins|A. Apisarnthanarak"
"359","13/04 12:00","1","P2578","Olivia BARTON-EVANS","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Fluoroquinolones, UK advisories, local guidelines: compliance and consideration of prescribing","O. Barton-Evans|A. Chavda|M. Gilchrist|T. Parks"
"614","13/04 12:00","2","P2579","Emanuele RANDO","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: a post hoc emulation trial of the SIMPLIFY randomised trial","E. Rando|M. Delgado-Valverde|A. Goikoetxea-Agirre|L. Guio Carrion|M. Blanco Vidal|B. José Luis|M. Perez-Rodriguez|L. Martinez Lamas|F. Arnaiz De Las Revillas|C. Arminanzas|C. Ruiz De Alegria-Puig|P. Jiménez Aguilar|M. Martinez-Rubio|C. Sáez-Bejar|C. De Las Cuevas|A. Martin-Aspas|F. Galán|J. Yuste|J. Leiva-Leon|G. Bou|P. Capon Gonzalez|L. Boix Palop|M. Xercavins-Valls|M. Goenaga-Sánchez|D. Anza|J. Caston|M. Recio Rufián|E. Merino|J. Rodriguez|B. Loeches|C. Rosso-Fernández|J. Bravo-Ferrer|P. Retamar-Gentil|J. Rodriguez Bano|L. Lopez Cortes"
"705","13/04 12:00","3","P2580","Marco BONGIOVANNI","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The carbapenem sparing antimicrobial stewardship (CASAS) project: an innovative approach to reduce carbapenem consumption in low-users hospital settings","M. Bongiovanni|B. Barda|L. Elzi|N. Ramponi|P. Bellini|C. Di Benedetto|M. Mombelli|N. Centemero|A. Colombo|D. Destefani|E. Bernasconi"
"888","13/04 12:00","4","P2581","Lopamudra DAS","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Cost-consequence analysis of diagnostic strategies for community-acquired pneumonia in Spain","O. Borisenko|L. Das"
"987","13/04 12:00","5","P2582","Jean O'DRISCOLL","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Watch the piperacillin! Raising awareness and reducing the use of piperacillin/tazobactam in a U.K. district general hospital","J. Littler|J. O'Driscoll|C. Brandish"
"1198","13/04 12:00","6","P2583","Sayli GORE","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Leveraging a simple tool for sustaining antimicrobial stewardship: a prospective audit and feedback initiative at a tertiary care centre in western India","A. Tirodkar|T. Sanap|S. Gore|S. Ganta|U. Agrawal|C. Rodrigues|S. Basu|A. Shetty|K. Mk|N. Shah|A. Sunavala"
"1208","13/04 12:00","7","P2584","Hazel PARKER","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","""They've got other fish to fry"": illuminating why surgeons don't prioritise antimicrobial stewardship, and strategies for change","H. Parker|R. Bethune|J. Day|J. Frost|M. Hollyman|K. Hand|A. Kajamaa|K. Mattick"
"1234","13/04 12:00","8","P2585","Raghu MAMULLAPALLY","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial point prevalence survey (PPS) made easy","A. Sheikh|R. Mamullapally|H. Virk"
"1390","13/04 12:00","9","P2586","Carine NAIM","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Retrospective analysis of antibiotic consumption patterns in defined daily dose among primary MSF settings in north-west Syria","C. Naim|M. Khalife|C. Arias Vicente|K. Moussally|Z. Ejielat|A. Ali|B. Alonso|P. Garcia-Vello|A. Wetti|A. Almohamad|A. Farra"
"1535","13/04 12:00","10","P2587","Helmi ERNANDES","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Assessment of physicians' knowledge and attitudes towards antibiotic prescription practices and antimicrobial resistance","S. Sallem|A. Bellaaj|I. Kooli|S. Besbes|S. Kaoual|H. Ernandes|S. Benzarti|R. Jribi"
"1570","13/04 12:00","11","P2588","Tamara HABEGGER","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Leveraging outpatient antibiotic use data to shape targeted stewardship interventions in Switzerland","J. Zufferey|O. Friedli|C. Pluss-Suard|A. Kronenberg|T. Habegger"
"1647","13/04 12:00","12","P2589","Nada DIA","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Model-based evaluation of an optimised meropenem dosing strategy for critically ill patients with preserved or augmented renal clearance","N. Dia|Z. Blaine|M. Gijsen|J. Wauters|I. Spriet|E. Dreesen"
"1742","13/04 12:00","13","P2590","Ng RONG XIANG","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of mobile health applications in the implementation of antimicrobial stewardship programme among healthcare professionals: a systematic review","R. Ng|S. Goh|A. Kukreja|R. Hisham Shunmugam|M. Wong|X. Hng|S. Sri La Sri Ponnampalavanar"
"1816","13/04 12:00","14","P2591","Gwen KNIGHT","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic prescribing patterns by age and sex in English primary care: how it varies and why is it important for AMR?","N. Waterlow|G. Knight"
"1847","13/04 12:00","15","P2592","Minhua CHEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Hospital multidisciplinary antimicrobial stewardship on clinical and economic impact of critical blood culture-positive patients","W. Jiangbo|Z. Zhaoce|W. Shuo|L. Zongbin|H. Yang|C. Minhua"
"1855","13/04 12:00","16","P2593","Myo Maung Maung SWE","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Benchmarking hospital antibiotic use in ten countries: comparing observed versus expected empiric use based on the WHO AWaRe antibiotic book","M. Swe|E. Vlieghe|I. Pauwels|M. Sharland|B. Cooper|C. Lim"
"1866","13/04 12:00","17","P2594","Nam NGUYEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic prescribing for common acute infections in Indonesia: an analysis using IQVIA prescriber healthcare surveys","N. Nguyen|S. Mangla|A. Cook|M. Thorn|P. Stephens|K. Pouwels|M. Sharland"
"2040","13/04 12:00","18","P2595","Junhao, Ray LIN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Pharmacist led cephalosporin drug challenge programme in inpatients with low risk penicillin allergy: an assessment of physician acceptance and outcomes","J. Lin|X. Ang|E. Ang|A. Yap|J. Teng|M. Wan|Y. Lee"
"2166","13/04 12:00","19","P2596","Sock Hoon TAN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists","S. Tan|A. Loo|M. Yap|Y. Chan|X. Lim|P. Chia|T. Ng|J. Tan"
"2174","13/04 12:00","20","P2597","Sock Hoon TAN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Analysis of antibiotic prescriptions preceding carbapenem-resistant Enterobacterales infections: opportunities for antimicrobial stewardship","S. Tan|D. Ren|Z. Lim|Z. Lin|Y. Chan|H. Tay|C. Teng"
"2259","13/04 12:00","21","P2598","Rebecca Rowena PEÑA-ZALBIDEA","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of hospital relocation and antibiotic consumption on the incidence of multidrug-resistant microorganisms","R. Pena-Zalbidea|L. Martin|J. Murillas|L. Perianez|A. Oliver|M. Hidalgo|E. Rojo|M. Lopez"
"2388","13/04 12:00","22","P2599","Toshibumi TANIGUCHI","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","""Squeezing the balloon"": impact of preauthorisation of broad-spectrum antimicrobials on DASC and antimicrobial usage patterns","S. Yamazaki|M. Yahaba|H. Yoshikawa|H. Igari|T. Taniguchi"
"2490","13/04 12:00","23","P2600","Carl LLOR","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of an intervention aimed at nursing staff on antibiotic use for nursing home residents with common infections","C. Llor|R. Monfà|A. Garcia-Sangenis|R. Morros|J. Mateos-Nozal|C. Zárate Sáez|C. Sáez Bejar|C. Rodriguez Jimenez|P. Matovelle|R. Magallon-Botaya|E. Lopez Perez|A. Moragas"
"2533","13/04 12:00","24","P2601","Suzanne KUIJPERS","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Training future antimicrobial stewards in the ESCMID AMS certificate training programme: from knowledge to action","S. Kuijpers|J. Prins|J. Ten Oever|T. Schoffelen|K. Sigaloff|M. Hulscher|B. Beovic|J. Schouten"
"2545","13/04 12:00","25","P2602","Suzanne KUIJPERS","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of an Antimicrobial Stewardship Bundle on the outcome of high-risk neutropenic patients with fever; a pre-post study","S. Kuijpers|J. De La Court|J. Prins|R. Schade|J. Heijmans|K. Sigaloff"
"2581","13/04 12:00","26","P2603","Frederick FELL","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Global antibiotic usage in humans, 2018-2021: an updated spatial modelling study","F. Fell|T. Runghien|A. Browne|B. Sartorius|B. Cooper|C. Dolecek"
"2742","13/04 12:00","27","P2604","Nathan PEIFFER-SMADJA","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The French society for infectious diseases top-five list of recommendations","J. Slama|C. Hobson|V. Meyssonier|A. Charmillon|B. Mollo|E. Bonnet|S. Diamantis|H. Ferrand|B. Rosolen|C. Vignes|C. Ourghanlian|A. Debard|F. L'hériteau|H. Aumaitre|M. Le Goff|L. Porte|V. Mondain|P. Thill|R. Lepeule|T. Flao|Y. Ruch|S. Kernéis|X. Lescure|V. Joly|N. Peiffer-Smadja"
"2824","13/04 12:00","29","P2606","Suhail Hassan JALAL","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","A comparative study of AI-generated vs pharmacist-generated prescription recommendations in south Indian pharmacies: a multicentre cohort study","S. Hassan|D. Sureshkumar|R. Murali"
"2840","13/04 12:00","30","P2607","Ermira TARTARI","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Large language model-based chatbot to promote prudent antibiotic use among patients: a mixed-methods usability study","G. Schranz|E. Tartari|V. Camilleri|M. Sciortino|M. Borg"
"2886","13/04 12:00","31","P2608","Beatrice BARDA","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic spectrum scores to evaluate antimicrobial stewardship programmes: where are we?","B. Barda|P. Bellini|E. Bernasconi|M. Bongiovanni"
"2908","13/04 12:00","32","P2609","Barbara TRAUTNER","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Number of emails sent correlated with implementation metrics in a national antimicrobial stewardship programme","J. Pesikoff|E. Amenta|T. Brehm|L. Grigoryan|R. Hernandez|D. Ramsey|J. Donnelly|A. Naik|V. Stevens|B. Trautner"
"2948","13/04 12:00","33","P2610","Niamh SPENCE","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Multicentre outpatient monitoring of long-term co-trimoxazole treatment","N. Spence|C. O'connor|H. Kershaw|T. Azamgarhi|W. Magambo Gasana|A. Vanhein Wallace|K. Crick|S. Hwa Chin|A. Scobie|C. Colthart|S. Collier|S. Mepham|N. Karunaharan|R. Lever|S. Warren|L. Lamb|R. Lester"
"3211","13/04 12:00","34","P2611","Elena DAMIAN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Socio-demographic patterns in outpatient antibiotic use in Belgium (2019-2023)","E. Damian|M. Kelly|B. Catry|L. Catteau"
"3339","13/04 12:00","35","P2612","Annelies BOVEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Identifying predictors for antibiotic use: a global point prevalence survey study among 130 hospitals in Belgium, the Philippines and South Africa","A. Boven|A. Versporten|I. Pauwels|N. Brusselaers|A. Ivanova|E. Vlieghe|M. De Los Reyes|J. Garcia|R. Bo|S. Mehtar|H. Finlayson"
"3376","13/04 12:00","36","P2613","Emelyne GRES","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic and diagnostic stewardship programms in low and lower-middle-income countries: a systematic review and meta-analysis","E. Gres|G. Brigadoi|E. Zamperetti|V. Leroy|D. Donà|E. Barbieri"
"3469","13/04 12:00","37","P2614","Xi LIN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Model-informed precision dosing of vancomycin in critically ill patients infected with Gram-positive organisms: a multi-centre cohort study","Z. Jing|Y. Wanqiu|X. Lin|F. Yaxin|Z. Huifang|Y. Gangfeng|Y. Haijun|W. Jufang|L. Nanyang|W. Hailan|C. Mengting|L. Jianfeng|W. Ruilan|L. Jian|W. Yixue|Z. Naiqing"
"3508","13/04 12:00","38","P2615","Roland GIESEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Quality of care, in-hospital mortality and length of hospital stay for community acquired pneumonia in German non-university hospitals before and after an antimicrobial stewardship and infectious diseases specialist intervention","F. Khaleqi|R. Giesen|G. Först|G. Fink|R. Allen|N. Wimmesberger|D. Hornuss|S. Horn|M. Sehlbrede|M. Schmid|A. Schmidt|T. Tremmel|C. Van Uden|F. Wagner|U. Witten-Stephan|Y. Wuwer|W. Kern|E. Farin-Glattacker|S. Rieg|S. Mertins"
"3582","13/04 12:00","40","P2617","Deborah TONG","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Priorities for updating the World Health Organisation AWaRe antibiotic book","N. Shamas|V. Zanichelli|B. Huttner|P. Chuki|D. Tong"
"3592","13/04 12:00","41","P2618","Moira KELLY","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic prescribing practices among Belgian dentists: 2017-2021","M. Kelly|B. Catry|L. Catteau"
"3618","13/04 12:00","42","P2619","Gesche FÖRST","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","A step towards rational antibiotic use: impact of a multicentre interventional study in ten German non-university hospitals on antimicrobial use, costs and patient outcomes","G. Först|R. Giesen|G. Fink|M. Sehlbrede|R. Allen|N. Wimmesberger|M. Löffler|K. Meyer|S. Muller|H. Niese|S. Polk|B. Reistle|M. Schneider|C. Schuhmacher|K. Winter|D. Wirth|W. Kern|E. Farin-Glattacker|S. Rieg"
"3658","13/04 12:00","43","P2620","Maria MAZZITELLI","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Outcomes of implementation of a multidimensional antimicrobial stewardship programme in a medical ward of a third-level university hospital in northern Italy","M. Mazzitelli|D. Mengato|G. Barbato|S. Lo Menzo|M. Boschetto|C. Contessa|D. Donà|F. Venturini|I. Castagliuolo|P. Stano|P. Simioni|A. Cattelan"
"3699","13/04 12:00","44","P2621","Lucy TUNN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Out-patient penicillin allergy de-labelling is safe, acceptable, and effective","L. Tunn|S. Hey|J. Brolly|J. Widdrington|M. Cain"
"3730","13/04 12:00","45","P2622","Hannah NÜRNBERG","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Penicillin allergy delabeling in a German university hospital: implementation in inpatient settings (PENGUIN-study)","H. Nurnberg|B. Morath|T. Hoppe-Tichy|C. Denkinger|E. Khatamzas"
"3739","13/04 12:00","46","P2623","Annelies BOVEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","A standardised approach for measuring outpatient antimicrobial use data: development and evaluation of the outpatient global point prevalence survey","A. Boven|P. Oshun|A. Versporten|I. Pauwels|N. Brusselaers|E. Vlieghe"
"3742","13/04 12:00","47","P2624","Tilleye RUNGHIEN","13","B","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Changes in human antimicrobial consumption in 21 European countries between 2018 and 2021","T. Runghien|A. Browne|E. Wool|M. Naghavi|F. Fell|B. Sartorius|B. Cooper|C. Dolecek"
"3859","13/04 12:00","1","P2626","Andrea Paola CASSATA","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","All you need is... a team! A successful antimicrobial stewardship programme in an ICU in a low middle income country (LMIC)","A. Cassata|G. Morea|M. Cannutt Gonzalez|S. Puebla Roig|A. Lopez|M. Caccavari|M. Staneloni|A. Malvicini|F. Nacinovich|F. Pasteran|W. Cornistein|S. Attorri"
"3871","13/04 12:00","2","P2627","Raquel DURO","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of a multistep antimicrobial stewardship intervention in cephalosporins prescription for community acquired pneumonia: an interrupted time series analysis","M. Meireles|A. Pacheco|F. Pinto|E. Carias|P. Palma|R. Ruas|R. Filipe|D. Guerra|L. Pires|R. Ferraz|R. Duro|R. Malheiro|M. Oliveira"
"3883","13/04 12:00","3","P2628","Philip HOWARD","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Reducing inappropriate fluoroquinolone prescribing in England in 2024","P. Howard|D. Jeyaratnam|E. Beech|A. Ridgway|N. Fleming|L. Whitney"
"3903","13/04 12:00","4","P2629","Kushlani JAYATILLEKE","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial use in a tertiary care hospital in a lower middle-income country","A. Sahid Ossan|K. Jayatilleke"
"4063","13/04 12:00","5","P2630","Antonella FRATTARI","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Monocyte distribution width (MDW): a biomarker to discriminate infectious from central fever in brain injury","A. Frattari|E. Polilli|C. Frassanito|E. Congedo|G. Parruti"
"4090","13/04 12:00","6","P2631","Shrey MATHUR","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Limited evidence of regulatory approval of oral AWaRe antibiotics not included in the WHO Essential Medicines List: the Grey Group","S. Mathur|D. Donà|A. Cook|K. Pouwels|E. Tayler|M. Sharland"
"4124","13/04 12:00","7","P2632","Maria NUNEZ-NUNEZ","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Quality and reporting of antimicrobial treatment guidelines in Spain","A. Homs-Estévez|I. Garcia-Gimenez|M. Velasco-Garcia|A. Bueno-Cavanillas|M. Nunez-Nunez"
"4185","13/04 12:00","8","P2633","Maria NUNEZ-NUNEZ","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Software to support antimicrobial stewardship programme: scoping review","M. Velasco-Garcia|J. Melchor-Rodriguez|A. Bueno-Cavanillas|M. Nunez-Nunez"
"4269","13/04 12:00","9","P2634","Ainhoa VIVERO","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of an outpatient parenteral antimicrobial therapy stewardship programme in a hospital at home unit","N. Sopena|G. Bonet|A. Vivero|L. Pedro-Botet|I. Casas"
"4315","13/04 12:00","10","P2635","Amal AL-BAKRI","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","AWaRe antibiotic prescribing in outpatient clinics at JU hospital: a retrospective study","A. Al Bakri|K. Abu Hammour|Q. Mansour"
"4463","13/04 12:00","11","P2636","Aislinn COOK","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Comparison of surveillance methodologies of respiratory tract infections and antibiotic prescribing in primary care practices in Europe","A. Cook|A. Van Der Velden|A. Vellinga|A. Moran|T. Van Der Linde|P. Sundvall|P. Duncan|R. Mears|J. Verbakel|D. Bos|J. Domen|S. Coenen|B. Njie|J. Goelen|C. Moore|K. Pouwels|M. Sharland"
"4464","13/04 12:00","12","P2637","Stephen HUGHES","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of early patient engagement on the outcome of their antimicrobial 48-72 hour review: an interrupted time-series intervention study","C. Maciver|L. Moore|S. Hughes"
"4509","13/04 12:00","13","P2638","Stephen HUGHES","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Reducing fluoroquinolone prescribing in high-risk patients to minimise toxicities","S. Hughes|A. Low|C. Maciver"
"4556","13/04 12:00","14","P2639","Racha IBRAHIM","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Effectiveness of clinical decision support system use for antibiotic stewardship in primary care: a systematic review","R. Ibrahim|C. Durand|M. Mcleod|X. Lescure|E. Charani|G. Birgand|A. Raheelah|N. Peiffer-Smadja"
"4578","13/04 12:00","15","P2640","Obed Kwabena Offe AMPONSAH","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Outpatient point prevalence survey on antimicrobial use at a district hospital in Ghana using the global PPS outpatient protocol","A. Abuelhana|K. Buabeng|N. Ayisi-Boateng|C. Boachie Danquah|E. Owusu-Ansah|B. Bosu|N. Buabeng|A. Courtenay|O. Amponsah|A. Osafo|N. Abruquah"
"4596","13/04 12:00","16","P2641","Sock Hoon TAN","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Analysis of antibiotic prescriptions preceding Clostridioides difficile infection: opportunities for antimicrobial stewardship","H. Tay|Z. Tay|Y. Cheng|W. Lin|Y. Chan|S. Tan|C. Teng"
"4603","13/04 12:00","17","P2642","Joana BATISTA","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Third-day AMS interventions in a medical ward: implementation and results","J. Batista|M. Alves|C. Rodrigues|P. Retamar-Gentil"
"4642","13/04 12:00","18","P2643","Melwin Kyle SOLIS","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Investigating the prevalence of statin co-prescription with known interacting antimicrobials and compliance with necessary intra-therapy biochemical monitoring in Beaumont hospital","M. Solis|S. Gash|N. Weir|C. O' Connor|S. O' Donnell"
"4646","13/04 12:00","19","P2644","Maura OLIVEIRA","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Pharmacist's perspective of antimicrobial stewardship programmes at primary care setting in San Paulo","K. Mendonça|A. Guedes|B. Tavares|D. Brandao|G. Madalosso|A. Levin|M. Oliveira|L. Perdigao-Neto"
"4652","13/04 12:00","20","P2645","Pietro VITALE","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial stewardship ward rounds: a strategy to reduce ICU antibiotic use","P. Vitale|R. Iannazzo|M. Barbara|I. Spalliera|A. Crea|D. Abate|A. Altieri|F. Leonardis|V. Ajello|M. Dauri|D. Cartesio|M. Iannetta|V. Malagnino|L. Sarmati"
"4707","13/04 12:00","21","P2646","Jemelyn GARCIA","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The global point prevalence survey (Global-PPS): quality indicators for antimicrobial use for adult patients in the Philippines, 2017-2023","M. De Los Reyes|A. Versporten|J. Garcia|R. Berba|M. Hufano|E. Vlieghe|I. Pauwels|R. Bo"
"4741","13/04 12:00","22","P2647","Zenaw WOLIE","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","An international multi-centre survey of antimicrobial use in outpatient parenteral antimicrobial therapy (OPAT) or hospital-in-the-home (HITH) programmes","Z. Wolie|J. Roberts|L. Lopez-Cortes|M. Miron-Rubio|J. Pollard|A. Marizan Nor|H. Aziz|C. Jameison|R. Seaton|M. Gilchrist|F. Sime"
"4745","13/04 12:00","23","P2648","Natalia IORIO","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial photodynamic therapy against a mixed biofilm composed of a cariogenic microbial consortium","T. Py|P. Motta|B. Thurler|G. Chianca|H. Povoa|K. Fontes|N. Iorio"
"4756","13/04 12:00","24","P2649","Hai Yen NGUYEN","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic use in outpatient departments of general hospitals in Vietnam and the opportunities for outreach interventions to improve patient and community knowledge and practices","H. Nguyen|H. Duong|P. Bui Bich|S. Trinh|T. Nguyen|N. Le|Q. Nguyen|H. Nguyen|M. Chau|H. Vo|T. Nguyen|T. Nguyen|T. Vu|H. Doorn|T. Kesteman|T. Vu"
"4807","13/04 12:00","25","P2650","Solomon Ahmed MOHAMMED","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Cost savings from outpatient parenteral antimicrobial therapy programme: a systematic review and meta-analysis","S. Mohammed|J. Roberts|M. Miron-Rubio|L. Lopez-Cortes|A. Getnet Mengistu|J. Pollard|K. Mccarthy|M. Gilchrist|M. Cotta|F. Sime"
"4813","13/04 12:00","26","P2651","Kim YONG CHAN","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Nationwide analysis of antimicrobial prescription in Korean hospitals between 2018 and 2022: the 2024 KONAS report","Y. Kim|J. Kim|I. Yun|S. Heo|J. Park|M. Lee|J. Chae|H. Kim|S. Park|B. Kim"
"4836","13/04 12:00","27","P2652","Francesco PERACCHI","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Post-prescription review of carbapenem-based therapies and occurrence of Clostridioides difficile infection","M. Merli|F. Peracchi|A. Bielli|A. Mulè|G. Travi|L. Salmaso|C. Oltolini|M. Vecchi|D. Motta|L. Denti|C. Rogati|R. Rossotti|N. Bana|A. Raimondi|M. Moioli|F. Crippa|C. Vismara|E. De Pasqual|C. Del Curto|M. Puoti|S. Nerini Molteni|F. D'amico"
"4959","13/04 12:00","28","P2653","Rod JAMES","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Implementation of a multi-modal One Health training programme for antimicrobial stewardship in the Asia Pacific region","R. James|R. Cheah|K. Thursky"
"4994","13/04 12:00","29","P2654","Yujeong KIM","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Changes in antibiotic use in South Korea from 2016 to 2023: using health insurance claim data","Y. Kim|H. Ko|E. Seo|S. Moon|H. Kim"
"5020","13/04 12:00","30","P2655","Hey Jin KO","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Inappropriate antibiotic prescriptions for cystitis in primary care in the Republic of Korea","Y. Kim|H. Ko|E. Seo|S. Moon|H. Kim"
"5155","13/04 12:00","31","P2656","Ritika Kondel BHANDARI","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Feasibility and cost-saving potential of outpatient antimicrobial therapy using elastomeric pumps in bone marrow transplant patients: a single-centre study in a tertiary care setting in India","S. Singh|T. Sidana|A. Khadwal|N. Shafiq|P. Malhotra|R. Bhandari|A. Kakkar|R. Rohilla|S. Malhotra"
"5352","13/04 12:00","32","P2657","Raqib HUQ","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Clinical outcomes in gentamicin prescribing and monitoring in United Kingdom hospitals (CO-GENT): national audit, service evaluation and rates of AKI with pre-dose vs nomogram monitoring","J. Wilson|R. Huq|S. Reddy|S. Bashir"
"5354","13/04 12:00","33","P2658","Melwin Kyle SOLIS","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The challenge of preserving reserve antimicrobials in acute surgical wards","M. Solis|S. Gash|N. Weir|N. Doyle|S. O' Donnell|H. Mcdermott|B. Dinesh|K. Burns|C. O' Connor"
"5367","13/04 12:00","34","P2659","Birgit UNTERKOEFLER","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","From overuse to optimised use: reducing fluoroquinolone prescribing through targeted antimicrobial stewardship interventions in tertiary care","B. Unterkoefler|M. Krauss|G. Brunhofer-Bolzer|C. Labut|M. Anditsch|B. Willinger|G. Laml-Wallner|E. Presterl|H. Burgmann|H. Lagler|I. Minichmayr|F. Loetsch"
"5428","13/04 12:00","35","P2660","Ammar MOHAMED MOHIDEEN","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of pharmacist-led interventions on antibiotic management in critical care: a prospective observational study of culture-guided therapy","A. Mohamed Mohideen|M. George|S. T.|F. Jones|R. Rajkumar"
"5475","13/04 12:00","36","P2661","Umang AGRAWAL","7","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Need for speed: earlier targeted treatment with BCID2 panel, report from an Indian ICU","U. Agrawal|S. Gore|S. Ganta|A. Sunavala|L. Drego|S. Basu|C. Rodrigues|A. Erande"
"5531","13/04 12:00","1","P2662","Elena CARRARA","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Towards tailored perioperative antibiotic prophylaxis: a multicentre pre-intervention analysis in the H2020 REVERSE project","E. Carrara|M. Tebon|M. Morra|A. Di Gioia|V. Mengardo|M. Genna|M. Da Meda|M. Pezzani|S. Zerva|A. Andritsos|I. Fieraru|D. Costin|I. Salcedo-Leal|C. Diaz-Lopez|A. Sonpar|B. Rodriguez Bano|P. Retamar-Gentil|N. Zuabi Garcia|W. Zingg|E. Tacconelli"
"5569","13/04 12:00","2","P2663","Julie DOMEN","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Hospital antimicrobial prescribing in Belgium: linking reimbursement data with clinical context","J. Domen|L. Bonacini|B. Catry|L. Catteau"
"5590","13/04 12:00","3","P2664","Lucy CATTEAU","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","2024 assessment of Belgium's national antimicrobial stewardship core elements: progress and areas for improvement","L. Catteau|C. Briquet|E. Damian|D. Huis In 't Veld|C. Vercheval"
"5613","13/04 12:00","4","P2665","Patricia KILFOYLE","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Joint expertise, smarter antibiotics: a collaborative approach to improving orthopaedic surgical antibiotic prophylaxis in a tertiary hospital","P. Kilfoyle|K. Wilks|S. Kingscote|L. Course"
"5747","13/04 12:00","5","P2666","Nikita SASS","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Point prevalence survey of antibiotic use in hospitals in northern Lesotho","N. Sass|A. Burgener-Gasser|J. Brown|N. Labhardt|I. Ayakaka|M. Moholoholo|M. Tlahali|L. Brockhaus"
"5878","13/04 12:00","6","P2667","Rebecca SCARDELLATO","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The role of early appropriate antibiotic treatment in febrile neutropaenia: identifying targets for antimicrobial stewardship interventions","R. Scardellato|M. Morra|M. Tebon|A. Azzini|M. Negulescu|A. Anghel|P. Zisimopoulos|O. Tsompikou|A. Araújo|M. Perez-Rodriguez|G. Nadali|C. Tecchio|A. Sonpar|J. Rodriguez Bano|P. Retamar-Gentil|N. Zuabi Garcia|W. Zingg|E. Tacconelli|E. Carrara"
"5932","13/04 12:00","7","P2668","Ieva VOITA","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Successful implementation and evaluation of challenges for an antimicrobial stewardship programme at a university hospital emergency department","A. Vilde|L. Springe|L. Skrauca|A. Bistrova|I. Jansone|A. Zilde|I. Voita|U. Dumpis|B. Sinha"
"5955","13/04 12:00","8","P2669","Alessia FRATER","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Reduction of carbapenem prescribing inappropriateness: an antimicrobial stewardship intervention through post-prescription review with feedback","A. Frater|P. Del Vecchio|F. Sangiorgi|E. Magrini|B. Liguoro|M. Gross|M. Fantoni|R. Murri|C. Torti"
"5956","13/04 12:00","9","P2670","Jessica GENTRY","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Building a foundation of a functioning microbiology diagnostic service in Kilifi county referral hospital","J. Gentry|M. Andersson|M. Morgan|J. Mwasemu|C. Mtanje|M. Shahada|N. Aliyan|B. Ng"
"5971","13/04 12:00","10","P2671","Natalie TUCKER","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Evaluation of a broad-spectrum antibiotic monitoring tool across a large academic hospital system","N. Tucker|D. Mcmanus|M. Davis|I. Moss|J. Topal|E. Santos|E. Minella|A. Michno|V. Fal"
"6009","13/04 12:00","11","P2672","Susanne Barbara SCHINK","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Where do physicians look for information on antibiotics and antimicrobial resistance? Challenges in keeping up to date, Germany 2024","S. Schink|A. Hoffmann|J. Möltgen|T. Eckmanns|N. Lilienthal|E. Pantke|J. Hermes"
"6019","13/04 12:00","13","P2674","Gina DE GUZMAN BETITO","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial stewardship implementation in a Philippine tertiary hospital: a seven-year surveillance of surgical prophylaxis prescribing practices","G. De Guzman Betito|J. Muere|J. Caoili|J. Garcia|M. De Los Reyes|I. Pauwels|A. Versporten|E. Vlieghe|M. Gler"
"6020","13/04 12:00","14","P2675","Maria NUNEZ-NUNEZ","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Comparability of outcomes in antimicrobial stewardship research","I. Garcia-Gimenez|A. Bibi|D. Hassan|C. Castano-Amores|A. Bueno-Cavanillas|M. Nunez-Nunez|R. Fernádez"
"6124","13/04 12:00","16","P2677","Susanne Barbara SCHINK","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Attitudes towards anticipated antibiotic resistance development varies by medical specialty, physician's gender, number of prescriptions, and years in practice, Germany 2024","S. Schink|A. Hoffmann|J. Möltgen|T. Eckmanns|N. Lilienthal|E. Pantke|J. Hermes"
"6178","13/04 12:00","17","P2678","Jennifer BRITTON","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Reinventing the antimicrobial stewardship wheel: specialist-led prospective meropenem prescription review and targeted prescriber's feedback","J. Britton|C. Mulrooney|Z. Ramsamaroo|H. Awad|J. Healy|V. Murphy|C. Fielding|M. Doyle|G. Chan"
"6340","13/04 12:00","19","P2680","Caroline THEUNISSEN","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antimicrobial stewardship in practice: designing interventions to improve surgical prophylaxis practices in a Rwandan university hospital, a mixed methods study using the behaviour change wheel","C. Theunissen|M. Muremba|L. Bitunguhari|A. Igizeneza|I. Hahirwa|F. Masaisa|F. De Bièvre|E. Vlieghe|E. Bottieau|J. Semuto Nganbonziza|J. Schouten"
"6347","13/04 12:00","20","P2681","Nathan PEIFFER-SMADJA","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Strategies adopted for the implementation of clinical decision support systems for antimicrobial stewardship in hospital settings: a systematic review","L. Giordano|C. Durand|R. Ahmad|L. Collias|X. Lescure|M. Thy|Y. Kherabi|M. Hamard|G. Birgand|N. Peiffer-Smadja"
"6385","13/04 12:00","21","P2682","Bee Yean NG","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The impact of antimicrobial stewardship ward rounds on antimicrobial use and predictors of advice, uptake, and outcomes","B. Ng|D. Eyre|G. Pill|L. Dunsmure|K. Jeffery|N. Jones|S. Paulus"
"6433","13/04 12:00","22","P2683","Wanda CORNISTEIN","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Enhancing nursing roles in antimicrobial stewardship: a clinical simulation-based training programme for ICU","M. Santos|M. Salas|J. Gonzalez|P. Byro|W. Cornistein"
"6436","13/04 12:00","23","P2684","Mélanie KERANFLEC'H","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Comparative clinical care with use of two rapid susceptibility testing techniques: BLT (2021) and MIC-RAST (2023) in Gram-negative bacilli bacteraemia","M. Keranflec'h|A. Michaud|C. Plouzeau Jayle|F. Roblot|C. Lemaigre|J. Turmel|C. Burucoa|G. Le Moal"
"6438","13/04 12:00","24","P2685","Sayli GORE","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Battling the sepsis clock using BIOFIRE BCID2 Panel: a pre-post intervention audit of time to active antibiotic therapy in an Indian ICU","S. Gore|S. Ganta|C. Rodrigues|S. Basu|A. Shetty|A. Sunavala|K. Mk|N. Shah|U. Agrawal"
"6446","13/04 12:00","25","P2686","Martina BELTRAMI","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of the implementation of an antimicrobial stewardship programme (ASP) in a haematologic ward of a tertiary hospital","M. Beltrami|Z. Palacios-Baena|B. Gutiérrez-Gutiérrez|M. Madrigal-Toscano|R. Flores-Cornejo|M. Delgado-Valverde|A. Suárez-Barrenechea|M. Beltran-Garcia|A. Rodriguez-Fernandez|J. Rodriguez-Bano"
"6471","13/04 12:00","26","P2687","Bee Yean NG","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The impact of prospective pharmacist-led fluroquinolone review on fluoroquinolone consumption","B. Ng|L. Dunsmure|H. Haque|T. Escayo|N. Jones|T. Parsons"
"6494","13/04 12:00","27","P2688","Maria Leonor SANTOS","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Point-of-care detection of carbapenemase-producing Enterobacterales and antimicrobial stewardship interventions","M. Santos|D. Albuquerque|C. Bárbara|M. Teixeira|A. Duarte|R. Pinto|D. Caetano|C. Caneiras"
"6510","13/04 12:00","28","P2689","Evelyn Nelima WESANGULA","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Remote stewardship, local impact: a case study assessing effectiveness of tele-stewardship on establishing antimicrobial stewardship programmes in Kenya","E. Wesangula|M. Ong'ayo|G. Mugane|A. Clarkson|A. Joseph|H. Amadi|N. Ngere|M. Matu|M. Boyd|N. Arakawa|D. Ashiru-Oredope"
"6529","13/04 12:00","29","P2690","Marco BONGIOVANNI","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The impact of β-lactam allergy labels on antibiotics guideline adherence","V. Battig|E. Bernasconi|C. Bussolino|P. Bellini|B. Barda|N. Ramponi|M. Bongiovanni"
"6545","13/04 12:00","30","P2691","Marika TSERETELI","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Successful implementation of surgical antibiotic prophylaxis (SAP) in ten hospitals of Georgia","M. Tsereteli|G. Cordoba|G. Chakhunashvili|D. Nathwani|A. Lenglet|D. Tsereteli|D. Chakhunashvili|P. Imnadze|R. Skov"
"6581","13/04 12:00","31","P2692","Awilly CHOFLE","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Dalbavancin in OPAT: a retrospective review of NHS greater Glasgow and Clyde experience","A. Chofle|C. Summerhill|V. Vallapareddy|N. Ritchie|B. White|R. Seaton"
"6604","13/04 12:00","32","P2693","Paola BELLINI","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Prolonged carbapenem use in the context of a dedicated antimicrobial stewardship programme: a sub-analysis of the CASAS (CArbapenem Sparing Antimicrobial Stewardship) project","P. Bellini|E. Bernasconi|N. Ramponi|B. Barda|L. Elzi|C. Di Benedetto|M. Mombelli|M. Bongiovanni"
"6612","13/04 12:00","33","P2694","Bee Yean NG","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of penicillin allergy label (PAL) on fluoroquinolone prescriptions","B. Ng|L. Dunsmure|H. Haque|T. Escayo|N. Jones"
"6653","13/04 12:00","34","P2695","Rachel BERRY","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","What indicators are used to estimate or measure appropriateness of antibiotic prescribing in high-income countries: a rapid systematic review protocol and initial findings","R. Berry|E. Magrini|F. Medioli|M. Caris|Y. Kherabi|L. Catteau|N. Peiffer-Smadja|R. Murri|M. De Boer|D. Ashiru-Oredope"
"6715","13/04 12:00","35","P2696","Esther CALBO","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of a regional antimicrobial stewardship intervention on enhancing antimicrobial appropriateness in E. coli bacteraemia treatment management","E. Calbo|L. Boix-Palop|S. Hernández|M. Giménez|A. Padullés|J. Badia|E. Limon|M. Pujol|J. Horcajada|V. Members Of The E.coli Study Group On Behalf Of Vincat Program."
"6736","13/04 12:00","36","P2697","Ahmed TRIGUI","8","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Analysis of antibiotic prescription trends in Tunisian tertiary hospitals based on the WHO AWaRe framework","A. Trigui|M. Trigui|B. Trabelsi|G. Nasri|M. Ben Hamida|S. Yaich|M. Kassis"
"6780","13/04 12:00","1","P2698","Quratulain SHAIKH","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Three-year experience of antimicrobial stewardship in a tertiary care hospital in Pakistan: successes and challenges","N. Salahuddin|Q. Shaikh|S. Sarfaraz|A. Hussain|A. Kazi|M. Hanif|M. Hussain"
"6817","13/04 12:00","2","P2699","Birgitta SCHWEICKERT","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Antibiotic consumption patterns of selected narrow- and broadspectrum antibiotics in German acute care hospitals from 2017 to 2023","B. Schweickert|N. Willrich|M. Schneider|M. Feig|M. Behnke|L. Pena-Diaz|C. Geffers|I. Wieters|K. Gröschner|D. Richter|M. Abu Sin|T. Eckmanns|A. Hoffmann"
"6977","13/04 12:00","3","P2700","Marco MUSSA","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","What are the factors associated with inappropriate antibiotic prescription in UTIs with a high prevalence of MDR pathogens?","M. Mussa|E. Staffilano|C. Montrucchio|S. Sciacca|M. Giusti|A. Di Vincenzo|A. Maiello|G. Di Perri|S. Bonora|A. Calcagno|R. Balbiano|G. Calleri|M. Verlengo|V. Ghisetti|M. Quario"
"7008","13/04 12:00","4","P2701","Christen ARENA","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Short- versus long-course antibiotic durations for uncomplicated infections in solid tumor patients receiving care in ambulatory oncology clinics","C. Arena|B. El-Tatari|K. Lovric|S. Greenlee|R. Kenney|S. Davis|M. Veve"
"7057","13/04 12:00","5","P2702","Cristiana LEANZA","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","The role of dedicated infectious disease consultant within an antimicrobial stewardship programme: towards a better patients' CARE (deIDcare)","C. Leanza|S. Covino|L. Martellone|A. Fiore|C. Franchi|F. Cancelli|M. Carnevalini|G. Magni|A. Mingoli|C. Mastroianni|A. Oliva"
"7137","13/04 12:00","6","P2703","Antonio CÁRDENAS","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Enhancing outpatient antimicrobial stewardship: the integral role of infection control nurses","M. Sanmarti|E. Moreno|M. Álvarez|A. Cardenas|E. Esteve-Palau|A. González-Cuevas|M. Guerrero|A. Capella|F. Medina|V. Diaz-Brito"
"7172","13/04 12:00","7","P2704","Uforma OGRIGRI","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Utilising technology to strengthen and inform antimicrobial stewardship strategies","U. Ogrigri|M. Gilchrist|A. Chavda|P. Kukadia|R. Wilson|N. Tickner|S. Moran|A. Fernandes|S. Prentice|R. Bedi|D. Samarasinghe|N. Raganathan|M. Pathiraja|C. Eades|A. Aiken|M. Coleman|D. Armstrong-James|C. Rodrigues|A. Bennett|F. Davies|F. Sanderson|A. Ghazy|N. Nagi"
"7209","13/04 12:00","8","P2705","Jose Ramon PANO-PARDO","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Aragon regional bacteraemia surveillance & stewardship (ARBASS) system","M. Vicente-Martinez|M. Garcia-Andreu|M. Valdovinos-Mahave|S. Férriz-Pérez|J. Pano-Pardo|G. Tirado-Anglés|M. Carmen|M. Mariela|M. Lavilla-Fernández|S. Loscos-Aranda|R. Martinez-Alvarez|C. Aspiroz|M. Corruchaga-Arregui|L. Torres-Sopena|P. Amador-Rodriguez|A. Pascual Del Riquelme-Babe"
"7236","13/04 12:00","9","P2706","Dumessa EDESSA","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Appropriateness of antibiotic access and use practices at the community level in eastern Ethiopia","D. Edessa|F. Kumsa|G. Dinsa|L. Oljira"
"7281","13/04 12:00","10","P2707","Natali JOKANOVIC","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Impact of an antimicrobial stewardship intervention in residential aged care: a multicentre, stepped-wedge cluster randomised trial (START trial)","S. Lee|T. Haines|S. Hilmer|Y. Jeon|D. Ayton|A. Stewardson|R. Stuart|A. Cheng|T. Peel|A. Peleg|N. Jokanovic"
"7419","13/04 12:00","11","P2708","Nosheen NASIR","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Evaluating the impact of a multifaceted antimicrobial stewardship intervention on age and gender inequity in antibiotic utilisation at a tertiary care centre in Karachi, Pakistan","N. Nasir|B. Khalid|S. Awan|S. Tajuddin|S. Sattar|S. Qureshi"
"7430","13/04 12:00","12","P2709","Nirlep AGRAVEDI","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Implementation of antimicrobial consumption dashboard: a data-driven approach at university hospitals of Birmingham, United Kingdom","N. Agravedi|A. Jenkins|M. Law|M. Westwood"
"7474","13/04 12:00","13","P2710","Lina Marcela PARRA","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Comprehensive assessment of antimicrobial use through yearly point prevalence surveys, 2012-2023","E. Jimenez|L. Parra|M. Cantero|A. Bianco|M. Garcia De La Vega|A. Asensio"
"7526","13/04 12:00","14","P2711","Kathryn THOMSON","9","C","05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","First-line antibiotic usage used in clinically diagnosed cases of neonatal sepsis in secondary and tertiary healthcare centres in Pakistan, Bangladesh and Nigeria","K. Thomson|J. Oduwo|B. Hassan|R. Farzana|C. Achi|R. Zahra|K. Iregbu|S. Hossain|A. Cooke|J. Rzaska|E. Rashid|S. Naqvi|S. Ahmed|S. Sawar|M. Muhammad|S. Amin|M. Babar|R. Temur|M. Memona|A. Khan|S. Riaz|A. Mehboob|M. Haroon Hamid|A. Muhammah|M. Khan|Y. Mohammad|M. Sabitu|J. Abubkar|B. Tajudeen|O. Oduyebo|A. Mabogunje|O. Olutekunbi|A. Aminu|S. Gambo|S. Suwaid|N. Medugu|T. Akujobi|A. Mairami|I. Nwafia|P. Nwachukwa|S. Chukwuma|S. Pervin|R. Farzana|N. Tasnim|K. Sands|T. Walsh"
"1318","13/04 12:00","18","P2715","Heather KENNEDY","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Penicillin allergy de labelling: a whole system approach","H. Kennedy|B. Mooka|J. Mcewen|D. Guthrie"
"1372","13/04 12:00","19","P2716","Cole HUDSON","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Reduction of vancomycin-associated nephrotoxicity with zileuton","C. Hudson|J. Smith|L. Vuong|V. Tam"
"1682","13/04 12:00","20","P2717","Karin RIEDL","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Assessing the skin sensitisation potential of common antiseptics using a novel in vitro bioassay developed for medical devices","E. Riegel|K. Riedl|C. Klaus|T. Czerny"
"3025","13/04 12:00","21","P2718","Jordan HAHN","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Adverse effects of long-term use of the oxazolidinones tedizolid and linezolid: a retrospective matched-cohort analysis","J. Hahn|R. Komson|M. Jeffres"
"3085","13/04 12:00","22","P2719","Justin SHIAU","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Detection of early acute kidney injury with urinary metabolomics in a high-dose vancomycin rat model","J. Shiau|E. Locci|E. D'aloja|A. Chighine|T. Xanthos|M. Scheetz"
"3558","13/04 12:00","23","P2720","Aneeka CHAVDA","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","An evaluation of the myelosuppressive effects of co-trimoxazole: a single centre observational review","A. Chavda|Y. Cho|R. Wilson|M. Gilchrist"
"3832","13/04 12:00","24","P2721","Paul MCGOVERN","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Ceftibuten/ledaborbactam etzadroxil in participants with varying degrees of renal function","C. De Oliveira|K. Lowe|P. Fatato|G. Winchell|P. Mcgovern|T. Marbury"
"4324","13/04 12:00","25","P2722","Sepideh ELYASI","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Promising efficacy of oral nano-silymarin formulation on prevention of vancomycin induced nephrotoxicity: a randomised, triple-blinded, placebo-controlled clinical trial","S. Elyasi|V. Soleimani|R. Khodashahi|M. Arian"
"4508","13/04 12:00","26","P2723","Louise F HILL","9","C","05e. Safety, hypersensitivity and adverse effects of treatment","Safety reporting in neonatal antibiotic trials: lessons from NeoSep1","A. Bekker|T. Cressey|S. Ellis|G. Kornmann|K. Lebeau|W. Stohr|M. Sharland|J. Bielicki|L. Hill"
"841","13/04 12:00","27","P2724","Syed Anas Daud GILANI","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Counting the pennies: calculating the cost of ancillaries in IV antibiotic administration","S. Gilani|A. Jenkins|A. Muhammad"
"1429","13/04 12:00","28","P2725","Gillian LEVINE","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Cost to families for severe community-acquired childhood pneumonia treatment with oral amoxicillin or co-amoxiclav vs IV-only antibiotic treatment in five sub-Saharan African countries: an economic analysis of the PediCAP randomised controlled trial","G. Levine|M. Clements|S. Zindela|M. Sidat|A. Muhandu|C. Mutata|L. Mark|M. Sharland|J. Bielicki|G. Fink"
"2117","13/04 12:00","29","P2726","Alice LIU","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Cost-effectiveness analysis of dalbavancin in an acute district hospital in UK","A. Liu"
"2573","13/04 12:00","30","P2727","Alfonso DE LOSSADA JUSTE","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Using the STEDI AMR value framework to estimate the clinical and economic value of aztreonam/avibactam in treating metallo-beta-lactamase-producing Enterobacterales infections in Spain","A. De Lossada|L. Martinez-Martinez|S. Luque|R. Ferrer|M. Maroto-Diaz|C. De Ceano-Vivas|Y. Moreno|J. Dennis|S. Nikolova|E. Broughton|M. Gheorghe"
"4109","13/04 12:00","31","P2728","Anders TERNHAG","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Sweden's partially de-linked reimbursement model for new antibiotics","J. Hellman|S. Linnros|C. Anderson Kronlid|C. Edlund|A. Ternhag"
"5540","13/04 12:00","32","P2729","Etienne RAPHAËL","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Cefotaxime vs ceftriaxone: current practices in Paris hospitals and new considerations","E. Raphaël|S. Huynh|V. Siorat|A. Sokal|D. Blez|A. Degrassat-Théas|A. Lefort|R. Lepeule"
"7003","13/04 12:00","33","P2730","Stephanie EVANS","9","C","05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","What is the cost of antibiotic prescriptions if the costs of antibiotic resistant infections are considered?","S. Evans|A. Andrews|A. Ledda|O. Nsonwu|J. Stimson|L. Miller|E. Van Leeuwen|M. Joyce|Z. Aiken|D. Lecky|J. Robotham"
"632","13/04 12:00","1","P3643","Fernanda VALDEZ-BLANCO","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Correlation of sociodemographic vulnerability versus RSV vaccination rates: preliminary results from a U.S. metropolitan area.","F. Valdez-Blanco"
"937","13/04 12:00","2","P3644","Mani BHARGAVA","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Development of bipolymer based novel nanoparticles in microsphere system as vaccine adjuvant","M. Bhargava|S. Bhargava"
"942","13/04 12:00","3","P3645","Himanshu SARAF","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Oral combination vaccine against hepatitis B and influenza: development and characterisation","H. Saraf|M. Bhargava"
"1011","13/04 12:00","5","P3647","Priyanka GOSAIN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Antibody coated liposomes for transmucosal vaccination","P. Gosain|S. Bhargava"
"1021","13/04 12:00","6","P3648","Sravani DHARMAVARAM","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Evaluation of functional antibody responses to sequential PCV13 and PPSV23 vaccination in type 2 diabetes mellitus adults: insights from a first study in the Indian population","S. Dharmavaram|S. Natesan|G. Nagaraj|R. Kl|V. Rajashekariah"
"1043","13/04 12:00","7","P3649","Goulia OHAN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","The impact of COVID-19 pandemic on poliomyelitis surveillance and immunisation in Armenia","N. Melkonyan|A. Badalyan|G. Ohan|M. Ter-Stepanyan"
"1266","13/04 12:00","8","P3650","Jose MONTES","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Current status of seasonal influenza vaccination policy in poultry industry workers in LATAM","J. Montes|M. Delgado|C. Saenz"
"1427","13/04 12:00","9","P3651","Kyra HOLLIDAY","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Safety and immunogenicity of a novel RH5.1/matrix-M malaria vaccine in UK healthy adults","K. Holliday|R. Payne|A. Minassian|C. Jarman|T. Winks|P. Lata|S. Draper|J. Cho|C. Nwankwo|B. Marshall|S. Silk|K. Skinner"
"1616","13/04 12:00","10","P3652","Dzhumber UGREKHELIDZE","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Assessing vaccine hesitancy and vaccine literacy in adults in Saudi Arabia, United Arab Emirates, Turkey and South Africa","D. Ugrekhelidze|J. Meyer|N. Al Kaabi|M. Younus Abu Hassan|M. Loulou|C. Lestriez|A. Morillo|M. Hleyhel|J. Milce|L. Levy-Bachelot"
"2164","13/04 12:00","11","P3653","Song XU","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Truncated VZV gE induces high-titer neutralising antibodies in micetruncated VZV gE induces high-titer neutralising antibodies in mice","S. Xu"
"2440","13/04 12:00","12","P3654","Omid REZAHOSSEINI","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Co-administration of pneumococcal vaccines with common travel vaccines: a systematic review of immunogenicity and safety","R. Niyati|O. Rezahosseini|C. Ekenberg|C. Larsen|Z. Harboe"
"2692","13/04 12:00","13","P3655","Soumaya ESSALIM","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Perception of vaccination during mild fever, insights from patients with a recent febrile illness and healthcare professionals: a qualitative study","S. Essalim|E. Vallier|A. Wargny|A. Gagneux-Brunon|E. Botelho-Nevers"
"2753","13/04 12:00","14","P3656","Zoi Dorothea PANA","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Assessing the willingness of future healthcare providers to participate in vaccine trials: a cross-sectional VACCELERATE European study","A. Yiallouris|C. Filippou|G. Shiamakkides|S. Themistocleous|A. Nearchou|C. Merakou|C. Argyropoulos|A. Sarantopoulos|E. Noula|C. Armeftis|G. Astras|M. Leonidou|A. Shaikh|F. Stewart|A. Kerstin|J. Salmanton-Garcia|J. Lecker|O. Cornely|A. Azzini|R. Davis|E. Tacconelli|L. Souckova|P. Husa|H. Hervius Askling|N. Pontus|E. Alvarez Barco|P. Mallon|J. Kopsidas|T. Zaoutis|D. Poulimeneas|L. Jancoriene|J. Baranda Prellezo|J. Cano Ochando|O. Valdenmaiier|S. Jakobsen|R. Cox|M. Hellemans|G. Hendrickx|P. Van Damme|Z. Pana"
"3005","13/04 12:00","15","P3657","Hebe Noemi VAZQUEZ","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Current status of HPV gender neutral vaccination (GNV) in Latin America: a call for health equity","H. Vazquez|J. Montes"
"3088","13/04 12:00","16","P3658","Rhoda NAMAKULA","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Impact of BCG vaccination on innate immune responses in HIV-exposed uninfected infants in Uganda: a randomised controlled trial","R. Namakula|H. Sommerfelt|K. Hanevik|S. Cose|V. Nankabirwa|O. Namugga|M. Netea|H. Steinsland"
"3240","13/04 12:00","17","P3659","Omid REZAHOSSEINI","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Immunogenicity and adverse effects of pneumococcal vaccines coadministered with influenza or SARS-CoV-2 vaccines in adults: a systematic review and meta-analysis","H. Khajeh Rahimi|A. Ayad Jasim|O. Rezahosseini|Z. Barrella Harboe"
"3250","13/04 12:00","18","P3660","Yehuda DAVIS","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Exploration of the risk-benefit profile of administering dengue vaccines with mixed efficacy estimates in different epidemiological contexts","Y. Davis|E. Maynard|N. Soor|M. Linley|T. Maguire|Z. Riyaz"
"3290","13/04 12:00","19","P3661","Omid REZAHOSSEINI","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Safety and immunogenicity of co-administration of herpes zoster vaccines with other vaccines in adults: a systematic review and meta-analysis","O. Rezahosseini|A. Mousavi|M. Eiberg|A. Printzlau Korsgaard|R. Niyati|C. Ekenberg|L. Nørregaard Nielsen|Z. Barrella Harboe"
"3307","13/04 12:00","20","P3662","Heather VANSEGGELEN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Pneumococcal disease and vaccination: descriptive results from a systematic literature review of knowledge, attitudes, and practices surveys and preference elicitation studies","A. Salem|E. Horn|H. Vanseggelen|P. Sharma|X. Wang|N. Jamet"
"3313","13/04 12:00","21","P3663","Marco DEL RICCIO","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Strategies for introducing and implementing vaccines for adults into National Immunisation Programmes in Europe: exemplary approaches and key insights of the adult immunisation board meeting","M. Del Riccio|S. Boccalini|A. Bechini|B. Weinberger|J. Wysocki|D. Martinelli|O. Wichmann|T. Likki|G. Hendrickx|P. Van Damme|C. Wyndham-Thomas|P. Bonanni|J. Pattyn"
"3452","13/04 12:00","22","P3664","Vittorio SAMBRI","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","High hydrostatic pressure technology for low-cost vaccine production: preclinical in vivo testing","M. Brandolini|P. Rocculi|M. Morbarigazzi|D. Lelli|A. Lavazza|F. Battioni|G. Dirani|A. De Pascali|S. Zannoli|M. Guerra|M. Cricca|A. Scagliarini|V. Sambri"
"4310","13/04 12:00","23","P3665","Niklas Dyrby JOHANSEN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among young and middle-aged adults with chronic disease: NUDGE-FLU-CHRONIC-2","N. Johansen|M. Vaduganathan|A. Bhatt|D. Modin|B. Claggett|K. Janstrup|C. Larsen|L. Larsen|L. Wiese|M. Dalager-Pedersen|L. Køber|S. Solomon|P. Sivapalan|J. Jensen|C. Martel|T. Krause|T. Biering-Sørensen"
"4329","13/04 12:00","24","P3666","Daniel J.G. THIRION","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Profiling vaccination patterns in immunosuppressed patients against respiratory infections in community pharmacies","D. Thirion|D. Chaput|A. Chadi"
"4459","13/04 12:00","25","P3667","Andzoa JAMUS","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Immunisation against Chlamydia trachomatis polymorphic membrane protein D tetrapeptide motifs limits early female reproductive tract infection in a mouse model","A. Jamus|A. Collar|J. Flanagan|S. Core|C. Wheeler|W. Geisler|K. Frietze"
"4746","13/04 12:00","26","P3668","Archchun ARIYARAJAH","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","The effect of time since first dose of measles-containing vaccine on measles IgG concentration and seronegativity: a retrospective cohort study","A. Ariyarajah|N. Crowcroft|K. Brown|J. Wang|J. Kwong|S. Bolotin"
"4822","13/04 12:00","27","P3669","Gamze SANLIDAG ISBILEN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Investigation of influenza, COVID-19 and pneumococcal vaccination status in adults","G. Sanlidag Isbilen|S. Gençer|H. Pullukçu|M. Tasbakan|I. Köksal"
"4834","13/04 12:00","28","P3670","Lin LIU","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","The emergence of a hypervirulent Streptococcus pneumoniae serotype 3 after PCV13: a whole-genome sequencing study in Zhejiang, China","L. Liu|Y. Wang|Y. Yu|X. Wu|T. Hong|S. Chen|J. Lu|Y. Fu"
"5008","13/04 12:00","29","P3671","Madelyn ROJAS CASTRO","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Hybrid protection against laboratory-confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021–2024","M. Rojas-Castro|R. Mulchandani|K. Szuldrzynski|A. Machado|C. Petru Popescu|R. Hrisca|K. Brolin|Z. Lovric Makaric|A. Uuskula|C. Bergin|C. Fleming|P. Bonfanti|R. Murri|V. Zvirbulis|D. Zavadska|D. Krievins|E. Barzdina|C. Valadas Henriques|A. Kosa|V. Miron|C. Munoz-Almagro|A. Milagro|S. Bacci|C. Savulescu|V. Gaio|S. Florescu|P. Subirats|L. Clusa|G. Sarajlic|J. Sui|C. Kenny|R. Santagelo|S. Lamonica|M. Lazar|S. Pohrib|M. Cisneros|M. Latorre-Millán|G. Petrovic|L. Lohur|J. Mcgrath|L. Ferguson|A. Spolti|K. De Gaetano Donati|I. Abolina|D. Gravele"
"5257","13/04 12:00","30","P3672","Julie MERINDOL","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Pneumococcal vaccination with PCV13 during hospitalisation for acute infection disease: a real-life opportunity for vaccination","I. Touitou|C. Cruzel|B. Seitz Polski|S. Breau|J. Courjon|M. Carles|E. Demonchy|J. Merindol|D. Payen"
"5404","13/04 12:00","31","P3673","Jade PATTYN","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Investigating the state of vaccine confidence among the general public and parents with young children in Flanders (Belgium)","J. Pattyn|N. Hanning|S. Valckx|T. Claessens|E. Karafillakis|G. Hendrickx|H. Theeten|V. Jong|P. Van Damme"
"5412","13/04 12:00","32","P3674","Mads Frederik EIBERG","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Short-term survival following an event of HZ: a register-based matched cohort study in Denmark","M. Eiberg|O. Rezahosseini|M. Andersen|C. Torp-Pedersen|C. Roed|C. Klint Johannesen|A. Egeskov-Cavling|T. Fischer|K. Rostgaard|H. Hjalgrim|Z. Barrella Harboe"
"6087","13/04 12:00","33","P3675","Derya KAYA","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","People living with HIV and vaccination: insights into awareness, recommendations, and attitudes at a tertiary care centre in Turkey","D. Kaya|O. Acet|A. Emecen|H. Pullukçu|D. Gökengin|M. Tasbakan"
"6090","13/04 12:00","34","P3676","Matt LOIACONO","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Roadmap to improve vaccine effectiveness research and evidence synthesis","D. Harris|M. Loiacono|S. Greenland|M. Knoll|D. Westreich|B. Gärtner|S. Gravenstein|S. Mahmud|A. La Caze|J. Diez-Domingo|T. Biering-Sørensen|A. Chit|G. David|M. Ryser|R. Harris"
"6886","13/04 12:00","35","P3677","Franziska JAKOBS","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Public health impact of herpes zoster vaccination for immunocompromised individuals aged 18-49 years in Germany","F. Jakobs|M. Nishimwe|S. Pedron|J. Hain|M. Krammer|M. Dichtl|M. Waize"
"7249","13/04 12:00","36","P3678","Benno KOHLMAIER","1","C","11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Effect of intravenous immunoglobulins on vaccine response of routine childhood vaccines","B. Kohlmaier|P. Gampawar|L. Ederer|U. Wiedermann-Schmidt|M. Egger|C. Zurl|W. Zenz|V. Strenger"
"981","13/04 12:00","1","P3679","Valentino D'ONOFRIO","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Paced immune activation by AS04 drives superior cross-protective antibody response in Cervarix","V. D'onofrio|A. Willems|A. Santana|M. Pauwels|G. Waerlop|I. Leroux-Roels|R. Sékaly|G. Leroux-Roels"
"1334","13/04 12:00","2","P3680","Marie NISHIMWE","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Consolidating evidence on the number needed to vaccinate against herpes zoster in older adults","N. Giannelos|D. Curran|S. Thakur|A. Cunningham|M. Nishimwe"
"1922","13/04 12:00","3","P3681","Lauren TINDALE","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Kinetics of B and T cell responses to vaccination with chikungunya virus virus-like particle vaccine","S. Stoddard|J. Jain|R. Rossi|A. Stano|L. Tindale|J. Mendy|L. Bedell|S. Stonier|P. Ajiboye|S. Raju|D. Weiskopf|L. Vang|B. Simone|M. Diamond"
"2434","13/04 12:00","4","P3682","Debasis BISWAS","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Impact of rotavirus vaccination on the aetiological profile of viral diarrhoea in under-five children in India","D. Biswas|S. Silodiya|A. Yadav|A. Pakhare|S. Tripathi|A. Malhotra|D. Namdeo|S. Nema"
"2939","13/04 12:00","5","P3683","Ana BANKO","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Identification of immunity gaps and risk groups for future outbreaks of measles, mumps, and rubella: cross-sectional study of seroprevalence in young healthcare professionals in Serbia","A. Banko|A. Cirkovic|D. Miljanovic|V. Petrovic|V. Vukovic|M. Ristic|D. Stankovic Djordjevic"
"4050","13/04 12:00","6","P3684","Fouelifack Nzeko ERIC","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Prevalence of HPV and associated risk factors for cervical lesions among women in northern Cameroon: a community-based study","K. Pamela Francine|F. Eric"
"5102","13/04 12:00","7","P3685","Bisi JEGEDE","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Recombinant zoster vaccine (RZV) does not increase the recurrence of herpes zoster (HZ) in adults ≥50 years of age with HZ history: a randomised clinical trial","B. Jegede|Y. Zhou|H. Hawksworth|D. Hui|N. Montenegro|A. Poder|J. Ramon|D. Villanueva Quintero|A. Mwakingwe-Omari"
"6031","13/04 12:00","8","P3686","Albiana CEKREZI","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Vaccination uptake among patients on PrEP: patterns and associated factors, 2021-2024","A. Cekrezi|D. Zaçe|C. Rosario Alessandro|F. Nina|N. Braccialarghe|D. Pucci|G. Alessio|G. Montagnari|L. Coppola|L. Campogiani|M. Iannetta|V. Malagnino|L. Sarmati"
"7256","13/04 12:00","9","P3687","Carlos Arturo ALVAREZ MORENO","2","C","11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Safety of LC16m8 vaccine in HIV-positive and high-risk populations in Bogotá, Colombia: a cohort study","C. Alvarez-Moreno|M. Ujiie|H. Gaitan-Duarte|S. Mine|J. Cortes|M. Hamana|M. Bautista-Gonzalez|N. Tomotsugu|L. Gonzalez|A. Ainai|J. Castellanos|C. Gomez|S. Valderrama|O. Sussman|M. Amaya|L. Nocua-Baez"
"530","13/04 12:00","10","P3688","Thundon NGAMPRASERTCHAI","2","C","11c. Antibacterial vaccines","Immunogenicity and safety of the higher valent pneumococcal conjugated vaccine compared to the 13-Valent pneumococcal conjugated vaccine in older adults: a systematic review and meta-analysis of randomised controlled trials","T. Ngamprasertchai|N. Ruenroegnboon|R. Kajeekul"
"825","13/04 12:00","11","P3689","Jiahui LI","2","C","11c. Antibacterial vaccines","Invasive pneumococcal disease and impact of 7- and 13-valent pneumococcal conjugate vaccines in Singapore children over 24 years","J. Li|C. Yung|K. Kam|K. Nadua|N. Tan|K. Thoon|M. Maiwald|C. Chong"
"871","13/04 12:00","12","P3690","Mark VAN DER LINDEN","2","C","11c. Antibacterial vaccines","Implications of recently revised pneumococcal vaccination recommendation for adults in Germany","M. Van Der Linden|A. Itzek"
"878","13/04 12:00","13","P3691","Zinan YI","2","C","11c. Antibacterial vaccines","Use of new 21-valent pneumococcal conjugate adult vaccine in the presence of uncertainties around increases in invasive pneumococcal disease clusters caused by serotype 4 in the United States: a model-based threshold analysis","Z. Yi|K. Owusu-Edusei|E. Flem|K. Feemster|E. Elbasha"
"907","13/04 12:00","14","P3692","Prince Kelechi CHIMA","2","C","11c. Antibacterial vaccines","Estimating the pneumococcal vaccine preventable incidence of childhood pneumonia towards the mitigation of AMR: a vaccine probe study of cross-sectional data from a household survey in rural Vietnam","P. Chima|S. Lewycka"
"927","13/04 12:00","15","P3693","Peter MUELLER","2","C","11c. Antibacterial vaccines","Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in Austria","P. Mueller|M. Klicznik-Hollerer|E. Walter|E. Tsoumani|A. Sonnenschein-Van Der Voort|Z. Yi|K. Owusu-Edusei"
"1313","13/04 12:00","16","P3694","Deepak KUMAR","2","C","11c. Antibacterial vaccines","Development of live attenuated candidate vaccine by gene knockout method","K. Deepak|K. Sudhir|N. Gopal"
"1351","13/04 12:00","17","P3695","Niccolò RAMPONI","2","C","11c. Antibacterial vaccines","Invasive Streptococcus pneumoniae infections in southern Switzerland: a preventable condition that is not actually prevented","N. Ramponi|E. Bernasconi|P. Bellini|G. Merlani|L. Muller|E. Pianezzi|C. Di Benedetto|M. Gallacchi Bouvier|M. Bongiovanni"
"1436","13/04 12:00","18","P3696","Oluwaseun SHAROMI","2","C","11c. Antibacterial vaccines","Predicting the public health impacts of using different adult pneumococcal vaccines in ≥65-years-old adults in Sweden","M. Klint|S. Sjölander|E. Tsoumani|G. Meleleo|R. Nachbar|T. Malik|K. Bakker|S. Oluwaseun|R. Oidtman"
"1501","13/04 12:00","19","P3697","Oluwaseun SHAROMI","2","C","11c. Antibacterial vaccines","Estimating the public health impacts of introducing an age-based national Immunisation programme for adult pneumococcal vaccination in Denmark","R. Oidtman|L. Roesgaard Kantsø|E. Theisen Honore|M. Holm Vinfeldt|E. Tsoumani|G. Meleleo|R. Nachbar|T. Malik|K. Bakker|S. Oluwaseun"
"2190","13/04 12:00","20","P3698","Lykke LARSEN","2","C","11c. Antibacterial vaccines","Torque teno virus load as a predictor of serotype-specific antibody response to the 13-valent conjugated pneumococcal vaccine in adult kidney transplant recipients","L. Larsen|C. Bistrup|S. Soerensen|C. Joergensen|S. Hoegh|R. Pedersen|I. Johansen"
"2528","13/04 12:00","21","P3699","Christian RAUSCHERT","2","C","11c. Antibacterial vaccines","Systematic literature review of the efficacy/effectiveness, immunogenicity and safety of booster vaccinations against pertussis in adults","A. Mahmood|C. Rauschert|A. Freitag|S. Luca|D. Heinze|L. Zhang|N. Mehra|P. Marijic|A. Heiseke|P. Dewda"
"2704","13/04 12:00","22","P3700","Rebeca SANTAMARINA","2","C","11c. Antibacterial vaccines","Development of a double-auxotrophic Klebsiella pneumoniae strain as a safe and effective oral vaccine candidate to prevent gastrointestinal colonisation","M. Moscoso|R. Santamarina-Fernández|V. Fuentes-Valverde|P. Garcia|G. Bou"
"2864","13/04 12:00","23","P3701","Qaiser AKRAM","2","C","11c. Antibacterial vaccines","Recombinant subunit combined vaccine, a preventable zoonotic One Health approach for enhanced safety and immunogenicity","Q. Akram|A. Naeem"
"3853","13/04 12:00","24","P3702","Shikha MISHRA","2","C","11c. Antibacterial vaccines","Pneumococcal vaccination rates among patients hospitalised for Pneumococcal infection at a community teaching hospital","S. Mishra|K. Ayabe|R. Johnson|M. Fang"
"4064","13/04 12:00","25","P3703","Giacomo PONTA","2","C","11c. Antibacterial vaccines","Factors influencing uptake of pneumococcal vaccination after invasive pneumococcal disease in two centres in northern Italy","G. Ponta|A. Raccagni|S. Carletti|C. Mauri|V. Morena|N. Gemignani|A. Callegaro|L. Daprai|P. Reali|R. Lolatto|S. Pontiggia|A. Castagna|M. Ripa|S. Piconi"
"4118","13/04 12:00","26","P3704","Maria CISNEROS","2","C","11c. Antibacterial vaccines","Early changes in incidence of paediatric invasive pneumococcal disease after introduction of 15-valent pneumococcal conjugate vaccine in Catalonia, Spain","M. Cisneros|A. Rosell|C. Alcaraz|D. Henares|A. Perez-Arguello|A. Soler-Garcia|M. Blanco-Fuertes|P. Brotons|C. Esteva|J. Garcia-Garcia|M. De Sevilla|C. Munoz-Almagro"
"4353","13/04 12:00","27","P3705","James WASSIL","2","C","11c. Antibacterial vaccines","Safety, tolerability, and immunogenicity of 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults =50 years: a Phase 1/2, randomised, active-controlled, dose-finding study","J. Wassil|J. Fairman|C. Fierro|J. Clark|S. Bennett|D. Johnson|T. Migone|A. Paschenko|J. Simon|S. Lamola|M. Hanson|M. Sisti"
"5974","13/04 12:00","29","P3707","María ALONSO GIRÓN","2","C","11c. Antibacterial vaccines","Serotype distribution of invasive disease-causing Streptococcus pneumoniae after 14 years of systematic vaccination","P. Juiz González|S. Méndez Lage|I. Losada Castillo|M. Rodriguez Mayo|G. Barbeito Castineiras|F. Vasallo Vidal|M. Paz Vidal|P. Capon Gonzalez|M. Pallares González|J. Alba Dominguez|M. Serrano Lopez|P. Alonso Alonso|J. Agulla Budino|M. Alonso Giron"
"6149","13/04 12:00","30","P3708","Selma BOUHERAOUA","2","C","11c. Antibacterial vaccines","Streptococcus pneumoniae carriage in children less than 25 months in North of Algeria (Blida) after introduction of PCV13","S. Bouheraoua|R. Laliam|F. Djedjig|A. Nadji|N. Zaouia|M. Mahfoud|S. Abdi|S. Mahrane|H. Tali Maamar"
"6695","13/04 12:00","31","P3709","Nathália ANDRADE","2","C","11c. Antibacterial vaccines","Silver and gold bimetallic nanoparticles as an innovative bacterial vaccine platform against infections caused by ESKAPE group species","N. Andrade|P. Paez"
"6706","13/04 12:00","32","P3710","Mekki BENSACI","2","C","11c. Antibacterial vaccines","Post-pandemic Streptococcus pneumoniae serotype epidemiology and antimicrobial susceptibility among adults =18 years old with invasive and noninvasive pneumococcal disease in the United States, 2022-2023","M. Bensaci|K. Bauer|K. Klinker|J. Cota|R. Mendes|K. Feemster"
"6799","13/04 12:00","33","P3711","Natasa OPAVSKI","2","C","11c. Antibacterial vaccines","Fifteen years of Streptococcus pneumoniae laboratory surveillance: alarming serotype shift and the impact of PCV in Serbia","N. Nedeljkov Tesin|M. Djuric|M. Hadnadjev|S. Delic|N. Opavski|M. Jovicevic|J. Kabic|D. Kekic|T. Kurucin|A. Sente-Zigmanovic|D. Medic|Z. Vasiljevic|O. Hadzic-Simovic|T. Djordjevic|S. Laban-Nestorovic|T. Tosic|R. Popovic|G. Nikolic|V. Karanovic|L. Ranin|I. Gajic"
"7106","13/04 12:00","34","P3712","Mohammadreza ASADIKARAM","2","C","11c. Antibacterial vaccines","Encapsulation of L7/L12 and OMP19 proteins from Brucella melitensis in liposomal adjuvant system as a strategy to develop an effective vaccine against brucellosis","R. Pirhajati|M. Habibi|N. Shahrokhi|M. Chiani|M. Asadikaram"
"4802","13/04 12:00","35","P3713","Luke MCGEOCH","2","C","11d. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)","Evaluation of immunoglobulin use as post-exposure prophylaxis during a national measles outbreak in England","P. Birmpili|L. Mcgeoch|R. Mearkle|R. Cordery|L. Fagan|V. Saliba"
"6555","13/04 12:00","36","P3714","Caspar GEENEN","2","C","11d. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)","Design of a smartphone app for recall-based contact tracing","C. Geenen|M. Tunç|S. Gorissen|J. Thibaut|E. Hosten|E. André"
"7322","13/04 12:00","2","P3716","Lin GENG","3","C","11d. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)","Potential public health impacts of gonorrhoea vaccination programmes under declining incidences: a modelling analysis","L. Geng"
"120","13/04 12:00","3","P3717","Ashish SHUKLA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Insecticide susceptibility of the sand fly leishmaniasis vector Phlebotomus argentipes in Bihar, India","A. Shukla|R. Chaubey|A. Kushwaha|R. Kumar|S. Sundar"
"194","13/04 12:00","4","P3718","Sameh BELGACEM","3","C","11e. Food & water safety, environmental health, vector epidemiology","Co-occurrence of Legionella pneumophila and free-living Amoebae in water conduits in southern Tunisia","S. Belgacem|Y. Moussa|F. Messadi|H. Babba"
"828","13/04 12:00","5","P3719","Manal ALMUSA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Detection and molecular characterisation of aflatoxin and ochratoxin produce Aspergillus species in Capsicum spices in Saudi Arabia","M. Almusa|F. Al-Otibi|F. Al-Reshoodi|A. Shahad|L. Mukhtar|A. Alharbi|a. Zyad|M. Alkaleeb|K. Alarjani|M. Alkhanani|Y. Alrujib|A. Aljardan|S. Alajel"
"1032","13/04 12:00","6","P3720","Ines KAMOUN","3","C","11e. Food & water safety, environmental health, vector epidemiology","Contamination of leafy vegetables and strawberries with Echinococcus granulosus sensu lato and Taenia spp. in Tunisia: implication for food safety","I. Kamoun|S. M'rad|L. Zemzemi|R. Barosi|H. Babba|F. Boué|G. Umhang|M. Oudni-M'rad"
"1247","13/04 12:00","7","P3721","Theevasha GOVENDER","3","C","11e. Food & water safety, environmental health, vector epidemiology","Genomic characterisation of zoonotic bacteria carried by wild birds during the migratory season in Gauteng, South Africa","T. Govender|T. Hamiwe|V. Ueckermann|M. Ehlers"
"1342","13/04 12:00","8","P3722","Laura CALIGARIS","3","C","11e. Food & water safety, environmental health, vector epidemiology","Evaluation of water quality through pipe microbiome characterisation using 16S gene metagenomics approach","L. Caligaris|L. Girolamini|F. Marino|C. Bonincontro|C. Derelitto|C. Sabelli|S. Cristino"
"1663","13/04 12:00","9","P3723","Babatunde ODETOYIN","3","C","11e. Food & water safety, environmental health, vector epidemiology","Prevalence and associated risk factors of vancomycin-resistant Enterococcus faecium in well water used for domestic purposes in Ile-Ife, southwestern Nigeria","B. Odetoyin|T. Bebe|E. Akinkumi"
"1798","13/04 12:00","10","P3724","Sylvia VALDEZATE","3","C","11e. Food & water safety, environmental health, vector epidemiology","Large scholar food-borne outbreak caused by Clostridium perfringens type F with plasmid enterotoxin CPE","S. Valdezate|M. Medina-Pascual|M. Valiente|P. Villalon|M. Pérez-Vázquez|C. Rodriguez|M. Rodriguez|J. Serrano|I. De Toro-Peinado"
"1815","13/04 12:00","11","P3725","Alexandra FOBE","3","C","11e. Food & water safety, environmental health, vector epidemiology","Advancing wastewater-based surveillance of antimicrobial resistance: a novel hybrid approach combining cultivation-based and molecular techniques for the detection of antibiotic resistant bacteria and resistance genes","A. Fobe|M. Koller|C. Kolm|T. Hohl|J. Vierheilig|B. Ströbele|M. Kalkgruber|P. Schmid|R. Martzy|M. Ante|A. Farnleitner|G. Zarfel|A. Kirschner"
"2044","13/04 12:00","12","P3726","Ahmad Ibrahim AL-MUSTAPHA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Wastewater-based genomic surveillance key to population-level monitoring of AmpC/ESBL-producing Escherichia coli","A. Al-Mustapha|A. Tiwari|R. Laukkanen-Ninios|K. Lehto|A. Lipponen|S. Oikarinen|T. Pitkanen|A. Heikinheimo"
"2203","13/04 12:00","13","P3727","Patricia ANTUNES","3","C","11e. Food & water safety, environmental health, vector epidemiology","Surface hygiene in food environments: challenges with biocide efficacy and bioindicators","P. Antunes|A. Peixoto|C. Matos|S. Dias Santos|J. Rodrigues|M. Saraiva|C. Belo Correia|R. Batista|L. Peixe|C. Novais"
"2241","13/04 12:00","14","P3728","Emilija HRAPOVIC","3","C","11e. Food & water safety, environmental health, vector epidemiology","Dominant species and serogroups of Legionella spp. in swimming pool water in the Federation of Bosnia and Herzegovina","E. Hrapovic|A. Mesihovic|A. Ibrahimagic"
"2430","13/04 12:00","15","P3729","Tiffany DIDIK","3","C","11e. Food & water safety, environmental health, vector epidemiology","Summer surge of sequence type 283 in Hong Kong: a five-year review of Group B Streptococcus molecular distribution in non-pregnant adults","T. Didik|H. Luk|G. Choi|H. Tse|C. Wong|D. Lung"
"3182","13/04 12:00","16","P3730","Ihssane OUADDANE","3","C","11e. Food & water safety, environmental health, vector epidemiology","Environmental surface sampling of respiratory and gastrointestinal pathogens during the 2022-2023 Grand Magal of Touba","I. Ouaddane|P. Gautret"
"3224","13/04 12:00","17","P3731","Miquel SÁNCHEZ-OSUNA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Mapping antimicrobial resistance landscape at a city scale sewage network","M. Sánchez-Osuna|C. Diaz-Garcia|A. Serra-Compte|I. Karakatsanidou|I. Gomez-Sanchez|B. Fidalgo|C. Barbuzana|M. Fittipaldi|R. Rosselli|J. Vinyoles|S. González|O. Pich|M. Espasa|M. Yanez"
"3276","13/04 12:00","18","P3732","Amir IBRAHIMAGIC","3","C","11e. Food & water safety, environmental health, vector epidemiology","Detection and prevalence of moulds and mycotoxins in food for young children and infants, nuts and grains","A. Ibrahimagic|E. Idrizovic|B. Hodzic|D. Hasanbasic|C. Kovac|A. Salkic|A. Agic|E. Hrapovic|B. Causevic"
"3334","13/04 12:00","19","P3733","Erica TIRLONI","3","C","11e. Food & water safety, environmental health, vector epidemiology","Performance comparison of two different sampling strategies in deli food production plant: FLOQSwab and sponges, for the detection of Listeria monocytogenes and Bacillus cereus","E. Tirloni|C. Bernardi|M. Addis|M. Penati|S. Stella"
"3732","13/04 12:00","20","P3734","Vanessa SILVA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Foodborne Listeria monocytogenes in chicken viscera products: implications for food safety and public health","V. Silva|S. Saraiva|A. Silva|V. Borges|R. Batista|J. Gomes|J. Borrero|G. Igrejas|E. Munoz-Atienza|L. Cintas|C. Saraiva|P. Poeta"
"3950","13/04 12:00","21","P3735","Sohail KHAN","3","C","11e. Food & water safety, environmental health, vector epidemiology","Methicillin resistant Staphylococcus aureus prevalance in abbatoirs and meat shops in the northern border regions between Pakistan and Afghanistan","S. Khan|A. Khan|M. Ali"
"4233","13/04 12:00","22","P3736","Carla NOVAIS","3","C","11e. Food & water safety, environmental health, vector epidemiology","Negligible impact of quaternary ammonium compounds on the spread of toxigenic and antibiotic-resistant Clostridium perfringens in rivers used for drinking water production","C. Matos|L. Nova|B. Gonzalez|T. Pacheco|A. Magalhaes|F. Pereira|B. Duarte|M. Valente|C. Tavares|J. Rodrigues|A. Almeida|R. Azevedo|E. Pinto|L. Peixe|P. Antunes|C. Novais"
"4826","13/04 12:00","23","P3737","Hyeon Woo CHO","3","C","11e. Food & water safety, environmental health, vector epidemiology","Emergence and clonal spread of livestock-associated methicillin-resistant Staphylococcus aureus harboring a novel variant staphylococcal chromosome cassette mec in Korean pig farms","H. Cho|Y. Kim|B. Jang|K. Park"
"4833","13/04 12:00","24","P3738","Yeona KIM","3","C","11e. Food & water safety, environmental health, vector epidemiology","Emergence and spreading of blaCTX-M-65 carrying Salmonella infantis in retail poultry meats in Korea","Y. Kim|H. Cho|M. Lee|S. Yang|J. Chae|K. Park"
"4927","13/04 12:00","25","P3739","Meshari ALHADLAQ","3","C","11e. Food & water safety, environmental health, vector epidemiology","The role of microbiological criteria for foodstuffs notably GSO 1016/2015 in controlling Escherichia coli O157 in meat in Saudi Arabia and other countries","M. Alhadlaq"
"5039","13/04 12:00","26","P3740","Letizia CIRASELLA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Rabbit production system and zoonotic Salmonella serovars: an Italian outbreak associated with Salmonella enteritidis ST11","L. Cirasella|E. Massella|G. Graziosi|S. Russo|L. Fiorentini|S. Perulli|C. Siclari|E. Catelli|G. Tosi|V. Ravaioli|G. Mescolini|C. Lupini"
"5047","13/04 12:00","27","P3741","John Jairo AGUILERA CORREA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Antiadherent effect of a polysilazane-based sol-gel coating against Listeria monocytogenes","J. Esteban|A. Altube|N. Indakoetxea|L. Trallero-Calvo|C. Ortega-Portas|J. Aguilera-Correa"
"5092","13/04 12:00","28","P3742","Syeda NURUNNAHAR","3","C","11e. Food & water safety, environmental health, vector epidemiology","Cross-contamination pathways and risk behaviours: insights from food and domestic surfaces in urban slums of bangladesh Enabl","S. Nurunnahar"
"5163","13/04 12:00","29","P3743","Evgeny A. IDELEVICH","3","C","11e. Food & water safety, environmental health, vector epidemiology","Seasonal distribution and diversity of Vibrio spp. in the Baltic Sea of northeastern Germany and associated water systems","L. Ulm|E. Eger|M. Sitter|S. Heiden|C. Kohler|K. Becker|K. Schaufler|E. Idelevich"
"5419","13/04 12:00","30","P3744","Kun Taek PARK","3","C","11e. Food & water safety, environmental health, vector epidemiology","Prevalence and genetic characterisation of Listeria monocytogenes isolated from pork production chain in South Korea","M. Lee|K. Park"
"5859","13/04 12:00","31","P3745","Javier DÍEZ DE LOS RÍOS","3","C","11e. Food & water safety, environmental health, vector epidemiology","Prevalence of multiresistant: Enterobacteriaceae in aquatic ecosystems in Osona, Spain","J. Diez De Los Rios|N. Parraga-Nino|M. Navarro|A. Vilamala|J. Serra-Pladevall|S. Quero|E. Arqué|L. Pedro-Botet|O. Mascaro|E. Reynaga"
"5936","13/04 12:00","32","P3746","Sandra TAPIA POZA","3","C","11e. Food & water safety, environmental health, vector epidemiology","From sea to clinic: a 13-year study of Vibrio and Shewanella infections in the Atlantic coastal waters in southern Spain and their environmental links","S. Tapia Poza|E. Jurado Tarifa|I. Guerrero Lozano|T. Trujillo-Soto|J. Sánchez Calvo|F. Galán-Sánchez|J. Trinanes Fernandez|J. Martinez Urtaza|M. Rodriguez Iglesias"
"6270","13/04 12:00","33","P3747","Ilaria TRIVA","3","C","11e. Food & water safety, environmental health, vector epidemiology","Compatibility study of transport medium with PCR kits for detecting listeria spp. and Staphylococcus aureus from environmental samples","I. Triva|S. Savi|R. Botrugno|M. Bernabini"
"6356","13/04 12:00","34","P3748","Gaia NOBILI","3","C","11e. Food & water safety, environmental health, vector epidemiology","Prevalence of extended-spectrum beta-lactamase producing-and carbapenemase-resistant Enterobacterales and methicillin-resistant S. aureus isolated from surface water in southern Italy","E. Poppa|G. Nobili|A. Cocomazzi|M. Basanisi|G. La Bella|A. Damato|R. Coppola|R. Colangelo|T. Scirocco|I. Franconieri|A. Stallone|M. Notarangelo|R. Petruzzelli|S. Pagliara|A. Didonna|P. Selicato|S. Faleo|G. Occhiochiuso|L. Dattoli|V. Bortolaia|G. La Salandra|F. Tolve"
"6363","13/04 12:00","35","P3749","Azucena MORA GUTIÉRREZ","3","C","11e. Food & water safety, environmental health, vector epidemiology","Monitoring rabbit colibacillosis and antimicrobial resistance: insights for effective interventions and public health impact","L. Carballeira|M. De Toro|V. Garcia|M. Bea|A. Méndez|Á. Pérez-Sala|A. Mora"
"6377","13/04 12:00","36","P3750","Martin ANDRE","3","C","11e. Food & water safety, environmental health, vector epidemiology","Detection of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacterales in hospital effluent: a pilot study","M. Andre|C. Garcia Graells|K. Van Hoorde|I. Van Damme|C. Saegerman|A. Peleg|M. Paul|X. Bertrand|S. Harbarth|M. De Kraker"
"6686","13/04 12:00","1","P3751","Jordan Aston Tregurtha MATHIAS","4","C","11e. Food & water safety, environmental health, vector epidemiology","Highest levels of antibiotic resistance seen in exclusively ExPEC Escherichia coli in Wyoming and Wales","J. Mathias|P. Boidya|D. Babenko|T. Fearing|R. Petit|J. Mildenberger|M. Toleman|B. Bisha"
"6699","13/04 12:00","2","P3752","Jordan Aston Tregurtha MATHIAS","4","C","11e. Food & water safety, environmental health, vector epidemiology","Re-measuring community ExPEC Escherichia coli carriage in wastewater five years on, 2019-2024","J. Mathias|P. Boidya|D. Babenko|T. Fearing|R. Petit|J. Mildenberger|B. Bisha|M. Toleman"
"6720","13/04 12:00","3","P3753","Jordan Aston Tregurtha MATHIAS","4","C","11e. Food & water safety, environmental health, vector epidemiology","Using wastewater to survey community carriage of Staphylococcus aureus at a genomic level in rural Wyoming","J. Mathias|P. Boidya|J. Spencer|C. Phillips|T. Jupe|T. Fearing|R. Petit|J. Mildenberger|M. Toleman|O. Spiller|B. Bisha"
"6744","13/04 12:00","4","P3754","Gauri GODBOLE","4","C","11e. Food & water safety, environmental health, vector epidemiology","The role of antibiotics in the management of persistent shedding of shiga toxin-producing Escherichia coli (STEC)","G. Godbole|E. Rodwell|I. Hayden|C. Jenkins|V. Wong"
"6790","13/04 12:00","5","P3755","Shaista UROOJ","4","C","11e. Food & water safety, environmental health, vector epidemiology","Phenotypic heterogeneity and biofilm formation in foodborne neomycin-resistant P. aeruginosa isolates","S. Urooj|Z. Mirani"
"7110","13/04 12:00","6","P3756","Emma HEFFERNAN","4","C","11e. Food & water safety, environmental health, vector epidemiology","A surveillance study of Cryptosporidium parvum present in organic waste used as fertiliser in Ireland","E. Heffernan|D. Bolton|P. Whyte|G. Barry"
"822","13/04 12:00","7","P3757","Carolina Nogueira GOMES","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Genomic analysis of Campylobacter coli strains tolerant to stress conditions associated to food safety suggests possible contamination amongst diverse sources in Brazil","C. Gomes|G. Pereira|S. Soares|A. Felice|M. Allard|S. Duque|J. Falcao"
"896","13/04 12:00","8","P3758","Lingyu HE","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Global insights into the accessory genome of Streptococcus equi subspecies equi","L. He|N. Khine|C. Loubière|P. Butaye"
"1048","13/04 12:00","9","P3759","Lamia ZEMZEMI","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Zoonotic gastrointestinal parasites in dogs: an epidemiologic study of agricultural zones in Tunisia","L. Zemzemi|M. Oudni-M'rad|I. Kamoun|V. Bastid|F. Boué|H. Babba|G. Umhang|S. M'rad"
"1066","13/04 12:00","10","P3760","Anja BERGER","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Toxigenic Corynebacterium ulcerans in raw milk of a cow with acute mastitis and the risk of milk-associated diphtheria in humans","A. Sing|L. Macias Luaces|A. Dangel|K. Bengs|V. Melnikov|A. Berger|S. Derramo"
"1344","13/04 12:00","11","P3761","Nathan SINGANO","4","C","11f. Veterinary microbiology and One Health (excl AMR)","One Health lens on rabies: genomic insights and human-animal interactions in rural Lilongwe, Malawi","N. Singano|E. Chatanga|H. Kainga|W. Muleya"
"1961","13/04 12:00","12","P3762","Idris Nasir ABDULLAHI","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Global prevalence and molecular features of high-priority Enterococcus faecium and E. faecalis from guts of food-producing and wild birds","I. Trabelsi|I. Abdullahi"
"2431","13/04 12:00","13","P3763","Ryusei TANIGUCHI","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Prevalence of Gram-positive cocci isolated from livestock and livestock farmers in Japan: high prevalence of Mammaliicoccus sciuri","R. Taniguchi|R. Nakano|A. Nakano|Y. Suzuki|Y. Ono|H. Yano"
"2662","13/04 12:00","14","P3764","Muhammad Umair AZIZ","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Unveiling tick diversity in cattle in Cameroon: emergence of Rhipicephalus microplus, replacing the original Rhipicephalus spp.","M. Aziz|J. Zeb|M. Lontsi-Demano|A. Almendros Cebrian|J. De La Fuente|O. Sparagano|P. Butaye"
"3007","13/04 12:00","15","P3765","Jessica GHODKE","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Cold atmospheric plasma as an alternative antimicrobial therapy to treat livestock wound infections","J. Ghodke|D. Teixeira|D. Hidalgo|M. Bell|O. Doran|A. Stratakos"
"3076","13/04 12:00","16","P3766","Aman Dev MOUDGIL","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Elucidating the endemicity of amphixenotic Ascaris lumbricoides in pigs: the most prospective cross-transmission threat to humans in Haryana, India","A. Moudgil|A. Nehra"
"3173","13/04 12:00","17","P3767","Els BROENS","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Active surveillance in an equine intensive care unit identifies clusters of ESKAPEE pathogens in the veterinary hospital environment","M. Sijtsema|T. Stringer|N. Hopman|L. Van Der Graaf-Van Bloois|B. Duim|A. Van Den Brom-Spierenburg|M. Theelen|A. Zomer|E. Broens"
"3196","13/04 12:00","18","P3768","Juliana ARAUJO NOBRE","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Detection of Leptospira spp. in Marmosets (Callithrix spp.) from the Atlantic Forest (Rio de Janeiro-RJ) of Brazil","J. Araujo Nobre|M. Carvalho Furtado|M. Portugal|R. Moratelli|M. Duarte Wakimoto|R. Caldas Menezes"
"4345","13/04 12:00","19","P3769","Sandra A. MARTÍNEZ-ÁLVAREZ","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Exploring the distribution of virulence factors associated with Escherichia coli through the One Health paradigm","S. Martinez-Alvarez|S. Herrera-Espejo|M. Zarazaga|J. Madec|M. Haenni|M. Pachon-Ibanez|C. Torres"
"4421","13/04 12:00","20","P3770","Kellie Ann KROSCHER","4","C","11f. Veterinary microbiology and One Health (excl AMR)","An unconjugated single composite peptide vaccine targeting highly conserved influenza epitopes induced broadly reactive and durable antibodies to multiple influenza viruses in pigs","K. Kroscher|C. Sei|K. Muema|A. Assiaw-Dufu|N. Rikhi|R. Schuman|J. Torrison|G. Fischer"
"5237","13/04 12:00","21","P3771","Efe ALTUNTAS","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Impact of different temperatures on Chlamydia abortus survival and infectivity over time","E. Altuntas|H. Marti|N. Borel"
"5283","13/04 12:00","22","P3772","Mariia TRUSH","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Exploring nitroxoline as a solution to antibiotic resistance in poultry production","M. Trush|Y. Zhou|L. Ibbotson|A. Lankapalli|A. Farley|C. Schofield|T. Walsh"
"5379","13/04 12:00","23","P3773","Raphaël BAUDIN","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Cure of a difficult-to-treat Pseudomonas aeruginosa chronic otitis externa (OE) in a dog with the PYO bacteriophage cocktail followed by antibiotics","R. Baudin|V. Ducret|J. Prados|K. Perron|L. Gentsch|G. Resch"
"6387","13/04 12:00","24","P3774","Victor GARCIA-BUSTOS","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Potentially azole-resistant and thermal tolerant human and coral pathogen Aspergillus sydowii in wild Spanish Cetaceans: implications for One Health","A. Ruiz-Gaitán|B. Acosta-Hernández|E. Degollada|F. Aznar|M. Cerdà Cuéllar|G. Castella Gomez|I. Rosario Medina|V. Garcia-Bustos"
"7018","13/04 12:00","25","P3775","Alessandro BELLATO","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Multidrug-resistant and ESBL-producing Salmonella Kentucky ST198: a veterinary outbreak with public health implications","A. Bellato|F. Chiesa|D. Scalas|P. Morra|A. Bertuglia|M. Bullone|T. Civera|L. Barco|A. Mannelli|F. Mezzalama|S. Petrin|M. Pitti|M. Bianchi|P. Robino|M. Stella|L. Zarucco|P. Nebbia"
"7082","13/04 12:00","26","P3776","Victor GARCIA-BUSTOS","4","C","11f. Veterinary microbiology and One Health (excl AMR)","Azole-resistant Aspergillus and Candida isolates in bottlenose dolphins: implications for One Health","V. Garcia-Bustos|A. Ruiz-Gaitán|B. Acosta-Hernández|T. Álvaro|C. Rojo-Solis|M. Valls|J. Pérez-Royo|I. Rosario Medina"
"261","13/04 12:00","27","P3777","Soichi TAKEISHI","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","The relationship between COVID-19 and final consumption expenditure","S. Takeishi|T. Inoue|K. Miyamura"
"302","13/04 12:00","28","P3778","Soichi TAKEISHI","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","An investigation of national age–specific fertility rates in the Middle East using cluster analysis","S. Takeishi|T. Inoue|K. Miyamura"
"339","13/04 12:00","29","P3779","Vishwa Deepak TIWARI","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Comparative analysis of NS1/IgM rapid diagnostic tests (RDT) with NS-1 and IgM ELISA for dengue cases and its possible correlation with under-reporting of dengue cases in India","V. Tiwari|S. Pandey|M. Gangwar|S. Mishra|G. Nath|J. Chakravarty"
"612","13/04 12:00","30","P3780","Antonio RIVERO-JUAREZ","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Strategic positioning of the ESGVH-ESCMID for global hepatitis E virus vaccination","S. Dudman|A. Zerja|I. Hasanoglu|S. Ruta|B. Van Welzen|L. Nicolini|P. Yonga|J. Øverbø|S. Rawat|S. Habibovic|T. Kim|A. Rivero-Juárez"
"619","13/04 12:00","31","P3781","Guido GRANATA","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review","G. Granata|E. Petersen|A. Capone|D. Donati|S. Cicalini|N. Petrosillo"
"696","13/04 12:00","32","P3782","Airin FRANKE","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","GENTRAIN: genome-based infection chain analysis to increase digitalisation level in the public health sector","A. Franke|M. Tröger|L. Fischer|C. Hornberg|A. Dilthey|P. Vogel|B. Kräling|J. Weber|J. Ptok|S. Fuchs|N. Luschow"
"867","13/04 12:00","33","P3783","Céline CAILLET","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","A digital tool for the selection of portable screening technologies for detecting substandard and falsified anti-infectives","C. Caillet|G. Gnegel|C. Hagel|J. Gabel|K. Phommachack|P. Matousek|P. Newton"
"1058","13/04 12:00","34","P3784","Jessica PIERCE","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Omadacycline demonstrated efficacy as both therapeutic treatment and post-exposure prophylaxis against inhalation anthrax and pneumonic plague in cynomolgus macaques","D. Pfefferle|B. Mccracken|M. Kirkbride|L. Aleshire|K. Bater|L. Mccabe|A. Hay|J. Bruskotter|A. Wenz|M. Anderson|L. Henning|M. Trang|S. Bhavnani|C. Rubino|J. Pierce|J. Tatem|S. Tanaka|A. Serio"
"1202","13/04 12:00","35","P3785","Ming-Han TSAI","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Under-estimated pertussis burden among older adults in Taiwan: a longitudinal seroepidemiological study from 2014 to 2020","H. Shih|C. Chen|C. Chiu|M. Tsai"
"1947","13/04 12:00","36","P3786","Sriram RADHAKRISHNAN","4","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","A cross-country comparison of antimalarial drug prices, availability, and affordability: insights from India and Nigeria","S. Radhakrishnan|V. Velmani|D. Eloghosa Ale|G. Mohanta|S. Dorairajan|S. K.|S. K."
"1984","13/04 12:00","1","P3787","Jay PATEL","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Evaluating the international performance of diagnostics systems for addressing antimicrobial resistance in 174 countries and territories: a systematic global analysis","J. Patel|S. Moghaddam|E. O'neill|S. Ranganathan|D. Sridhar|V. Aggarwal"
"2773","13/04 12:00","2","P3788","Benoit VISSEAUX","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Impact of French public health alerts in a specialty laboratory","M. Roussel|L. Verdurme|C. Dhumieres|S. Trombert-Paolantoni|B. Visseaux|B. Roquebert"
"2960","13/04 12:00","3","P3789","Helen MUELLER","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Factors influencing work absenteeism due to acute respiratory infections (ARIs) among healthcare workers","H. Muller|J. Mees|M. Mayerhöfer|S. Kampmeier|A. Gabel|I. Wagenhäuser|N. Petri|M. Krone"
"3262","13/04 12:00","4","P3790","Anna GORSKA","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Automating systematic reviews and meta-analyses: a framework for living evidence synthesis in infectious diseases","A. Gorska|A. Nazeri|A. Visentin|T. Evelina"
"3370","13/04 12:00","5","P3791","Christel Baagø SCHJØRRING","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Differences in causes of death between males and females during periods with and without elevated mortality","C. Schjørring|J. Nielsen|A. Kalnaes|J. Rantzau|L. Vestergaard|B. Søborg|S. Nørgaard"
"3600","13/04 12:00","6","P3792","Sarika SARIKA","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","When the rain pours, soars the pill: a pharmaco-audit of doxycycline sales in Chennai following Tamil Nadu's flood advisory","K. Sarika|B. Rithik Dharan|A. Surendhar"
"3669","13/04 12:00","7","P3793","Jan GOELEN","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Developing AWaRe-based antibiotic use quality indicators using sequential consensus methodology","J. Goelen|E. Funiciello|G. Lorenzetti|F. Djukic|C. Moore|A. Cook|B. Godman|S. Campbell|M. Sharland"
"4069","13/04 12:00","8","P3794","Isabell WAGENHÄUSER","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Sustainability challenges and opportunities of SARS-CoV-2 antigen rapid detection tests in the COVID-19 pandemic: a life cycle assessment","I. Wagenhäuser|M. Krone"
"5003","13/04 12:00","9","P3795","Sarah Kristine NØRGAARD","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Excess mortality during the COVID-19 pandemic compared to previous influenza seasons: estimates from 26 countries in the EuroMOMO network","S. Nørgaard|J. Nielsen|C. Schjørring|A. Kalnaes|B. Søborg|T. Krause|K. Mølbak|L. Vestergaard|N. Bundle"
"5183","13/04 12:00","10","P3796","Olajumoke SULE","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Learning from strengthening national laboratory systems towards global health security: experience of the UK Health Security Agency (UKHSA) international health regulations strengthening project (IHR-SP) laboratory team working across countries in Asia and Africa.","A. Ajileye|E. Musongole|S. Abid|H. Hailu|O. Balogun|O. Negedu-Momoh|T. Machawi|K. Skinner|I. Gonsalvez|A. Seth|C. Musonda|L. Devine|A. Breathnach|J. Moll|L. Trelfa|A. Sharp|O. Sule"
"5319","13/04 12:00","11","P3797","Shinhee HONG","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Korean pandemic response repository through microbial and immunological surveillance and epidemiology (K-PREMISE)","S. Hong|Y. Park|J. Lee|J. Eom|H. Shi"
"5415","13/04 12:00","12","P3798","Daniela DEBONE","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Climate-driven antifungal resistance: new challenges in public health","D. Debone|G. Cuba|A. Assef|M. Pillonetto|A. Abreu|R. Peral|D. Kulek|J. De Almeida Junior|S. Miraglia|C. Kiffer|A. Colombo"
"5555","13/04 12:00","13","P3799","Manoela LENZI PINTO","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Clinical-epidemiologic versus laboratorial exam in the diagnosis on dengue fever in the environmental catastrophe scenario in Rio Grande do Sul, Brazil in 2024","E. Pereira|M. Pinto"
"5616","13/04 12:00","14","P3800","Cale HARRISON","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Modeling the potential public health and economic impact of timely COVID-19 vaccination with an adapted vaccine in the United Kingdom","C. Harrison|J. Yang|R. Butfield|B. Yarnoff|C. Reynard"
"5838","13/04 12:00","15","P3801","Tomislav MESTROVIC","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","A comprehensive analysis of disability-adjusted life years (DALYs) across 85 pathogens: the first-ever pathogen impact atlas on a global, regional and national scale","T. Mestrovic"
"6083","13/04 12:00","16","P3802","Lorenzo Maria CANZIANI","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Learning from post-COVID-19 condition for pandemic preparedness: a catalogue of variables for future post-acute infection syndromes","L. Canziani|A. Gorska|E. Rinaldi|Z. Pana|S. Beale|F. Bai|B. Boxma-De Klerk|S. De Bruijn|D. Donà|M. Ekkelenkamp|F. Incardona|P. Mallon|G. Marchetti|M. Puhan|A. Riva|V. Simensen|M. Vaillant|M. Van Der Zalm|S. Van Kuijk|S. Van Wingerden|A. Judd|E. Tacconelli|J. Penalvo"
"6242","13/04 12:00","17","P3803","Rasha ABDELSALAM ELSHENAWY","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Advancing antimicrobial stewardship with the SMART-AMS model: a strategic framework to combat antimicrobial resistance for a healthier future","R. Abdelsalam Elshenawy|N. Umaru|Z. Aslanpour"
"6511","13/04 12:00","18","P3804","Nina RISE","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Heavy rainfall and flooding events and infectious diseases in Denmark","N. Rise|P. Jokelainen"
"6613","13/04 12:00","19","P3805","Kristina ALUZAITE","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","One Health criteria: considerations for One Health interventions and AMR national action plan designs","K. Aluzaite|J. Robotham|D. Belay|D. Chan|M. Dione|E. Emes|Y. Endalew|J. Guitian|F. Wanyoike|P. White|G. Knight"
"7198","13/04 12:00","20","P3806","Ahreej ELTAYEB","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Time for a multi-generational household respiratory infection vaccination strategy: scoping review","A. Eltayeb|J. Ordonez-Mena|S. De Lusignan"
"7353","13/04 12:00","21","P3807","Lin GENG","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Effects of climate change on Aedes aegypti abundance and dengue transmission","L. Geng"
"7368","13/04 12:00","22","P3808","Tomislav MESTROVIC","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Newest insights into the burden of antimicrobial resistance in Southeast Asia in 2021: a comparative evaluation of predominant resistant pathogens and pathogen-drug combination across countries of the region","T. Mestrovic|G. Robles Aguilar|A. Gray|L. Swetschinski|K. Ikuta|E. Wool|R. Hsu|C. Han|E. Chung|D. Araki|N. Weaver|A. Gershberg Hayoon|C. Dolecek|B. Cooper|C. Murray|M. Naghavi"
"7369","13/04 12:00","23","P3809","Andrew BOWSKILL","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Trends in prescriber applications to access unregistered antimicrobials in Australia: demonstrating the unmet need in a smaller population","N. Hillock|A. Bowskill|A. Cheng"
"7571","13/04 12:00","24","P3810","Priya SHREEDHAR","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Political, ethical, administrative, regulatory and legal (PEARL) barriers to site activation experienced in a pan-European warm-base clinical trial network","P. Shreedhar|H. Ana Catalina|M. Pablo|K. Ankur|M. Lauren"
"7621","13/04 12:00","25","P3811","Shiyu CHEN","5","C","11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Epidemiological study of Streptococcus pyogenes in China and data mining based on global isolates","C. Shiyu|J. Xinmiao|Y. Qiwen"
"233","13/04 12:00","26","P3812","Urvashi Geeta RAI","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Outbreak investigation of visceral leishmaniasis in Bihar, India: insights from an endemic region","U. Rai|A. Neyaz|S. Pandey|A. Singh|S. Sundar"
"414","13/04 12:00","28","P3814","Hope KALASA","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Correlates of acceptability of COVID-19 vaccine among health care workers(HCWs) at Ndola teaching hospital (NTH), Ndola, Zambia","V. Daka|M. Mwaba|H. Kalasa"
"528","13/04 12:00","29","P3815","Fahmeeda IDREES","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Infectious disease control: vaccine access and healthcare disparities in Pakistan","F. Idrees"
"1052","13/04 12:00","30","P3816","Elif AGULOGLU-BALI","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Multicentre insights into outpatient parenteral antimicrobial therapy (OPAT): a comprehensive analysis of Türkiye's unstructured system","E. Aguloglu-Bali|B. Coskun|H. Cavlak|Y. Gezer|A. Tarakci|F. Akçi?n|L. Altunal|B. Manavli|P. Konya|C. Semet|S. Özdemi?r-Al|C. Mermutluoglu|E. Yilmaz|A. Senbaba-Kara|M. Kultur|N. Saltoglu|G. Dalgan|U. Önal|A. Dogan|M. Toker|M. Çelik|D. Cercioglu-Ozdemir|S. Karabulut|S. Koç|F. Yasar|Y. Cakir|Ö. Eren-Korkmaz|H. Demi?rköse|E. Alp"
"1288","13/04 12:00","31","P3817","Paul RAHDEN","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Results of a randomised feasibility study of an intestinal adsorbent in acute diarrhoea in children in the Gambia","P. Rahden|A. Fatty|M. Jobarteh|A. Sallah|E. Jaiteh|A. Allen|D. Umoh|F. Bass|M. Dodd|C. Howell|E. Markaryan|R. Hnatic|S. Allen"
"1321","13/04 12:00","32","P3818","Murong YANG","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","A distributional regression approach to socioeconomic inequalities in infectious diseases in the UK","M. Yang|N. Nguyen|A. Walker|J. Robotham|E. Van Leeuwen|K. Pouwels"
"2263","13/04 12:00","33","P3819","Carlos KIFFER","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Bottom-up approach for an infection burden estimate approach: a Brazilian experience on ICD-10 standardisation process for the use on local secondary database studies","É. Carmo|A. Aquino|B. Franzon|M. Otani|P. Charf|C. Wagner|A. Marinonio|A. Colombo|C. Kiffer"
"2707","13/04 12:00","34","P3820","Liselotte HARDY","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Improving global access to microbiology diagnostics by means of a comprehensive online open repository","L. Hardy|J. Ronat|T. Oakley|T. Kesteman|J. Ferguson|J. Ridderhof"
"3489","13/04 12:00","36","P3822","Gerrit BURGER","5","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","The malaria care cascade and factors associated with receiving a malaria test in children under five and pregnant women with fever : a cross-sectional household survey from Guinea and Sierra Leone","L. Feddern|F. Pozo-Martin|B. Geurts|H. Baldé|I. Kaba|S. Menelik-Obbarius|K. Stein|V. Merhi|H. Weishaar|M. Kallon|K. Dumbuya|J. Sellu|A. Mbawah|A. Delamou|C. El Bcheraoui|H. Fischer|G. Burger|K. Röbl"
"3979","13/04 12:00","1","P3823","Linda KALJEE","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Development, implementation, and evaluation of a cross-generational strategy to support introduction of the human papillomavirus vaccine and utilisation of cervical cancer screening in Nepal","L. Kaljee|S. Srinivasan|A. Pach|T. Prentiss|B. Lal|A. Gautam|S. Paudel|R. Amatya|K. Karki|S. Adhikari|L. Awal|D. Bajracharya"
"4103","13/04 12:00","2","P3824","Harshitha SURESHKUMAR","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Antibiotic misuse via OTC medications in south India: results from the BEWARE study","H. Sureshkumar|S. Saravanakumar|S. Selvaganesan|S. J.|S. Dorairajan"
"4845","13/04 12:00","3","P3825","Miriam MÜLLER","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Clinical care for adults with chronic Chagas disease in Bolivia: a scoping review","M. Muller|T. Zoller|K. Verdonck"
"4848","13/04 12:00","4","P3826","Marcelo DIAZ-CONDE","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Evaluating the burden of Streptococcus pneumoniae and the pneumococcal vaccine implementation in Mexico","M. Diaz|M. Gargollo|C. Martinez|M. Betancourt"
"5493","13/04 12:00","5","P3827","Jaya TAPADAR NÉE CHAKRAVARTY","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Understanding acute encephalitis syndrome in adults: an etiological perspective from Eastern Uttar Pradesh","U. Rai|T. Rai|B. Pratap|J. Chakravarty"
"5506","13/04 12:00","6","P3828","Merve MERT VAHABI","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Assessment of HIV-related stigma among healthcare providers","M. Mert Vahabi|B. Kenanoglu|O. Acet|C. Tol|B. Sullu|S. Istek|D. Gökengin"
"5515","13/04 12:00","7","P3829","Raghu SRIRAM","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Development of a WHO list of essential diagnostic tests for bacterial and fungal infections and antimicrobial resistance","R. Sriram|S. Bertagnolio|C. Centner|M. Nicol"
"5588","13/04 12:00","8","P3830","Nita VERULAVA","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Awareness, misconceptions and uptake of HPV vaccination among university students in Georgia","N. Verulava|K. Abesadze"
"5620","13/04 12:00","9","P3831","Nafital Joao FRANCISCO","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Antimicrobial resistance of bacterial infections in Mozambique: a systematic review and meta-analysis","N. Francisco|M. Lina Estefania|D. Florence|K. Mohamad|B. Christine|D. Benedito|A. Leonel Diamantino|E. Virginia Lara|N. Carine|D. Giovanni|G. Pilar"
"5712","13/04 12:00","10","P3832","Eskedar AZEREFEGNE","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Patient satisfaction with antiretroviral therapy services in selected hospitals of addis ababa, ethiopia using the donabedian model","B. Mamo|D. Tefera|E. Azerefegne|M. Jibril"
"5750","13/04 12:00","11","P3833","Chasinga BAHARANYI","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","The mini-lab: the next step towards integrated antimicrobial resistance surveillance in South-Kivu Province, Democratic Republic of Congo","C. Chasinga|M. Hallin|A. Kusinza|E. Munguakonkwa|C. Franquesa|B. Baillet|O. Vanderberg|A. Natale"
"6022","13/04 12:00","12","P3834","David MOYNAN","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Latent tuberculosis infection (LTBI) in an urban homeless population","D. Moynan|S. Donohue|A. Fitzgerald|E. Groarke|A. Mooney|F. Gaffney|K. Brandon|K. Jones|N. Conlon|C. Ni Cheallaigh|N. Allen"
"6272","13/04 12:00","13","P3835","Sante Leandro BALDI","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Implementation of urine-based HR-HPV testing for cervical cancer prevention in a rural clinic in Eswatini, January 2023-February 2024","V. Msibi|M. Sikhondze|B. Nhleko|N. Niemann|B. Khumalo|T. Motsa|E. Valentini|C. Fappani|S. Villa|M. Gori|S. Baldi|P. Angelone|X. Dlamini|G. Maphalala|G. Buthelezi|F. Tediosi|A. Amendola|E. Tanzi|M. Raviglione"
"6323","13/04 12:00","14","P3836","Adonis SOTOODEH","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Socioeconomic factors and treatment limitations of intensive care in hospitalised COVID-19 patients","A. Sotoodeh|P. Hedberg|J. Martensson|P. Nauclér"
"6869","13/04 12:00","15","P3837","Laurent BÉLEC","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Atypical distribution of cervical HR-HPV in the Congo basin: implication for cervical cancer prevention","L. Bélec|S. Tonen-Wolyec|J. Muwonga Tukisadila|P. Lemba Tsimba|R. Mboumba Bouassa"
"7073","13/04 12:00","16","P3838","Alpana MOHTA","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Acceptance of self-sampling and knowledge about human papilloma virus among women in north India","A. Mohta"
"7246","13/04 12:00","17","P3839","Raquel GARCIA-BATAN","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Challenges in preventing pneumococcal disease in Costa Rica: serotypes, vaccination, and risk factors","R. Garcia-Batan|M. Ramirez-Cardoce"
"7569","13/04 12:00","18","P3840","Shanthosh Priyan SUNDARAM","6","C","11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Burden of sexually transmitted diseases (STDs) and impact of the comprehensive health promotion package on screening and prevention among commercial sex workers in northeast India","S. Sundaram"
"554","14/04 12:00","1","P1185","Pauline SORLIN","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Assessment of the European antibiotic resistance epidemiology in community care across drug-bacterium pairs: a spatial-temporal analysis using national surveillance data","N. Mutters|K. Akinosoglou|Y. Carmeli|E. Carrara|S. De Greeff|H. Humphreys|J. Oteo-Iglesias|A. Kronenberg|A. Leroy|L. Moore|C. Palos|C. Papan|T. Rawson|O. Sandulescu|K. Tryfinopoulou|C. Tsioutis|G. Birgand|O. Lemenand|P. Sorlin|V. Reynault"
"627","14/04 12:00","2","P1186","Liteboho MADUNA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial resistance and genomic diversity of Neisseria gonorrhoeae in Maseru, Lesotho","L. Maduna|M. Taole|K. Motanteli|T. Mosehle|I. Mothobi|R. Peters"
"664","14/04 12:00","3","P1187","Tizazu ZELELIE","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Multidrug-resistant and distribution of ß-lactamase genes among diarrheagenic Escherichia coli isolated from under-five children in central Ethiopia","T. Zelelie|T. Eguale|Z. Desalegn|D. Beshah|S. Gebre-Selassie|A. Mihret|T. Abebe"
"773","14/04 12:00","4","P1188","Rada RUSU","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","E. coli antimicrobial susceptibility patterns and social determinants of health: an ecological study in Ontario, Canada from 2017-2022","R. Rusu|B. Langford|D. Macfadden|J. Brownstein|D. Buckeridge|W. Russell"
"889","14/04 12:00","5","P1189","Samuel KARIUKI","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Multidrug-resistant invasive non-typhoidal Salmonella in children: asymptomatic shedding as an important source of community infection spread in Kenya","S. Kariuki|K. Kering|C. Mbae|C. Wairimu"
"965","14/04 12:00","6","P1190","Swati PUNDIR","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Phenotypic and genotypic distribution of ESBL uropathogens in the community setting of India: a multicentric cross-sectional study","S. Pundir|S. Mohapatra|S. Venugopal|S. Chunchanur|R. Panigrahy|V. Tak|S. Chaudhuri|H. Gautam|S. Sood|B. Das|K. Arti|P. Hari|A. Kumar|R. Kumari|S. Harshal"
"998","14/04 12:00","7","P1191","Fernando PASTERAN","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Genomic insights of carbapenemase-producing Enterobacter spp. in Argentina","J. De Mendieta|A. Menocal|M. Sanz|D. De Belder|P. Ceriana|T. Pocklepovich|F. Pasteran|A. Corso|S. Gomez"
"1080","14/04 12:00","8","P1192","Sangeeta BANERJI","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Genomic surveillance identifies C. jejuni lineages carrying a multi resistance gene cassette of Gram-positive origin","S. Banerji|A. Fruth"
"1110","14/04 12:00","9","P1193","Aula ABBARA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Conflict-associated wounds and burns infected with GLASS pathogens in the eastern Mediterranean region: a systematic review","A. Wild|A. Abbara|C. Shortall|O. Dewachi|C. Naim|A. Green|S. Hussain"
"1569","14/04 12:00","11","P1195","Sayaka ANDO","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Prevalence and characteristics of methicillin-resistant Staphylococci colonisation in the nasal vestibule of healthy individuals in Japan","S. Ando|R. Nakano|A. Nakano|Y. Suzuki|H. Yano"
"1607","14/04 12:00","12","P1196","Iren Høyland LÖHR","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","High prevalence of extended-spectrum beta-lactamase-producing Enterobacterales in patients admitted to a rural hospital in Tanzania","H. Syre|I. Löhr|M. Justine|E. Bernhoff|M. Hetland|J. Bayda|A. Daniel|R. Rashidi|E. Nuwass|P. Makambay|K. Vliegenthart"
"1720","14/04 12:00","13","P1197","James POWELL","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Evidence for antimicrobial stewardship and reduced antimicrobial resistance in the mid-west of Ireland, 2012 - 2023: findings from a One Health study","J. Powell|N. O' Connell|S. Sharma|S. Barrett|A. Johnson|C. Garvan|C. Dunne"
"2131","14/04 12:00","14","P1198","Tajana BALABAN","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Virulence and fitness of CTX-M producing Escherichia coli O25 ST131 in community acquired urinary tract infections in Croatia","M. Anusic|T. Balaban|L. Vlahek|V. Ticic|I. Kolcic|T. Marijan|B. Bedenic|J. Vranes"
"2248","14/04 12:00","15","P1199","Olivier LEMENAND","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Impact of national guidelines for the treatment of community acquitted urinary tract infection on antibiotic resistance in Enterobacterales","O. Lemenand|S. Thibaut|T. Coëffic|G. Birgand"
"2329","14/04 12:00","16","P1200","Anand MANOHARAN","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Comparison of antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae from blood and non-blood cultures: analysis from the survey of antibiotic resistance (SOAR) study, 2018-2021","A. Manoharan|D. Torumkuney|I. Morrissey|C. Aschinger|S. Hawser"
"2361","14/04 12:00","17","P1201","Gilbert LAZARUS","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Improving geospatial coverage and granularity of global AMR prevalence estimates: comprehensive systematic literature reviews to complement WHO's global AMR surveillance system (2018-2022)","G. Lazarus|B. Caddey|V. Wangsaputra|J. Conly|H. Barkema|D. Nobrega|A. Dean|E. Van Kleef|O. Tosas Auguet|S. Bertagnolio|S. Radiani|R. Hamers"
"2819","14/04 12:00","18","P1202","Stefan-Vasile CRISTEA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antibiotic susceptibility profiles of Gram-negative bacteria isolated from paediatric and adult UTI patients","S. Cristea|C. Olteanu|C. Grigore|N. Grigore|A. Barbu"
"2853","14/04 12:00","19","P1203","Meredith HACKEL","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","In vitro activity of ceftaroline and comparator agents against bacterial pathogens from adult patients collected during the ATLAS global surveillance programme in 2019-2023","M. Hackel|G. Stone|K. Perez|D. Sahm"
"2863","14/04 12:00","20","P1204","Meredith HACKEL","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","In vitro activity of ceftaroline against bacterial pathogens from paediatric patients collected during the ATLAS global surveillance programme in 2019-2023","M. Hackel|G. Stone|K. Perez|D. Sahm"
"2917","14/04 12:00","21","P1205","Maria Belén MANCINO","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Mycoplasma genitalium: what is going on in Argentina? First report","M. Mancino|M. Vacchino|P. Cristaldo|G. Baldoni|L. Fernandez Canigia|J. Smayesvky|V. Manias|L. Espadachini|A. Rodrigo|M. Rizzo|A. Berejnoi|C. Baldoni|M. Montoto|M. Machain|C. Garbaz|A. Magdaleno|S. Ratti|M. Botiglieri|L. Maccari|P. Galarza"
"3156","14/04 12:00","22","P1206","Devanshi SHARMA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Trends of azithromycin resistance in Neisseria gonorrhoeae from across the Indian subcontinent: time to reflect","D. Sharma|S. Muralidhar|N. Joshi"
"3189","14/04 12:00","23","P1207","Silvija Soprek Strugar","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Ten-year study of Shigella sonnei: antimicrobial susceptibility trends and risk factors in a Croatian tertiary care clinic","S. Soprek Strugar|N. Andrijasevic|V. Romih Pintar|S. Zekan|J. Begovac|A. Tambic Andrasevic|K. Bodulic"
"3234","14/04 12:00","24","P1208","Xi LI","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Global phylogeography and genomic surveillance of a recent epidemic Bordetella pertussis ST2 high-risk international clone: a multicentre study in China","X. Li|H. Liu|Y. Yu"
"3322","14/04 12:00","25","P1209","Feline VELTHUIS","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Increasing eight-year trend in fusidic acid resistance among MRSA isolates in the Netherlands","F. Velthuis|I. Nauta|W. Altorf-Van Der Kuil|D. Notermans|R. Zwittink|A. Schoffelen|S. De Greeff"
"3417","14/04 12:00","26","P1210","Daisuke KITAGAWA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Genotype and phenotype of clinical isolates of Aeromonas species and epidemiology of carbapenem-resistant strains in Japan","D. Kitagawa|Y. Suzuki|T. Asada|S. Suzuki|A. Nakano|R. Nakano|H. Yano|A. Yamamoto|R. Uejima|F. Nakamura"
"3449","14/04 12:00","27","P1211","Amy PRICE","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","A systematic review of resistance patterns of Corynebacterium diphtheriae.","A. Price|A. Patel|S. Hussain|C. Shortall|A. Abbara"
"3514","14/04 12:00","28","P1212","Eren OZTURK","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","The aetiologic agents and resistance rates in community-acquired complicated intra-abdominal infections: where are we locally?","E. Ozturk|I. Akdemir|E. Ontas|G. Cinar|E. Saricaoglu|E. Gulten|S. Ersoz|K. Memikoglu"
"3551","14/04 12:00","29","P1213","Alexandra SERRIS","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Emergence of fluoroquinolone resistance in Salmonella paratyphi A isolates from sub-Saharan Africa","A. Serris|E. Njamkepo Nguemkam|M. Pardos De La Gandara|O. Lortholary|F. Weill"
"3571","14/04 12:00","30","P1214","Taichi ITO","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Ten-year trends in methicillin resistance rates of Staphylococcus lugdunensis: a multi-centre surveillance study in Kagawa prefecture, Japan (2013-2023)","T. Ito|Y. Fukumori|K. Yokota"
"3668","14/04 12:00","31","P1215","Rodrigo E. MENDES","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Gepotidacin activity against Escherichia coli and Klebsiella pneumoniae, including molecularly characterised fluoroquinolone not susceptible subsets causing urinary tract infections in Europe and adjacent regions (2023)","R. Mendes|Z. Kockler|D. Beekman|R. Kapoor|N. Scangarella-Oman|S. Arends"
"3684","14/04 12:00","32","P1216","S. J. Ryan ARENDS","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Gepotidacin activity against and analysis of susceptibility to oral standard-of-care antibiotics for urinary tract infections caused by Escherichia coli and Klebsiella pneumoniae collected in Europe in 2023","S. Arends|R. Kapoor|N. Scangarella-Oman|R. Mendes"
"3724","14/04 12:00","33","P1217","Rodrigo E. MENDES","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Activity of gepotidacin against molecularly characterised beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2023)","R. Mendes|Z. Kockler|A. Scullin|R. Kapoor|N. Scangarella-Oman|S. Arends"
"3783","14/04 12:00","34","P1218","Ander URIBARRI","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Trends in clindamycin and metronidazole susceptibility of anaerobic clinical isolates: a ten year surveillance","M. Olazabal|A. Uribarri|M. Portillo|M. Aguirregabiria|C. Ezpeleta"
"3909","14/04 12:00","35","P1219","Antonio CASABELLA PERNAS","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial susceptibility of Legionella pneumophila to azithromycin and levofloxacin","P. Ponton Martinez|A. Casabella Pernas|N. Gonzalez Hernando|N. Garcia Cervera"
"3958","14/04 12:00","36","P1220","Alice NAVA","1","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Mycoplasma genitalium: two years prevalence of azithromycin and moxifloxacin resistance","L. Romeo|E. Nicolini|F. Borreca|A. Busni|F. Mazzilli|A. Russo|A. Nava|C. Vismara|D. Fanti"
"4048","14/04 12:00","1","P1221","Shaikha AL-SHOKRI","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial resistance trends of Campylobacter species from a tertiary hospital, 2010-2024","S. Al-Shokri|O. Abu Saleh|M. Fida"
"4091","14/04 12:00","2","P1222","Angie Katherine CASTILLO PEÑA","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Analysis of studies about antibiotic resistance of Enterobacter spp. between 2015 and 2022 through One Health approach","A. Castillo|J. Ruiz"
"4180","14/04 12:00","3","P1223","Meredith HACKEL","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Distribution of macrolide resistance among Streptococcus pneumoniae clinical isolates collected from global populations, 2018-2019 and 2022-2023","M. Hackel|G. Stone|K. Perez|D. Sahm"
"4357","14/04 12:00","4","P1224","William NEVIN","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Improving understanding of Staphylococcus aureus carriage and resistance patterns in high-risk UK armed forces populations: prevalence of MRSA, PVL-SA carriage and emergence of a MSSA ST398 clone","W. Nevin|E. Jauneikaite|S. Pallett|J. Melhuish|R. Wakefield|K. Bhanot|S. Guest|R. Toriro|T. Troth|M. Routledge|A. Mason|N. Beeching|M. O'shea|T. Fletcher|L. Lamb"
"4426","14/04 12:00","5","P1225","Sandra A. MARTÍNEZ-ÁLVAREZ","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Genomic epidemiology and distribution of carbapenemases and extended-spectrum beta-lactamases in Escherichia coliand Klebsiella pneumoniae at a Spanish hospital during 2019-2024","S. Martinez-Alvarez|M. Asencio|T. Cardona-Cabrera|M. Zarazaga|U. Höfle|C. Torres"
"4477","14/04 12:00","6","P1226","Diamantina LYMPERATOU","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Risk factors associated with community-acquired multidrug-resistant infections","D. Lymperatou|S. Filippas-Ntekouan|D. Biros|L. Athanasiou|R. Konstantopoulou|V. Samanidou|A. Koutsogianni|P. Adamidis|S. Sakkou|M. Florentin|R. Matzaras|C. Milionis|G. Liamis|E. Christaki"
"4591","14/04 12:00","7","P1227","Isadora BARCELLOS","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Investigation of Escherichia coli ST131 characteristics, an emerging pathogen in Rio de Janeiro","I. Barcellos|E. De Castro|B. Moreira|R. Picao|K. Miranda"
"4702","14/04 12:00","8","P1228","Yasumitsu NOMURA","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Molecular genetic analysis of extended-spectrum beta-lactamase-producing Escherichia coli isolated from outpatients at a tertiary care emergency centre: emergence of CTX-M-132-producing Escherichia coli in Japan","Y. Nomura|D. Kitagawa|R. Nakano|A. Nakano|Y. Suzuki|H. Yano"
"4856","14/04 12:00","9","P1229","Maximiliano Gabriel CASTRO","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Prevalence and risk factors for ESBL-producing Enterobacterales rectal carriage in a public hospital from Argentina","M. Castro|M. Beloso|S. Paris|J. Coduri|F. Cogliano|A. Amato|G. Munoz Cena|A. Gomez Colussi|F. Argarana|F. Galluccio"
"5166","14/04 12:00","10","P1230","Rony Elisabeth ZOETIGHEID","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Six-year trend in decreasing (benzyl)penicillin diameter distribution in Streptococcus pyogenes in the Netherlands","R. Zoetigheid|D. Notermans|W. Altorf-Van Der Kuil|A. Schoffelen"
"5205","14/04 12:00","11","P1231","Mormeneo Bayo SARAY","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Molecular epidemiology of mupirocin-resistant Staphylococcus aureus isolated from skin and soft-tissue infections in children","E. Sánchez Báscones|A. Castellano Verdasco|S. Mormeneo Bayo|A. Blanquero Porras|A. Bellés-Bellés|M. Riesgo Magana|E. Lopez Gonzalez|A. Bernet Sánchez|I. Prats Sánchez|M. Garcia Gonzalez"
"5284","14/04 12:00","12","P1232","Janko SATTLER","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Circulation of blaOXA-244, an emerging resistance gene, in polyclonal E. coli strains in Jerusalem, Israel","J. Sattler|H. Seth-Smith|A. Michael-Gayego|Y. Oster|D. Reshef|V. Temper|K. Borgwardt|A. Egli|J. Strahilevtiz|J. Moran-Gilad"
"5418","14/04 12:00","13","P1233","Mercedes MONTERO-VALE","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","High prevalence of macrolide resistance in Streptococcus pneumoniae isolated from nasopharyngeal samples among naïve six-week-old children in Sierra Leone: a resistome approach","M. Montero-Vale|H. Chen|E. Rubio-Garcia|A. Lara-Munoz|E. Guiral|C. Casals-Pascual|J. Vila|C. Menéndez"
"5498","14/04 12:00","14","P1234","Sílvia OLIVEIRA","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial agents in dentifrices and mouthwashes: induction of antiseptic and antibiotic tolerance","B. Sinhorelli|G. Polesello|S. Oliveira"
"5719","14/04 12:00","15","P1235","Eirini SIATRAVANI","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Increase in azithromycin resistance rate of Neisseria gonorrhoeae during the period 2020-2023 in Greece","E. Siatravani|A. Panopoulou|S. Chryssou|I. Magaziotou|A. Beloukas|E. Tzelepi|V. Miriagou"
"5779","14/04 12:00","16","P1236","Paula EGUIZÁBAL","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Molecular characterisation of Staphylococcus aureus from persistent respiratory infections: high detection of CC398 isolates","P. Eguizábal|C. González-Azcona|I. Maranon-Clemente|C. Aspiroz|R. Cebollada-Sánchez|A. Bellés-Bellés|S. Mormeneo Bayo|C. Alonso|L. Fernández-Ciriza|C. Seral|J. Castillo|A. Lopez-Calleja|A. Rezusta|C. Torres|C. Lozano"
"5923","14/04 12:00","17","P1237","Leanne DAVIES","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","/em>Neisseria gonorrhoeae resistance rates in Cardiff Wales compared to those at a national level according to gonococcal resistance to antimicrobial susceptibility programme (GRASP)","L. Davies|M. Wootton"
"5952","14/04 12:00","18","P1238","Michinori SHIRANO","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Distribution of Mycoplasma pneumoniae macrolide-resistant strains in two regional hospitals in Japan","M. Shirano|Y. Fujikawa|R. Morita|R. Fukuoka|T. Asaoka|K. Iida|H. Nakagawa|K. Shiota|H. Okuno|K. Amou|Y. Kasamatsu|T. Goto"
"6049","14/04 12:00","19","P1239","Julinha THELEN","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Higher prevalence of blaOXA-244 in ESBL producing Escherichia coli isolates in the Netherlands: a prospective cohort study","J. Thelen|M. Kristensen|C. Man|L. De Bruine|J. Tjhie|B. Diederen|A. Van Arkel|J. Verweij|J. Murk|W. Van Den Bijllaardt|V. Weterings|J. Stohr"
"6113","14/04 12:00","20","P1240","Jemimmah MWANGI","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Epidemiology and prevalence of antimicrobial-resistant bacteria in wildlife in Africa","J. Mwangi|A. Moodley|D. Muloi"
"6159","14/04 12:00","21","P1241","Lynette PHEE","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","A five-year antimicrobial resistance trends in Gram-negative bacteraemia isolates","L. Phee|A. Sivaramakrishnan"
"6260","14/04 12:00","22","P1242","Julio SEMPERE","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Comparing the activity of oral cefditoren with other cephalosporins in Streptococcus pneumoniae clinical isolates non-susceptible to penicillin, 2019-2020","M. Llamosi|C. Perez-Garcia|E. J. Vidal|A. Úbeda|I. Pareja|E. Gomez-Rubio|P. Coronel|M. Domenech|J. Sempere|J. Yuste"
"6280","14/04 12:00","23","P1243","Shipra TOMAR","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Colistin resistance as an emergent threat among Uropathogenic Escherichia coli and Klebsiella pneumoniae from a rural community health centre, India","S. Tomar|I. Singh|A. Bhatt|V. Modgil|N. Taneja"
"6427","14/04 12:00","24","P1244","Zander NIEHAUS","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Associations of CRISPR-Cas systems with antibiotic resistance and virulence genes of clinical Enterococcus faecalis isolates in Gauteng, South Africa","Z. Niehaus|T. Hamiwe|T. Govender|L. Skosana|M. Kock|M. Ehlers"
"6495","14/04 12:00","25","P1245","Cemre ÖZKANCA","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","The impact of ceragenins on Streptococcus mitis clinical isolates","C. Özkanca|S. Dosler|C. Bozkurt Guzel|P. Savage"
"6584","14/04 12:00","26","P1246","Asma AMMAR","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Knowledge of medical residents towards antibiotic resistance and appropriate prescribing","O. Ezzi|A. Ammar|S. Zahaf|N. Omri|S. Chelly|M. Mahjoub"
"6603","14/04 12:00","27","P1247","Salma ABBES","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Study of antimicrobial susceptibility in Brucella spp. strains isolated at CHU Rabta, Tunisia","S. Abbes|M. Ben Halima|N. Guenanou|L. Jelleli|H. Battikh|M. Zribi"
"6809","14/04 12:00","28","P1248","Iana AMKE","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Genomic characterisation of community-level transmission dynamics of extended-spectrum E. coli in rural Burkina Faso","I. Amke|S. Van Puyvelde|E. Van Kleef|B. Cooper|S. Yougbare|H. Tinto|B. Ingelbeen|M. Van Der Sande|D. Valia|Z. Garba|A. Tiendrebeogo|P. Lompo"
"6916","14/04 12:00","29","P1249","Lamia KANZARI","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Whole-genome sequencing analysis of an ESBL producer Shigella sonnei causing an outbreak in Tunisia","L. Kanzari|S. Ferjani|Z. Hamzaoui|L. Jomni|A. Ferjani|A. Fakhfakh|S. Trabelsi|D. Itani|E. Foster-Nyarko|I. Boutiba Ben-Boubaker"
"6933","14/04 12:00","30","P1250","Matijs HOUBEN","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial resistance surveillance in Belgian ambulatory care: SARPRIC-UTI study focussing on uncomplicated urinary tract infections in 2024","M. Houben|A. Asteur|L. Catteau"
"6960","14/04 12:00","31","P1251","Kitty ZNIDAR","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Piperacillin/tazobactam susceptibility in AmpC beta-lactamase producing Enterobacterales","K. Znidar|N. Bozic|A. Gobec|I. Velimirovic"
"6963","14/04 12:00","32","P1252","Kitty ZNIDAR","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Antimicrobial susceptibility testing of Gardnerella spp. vaginal isolates from a tertiary care centre in Slovenia","K. Znidar|J. Germ|P. Maver Vodicar|A. Sterbenc"
"7201","14/04 12:00","33","P1253","Eduarda SILVEIRA","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Prevalence of multidrug-resistant CS31A-producing E. coli in neonatal calf diarrhea outbreaks in central France","C. Provost|H. Yanes|G. Mosnier|T. Lima|G. Jorge Da Silva|A. Pedro|M. Saavedra|E. Silveira"
"7253","14/04 12:00","34","P1254","Özgen KÖSEOGLU ESER","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","A multicentre study: emm typing, PFGE analysis, antimicrobial resistance and biofilm production in Streptococcus pyogenes","B. Kurumanastirli|Ö. Gurpinar Tosun|I. Dolapci|A. Tekeli|B. Sancak|S. Yagci|M. Yucel|U. Oral|Z. Çizmeci|R. Berkem|S. Aksaray|Ö. Köseoglu Eser"
"7279","14/04 12:00","35","P1255","Thu-Trang VU","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Multidrug-resistant Streptococcus pneumoniae in Vietnamese children: results from a household prevalence survey","T. Vu|H. Le|A. Nguyen|T. Nguyen|B. Vu|N. Do|D. Vu|N. Nguyen|T. Vu|T. Pham|A. Dang|H. Tran|H. Nguyen|H. Duong|V. Khuong|T. Lai|H. Vu|J. Nuil|M. Chambers|H. Doorn|T. Kesteman|S. Lewycka"
"7409","14/04 12:00","36","P1256","Yoleidys MARTINEZ-YSASIS","2","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Carbapenemase-producing Enterobacterales on the rise in community-onset infections","Y. Martinez-Ysasis|C. Soares|M. Gordo-Basté|S. Exposito|R. Altaba|D. De Miniac|M. Rubio|M. Puig|S. Herrera|J. Ruiz|F. Navarro|A. Rivera"
"7456","14/04 12:00","1","P1257","Mormeneo Bayo SARAY","3","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Molecular characterisation of livestock-associated methicillin-resistant Staphylococcus aureus causing bacteraemia","S. Mormeneo Bayo|A. Bellés-Bellés|C. Torres Manrique|E. Lopez Gonzalez|I. Prats Sánchez|M. Riesgo Magana|A. Bernez Sanchez|E. Sánchez Báscones|A. Castellano Verdasco|A. Blanquero Porras|M. Garcia Gonzalez"
"7472","14/04 12:00","2","P1258","Hugo CRUZ","3","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Prevalence and antimicrobial susceptibility of community-acquired urinary isolates of ESBL-producing Enterobacterales: a three-year retrospective study","H. Cruz|A. Diniz|L. Rebelo|M. Silva|V. Rosa|L. Marques Da Silva|J. Oliveira Neves|P. Freitas"
"7630","14/04 12:00","3","P1259","Kwok KIN ON","3","A","03a. Resistance surveillance & epidemiology: Community-acquired bacteria","High household co-carriage of extended-spectrum beta-lactamases in Hong Kong","K. Kin On|W. Wei|T. Tsoi|M. Ip"
"319","14/04 12:00","4","P1260","Fernando PASTERAN","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Exploring the role of KPC variants in cross-resistance to last-line antibiotics","S. Gomez|M. Sanz|U. Akhtar|V. Mezcord|J. Escalante|A. Corso|G. Rao|M. Tolmasky|D. Paterson|R. Bonomo|F. Pasteran|M. Ramirez|M. Hamza|G. Traglia|L. Maccari"
"326","14/04 12:00","5","P1261","Yu-Mi LEE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in incidence rates of microorganisms among patients with bloodstream infections at intensive care units in South Korea from 2011 to 2022: data from the Korean national healthcare-associated infections surveillance system (KONIS)","Y. Lee|K. Park|M. Lee"
"354","14/04 12:00","6","P1262","Yun WU","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activities of the essential antimicrobial agents including aztreonam/avibactam, eravacycline, colistin, and other comparators against carbapenem-resistant organisms with different carbapenemase genes: a multicentre study in China, 2021","Y. Wu|Y. Liu"
"436","14/04 12:00","7","P1263","Rafael SILVA ROSA","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","First identification of Enterobacterales co-producing mcr-10 and broad-spectrum β-lactamase genes in Brazil","J. Rueda Furlan|R. Silva Rosa|M. Santana Ramos|L. Rodrigues Dos Santos|E. Angelino Savazzi|E. Guedes Stehling"
"474","14/04 12:00","8","P1264","Tu-Hsuan CHANG","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Transmission dynamics of multidrug-resistant Klebsiella pneumoniae ST792 and novel ST7120 strains in the paediatric intensive care unit","H. Ting-Yun|C. Po-Yu|C. Chi-Chung|T. Hung-Jen|T. Wei-Chun|H. Hsiao-Lun|C. Yu-Chin|H. Chung-Han|C. Tu-Hsuan|K. Cheng-Yen|H. Ju-Hao"
"483","14/04 12:00","9","P1265","Kuenyoul PARK","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Genomic insights into Enterococcus faecium: resistance, virulence, and phylogenetic analysis","K. Park|K. Lee|H. Sung|M. Kim"
"522","14/04 12:00","10","P1266","Nagendra Babu DANAVATH","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Global epidemiology, trends, and clinical severity of hypervirulent Klebsiella pneumoniae infections","N. Danavath|S. Chaudhuri|V. Kalwaje Eshwara|M. Varma|V. Shanbhag"
"540","14/04 12:00","11","P1267","Otar CHOKOSHVILI","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence of healthcare-associated infections and antimicrobial use in ICU wards in Georgia: results of the first ECDC point prevalence survey in 25 hospitals","O. Chokoshvili|L. Janashvili|M. Baidauri|T. Bakradze|T. Gabrichidze|I. Khonelidze"
"857","14/04 12:00","12","P1268","Rami SOMMERSTEIN","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Surveillance of temporal trends and antimicrobial resistance in nosocomial respiratory pathogens, Switzerland, 2007 to 2022","C. Bischof|A. Kronenberg|R. Sommerstein"
"868","14/04 12:00","13","P1269","Sandra SANCHEZ-URTAZA","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates recovered in intensive care units in Paraguay","S. Sánchez-Urtaza|L. Alfonso|R. Arazo Del Pino|T. Burgwinkel|K. Xanthopoulou|P. Higgins|I. Alkorta|L. Gallego|R. González|A. Ocampo Sosa"
"5441","14/04 12:00",,"P1270","Beate SCHLOSSER",,,"03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Contact precautions vs horizontal strategies to limit the spread of third-generation cephalosporin resistant Gram-negative bacteria on intensive care units: results of a country-wide, multicentred, non-randomised, before-after studies on intensive care units","B. Schlosser|E. Lemke|F. Schwab|C. Geffers|S. Aghdassi|R. Leistner"
"948","14/04 12:00","15","P1271","Sae Am SONG","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Evaluation of the efficacy of novel beta-lactam/beta-lactamase inhibitors against carbapenem-resistant Enterobacterales","S. Song"
"1031","14/04 12:00","16","P1272","Sophida BOONSATHORN","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence of carbapenem-resistant Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii ????colonisation among hospitalised immunocompromised and critically ill paediatric patients","S. Boonsathorn|N. Pimtimanon|N. Apiwattanakul|S. Assawawirunhakarn"
"1063","14/04 12:00","17","P1273","Mariana CASTANHEIRA","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Increase in blaNDM-1 among carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex clinical isolates collected in 2023 from US and European medical centres","J. Kimbrough|M. Karr|T. Doyle|M. Castanheira"
"1077","14/04 12:00","18","P1274","Anastasios VOGIATZAKIS","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against clinical isolates of KPC-producing Klebsiella pneumoniae from a Greek hospital","A. Vogiatzakis|S. Smilakou|A. Pantazatou|A. Rigatou|D. Tsakri|O. Voulgari|I. Deliolanis"
"1191","14/04 12:00","19","P1275","Peiyi Vicki CHOW","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Evaluating chlorhexidine antimicrobial susceptibility of S. aureus and methicillin-resistant S. aureus blood culture isolates following implementation of CHG-bathing","P. Chow|L. Eng|J. Li|T. Tan"
"1200","14/04 12:00","20","P1276","Renata DA COSTA","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular characterisation and epidemiology of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa (CRE/CRPA) among hospitalised patients in five public hospitals from South Africa","R. Augusto Da Costa|F. Patel|S. Africa|E. Du Toit|R. Marais|E. Geza|L. Mnqokoyi|J. Wadula|A. Whitelaw|K. Han Swe|E. Correia|F. Franceschi|A. Brink"
"1204","14/04 12:00","21","P1277","Laura LOPEZ GONZALEZ","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Microbiological and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae in urine cultures during the year 2024 at a tertiary hospital","A. Vera Mendoza|L. Lopez-Gonzalez|A. Delgado-Iribarren|A. Arribi Vilela|F. Candel González"
"1223","14/04 12:00","22","P1278","Tsolaire SOURENIAN","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Outbreak investigation of extensively drug-resistant Acinetobacter baumannii of ST2 in the intensive care unit of a Lebanese hospital","T. Sourenian|M. Finianos|J. Hrabak|A. Medlij|B. Ibrahim"
"1224","14/04 12:00","23","P1279","Balaji VEERARAGHAVAN","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular characterisation and epidemiology of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa (CRE/CRPA) among hospitalised patients in five public/private hospitals from India","R. Augusto Da Costa|Y. Devi Bakthavatchalam|C. Mukhopadhyay|S. Bhattacharya|C. Rodrigues|S. Basu|N. Taneja|A. Angrup|R. Derajavan|F. Franceschi|B. Veeraraghavan"
"1280","14/04 12:00","24","P1280","Mia AARRIS","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","RpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis","M. Aarris|S. Edslev|K. Nielsen|F. Hertz|T. Johannesen|C. Kolenda|F. Laurent|E. Mansson|B. Söderquist|M. Stegger"
"1331","14/04 12:00","25","P1281","Amrita PONDIT","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Linking carbapenem-resistant E. coli in hospital-admitted patients and the environment in Bangladesh: An emerging public health threat.","R. Farzana|S. Rahman|S. Saha|S. Islam|J. Parkhill|M. Azad|S. Nasreen|T. Walsh|A. Pondit"
"1337","14/04 12:00","26","P1282","Paul TURNER","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Carbapenem resistance enterobacteriaceae (CRE) at university college hospital, Ibadan, Nigeria","J. Erakhaiwu|B. Ogunbosi|O. Adekanmbi|I. Adebiyi|J. Asika|B. Ajakaiye|A. Oduola|R. Oladokun|O. Omolawal|K. Ojifinni|O. Tongo|I. Ude|A. Kehinde|J. Hopkins|H. Van Doorn|P. Turner|I. Okeke"
"1470","14/04 12:00","27","P1283","Mark WISE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa isolates from geriatric patients with respiratory tract infections in the Asia/Pacific region: SMART, 2019-2023","M. Wise|W. Chen|F. Siddiqui|K. Young|M. Motyl|D. Sahm"
"1474","14/04 12:00","28","P1284","Mark WISE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of ceftolozane/tazobactam, imipenem/relebactam and comparators against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Kuwait, Oman, Qatar, and United Arab Emirates: SMART 2018-2023","M. Wise|I. Pittex|I. Alekseeva|F. Siddiqui|K. Young|M. Motyl|D. Sahm|S. Hawser"
"1481","14/04 12:00","29","P1285","Mark WISE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of ceftolozane/tazobactam and comparators against phenotypic ESBL-producing, carbapenemase-negative clinical Enterobacterales isolates from South Africa: SMART 2018-2023","M. Wise|I. Pittex|I. Alekseeva|F. Siddiqui|K. Young|M. Motyl|S. Hawser|D. Sahm"
"1489","14/04 12:00","30","P1286","Mark WISE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of ceftolozane/tazobactam, imipenem/relebactam and comparators against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Southeastern Europe: SMART 2018-2023","M. Wise|I. Pittex|I. Alekseeva|F. Siddiqui|K. Young|M. Motyl|S. Hawser|D. Sahm"
"1493","14/04 12:00","31","P1287","Uzair Akbar ALI","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","A systematic review of prevalence and epidemiological characteristics of carbapanemease-producing Enterobacterales (CPE) in the United Kingdom","U. Ali|T. Saluja"
"1495","14/04 12:00","32","P1288","Mark WISE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of imipenem/relebactam and comparators against clinical Gram-negative isolates collected in the Latin American region: SMART 2021-2023","M. Wise|T. Polis|F. Siddiqui|K. Young|M. Motyl|D. Sahm"
"1553","14/04 12:00","33","P1289","Inara KAMPENUSA","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Precision analysis of the carbapenemase- and/or ESBL-producing Acinetobacter baumannii clinical isolates by national microbiology reference laboratory in Latvia","I. Kampenusa|B. Niedre-Otomere|J. Bodrenko|R. Vangravs|K. Liepina|K. Lozovska|B. Vilima|D. Zemite|M. Dolgusevs|D. Rudzite|G. Skenders|O. Savicka|Z. Sirmaca|E. Lavrinovica"
"1625","14/04 12:00","34","P1290","Nadjat AGGOUNE KHINACHE","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence of Klebsiella pneumoniae ST-11 expressing KPC-2 and NDM-5 carbapenemases in an Algerian university hospital","N. Aggoune|F. Assaous|F. Djedjig|N. Zourdani|S. Akbi|D. Bensersa|S. Mahrane|H. Tali-Maamar|A. Zerouki"
"1707","14/04 12:00","35","P1291","Salma SALEM","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The clonal diversity of extensively resistant Acinetobacter baumannii isolated in Egyptian clinical settings","S. Salem|D. Osama|N. Abdelsalam|M. Elhadidy|S. Mouftah"
"1787","14/04 12:00","36","P1292","Gabriela Alejandra BAEZ BARROSO","3","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of the novel beta-lactam/beta-lactamase inhibitor combination cefepime/enmetazobactam against Acinetobacter spp.","G. Báez-Barroso|A. Rodriguez-Coello|M. Outeda-Garcia|P. Guijarro-Sánchez|A. Garcia-Pose|I. Alonso-Garcia|S. Rodriguez-Pallares|L. González-Pinto|J. Vázquez-Ucha|J. Arca-Suárez|G. Bou|A. Beceiro"
"1834","14/04 12:00","1","P1293","Laura MATASEJE","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The landscape of carbapenemases in Canada 2019-2023, data from the Canadian nosocomial infection surveillance programme (CNISP)","L. Mataseje|E. Mcgill|K. Fakharuddin|J. Cayen|L. Yves"
"1900","14/04 12:00","2","P1294","Meredith HACKEL","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Cefepime/taniborbactam exhibits limited cross-resistance with ceftazidime/avibactam and ceftolozane/tazobactam against carbapenem-nonsusceptible Enterobacterales and multidrug-resistant Pseudomonas aeruginosa from Europe 2018-2023","M. Hackel|M. Wise|G. Moeck|D. Sahm"
"1903","14/04 12:00","3","P1295","Mark WISE","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of cefepime/taniborbactam and comparators against Enterobacterales and P. aeruginosa collected in Europe (2018-2023) stratified by beta-lactamase carriage","M. Wise|M. Hackel|D. Sahm"
"2060","14/04 12:00","4","P1296","Maria De Las Huertas GARCIA ATIENZA","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence and persistent spread of NDM-carrying Klebsiella pneumoniae high-risk clones in a tertiary hospital in Tenerife","N. Hernando Parreno|C. Mateo Leon|D. Garcia Martinez De Artola|E. Canton-Benito|M. Garcia Atienza|E. Pérez Roth|J. Alcoba Florez"
"2075","14/04 12:00","5","P1297","Esther WOHLFARTH","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Resistance to antimicrobial agents in Escherichia coli and Klebsiella pneumoniae from hospitalised patients: results of the PEG surveillance study, 1984-2022/23","E. Wohlfarth|M. Kresken|Y. Pfeifer|G. Werner|F. Layer-Nicolaou|J. Bender|H. Seifert|P. Higgins|S. Gatermann|N. Pfennigwerth|K. Becker|T. Wichelhaus"
"2089","14/04 12:00","6","P1298","Kemar BARRETT","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Multidrug-resistant Pseudomonas aeruginosa: Mayo Clinic ten-year experience","K. Barrett|P. Crowley|P. Mira|O. Abu Saleh"
"2200","14/04 12:00","9","P1301","Katerina CHUDEJOVA","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Fosfomycin resistance in Enterobacterales: a one-year surveillance in northern Italy","K. Chudejova|V. Mattioni Marchetti|M. Caltagirone|A. Rezzani|A. Navarra|I. Bitar"
"2352","14/04 12:00","10","P1302","Sayaka YAMAGUCHI","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and mechanisms of drug-resistant Acinetobacter baumannii isolated from hospitals in Japan: emergence of colistin resistance","S. Yamaguchi|R. Nakano|A. Nakano|Y. Suzuki|G. Kamoshida|K. Yamaguchi|R. Sakata|M. Ogawa|H. Yano"
"2413","14/04 12:00","11","P1303","Samar AKBI","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Colistin resistance among multidrug-resistant Enterobacterales in an Algerian hospital: preliminary findings","N. Aggoune|A. Zerouki|S. Akbi"
"2463","14/04 12:00","12","P1304","Nimitha K MOHAN","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Real world in vitro synergy to doxycycline, ceftriaxone/sulbactam/edetate, and chloramphenicol in ceftazidime/avibactam-resistant, aztreonam synergy-negative isolates from a tertiary referral centre in southern India","N. Mohan|R. Babu|S. Sathar|A. Warrier|S. Johney|A. Sekhar|S. Mary"
"2486","14/04 12:00","13","P1305","Jan TKADLEC","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology of methicillin-resistant Staphylococcus aureus in central, eastern, and south-eastern Europe: systematic review","J. Tkadlec|M. David"
"2487","14/04 12:00","14","P1306","Jan TKADLEC","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology of methicillin susceptible Staphylococcus aureus in the Czech Republic: prospective multicentre study","J. Tkadlec|E. Nycova|A. Rozsypalkova|I. Vitkova|D. Fackova|K. Neradova|A. Siváková|D. Riedlova|K. Fiserova|N. Bartonikova|J. Drozenova|J. Amlerova|M. Balejová|L. Dvorakova|M. Mednansky|J. Tkadlec|O. Melter|P. Drevinek"
"2503","14/04 12:00","15","P1307","Akshata Sushant MANE","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of aztreonam/avibactam and comparator agents against metallo-beta-lactamase (MBL)-positive carbapenem-resistant E. coli and Klebsiella spp.collected from patients with bloodstream infections (BSI) as part of the ATLAS surveillance programme (2020-2022), India","A. Routray|A. Mane"
"2535","14/04 12:00","16","P1308","Diana Isabela STRACHINARU","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial resistance in bacterial isolates from nine Ukrainian war casualties: a retrospective bicentric observational study","Y. Van Der Beken|F. T'sas|M. Beynsberger|T. Rose|P. François|D. Costescu Strachinaru|A. Stoefs|A. Verroken|P. Vanbrabant|P. Soentjens|H. Rodriguez-Villalobos|S. Schulz-Drost|L. Briedigkeit|N. Pfennigwerth|F. Lestin-Bernstein"
"2544","14/04 12:00","17","P1309","Magda METREVELI","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Multidrug-resistant organisms amidst ongoing conflict in Ukraine: surveillance and resistance patterns","M. Metreveli|T. Chumachenko|M. Railian|T. Aptsiauri|A. Sapre|M. Martin|P. Mc Gann|N. Trapaidze|T. Musich"
"2552","14/04 12:00","18","P1310","Sean NGUYEN","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Cefiderocol activity against resistant bacteria from patients with ventilator associated pneumonia from European and US hospitals","S. Nguyen|B. Dejonge|J. Bryowsky|J. Maher|R. Mendes|C. Longshaw|H. Yamashiro|Y. Yamano"
"2558","14/04 12:00","19","P1311","Nino TRAPAIDZE","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Analysis of multidrug-resistant organisms from Poland and Estonia","M. Metreveli|A. Olczak-Pienkowska|A. Guzek|A. Bachta|K. Warda|P. Mitt|K. Kermes|T. Aptsiauri|A. Sapre|M. Martin|P. Mc Gann|N. Trapaidze|T. Musich"
"2632","14/04 12:00","20","P1312","Christopher LONGSHAW","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of cefiderocol against clinical isolates of Acinetobacter baumannii complex collected from five European countries as part of SENTRY antimicrobial surveillance programme, 2020-2023","C. Longshaw|J. Maher|R. Mendes|H. Yamashiro|Y. Yamano"
"2638","14/04 12:00","21","P1313","Christopher LONGSHAW","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of cefiderocol against clinical isolates of Stenotrophomonas maltophilia collected from five European countries as part of the SENTRY antimicrobial surveillance programme 2020-2023","C. Longshaw|J. Maher|R. Mendes|H. Yamashiro|Y. Yamano"
"2641","14/04 12:00","22","P1314","Rodrigo E. MENDES","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of omadacycline against multidrug-resistant and molecularly characterised Acinetobacter baumannii-calcoaceticus complex clinical isolates from United States hospitals, 2020-2023","R. Mendes|M. Huband|D. Beekman|A. Scullin|M. Winkler|M. Castanheira"
"2643","14/04 12:00","23","P1315","Aubrey POWELL","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Epidemiology of multi-drug resistant bacteria among foreign combatants wounded in Ukraine","A. Powell|H. Dao|T. Luo|M. Martin|V. Kovalchuk|V. Kondratiuk|I. Kovalenko|B. Plaza|J. Kettlewell|C. Anderson|J. Smedberg|A. Ong|R. Maybank|Y. Kwak|J. Hawley-Molloy|F. Lebreton|P. Mc Gann|J. Bennett"
"2666","14/04 12:00","24","P1316","Mariano Paulo ECHEGORRY","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of mecillinam against multi-drug resistant Enterobacterales","M. Soto|M. Cima Clave|C. Lucero|P. Ceriana|M. Rapoport|A. Menocal|E. Albornoz|M. Echegorry|L. Gonzalez|A. Vila|A. Corso|F. Pasteran"
"2670","14/04 12:00","25","P1317","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of aztreonam/avibactam against ceftazidime/avibactam-resistant Enterobacterales isolates collected as a part of the ATLAS global surveillance Sstudy, 2019-2023","M. Estabrook|H. Li|G. Stone|K. Perez|D. Sahm"
"2688","14/04 12:00","26","P1318","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global urveillance study in Latin America, 2019-2023","M. Estabrook|J. Dickson|G. Stone|K. Perez|D. Sahm"
"2694","14/04 12:00","27","P1319","Erika ASPERGES","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and risk factors for multi-drug resistant Enterobacterales in long-term care facilities","E. Asperges|E. Pagani|P. Cambieri|M. Corbella|E. Bono|F. Puci|L. Marvulli|M. Maggi|F. Cavallini|A. Fortunato|Y. Sudiero|P. Sacchi|A. Paiano|R. Bruno|D. Galaschi|G. Filice|V. Zambianchi|C. Battegazzorre|I. Morelli|V. Martellosio|D. Gasperi|A. Stomeo|S. Romeo|C. Riggi|F. Cantoni|S. Aureli|M. Morelli"
"2714","14/04 12:00","28","P1320","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Middle East/Africa, 2019-2023","M. Estabrook|J. Dickson|G. Stone|K. Perez|D. Sahm"
"2731","14/04 12:00","29","P1321","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Asia/Pacific, 2019-2023","M. Estabrook|J. Dickson|G. Stone|K. Perez|D. Sahm"
"2740","14/04 12:00","30","P1322","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Europe, 2019-2023","D. Sahm|M. Estabrook|J. Dickson|G. Stone|K. Perez"
"2776","14/04 12:00","31","P1323","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of aztreonam/avibactam against Enterobacterales isolates collected from patients in intensive care units and other wards, by global region ATLAS surveillance study, 2019-20","M. Estabrook|H. Li|G. Stone|K. Perez|D. Sahm"
"2782","14/04 12:00","32","P1324","Mark WISE","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Susceptibility of Enterobacterales collected globally to aztreonam/avibactam and comparator agents stratified by infection source: ATLAS surveillance programme 2019-2023","M. Wise|G. Stone|K. Perez|D. Sahm"
"2783","14/04 12:00","33","P1325","Umang AGRAWAL","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","High prevalence of NDM-production and its adverse impact on in-vitro susceptibility of newer antibiotics against Indian Pseudomonas aeruginosa isolates","U. Agrawal|S. Basu|P. Kambli|A. Shetty|C. Rodrigues"
"2793","14/04 12:00","34","P1326","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of aztreon/amavibactam against carbapenem-resistant Enterobacterales isolates by region collected as a part of the ATLAS global surveillance study, 2019-2023","M. Estabrook|H. Li|G. Stone|K. Perez|D. Sahm"
"2816","14/04 12:00","35","P1327","Mark ESTABROOK","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of ceftazidime/4avibactam and beta-lactamase carriage among Pseudomonas aeruginosa isolates collected as a part of the ATLAS global surveillance study in 2019-2023","M. Estabrook|H. Li|G. Stone|K. Perez|D. Sahm"
"2823","14/04 12:00","36","P1328","Meredith HACKEL","4","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of ceftazidime/avibactam (CAZ-AVI) and comparators against Pseudomonas aeruginosa collected worldwide stratified by ICU vs non-ICU, ATLAS global surveillance programme, 2019-2023","M. Hackel|G. Stone|K. Perez|D. Sahm"
"2829","14/04 12:00","1","P1329","Laure-Line JOUBERT","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence of resistance and consumption of cefazolin vs anti-Staphylococcal penicillins: an exploratory cross-sectional study in French healthcare facilities","L. Joubert|E. Jeanbert|L. Dugravot|L. Simon|A. Jouzeau|M. Simon|B. Lefèvre"
"2836","14/04 12:00","2","P1330","Mark ESTABROOK","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in the in vitro activity of ceftazidime/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Europe, by subregion 2019-2023","M. Estabrook|H. Li|G. Stone|K. Perez|D. Sahm"
"2843","14/04 12:00","3","P1331","Meredith HACKEL","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of ceftazidime/avibactam against Enterobacterales stratified by global region and year of collection, ATLAS global surveillance programme, 2018-2023","M. Hackel|G. Stone|K. Perez|D. Sahm"
"2858","14/04 12:00","4","P1332","Fabrizzio Nicolás MORANDINI","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Phylogenetic and population structure analyses reveal intra-clonal diversification and emergence of successful clades of carbapenemase-producing Klebsiella pneumoniae ST258 from Argentina","F. Morandini|F. Lipari|S. Ruiz|G. Irrazabal|A. Saka"
"3041","14/04 12:00","5","P1333","Timothy BARKHAM","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Proportion of Staphylococcus aureus with a vancomycin MIC of 1 mg/L increases from 12% in 2013 to 70% in 2020, during COVID-19 restrictions in Singapore","Y. Jiang|Y. Chen|T. Barkham"
"3057","14/04 12:00","6","P1334","Qingye XU","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of sulbactam/durlobactam against clinical Acinetobacter baumannii isolates in China","Q. Xu|Y. Yu"
"3075","14/04 12:00","7","P1335","Juliana CAIERÃO","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro evaluation of the efficacy of aztreonam/avibactam and aztreonam plus ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa: revisiting the role of ceftazidime","G. Collar|N. Moreira|P. Barth|A. Barth|J. Caierao"
"3116","14/04 12:00","8","P1336","Xiao TINGTING","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated in intensive care unit","T. Xiao|Y. Xiao"
"3120","14/04 12:00","9","P1337","Sophie Louise MÖLLER","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial activity of aztreonam-avibactam against carbapenemase-producing Pseudomonas aeruginosa from German hospitals","S. Möller|T. Becker|N. Pfennigwerth|S. Gatermann"
"3135","14/04 12:00","10","P1338","Syrine Nouara BOUCHERABINE","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Genomic insights into methicillin resistant Staphylococcus aureus population structure, dissemination and diversity in the United Arab Emirates using whole-genome sequencing","S. Boucherabine|B. Aloba|M. Segnhore|R. Nassar|D. Moradigaravand|S. Monecke|R. Ehricht|D. Everett|A. Senok"
"3175","14/04 12:00","11","P1339","Jill HOPKINS","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","ACORN2: prospective clinically oriented antimicrobial resistance surveillance data from 19 hospitals across Africa and Asia","J. Hopkins|J. Opintan|R. Hamers|S. Akech|N. Feasey|E. Ashley|A. Karkey|I. Okeke|C. Painter|Y. Lubell|N. Waithira|S. Lee|T. Roberts|C. Ling|H. Van Doorn|P. Turner"
"3197","14/04 12:00","12","P1340","Marjan MOTAMEDI","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro antimicrobial susceptibility testing of cefiderocol against Gram-negative bacteria isolated from cystic fibrosis patients","B. Willinger|M. Motamedi|K. Spettel|S. Frank|M. Loy"
"3236","14/04 12:00","13","P1341","Valentina DIMARTINO","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Surveillance of Acinetobacter baumannii by clustering analysis with sequence type characterisation","C. Rotondo|V. Dimartino|B. Riccitelli|O. Butera|S. D'Arezzo|M. Selleri|C. Venditti|C. Fontana|A. Rossi"
"3475","14/04 12:00","14","P1342","Yüsra AGAOGLU","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Evaluating cefiderocol susceptibility in carbapenem-resistant Klebsiella pneumoniae: a comparative analysis of CLSI and EUCAST guidelines","Y. Agaoglu|S. Heydarova|A. Benli|S. Basaran|A. Cagatay|S. Simsek Yavuz|O. Oncul|H. Ozsut"
"3476","14/04 12:00","15","P1343","Mohamed SAID","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Characterisation of colistin resistant Enterobacterales isolated from clinical specimens from public hospitals in Gauteng, South Africa","S. Simons|M. Ehlers|T. Hamiwe|M. Said"
"3481","14/04 12:00","16","P1344","Ivana MAREKOVIC","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial susceptibility and virulence profiles of invasive and non-invasive vancomycin-resistant Enterococci at the university hospital centre Zagreb: preliminary results","M. Markanovic|I. Juric|A. Maravic|Z. Bosnjak|T. Kulis|I. Marekovic"
"3485","14/04 12:00","17","P1345","Daniel PAN","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The prevalence and prognostic value of antimicrobial resistance within nosocomial settings: a global systematic review and meta-analysis of over 20,000 patients","N. George|D. Pan|L. Silva|R. Baggaley|P. Irizar|P. Divall|A. Al-Oraibi|D. Khan|C. Martin|J. Nazareth|I. Collins|S. Chew|D. Jenkins|L. Nellums|M. Pareek"
"3510","14/04 12:00","19","P1347","Murat TELLI","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Temporal changes in carbapenem resistance genes in Klebsiella pneumoniae: a 12-year study from a university hospital in Turkey","M. Telli|A. Çoban Acar"
"3537","14/04 12:00","20","P1348","Boudewijn DEJONGE","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of cefiderocol against metallo-beta-lactamase-carrying Enterobacterales, stratified by allele, collected as part of the SENTRY antimicrobial surveillance programme","B. Dejonge|S. Nguyen|J. Bryowsky|C. Longshaw|J. Maher|R. Mendes|H. Yamashiro|Y. Yamano"
"3581","14/04 12:00","21","P1349","Rodrigo E. MENDES","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa, including molecularly characterised clinical isolates, causing infections in hospitals in European and adjacent regions, 2020-2023","R. Mendes|D. Beekman|J. Maher|A. Scullin|H. Sader|M. Castanheira"
"3588","14/04 12:00","22","P1350","Jason J. BRYOWSKY","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The activity of cefiderocol against Enterobacterale carrying multiple carbapenemases, collected as part of the SENTRY antimicrobial surveillance programme","J. Bryowsky|S. Nguyen|B. Dejonge|C. Longshaw|J. Maher|R. Mendes|H. Yamashiro|Y. Yamano"
"3599","14/04 12:00","23","P1351","Rodrigo E. MENDES","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex, including molecularly characterised clinical isolates, causing infections in hospitals in European and adjacent regions, 2020-2023","R. Mendes|J. Kimbrough|D. Beekman|J. Maher|H. Sader|M. Castanheira"
"3673","14/04 12:00","25","P1353","Samar BOSWIHI","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Tracking of trimethoprim resistance determinants in MRSA: a genetic analysis of hospital isolates in Kuwait","S. Boswihi|A. Almaraghi|A. Alenezi|H. Abdulrahman|E. Alsafi|E. Udo"
"3697","14/04 12:00","26","P1354","Egan MULONDO","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Association of integron diversity with reduced biocide susceptibility of multidrug-resistant Pseudomonas aeruginosa isolates from public hospitals in Gauteng, South Africa","T. Hamiwe|E. Mulondo|T. Govender|A. Bosch|M. Kock|M. Ehlers"
"3748","14/04 12:00","27","P1355","Jussimara MONTEIRO NURMBERGER","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Frequency and antimicrobial resistance pattern of microorganisms isolated from cerebrospinal fluid samples in Brazilian public hospitals","J. Monteiro Nurmberger|F. Matsiko Inoue|S. Macedo Vieira|A. Lobo|D. Ribeiro Ramadan|S. Tufik"
"3808","14/04 12:00","28","P1356","Imke WIETERS","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Automated surveillance of bloodstream infections in Germany: a proof-of-concept study and first results","I. Wieters|C. Bothe|N. Willrich|M. Schneider|A. Von Laer|I. Noll|B. Schweickert|K. Gröschner|M. Feig|M. Abu Sin|M. Abu Sin|T. Eckmanns|A. Hoffmann"
"3830","14/04 12:00","29","P1357","Tania BLANCO MARTÍN","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The highly resistant NDM-14-producing K. pneumoniae ST147 clone reaching the Canary Islands, Spain, 2023","C. Mateo Leon|P. Aja-Macaya|T. Blanco-Martin|C. Del Rosario-Quintana|C. Pina Delgado|E. De La Cruz-Tabares|S. Rodriguez-Pallares|L. González-Pinto|L. Sanchez-Pena|A. Beceiro|M. Oviano|D. Garcia Martinez De Artola|G. Bou|J. Arca-Suárez"
"3860","14/04 12:00","30","P1358","Wejdene MANSOUR","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Colistin and carbapenem-resistant Klebsiella pneumoniae isolates from Tunisia: a decade of rising resistance, 2012-2023","N. Jaidane|W. Mansour|Y. Ben Lamine|S. Azaiez|S. Oueslati|A. Berriri|H. Trabelsi|W. Naija|M. Haenni|R. Bonin|L. Tilouche|T. Naas"
"3882","14/04 12:00","31","P1359","Eduardo PÉREZ ROTH","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Retrospective detection of mcr-9-carrying Enterobacter cloacae cpx. clinical isolates in a tertiary hospital in Tenerife","H. Gil Campesino|D. Garcia Martinez De Artola|C. Mateo Leon|E. Pérez Roth|G. Lopez Cruz"
"3914","14/04 12:00","32","P1360","Damien KELLY","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Tracking resistance in anaerobic bacteria (2016-2024) from an Irish hospital's perspective","D. Kelly|J. Donnelly|M. Perry|T. Morris|S. Copsey-Mawer|H. Mc Dermott"
"3962","14/04 12:00","33","P1361","Rocco MORENA","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Risk factors for development of hospital-acquired pneumonia in colonised patients by carbapenem-resistant Acinetobacter baumannii and the role of multisite colonisation: a multicentre clinical experience","R. Morena|F. Serapide|F. Alessandri|S. Gulli|A. Bruni|E. Garofalo|A. Quirino|N. Marascio|G. Matera|G. D'ettorre|F. Pugliese|C. Mastroianni|E. Trecarichi|G. Ceccarelli|A. Russo"
"3967","14/04 12:00","34","P1362","Maitane ARANZAMENDI ZALDUMBIDE","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Retrospective analysis of 22 years of surveillance of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary hospital in northern Spain","M. Aranzamendi|S. Sánchez-Urtaza|R. Arazo Del Pino|M. Pérez-Vázquez|J. Oteo-Iglesias|J. Marimon|K. Xanthopoulou|M. Sota|H. Seifert|P. G. Higgins|L. Gallego"
"3969","14/04 12:00","35","P1363","Fernando DEL NOGAL","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Comparative effectiveness of cefiderocol and ceftazidime/avibactam plus aztreonam against metallo-beta-lactamase-producing Gram-negative isolates","F. Del Nogal|B. González-Blanco|R. Recio|P. Branas|I. Munoz-Gallego|M. Meléndez|J. Carrion|M. Sanz Ramos|E. Viedma|J. Villa"
"3970","14/04 12:00","36","P1364","Carlos SAÚCO CARBALLO","5","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and genetic context of the blaOXA-1 gene in bloodstream isolates of Escherichia coli","C. Saúco-Carballo|M. R Pulido|A. Velázquez- Escudero|L. Lopez-Cerero|J. Rodriguez-Martinez|Á. Pascual|J. Rodriguez Bano|F. Docobo-Pérez"
"4088","14/04 12:00","1","P1365","Christina LOUKA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Is the glass half empty? High resistance rates amongst carbapenem-resistant bacteria in a cefiderocol-naive setting","C. Louka|A. Rovatsou|I. Daniil|O. Kappatos|N. Rekleiti|V. Papadouli|V. Mamali|O. Zarkotou"
"4267","14/04 12:00","2","P1366","Zhayne HACKETT","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","High genetic relatedness between historical and contemporary multidrug resistant bacteria associated with Ukraine","T. Luo|V. Kondratiuk|V. Kovalchuk|N. Pfennigwerth|B. Jones|N. Fomina|F. Fuchs|J. Hans|J. Eisfeld|A. Ong|S. Gatermann|J. Bennett|F. Lebreton|P. Mc Gann|Z. Hackett"
"4297","14/04 12:00","3","P1367","Maria SÁNCHEZ CUETO","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence and spread of transferable linezolid resistance among Enterococcus faecium in a tertiary hospital in Spain","M. Sánchez-Cueto|D. Rodriguez-Temporal|J. Serrano-Lobo|D. Gomez-Costas|M. Marin|B. Rodriguez-Sanchez|P. Munoz|E. Cercenado"
"4327","14/04 12:00","4","P1368","Phillip COX","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae bloodstream and pneumonia isolates","P. Cox|J. Teo|D. Fouts|T. Clarke|F. Ruffin|V. Fowler|J. Thaden|A. Kwa"
"4399","14/04 12:00","5","P1369","Ying ZHU","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and mechanism of colistin heteroresistance in Klebsiella pneumoniae in China","Y. Zhu|X. Jia|X. Chu|X. Liu|W. Yu|P. Jia|Y. Xu|Q. Yang"
"4514","14/04 12:00","6","P1370","Alicia GALAR","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Evolution of incidence, risk factors and management of carbapenemase-producing Enterobacterales in a tertiary hospital over the last ten years","A. Galar|T. Vicente|P. Garcia-Clemente|E. Cercenado|A. Alvarez-Uria|L. Martin-Aguilera|E. Bouza|P. Munoz|M. Marin"
"4581","14/04 12:00","7","P1371","Po-Ren HSUEH","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Geographic variations in distributions of carbapenemase-encoding genes, susceptibilities, and minimum inhibitory concentrations of inpatient meropenem-resistant Enterobacterales to ceftazidime/avibactam, meropenem/vaborbactam, and aztreonam/avibactam across four global regions: 2020-2022 data from the antimicrobial testing leadership and surveillance","P. Hsueh|S. Jean"
"4590","14/04 12:00","8","P1372","I Made Bayu ANGGRIAWAN","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and risk factors of fluoroquinolone resistance in Gram-negative bacterial infections: a systematic review and meta-analysis","B. Anggriawan|I. Rochmawati"
"4740","14/04 12:00","9","P1373","Satoshi NISHIDA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Phylogenomic analysis of IMP-producing Acinetobacter colistiniresistens revealed a predominant lineage in the regional spread","S. Nishida|Y. Ono|Y. Yoshino"
"4786","14/04 12:00","10","P1374","Regina RUSSANOVA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence of a novel sequence type carbapenem-resistant Klebsiella pneumoniae ST7462 in a healthcare-associated outbreak in Estonia","R. Russanova|L. Lilje|K. Helde|T. Riit|K. Tonsau|J. Ovtsinnikova|D. Jefimova|M. Leevik|L. Dotsenko|T. Reisberg|M. Altmets|S. Laks|J. Burkovskaja|N. Metelskaja|J. Pullat"
"4830","14/04 12:00","11","P1375","Diego ERDMENGER","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Cephalosporin use and the rise of multidrug-resistant infections: evidence from Guatemala","K. Algaba|D. Erdmenger|L. Rodriguez|C. Arango|S. Aguilar"
"4897","14/04 12:00","12","P1376","Malgorzata GRZEGORCZYK","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","VanA Enterococcus faecalis isolated from blood in Poland between 2022-2024","E. Sztangierska|M. Grzegorczyk|M. Herda|K. Malinowska|W. Wygoda|A. Polak|K. Belkiewicz|D. Fabisiak|E. Literacka|D. Zabicka"
"4912","14/04 12:00","13","P1377","Tzu-Wen HUANG","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae in Taiwan, 2014-2020","T. Huang|W. Huang|P. Chen|Y. Shiau|H. Wang|J. Lai|I. Huang|T. Lauderdale|S. Kuo"
"4921","14/04 12:00","14","P1378","Cong SHEN","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence and outbreak of ST80 vancomycin-resistant Enterococcus faecium in Guangdong province, China from 2021 to 2023","C. Shen|C. Chen|X. Zhang|B. Yang|Y. Zhang|L. Zhang|Y. Xiao"
"4952","14/04 12:00","15","P1379","Agnes Maria SONNEVEND","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence and spread of OXA-48-like carbapenemase-producing Escherichia coliin Baranya County, Hungary","F. Mohamed|A. Nyul|E. Urbán|P. Urbán|A. Gyenesei|T. Pál|Á. Sonnevend"
"4957","14/04 12:00","16","P1380","Jocelyn TEO","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro susceptibility of cefiderocol against carbapenem-resistant Gram-negative bacilli (CRGNB) from Singapore","J. Teo|S. Tan|H. Chang|Y. Tan|A. Kwa"
"4970","14/04 12:00","17","P1381","Esther WOHLFARTH","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Synergistic and additive effects of fosfomycin in MBL-producing Klebsiella pneumoniae and Pseudomonas aeruginosa isolates","E. Wohlfarth|M. Bernardo|A. Dinh|G. Vrioni|D. Zabicka|C. Tascini"
"5032","14/04 12:00","18","P1382","Jörg B. HANS","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The integrated genomic surveillance reveals extensive clustering among increasing rates of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Germany","J. Hans|J. Eisfeld|S. Wolf|N. Pfennigwerth|M. Sandfort|F. Reichert|M. Driller|T. Houwaart|M. Fischer|T. Eckmanns|G. Werner|T. Semmler|S. Haller|S. Gatermann"
"5064","14/04 12:00","19","P1383","Janko SATTLER","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular characterisation of OXA-48-like-producing Enterobacterales in Germany: insights from the DIOGENES study","J. Sattler|B. Bader|J. Muller|S. Peter|A. Hamprecht|A. Wendel"
"5162","14/04 12:00","20","P1384","Tim ERLER","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial resistance and genetic insights into clinical pathogens from a Kyiv polyclinic","B. Xavier|J. Rossen|O. Moshynets|N. Mutters|T. Erler|K. Rudnieva|M. Savin|A. Anselm|J. Hammerl|A. Ströhlein|V. Potochilova|O. Iungin|C. Papan|A. Bari"
"5294","14/04 12:00","21","P1385","Nida FATIMA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Assessment of in vitro synergy of colistin combined with meropenem, minocycline and Tigecycline in clinical isolates of carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli","N. Fatima|A. Pathak|C. Sahu"
"5324","14/04 12:00","22","P1386","Coraline BERNACHOT","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Admission incidence rate and diffusion dynamics of ESBL-producing Klebsiella pneumoniae in adult intensive care units: a five-year genomic monocentre study","C. Bernachot|N. Nesi|S. Lecoutour|C. Jeanne-Leroyer|D. Du Cheyron|N. Laquay|K. Le Neindre|P. Thibon|J. Parienti|S. Le Hello|O. Join-Lambert|F. Gravey|J. Decros|J. Moyer|S. Derville"
"5362","14/04 12:00","23","P1387","Kyriaki XANTHOPOULOU","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Diversity of the vanB cassette within ST117 vancomycin-resistant Enterococcus faecium isolates from Germany","K. Xanthopoulou|J. Wille|V. Persy|H. Seifert|P. Higgins"
"5372","14/04 12:00","24","P1388","Annette EYKING-SINGER","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Medical tourism in western Germany: review of Arab and Russian patients and their MRSA- and MRGN-status at a tertiary care facility in north Rhine-Westphalia","A. Eyking-Singer|J. Zweigner|B. Steffens|D. Kalhöfer-Thole|A. Jurke"
"5430","14/04 12:00","25","P1389","María Alejandra MATEO VARGAS","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Intra- and inter-patient evolution of cgMLST in ST-512 KPC-producing Klebsiella pneumoniae","M. Mateo Vargas|S. Rodriguez-Pallares|M. Rodriguez-Iglesias|F. Galán-Sánchez"
"5466","14/04 12:00","26","P1390","Guillem PUIGSECH BOIXEDA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Unveiling hidden reservoirs of carbapenemases in Pseudomonas spp. beyond P. aeruginosa","G. Puigsech-Boixeda|A. Moreno-Mingorance|E. Del Barrio-Tofino|A. Bravo|N. Aguilar|K. Garcia-Comunas|M. Piquer|E. Dima|E. Agusti|J. Rovira-Plujà|Y. Hoyos-Mallecot|J. Trejo-Zahinos|M. Lung|P. Salmeron|M. Martin-Gomez|D. Romero-Herrero|B. Vinado-Perez|N. Larrosa|J. Gonzalez-Lopez"
"5511","14/04 12:00","27","P1391","Caitlin FARLEY","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Greater multidrug resistance in Enterococcus faecium but greater pathogenicity in Enterococcus faecalis isolated from Welsh ICU patients","C. Farley|J. Mathias|I. Boostrom|M. Mentasti|M. Wootton|L. Jones|O. Spiller|J. Aziz"
"5666","14/04 12:00","28","P1392","Ana ALMEIDA SANTOS","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Silent dissemination of identical VanA-carrying linear plasmids in vancomycin-variable Enterococcus faecium: a growing diagnostic concern","A. Almeida Santos|A. Tedim|L. Silva|J. Teixeira|A. Castro|C. Novais|L. Peixe|A. Freitas"
"5684","14/04 12:00","29","P1393","Rani Rashmani DE LA RIVIÈRE","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Enterobacterales involved in plasmid-mediated carbapenem resistance outbreaks in Portuguese hospitals","R. De La Rivière|P. Teixeira|V. Manageiro|M. Caniça"
"5826","14/04 12:00","30","P1394","Merve MERT VAHABI","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Retrospective evaluation of culture-proven carbapenem-resistant Gram-negative infections a tertiary care educational university hospital: analysis of 888 cases","M. Mert Vahabi|D. Akyol Seyhan|B. Kenanoglu|G. Sanlidag Isbilen|M. Özkara|S. Dirik|O. Acet|D. Kaya|S. Ketentzi|C. Bulut Avsar|A. Kaya|D. Baskol Elik|A. Uyan Önal|U. Önal|M. Ceylan|N. Yalcin|C. Tol|S. Istek|G. Quliyeva|M. Demir Gorur|G. Vatansever|B. Arikan|A. Parmaksizoglu Aydin|D. Yaman|K. Bagir|B. Sullu|S. Aydemir|H. Erdem|M. Tasbakan|B. Arda|H. Sipahi|O. Sipahi|H. Pullukçu|T. Yamazhan"
"5839","14/04 12:00","31","P1395","Alina GONCHAROVA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Cefiderocol-resistant Acinetobacter baumannii: before cefiderocol introduction","A. Goncharova|V. Gostev|A. Andreeva|N. Goncharov|D. Polev|A. Saitova|L. Kraeva|N. Gladyshev|V. Pleshkov|L. Popenko|A. Kruglov|S. Gordeeva|S. Sidorenko"
"5887","14/04 12:00","32","P1396","Aida CASTANY CARRASCO","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Characterisation of carbapenem-resistant Klebsiella pneumoniae lineages in bloodstream infections in Barcelona (2021-2024)","A. Castany|A. Gonzalez-Diaz|S. Marti|F. Tubau|R. Costa|D. Berbel|M. Dominguez|C. Ardanuy|J. Càmara|N. Prim"
"5889","14/04 12:00","33","P1397","Elias NDIBAREMA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial resistance patterns among patients admitted with sepsis at a tertiary hospital in Uganda","E. Ndibarema|T. Mugabi|R. Olum|J. Ogavu|S. Bahendeka|A. Makhoba|R. Mwebaze"
"5928","14/04 12:00","34","P1398","Celia SÁNCHEZ-MARTÍNEZ","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro activity of delafloxacin against quinolone-resistant Staphylococcus aureus should always be tested","C. Sanchez-Martinez|L. Urbina|T. Carrasco Gil|C. Martin-Martin|F. Camero|M. Marin|P. Munoz"
"5939","14/04 12:00","35","P1399","Ana Belén BORREGO ALCAIDE","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Description of susceptibility profile of metallo-beta-lactamases-producing and non-carbapenemase-producing P. aeruginosa","A. Borrego-Alcaide|M. Lerate-Alba|J. Sanz-Cánovass|F. Chamizo-Lopez|M. Rojo-Martin|B. Palop-Borrás"
"5942","14/04 12:00","36","P1400","Emanuele NICITRA","6","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","A Klebsiella pneumoniae ST147 NDM-1/OXA-48 unique clone circulating in diverse hospitals in southern Italy","E. Nicitra|M. Terrana|G. Privitera|M. Calvo|D. Bongiorno|A. Mastroianni|S. Greco|V. Vangeli|M. Greco|F. Greco|M. Mauro|E. Trecarichi|F. Serapide|A. Russo|G. Matera|A. Quirino|N. Marascio|M. Pantanella|S. Stefani"
"6002","14/04 12:00","1","P1401","Mercedes DELGADO VALVERDE","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Activity of novel broad-spectrum antimicrobials against multi-carbapenemase producers Enterobacterales from southern Spain, 2018-2023","I. Lopez Hernandez|M. Delgado-Valverde|F. Fernández Cuenca|Á. Pascual"
"6012","14/04 12:00","2","P1402","Asma BENMOHAMMED","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antibiotic resistance patterns in Pseudomonas spp.: an eight year surveillance study in an Algerian hospital","A. Benmohammed|L. Afer|F. Mechouet|M. Chitour|Z. Hanifa"
"6043","14/04 12:00","3","P1403","Estíbaliz UGALDE","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Coproduction of carbapenemases in Enterobacterales: emergence of a new phenomenon in a Spanish tertiary hospital","E. Ugalde Zárraga|M. Vidal-Garcia|M. Urrutikoetxea-Gutierrez|J. Aragon Diez|I. Angulo Lopez|J. Diaz De Tuesta Del Arco"
"6067","14/04 12:00","4","P1404","Tharani Priya THIRUMOORTHY","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Recent emergence of carbapenem-resistant Salmonella paratyphi in India: resistance profile and phylogenetic analysis","T. Thirumoorthy|J. Jacob|S. R.|P. S.|M. S.|S. Nagaraj|S. J.|P. Padaki|A. Nair|V. Nagarekar|C. Rodrigues|J. John|B. Veeraraghavan"
"6073","14/04 12:00","5","P1405","Valentina PENNETTA","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Genotype and phenotype of carbapenemase-producing Escherichia coli in England, 2023-24","V. Pennetta|D. Nagy|K. Hopkins|A. Roohi|D. Karageorgopoulos|M. Avison|A. Mathers|R. Hope|D. Williams|A. Ledda|J. Robotham|C. Brown|S. Walker|K. Hopkins|S. Lipworth|N. Stoesser|R. Moran"
"6145","14/04 12:00","6","P1406","Anders SKYRUD DANIELSEN","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Impact of the cessation and reopening of international travel during the COVID-19 pandemic on the incidence of MRSA and CPO in Norway, 2016-2024","A. Danielsen|P. Langlete|C. Souque|C. Yoon|M. Molvik|M. Sare|H. Eriksen-Volle|U. Gopinathan|P. Elstrøm"
"6227","14/04 12:00","7","P1407","Rosario OPORTO LLERENA","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence and Antimicrobial Susceptibility of blaOXA-51 negative Acinetobacter spp. as a Cause of Human Infection in Perú.","R. Oporto-Llerena|R. Huerto-Huánuco|Y. Quispe-Hualpa|G. Soza|J. Rojas-Jaimes|P. Gonzales|L. Pollack|A. Gomez|G. Salvador-Luján|E. Cuaresma|N. Luque|M. Casapia|K. Arteaga-Livias|M. Pons|J. Ruiz"
"6258","14/04 12:00","8","P1408","Carlotte ROZEMOND","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology of carbapenemase-producing Enterobacterales, extended-spectrum beta-lactamase-producing Enterobacterales, and carbapenem-producing Pseudomonas aeruginosa in hospitalised patients in Suriname","C. Rozemond|T. Mawie|S. De Greeff|A. Hendrickx|E. Van Duijkeren|S. Vreden|J. Hordijk|J. Van Dissel"
"6273","14/04 12:00","9","P1409","Ina GAJIC","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Comprehensive study on healthcare-associated urinary tract infections in Serbia","I. Gajic|M. Jovicevic|J. Kabic|D. Kekic|S. Delic|A. Damjanovic|V. Kovacevic Jovanovic|M. Hadnadjev|A. Trudic|D. Andjelkovic|S. Djordjevic|T. Boskovic|M. Brankovic|A. Ilic|A. Prokic|N. Nikolic|D. Popadic|Z. Todorovic|M. Zdravkovic|N. Opavski|L. Ranin|S. Mladenovic|B. Andjelkovic"
"6275","14/04 12:00","10","P1410","Esther VAN KLEEF","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","WHO's global antimicrobial resistance and use surveillance system (GLASS): is national surveillance coverage improving?","O. Tosas Auguet|E. Van Kleef|S. Tolba|S. Eremin|K. Pouwels|B. Cooper|A. Dean|S. Bertagnolio"
"6279","14/04 12:00","11","P1411","Sofia ZERVA","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","One-year epidemiological surveillance of Klebsiella pneumoniae producing both NDM and OXA-48 Carbapenemases in an acute-care healthcare setting","S. Zerva|A. Karapanou|M. Sampanis|A. Andritsos|I. Deliolanis|A. Pantazatou|D. Basoulis|F. Ntziora|E. Apostolidi|P. Voutsinas|M. Gkamaletsou|M. Samarkos|N. Sipsas"
"6291","14/04 12:00","12","P1412","Laura CZEKSTER ANTOCHEVIS","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","In vitro susceptibility to sulbactam/durlobactam of carbapenem-resistant Acinetobacter baumannii isolated from bloodstream infections: a multicentre study in Brazil","L. Antochevis|C. Wilhelm|J. Santos|D. Castro|P. Barth|L. Sudbrack|A. Martins|B. Arns|L. Guimaraes|J. Pascual|V. Rocha|E. Girao|A. Barth|A. Zavascki|L. Lutz|J. Telles|R. Leao|A. Coelho"
"6305","14/04 12:00","13","P1413","Dorota ZABICKA","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Antimicrobial susceptibility and clonal structure of Acinetobacter spp. isolated from hospitalised patients in Poland in 2023","D. Zabicka|E. Wardal|K. Belkiewicz|M. Grzegorczyk|M. Herda|K. Malinowska|D. Fabisiak|W. Wygoda|A. Polak"
"6388","14/04 12:00","14","P1414","Yunus Emre TOK","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in antimicrobial resistance: a three-year cumulative AST analysis of blood culture isolates in a tertiary hospital in Istanbul","Y. Tok|B. Bayraktar"
"6406","14/04 12:00","15","P1415","Michalis POLEMIS","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Enhanced surveillance and outbreak investigation through the use of whole-genome sequencing (WGS) in Greece","M. Polemis|K. Karadimas|A. Tzoukmani|E. Maikousi|O. Pappa|G. Mandilara"
"6552","14/04 12:00","16","P1416","Linda HADJADJ","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Emergence of carbapenemase-producing Enterobacter hormaechei in Marseille hospitals, France: a success-story analysis","L. Hadjadj|A. Balandraud|G. Dubourg|S. Baron"
"6575","14/04 12:00","17","P1417","Adrienn HANCZVIKKEL","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular epidemiology of carbapenemase-producing Enterobacter spp. in Hungary","G. Farkas|A. Hanczvikkel|D. Göbhardter|N. Derzsy|E. Ungvári|A. Darab|L. Holub|L. Majoros|K. Kristof|E. Török|Z. Liska|K. Kamotsay|V. Cser|I. Wolf|Á. Toth"
"6685","14/04 12:00","18","P1418","Estíbaliz UGALDE","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The changing epidemiology of carbapenemase producing Enterobacterales in a Spanish tertiary hospital","E. Ugalde Zárraga|M. Vidal-Garcia|M. Urrutikoetxea-Gutierrez|J. Aragon Diez|I. Angulo Lopez|J. Diaz De Tuesta Del Arco"
"6843","14/04 12:00","19","P1419","Maria MENESES","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa strains in Portugal","M. Meneses|D. Mendes Pedro|A. Bruschy-Fonseca|E. Gonçalves|D. Ranhel|C. Conceicao|A. Pedrosa|A. Silva|A. Duarte|L. Méndez|C. Toscano|J. Cristino-Melo|C. Caneiras"
"6850","14/04 12:00","20","P1420","Dip MUKHERJEE","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Synergistic effect of ceftazidime/avibactam with aztreonam on carbapenemase-producing Enterobacteriaceae: the ray of hope against NDM","D. Mukherjee|S. Seal"
"6935","14/04 12:00","21","P1421","Jawaria AZIZ","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Characterisation of coagulase-negative Staphylococci neonatal sepsis isolates from low-to-middle-income countries for resistance, virulence and phylogeny","J. Aziz|K. Sands|K. Thomson|R. Zahra|K. Iregbu|M. Sekikubo|K. Ledoare|T. Walsh|O. Spiller"
"6938","14/04 12:00","22","P1422","Serge TOMASSIAN","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Fifteen-year trends in resistance patterns of urinary pathogens at a Lebanese tertiary care centre","S. Tomassian|H. Mezher|O. Zmerli|E. Azar"
"6956","14/04 12:00","23","P1423","Veronica WETERINGS","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Prevalence of rectal carriage and genomic characterisation of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae: results of annual point prevalence studies in a Dutch hospital, 2013-2023","V. Weterings|K. Houkes|M. Tinga|M. Van Rijen|J. Stohr|W. Van Den Bijllaardt"
"7105","14/04 12:00","24","P1424","Azucena MORA GUTIÉRREZ","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","CTX-M-15-producing high-risk Escherichia coli CC131 and first report of ST1193 causing urinary tract infections in Algeria","C. Fadela|H. Ziadi|V. Garcia|L. Carballeira|A. Mora"
"7117","14/04 12:00","25","P1425","Eline VERHAGEN","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Carbapenamese resistance in European hospitals: two consecutive point prevalence surveys of Acinetobacter baumannii and Klebsiella pneumoniae","E. Verhagen|G. Boland|D. De Vries|A. Fluit|A. Sonpar|W. Zingg|E. Carrara|P. Retamar-Gentil|G. Daikos|A. Hristea|J. Kluytmans"
"7134","14/04 12:00","26","P1426","Iván BLOISE","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Arising from the shadows: clonal analysis of multi-drug resistant Enterococcus faecium","M. Amoroto-Bengoetxea|C. Sanz-González|E. Rubio-Mora|F. Lázaro-Perona|J. Mingorance|I. Bloise"
"7138","14/04 12:00","27","P1427","Akos TOTH","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Insight into the evolution of a carbapenemase-producing Klebsiella pneumoniae ST395 strain in Hungary","Á. Toth|A. Hanczvikkel|K. Toth|L. Holub|D. Göbhardter|A. Darab|E. Ungvári|N. Derzsy|L. Buzgo|L. Majoros|B. Balázs|K. Mályi|K. Papp|M. Farkas|K. Kristof|Á. Kelemen|I. Damjanova"
"7154","14/04 12:00","28","P1428","Annarita MAZZARIOL","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","The activity of cefiderocol against Achromobacter xylosoxidans clinical isolates","G. Toccacieli|E. Addis|A. Verzini|F. Tolio|A. Bertoncelli|A. Mazzariol"
"7238","14/04 12:00","29","P1429","Ada Evangelina BRIZUELA","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Understanding antimicrobial resistance mortality in intensive care units in Paraguay (2022-2023): pilot study","V. De Egea|F. Ovando|A. Brizuela|A. Nunez|R. Lopez|S. Ibarra|R. Montoya|J. Hsieh|P. Ramon-Pardo|G. Sequeira"
"7299","14/04 12:00","30","P1430","Gisela ROBLES AGUILAR","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Trends in fatal burden of antibiotic-resistant infections across EU countries from 1990 to 2021","G. Robles Aguilar|T. Mestrovic|L. Swetschinski|A. Gray|K. Ikuta|E. Wool|C. Han|R. Hsu|D. Araki|E. Chung|A. Gershberg Hayoon|N. Weaver|B. Cooper|C. Dolecek|C. Murray|M. Naghavi"
"7355","14/04 12:00","31","P1431","Ewa Nina WARDAL","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Multicentre spread of vancomycin- and linezolid-resistant Enterococcus faecium ST2023 in Polish hospitals","E. Wardal|D. Zabicka|E. Sadowy"
"7422","14/04 12:00","32","P1432","Silva TAFAJ","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Concerning rise in antibiotic resistance: insights from clinical bacterial isolates at an Albanian university hospital (TWIW 2020 Study)","S. Tafaj"
"7484","14/04 12:00","33","P1433","Georgios SCHINAS","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","MDR bacteraemia in critically ill patients during the COVID-19 pandemic: the MARTINI study","C. Petropoulou|G. Schinas|S. Kefala|D. Bousis|F. Fligou|G. Dimopoulos|K. Akinosoglou"
"7602","14/04 12:00","34","P1434","Jaya PRASANTHI","7","A","03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","A five year trend analysis of prevalence and antimicrobial susceptibility pattern of coagulase-negative Staphylococci (CoNS) in a tertiary care centre, south India","S. Jaya Prasanthi|I. Dhinakaran|I. Imanuvel"
"101","14/04 12:00","35","P1435","Patrick FORSTNER","7","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Colistin, meropenem/vaborbactam, imipenem/relebactam, and eravacycline testing in carbapenem-resistant Gram-negative rods: a comparative evaluation of broth microdilution, gradient test, and VITEK 2","P. Forstner|L. Fuchs|J. Luxner|A. Grisold|I. Steinmetz|K. Dichtl"
"241","14/04 12:00","36","P1436","Angela CHARLES","7","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In-vitro activity of cefiderocol and eravacycline in multidrug-resistant strains of Achromobacter xylosoxidans and Achromobacter denitrificans: implementation of a rapid testing protocol","J. Alexander|A. Charles"
"353","14/04 12:00","1","P1437","Yun WU","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Optimisation and improvement of in vitro drug susceptibility method for mucoid Pseudomonas aeruginosa","Y. Wu|Y. Liu|Y. Xu"
"356","14/04 12:00","2","P1438","Yun WU","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Synergistic effect of ceftazidime/avibactam with meropenem and aztreonam against carbapenem-resistant Klebsiella pneumoniae","Y. Wu"
"405","14/04 12:00","3","P1439","Elinor MCSORLEY","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Unlocking rapid phenotypic AST direct-from-blood with automated microbial detection and quantitative growth monitoring","D. Lockhart|A. Aman|S. La Fauci|C. Johansson|E. Mcsorley|C. Mestiri|A. Olsson|C. Malmberg|W. Mullen"
"563","14/04 12:00","4","P1440","Ka Lip CHEW","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Antimicrobial susceptibility testing and clinical outcomes of non-cystic fibrosis Burkholderia cepacia complex infections","J. Ngiam|M. Koh|P. Soh|K. Chew"
"706","14/04 12:00","5","P1441","Ulrik Stenz JUSTESEN","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of a ready-to-use metronidazole agar dilution panel for antimicrobial susceptibility testing of anaerobic bacteria","Z. Acar|R. Thomsen|U. Justesen"
"708","14/04 12:00","6","P1442","Guido GRANATA","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Metallo-beta-lactamase producing Pseudomonas aeruginosa: the fractional inhibitory concentration index as a tool to evaluate antibiotic synergy","G. Granata|C. Venditti|C. Rotondo|G. Parisi|A. Capone|C. Fontana|S. Cicalini"
"833","14/04 12:00","7","P1443","Hanshu FANG","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparison of three methods for detecting metronidazole resistance determinants (nim) in Bacteroides fragilis group organisms","H. Fang|M. Tong|K. Chow|H. Cao|P. Ho"
"840","14/04 12:00","8","P1444","Sarita MOHAPATRA","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Cefiderocol susceptibility against carbapenem-resistant Gram-negative bacilli: a study on Indian clinical strains","S. Mohapatra|A. Didwania|D. Kocher|H. Gautam|A. Kumar|M. Soneja|.. Vikram|S. Sood|B. Dhawan|B. Das|N. Wig"
"900","14/04 12:00","9","P1445","Hedda Luise VERHASSELT","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activity of cefiderocol against Burkholderia cepacia complex from patients with cystic fibrosis assessed by two methods","L. Kirchhoff|J. Wessel|J. Steinmann|P. Rath|H. Verhasselt"
"970","14/04 12:00","10","P1446","Prenika JAGLAL","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluating in vitro antibiotic synergy for paediatric multidrug-resistant Gram-negative bloodstream isolates at a tertiary public hospital in South Africa","P. Jaglal|S. Velaphi|C. Menezes|K. Swe-Swe Han"
"986","14/04 12:00","11","P1447","Suzane SILBERT","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of the VITEK REVEAL AST system vs Accelerate Pheno for antimicrobial susceptibility testing of Gram-negative bacteria directly from positive blood cultures","C. Simmons Williams|D. Becker|A. Lima|L. Rowe|L. Soares|D. Uy|T. Okeyo Owuor|H. Salazar|S. Silbert"
"1072","14/04 12:00","12","P1448","Manohar MUTNAL","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of FDA-cleared rapid antimicrobial susceptibility testing (AST) methods for bloodstream infections: impact on clinical decision-making in a tertiary care setting","M. Mutnal|N. Henry|P. Binsol|M. Sheth|S. Ranganath|T. Ladow|R. Beaver|L. Sisco|J. Midturi|A. Rao"
"1131","14/04 12:00","13","P1449","Michael BUHL","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Laboratory performance in antimicrobial susceptibility testing of anaerobic bacteria (EUCAST disc diffusion methodology): results of an external quality assessment study, 2024","M. Buhl|J. Jung|C. Stingu|S. Copsey-Mawer|J. Held"
"1145","14/04 12:00","14","P1450","Jennifer Stella WIRTH","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Increased antibiotic susceptibility of Gram-positive bacteria in cerebrospinal fluid compared to broth","J. Wirth|M. Djukic|K. Biesner|U. Reichard|R. Nau|J. Seele"
"1232","14/04 12:00","15","P1451","Mark ESTABROOK","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activities of aztreonam/nacubactam and cefepime/nacubactam against carbapenemase-producing Enterobacterales collected as part of a global surveillance study in 2021-2022","M. Estabrook|A. Shimizu|H. Okade|D. Sahm"
"1243","14/04 12:00","16","P1452","Zoja GERMUSKOVA","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Emerging evidence of antimicrobial resistance in Capnocytophaga canimorsus may have significant implications for empiric treatment choices","M. Barancekova|C. Beauruelle|I. Bianconi|A. Cizek|C. Giske|H. Rohde|T. Roloff|P. Sendi|T. Song|T. Sunnerhagen|A. Skovby|C. Tellapragada|D. Van Dam|R. Widerström|E. Broens|K. Søgaard|F. Renzi|A. Egli|Z. Germuskova"
"1452","14/04 12:00","17","P1453","Irmak OZKUBAT KORKMAZ","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Colistin susceptibility in Klebsiella pneumoniae isolates: comparison of broth microdilution and automated systems with qPCR-based investigation of mcr gene presence","I. Ozkubat Korkmaz|B. Dinç|N. Coplu"
"1692","14/04 12:00","18","P1454","Masaw AKBARI","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance of the LifeScale rapid AST vsclinical standards of care","M. Akbari|J. Tedesco|E. Hennessee|C. Schneider|K. Babcock"
"1694","14/04 12:00","19","P1455","Alex HOWARD","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Personalised antimicrobial susceptibility clinical breakpoint interpretation using clinical prediction modelling: a microsimulation study","A. Howard|Y. Zhong|A. Gerada|C. Rosato|P. Green|A. Velluva|I. Buchan|W. Hope"
"1865","14/04 12:00","20","P1456","Aurélie COLLANGE","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","ETEST imipenem/relebactam (IRPA) for antimicrobial susceptibility testing of Pseudomonas aeruginosa: performance results from a multicentre study","A. Collange|E. Csiki-Fejer|H. Dwight|M. Yarbrough|M. Wootton|F. Trunet|C. Franceschi"
"1940","14/04 12:00","21","P1457","Christine HASTEY","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of imipenem/relebactam for MicroScan dried Gram-negative MIC panels from a multicentre assessment of Enterobacterales and Pseudomonas aeruginosa","K. Dawa|R. Brookman|C. Hastey|A. Harrington|O. Garner|S. Riedel|S. Desjarlais|B. Guzman"
"1993","14/04 12:00","22","P1458","Erika MATUSCHEK","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Combining oxacillin and benzylpenicillin disk diffusion to categorise benzylpenicillin susceptibility in Streptococcus pneumoniae without MIC testing","E. Matuschek|L. Ortega Roco|L. Rodriguez|J. Ahman|G. Kahlmeter"
"2188","14/04 12:00","23","P1459","Mariano Paulo ECHEGORRY","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Standardising aztreonam/relebactam disk diffusion susceptibility testing in Enterobacterales: a step towards reliable clinical application","M. Echegorry|M. Dumas|P. Ceriana|E. Albornoz|M. Rapoport|A. Corso|F. Pasteran"
"2257","14/04 12:00","24","P1460","Liliana CAYTUIRO","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activity of aztreonam and aztreonam/avibactam against carbapenemase-producing Enterobacterales in Peru","L. Caytuiro|Y. Reyes|L. Astocondor|M. Riveros|F. Krapp|R. Sandoval|G. Pérez|C. Cucho|M. Melo|I. Sabogal|L. Lino|A. Lachira|K. Michilot|J. Rojas|E. Cuaresma|R. Diaz|C. Amaro|S. Andrade|L. Hernandez|A. Briones|A. Olivares|S. Burgos|C. Garcia"
"2274","14/04 12:00","25","P1461","Eric RANSOM","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A sepsis solution in a large clinical laboratory: evaluation of three fast phenotypic antimicrobial susceptibility testing approaches from positive blood cultures","E. Ransom|H. Mohammad|D. Savadekar|C. Lawson|A. Hubal|S. Dong|A. Windau"
"2332","14/04 12:00","26","P1462","Kavitha KUMAR","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Colistin resistance in Klebsiella pneumoniae: phenotypic assays shed light on genomic mechanisms","K. Kumar|V. Shamanna|M. Malathi|G. Nagaraj|D. Aanensen|R. Kadalahalli"
"2386","14/04 12:00","27","P1463","Fatma ERDEM","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evolution of rapid colistin resistance detection methods in Klebsiella pneumoniae and Acinetobacter baumannii strains","F. Erdem|M. Yilmaz|G. Durmaz"
"2504","14/04 12:00","28","P1464","Francesca SIVORI","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Meropenem/vaborbactam against planktonic and biofilm forms of carbapenem-resistant Klebsiella pneumoniae","F. Sivori|I. Cavallo|M. Truglio|M. Francalancia|G. Prignano|A. Mastrofrancesco|G. Fabrizio|F. Pimpinelli|E. Di Domenico"
"2547","14/04 12:00","29","P1465","Yeliz TANRIVERDI CAYCI","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of meropenem, ertapenem and temocillin screening breakpoints in the EUCAST rapid antimicrobial susceptibility testing (RAST) for rapid detection of OXA-48-producing Klebsiella pneumoniae directly from positive blood cultures","B. Sancak|I. Biyik|A. Colak|Y. Tanriverdi Cayci|A. Birinci"
"2569","14/04 12:00","30","P1466","Anezka GRYNDLEROVA","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Do we still have treatment options for infections caused by carbapenemase-producing Enterobacterales?","A. Gryndlerová|B. Dratvová|S. Prasad|M. Brajerová|P. Kabelikova|O. Nyc|P. Drevinek|M. Krutova"
"2650","14/04 12:00","31","P1467","Ilaria CAVALLO","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Biofilms and beta-lactamases affect cefiderocol activity in multidrug-resistant Acinetobacter baumannii","I. Cavallo|F. Sivori|M. Truglio|G. D'agosto|E. Abril|R. Riveros Cabral|F. Pimpinelli|E. Di Domenico"
"2671","14/04 12:00","32","P1468","Greg MOECK","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Cefepime/taniborbactam (FTB) epidemiological cutoff values (ECOFFs) against key Enterobacterales species and Pseudomonas aeruginosa","A. Belley|M. Hackel|M. Wise|D. Sahm|C. Chatwin|B. Miller|A. Stevenson|M. Edwards|D. Daigle|G. Moeck"
"2727","14/04 12:00","33","P1469","Ping REN","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of a novel rapid phenotypic antimicrobial susceptibility testing system","F. Cerqueira|N. Williams-Bouyer|P. Ren"
"2751","14/04 12:00","34","P1470","Greg MOECK","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance assessment of a cefepime-taniborbactam gradient diffusion strip for antimicrobial susceptibility testing of Enterobacterales and Pseudomonas aeruginosa","A. Belley|L. Koeth|J. Fisher|F. Demetrio|C. Chatwin|B. Miller|A. Stevenson|M. Edwards|S. Cusick|G. Moeck"
"2803","14/04 12:00","35","P1471","Anna DUDAKOVA","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparison of broth microdilution and antimicrobial gradient strip test in determining in vitro activity of aztreonam/avibactam in metallo-beta-lactamase-producing Enterobacterales","A. Dudakova|M. Simon|S. Kolar|P. Higgins|K. Xanthopoulou|T. Ruegamer|J. Jantsch"
"2826","14/04 12:00","36","P1472","Austin YAN","8","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of direct-from-blood-culture disc diffusion testing for Gram-negative bacteraemia at a regional microbiology laboratory","A. Yan|V. Deslandes"
"2859","14/04 12:00","1","P1473","Jose Carlos DE GRACIA DÍAZ","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Area of technical uncertainty: a paradigm for clinical microbiology","J. Jover Garcia|C. Lopez Millan|A. Martin Bermudez|D. Lopez Acosta|B. Cuadrado Garcia|E. Brunas Yanes|M. Lecuona Fernandez|J. De Gracia Diaz"
"2909","14/04 12:00","2","P1474","Lucia MACCARI","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activity of cefepime/zidebactam (FPZ) against extended-spectrum beta-lactamase (ESBL) producers and carbapenem-resistant Enterobacterales (CRE) isolates","L. Maccari|P. Ceriana|C. Lucero|M. Rapoport|A. Menocal|A. Corso|F. Pasteran|L. Gonzalez|A. Vila"
"2934","14/04 12:00","3","P1475","Markus HELL","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Delafloxacin as the only anionic flouroquinolone with excellent activity against multi-drug resistant bacteria especially in acidic environments: an in vitro study","M. Hell|H. Schimpl|I. Schwingenschlögel|A. Indra"
"3269","14/04 12:00","4","P1476","Rita ABOU ABDALLAH","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Novel antibiotic susceptibility testing (AST) of Coxiella burnetii towards doxycycline using tabletop scanning electron microscopy (SEM)","A. El Moutawakil|O. Zmerli|J. Bou Khalil|P. Fournier|R. Abou Abdallah"
"3405","14/04 12:00","5","P1477","Jenny GÖRANSSON","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Controlled inoculum functionality of an automated rapid AST system leads to consistent MIC determination","J. Göransson|H. Osman|J. Grawé|A. Karman|S. Vincentsson|L. Levén|O. Mainwaring|Y. Molin"
"3409","14/04 12:00","6","P1478","Veronique SAUVONNET","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Gepotidacin MIC determination: comparative evaluation of a new gradient strip to the CLSI 2024 reference method on 290 clinical isolates","V. Sauvonnet|L. Hiblot|D. Halimi|C. Franceschi|N. Scangarella-Oman|L. Mc Closkey"
"3488","14/04 12:00","7","P1479","Montserrat MUÑOZ ROSA","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Phenotypic and molecular analysis of the in vitro activity of fluoroquinolones against clinical isolates of Corynebacterium spp.","M. Munoz-Rosa|C. Elias-Lopez|R. Pedraza-Merino|L. Martinez-Martinez"
"3589","14/04 12:00","9","P1481","Alexander STURM","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Ultra-rapid antibiotic susceptibility testing workflow for neonatal sepsis: from blood sample to AST result in nine hours","M. Pla Verge|C. Mestiri|D. Wilson-Owen|S. La Fauci|E. Mc Sorley|E. Delarze|G. Jozwiak|D. Cichocka|D. Lockhart|W. Mullen|A. Sturm"
"3603","14/04 12:00","10","P1482","Jenny GÖRANSSON","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rapid phenotypic susceptibility testing from patient blood cultures with growth of Streptococci or other Gram-positive bacteria","J. Göransson|C. Egelund Christensen|J. Grawé|E. Rennel-Dickens|O. Mainwaring|J. Gorm Lisby"
"3615","14/04 12:00","11","P1483","Yohann BALA","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance of a new system for rapid antimicrobial susceptibility testing of Gram-negative bacteraemia: results from a prospective mono centric study in South Africa","Y. Bala|L. Isaacs|S. Lalloo|K. Iyappen|R. Richard|G. Noel|G. Laborde|C. Samuel|V. Howell"
"3650","14/04 12:00","12","P1484","Merav STRAUSS","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of a semi-automated system for antibiotic susceptibility testing: a comparison with manual method","M. Strauss|D. Sagas|K. Zoabi|N. Lauz|C. Kasher|B. Chazan|A. Yanovskay|M. Abu Much|M. Landes"
"3657","14/04 12:00","13","P1485","Frida MALM","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of MIC determination with dalbavancin gradient test in Enterococcus faecalis, Enterococcus faecium and Staphylococcus epidermidis","A. Duhan|F. Malm|E. Matuschek"
"3661","14/04 12:00","14","P1486","Emily JACOBS","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance of ceftazidime/avibactam and ceftolozane/tazobactam automated susceptibility testing results for carbapenem-resistant Pseudomonas aeruginosa","E. Jacobs|Y. Bergman|T. Tekle|P. Tamma|P. Simner"
"3662","14/04 12:00","15","P1487","Marion POMPILO","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparative study on the effectiveness of two gradient strips with imipenem/relebactam on Enterobacterales and P. aeruginosa strain collections","D. Halimi|M. Pompilio|F. Trunet|P. Basque|M. Roland"
"3696","14/04 12:00","16","P1488","Ye LU","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activity of cefiderocol against carbapenem-resistant Escherichia coli (CREC): a multicentre study in China","Y. Lu"
"3709","14/04 12:00","17","P1489","Amira Zhor Rim ZINAI","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Exploring microtubule targeting agents as novel antimicrobial therapeutics","A. Zinai|M. Gaye|V. Baksheeva|F. Fenollar|O. Mediannikov|P. Tsvetkov"
"3788","14/04 12:00","18","P1490","Esther WOHLFARTH","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance evaluation of three routine methods for testing the susceptibility of 450 outpatient Escherichia coli isolates to mecillinam","B. Körber-Irrgang|K. Sallhan|E. Wohlfarth|H. Wisplinghoff|N. Jazmati"
"3797","14/04 12:00","19","P1491","Dalon ARRINGTON","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro antibacterial activity of a fosfomycin/trimethoprim/sulfamethoxazole combination plus anti-mycobacterial agents against reference strains of non-tubercular Mycobacterium spp.","D. Arrington|C. Townes|N. Stuart|T. Hartsell|S. Gardlik|V. Steven|J. Pace"
"3810","14/04 12:00","20","P1492","Denise STARK","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Antimicrobial susceptibility of anaerobic bacteria from bloodstream infections in Germany: a multicentre study","D. Stark|R. Köck|J. Esser|F. Schaumburg|I. Olaru|F. Schuler|J. Elias|A. Hamprecht|V. Fadel"
"3869","14/04 12:00","21","P1493","Marion POMPILO","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparative evaluation of cefepime/taniborbactam MIC testing with gradient strip and CLSI broth microdilution methods","M. Pompilio|D. Halimi|P. Basque|F. Trunet|E. Lenglart|R. Martelin|C. Franceschi"
"3918","14/04 12:00","22","P1494","Sara CARLONI","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Cefiderocol's dark side: the challenge of accurate in vitro testing","M. Antonello|R. Renzulli|M. Bonvegna|Z. Asif|C. Scuderi|E. Cavedoni|M. Calabro|D. Cirasola|C. Daleno|L. Peiretti|L. Bussini|D. Bavaro|M. Bartoletti|G. Da Rin|E. Casari|V. Cento|S. Carloni"
"3926","14/04 12:00","23","P1495","Ines Maria PORTILLO CALDERON","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Challenges of cefiderocol susceptibility testing: agreement between a commercial method and disk-diffusion in metallobetalactamase-producing Klebsiella spp.","I. Portillo-Calderon|M. Delgado-Valverde|L. Lopez-Cerero|Á. Pascual"
"4047","14/04 12:00","24","P1496","Lorena LÓPEZ CERERO","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparative study of nalidixic acid and pefloxacin for quinolone resistance screening in Enterobacterales","V. Vilar-Garcia|L. Lopez Cerero|J. Rodriguez-Martinez|Á. Pascual"
"4066","14/04 12:00","25","P1497","Jennifer GIESEN","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Inducible clindamycin resistance in Streptococcus harboring erm genes: evaluation of a new screening test","J. Giesen|R. Griffith|C. Huff|D. Kingsley|J. Slaughter|K. Engelhard|S. Rajavallaban|V. Girard"
"4068","14/04 12:00","26","P1498","Clara MORETÓ-CASTELLSAGUÉ","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Phenotypic detection of transferable linezolid resistance in Enterococcus faecalis: implications for monitoring gene dissemination","C. Moreto-Castellsague|J. Bender|A. Gonzalez-Diaz|M. Fischer|F. Tubau|M. Dominguez|C. Ardanuy|G. Werner|J. Càmara"
"4188","14/04 12:00","27","P1499","Christine UITZ","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A prospective comparison of five methods for rapid antimicrobial susceptibility testing (RAST) for Gram-negative bacteraemia","K. Aurenhammer|K. Dichtl|C. Uitz"
"4394","14/04 12:00","29","P1501","Banu BAYRAKTAR","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of the broth disk elution method for determining the synergistic activity of the aztreonam and ceftazidime-avibactam combination","B. Yilmaz Guler|H. Tutan|A. Baris|B. Bayraktar"
"4460","14/04 12:00","30","P1502","Chloé BELOT","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of the Sysmex PA-100 system for rapid antibiotic susceptibility testing in urinary samples from borate tubes","C. Belot|O. Dauwalder|C. Sobas|A. Besson|M. Garcia|A. Viscogliosi|F. Zekal|E. Zuner|M. Dufour|A. Primois"
"4504","14/04 12:00","31","P1503","Roland NAU","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared to Mueller-Hinton broth and artificial cerebrospinal fluid","K. Biesner|M. Djukic|U. Reichard|R. Nau|J. Seele"
"4622","14/04 12:00","32","P1504","Julie CREIGHTON","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A 2-plate method for the detection of ESBL and carbapenemase-producing Enterobacterales.","J. Creighton"
"4672","14/04 12:00","33","P1505","Getnet ASSEFA","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A systematic review and individual bacterial species-level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria","G. Assefa|J. Roberts|A. Aslan|A. Mohammed|F. Sime"
"4732","14/04 12:00","34","P1506","Min Kyung SO","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Early evaluation of rapid antimicrobial susceptibility testing by volatile organic compounds detection: a comparative study","J. Park|M. Kim|H. Chung|M. So|M. Lee"
"4752","14/04 12:00","35","P1507","Li ZHIDONG","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Study on the susceptibility of the fifth-generation cephalosporin ceftaroline to Gram-positive bacteria","J. Fang|Y. Zhang|X. Ma|Y. Shao|X. Feng|Z. Li|C. Li"
"4861","14/04 12:00","36","P1508","Yan CHEN","9","A","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of CLSI, EUCAST and a lab developed rapid antimicrobial susceptibility test directly from positive blood culture","Y. Chen|L. Matukas|K. Anderson|P. Jeong"
"4989","14/04 12:00","1","P1509","Cristina ELÍAS LÓPEZ","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro activity of delafloxacin against Escherichia coli isolates producing bacteraemia with different susceptibility profiles to ciprofloxacin and levofloxacin","R. Pedraza-Merino|C. Arjona-Torres|C. Elias Lopez|M. Munoz-Rosa|C. Riazzo|L. Martinez-Martinez"
"5053","14/04 12:00","2","P1510","Maria ROLF","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rapid AST for patients with suspected urosepsis: optimised sample management to reduce time to guide antibiotic therapy","M. Rolf|E. Davies|E. Lönn|J. Fernberg|K. Nahar|A. Rafeletou|A. Aman|H. Öhrn|J. Angstrom|C. Johansson|A. Olsson|C. Malmberg|M. Sundqvist"
"5054","14/04 12:00","3","P1511","Daniel SPENCER","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Extraction of viable Gram-positive bacteria from blood for rapid antimicrobial susceptibility testing","R. Hodges|D. Spencer|H. Morgan|T. King|L. Bock|M. Sutton"
"5137","14/04 12:00","4","P1512","Cansu CIMEN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance of antibiotic susceptibility testing methods for novel beta-lactam/beta-lactamase inhibitors and temocillin in carbapenemase-producing Enterobacterales: a comparative study","C. Cimen|J. Sattler|P. Siemer|M. Berends|A. Hamprecht"
"5184","14/04 12:00","5","P1513","Sarah DI SOPRA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rapid antimicrobial resistance diagnosis in sepsis: a comparative study of a microfluidic rapid AST system and broth microdilution on Gram-negative pathogens","S. Di Sopra|I. Bekas|V. Conciatori|E. Valente|A. Stocco|E. De Canale|C. Del Vecchio|I. Castagliuolo"
"5190","14/04 12:00","6","P1514","Giorgia CARUANA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A prospective, observational, cross-sectional, single-arm study using nanomotion-based technology (Resistell AST) for rapid Gram-negative antibiotic susceptibility testing (NANO-RAST)","G. Caruana|A. Kritikos|A. Vocat|F. Tagini|A. Delfino|A. Luraschi-Eggemann|E. Delarze|J. Delaloye|M. Pla Verge|D. Jacot|J. Winnicki|C. Orlando|A. Sturm|G. Jozwiak|D. Cichocka|G. Greub"
"5321","14/04 12:00","7","P1515","Ekin Kirbas","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparison of various methods for identifying Nocardia isolates and determining antibiotic susceptibilities","E. Kirbas|T. Kucukbahar|E. Tanriverdi|B. Otlu|Ö. Köseoglu Eser|B. Sancak"
"5339","14/04 12:00","8","P1516","François GRAVEY","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of the card VITEK AST-N442 among a collection of clinical Enterobacteriaceae isolates","G. Bouland|S. Le Hello|I. Renouard|F. Gravey|D. Malandain"
"5388","14/04 12:00","9","P1517","Elena ALVARADO","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Two years with RAST in Enterobacteria: clinical impact and concordance","E. Alvarado|H. Garcia|S. Arnal|M. Sarvisé|C. Zumeta|A. Achkir|M. Riesgo Magana|M. Ducons|M. Perez-Batallon|M. Martinez|E. De Pablo|H. Condado|C. Seral"
"5397","14/04 12:00","10","P1518","Archana ANGRUP","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Synergistic potential of colistin combinations against carbapenem- and colistin-resistant enterobacteriaceae: in-vitro and in-vivo insights","S. Soni|A. Angrup|J. Kundu|S. Kansal|S. Mamik|S. Kaur|N. Kaushal|M. Biswal|P. Ray|K. Walia|N. Taneja"
"5443","14/04 12:00","11","P1519","Laurent DORTET","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Detection and differentiation of carbapenemases among Enterobacterales isolates using advanced system expert and new expertise rules of the VITEK 2","L. Dortet|C. Emeraud"
"5552","14/04 12:00","12","P1520","Eleni VOUDANTA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro synergistic effect of mecillinam with avibactam against Klebsiella pneumoniae clinical isolates producing various carbapenemases","E. Voudanta|V. Koumaki|J. Meletiadis|A. Tsakris"
"5573","14/04 12:00","13","P1521","Julie HART","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Towards antibiotic susceptibility testing (AST) direct from urine: interim results from the analytical validation of microcapillary AST","S. Needs|J. Hart|H. Lam|O. Hancox|S. Kidd|A. Edwards"
"5651","14/04 12:00","14","P1522","Omar ZMERLI","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Antimicrobial susceptibility testing assay using scanning electron microscopy for aminoglycosides: a pilot investigation","O. Zmerli|S. Bellali|A. Hodzic|J. Bou Khalil"
"5847","14/04 12:00","15","P1523","Birgit SCHELLHORN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rifabutin MIC test strip development for susceptibility testing against Acinetobacter baumannii","F. Demetrio|S. Pomponio|G. Dale|V. Trebosc|C. Kemmer|B. Schellhorn"
"5858","14/04 12:00","16","P1524","Laurence PAGES MONTEIRO","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance for detecting carbapenemase classes with an automated antimicrobial susceptibility testing system","L. Pages-Monteiro|C. Gustave|S. Rivat|L. Nougier|C. Franceschi|L. Schuermeyer|G. Durand|G. Zambardi"
"6064","14/04 12:00","17","P1525","Eleni KALOGEROPOULOU","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Antimicrobial susceptibility and resistance mechanisms in clinical Bacteroides fragilis group isolates","E. Kalogeropoulou|A. Alvanidi|S. Vourli|S. Damianidou|E. Oikonomoula|A. Tarpatzi|A. Vasilakopoulou|P. Karakosta|M. Kostoula|M. Vargiami|P. Tsilikis|V. Anagnosti|K. Orlandou|K. Tsekouras|F. Kontos|J. Meletiadis|S. Pournaras"
"6172","14/04 12:00","18","P1526","Özgen KÖSEOGLU ESER","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Cefiderocol is a promising treatment alternative agent against highly virulent and antimicrobial-resistant Stenotrophomonas maltophilia, an emerging pathogen","S. Özyar Kurtçu|Ö. Gurpinar Tosun|M. Gurler|Z. Karahan|Ö. Köseoglu Eser"
"6189","14/04 12:00","19","P1527","Paraskevi MANTZANA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rapid direct antibiotic susceptibility testing of positive blood cultures using cell pellet","P. Mantzana|P. Koutra|E. Keskilidou|A. Takardaki|T. Chatziantoniou|A. Greco|Z. Tsinaris|A. Tychala|G. Meletis|O. Vasilaki|G. Kagkalou|E. Protonotariou|L. Skoura"
"6198","14/04 12:00","20","P1528","Rebekah DUMM","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of VITEK REVEAL fast antimicrobial susceptibility testing compared to disk diffusion for Gram-negative bloodstream infections","T. Bui-Bullock|C. Muenks|A. Brown|R. Dumm"
"6246","14/04 12:00","21","P1529","Jamie WORSWICK","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Direct antimicrobial susceptibility testing on clinical urine samples by laboratory automation","J. Worswick"
"6283","14/04 12:00","22","P1530","Cidália PINA-VAZ","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","A novel ultra-rapid phenotypic susceptibility method for ceftazidime/avibactam","I. Martins-Oliveira|B. Pérez-Viso|R. Gomes|D. Abreu|A. Silva-Dias|R. Canton|C. Pina-Vaz"
"6287","14/04 12:00","23","P1531","Paraskevi MANTZANA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Performance evaluation of a novel rapid AST system on Gram-negative blood culture isolates at a tertiary university hospital in northern Greece","P. Mantzana|E. Keskilidou|P. Koutra|T. Chatziantoniou|A. Daviti|A. Skoura|Z. Tsinaris|A. Tychala|G. Meletis|O. Vasilaki|G. Kagkalou|E. Protonotariou|L. Skoura"
"6324","14/04 12:00","24","P1532","Romain MILLOT","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro synergistic activity of amoxicillin and cephalosporin on non-faecalis and non-faecium Enterococcaceae","R. Millot|G. Le Moal|C. Burucoa|C. Plouzeau Jayle|J. Buyck|J. Moreau|L. Prouvensier|G. Beraud|S. Marchand|M. Pichon"
"6359","14/04 12:00","25","P1533","Matteo LUCCHINI","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of a wide panel of antibiotic discs and Mueller-Hinton agar plates with laboratory automation","M. Lucchini|G. Uberti|N. Schepis|A. Calorini"
"6367","14/04 12:00","26","P1534","Maria Adelina GIMENO","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of a two-hour antimicrobial susceptibility assay for bacteraemia using flow cytometry","M. Gimeno|C. Velasco|C. Soto|E. Marin|A. Caro|J. Lepe"
"6390","14/04 12:00","27","P1535","Giang NGUYEN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Development of a novel antibiotic susceptibility test using Raman spectroscopy","G. Nguyen|E. Ebrahimi|M. Hermine|L. Jeff|S. Haroun|S. Ajit"
"6391","14/04 12:00","28","P1536","Bernardo Alfonso MARTINEZ-GUERRA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Penicillin-resistant, ampicillin-susceptible Enterococcus faecalis (PRASEF) strains and their extended beta-lactam resistance","R. Espinosa-González|L. Xancal-Salvador|P. Diaz-Lomeli|A. Ponce-De-Leon|M. González-Lara|R. Gamboa-Martinez|B. Martinez-Guerra"
"6458","14/04 12:00","29","P1537","Brian WERTH","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Synergy between orally bioavailable antibiotics and dalbavancin against MRSA","M. Foreman|E. Ahrendt|B. Werth"
"6485","14/04 12:00","30","P1538","Caitlin DUGGAN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","The effect of beta-lactamase genes and chromosomal gene mutations on the cefiderocol susceptibility of New Delhi metallo-beta-lactamase (NDM) producing Enterobacterales isolates from Merseyside hospitals, comparing cefiderocol antibiotic susceptibility testing methods","C. Duggan|D. Lawrie|A. Fraser|T. Neal|J. Cruise|V. Owen|F. Graf|J. Lewis|D. Cantillon|C. Brookfield|E. Heinz|T. Edwards"
"6490","14/04 12:00","31","P1539","Luis GAGO MANTILLA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of cefepime/enmetazobactam efficacy against BLEE + OXA 48 resistant strains","E. Sanchez Sanchez|B. Iturbe Sanz|L. Gago Mantilla|B. Laguna Fonseca|J. Marroyo Laso|S. Frometa Carrillo|I. Diaz De La Torre|F. Braojos Sanchez|K. Estrada Rodriguez|A. Vera Mendoza|F. Candel"
"6655","14/04 12:00","32","P1540","Gilles ZAMBARDI","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Resistance detection to fluoroquinolones by an automated AST system in Escherichia coli","D. Dechaume|C. Franceschi|G. Zambardi"
"6781","14/04 12:00","33","P1541","Al Hawaj HASSAN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of direct blood culture antimicrobial susceptibility testing in routine diagnostic settings","H. Alhawaj|N. Alghamdi|A. Sawan|M. Abdelwahab|K. Alkharsah|R. Al Jindan"
"6824","14/04 12:00","34","P1542","Elin FERMÉR","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of aztreonam/avibactam alone and in combination with colistin against ESBL- and carbapenemase-producing Klebsiella pneumoniae","E. Fermér|S. Wilson|P. Lagerbäck|L. Sandegren|T. Tängdén"
"6913","14/04 12:00","35","P1543","Anne-Christine AUST","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Influence of pH on antibiotic efficacy against uropathogenic Escherichia coli","A. Aust|F. Wagenlehner"
"6945","14/04 12:00","36","P1544","Oluwasegun DARAMOLA","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparative analysis using linear regression models to identify predictors of AMR in Africa","O. Daramola|R. Adedeji|A. Akomolafe|A. Tochukwu"
"7234","14/04 12:00","37","P1545","Andrew E. CLARK","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of rapid phenotypic antimicrobial susceptibility testing from positive blood cultures at a quaternary care academic medical centre","A. Clark|D. Desai|M. Monogue|D. Greenberg"
"7260","14/04 12:00","38","P1546","Jacqueline FINDLAY","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa","Y. Zhu|J. Findlay|M. Bouvier|Q. Yang|Y. Xu|P. Nordmann"
"7272","14/04 12:00","39","P1547","Özgen KÖSEOGLU ESER","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Identification of Corynebacterium clinical isolates at the species level using phenotypic, molecular methods and assessment of the rapid emergence of high-level resistance to daptomycin and vancomycin","T. Kucukbahar|E. Kirbas|Ö. Gurpinar Tosun|S. Unal|B. Sancak|Ö. Köseoglu Eser"
"7291","14/04 12:00","40","P1548","Dhouha KARRAY","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","The PIM test: rapid phenotypic detection of penicillinase-producing Staphylococcus aureus without zone edge reading","D. Karray|A. Zribi|M. Agsous|M. Mainardis|A. Braille|B. Berçot|F. Caméléna"
"7323","14/04 12:00","41","P1549","Vasiliki KOUMAKI","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Are disk diffusion and agar gradient diffusion reliable for mecillinam susceptibility?","V. Koumaki|J. Meletiadis|A. Tsakris|E. Voudanta"
"7345","14/04 12:00","42","P1550","Amanda ÅMAN","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Rapid susceptibility testing of cefiderocol directly from positive blood cultures using a microfluidic agar-diffusion assay","A. Aman|M. Chatzopoulou|H. Öhrn|L. Faxén|C. Johansson|A. Olsson|P. Lagerbäck|T. Tängdén|C. Malmberg"
"7473","14/04 12:00","43","P1551","Özlem Gizem NIGDELIOGLU SEZER","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Comparative evaluation of an automated antimicrobial testing system for carbapenemase detection in K. pneumoniae and E. coli isolates using CIM and genotypic methods","G. Nigdelioglu|D. Tezer|S. Özsoy|S. Tigli|N. Ulger|A. Ilki"
"7501","14/04 12:00","44","P1552","Eleni KALOGEROPOULOU","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Resistance levels to beta-lactams based on oxacillin disk difusion test in Sreptococcus pneumoniae","E. Kalogeropoulou|P. Georgiou|S. Damianidou|P. Karakosta|M. Vargiami|M. Kostoula|A. Tarpatzi|A. Vasilakopoulou|E. Oikonomoula|J. Meletiadis|S. Pournaras"
"7574","14/04 12:00","45","P1553","Arzu ILKI","1","B","03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Evaluation of an automated antimicrobial susceptibility testing system performance for colistin susceptibility in Klebsiella pneumoniae and Escherichia coli isolates","A. Ilki|D. Tezer|G. Nigdelioglu|S. Alpsoy|N. Ulger"
"109","14/04 12:00","46","P1554","Ka Lip CHEW","1","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Aztreonam/avibactam resistance rates and resistance mechanisms of NDM-carbapenemase-producing-Enterobacterales (CPE) and NDM/OXA48-like-dual-CPE in Singapore","K. Chew|J. Cabang|J. Teo"
"198","14/04 12:00","47","P1555","Bingjie WANG","1","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterisation of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae","B. Wang"
"409","14/04 12:00","48","P1556","Sophie GUILLIER","1","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterisation of DHFR mutation conferring resistance to trimethoprim in Burkholderia thailandensis","E. Schmitt|C. Lemoigne|C. Lazennec-Schurdevin|L. Mondange|O. Lamer|E. Menicacci|O. Gorgé|T. Simonson|L. Koch|J. Garrec|Y. Mechulam|F. Biot|S. Guillier"
"475","14/04 12:00","1","P1557","Han YU-LING","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Phenotypic and genomic characterisation of ST11-K1 CR-hvKP with highly homologous blaKPC-2-bearing plasmids in China","Z. Wen-Qi|H. Yu-Ling|W. Hua|Z. Hong-Zhe|H. Zhi-De"
"623","14/04 12:00","2","P1558","Tu-Hsuan CHANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Resistance mechanisms in multidrug-resistant Klebsiella pneumoniae ST792 and ST7120 strains causing invasive disease in the paediatric intensive care unit","L. Yi-Ching|C. Po-Yu|C. Wei-Yu|C. Yun|C. Yi-Hsin|H. Te-Yu|T. Hung-Jen|C. Yu-Chin|H. Chung-Han|C. Tu-Hsuan|K. Cheng-Yen"
"772","14/04 12:00","4","P1560","Raquel NUNES","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Impact of pBMB9393 plasmid in biofilm formation and autolysis in MRSA ST239","R. Soares Casaes Nunes|A. Nunes Botelho|A. Marie Sá Figueiredo"
"787","14/04 12:00","5","P1561","Kate BAKER","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Phage-plasmid borne methionine tRNA ligase mediates epidemiologically relevant antimicrobial persistence","Y. Tam|P. De Silva|C. Barker|R. Li|G. Batisti Biffignandi|L. Santos|C. Chong|L. Mason|S. Nair|P. Ribeca|S. Bayliss|C. Jenkins|S. Bakshi|J. Hall|L. Cowley|K. Baker"
"823","14/04 12:00","6","P1562","Tsuey-Ching YANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","NagX, a periplasmic b-N-acetylglucosaminidase, contributes to NagZ-independent beta-lactamase expression in Stenotrophomonas maltophilia","T. Yang|Y. Lu|E. Hu"
"826","14/04 12:00","7","P1563","Shengnan JIANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence and spread of ST5 methicillin-resistant Staphylococcus aureus with accessory gene regulator dysfunction: genomic insights and therapeutic challenges","S. Jiang|Y. Chen|Y. Yu"
"874","14/04 12:00","8","P1564","Warren ROSE","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Genetic correlates of synergy mechanisms of daptomycin plus fosfomycin in daptomycin-susceptible and -resistant methicillin-resistant Staphylococcus aureus","W. Rose|N. Mishra|S. Ersoy|W. Abdelhady|A. Elsayed|S. Baines|B. Howden|R. Proctor"
"993","14/04 12:00","9","P1565","Aimee DAUM","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Heteroresistance to polymyxin B in Acinetobacter baumannii","A. Daum|M. Attwood|K. Heesom|M. Avison|A. Macgowan"
"1061","14/04 12:00","10","P1566","Mollie M. HURST","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Tigecycline resistance in Staphylococcus aureus resulting from the combined action of tetracycline resistance determinants tetM and tetL","M. Hurst|A. O'neill|L. Galarion"
"1076","14/04 12:00","11","P1567","Laurent POIREL","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Colistin and octenidineiInduced in-vitro selective pressure on Pseudomonas aeruginosa clinical isolates: antimicrobial activity and mechanisms of cross-resistance","S. Freire|O. Hallal Ferreira Raro|P. Nordmann|L. Poirel"
"1267","14/04 12:00","12","P1568","Shen SIQUAN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Complex evolution of KPC variants conferring ceftazidime-avibactam resistance from a single patient during ceftazidime-avibactam therapy","S. Shen|H. Fupin"
"1340","14/04 12:00","13","P1569","Giovanni LORENZIN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence of Klebsiella pneumoniae ST15 isolates harbouring blaSFO-1 on a conjugative plasmid: a silent and persistent threat in community-acquired infections","G. Lorenzin|A. Casadei|P. Fassan|M. Sandei|C. Scarparo"
"1583","14/04 12:00","14","P1570","Anita NOVAK","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","High level of clindamycin resistance in clinically relevant anaerobes and emergence of cfiA gene mediated carbapenem-resistance in Bacteroides spp., a phenotypic and molecular perspective from Croatia","A. Novak|M. Lozina|J. Marinovic|I. Goic-Barisic|Z. Rubic|M. Radic-Skelin|D. Juric|M. Tonkic|M. Bogdan|J. Soki|K. Milanovic|A. Saskor"
"1584","14/04 12:00","15","P1571","Zahra SADEGHI","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Investigating the prevalence and mechanisms of antibiotic resistance in Enterobacteriaceae: insights into carbapenemase and colistin resistance genes","Z. Sadeghi|A. Aboofazeli|S. Jazayeri"
"1618","14/04 12:00","16","P1572","Maria Milagro MONTERO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Preventing OXA-type beta-lactamase producing XDR Pseudomonas aeruginosa infections: correlating clinical outcomes with hollow-fiber model results for ceftazidime/avibactam therapy","M. Montero|A. Fernandez-Munoz|S. Domene-Ochoa|S. Castaneda|I. Lopez-Montesinos|S. Cortés-Lara|S. Luque|L. Sorli Redo|E. Padilla|A. Oliver|J. Horcajada"
"1622","14/04 12:00","17","P1573","Sandra DOMENE","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Optimising ceftolozane/tazobactam therapy against OXA-type beta-lactamase producing XDR Pseudomonas aeruginosa: insights from clinical case and hollow-fiber model correlations","S. Domene-Ochoa|M. Montero|A. Fernandez-Munoz|S. Castaneda|I. Lopez-Montesinos|S. Cortés-Lara|S. Luque|L. Sorli Redo|E. Padilla|J. Horcajada|A. Oliver"
"1721","14/04 12:00","18","P1574","Piña Delgado CARMEN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Description of the first cases of GES-type Class A carbapenemase-producing Pseudomonas aeruginosa in the Canary Islands","C. Pina Delgado|C. Del Rosario-Quintana|D. Garcia Martinez De Artola"
"1845","14/04 12:00","19","P1575","Nadira RAKHI","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Tigecycline drives the adaptive evolution of TetX-positive Klebsiella pneumoniae into hyper-resistant mutants of different mucoid types","N. Rakhi|T. Lanyon-Hogg|T. Walsh"
"1983","14/04 12:00","20","P1576","Mei-Hui LIN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Energy metabolism deficiencies enhance the susceptibility of Staphylococcus aureus and its small colony variants (SCVs) to lugdunin","M. Lin"
"2147","14/04 12:00","21","P1577","Bongyoung KIM","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular and microbiological characteristics of E. coli harboring mutant CTX-M-15 (A80V)","K. Heejeong|K. Jeoungyeon|K. Jinnam|P. Se Yoon|Y. Choseok|L. Yangsoon|K. Bongyoung"
"2159","14/04 12:00","22","P1578","Sevval ARDUC","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Investigation of OXA-48 variants in Enterobacterales isolates in an OXA-48 endemic area","S. Arduç Tok|L. Genç|A. Baris|E. Aktas"
"2204","14/04 12:00","23","P1579","Piña Delgado CARMEN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Presence of the hypervirulent Clone ST23 of Klebsiella pneumoniae producing VIM-1 in the Canary Islands","C. Pina Delgado|D. Garcia Martinez De Artola|C. Del Rosario-Quintana"
"2324","14/04 12:00","24","P1580","Jee Hong KIM","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","DNA methyltransferases in Escherichia coli affects fitness and genome stability","J. Kim|K. Ko"
"2342","14/04 12:00","25","P1581","Gabriel TALTAVULL PONS","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Persistence, dissemination and evolution of IMP-15 carbapenemase-producing isolates of Pseudomonas aeruginosa in Gran Canaria","B. Taltavull|L. Iglesias-Llorente|J. Moreno-Dominguez|L. Alonso-Acero|D. Garcia Martinez De Artola|L. Floren-Zabala|G. Cabot|C. Lopez-Causape|C. Juan|A. Oliver"
"2407","14/04 12:00","26","P1582","Jocelyn TEO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterisation of major OXA-48-carrying plasmids within a tertiary healthcare institution","J. Teo|C. Tang|H. Chang|S. Tan|A. Kwa|R. Ong"
"2414","14/04 12:00","27","P1583","Koichi YAMAGUCHI","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence of novel genetic combination in blaIMP-6 encoding plasmids harboured by Enterobacterales: diverse genetic backgrounds","K. Yamaguchi|R. Nakano|A. Nakano|M. Ogawa|R. Sakata|Y. Suzuki|H. Yano"
"2421","14/04 12:00","28","P1584","Nelly ALANBARI","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Temocillin efficacy and emergence of resistance in Enterobacter cloacae complex in a murine peritonitis model","N. Alanbari|A. Amoura|F. Guérin|G. Cosson|S. Magreault|I. El Meouche|A. Lefort|B. Fantin|V. De Lastours|V. Cattoir"
"2491","14/04 12:00","29","P1585","Gabriel TALTAVULL PONS","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Description and characterisation of blaIMP-106: a new blaIMP variant from Pseudomonas aeruginosa isolated in a bacteriemia from a paediatric haematological patient in Canary Islands","B. Taltavull|N. Hernando Parreno|C. Mateo Leon|D. Garcia Martinez De Artola|G. Cabot|A. Oliver|C. Lopez-Causape"
"2608","14/04 12:00","30","P1586","Claudia VAIANA","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Whole-genome sequencing characterisation of a new KPC variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam","C. Vaiana|R. Vazzana|S. Castelbuono|A. Cona|A. Mularoni|R. Minucci|F. Monaco|D. Di Carlo|P. Conaldi|A. Gallo|N. Cuscino"
"2612","14/04 12:00","31","P1587","Tram VO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Chromosomal integration of vanA operon conferring vancomycin resistance in Enterococcus faecium: a genomic investigation","T. Vo|P. Pontarotti|J. Rolain|V. Merhej"
"2644","14/04 12:00","32","P1588","Weiwei YANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Resistance, transfer and evolution mechanism research of ceftazidime/avibactam-resistant Klebsiella pneumoniae causing nosocomial cloning spread","W. Yang|C. Tang|H. Ou|Q. Shi|Y. Guo|F. Hu"
"2646","14/04 12:00","33","P1589","Xiaobing CHU","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","A strain of Serratia marcescens exhibiting high-level tolerance to meropenem","X. Chu|Q. Yang"
"2656","14/04 12:00","34","P1590","Xiaobing CHU","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Genetic and phenotypic characterization of a novel ST45-K43 Carbapenem-resistant Klebsiella pneumoniae strain causing bloodstream infection: a potential clinical threat","X. Chu|Q. Yang"
"2716","14/04 12:00","35","P1591","Chengkang TANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular mechanisms and distribution of cefiderocol-non-susceptible NDM-producing Escherichia coli in China","C. Tang|F. Hu"
"2805","14/04 12:00","36","P1592","Kavindra SINGH","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","The GelE metalloprotease is a key modulator of the LiaFSR response against daptomycin and antimicrobial peptides through LiaX cleavage in Enterococcus faecalis","K. Singh|A. Streling|D. Panesso|W. Miller|C. Arias"
"2831","14/04 12:00","37","P1593","Diana PANESSO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","LiaF is required for LiaX-mediated protection against cell membrane acting antibiotics like daptomycin and bacitracin but not vancomycin","D. Panesso Botero|K. Singh|A. Streling|S. Gomez-Villegas|W. Miller|C. Arias"
"2903","14/04 12:00","38","P1594","Zhuoren ZHUOREN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Decreased porin transcription promotes resistance to taniborbactam when combined with meropenem","Z. Ling|Y. Zhang|A. Lankapalli|A. Farley|C. Schofield|T. Walsh"
"2949","14/04 12:00","39","P1595","Peechanika PINWEHA","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Experimental evolution of mutational pathways to aminoglycoside resistance in Escherichia coli","P. Pinweha|M. Avison"
"2954","14/04 12:00","40","P1596","Olga KOUTSOPETRA","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Investigation of carbapenem-resistant Klebsiella pneumoniae harboring double resistance mechanisms","O. Koutsopetra|S. Vourli|G. Stravopodis|S. Hatzianastasiou|S. Dimopoulos|D. Tassi-Papatheou|S. Pournaras|J. Papaparaskevas"
"3008","14/04 12:00","41","P1597","Mullika CHOMNAWANG","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterising cas gene variability and its impact on antibiotic resistance in carbapenem-resistant Acinetobacter baumannii","K. Thirapanmethee|M. Wiradiputra|N. Rojjanavijit|M. Chomnawang|P. Montakantikul|K. Taesoongnern"
"3077","14/04 12:00","42","P1598","Junxin ZHOU","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Ceftazidime/avibactam resistance characteristics emerged diversely in carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa from an intensive care unit","J. Zhou|M. Chen|M. Liang|X. Han|R. Weng|Y. Li|Y. Jiang|X. Hua|X. Du|W. Wang|Z. Zhou|Y. Yu"
"3091","14/04 12:00","43","P1599","Ryuichi NAKANO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular mechanism of Sed-1 beta-lactamase expression and high-level resistance in Citrobacter sedlakii","R. Nakano|M. Watanabe|K. Yamamoto|A. Nakano|Y. Suzuki|K. Saito|S. Nakashima|K. Endo|K. Narita|H. Yano"
"3167","14/04 12:00","44","P1600","Lydia GALVEZ BENITEZ","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","In vivo acquired-resistance to ceftazidime/avibactam, cefiderocol and meropenem/vaborbactam in KPC-producing Klebsiella pneumoniae","L. Galvez|J. Ortiz De La Rosa|G. Martin Gutierrez|Á. Rodriguez Villodres|M. Garcia Soto|J. Cisneros|J. Lepe"
"3210","14/04 12:00","45","P1601","Zitong PAN","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular mechanism of eravacycline resistance in tigecycline-nonsusceptible Acinetobacter baumannii","Z. Pan|J. Tong|L. Fu|P. Gu|Z. Wang|H. Li"
"3215","14/04 12:00","46","P1602","Arianna RODRÍGUEZ COELLO","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","In vivo efficacy of cefiderocol in a murine sepsis model against Pseudomonas aeruginosa: impact of resistance development to ceftolozane/tazobactam and ceftazidime/avibactam","A. Rodriguez Coello|M. Outeda-Garcia|L. González Pinto|P. Guijarro-Sánchez|G. Báez-Barroso|A. Garcia Pose|G. Bou Arévalo|J. Arca-Suárez|J. Vázquez Ucha|A. Beceiro|L. Sanchez Pena|T. Blanco Martin|A. Oliver"
"3264","14/04 12:00","47","P1603","Kaan KOCER","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Longitudinal antimicrobial resistance development in uropathogenic Escherichia coli in kidney transplant recipients","K. Kocer|S. Boutin|D. Nurjadi|C. Nusshag|M. Zeier|K. Heeg"
"3305","14/04 12:00","48","P1604","Albane ROZEHOLC","2","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Dual AmpC and AmpD mutations in Pseudomonas aeruginosa: unraveling the mechanisms of resistance to ceftazidime and avibactam","A. Rozenholc|L. Gonnord|L. Deroche|J. Moreau|L. Prouvensier|J. Clarhaut|S. Marchand|J. Buyck"
"3324","14/04 12:00","1","P1605","Réka MESZÉNA","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","In238 mediated dissemination of blaVIM-4 gene into various species of Enterobacterales at a university hospital in Hungary","R. Meszéna|B. Timmer|P. Urban|A. Gyenesei|T. Pál|Á. Sonnevend|L. Milo|L. Laczko|G. Kardos"
"3391","14/04 12:00","2","P1606","Katie HOPKINS","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","KHM-2, a novel metallo-carbapenemase identified in Pseudomonas mosselii","L. Dortet|D. Meunier|K. Hopkins|J. Turnbull|M. Ellington|J. Turton|J. Dicks|P. Khanna|G. Rao|N. Woodford|S. Oueslati"
"3457","14/04 12:00","3","P1607","Cristina ELÍAS LÓPEZ","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Heteroresistance to cefiderocol in clinical isolates of Stenotrophomonas maltophilia","C. Elias-Lopez|T. Blanco-Martin|R. Bonnin|L. Dortet|T. Naas|L. Martinez-Martinez"
"3513","14/04 12:00","4","P1608","Bing LI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Natural rare alleles in NucS increased mutation rates to clarithromycin and amikacin in Mycobacterium abscessus","J. Li|J. Fan|Y. Jia|R. Li|B. Li|H. Chu"
"3523","14/04 12:00","5","P1609","Yue YAO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Ribosomal mutations mediated reduced omadacycline susceptibility in Acinetobacter baumannii","Y. Yao|H. Xiaoting"
"3601","14/04 12:00","6","P1610","Ghazal SHAHROKHI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Mercury exposure stimulates colistin resistance and virulence in Acinetobacter baumannii","G. Shahrokhi|J. Boral|A. Akpinar|C. Vatansever|F. Can"
"3617","14/04 12:00","7","P1611","Laurence ARMAND-LEFEVRE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Influence of iron acquisition systems on the in vitro activity of cefiderocol on Escherichia coli","E. Mallecot|V. Berti|M. Petitjean|J. Meyer|S. Gueye|O. Clermont|G. Royer|L. Poirel|E. Denamur|L. Armand-Lefevre"
"3819","14/04 12:00","8","P1612","Eduardo PÉREZ ROTH","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Comparative in silico characterisation of plasmids carrying the high-level mupirocin resistance ileS2 gene","E. Pérez Roth|M. J. Calcutt|L. Paz Rodriguez|R. Baz Dávila"
"3888","14/04 12:00","9","P1613","Lucía GONZÁLEZ PINTO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence of resistance to beta-lactam/beta-lactamase inhibitor combinations through horizontally acquired carbapenem-hydrolysing class D beta-lactamase OXA-1054 in Pseudomonas aeruginosa sequence type 303","P. Aja-Macaya|M. Gomis-Font|L. Sanchez-Pena|S. Rodriguez-Pallares|T. Blanco-Martin|A. Beceiro|A. Oliver|G. Bou|J. Arca-Suárez|L. González-Pinto"
"3924","14/04 12:00","10","P1614","Luciano Augusto PALOMINO KOBAYASHI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Description of lysogenic phages present in carbapenem-resistant Pseudomonas aeruginosa isolates from Peru","L. Palomino-Kobayashi|F. Guzmán-Escudero|P. Fernandez-Castro|R. Gavilan|M. Pons|J. Ruiz"
"3977","14/04 12:00","11","P1615","Nadia JAIDANE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","First report of OXA-204-producing Pseudomonas guariconensis: expanding the horizon of carbapenemase dissemination","S. Karaborni|L. Dufraysseix|N. Mahdhi|A. Trabelsi|J. Madec|M. Haenni|T. Naas|N. Jaidane|W. Mansour|L. Tilouche|P. François|Y. Ben Lamine|P. Châtre|A. Lupo|S. Oueslati"
"3989","14/04 12:00","12","P1616","Sofia ASENSIO GALLEGO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular basis of amoxicillin-clavulanate resistance in clinical isolates of Escherichia coli","S. Asensio-Gallego|M. Delgado-Valverde|C. Saúco-Carballo|L. Lopez-Cerero|Á. Pascual|J. Rodriguez Bano"
"4065","14/04 12:00","13","P1617","Guillem LÓPEZ DE EGEA VEGAS","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Macrolide resistance determinants and their associations in streptococci from selected livestock and wildlife species","G. Lopez De Egea|A. Gonzalez-Diaz|V. Aragon|O. Cabezon|G. Guédon|D. Berbel|J. Espunyes|M. Planellas|M. Dominguez|N. Leblond-Bourget|C. Ardanuy"
"4181","14/04 12:00","14","P1618","Ting LUO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Dated evolutionary analysis of ST-78 A. baumannii pinpoints acquisition of antimicrobial resistance genes prior to clonal expansion and global spread","T. Luo|F. Lebreton|K. Xanthopoulou|F. Fuchs|M. Metreveli|T. Burgwinkel|N. Trapaidze|R. Arazo Del Pino|Y. Pfeifer|T. Musich|J. Bennett|P. Mc Gann|P. Higgins"
"4292","14/04 12:00","15","P1619","Thabo HAMIWE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Genomic characterisation of acquired colistin resistance determinants in Pseudomonas aeruginosa isolated from people with cystic fibrosis in Gauteng, South Africa","T. Hamiwe|V. Ueckermann|A. Smith|S. Kwenda|S. Mahabir|K. Gama|M. Ehlers"
"4349","14/04 12:00","16","P1620","Idris Nasir ABDULLAHI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Do CRISPR-Cas control the levels of plasmid-associated antimicrobial resistance genes in coagulase-negative staphylococci?","I. Abdullahi|C. Lozano|M. Zarazaga|M. Stegger|C. Torres"
"4350","14/04 12:00","17","P1621","Rachael DELLAR","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Jumping to conclusions: the role of tetM in Group B Streptococcus (GBS) evolution","R. Dellar|D. Jamrozy|U. Khan|H. Hung|O. Lorenz|S. Bentley"
"4410","14/04 12:00","18","P1622","Vincent JEAN-PIERRE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Linezolid-resistance in the Finegoldia genus: a yet undescribed resistance emergent in bone infections","M. Moulieras|V. Jean-Pierre|A. Pantel|J. Lavigne|A. Boudet|H. Marchandin"
"4627","14/04 12:00","19","P1623","Romina PAPA-EZDRA","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Multiple dissemination mechanisms of blaNDM-1 in a single institution revealed by whole-genome sequencing","F. Ferreira|L. Caiata|R. Papa-Ezdra|N. Cordeiro|M. Outeda|P. Ávila|P. Gadea|R. Palacio|V. Garcia-Fulgueiras|V. Seija|R. Vignoli|I. Bado"
"4765","14/04 12:00","20","P1624","Sandra Y. SAAVEDRA","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","First detection of plasmid-mediated PAC-2 beta-lactamase conferring resistance to ceftazidime/avibactam in Klebsiella quasipneumoniae ST526","E. Montilla|M. Ovalle|J. Triana|Y. Torres|N. Vargas|A. Gutierrez|A. Barrera|C. Duarte|S. Saavedra|D. Garcia|H. Amaya"
"4768","14/04 12:00","21","P1625","Tanzina AKTER","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Comparative molecular study of virulence factors and antibiotic resistance between exoU and exoS Pseudomonas aeruginosa from microbial keratitis","T. Akter|F. Stapleton|M. Willcox"
"4795","14/04 12:00","22","P1626","Jeong Hwan SHIN","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence of blaCTX-M-65 producing non-typhoidal Salmonella isolates in Korea","J. Shin|H. Choi|S. Kim|Y. Kim|N. Ryoo|J. Shin|K. Shin|Y. Uh|S. Kim|J. Lee|E. You|S. Jeong|H. Kim|Y. Kim|E. Kim|J. Cho"
"4812","14/04 12:00","23","P1627","Vera SCHWIERZECK","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","A dominant antimicrobial resistance plasmid in multidrug-resistant Escherichia coli isolates of a tertiary care hospital","A. Sobkowiak|N. Scherff|F. Schuler|A. Mellmann|V. Van Almsick|V. Schwierzeck"
"4817","14/04 12:00","24","P1628","Rafael VIGNOLI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","First national survey of antibiotic susceptibility in E. coli isolated from urine cultures in Uruguay and the emergence of blaCTX-M-27 in human clinical isolates in South America","N. Cordeiro|A. Inchausti|M. Acevedo|V. Garcia|I. Bado|R. Papa|C. Mogdasy|T. Camou|M. Lopez|P. Ávila|V. Seija|A. Galiana|B. Maidana|C. Gutierrez|M. Outeda|L. Anzalone|M. Klein|N. Burger|P. Aguerrebere|G. Rodriguez|C. Gomez|E. Isper|E. Nikichuk|F. Crossa|I. Mota|R. Vignoli"
"4932","14/04 12:00","25","P1629","Chandrayee DESHAMUKHYA","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Sub-inhibitory concentration of imipenem exposure influences the transcriptional response of auto-inducer II quorum-sensing system in Escherichia coli harbouring blaNDM","C. Deshamukhya|S. Ahmed|B. Das|D. Dhar|A. Bhattacharjee"
"4948","14/04 12:00","26","P1630","Cristina ELÍAS LÓPEZ","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Phenotypic and kinetic characterisation of in vivo selected KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam","B. Iorga|L. Martinez-Martinez|T. Naas|C. Elias-Lopez|S. Oueslati|C. Riazzo|O. Vanparis"
"4983","14/04 12:00","27","P1631","Christophe LE TERRIER","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","The emerging concern of IMP variants being resistant to the only IMP-type metallo-beta-lactamase inhibitor, xeruborbactam","C. Le Terrier|P. Nordmann|J. Pitout|S. Drusin|G. Peirano|A. Vila|D. Moreno|L. Poirel"
"5011","14/04 12:00","28","P1632","Selin BELGE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Hypervirulance profiling of Klebsiella pneumoniae in abscess samples","M. Uygun|N. Ataç|S. Belge|Z. Kuloglu|F. Can|E. Aktas|C. Vatansever|S. Sahin|A. Baris|A. Oncul"
"5019","14/04 12:00","29","P1633","Ángela ALCARAZ MARTÍNEZ","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Drugging the epigenome: G4s as a new therapeutical target in bacteria","Á. Alcaraz Martinez|P. Munoz Baez|B. Garcia Perez|M. Pérez Soto|P. Penalver|J. Morales|R. Cebrián Castillo"
"5242","14/04 12:00","30","P1634","Julian SOMMER","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterisation of the novel carbapenemase OXA-1207","M. Welter|S. Göttig|L. Ilievski|J. Sommer"
"5369","14/04 12:00","31","P1635","Blandine HAREL","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Identification of the RamR regulon of Enterobacter cloacae complex by omic approaches","B. Harel|F. Gravey|B. Bernay|E. Lequesne|F. Guérin|S. Le Hello|J. Giard"
"5387","14/04 12:00","32","P1636","Sophie Alexandra BARON","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","The role of the AcrAB-TolC efflux pump in glyphosate tolerance and its antagonistic effect with ciprofloxacin in Escherichia coli","H. Zerrouki|L. Hadjadj|M. Hamel|A. Hamieh|J. Rolain|S. Baron"
"5399","14/04 12:00","33","P1637","Melina RUGGIERO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Phenotypic and kinetic characterisation of PER-14: a novel beta-lactamase variant resistant to avibactam and relebactam","M. Ruggiero|M. Garcia Alonso|J. Briceno Munoz|G. Gutkind|P. Power"
"5403","14/04 12:00","34","P1638","Reham SOBHY","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Development of Colistin Resistance is associated with loss Of Hypermucoviscocity phenotype In CR-HVKP","R. Sobhy|M. Lotfi|M. Elanany|L. Shalaby|A. Sayed|D. Jalal"
"5411","14/04 12:00","35","P1639","Laurent DORTET","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Diversity and characterisation of intrinsic Ambler class B metallo-beta-lactamases in Sphingobacterium spp.","D. Girlich|C. Emeraud|A. Jacquemin|S. Oueslati|D. Essaleh|L. Latour|R. Bonnin|L. Dortet"
"5420","14/04 12:00","36","P1640","Coraline BERNACHOT","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Comparative genomic analysis identifies specific genes associated with a high-risk diffusion Klebsiella pneumoniae ST405 intensive care unit clone","C. Bernachot|B. Langlois|N. Nesi|O. Join-Lambert|F. Gravey|S. Le Hello|N. Laquay|D. Du Cheyron"
"5479","14/04 12:00","37","P1641","Yolanda SAENZ","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Genomic islands as drivers of carbapenem resistance and virulence in Pseudomonas aeruginosa ST235","M. Lopez|B. Rojo-Bezares|M. Fethi|G. Ochi|N. Klibi|Y. Sáenz"
"5553","14/04 12:00","38","P1642","Alessandra PICCIRILLI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Exploring the whole-genome of XDR A. baumannii strains isolated from patients treated with cefiderocol","S. Di Marcantonio|A. Piccirilli|L. Torrini|F. Diaco|F. Sacco|A. Oliva|G. Raponi|G. Antonelli|M. Perilli"
"5572","14/04 12:00","39","P1643","Nikita KARMAKAR","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","An elevated expression of mrcB is an indicative potential biomarker for AMR detection","N. Karmakar|R. Chakraborty|K. Das|J. Wangkheimayum|A. Bhattacharjee"
"5631","14/04 12:00","40","P1644","Alessandra PICCIRILLI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Improvement of hydrolytic activity against meropenem in NDM-1Q123Y variant: first identification in a P. aeruginosa clinical strain","A. Piccirilli|L. Torrini|F. Diaco|S. Di Marcantonio|A. Viscido|M. Perilli|G. Antonelli|G. Raponi"
"5634","14/04 12:00","41","P1645","Inés BADO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","First report of CTX-M-15-producing Salmonella enterica ser. Typhimurium (S. Typhimurium) in South America","N. Cordeiro|V. Garcia-Fulgueiras|R. Papa-Ezdra|I. Mota|I. Bado|R. Vignoli"
"5681","14/04 12:00","42","P1646","Lisa-Marie HÖFKEN","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","First characterisation of newly discovered extended spectrum betalactamase SED-2","L. Höfken|S. Gatermann|N. Pfennigwerth"
"5789","14/04 12:00","43","P1647","Bálint TIMMER","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Plasmid network analysis reveals key drivers of third generation cephalosporin resistance in urinary Escherichia coli isolates","B. Timmer|M. Szabo|R. Meszéna|L. Laczko|L. Milo|P. Urbán|A. Gyenesei|G. Kardos|T. Pál|Á. Sonnevend"
"5870","14/04 12:00","44","P1648","Pia TUROWSKI","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Influence of ligand gated ion channel on cefiderocol susceptibility in clincal E. hormaechei isolates","P. Turowski|S. Gatermann|N. Pfennigwerth"
"5871","14/04 12:00","45","P1649","Roberto SIERRA","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Production of multiple carbapenemases linked to heteroresistance in Enterobacterales","R. Sierra|B. Castro|M. Roch|E. De La Cadena|J. Garcia-Betancur|M. Villegas|D. Andrey"
"5894","14/04 12:00","46","P1650","Roberta Maria ANTONELLO","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Activity of zidovudine against carbapenemase-producing Enterobacterales, including cefiderocol and aztreonam/avibactam resistant isolates, and characterisation of in vitro selected resistant isolates","R. Antonello|N. Aiezza|M. Coppi|A. Antonelli|C. Niccolai|A. Farese|T. Giani|A. Bartoloni|G. Rossolini"
"5899","14/04 12:00","47","P1651","Jacqueline FINDLAY","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","In vivo development of high-level cefiderocol and ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase, EnvZ","J. Findlay|G. Bianco|M. Boattini|P. Nordmann"
"5925","14/04 12:00","48","P1652","Thabo HAMIWE","3","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Characterisation of plasmids harboured by drug-resistant Acinetobacter baumannii isolates and their role in antibiotic resistance","J. Potgieter|J. Pitout|T. Govender|T. Hamiwe|C. Buys|M. Ehlers|M. Kock"
"5934","14/04 12:00","1","P1653","Maria AZNAR FERNANDEZ","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Carbapenem resistance mechanisms in Bacteroides spp.","M. Aznar Fernández|J. Ortiz De La Rosa|M. Gomez Gomez|Á. Rodriguez Villodres|J. Cisneros|J. Lepe"
"6017","14/04 12:00","2","P1654","Iván BLOISE","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Clonal analysis of multidrug-resistant Pseudomonas aeruginosa: differences between carbapenemase-producing and non-carbapenemase-producing isolates","C. Sanz-González|M. Amoroto-Bengoetxea|F. Lázaro-Perona|J. Mingorance|J. Cacho-Calvo|I. Bloise"
"6144","14/04 12:00","3","P1655","Arwa AL RUJAIBI","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Detection of OXA-48-like in carbapenem-resistant Klebsiella pneumonia: a challenge for diagnostic microbiological laboratories","A. Al Rujaibi|M. Rizvi|Z. Aljabri"
"6319","14/04 12:00","4","P1656","Alice FRASER","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","A high-resolution genomic and phenotypic analysis of resistance evolution of an Escherichia coli strain from a critically unwell patient treated with piperacillin/tazobactam","A. Fraser|R. Ball|D. Cantillon|L. Brettell|F. Graf|J. Munnoch|P. Hoskisson|J. Lewis|J. Van Aartsen|C. Parry|E. Heinz|T. Edwards"
"6466","14/04 12:00","5","P1657","Vicky BENNETT","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Correlating phenotypic and genotypic determinants of biocide tolerance and adaptation in Proteus mirabilis","V. Bennett|O. Clarke|M. Ravari|E. Denham|B. Jones"
"6508","14/04 12:00","6","P1658","Jane FREEMAN","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Are we overdosing with vancomcyin? Eagle effect of vancomycin against Clostridioides difficile observed in vitro","C. Normington|E. Clark|K. Bentley|J. Altringham|A. Berry|W. Spittle|D. Ewin|A. Kirby|M. Wilcox|K. Davies|J. Freeman"
"6535","14/04 12:00","7","P1659","Wadha ALFOUZAN","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Molecular detection of gyr A and par C mutations in clinical isolates of Pseudomonas aeruginosa obtained from Farwaniya hospital in Kuwait","W. Al-Fouzan|A. Mustafa|R. Al-Thaferi"
"6562","14/04 12:00","8","P1660","Hanife TUTAN","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Distribution of carbapenemase genes in A. baumannii isolates in a region with high carbapenem resistance","H. Tutan|B. Mazlumoglu|E. Tanriverdi|L. Genç|Z. Çizmeci|M. Bulut|E. Aktas"
"6579","14/04 12:00","9","P1661","Frank WILLIAMS","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","IncHI2 plasmids drive dissemination of carbapenemase gene blaIMP among healthcare-associated Enterobacterales in the UK, 2014-2022","F. Williams|Y. Wan|F. Davies|K. Hopkins|E. Jauneikaite"
"6626","14/04 12:00","10","P1662","Scott PALLETT","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Evolving characteristics of multidrug-resistant Gram-negative conflict-associated wound infections in Ukraine, 2024","S. Pallett|A. Morkowska|S. Woolley|V. Potochilova|K. Rudnieva|O. Iungin|V. Sgro|S. Boyd|Z. Lambert|N. Reece|N. Tan|N. Mughal|M. O'shea|L. Moore|O. Moshynets"
"6638","14/04 12:00","11","P1663","Laura LEAL-VÉLEZ","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","The role of Pseudomonas aeruginosa extracellular vesicles in antimicrobial resistance and virulence","L. Leal-Vélez|B. Rojo-Bezares|M. Lopez|E. Martinez-Gorgonio|P. Lozano-Zarain|L. Álvarez-Erviti|Y. Sáenz"
"6663","14/04 12:00","12","P1664","Sirine MEJRI","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Prevalence and genetic characterisation of carbapenem-resistance mechanisms and integrons in Pseudomonas aeruginosa isolates from poultry in Tunisia","S. Mejri|H. Ben Yahia|M. Pino-Hurtado|C. Torres Manrique|K. Ben Slama"
"6787","14/04 12:00","13","P1665","Yingying DU","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Scarless excision of an insertion sequence in the OmpK36 promoter restores meropenem susceptibility in a non-carbapenemase-producing Klebsiella pneumoniae","Y. Du"
"6949","14/04 12:00","14","P1666","Xiaojuan WANG","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Emergence of polymyxin B-resistant Klebsiella pneumoniae in experiment tigecycline resistance evolution without exposure to polymyxin B","J. Kuai|Y. Zhao|X. Wang"
"6997","14/04 12:00","15","P1667","Matteo CECCARELLI","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Understanding bacterial resistance mechanisms: insights from porin mutations in Klebsiella pneumoniae","M. Ceccarelli|G. Serci|S. Milenkovic"
"7010","14/04 12:00","16","P1668","Yolanda SAENZ","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Antimicrobial resistance and virulence in Pseudomonas aeruginosa strains from hospitalised COVID-19 patients in an international hospital","G. Ochi|B. Rojo-Bezares|M. Lopez|P. Toledano|S. Melki|I. Ouzari|N. Klibi|Y. Sáenz"
"7069","14/04 12:00","17","P1669","Terri CAMESANO","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Mechanisms of antimicrobial peptide and antibiotic interactions on membrane permeabilisation and deactivation of Escherichia coli","W. Han|T. Camesano"
"7275","14/04 12:00","18","P1670","Camille COTET","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Pseudomonas aeruginosa mechanisms involved in decreased susceptibility to a quaternary ammonium compound","C. Cotet|B. Langlois|S. Galopin|F. Gravey|S. Le Hello|L. Rodrigues"
"7293","14/04 12:00","19","P1671","Dhouha KARRAY","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Staphylococcus aureus bacteraemia: detection and characterisation of blaZ","D. Karray|A. Zribi|M. Agsous|M. Minardis|A. Braille|B. Berçot|F. Caméléna"
"7347","14/04 12:00","20","P1672","Riccardo POLANI","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Engineered conjugative vectors as vehicles to study resistance and virulence in Klebsiella pneumoniae","R. Polani|A. De Francesco|M. Equestre|G. Arcari|G. Prosseda|B. Colonna|A. Carattoli"
"7348","14/04 12:00","21","P1673","Thierry NAAS","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Role of S155, D159 and R214 amino-acid residues in the active site of OXA-48 variants","R. Nermont|S. Oueslati|P. Retailleau|D. Girlich|L. Dortet|R. Bonnin|B. Iorga|T. Naas"
"7357","14/04 12:00","22","P1674","Cansel VATANSEVER","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Integrated genomic and transcriptomic analysis of multi-drug resistant colistin tolerant Pseudomonas aeruginosa to identify tolerance related genes","S. Kolsuz|C. Vatansever|A. Akpinar|J. Boral|G. Ozcan|M. Gönen|F. Can"
"7366","14/04 12:00","23","P1675","Valerio CAPITANI","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","In vivo emergence of cefiderocol resistance in both Klebsiella pneumoniae and Acinetobacter baumannii during prolonged treatment in a single patient","V. Capitani|D. Tomolillo|A. De Francesco|G. Arcari|M. Ceparano|R. Polani|A. Carattoli|P. Villari|C. Marzuillo"
"7508","14/04 12:00","24","P1676","Christian VON WINTERSDORFF","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Prevalence of vancomycin variable enterococci in the Netherlands and the mechanism of resistance induction","C. Von Wintersdorff|M. Roelofsen|L. Versteegh|C. Jamin|Y. Benyahya|M. Mulder|M. Van Meer|J. Flipse"
"7641","14/04 12:00","25","P1677","Stefano Adrián ENDARA REGALADO","4","B","03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Plasmid-mediated antimicrobial resistance in Enterobacter cloacae blood isolates: a bioinformatic approach","S. Endara Regalado|E. Cano Ocana|M. Montalvo Lalaleo|D. Pérez Rueda|D. Endara Sánchez|J. Acosta-Espana|A. Herrera-Yela"
"247","14/04 12:00","26","P1678","Sheeba Santhini BASIL","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Transcriptomic analysis of ceftriaxone tolerant- phenotypes of Neisseria gonorrhoeae reveals downregulation of ribosomal gene expression","S. Manoharan-Basil|M. Balduck|Z. Gestels|S. Abdellati|T. Block|C. Kenyon"
"295","14/04 12:00","27","P1679","Christen ARENA","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Whole-genome analysis of extensively drug-resistant Enterobacter hormaechei isolated from two US hospitalised patients","G. Suleyman|J. Kaur|M. Veve|R. Tibbetts|C. Arena"
"782","14/04 12:00","28","P1680","Jiaxin YU","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Predicting carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures with MALDI-TOF mass spectrometry and machine learning","J. Yu|S. Chang|Y. Peng|S. Lin|C. Chin"
"846","14/04 12:00","29","P1681","Abdurrahman Hassan JIBRIL","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic characterisation of zoonotic multidrug-resistant Salmonella isolated from slaughtered chickens in northwest Nigeria","A. Jibril|G. Mahouton|I. Okeke|A. Dalsgaard|J. Olsen"
"924","14/04 12:00","30","P1682","Eva NAUMANN","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Clinical performance of the RIDA GENE MRSA real-time PCR assay in human nasal/throat swabs, wound swabs, and culture under IVDR","A. Hiergeist|S. Förster|U. Reischl|S. Hammer|E. Naumann"
"1100","14/04 12:00","31","P1683","Abdulaziz ASCANDARI","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Integrative metagenomics and an ensemble learning model reveals novel microbial biomarkers and pathogenic elements in colorectal cancer patients","A. Ascandari|S. Aminu|R. Daoud"
"1255","14/04 12:00","32","P1684","Kasim ALLEL","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Advancing monitoring and prediction of antimicrobial resistance trajectories using flexible spatiotemporal modelling: a roadmap for early warning systems","K. Allel|D. Smith|N. Nguyen|S. Lipworth|K. Pouwels"
"1320","14/04 12:00","33","P1685","Daniel PABLO MARCOS","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Optimising an accurate amplification-free CRISPR/Cas12a-based assay for GES beta-lactamases detection","D. Pablo|L. Fernández|J. Rodriguez|N. Fraile|O. Pacios|C. Ortiz|S. Garcia|S. Garcia|L. Blasco|A. Ocampo Sosa|J. Calvo|M. Tomás|R. Maria Pia"
"1464","14/04 12:00","34","P1686","Sanne VAN DEN BERG","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Pilot study on development of a fast clinical diagnostic test to detect synergy between two antibiotics using growth curve kinetics","S. Van Den Berg|W. De Jong|C. Boonman|M. Ten Kate|B. Koch|M. Bexkens|A. Muller"
"1505","14/04 12:00","35","P1687","Camille HAMULA","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Comparative performance of two PCR-based platforms for the detection of Staphylococcus aureus small colony variants","C. Hamula|N. Mehta|C. Carson|G. Tyrrell|J. Pilon"
"1556","14/04 12:00","36","P1688","Bin SUN","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Comparative analysis of rapid phenotypic tests for carbapenem-resistance in Aeromonas","H. Liu|L. Zhang|Y. Wang|B. Sun"
"1581","14/04 12:00","37","P1689","Quentin J LECLERC","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rethinking AMR sampling: can non-sterile samples predict resistance in blood/sterile samples at a country level?","Q. Leclerc|A. Kovacevic|G. Knight|L. Opatowski|C. Moore"
"1589","14/04 12:00","38","P1690","Henar ALONSO-EZCURRA","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Clinical performance evaluation of a vancomycin resistance real time PCR assay in the context of a vanB-carrying Enterococci outbreak in a tertiary hospital in Spain","B. Dehesa-Garcia|A. Milagro-Beamonte|P. Abad|B. Fortuno|C. Lopez|A. Rezusta|H. Alonso-Ezcurra|N. Martinez-Cameo|B. Gilaberte-Angos|D. Martinez-Mateos|M. Alejandre-Alegre|C. Escolar|A. Lopez"
"1770","14/04 12:00","39","P1691","Sylvia VALDEZATE","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Tracking the emergence of cephalosporinase cepA and carbapenemase cfiA Bacteroides hominis (former Bacteroides fragilis division II) strain","S. Valdezate|M. Medina-Pascual|F. Cobo|N. Garrido|S. Monzon|I. Cuesta|P. Villalon"
"1835","14/04 12:00","40","P1692","Hawa AHMED","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Using random mutagenesis to predict mutations within the KPC-2 gene that confer resistance to beta-lactam/beta-lactamase inhibitor combinations","H. Ahmed|M. Domingo-Sananes|G. Mcvicker|A. Hubbard"
"1915","14/04 12:00","41","P1693","Maria De Las Huertas GARCIA ATIENZA","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Use of melting curve assays for the characterisation of macrolides and fluoroquinolones resistance in Mycoplasma genitalium","C. Mateo Leon|B. Pino Calm|D. Garcia Martinez De Artola|M. Garcia Atienza|N. Hernando Parreno|J. Alcoba Florez"
"2121","14/04 12:00","42","P1694","Zaaima AL-JABRI","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Antibiotic resistance and genetic determinants in Helicobacter pylori: insights from Omani clinical isolates","A. Al-Hinai|M. Rizvi|S. Al Busafi|M. Kashoob|Z. Al Muharrmi|A. Al-Darmaki|Z. Al Jabri"
"2368","14/04 12:00","43","P1695","Tim T. SEVERS","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Optimising long-read sequencing for AMR gene detection: a comparative study","T. Severs|A. Bari|M. Cardoso|N. Couto|S. Debast|H. Gremmels|B. Xavier|B. Sinha|J. Rossen"
"2509","14/04 12:00","44","P1696","Ivan BARISIC","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","A DNA nanopore sensor for the rapid detection of antibiotic resistance","J. Andersson|N. Mutter|I. Barisic"
"2848","14/04 12:00","45","P1697","Tin Long LUI","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Evaluation of Bacteroides fragilis cfiA subtyping by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry and comparison of EUCAST and CLSI based susceptibility testing","T. Lui|R. Wong|I. Cheung|V. Chow|A. Lee"
"2998","14/04 12:00","46","P1698","Noelia HERNANDO PARREÑO","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic analysis of invasive Streptococcus pneumoniae isolates in the Canary Islands: role of penicillin-binding protein transpeptidase domains in predicting beta-lactam susceptibility","N. Hernando Parreno|D. Garcia Martinez De Artola|C. Mateo Leon|J. Alcoba Florez"
"3030","14/04 12:00","47","P1699","Nanphanita CHOMNAWANG","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rapid and cost-effective detection of blaOXA-23-like carbapenemase genes in Acinetobacter baumannii using the LAMP technique","N. Chomnawang|T. Pholthong|K. Thirapanmethee"
"3108","14/04 12:00","48","P1700","Kaisu Hellevi RANTAKOKKO-JALAVA","4","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Importance of rapid species identification vs rapid AST in processing positive blood cultures","K. Rantakokko-Jalava|V. Pirhonen|D. Riihiaho|A. Pietikäinen"
"3147","14/04 12:00","1","P1701","Stefano MANCINI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Diagnostic algorithm for the detection of carbapenemases and extended spectrum beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa","S. Mancini|L. Garcia-Verellen|H. Seth-Smith|P. Keller|N. Kolesnik-Goldmann|M. Ali Syed|I. Ullah|T. Roloff|V. Hinic|A. Egli|O. Nolte"
"3288","14/04 12:00","2","P1702","Christophe LE TERRIER","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rapid NP detection of cefepime/taniborbactam susceptibility/resistance in Enterobacterales","C. Le Terrier|A. Kerbol|M. Bouvier|L. Poirel|P. Nordmann"
"3511","14/04 12:00","3","P1703","Mahkameh SALEHI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Antibiotic resistance in metagenomes on global and population scales","K. Pärnänen|M. Ruuskanen|M. Salehi|S. Bhanushali|S. Guilhem|V. Laitinen|G. Meric|M. Inouye|R. Knight|V. Salomaa|A. Havulinna|T. Niiranen|J. Bengtsson-Palme|P. Collignon|L. Lahti"
"3922","14/04 12:00","4","P1704","Lorena LÓPEZ CERERO","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rapid detection of temocillin resistance in third-generation cephalosporin resistant Enterobacteriaceae","J. Rodriguez Ochoa|Á. Bulnes-Ramos|A. Velázquez-Escudero|J. Rodriguez-Bano|F. Docobo-Pérez|Á. Pascual|L. Lopez Cerero"
"4145","14/04 12:00","5","P1705","Geehan SULEYMAN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic analysis of vancomycin-resistant Staphylococcus aureus","G. Suleyman|J. Kaur|M. Zervos"
"4176","14/04 12:00","6","P1706","Vittoria MATTIONI MARCHETTI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Klebsiella pneumoniae ST22: a novel menace?","V. Mattioni Marchetti|S. Gaiarsa|A. Piazza|F. Piscopiello|I. Petrizzi|R. Migliavacca"
"4206","14/04 12:00","7","P1707","Sandra A. MARTÍNEZ-ÁLVAREZ","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic insights into CRISPR-Cas systems vsvirulence platforms and drug resistance among Escherichia coli isolates","S. Martinez-Alvarez|S. Herrera-Espejo|M. Zarazaga|J. Madec|M. Haenni|M. Pachon-Ibanez|C. Torres"
"4265","14/04 12:00","8","P1708","Marcelo PILLONETTO","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Analysis of available Phytobacter spp. genomes indicates the emergence of a potential new multidrug-resistant opportunistic pathogen within the Enterobacterales","M. Pillonetto|L. Oliveira De Morais|G. Vizentainer|D. N. O. Kulek|J. F. C. Neto|G. A. Gonçalves|H. R. S. D'espindula|F. Rezzonico|T. H. M. Smiths"
"4544","14/04 12:00","10","P1710","Liang-Chun LIU","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Development and comparative evaluation of antimicrobial resistance quality control materials through absolute quantification using ddPCR and dPCR systems","L. Liu|T. Sung|N. Umblas|R. Feigelman|S. Dimmer|Q. Gan"
"4574","14/04 12:00","11","P1711","Shivang BHANUSHALI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Shared resistome and mobilome in global human and poultry gut metagenomes","S. Bhanushali|K. Pärnänen|M. Beracochea|V. Kale|A. Escobar|L. Richardson|R. Finn|L. Lahti"
"4682","14/04 12:00","12","P1712","Scaccia NAZARENO","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Development of loop-mediated isothermal amplification (LAMP)-based assay for rapid detection of fosfomycin resistance gene","N. Scaccia|L. Silva Figueiredo|I. Van Der Heijden Natário|S. Figueiredo Costa"
"4761","14/04 12:00","13","P1713","Bernardo Alfonso MARTINEZ-GUERRA","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Development of a clinical scoring system to predict carbapenem-resistant Enterobacterales in patients with pneumonia","D. Seniscal-Arredondo|G. Santos-Vázquez|S. Rodriguez-Cortez|L. Xancal-Salvador|M. González-Lara|A. Ponce-De-Leon|B. Martinez-Guerra"
"4865","14/04 12:00","14","P1714","Diego JOSA","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rectal resistome analysis of patients colonised and non-colonised by carbapenemases by PCR and hybridisation","D. Josa|D. Martinez|A. Pescador|P. Trujillo|R. Leal|R. Benavides|D. Montano|E. Silva|J. Osorio|P. Hernandez|J. Mejorano|S. Rodriguez|I. Torres|F. Cortes"
"4901","14/04 12:00","15","P1715","Junbum LEE","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Comparative genomic analysis of extended spectrum beta-lactamase (ESBL) producing Salmonella enteritidis showed ESBL dissemination pattern mediated by transposon Tn21","J. Lee|H. Song|J. Moon|S. Cho"
"4938","14/04 12:00","16","P1716","Shristi MAHABIR","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Mutational analysis of hypermutable Pseudomonas aeruginosa from people with cystic fibrosis in South Africa","S. Mahabir|T. Hamiwe|A. Smith|K. Kopotsa|S. Kwenda|C. Van Wyk|M. Ehlers"
"5055","14/04 12:00","17","P1717","Cristina RIAZZO","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Cefiderocol resistance in clinical isolates of KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: molecular insights","C. Riazzo|C. Elias-Lopez|M. Munoz-Rosa|R. Pedraza-Merino|I. Gracia-Ahufinger|I. Machuca|J. Torre-Cisneros|J. Arca-Suárez|G. Bou|L. Martinez-Martinez"
"5068","14/04 12:00","18","P1718","Diego JOSA","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Suboptimal performance of three screening methods in rectal swab for the detection of carbapenemase-producing Gram-negative bacilli","D. Josa|E. Silva|D. Martinez|A. Pescador|P. Trujillo|J. Osorio|R. Leal|P. Hernandez|S. Rodriguez|I. Torres|F. Cortes"
"5093","14/04 12:00","19","P1719","Mairead SKALLY","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Are cycle threshold (Ct) values useful for predicting culture results of molecular positive carbapenemase producing Enterobacterales (CPE) screening samples?","M. Skally|J. Cafferky|M. Russell|L. Mc Brierty|R. Bijoy|K. Burns|K. Bennett|H. Humphreys|F. Fitzpatrick"
"5193","14/04 12:00","20","P1720","Sara CARLONI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Novel chromosomal target of cefiderocol resistance in Acinetobacter baumannii: a genomic and functional analysis to identify and validate in vivo acquired chemoresistance","L. Morosi|D. Golzato|B. Linda|H. Guma|F. Tordato|F. Armanini|Z. Asif|F. Carella|P. Morelli|M. Bartoletti|G. Da Rin|E. Casari|G. Martano|M. Rescigno|N. Segata|S. Carloni|V. Cento"
"5285","14/04 12:00","21","P1721","Yunus Emre TOK","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Investigation of a modified carbapenem inactivation method for rapid detection and characterisation of carbapenemase production in Klebsiella pneumoniae isolates from blood culture","Y. Tok|B. Bayraktar"
"5296","14/04 12:00","22","P1722","Riyad RAZZOUK","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Methyltransferases in candidate phyla radiation: a weapon or a simple shield?","R. Razzouk|J. Rolain|F. Bittar"
"5363","14/04 12:00","23","P1723","Alexandros GRECO","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Evaluation of a diagnostic algorithm for rapid detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures","A. Tychala|Z. Sereni|G. Meletis|P. Trikoupis|Z. Tsinaris|C. Katsanou|A. Greco|O. Vasilaki|G. Kagkalou|P. Mantzana|L. Skoura|E. Protonotariou"
"5409","14/04 12:00","24","P1724","Stefanus Petrus RAUTENBACH","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Simple models can be used to assess impact of antibiotic consumption on resistance in critical priority bacteria and the role of interventions in its reduction","T. Maguire|S. Rautenbach"
"5567","14/04 12:00","25","P1725","Frederic LAURENT","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","A long-awaited tool for reliable detection of staphylococcal penicillinase using an innovative fluorogenic probe","C. Dupieux-Chabert|P. Martins-Simoes|B. Youenou|F. Vandenesch|A. Tristan|F. Laurent"
"5657","14/04 12:00","26","P1726","Ema HOLUBOVÁ","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","whole-genome sequencing of linezolid-resistant Enterococcus faecium: unravelling resistance mechanisms and outbreaks","S. Hodová|M. Lengerová|E. Holubová|M. Bezdicek|M. Jakubickova|I. Kocmanová|P. Kubackova"
"5686","14/04 12:00","27","P1727","Jennifer LAWRENCE","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Iridium oxide-based biosensors towards the quantification of ESBL production","J. Lawrence|D. O' Hare|M. Sutton|T. Rawson|A. Holmes"
"5707","14/04 12:00","28","P1728","Yiyi CHEN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Widespread diversity of fosfomycin resistance gene in Staphylococci: a silent threat","Y. Chen|Y. Yu|Y. Chen"
"5755","14/04 12:00","29","P1729","Bryan VAN DEN BRAND","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","CefiderocolFinder: a pipeline to detect genetic adaptations implicated in cefiderocol resistance in multidrug-resistant microorganisms of Ukrainian patients in the Netherlands","B. Van Den Brand|D. Notermans|N. Verkaik|A. Hendrickx"
"5883","14/04 12:00","30","P1730","Ozlem KOYUNCU OZYURT","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Molecular mechanisms of CAZ-AVI resistance in K. pneumoniae from a tertiary care hospital in Turkey","O. Koyuncu Ozyurt|S. Oueslati|T. Karpuz|I. Mehidi|H. Yazisiz|M. Ogunc|D. Colak|T. Naas"
"6028","14/04 12:00","32","P1732","Guillermo Carlos MARTÍNEZ CARRIÓN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Evaluation of a rapid automatised system for MDR bacteria carriers detection on ICU patients","G. Martinez-Carrion|A. Campos-Baranda|A. Aguinaga|A. Bejarano-Suarez|J. Lobo-Palanco|C. Ezpeleta"
"6069","14/04 12:00","33","P1733","Callebaut CALLEBAUT","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Expediting carbapenemase-producing Enterobacterales detection in positive blood cultures","K. Callebaut|T. Chin|M. Reynders|A. Muyldermans|K. Floré"
"6089","14/04 12:00","34","P1734","Arnaud CHALIN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures using the NG-TEST blood culture PREP and the NG-TEST CARBA 5 assays","S. Oueslati|D. Girlich|S. Bernabeu|G. Orlandi|B. Baumy|L. Francius|A. Chalin|T. Naas"
"6169","14/04 12:00","35","P1735","Amal BERRIRI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Detection of carbapenemases in extensively-drug resistant Klebsiella pneumoniae","A. Berriri|Y. Ben Lamine|N. Jaidane|A. Lazzem|F. Azouzi|L. Tilouche|S. Boughattas|S. Ketata|A. Trabelsi|O. Saoussen|T. Naas"
"6232","14/04 12:00","36","P1736","Arnaud CHALIN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Evaluation of the NG-TEST blood culture PREP kit for ESBL detection directly from positive blood cultures using the NG-TEST CTX-M MULTI lateral flow immunoassay","S. Oueslati|N. Visvanathan|G. Orlandi|B. Baumy|L. Francius|A. Chalin|T. Naas"
"6449","14/04 12:00","37","P1737","Lukas Markus SCHAFFARCZYK","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Molecular characterisation of carbapenemase-producing Serratia marcescens in Germany","J. Noster|L. Schaffarczyk|J. Sattler|Y. Stelzer|S. Göttig|S. Gatermann|A. Hamprecht"
"6477","14/04 12:00","38","P1738","Ella SVEGRUP","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic traits associated with phenotypic antimicrobial resistance to trimethoprim-sulfamethoxazole in Staphylococcus epidermidis","E. Svegrup|R. Sieber|B. Söderquist|M. Stegger"
"6481","14/04 12:00","39","P1739","Maria Leonor SANTOS","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","New accurate point-of-care device for detection of Klebsiella pneumoniae carbapenemase","M. Santos|D. Albuquerque|C. Bárbara|M. Teixeira|A. Duarte|R. Pinto|D. Caetano|C. Caneiras"
"6538","14/04 12:00","40","P1740","Roméo TSAYEM FOUÉMÉNÉ","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Whole-genome sequencing of carbapenemase-producing Klebsiella pneumoniae isolated from a medical laboratory in Yaounde: first report of a blaNDM-1 positive- high-risk clone ST 147 in Cameroon","R. Tsayem Fouéméné|M. Morsli|T. Ngouana Kammalac|C. Magnan|A. Pantel|C. Pouget|D. Catherine"
"6615","14/04 12:00","41","P1741","Xavier MULET","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Detection of major high-risk clones of Pseudomonas aeruginosa using MALDI-TOF mass spectrometry and machine learning algorithms","D. Rodriguez-Temporal|C. Lopez-Causape|C. Pitart|M. Sastre-Femenia|A. Salido-Medina|A. Fernandez-Munoz|L. Mancera Pascual|B. Rodriguez-Sanchez|A. Oliver|X. Mulet|J. Viana-Ramirez|M. Arroyo"
"6649","14/04 12:00","42","P1742","Kathryn HOLT","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","AMRrules: expert-curated interpretive standards for AMR genotypes","K. Holt|J. Hawkey|N. Couto"
"6656","14/04 12:00","43","P1743","Olalekan John OKESANYA","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Reinvigorating AMR resilience leveraging CRISPR-Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security : a systematic review","O. Okesanya|M. Ahmed|J. Ogaya|B. Ukoaka|D. Lucero Prisno Iii"
"6757","14/04 12:00","44","P1744","Tarun Kumar SUVVARI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Molecular characterisation of Klebsiella pneumoniae clinical isolates through whole-genome sequencing: a comprehensive analysis of serotypes, sequence types, and antimicrobial and virulence genes","T. Suvvari|V. Kandi|M. Vinay Kumar|B. Vallab Ganesh|P. Eswar"
"6789","14/04 12:00","45","P1745","Leila VALI","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Lethal pan-drug-resistant hypervirulent strains of Klebsiella pneumoniae with diverse genotypes","L. Vali|A. Dashti|K. Abraham|S. El-Shazley|K. Dashti|N. Almaraghi"
"6884","14/04 12:00","46","P1746","Harin NAVALAN","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Extended susceptibility testing for refractory Helicobacter pylori infection: an argument for regional testing to guide antimicrobial decision making","H. Navalan|M. Paroikaki|S. Pallett|N. Mughal|F. Davies|S. Alqhatani|L. Moore"
"7099","14/04 12:00","48","P1748","Deneke WOLDE","5","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Genomic characterisation of extended-spectrum beta-lactamase-producing and third-generation cephalosporin-resistant Escherichia coli isolates from Ethiopia","D. Wolde|T. Eguale|G. Medhin|A. Feleke Haile|H. Alemayehu|A. Mihret|M. Pirs|K. Strasek Smrdel|J. Avbersek|D. Kusar|T. Cerar Kisek|T. Janko|A. Steyer|M. Starcic Erjavec"
"7145","14/04 12:00","1","P1749","Isabel Cristina LÓPEZ MESTANZA","6","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Rapid detection of cfia-positive Bacteorides fragilis from blood culture using matrix-assisted laser desorption ionisation time of flight mass spectrometry in a tertiary hospital in Spain","I. Lopez Mestanza|M. Miguel Gomez|S. Rojo Rello|J. Eiros Bouza|V. Cerpa Almenara|M. Uruena Garcia|N. González Espinosa"
"7288","14/04 12:00","2","P1750","Babatunde BEYIOKU","6","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Detection of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales in wildlife","B. Beyioku|R. Lapid|T. Nissimyan|R. King|J. Moran-Gilad"
"7672","14/04 12:00","3","P1751","Hsi-Hsun LIN","6","B","03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Increasing prevalenc and molecular epidemiology of carbapenemase-producing carbapenem resistant Enterobacterales in Taiwan","S. Lee|H. Hsia|Y. Lee|C. Chen|T. Huang|H. Lin"
"543","14/04 12:00","4","P1752","Pansachee DAMRONGLERD","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Evaluating the efficacy of tobramycin and gentamicin spacers in managing prosthetic joint infections caused by Pseudomonas aeruginosa, implications of changing minimal inhibitory concentration breakpoints","P. Damronglerd|O. Abu Saleh|N. Bedard|M. Abdel|D. Osmon"
"824","14/04 12:00","5","P1753","Sho SAITO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparison of the clinical outcomes of patients with carbapenem-resistant and susceptible Enterobacterales in Japan","S. Saito|Y. Asai|A. Sakurai|M. Suzuki|Y. Matsumura|R. Hase|H. Kato|M. Mawatari|J. Yu|K. Hayakawa|K. Uemura|N. Ohmagari|D. Duin|Y. Doi"
"951","14/04 12:00","6","P1754","Mabel Zhi Qi FOO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparative analysis of 30-day and one-year mortality in carbapenem-resistant vs non-carbapenem resistant Enterobacterales bacteraemia","M. Foo|Y. Yang|D. Lai|S. Arora|M. Aung|M. Aung|D. Chan|J. Sim|M. Ling|I. Venkatachalam"
"1114","14/04 12:00","7","P1755","Bibek KOIRALA","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Early vs late combination daptomycin and ceftaroline therapy in patients with persistent MRSA (methicillin-resistant Staphylococcus aureus) bacteraemia","B. Koirala|G. Reed|M. Wessolossky"
"1239","14/04 12:00","8","P1756","Luis FUERTES","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Adherence to EUCAST-2024 guidelines in the management of urinary tract infections caused by inducible AmpC beta-lactamase-producing Enterobacterales in a tertiary hospital","L. Fuertes-Pina|S. Fuente|M. Dominguez|P. Ruiz-Garbajosa|R. Canton|M. Ponce-Alonso"
"1274","14/04 12:00","9","P1757","Bin SUN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Exploring antibiotic options for different carbapenemase-producing CRE strains","B. Sun|Y. Wang|Y. Ren|M. Jiang|Y. Zhang|Y. Wang"
"1279","14/04 12:00","10","P1758","Abdullah Tarik ASLAN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparison of ceftazidime/avibactam with best available therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections: a multi-centre retrospective matched-cohort study","A. Aslan|E. Tanriverdi|E. Yilmaz|Y. Cicek|M. Yilmaz|S. Yildiz Kaya|G. Dalgan|N. Saltoglu|C. Erol|Ö. Kurt Azap|G. Hazirolan|O. Dag|D. Boztas|M. Isik|Z. Ture Yuce|B. Otlu|P. Harris|D. Paterson|M. Akova"
"1358","14/04 12:00","11","P1759","Heather HENDERSON","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Socio-economic status is linked to disparities in 30-day mortality among patients with antibiotic non-susceptible Enterobacterales","H. Henderson|B. Williams|K. Alby|T. Andermann|S. Napravnik|D. Van Duin"
"1359","14/04 12:00","12","P1760","Luis GAGO MANTILLA","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Evolution of carbapenemase-producing Enterobacteriaceae during 2023 and 2024 in urine cultures at a tertiary hospital","L. Gago Mantilla|L. Lopez Gonzalez|A. Vera Mendoza|A. Delgado-Iribarren|A. Arribi Vilela|F. Candel González"
"1426","14/04 12:00","13","P1761","Flavio SANGIORGI","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Monomicrobial infections by carbapenemase-resistant A. baumannii, difficult-to-treat resistant Pseudomonas aeruginosa and metallo-beta-lactamase-producing Enterobacterales: preliminary data from an emulation trial","E. Rando|F. Sangiorgi|G. Leanza|B. Andriolo|E. Magrini|B. Fiori|G. De Pascale|M. Antonelli|R. Murri|C. Torti"
"1701","14/04 12:00","14","P1762","Luisa FRALLONARDO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Increasing antimicrobial resistance in chronic endometritis: a 2020-2024 cross-sectional study","F. Di Gennaro|L. Frallonardo|A. Saracino|G. Guido|E. Cicinelli"
"1734","14/04 12:00","15","P1763","Kevin BROWN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","The burden of antimicrobial resistant bacteraemia in Ontario: a population-wide cohort study of attributable mortality from 110 pathogen-antibiotic combinations","K. Brown|D. Fridman|G. Garber|J. Johnstone|B. Langford|V. Leung|D. Macfadden|S. Patel|K. Schwartz|B. Sander|N. Daneman"
"1882","14/04 12:00","16","P1764","Dayu CHEN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Reassess the breakpoint of polymyxin B: comparing polymyxin B and ceftazidime/avibactam in CRE infection","N. Hu|Y. Chen|Q. Gu|F. Xiao|M. Liu|P. Liang|Y. Xu|Y. Xu|Y. Li|Y. Liu|R. Wang|X. Zhu|Y. Du|X. Chen|M. Kong|X. Fu|J. Liu|X. Luo|W. Ge|D. Chen|H. Zhang"
"2080","14/04 12:00","17","P1765","Wei Ting LIN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Molecular and clinical characteristics of community-acquired, community-onset healthcare-associated, and hospital-acquired extended-spectrum beta-lactamases-producing Escherichia coli bacteraemia","P. Chou|W. Lin|S. Chang|J. Wang|Y. Huang"
"2097","14/04 12:00","18","P1766","Morgan WALKER","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Has survival from difficult-to-treat antibiotic resistant (DTR) Gram-negative infections improved in the era of next-generation antibiotics? Retrospective cohort study, 262 US hospitals, 2016-2023","M. Walker|C. Yek|S. Warner|B. Swihart|K. Goodman|J. Baghdadi|A. Harris|S. Kadri"
"2103","14/04 12:00","19","P1767","Yi-Tsung LIN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Risk factors for mortality in patients treated with ceftazidime/avibactam for carbapenem-resistant Klebsiella pneumoniae bacteraemia","Y. Lin|S. Lin|C. Chuang|S. Liu|Y. Ho|C. Juan|S. Chou"
"2219","14/04 12:00","20","P1768","Sergio ALVAREZ MULETT","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Clinical outcomes of Stenotrophomonas maltophilia bloodstream infection: role of comorbidities and antimicrobial susceptibility profile","S. Alvarez Mulett|S. Molina Garcia|P. Crowley|O. Abu Saleh|P. Mira"
"2284","14/04 12:00","21","P1769","Nicole SLAIN","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Cefepime vs carbapenems for AmpC-producing Enterobacterales in bacteraemia from deep-seated sources: phenotypic and genotypic focus","N. Slain|A. Kunz Coyne|K. Lucas"
"2363","14/04 12:00","22","P1770","Yongseop LEE","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Effectiveness of ceftazidime/avibatam in carbapenem-resistant Enterobacterales bacteraemia","Y. Lee|J. Seong|J. Lee|J. Kim|J. Ahn|S. Jeong|J. Choi|J. Yeom|N. Ku"
"2501","14/04 12:00","23","P1771","Sotiria GRIGOROPOULOU","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","A two-year prospective study on hospital-acquired bacteraemias caused by multidrug-resistant organisms in a high-prevalence country","S. Grigoropoulou|M. Tsakona|P. Kazakou|C. Charalampidis|M. Kostoula|A. Antoniadou|F. Kontopidou|G. Daikos|S. Tsiodras|K. Thomas"
"2676","14/04 12:00","24","P1772","Paula OLIVARES NAVARRO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Impact of extended-spectrum beta-lactamase (ESBL) production on mortality in patients with bloodstream infection due to Escherichia coli: analysis of the PROBAC cohort","P. Olivares Navarro|M. Perez Rodriguez|A. Goikoetxea Aguirr|A. Plata|M. Mantecon Vallejo|J. Cuquet Pedragosa|C. Arminanzas|L. Boix Palop|T. Marrodán Ciordia|A. Jover Sáenz|I. Lopez Hernandez|J. Bravo Ferrer|P. Retamar-Gentil|L. Lopez Cortes|J. Rodriguez Bano"
"2870","14/04 12:00","25","P1773","Kibrewossen AKILILU","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Clinical profile and outcomes of patients infected with carbapenemase-producing carbapenem-resistant Enterobacterales: a cross sectional study from two hospitals in Ethiopia","K. Akililu|T. Eguale|Z. Kasa|F. Senbato|M. Tessema|Z. Bonger|E. Zeleke|Y. Duffa|M. Mitiku|S. Welelaw|L. Chekol|G. Tasew|D. Beyene|Y. Mekonen|Z. Ayenew|E. Admasu|E. Seyoum|F. Sahle|D. Degefaw|N. Reese|J. Balada-Llasat|Z. Mekuria|H. Osuka|S. Wang"
"2916","14/04 12:00","26","P1774","Ilaria DE LUCA","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Piperacillin/tazobactam vs cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis","I. De Luca|O. Onorato|A. Salvati|C. Monari|N. Coppola"
"3073","14/04 12:00","28","P1776","Hunter CURRY","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparative evaluation of definitive therapy for deep-seated Stenotrophomonas maltophilia infections","H. Curry|D. Casaus|K. Lucas|A. Kunz Coyne"
"3124","14/04 12:00","29","P1777","Akshay Arjun SHELKE","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Epidemiology and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae infections in cancer patients: a prospective cohort study","A. Shelke|P. Priya|R. Chauhan|S. Dhingra"
"3151","14/04 12:00","30","P1778","Jill HOPKINS","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Effect of Escherichia coli and Staphylococcus aureus antimicrobial resistance on bloodstream infection outcomes in low- and middle-income countries: results from the ACORN2 study","H. Van Doorn|P. Turner|S. Lee|J. Hopkins|C. Painter|Y. Lubell|S. Akech|E. Ashley|N. Feasey|R. Hamers|A. Karkey|I. Okeke|J. Opintan|O. Tosas Auguet"
"3333","14/04 12:00","31","P1779","Mohamed TOORANI","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Treatment failure rates do not differ according to temocillin MIC in the treatment of Enterobacterales blood stream infection: an observational study","M. Toorani|L. Sweeney|F. Price"
"3425","14/04 12:00","32","P1780","Gugulethu PHAMBANE","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Extensively drug-resistant Acinetobacter baumannii complex (XDR-AB) colonisation and clinical outcomes in neonates: a retrospective case-control study","G. Phambane|R. Chomba|S. Ndzabandzaba|J. Fredericks"
"3729","14/04 12:00","33","P1781","Jiancong WANG","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Mortality risk associated with healthcare-associated infections caused by multidrug-resistant Pseudomonas aeruginosa in southern China: a competing risk model analysis using a propensity-score-matching longitudinal cohort","J. Wang|M. Zhou|R. Brinks"
"3857","14/04 12:00","34","P1782","Yen Tsen SAW","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Impact of macrolide resistance on clinical outcomes in Mycoplasma pneumoniae infections: a retrospective observational review","Y. Saw|R. Bogale|D. Haigh|T. Lamb|E. Davies"
"3863","14/04 12:00","35","P1783","Dimitrios BASOULIS","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Ceftolozane/tazobactam vs carbapenems for treatment of ESBL bloodstream infections","D. Basoulis|A. Gkoufa|E. Mastrogianni|A. Pantazatou|I. Deliolanis|A. Rigatou|A. Karapanou|S. Zerva|M. Samarkos|S. Nikolaos V."
"4171","14/04 12:00","36","P1784","Raluca-Mihaela MATORU","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Clinical, microbiological and costs dynamics of Streptococcus pneumoniae infections related to COVID-19 pandemic: could macrolide resistance tell a story?","R. Matoru|L. Tirlescu|M. Gorea|C. Niculae|A. Hristea"
"4284","14/04 12:00","37","P1785","Amalia ANASTASOPOULOU","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparison of novel β-lactam/β-lactamase inhibitors in a prospective single-institution study","P. Voutsinas|E. Athanasoula|A. Rigatou|A. Pantazatou|M. Samarkos|A. Anastasopoulou"
"4400","14/04 12:00","38","P1786","Antonella GALLICCHIO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Preliminary analysis of a retrospective cohort of patients with invasive infections caused by difficult-to-treat-resistance Pseudomonas aeruginosa (DTR-PA)","A. Gallicchio|A. Maraolo|R. Scotto|M. Catania|E. Roscetto|R. Egidio|I. Gentile"
"4860","14/04 12:00","39","P1787","Bernardo Alfonso MARTINEZ-GUERRA","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Universal need for appropriate treatment: risk factors for mortality in patients with infections due to carbapenem-resistant Gram-negative bacteria","E. Flores-Ortiz|A. Mercado-Velasco|S. Rodriguez-Cortez|L. Xancal-Salvador|A. Ponce-De-Leon|M. González-Lara|B. Martinez-Guerra"
"5073","14/04 12:00","40","P1788","Lorenzo CHIUSAROLI","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Effectiveness and safety of ceftazidime/avibactam in the paediatric population: an interim analysis of prospective observational study","D. Donà|L. Chiusaroli|L. Romani|C. Tripiciano|B. Grotto|G. Castelli Gattinara|A. Lo Vecchio|C. Cozzolino|M. De Luca|S. Chiurchiù|S. Garazzino|E. Funiciello|G. Menegatti|A. D' Avolio|S. Bosis|L. Pierantoni"
"5424","14/04 12:00","41","P1789","Christelle ELIAS","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Determinants of the change of empiric antibiotic therapy upon reception of laboratory data: results from a nationwide antibiotic surveillance system in Madagascar, the TSARA project","C. Elias|S. Rasoanandrasana|A. Raherinandrasana|V. Andriananja|P. Razanakolona|L. Raskine|P. Vanhems|F. Babin"
"5426","14/04 12:00","42","P1790","Imran HASANOGLU","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparative efficacy and renal safety of ceftazidime/avibactam vscolistin-based regimens in XDR Gram-negative infections: a propensity score matched cohort study","I. Hasanoglu|R. Guner|A. Dalkiran Baydar|A. Kaya|A. Sertcelik|F. Eser|Z. Bilgic|B. Kayaaslan"
"5559","14/04 12:00","43","P1791","Elena SENDRA ÁLVAREZ DE CIENFUEGOS","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Comparison of clinical characteristics and outcomes in non multidrug-resistant and multidrug-resistant Pseudomonas aeruginosa bacteraemia: preliminary results of a Spanish multicentre prospective cohort study (IRVIPA study)","E. Sendra|M. Macias|N. Maldonado|S. Castaneda|A. Fernandez-Munoz|G. Euba|L. Lopez-Cortes|M. Colomar|I. Grau|C. Hidalgo-Tenorio|F. Carmona-Torre|L. Gisbert|S. Calzado|P. Hernández-Jimenez|V. Pintado|A. Siverio Parés|N. Antona-Urieta|I. Lopez-Montesinos|C. Juan|A. Oliver|J. Horcajada|S. Gomez-Zorrilla"
"5638","14/04 12:00","44","P1792","Sara COVINO","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Real-life use of cefiderocol in the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) infections: comparison between cefiderocol regimens and monotherapy","S. Covino|L. Liguori|F. Alessandri|S. Lobello|F. Cogliati Dezza|F. Petrucci|F. Cancelli|M. Comi|S. Figliomeni|C. Leanza|F. Sacco|A. Viscido|G. Ceccarelli|G. Raponi|C. Mastroianni|A. Oliva"
"5721","14/04 12:00","45","P1793","Flavia BADALUCCO CIOTTA","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Management and outcomes of haematological patients colonised by MBL-producing Enterobacterales: a single-centre retrospective analysis","F. Badalucco Ciotta|M. Parrinello|R. Dell'acqua|V. Spagnuolo|E. Scifo|F. Farina|D. Clerici|M. Ripa|R. Greco|C. Corti|S. Carletti|P. Scarpellini|A. Castagna|F. Ciceri"
"5723","14/04 12:00","46","P1794","Yoon Soo PARK","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Analysis of 30-day mortality in patients with carbapenem-resistant Enterobacterales (CRE) bacteraemia: non-carbapenemase CRE and antimicrobial stewardship","Y. Baek|S. Park|J. Kim|H. Seong|B. Kim|Y. Kim|J. Yoon|R. Lee|S. Park|J. Park|H. Seok|M. Hyun|K. Park|K. Kwon|S. Moon|J. Song|J. Choi|Y. Park"
"6061","14/04 12:00","47","P1795","Juliette DESSEMON","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","The impact of carbapenem-resistant infections in intensive care units: focus on non-fermenting Gram-negative bacilli and survival analysis","J. Dessemon|C. Vacheron|A. Savey|A. Machut|A. Friggeri|A. Lepape|C. Elias"
"6760","14/04 12:00","48","P1796","Thejesh SRINIVAS","6","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","High prevalence of multi-drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae isolates amongst mechanically ventilated acute respiratory distress syndrome patients as an independent predictor of mortality","T. Srinivas|S. Chaudhuri|G. Hanumaiah|S. R.|D. Nagendra"
"6773","14/04 12:00","1","P1797","Mohammed A. EL-KHOLY","7","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Ceftaroline as a therapeutic option: an in vitro study on methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from Alexandria, Egypt","H. Sallam|A. Ramadan|N. Attia|A. Elbaradei|S. Shawky|M. El-Kholy"
"6842","14/04 12:00","2","P1798","Sarah BARNI","7","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Trends, management and outcome of infections caused by MBL-producing organisms in paediatric ICUs: a five-year experience at an Italian tertiary care hospital","S. Barni|C. Tripiciano|L. Romani|V. Cortazzo|M. Pereyra Boza|S. Chiurchiù|F. Calo Carducci|R. Tarquini|S. Bernardi|G. Bottari|T. Fragasso|L. Lancella|P. Bernaschi|M. De Luca"
"7159","14/04 12:00","3","P1799","Tommaso MANCIULLI","7","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Ceftolozane/tazobactam for the treatment of pulmonary exacerbations in adult cystic fibrosis patients: clinical experience from a tertiary care centre","T. Manciulli|B. Borchi|S. Pollini|I. Campolmi|A. Galano|A. Cavallo|K. Koroveshi|J. Mencarini|G. Tacccetti|G. Rossolini|A. Bartoloni|S. Bresci"
"7208","14/04 12:00","4","P1800","Laura MORATA","7","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Clinical characteristics of patients with hospital-acquired P. aeruginosa ST773 NDM-1 clonal spread","A. Soriano|M. Bodro|L. Morata|A. Del Rio|C. Garcia-Vidal|M. Verdejo|G. Cuervo|S. Cabezal|J. Martinez|P. Puerta-Alcalde|C. Pitart|M. Espasa"
"7417","14/04 12:00","5","P1801","Lina Marcela PARRA","7","B","03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Impact of antimicrobial resistance on mortality in Spanish hospitals (2022–2024)","C. Salamanca|M. Cantero|L. Parra|R. Escuredo|M. Gonzalez|A. Asensio"
"156","14/04 12:00","6","P1802","Natália CARRILLO GAETA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Critical emergence and spread of multidrug-resistant CTX-M-15-producing Enterobacteriaceae in a veterinary teaching hospital settings: implications for infection control and One Health","A. S. Gonçalves|L. K. Franco|T. K. Jacobsen|G. De Bastiani|A. Haisi|J. Araújo Jr|M. B. Heinemann|M. M. Alievi|R. F.s. Raimondo|N. Carrillo Gaeta"
"206","14/04 12:00","7","P1803","Idris Nasir ABDULLAHI","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Guts of healthy humans and animals habor critical priority and pandemic Escherichia coli clones","I. Abdullahi|I. Trabelsi"
"208","14/04 12:00","8","P1804","Idris Nasir ABDULLAHI","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Nasal carriage and multiple antibiotic resistance indices of Staphylococcus aureus among healthcare students at the Ahmadu Bello university, Nigeria","S. Abdullahi|I. Abdullahi"
"472","14/04 12:00","9","P1805","Chris KENYON","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Acceptable' concentrations of enrofloxacin in food lead to reduced enrofloxacin susceptibility in a mouse model of gastrointestinal Klebsiella pneumoniae","Z. Gestels|B. Torfs|S. Abdellati|I. De Baetselier|C. Rombouts|V. Dermauw|S. Manoharan-Basil|C. Kenyon"
"703","14/04 12:00","10","P1806","Natália CARRILLO GAETA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Phylogroups, resistance, and risk: a study of STEC in Brazilian dairy sheep","A. Silveira Gonçalves|R. Fraga E Silva Raimondo|M. Bryan Heinemann|A. Vasquez Peyser|A. Cortez|N. Carrillo Gaeta"
"836","14/04 12:00","12","P1808","Fang You YU","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","LuxS/AI-2 system facilitate the dissemination of antibiotic-resistant plasmids in Klebsiella pneumoniae","Y. Zhou|F. Yu"
"894","14/04 12:00","13","P1809","Mulatu GASHAW","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Resistome and phylogenomic of Escherichia coli strains obtained from diverse sources in Jimma, Ethiopia","R. Matar|G. Froeschl|T. Seeholzer|A. Kroidl|A. Wieser|M. Gashaw|E. Gudina"
"916","14/04 12:00","14","P1810","Jacopo GARLASCO","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","The emerging resistance index: ranking resistance to newly-approved antibiotics in the 2024 WHO critical- and high-priority bacterial pathogens","J. Garlasco|F. Arieti|M. Morra|F. Manco|M. Tebon|D. Ortiz Quiroga|S. Foster|M. Pezzani|K. Odoj|E. Addis|C. Magnabosco|A. Savoldi|E. Tacconelli|E. Magrini"
"926","14/04 12:00","15","P1811","Victoria Del Pilar BALLÉN TORRES","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Characterisation of antibiotic-resistant Klebsiella spp. isolated from wastewater and drinking water treatment plants in the metropolitan area of Barcelona, Spain","V. Ballén|K. Delgado|L. Mondéjar|Y. Gabasa|L. Castellsagués|A. Pinar-Méndez|C. Vilaro|B. Galofre|S. Soto"
"955","14/04 12:00","16","P1812","Nwai Oo KHINE","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Genomic analysis of tetX(4) carrying colistin-resistant E. coli from pigs in Thailand","N. Khine|T. Wongsurawat|P. Jenjaroenpun|P. Butaye|N. Prapasarakul"
"1195","14/04 12:00","17","P1813","Chahrazed BELHOUT","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Diversity of SCCmec elements in bovine methicillin-resistant Staphylococcus haemolyticus: uncovering shared and novel multidrug-resistance cassettes","C. Belhout|V. Perreten"
"1384","14/04 12:00","18","P1814","Chen CHYI-LIANG","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence and role of contact-dependent growth inhibition (CDI) system, cdiTYTH-1, in carbapenem-resistant Acinetobacter baumannii","C. Chen|Y. Chang|C. Chiu"
"1466","14/04 12:00","19","P1815","Paul G. HIGGINS","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Isolation of hospital-associated vancomycin resistant Enterococcus faecium clones from German rivers","P. Higgins|E. Sib|R. Arazo Del Pino|T. Burgwinkel|G. Bierbaum|A. Classen|C. Imirzalioglu|W. Kern|N. Mutters|H. Rohde|J. Rupp|H. Seifert|J. Vehreschild|M. Vehreschild|K. Xanthopoulou|L. Biehl"
"1592","14/04 12:00","20","P1816","Isidro GARCÍA-MENIÑO","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Imported herbs represent a source of clinically-relevant lineages of Klebsiella spp. in the food chain","I. Garcia-Menino|J. Hammerl"
"1699","14/04 12:00","21","P1817","João Pedro RUEDA FURLAN","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Carbapenemase-positive Enterobacterales from residual waters: prevalence of high-risk clones producing KPC-2","J. Rueda Furlan|G. Carrasco Bueno|R. Renato Sousa-Carmo|N. Lincopan|S. Schenkman|R. Lourenço Oliveira Silva|M. Renata Funada Barbosa|M. Ines Zanoli Sato"
"1811","14/04 12:00","22","P1818","Gwen KNIGHT","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Predicting the future burden of antimicrobial resistance depends on population demographics, and the age and sex-specific rates of incidence and resistance","N. Waterlow|G. Knight"
"1814","14/04 12:00","23","P1819","Gwen KNIGHT","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Mechanistic exploration of the factors contributing to differing patterns of antibiotic resistance in Staphylococcus aureus bloodstream infection by demography in the UK","N. Waterlow|G. Knight"
"1817","14/04 12:00","24","P1820","Simon PROCTER","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Unveiling the sex-specific impact on antimicrobial resistance (AMR): a Bayesian hierarchical model approach using vivli data","N. Waterlow|C. Kim|A. Clements|S. Procter|G. Knight"
"2002","14/04 12:00","25","P1821","Signara GUEYE","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","One Health circulation of carbapenemase-producing Enterobacterales in Lome, Togo","C. Le Jannou|L. Armand-Lefevre|M. Salou|D. Ekouevi|M. Bodombossou|I. Tchaou|M. Petitjean|V. Berti|A. Siliadin|E. Tchedie|S. Gamahizome|E. Cardinale|S. Bouvier|Z. Dossou|A. Bedekelabou|K. Dogno|A. Dagnra|L. Bawe|A. Bassowa|A. Abalo|D. Atakouma|S. Gueye|R. Atoun|K. Adjessoklou|A. Kotosso|A. Djagadou|G. Brucker|D. Salmon|P. Le Roux"
"2128","14/04 12:00","26","P1822","Thabo HAMIWE","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Relationship between the molecular diversity of plasmids and antibiotic resistance of Staphylococcus aureus isolates from private hospitals in Gauteng, South Africa","K. Ngoie|T. Govender|C. Kingsburgh|T. Hamiwe|M. Ehlers"
"2344","14/04 12:00","27","P1823","Hui LIU","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Epidemiology and genomic features of blaNDM-carrying carbapenem-resistant Salmonella enterica","B. Sun|H. Liu|Y. Wang|L. Zhang"
"2476","14/04 12:00","28","P1824","Laura MONGE-OLIVARES","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Detection of blaKPC-2-carrying IncP-6 plasmids in Aeromonas isolates from different wastewaters settings in Spain","L. Monge-Olivares|L. Roer|A. Rasmussen|M. Pulido|L. Cuberos|S. Ballesta|L. Lopez-Cerero|H. Hasman"
"2739","14/04 12:00","29","P1825","Ulrika WINDAHL","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Sources of methicillin-resistant Staphylococcus aureus isolates in Swedish dogs","U. Windahl|M. Myrenas|K. Pedersen"
"3003","14/04 12:00","30","P1826","Suhanya Veronica PRASAD","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Travelling increases the diversity of extended-spectrum beta-lactamases carrying Enterobacterales and plasmids in the Czech Republic","S. Prasad|B. Dratvová|M. Antuskova|M. Brajerová|E. Nycova|M. Trojánek|J. Tkadlec|P. Drevinek|M. Krutova"
"3131","14/04 12:00","32","P1828","Lucie COLLINEAU","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","EARS-Vet: a network for surveillance of antimicrobial resistance in clinical isolates from animals in the EU/EEA","L. Collineau|S. Bareille|P. Damborg"
"3148","14/04 12:00","33","P1829","Rosa Elena HERNÁNDEZ","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Spread of multiple E. coli clones from pigs carrying blaCTX-M-32 on the chromosome in Cuba","R. Hernández|H. Bello|N. Khine|S. Theuns|E. Cox|P. De La Fe|P. Butaye"
"3183","14/04 12:00","34","P1830","Els BROENS","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Carbapenemase producing Enterobacterales monitoring in dogs and cats in the Netherlands","E. Broens|B. Duim|J. Hordijk|A. Timmerman|M. Broekhuizen-Stins|H. Zweerus|J. Wagenaar|K. Veldman"
"3194","14/04 12:00","35","P1831","Yuki SUZUKI","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Molecular and genetic characteristics of drug resistant Enterobacterales isolated from hospital sewage in Japan","Y. Suzuki|R. Nakano|A. Nakano|A. Oi|H. Fujikura|Y. Nomura|S. Ando|S. Horiuchi|K. Yamaguchi|K. Kasahara|H. Yano"
"3217","14/04 12:00","36","P1832","Yanfang ZHANG","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Surveillance of wastewater in San Paulo, Brazil, identifies geographic and socio-economic factors linked to antimicrobial resistance and virulence in Escherichia coli strains","W. Martins|R. Andrade|A. Valêncio|A. Lankapalli|M. Li|J. Mathias|Y. Zhang|Z. Ling|E. Portal|K. Sands|L. Michael|M. Toleman|A. Gales|T. Walsh"
"3251","14/04 12:00","37","P1833","Rémi GSCHWIND","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Identification of cefiderocol resistance genes in environmental samples","T. Berendonk|R. Gschwind|M. Bonnet|U. Loeber|M. Wenne|A. Abramova|F. Tskhay|N. Fozia|U. Klumper|S. Forslund|R. Zahra|J. Bengtsson-Palme|E. Ruppé"
"3302","14/04 12:00","38","P1834","Yang ZHONG","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","WGS analysis of ESBL-producing Enterobacterales and aeromonas from Singapore surface water reveals aquatic drug-resistant isolates as hidden reservoirs of mobile resistance elements","Y. Zhong|J. Teo|A. Kwa|R. Ong"
"3327","14/04 12:00","39","P1835","Erika NAGRAND","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Identifying antibiotic resistance genes against novel beta-lactamase inhibitor-antibiotic combinations in environmental and clinical resistomes","E. Nagrand|D. Kovács|T. Stirling|B. Vásárhelyi|O. Méhi|B. Kintses"
"3356","14/04 12:00","40","P1836","Theevasha GOVENDER","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","High-risk clones and plasmids associated with extended spectrum beta-lactamase producing Klebsiella pneumoniae isolates from environmental water, broiler poultry and humans in South Africa","K. Kambuyi|J. Pitout|D. Qekwana|K. Strydom|J. Featherston|M. Ehlers|M. Said|T. Govender|M. Kock"
"3372","14/04 12:00","41","P1837","Vanessa SILVA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Population dynamics of multidrug-resistant Klebsiella pneumoniae infections in Portuguese companion animals","V. Silva|C. Freitas|M. Lopez|B. Rojo-Bezares|Y. Sáenz|D. Salinas|A. Silva|P. Poeta|G. Igrejas"
"3539","14/04 12:00","42","P1838","Silvia Figueiredo COSTA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Presence of carbapenem-resistant Enterobacteriaceae and antibiotics residues in urban surface water","C. Rizek|P. Ferraro|M. Dropa|S. Martone-Rocha|D. Walan|B. Meiwald|M. Aguiar|A. Marques|G. Damico|G. Aragao|N. Scaccia|N. Duarte|L. Kanda|A. Holmes|A. Levin|S. Costa|M. Razzolini|E. Manuli"
"3566","14/04 12:00","43","P1839","Vanessa SILVA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Wildlife and aquatic reservoirs of mecC-MRSA: a study on prevalence, genetic diversity, and resistance","V. Silva|M. Caniça|A. Nunes|J. Gomes|P. Poeta|G. Igrejas"
"3637","14/04 12:00","44","P1840","Theresa HOHL","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","The ARISE project: evaluating wastewater-based antimicrobial resistance surveillance strategies in alignment with EU regulatory changes","C. Kolm|T. Hohl|J. Vierheilig|A. Kirschner|G. Zarfel|B. Ströbele|A. Fobe|I. Dielacher|M. Koller|M. Leifels|M. Kalkgruber|M. Finsterwald|G. Zepke|A. Manica|R. Martzy|M. Ante|S. Klee|U. Graichen|R. Strauss|A. Lehner|J. Weber|H. Muller-Rechberger|L. Nykyforuk|A. Farnleitner"
"3666","14/04 12:00","45","P1841","Gabriele RATTI","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","ESBL-/AmpC- and carbapenemase-producing Escherichia coli detection in urine samples of companion animals in Italy","G. Ratti|S. Alessandro|L. Birbes|F. Guarneri|A. Pitozzi|N. Formenti|G. Alborali|A. Grassi"
"3692","14/04 12:00","46","P1842","Victorien DOUGNON","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Antibiotic resistance profiles and genetic characterisation of Gram-negative bacteria isolated from lake Nokoué and surrounding environments in Benin","K. Fabiyi|K. Sintondji|P. Assogba|H. Koudokpon|B. Legba|L. Houngbo|N. Kelome|V. Dougnon"
"3794","14/04 12:00","47","P1843","Trang NGUYEN","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","A first step towards One Health: genomic comparison of Klebsiella pneumonia from different ecological niches in Vietnam","T. Nguyen|L. Chu|T. Nguyen|D. Nguyen|N. Pham|H. Van Doorn|T. Kesteman|S. Lewycka|G. Vu|B. Vu|N. Oanh"
"3879","14/04 12:00","48","P1844","Guillermo Moisés PORRAS COTRINA","7","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Escherichia coli carrying extended spectrum of beta-lactamase in pets and pregnant women in San Paulo, Brazil: an One Health view, preliminary data","G. Porras Cotrina|D. Kalliope De Sa Paraskevopoulos|N. Scaccia|F. Komurian-Pradel|T. Guimaraes|S. Figueiredo Costa|M. Milenkov"
"3942","14/04 12:00","1","P1845","Iñaki BEGUIRISTAIN CALVO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Clonal spread of topical treatment-resistant Staphylococcus aureus causing childhood impetigo in Navarra","I. Beguiristain|M. Olazabal|A. Alonso|M. Portillo|M. Alfaro|C. Ezpeleta"
"4127","14/04 12:00","2","P1846","Aitezaz AHSAN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Multidrug-resistant Salmonella in slaughtered food animals: a growing public health concern in Pakistan","A. Ahsan|H. Irshad|M. Shahzad|A. Siddique|M. Usman|U. Talib"
"4130","14/04 12:00","3","P1847","Ini ADEBIYI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence and characterisation of extended-spectrum beta-lactamase-producing Escherichia coli from hospital patients and poultry farmers in Ibadan, Oyo state","I. Adebiyi|H. Patel|A. Davies|C. Ryan|C. Brown|R. Card|K. Hopkins"
"4194","14/04 12:00","4","P1848","Marina MURILLO TORRES","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Occurrence of carbapenemase resistance genes and proteins in Klebsiella pneumoniae extracellular membrane vesicles","M. Murillo-Torres|P. Ayala-Garcia|A. Arce-Rodriguez|E. Recacha|F. Fernández-Cuenca|J. Borrero-De Acuna|J. Rodriguez-Martinez"
"4387","14/04 12:00","5","P1849","Ilana CAMARGO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Evaluation of humans, dogs, and household dust as reservoirs of methicillin-resistant Staphylococcus spp. in the community and analysis of an intervention to reduce air-bound dissemination","L. Souza|F. Campioni|F. Manieri|M. Argentin|G. Pereira|A. Bossers|I. Camargo"
"4449","14/04 12:00","6","P1850","Shonnette PREMCHAND-BRANKER","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Clinical threat of blaNDM-positive Providencia spp. harboured by flies collected in hospitals across Nigeria","S. Premchand-Branker|C. Achi|E. Portal|K. Iregbu|S. Afegbua|A. Aminu|Y. Mohammed|I. Nwafia|O. Oduyebo|A. Ibrahim|Z. Tanko|T. Walsh|K. Sands|M. Li"
"4502","14/04 12:00","7","P1851","Islem TRABELSI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","High-frequency detection of vancomycin- and linezolid-resistant Enterococci in poultry caecum samples from slaughterhouses in Tunisia","I. Trabelsi|J. Latorre-Fernández|H. Rouissi|C. González-Azcona|C. Torres|K. Ben Slama"
"4638","14/04 12:00","8","P1852","Ilana CAMARGO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Third-generation cephalosporins-resistant Enterobacterales in community-dwelling individuals, their pet dogs, and household dust","F. Manieri|F. Campioni|L. Souza|D. Prado|A. Bossers|I. Camargo"
"4641","14/04 12:00","9","P1853","Hazem RAMADAN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Circulation of emerging MCR-1-producing Salmonella infantis from retail food in Egypt","H. Ramadan|T. Omara|H. Elshebrawy|S. House|J. Frye|C. Jackson"
"4675","14/04 12:00","10","P1854","Rida TOUFIQ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Comparing aminoglycoside and β-lactam resistance gene prevalence in neonatal gut microbiome according to mode of delivery","R. Toufiq|K. Sands|A. Shahid|R. Zahra|K. Thomson|A. Lankapalli|T. Walsh|B. Hassan|S. Aftab|J. Zafar"
"4709","14/04 12:00","11","P1855","Akiyo NAKANO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence and genetic characteristics of drug-resistant Escherichia coli isolated from wild deer inhabiting tourist spots in Japan","A. Nakano|R. Nakano|Y. Suzuki|S. Horiuchi|Y. Nomura|R. Sakata|M. Ogawa|H. Yano"
"4818","14/04 12:00","12","P1856","Natalia GONZALEZ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Evaluating the effect of feeding calves waste milk on the distribution of bacterial taxa and resistance genes distribution in faecal samples in dairy farms in New Zealand","N. Gonzalez|P. Biggs|A. Midwinter|S. Mcdougall|A. Cookson|A. Fayaz|S. Zhao|R. Van Vleck Pereira|B. Seale|S. Burgess"
"4828","14/04 12:00","13","P1857","Brendan JONES","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Emergence of IMP-producing Pseudomonas aeruginosa ST1047 with pandemic potential from Ukraine","B. Jones|V. Kondratiuk|V. Kovalchuk|T. Luo|A. Hendrickx|N. Fomina|F. Fuchs|A. Ong|J. Bennett|F. Lebreton|P. Mc Gann"
"4853","14/04 12:00","14","P1858","Hiroyuki FUJIKURA","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","First identification of carbapenemase genes in Delftia tsuruhatensis isolated from hospital sewage in Japan","H. Fujikura|Y. Suzuki|R. Nakano|A. Nakano|S. Horiuchi|Y. Nomura|K. Yamaguchi|K. Kasahara|H. Yano"
"4956","14/04 12:00","15","P1859","Amir IBRAHIMAGIC","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Detection of cefotaxime resistance Escherichia coli isolates collected from livestock waste","A. Ibrahimagic|M. Fetahagic|J. Dizdarevic|M. Skomorac"
"5058","14/04 12:00","17","P1861","Sam ABRAHAM","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Development and deployment of robotic antimicrobial susceptibility platform (RASP) for high resolution One Health AMR surveillance","S. Abraham|D. Jordan|M. Stegger|S. Mukerji|H. Allison|A. Truswell|R. Abraham"
"5110","14/04 12:00","18","P1862","Quentin LE BASTARD","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Pre-treatment microbiome predicts ESBL-producing Enterobacteriaceae colonisation in ceftriaxone-exposed patients","Q. Le Bastard|M. Vibet|E. Batard|E. Montassier|E. Ruppé"
"5156","14/04 12:00","19","P1863","Ellinor BERGGREN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Carriage of antibiotic-resistant Escherichia coli in Swedish children: a nationwide study","E. Berggren|M. Rolf|S. Börjesson|L. Moreus|H. Bjermo|J. Ottosson|M. Sundqvist"
"5214","14/04 12:00","20","P1864","Javier Eduardo FERNANDEZ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Core genome analysis of 1302 IncI1 plasmids from a multi-species international collection reveals geographic- and/or species-specific plasmid evolution","J. Fernandez|V. Perreten"
"5255","14/04 12:00","21","P1865","Gabrielle LEVI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Carbapenemase-producing Kluyvera: epidemiology of an evolving species","G. Levi|M. Lurie-Weinberger|D. Schwartz|A. Andrement|A. Keren Paz|Y. Carmeli"
"5286","14/04 12:00","22","P1866","Pedro TEIXEIRA","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","One Health approach to antimicrobial resistance: insights from a Portuguese open air laboratory","P. Teixeira|R. Rivière|M. Ramos|M. Azevedo|M. Cano|E. Dias|V. Manageiro|M. Caniça"
"5355","14/04 12:00","24","P1868","Isma BENMAZOUZ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Investigating ESBL-producing E. coli circulating among domestic dogs and wild hooded crows in Hungary's largest cities using whole-genome sequencing","I. Benmazouz|A. Alamanova|S. Jordán|C. Freytag|L. Laczko|G. Kardos"
"5473","14/04 12:00","25","P1869","Yang ZHONG","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Negative correlation between bloodstream iron acquisition virulence factors and non-classical terminal class 1 integrons in ESBL-producing Escherichia coli suggests potential fitness trade-offs between virulence and resistance","Y. Zhong|J. Teo|R. Ong|A. Kwa"
"5488","14/04 12:00","26","P1870","Valentine BERTI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Intra and interhost evolution analysis revealed the circulation of two closely related plasmids carrying blaNDM-1 gene","V. Berti|M. Petitjean|T. Morel-Journel|L. Armand-Lefevre|S. Gueye"
"5524","14/04 12:00","27","P1871","Mashkoor MOHIN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Critically important antimicrobials consumption and resistance in the One Health context in Pakistan","M. Mohin"
"5611","14/04 12:00","28","P1872","Joseph LEWIS","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Quantifying the bystander effect of antimicrobials on microbiome composition and resistome to optimise antimicrobial stewardship","E. Cunningham-Oakes|V. Price|M. Mphasa|J. Mallewa|A. Darby|N. Feasey|J. Lewis"
"5643","14/04 12:00","29","P1873","Geetha NAGARAJ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Novel strains of Escherichia coli among paediatric population of rural communities in India: genomic insights","N. Geetha|S. Varun|K. Ravikumar"
"5732","14/04 12:00","30","P1874","Camille COTET","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Diffusion of OXA-48-producing Enterobacterales strains in Normandy: a five years prospective study","L. Dortet|C. Cotet|N. Nesi|P. Thibon|F. Borgey|L. Guet|G. Leduc|I. Renouard|A. Rousseau|S. Le Hello|F. Gravey"
"5781","14/04 12:00","31","P1875","Maria PIQUET FERRET","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","MDRO Colonisation in HIV patients: effects of probiotic and synbiotic treatments","M. Piquet|A. Sellarès-Crous|N. Botella|E. Guiral|S. Sanz|O. Careta|F. Català-Moll|R. Paredes|E. Rubio|J. Vila"
"5966","14/04 12:00","32","P1876","Praveen THILAGAN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Emergence and spread of ceftriaxone resistant Salmonella Kentucky in India: One Health approach","P. Thilagan|J. Jacob|A. Velmurugan|Y. Muniyadi|T. Thirumoorthy|S. Kulkurani|K. Walia|R. Iyadurai|B. Veeraraghavan"
"6008","14/04 12:00","33","P1877","Teresa IANNETELLI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Carbapenem resistance in ESPAKEE pathogens isolated from filth-flies collected from hospital wards","J. Acolatse|V. Dougnon|T. Walsh|S. Kirsty|T. Iannetelli|S. Premchand-Branker|E. Portal|T. Beard|C. Achi|M. Li|K. Cook|A. Lankapalli|K. Iregbu|A. Gaye|O. Sy|A. Mansaray|A. Soliman|A. Seck|P. Nel|E. Carretto|M. Zukowski"
"6055","14/04 12:00","34","P1878","Peter DELPUTTE","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Monitoring pathogens and AMR in wastewater using nanopore sequencing","W. Cuypers|N. Ul Hudda|P. Delputte|K. Laukens"
"6056","14/04 12:00","35","P1879","Kaiwen SONG","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","The global emergence of tmexCD-toprJ and blakpc/ndm co-carrying superbugs","K. Song|R. Wang|H. Wang"
"6080","14/04 12:00","36","P1880","Babatunde BEYIOKU","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence of extended spectrum beta-lactamase (ESBL)-producing Enterobacterales among wildlife in Israel","B. Beyioku|R. Lapid|T. Nissimyan|R. King|J. Moran-Gilad"
"6117","14/04 12:00","37","P1881","Deirdre GILPIN","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Wastewater based epidemiology (WBE) as a tool for tracking pathogens and antimicrobial resistance within care homes","D. Gilpin|A. Lee|M. Reyne|E. Baas|H. Saadi|J. Mcgrath"
"6174","14/04 12:00","38","P1882","Carmen GONZÁLEZ-AZCONA","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","High prevalence of mecC-carrying S. aureus isolates in nasal microbiota of European-wild-rabbits in the Iberian-Peninsula","C. González-Azcona|T. Alvarez-Gomez|I. Maranon-Clemente|N. Santo|S. Jiménez-Ruiz|F. Solano-González|S. Ciriano-Palacios|C. Alonso|A. Campana-Burguet|P. Eguizábal|C. Lozano|C. Torres"
"6239","14/04 12:00","39","P1883","Vanesa GARCÍA MENÉNDEZ","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Wildlife or human health in danger? Wild boar (Sus scrofa) as environmental sentinels of antimicrobial resistance (AMR) and food safety risks","V. Garcia|A. Lopez-Beceiro|F. Quiros|L. Carballeira|A. Mora"
"6357","14/04 12:00","40","P1884","Daniel VALIA","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Faecal colonisation with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in rural Burkina Faso","D. Valia|B. Ingelbeen|I. Karama|Z. Garba|E. Van Kleef|P. Lompo|E. Tiendrebeogo|A. Tiendrebeogo|S. Yougbare|S. Van Puyvelde|M. Van Der Sande|A. Robert|H. Tinto|H. Rodriguez-Villalobos"
"6371","14/04 12:00","41","P1885","Chloé DUPONT","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Focus on the neglected class A carbapenemases (IMI, NmcA and FRI) using a One Health approach","G. Conquet|N. Martel|J. A. Benavides|L. Sababadichetty|C. Dupont|S. Godreuil|G. Miltgen"
"6383","14/04 12:00","42","P1886","Adriana SILVA","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Critical antibiotic resistance detected in pig and rabbit farms threatens public health: high-risk clones on the rise","A. Silva|V. Silva|G. Igrejas|P. Valentao|V. Falco|P. Poeta"
"6498","14/04 12:00","43","P1887","Mario Sergio PINO HURTADO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Wastewater environment as reservoir of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae: a molecular characterisation study","M. Pino-Hurtado|L. Rubio-Tomás|R. Fernández-Fernández|C. Lozano|M. Zarazaga|C. Torres"
"6503","14/04 12:00","44","P1888","Otavio RARO","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Where global warming stands on plasmids-encoded resistance transfer?","O. Raro|L. Poirel|P. Nordmann"
"6616","14/04 12:00","45","P1889","Rafael VIGNOLI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence of resistance to critically important antibiotics for human health in different intensive livestock production systems in Uruguay","F. Rivero|N. Cordeiro|C. Morales|V. Rodriguez|M. Schanzembach|E. Giannechini|R. Vignoli"
"6631","14/04 12:00","46","P1890","Sophie Alexandra BARON","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Identification of IncF plasmids conferring both glyphosate and paraquat tolerance in Klebsiella spp. clinical strains isolated from farmers in Thailand: a new One Health threat?","A. Hamieh|H. Zerrouki|T. Vo|S. Morand|J. Rolain|S. Baron"
"6866","14/04 12:00","47","P1891","Khaloud ALZAHRANI","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Large-scale genomic survey of non-typhoidal Salmonella enterica Serovar Minnesota strains in chicken products reveals the emergence of multidrug-resistant clones","K. Alzahrani|H. Jiayi|M. Danesh|A. Suliman|A. Fahad"
"6914","14/04 12:00","48","P1892","Gijs TEUNIS","8","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Nation-wide spread of an outbreak-associated IncFIB-multidrug-resistance plasmid, the Netherlands, 2016-2022","G. Teunis|W. Van Der Reijden|D. Notermans|W. Ang|F. Landman|S. Witteveen|A. De Haan|J. Bos|S. Lansu|L. Mughini-Gras|A. Schurch|A. Hendrickx"
"7026","14/04 12:00","1","P1893","Alessandro BELLATO","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Staphylococcus aureus carriage in hedgehogs (Erinaceus europaeus) admitted to a wildlife rescue centre in north-western Italy","A. Bellato|I. Prandi|P. Robino|O. Roch-Dupland|M. Stella|M. Von Degerfeld|G. Quaranta|P. Nebbia"
"7111","14/04 12:00","2","P1894","Ilaria PRANDI","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Antibiotic resistance of Escherichia coli isolated from European hedgehogs (Erinaceus europaeus) in a wildlife rehabilitation centre","I. Prandi|A. Bellato|P. Nebbia|O. Roch-Dupland|M. Stella|M. Mauthe Von Degerfeld|G. Quaranta|P. Robino"
"7242","14/04 12:00","3","P1895","Aitezaz AHSAN","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence, antibiotic resistance, and molecular characterisation of methicillin-resistant Staphylococcus aureus: a study from peri-urban dairy farms in Pakistan????","A. Ahsan|M. Shahzad|H. Irshad|U. Talib|R. Waseeullah|F. Tahir"
"7315","14/04 12:00","4","P1896","Josip UJEVIC","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Molecular epidemiology of NDM-producing Escherichia coli isolates in Croatia","J. Ujevic|M. Jelic|A. Tambic Andrasevic|I. Butic"
"7498","14/04 12:00","5","P1897","Sonia GALAZKA","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Microbial biodiversity as a barrier to the spread of antimicrobial resistance in soil","S. Galazka|V. Vigl|E. Radu|M. Kuffner|G. Rab|P. Strauss|J. Vierheilig|N. Kreuzinger|I. Dielacher|K. Spettel|R. Kriz|U. Klumper|G. Gionchetta|E. Catao|X. Bellanger|L. Tomschiczek|A. Goryluk-Salmonowicz|M. Szadziul|M. Popowska|F. Walsh|H. Burgmann|C. Merlin|T. Berendonk|M. Wögerbauer"
"7529","14/04 12:00","6","P1898","Maria MICIELI","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Antimicrobial resistance through a One Health perspective: insights from a survey on the commensal microbiota of heavy breeder hens from Bolivian farms","M. Micieli|J. Samaricha Ortiz|T. Di Maggio|A. Barbiero|M. Rivero Mamani|M. Strohmeyer|M. Spinicci|L. Pallecchi|G. Rossolini|A. Bartoloni"
"7544","14/04 12:00","7","P1899","Raneem AIZOUK","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Drivers of community-level transmission dynamics of antimicrobial resistance in rural Burkina Faso","R. Aizouk|B. Cooper|E. Van Kleef|D. Valia|M. Van Der Sande|B. Ingelbeen|H. Tinto"
"7648","14/04 12:00","8","P1900","Chaokun HONG","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Global landscape of community carriage of antimicrobial resistant bacterial pathogens: a systematic review and meta-analysis","S. Lewycka|C. Hong|H. Le|M. Wijk|H. Ngo|K. Moon|A. Tran|S. Umenthala|R. Otuko|B. Cooper"
"7653","14/04 12:00","9","P1901","Nicolas MARTEL","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Phenotypic and genomic characterization of cephalosporinase-producing Proteus mirabilis isolates from gulls in southern France","N. Martel|G. Conquet|S. Godreuil|C. Dupont"
"7665","14/04 12:00","10","P1902","Ricardo LEON-SAMPEDRO","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Multi-layered ecological interactions determine growth of clinical antibiotic-resistant strains within human microbiomes","R. Leon-Sampedro|M. Boumasmoud|M. Reichlin|K. Pfrunder-Cardozo|N. Noll|A. Egli|A. Hall"
"7673","14/04 12:00","11","P1903","Fiorenza PETRUZZI","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Prevalence and antimicrobial resistance of Salmonella strains isolated from chicken samples in southern Italy","F. Petruzzi|P. Di Taranto|G. Normanno|C. Pedarra|S. Faleo|G. Occhiochiuso|A. Didonna|D. Galante|L. Pace|V. Rondinone|C. Trisolini|L. Del Sambro|M. Beverelli|A. Di Castri|R. Catanzariti|M. Caruso|L. Palazzo|A. Parisi"
"7684","14/04 12:00","12","P1904","Jaime David ACOSTA ESPAÑA","9","B","03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Identification of antibiotic resistance genes in bacterial pathogens from street food sold at urban parks in Quito, Ecuador","M. Benitez-Teran|D. Brborich-Boada|S. Ojeda-Ahmed|A. Herrera-Yela|D. Intriago-Baldeon|A. Maldonado|J. Acosta-Espana"
"214","14/04 12:00","13","P1905","Arya KUMAR","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Expansion of antimicrobial stewardship and infection control programme of ICMR in secondary care hospitals","A. Kumar|R. Tk|S. Singh"
"788","14/04 12:00","14","P1906","Elly NUWAMANYA","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Economic burden of antibiotic resistance on the human health sector: a cost of illness study in tertiary hospitals in Uganda","E. Nuwamanya|J. Mayito|D. Byonanebye|R. Galiwango|S. Nakasendwa|S. Okoboi|F. Dhikusooka|C. Tumwiine|M. Hope|R. Kiggundu|V. Twemanye|E. Twinomuhwezi|J. Nabisere|F. Kakooza|A. Kambugu"
"804","14/04 12:00","15","P1907","Catherine FLECK-VIDAL","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Vaccines and AMR: an analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries","C. Fleck-Vidal|L. Plant|C. Gerke|U. Lamichhane|R. Sudbrak|L. Ogilvie|T. Wartel|J. Kim|A. Doubell"
"904","14/04 12:00","16","P1908","Emily GAURUHN","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Wider health system strengthening would be required to optimise the impact of new AWaRe antibiotics in low- and middle-income countries across sub-Saharan Africa","E. Gauruhn|M. Sijbom|J. Iyer|M. Mendelson|M. Sharland"
"1135","14/04 12:00","17","P1909","Bode Ireti SHOBAYO","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","A cross-sectional study on the prevalence and patterns of over-the-counter purchase of antibiotics in Liberia; an urgent call for rational use","B. Shobayo|M. Sharma|C. Lundborg|H. Nordenstedt|M. Fallah|T. Fayiah"
"1375","14/04 12:00","18","P1910","George Dalitso LIMWADO","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Prevalence of antibiotic self-medication and knowledge of antimicrobial resistance among community members in Neno district rural Malawi: a cross-sectional study","G. Limwado|M. Aron|K. Mpinga|H. Phiri|S. Chibvunde|E. Ndarama|C. Walyaro|E. Connolly"
"1636","14/04 12:00","19","P1911","Anna Karin SJOBLOM","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","From people to leaders: bridging communities and policy for global AMR mitigation","M. Pränting|A. Quizhpe Peralta|A. Sjöblom|N. El Omeiri|J. Nyamupachitu|S. Mwango Kalufyanya|L. Sadasivan Sreemathy|A. Caputo Svensson|S. Sivaraman"
"1830","14/04 12:00","20","P1912","Kasim ALLEL","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Global pricing of key AWaRe (access, watch, reserve) antibiotics: ensuring affordability and equity in optimising antimicrobial use","K. Allel|F. Djukic|M. Thorn|A. Cook|B. Cooper|J. Goelen|C. Moore|R. Laxminarayan|M. Sharland|K. Pouwels"
"2099","14/04 12:00","21","P1913","Sarah WARNER","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Impact of disparities in access to antibiotics on inferring burdens of difficult-to-treat antibiotic resistance: a real-world data analysis and simulation study","S. Warner|M. Walker|C. Yek|S. Sarzynski|S. Angelo|S. Kadri"
"2261","14/04 12:00","22","P1914","Menuk JAYAWARDENA","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Strengthening antimicrobial resistance surveillance through external quality assessment","M. Jayawardena|K. Ryan|O. Melanie|T. Theis|J. Elvy"
"2397","14/04 12:00","23","P1915","Ha LE THANH","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Social determinants of antibiotic use in Vietnam: a mediation analysis","H. Le Thanh|T. Vu|T. Tran Phuong|A. Nguyen Thi Ngoc|S. Lewycka"
"3065","14/04 12:00","24","P1916","Jill HOPKINS","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Bacterial culture practices and views on antimicrobial resistance among hospital physicians in Africa and Asia: ACORN2 KAP survey","J. Hopkins|J. Opintan|S. Akech|E. Ashley|N. Feasey|A. Karkey|I. Okeke|H. Van Doorn|R. Hamers|P. Turner"
"3123","14/04 12:00","25","P1917","Jill HOPKINS","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Health economic impact of antimicrobial resistance in bloodstream infections in low- and middle-income countries: results from the ACORN2 study","J. Hopkins|C. Painter|J. Opintan|R. Hamers|S. Akech|E. Ashley|N. Feasey|A. Karkey|I. Okeke|S. Lee|Y. Lubell|H. Van Doorn|P. Turner"
"3414","14/04 12:00","26","P1918","Jasmine KAUR","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","AMROrbit Scorecard: a dynamic phase space model for strategic monitoring and actionable insights on global AMR trajectories","J. Kaur|T. Sethi|N. Tiju|A. Gupta|R. Pendyala|M. Vairamuthu"
"3604","14/04 12:00","27","P1919","Adrian SHEPHARD","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Insights from STAR 2 on understanding changing attitudes and perceptions towards antibiotic use for respiratory tract infections in Europe","A. Altiner|M. Duerden|R. Kozlov|E. Lopez-Pintor|A. Mastalerz-Migas|G. Musat|A. Sessa|A. Shephard|A. Van Der Velden"
"4358","14/04 12:00","29","P1921","Aislinn COOK","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Fair share of AWaRe using benchmarking to derive ""expected"" levels of access/watch/reserve antibiotic use for 177 countries based on population health needs","A. Cook|K. Pouwels|M. Sharland"
"4433","14/04 12:00","30","P1922","Abdullah Al MASUD","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Antibiotic dispensing in community pharmacies: a critical area for multifaceted antimicrobial stewardship on the supply and demand sides","A. Masud|R. Walpola|M. Sarker|A. Kabir|M. Asaduzzaman|M. Islam|A. Tasnim Mostafa|Z. Akhtar|H. Seale"
"4624","14/04 12:00","31","P1923","Chaelin KIM","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: systematic review and meta-analysis","C. Kim|I. Frost|N. Naylor|H. Au|Y. Kim|Y. Lee|A. Bzymek|K. Majgier|A. Moldoveanu|O. Salman|S. Simiyu|D. Youssef|M. Hasso-Agopsowicz|K. Abbas"
"5784","14/04 12:00","32","P1924","Deepshikha BATHEJA","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Women with higher household bargaining power have greater knowledge of antibiotics and antimicrobial resistance: evidence from rural Vietnam","S. Goel|S. Lewycka|D. Batheja"
"6095","14/04 12:00","33","P1925","Diego ORTIZ","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Strengthening antimicrobial stewardship: the role of national surveillance and reporting in reducing antimicrobial resistance","D. Ortiz|J. Garlasco|F. Manco|K. Odoj|C. Magnabosco|M. Pezzani|F. Arieti|E. Addis|O. Awwad|E. Tacconelli"
"6428","14/04 12:00","34","P1926","S M Murshid HASAN","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Understanding power dynamics and financial interest among stakeholders: antibiotic transaction in commercial poultry farming in Bangladesh","S. Hasan|W. Sakcamduang|P. Pradabmook-Sherer|L. Sringernyuang"
"6489","14/04 12:00","35","P1927","Juliana CORRÊA","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Operationalising One Health to combat antimicrobial resistance in Brazil: challenges, governance, and pathways to integration","J. Corrêa"
"6648","14/04 12:00","36","P1928","Deborah EKUSAI SEBATTA","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Understanding the contextual factors in the management of antimicrobial resistance in Uganda","D. Ekusai Sebatta|E. Rutebemberwa|J. Kapisi|A. Sserwanga|J. Nkeramahame|F. Kitutu|H. Hopkins|D. Kaawa-Mafigiri|P. Horgan"
"6876","14/04 12:00","37","P1929","Miriam NANTAMU","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","It is not the lack of access but the lack of money that affects patients' ability to treat uncomplicated UTIs in the community in Uganda","M. Nantamu|D. Ekusai Sebatta|H. Tuheirwe|J. Enomut|S. Nakamanya|P. Kirabo|S. Gobba|M. Iwami|H. Kajumbula|F. Kitutu|J. Kapisi|C. Moore"
"7534","14/04 12:00","38","P1930","Samkele MKUMBUZI","9","B","03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Current framing of antimicrobial resistance to the public, subject experts, and policy makers: a scoping review of national action plans and key policy documents","S. Mkumbuzi|C. Bonaconsa|A. Kona|M. Tlangelani|C. Esmita|M. Mendelson"
"385","14/04 12:00","1","P1931","Jessica LEWIS","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","A service evaluation of peritoneal dialysis fluid culture methods: universal and blood culture bottles","J. Lewis|N. Young|T. Folaranmi"
"559","14/04 12:00","2","P1932","Johanna SANDLUND","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","A novel ultrasensitive single-molecule counting C. difficile toxin A/B assay for reduced testing complexity and more accurate diagnosis of disease","G. Dave|T. Truong|M. Soban|J. Nguyen|N. Nolan|R. Tobias|F. Zaugg|P. Wagner|V. Brachet|J. Sandlund"
"897","14/04 12:00","3","P1933","Bastian DIRK","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Early diagnosis of urinary tract infection requires direct testing of bacterial counts in urine","L. Von Muller|B. Dirk|T. Hwandih|M. Holz|B. Schönbeck"
"925","14/04 12:00","4","P1934","Hannah JEAL","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Investigating chlamydia specific antibody titres and avidity in trachoma infection and disease progression","H. Jeal|E. Mafuru|A. Malissa|M. Holland|A. Barton|A. Ramadhani|T. Mtuy|P. Massae|T. Derrick|A. Harte|H. Pickering|M. Burton|A. Sillah|N. Faal|R. Bailey|D. Mabey"
"930","14/04 12:00","5","P1935","Helene FAURY","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Performance of a rapid test for Group A Streptococcus in paediatric pleural empyema","H. Faury|A. Flamant|A. Ferroni|J. Cohen"
"1157","14/04 12:00","6","P1936","Ayan MANDAL","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of shorter incubation time for automated blood culture systems in critically ill patients","A. Mandal|A. Varadarajan|M. Soneja|S. Mahapatra|B. Kumar Das"
"1190","14/04 12:00","7","P1937","Andreas JACOBS ØSTERHEGN JENSEN","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Impact of delayed incubation on blood culture diagnostics","A. Jacobs Østerhegn Jensen|C. Moser"
"2135","14/04 12:00","8","P1938","Leong Tung ONG","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Diagnostic pitfalls of auramine O smear microscopy: a retrospective study of adult nontuberculous mycobacteria infections misdiagnosed with and treated for tuberculosis","L. Ong|A. Abdullah|T. Loh|C. Wong|N. Atiya"
"2379","14/04 12:00","9","P1939","Ellen BROWNE","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Reducing the blood culture contamination rate in the emergency department: a good start","E. Browne|M. Russell|G. Kalukondanahally|M. Abbas|O. Keane|H. Mc Dermott"
"2481","14/04 12:00","10","P1940","Delphine JACOB","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Early detection of Aerococcus species from automated incubation of chromogenic media","G. Durand|D. Jacob|C. Fulchiron"
"2642","14/04 12:00","11","P1941","Joshua HERR","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Capability of automated individual blood volume measurement system for monitoring paediatric blood culture volumes","J. Herr|D. Turner|C. Massey|B. Newcomb|K. Robinson"
"2744","14/04 12:00","12","P1942","Colin HUDSON","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Not all positive blood cultures are significant, so why process them as such?","C. Hudson|J. Clayton"
"2749","14/04 12:00","13","P1943","Kayla VAN BENTEN","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Improved time-to-detection with the new formulation of commercially available aerobic blood culture vials: a real-world evidence study","K. Van Benten|V. Parvu|S. Kodsi|L. Cooper|M. Howard|M. Westcott"
"2796","14/04 12:00","14","P1944","A.M.B. Nilmini WIJESOORIYA","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","The ongoing relevance of conventional culture method in the recovery of Salmonella spp. from faecal samples tested with real-time PCR","N. Wijesooriya|H. Donaldson|Z. Kiliddar|A. Morkowska"
"2907","14/04 12:00","15","P1945","Lamiss MEJDOUBI","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of a sponge-based transport device for urine culture in a nephrology outpatient clinic","L. Mejdoubi|A. Nader|K. Mejdoubi|J. Werzowa"
"3112","14/04 12:00","16","P1946","Hui YANG","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Comparison of multiple blood cultures and unique blood cultures in testing performance for suspected bloodstream infections","H. Yang|N. Xu|L. Yang|S. Wen|K. Xu|G. Wang"
"3762","14/04 12:00","17","P1947","Francesco BONOMETTI","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Comparison of commercially available liquid amies collection and transport systems for the viability preservation of aerobes, anaerobes and fastidious bacteria","F. Bonometti"
"4032","14/04 12:00","18","P1948","García García SAMUEL","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Retrospective study of an urinary antigen detection test performance for the diagnosis of Legionella pneumophila pneumonia in a Spanish tertiary hospital","S. Garcia Garcia|I. Pérez Del Molino Bernal|S. Garcia Martin|Z. Moure Garcia|A. Rodriguez Fernandez|D. Ferrer Pargada|A. Ocampo Sosa|J. Calvo Montes|M. Roiz Mesones"
"4077","14/04 12:00","19","P1949","Silvia Figueiredo COSTA","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Discrimination of foodborne bacteria using an electronic nose based on MOS sensors","A. Hidifira|P. Sousa|N. Scaccia|E. Sabino|A. Levin|G. Rehder|V. Nascimento|J. Gruber|S. Costa"
"4376","14/04 12:00","20","P1950","Olivier DAUWALDER","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","A new formulation of CHROM-ID OXA48 chromogenic media: a before/after impact study for carbapenemase-producing Enterobacterales detection","O. Dauwalder|R. Bonnin|T. Roussel-Gaillard|C. Emeraud|B. Joannard|A. Jousset|W. Salka|C. Dupieux-Charbert|G. Lina|J. Rasigade|F. Vandenesch|L. Dortet"
"4501","14/04 12:00","21","P1951","Marco Antonio SEMPERE ALCOCER","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Comparison of the performance of a new chemiluminescent immunoassay for Helicobacter pylori faecal antigen detection","M. Garcia-Lopez|A. Lopez-Gonzalez-Salido|M. Sempere-Alcocer|L. Balderas-Fernandez|P. Salas-Fernández"
"4530","14/04 12:00","22","P1952","Xuan QIN","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","No culture left behind and no sepsis left unchecked: use the latest technologies at their full potentials","X. Qin|S. Downs|G. Fan"
"5133","14/04 12:00","23","P1953","Eun Jeong WON","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of performance of antimicrobial-neutralising effect of novel resin blood culture vials","B. Park|K. Yun|S. Seol|E. Won|H. Sung|M. Kim"
"5169","14/04 12:00","24","P1954","Christian Johann LERCHE","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","A single centre prospective comparative study: roll-plate vs sonication technique of microbiological diagnosis of tunneled long-term catheters","C. Lerche|S. Tribler|M. Rix|T. Elung-Jensen|P. Jeppesen|C. Moser"
"5482","14/04 12:00","25","P1955","Martin FAYOLLE","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Validation of a new microbiological control protocol for corneal grafts stored in tissue-C","J. Samard|M. Fayolle|S. Ninotta|S. Acquart|Z. He|P. Gain|G. Thuret|C. Talon|N. Fonsale|M. Lleres-Vadeboin|P. Verhoeven|A. Carricajo"
"5647","14/04 12:00","26","P1956","Miriam CORDOVANA","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of the suitability of MDR enterobacteria chromogenic media for Fourier-transform infrared spectroscopy","M. Cordovana|N. Mauder"
"5985","14/04 12:00","27","P1957","Sandra REISCHL","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Synergy of electric field-mediated sample preparation and light-scattering based pathogen growth detection for accelerated time to positivity","S. Reischl|D. Pittrich|S. Ceschia|T. Wimberger|K. Wassermann|K. Karnpakdee|D. Garlatti"
"6033","14/04 12:00","28","P1958","Rahul GARG","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Contamination of CSF culture: serious risk to patient safety","R. Garg|R. S.|R. Narang"
"6183","14/04 12:00","29","P1959","Callebaut CALLEBAUT","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluating semi-automatic homogenisation of tissue samples for improved diagnostics of tissue infections","K. Callebaut|L. Boucher|K. Claeijs|C. Labit|S. Steyaert"
"6247","14/04 12:00","30","P1960","Manuel Antonio RODRIGUEZ IGLESIAS","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of an immunofluorescence point-of-care device for to detect cell wall polysaccharides of Streptococcus pneumoniae in urine samples","V. Guirado|J. Rodriguez|E. Jurado-Tarifa|F. De La Rubia|T. Trujillo|M. Rodriguez"
"6515","14/04 12:00","31","P1961","Farah FIECHTER","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","""Beat it!"": tissue homogenisation by vibratory mill provides high bacteriological culture yield in routine tissue samples","F. Fiechter|V. Hinic|B. Schulthess|O. Beer|O. Nolte"
"6676","14/04 12:00","32","P1962","Melanie YARBROUGH","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Where do we stand with the Gram stain? Evaluation of the reproducibility of Gram stain preparation and reading of bronchoalveolar lavage and endotracheal aspirate specimens","M. Yarbrough|M. Pesesky|M. Porter|M. Eickhoff|K. Alvarado|M. Wallace|C. Muenks|C. Burnham"
"6901","14/04 12:00","33","P1963","Maitrayee NARAYAN","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Reaffirming the role of the reverse algorithm diagnostic strategy in syphilis screening through the performance of a treponemal point-of-care test","M. Narayan|H. Gautam|P. Batra|B. Das"
"6905","14/04 12:00","34","P1964","Peter Michael KELLER","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Comparative performance evaluation of routine swab systems in microbiology and molecular diagnostics","K. Narr|P. Keller"
"7131","14/04 12:00","35","P1965","Mariana CARVALHO","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Evaluation of the impact of a rapid test for Group A streptococcal antigen in a community pharmacy","M. Carvalho|E. Barata|P. Cavaco-Silva"
"7360","14/04 12:00","36","P1966","Zahra AZIZI","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Towards improved diagnostics: a tunable sputum model for streamline sample preparation and diagnosis","Z. Azizi|J. Dolezel|S. Vasantham|S. Barratt|A. Sturm|A. Vocat|G. Resch|T. Wimberger|K. Wassermann|S. Gutierrez"
"7416","14/04 12:00","37","P1967","Ellen MITCHELL","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Sputum collection in children 6 -14 years: sequence randomised crossover trial of a low-cost positive expiratory pressure device for tuberculosis testing","E. Mitchell|S. Mitarai|C. Mbuli|M. Sander|E. Hasker"
"7587","14/04 12:00","38","P1968","Giulio CAMARLINGHI","10","B","04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","I-dOne: a diagnostic tool in the field of identification of clinically relevant microbial strains","E. Parisio|G. Camarlinghi|A. Ognibene"
"1069","14/04 12:00","39","P1969","Sara Giordana RIMOLDI","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Does lab automation reduce incubation time in diagnosis of orthopaedic infections? Laboratory automation combined with NGS for the diagnosis of infections: first results from a reference centre","S. Rimoldi|C. Pagani|M. Passerini|D. Brioschi|M. Stracuzzi|A. Mancon|A. Gigantiello|S. Grosso|A. Gori|A. Manzotti"
"1603","14/04 12:00","40","P1970","Delphine JACOB","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Early MDRO screening on chromogenic media with automated culture systems","O. Legrand|N. Janvier|C. Bisilliat-Gardet|D. Jacob|G. Durand|C. Fulchiron|B. Berçot|A. Goffin"
"1824","14/04 12:00","41","P1971","Maxencia NABIRYO","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Pre-analytical resource development supporting clinical integration of microbiology services in LMICs","N. D'arcy|C. Brandish|K. Yamba|N. Moremi|M. Jemma|J. O'driscoll|V. Rutter|M. Nabiryo"
"1933","14/04 12:00","42","P1972","Ameeka THOMPSON","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Improving diagnostic stewardship: an example from Coxiella serology","A. Thompson|J. Osborne|N. Gordon"
"2026","14/04 12:00","43","P1973","Zahraa AL-SULTANI","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","5Ws analysis of blood culture contamination rates in an Australian medical laboratory","Z. Al-Sultani|M. Reynolds|L. Thomas|S. Barnard|B. Mcfadden|T. Inglis"
"2500","14/04 12:00","44","P1974","Alberto VAZQUEZ BLANQUIÑO","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Round-the-clock microbiology: a game changer for early bacteraemia detection and treatment","A. Vazquez Blanquino|A. Alberola Romano|L. Perez Rodriguez|N. Chueca Porcuna|F. Garcia"
"3155","14/04 12:00","45","P1975","Yuling XIAO","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Setting automatic review rules to improve the accuracy of rapid antimicrobial susceptibility testing results","S. Wu|J. Deng|Y. Xie|Y. Xiao"
"3279","14/04 12:00","46","P1976","Riccardo CAPUANO","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","How to implement a 24/7 lab with full automation to improve patient management and antimicrobial stewardship: a preliminary single-centre experience","R. Capuano|N. Mancini|G. Arcari|M. Carbotti|P. Gigante|R. Pasciuta"
"3348","14/04 12:00","47","P1977","Colin MANS","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Automation of blood cultures using microbiology laboratory automation: enhancing efficiency in microbiological diagnostics","D. Elshout|C. Mans|F. Habets|E. De Brauwer|L. Van Der Velden"
"3361","14/04 12:00","48","P1978","Demi ELSHOUT","10","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Automated inoculation of respiratory samples for enhanced bacteriological analysis","D. Elshout|C. Mans|E. De Brauwer|L. Van Der Velden"
"3740","14/04 12:00","1","P1979","Charline KATUROLE","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Barriers to quality management system implementation and accreditation in Teso sub-region, Uganda: a study on laboratory non-conformances","C. Katurole|D. Mujuni"
"3864","14/04 12:00","2","P1980","Béatrice CELLIÈRE","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Encoding culture media tests using LOINC terminology","B. Celliere|L. Nougier|S. Rivat|X. Gansel|M. Dante|L. Devigne|L. Pages-Monteiro|G. Durand"
"5289","14/04 12:00","3","P1981","João PIRES","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Automatising the identification of invasive Group A Streptococcus through laboratory data available in the Norwegian surveillance system for communicable diseases laboratory database","J. Pires|P. Cyr|N. Aasand|A. Kran"
"6112","14/04 12:00","4","P1982","Volkan ÖZENCI","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Consequences of method change on plastic waste consumption in clinical microbiology","L. Eneh|Ö. Dogan|S. Alavi|A. Böhlin Wiener|V. Özenci"
"6142","14/04 12:00","5","P1983","Stanca-Luci PANDREA","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Automated culture systems in a microbiology laboratory specialising in gastroenteric samples","B. Szoros|M. Tompa|A. Moise|S. Pandrea|S. Pandrea|M. Ciontea"
"6167","14/04 12:00","6","P1984","Conor MULROONEY","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Optimising blood culture turnaround times: analysis of a regional microbiology hub and spoke laboratory network","C. Mulrooney|F. O'rourke|M. Doyle|G. Chan"
"6763","14/04 12:00","7","P1985","Evangelina ARAUJO","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Pre-analytical features of the first routine blood culture from 55,558 patients at a tertiary hospital in San Paulo, Brazil","E. Da Motta Pacheco Alves De Araujo|E. Da Motta Pacheco Alves De Araujo|M. Claudia Stockler|S. Figueiredo Costa|A. Posch|L. Santana|F. Fábio Augusto Rodrigues Gonçalves|A. Cury|M. M. C. Magri|T. Sabato Romano Di Gioia|E. Cerdeira Sabino|L. Antonangelo"
"6810","14/04 12:00","8","P1986","Paola BERNASCHI","11","B","04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Laboratory automation in microbiology: a positive impact on turnaround time (TAT) of paediatric microbiological samples","M. Argentieri|A. Angelaccio|V. Tuccio Guarna Assanti|M. Rossitto|M. Lepanto|N. Essa|G. Foglietta|A. Sisto|S. Tredici|I. Zullino|C. Parlavecchio|G. Tatangelo|C. Perno|P. Bernaschi"
"203","14/04 12:00","9","P1987","Alicia BORONAT MUÑOZ","11","B","04c. MALDI-TOF and other proteomic methods","Mycobacterium avium complex (MAC): a group of emerging pathogenic species, in patients with diseases associated to the respiratory tract","A. Boronat Munoz|E. Cuchi Burgos|I. Morales Salmeron|M. Velasco Gálvez|J. González|P. Pérez Jove"
"1314","14/04 12:00","10","P1988","Juliana CAIERÃO","11","B","04c. MALDI-TOF and other proteomic methods","DOT-MGA for rapid determination of susceptibility to ceftazidime/avibactam and aztreonam combination among Enterobacterales","N. Moreira|G. Collar|P. Barth|A. Barth|J. Caierao"
"1639","14/04 12:00","11","P1989","Craig WILLIAMS","11","B","04c. MALDI-TOF and other proteomic methods","Infra-red spectroscopy (FTIR) for the rapid identification of Gram-negative bacteria involved in urosepsis","C. Williams|G. Rozada|T. Edwards|C. Meza|A. Segura|I. Rehman"
"1792","14/04 12:00","12","P1990","Miriam STERNEL","11","B","04c. MALDI-TOF and other proteomic methods","Discrimination of cronobacter sakazakii from other Cronobacter strains using lipid analysis with MALDI-ToF MS in negative ion mode","M. Sternel|J. Axe|B. Oberheitmann|M. Kostrzewa"
"2091","14/04 12:00","13","P1991","Peter LASCARIDES","11","B","04c. MALDI-TOF and other proteomic methods","Comparison of the filamentous fungi library database of the matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) with the MSI-2 database for identification of medically important molds","P. Lascarides|W. Memon|S. Zhang|T. Walsh"
"2199","14/04 12:00","14","P1992","Miriam CORDOVANA","11","B","04c. MALDI-TOF and other proteomic methods","Fast and user-friendly discrimination of highly virulent Streptococcus agalactiae clonal complexes by MALDI-TOF MS","M. Cordovana|F. Joppe|M. Kostrzewa|T. Perme|S. Jeverica|D. Golparian|M. Unemo|N. Omahen"
"2300","14/04 12:00","15","P1993","Dehao ZHOU","11","B","04c. MALDI-TOF and other proteomic methods","Application of MALDI-TOF MS in the detection of drug-resistant phenotype of Staphylococcus aureus","S. Feng|M. Liu|G. Zhao|D. Zhou|Z. Li|C. Li|F. Chen|G. Fu"
"2310","14/04 12:00","16","P1994","Guangyu FU","11","B","04c. MALDI-TOF and other proteomic methods","Application evaluation of MALDI-TOF MS in rapid identification of filamentous fungi","S. Feng|M. Liu|G. Zhao|D. Zhou|Z. Li|C. Li|F. Chen|G. Fu"
"2680","14/04 12:00","17","P1995","Kaley REEDY","11","B","04c. MALDI-TOF and other proteomic methods","Evaluation of a new device using MALDI-TOF systems for fast identification of Gram-negative pathogens from positive blood cultures","K. Reedy|J. Gafsi|N. Hanson|D. Hardy|D. Rhoads|Y. Ying"
"3286","14/04 12:00","18","P1996","Yukino GÜTLIN","11","B","04c. MALDI-TOF and other proteomic methods","Toward sustainable and reproducible MALDI-TOF MS: impact of target selection and hardware maintenance on mass spectral quality","Y. Gutlin|A. Egli"
"3908","14/04 12:00","19","P1997","Donatella LOMBARDO","11","B","04c. MALDI-TOF and other proteomic methods","A novel approach for Klebsiella pneumoniae typing by Fourier-transform infrared spectroscopy","D. Lombardo|M. Cordovana|N. Mauder|F. Piscopiello|I. Petrizzi|A. Piazza|A. Simone|R. Migliavacca"
"3933","14/04 12:00","20","P1998","Esther RECACHA","11","B","04c. MALDI-TOF and other proteomic methods","Comparison of mass spectrometry (MALDI-TOF MS) and genomic analysis (rMLST, hsp60 and chromosomal AmpC) for the identification of Enterobacter cloacae complex species","E. Recacha|L. Lopez-Cerero|S. Asensio-Gallego|Â. Novais|Á. Pascual|A. Gonçalves"
"4301","14/04 12:00","21","P1999","Evgeny A. IDELEVICH","11","B","04c. MALDI-TOF and other proteomic methods","Performance of a rapid MALDI-TOF MS assay for antimicrobial susceptibility testing","E. Idelevich|K. Alpers|M. Buhl|O. Drews|S. Kidd|M. Kostrzewa|N. Moore|I. Nix|B. Oberheitmann|F. Pereira|A. Pranada|I. Scholz|K. Sparbier|J. Steinmann|J. Weferling|S. Zimmermann|K. Becker"
"5122","14/04 12:00","22","P2000","Run HUANG","11","B","04c. MALDI-TOF and other proteomic methods","Streamlining pathogen identification: advanced rapid blood culture enrichment technology for MALDI-TOF MS diagnostics","Y. Li|J. Tong|T. Ma|R. Huang|F. Lu"
"5575","14/04 12:00","23","P2001","Kamelia Zahra YALA","11","B","04c. MALDI-TOF and other proteomic methods","Evaluation of the performance of a bacterial identification system by mass spectrometry by matrix-assisted laser desorption/ionisation and time of flight (MALDI-TOF MS)","K. Yala|F. Djedjig|S. Bouheraoua|D. Boucherih|M. Ifticene|S. Mahrane|H. Tali Maamar|Z. Chettouh|D. Bensersa"
"5630","14/04 12:00","24","P2002","Miriam CORDOVANA","11","B","04c. MALDI-TOF and other proteomic methods","Evaluation of FT-IR spectroscopy for E. coli ST-131 differentiation","A. Veloo|M. Cordovana|G. Fleurke|L. Gard|M. Lokate|M. Fliss"
"7325","14/04 12:00","25","P2003","Andre INGEBRETSEN","11","B","04c. MALDI-TOF and other proteomic methods","Prediction of linezolid-resistant Enterococcus faecium using MALDI-TOF MS and machine learning","A. Ingebretsen|M. Hagbø|A. Steffensen|J. Bjørnholt|F. Muller"
"124","14/04 12:00","26","P2004","Jeonghyun CHANG","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Utilisation of the BioFire FilmArray blood culture identification 2 panel for rapid and accurate identification of bacteraemia pathogens","J. Chang|S. Shin|D. Whang|T. Um|C. Cho"
"175","14/04 12:00","27","P2005","Lucie CÍCHOVÁ","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Rapid detection of ESKAPE pathogens from whole blood in patients with spondylodiscitis and infective endocarditis combining PCR and MRI","O. Dzupova|K. Herrmannová|L. Cichova"
"176","14/04 12:00","28","P2006","Isabella ELLENA TICKLER","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Updated coverage of circulating and emerging toxigenic Clostridioides difficile strains by a commercial PCR test","I. Tickler|S. Mitchell|M. Loeffelholz"
"400","14/04 12:00","29","P2007","Rhys EVANS","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Laboratory evaluation of the Biofire FilmArray pneumonia panel compared to standard-of-care testing in patients admitted to an ICU in Swansea, UK","R. Evans|A. Daniel|P. Naicker|J. Hudson|J. Rogers"
"546","14/04 12:00","30","P2008","Hyun-Seung LEE","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Analytical performance evaluation of automated multiplex real-time PCR for detection of pathogens related with acute undifferentiated febrile illnesses: severe fever with thrombocytopenia syndrome virus, Orientia tsutsugamushi, Leptospira, and hantavirus","H. Lee"
"553","14/04 12:00","31","P2009","Leilei WANG","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparison of molecular testing methods for diagnosing non-tuberculous mycobacterial infections","R. Bao|L. Wang|Y. Chen|Q. Wang|Y. Ji|B. Hu|Q. Miao"
"665","14/04 12:00","32","P2010","Chien-Chang LEE","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Impact of multiplex PCR for rapid microbiological diagnosis of patients with severe pneumonia in emergency department: a pragmatic controlled trial","C. Lai|Y. Hsein|C. Su|S. Chang|C. Lee"
"697","14/04 12:00","33","P2011","Coralie BOUCHIAT","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Optimisation of diagnostic specificity in bacterial infections by duplex 16S rDNA PCR","C. Bouchiat|L. Martinuzzi|T. Roussel-Gaillard|A. Souche|O. Dauwalder|Y. Benito|F. Vandenesch|H. Salord"
"719","14/04 12:00","34","P2012","Amy LEBER","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Diagnostic yield of bacterial PCRs for identifying the infectious etiology for paediatric pleural effusion","A. Leber|S. Oyeniran|H. Wang"
"723","14/04 12:00","35","P2013","Dhruv GANDHI","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Utility of stool Xpert assay in the diagnosis of paediatric pulmonary and intestinal tuberculosis: a study from western India","D. Gandhi|I. Shah|D. Mamtora|M. Dey|S. Jain|S. Patil|M. D'souza|S. Mattoo|D. Shah|V. Puri|M. Bodhanwala"
"839","14/04 12:00","37","P2015","Zeqi ZHOU","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Development of a multiplex real-time PCR assay for the simultaneous detection of three fungal pathogens in respiratory samples","D. Jiang|S. Li|Z. Wang|Y. Wang|Y. Zhang|H. Wang|Y. Su|Z. Zhou"
"917","14/04 12:00","38","P2016","Martine BOS","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance of interspace profiling (ISpro) for diagnosis of bacterial pericarditis","M. Bos|M. Miguélez Sánchez|L. Remijas|D. Budding|R. Van Houdt"
"994","14/04 12:00","39","P2017","Maria TERZAKI","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Application of a film array meningitis/encephalitis panel for the diagnostic investigation of adult patients with syndromic symptomatology: a five-year retrospective epidemiological study","M. Terzaki|M. Zarfeiadou|C. Zarras|D. Kouroupis|C. Michailidou|P. Pateinakis|E. Paida|P. Soukiouroglou|E. Vasilaki|M. Chatziapostolou|E. Simoulidou|T. Koufakis|M. Doumas|A. Pyrpasopoulou"
"1134","14/04 12:00","40","P2018","Elif Ozge DAMAR MIDIK","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Distribution of microorganisms in patients followed up with a diagnosis of central nervous system infection and evaluation of clinical usefulness of cerebrospinal fluid multiplex PCR panel","E. Damar Midik|A. Batirel|S. Demir Tekol"
"1151","14/04 12:00","41","P2019","Julien DESSAJAN","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of multiplex PCR panel dynamics during antibiotic treatment to predict clinical success in ICU patients with severe hospital-acquired pneumonia: a multicentre prospective study","J. Dessajan|M. Thy|M. Doman|J. Stern|A. Gallet|G. Fouque|S. Chosidow|S. Ruckly|S. Gueye|E. Rondinaud|L. Bouadma|R. Sonneville|E. De Montmollin|L. Armand-Lefevre|J. Timsit"
"1153","14/04 12:00","42","P2020","James Roderick GRIFFITHS","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Outcomes of a meningitis/encephalitis syndromic PCR algorithm at a regional UK hospital","J. Griffiths|K. Bamford|G. Vanstone|M. Robert"
"1187","14/04 12:00","43","P2021","Dana SAGAS","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Rapid random-access molecular diagnostic assay for STI pathogens","D. Sagas"
"1290","14/04 12:00","44","P2022","Sarah SEDIK","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Mucorales PCR testing in bronchoalveolar lavage samples of immunocompromised patients with and without fungal infections","S. Sedik|K. Dichtl|U. Glatz|M. Egger|M. Hoenigl|J. Prattes"
"1338","14/04 12:00","45","P2023","Elizabeth PAZ GOMERO","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance of an automated, multiplex RT-PCR panel with external quality assessment programmes for respiratory pathogens","E. Paz Gomero|S. Eriksson|F. Vytrisal"
"1412","14/04 12:00","46","P2024","Tugçe ÖZYOL ATKAYA","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Can syndromic molecular tests be used for the diagnosis of urinary tract infections?","T. Özyol Atkaya|R. Berkem"
"1532","14/04 12:00","47","P2025","Golara GOLBAGHI","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Lyophilisation as a successful technique to produce easy-to-use, robust, and room-temperature-stable magnetic particles for molecular diagnostic applications","G. Golbaghi|J. Daoud|D. Felstead|E. Dupere|R. Rouag|N. Klai|V. Eroukova"
"1649","14/04 12:00","48","P2026","Golara GOLBAGHI","11","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Transforming reagents for revolutionary point-of-care molecular diagnostics: lyophilised PCR master mix beads for cold-chain-free and rapid testing","G. Golbaghi|M. Hajikarimlou|V. Eroukova"
"1782","14/04 12:00","1","P2027","Henar ALONSO-EZCURRA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Validation of a real time PCR assay using cerebrospinal fluid samples with clinical suspicion of bacterial meningitis from a tertiary hospital in Spain","B. Dehesa-Garcia|A. Milagro-Beamonte|P. Abad|N. Martinez-Cameo|D. Martinez-Mateos|B. Gilaberte-Angos|L. Laborda-Balaguer|M. Alejandre-Alegre|H. Alonso-Ezcurra|A. Rezusta"
"1791","14/04 12:00","2","P2028","Peter MUIR","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the hologic aptima vaginitis assays for microbiological diagnosis of vaginitis in women with abnormal vaginal discharge attending primary care","P. Muir|B. Vipond|N. Childs|R. Hopes|D. Hirst|K. Soni"
"1805","14/04 12:00","3","P2029","Susanne WOLFENSTETTER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","No time, no problem: transitioning to extraction-free workflow for stool testing using PCR","P. Gunadi|S. Wolfenstetter"
"2063","14/04 12:00","4","P2030","Frédéric BARBUT","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparative evaluation of the standard M10 and Xpert C. difficile assays for the detection of toxigenic Clostridioides difficile in stools","Y. Roukoz-Diab|M. Ehmig|S. Luce|C. Eckert|S. Timsit|I. Mostaghat|J. Couturier|F. Barbut"
"2073","14/04 12:00","5","P2031","Laura SEIJAS PEREDA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","A comparative evaluation of multiplex PCR panels for gastrointestinal pathogen detection in clinical stool samples","L. Seijas-Pereda|A. Martin|R. Menchero|C. Rescalvo-Casas|M. Hernando-Gozalo|R. Pérez-Tanoira"
"2109","14/04 12:00","6","P2032","Pninit SHAKED MISHAN","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Improved accuracy in Group B Streptococcus detection: a validation study across two medical centres","D. Sagas|O. Salah|P. Shaked Mishan|L. Matanis|M. Strauss"
"2217","14/04 12:00","7","P2033","Martina GASSNER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Enhanced pathogen detection and antimicrobial optimisation in ARDS: multiplex PCR vs standard diagnostics","M. Gassner|J. Sagmuller|C. Spies"
"2444","14/04 12:00","8","P2034","Nathan NICOLAU-GUILLAUMET","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Selective application of FilmArray for effective antibiotic management in meningitis patients","N. Nicolau-Guillaumet|C. Plouzeau Jayle|G. Péan De Ponfilly|A. Ranc|V. Courbin|M. Moutel|T. Guillard"
"2520","14/04 12:00","9","P2035","Camenforte NESTOR","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Ct values in fast syndromic testing: putative applications in CNS infection diagnosis","N. Camenforte|M. Contreras|J. Aldana|S. Jiménez|S. Rodriguez|Y. Márquez|R. Porco|L. Penarrubia|G. Pueyo|M. Rey|M. Juanola-Falgarona|F. Van Deursen|D. Lueerssen"
"2559","14/04 12:00","10","P2036","Jasmin KÖFFER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Clinical performance of a fully automated real-time PCR assay for the detection of Chlamydophila pneumonia, Legionella pneumophila and Mycoplasma pneumoniae in human bronchoalveolar lavage under IVDR","J. Koeffer|M. Kolb|U. Eigner"
"2566","14/04 12:00","11","P2037","Jasmin KÖFFER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Clinical performance of a fully automated real-time PCR assay for the detection of Clostridium difficile in human stool samples under IVDR","M. Kolb|J. Köffer|C. Eckel|U. Eigner"
"2627","14/04 12:00","12","P2038","Susana GARDETE-HARTMANN","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance of a novel molecular test in culture-negative periprosthetic hip and knee periprosthetic joint infections","S. Gardete-Hartmann|S. Sebastian|S. Berdalli|S. Simon|J. Hofstaetter"
"2702","14/04 12:00","13","P2039","Pedro L. RODRIGUEZ","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Analytical feasibility of the cobas eplex gastrointestinal panel: a multiplex PCR syndromic test currently in development","P. Rodriguez|Y. Li|N. Sikhamsay|K. Menge"
"2914","14/04 12:00","14","P2040","Myrthe Margriet Anne TOOROP","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Failure to detect Streptococcus pneumoniae due to false negative PCR results caused by a large insertion in the Spn9802 fragment","M. Toorop|M. Kraakman|E. Claas|E. Wessels|S. Boers"
"3000","14/04 12:00","15","P2041","Merve BUYUKKORUK","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the effect of gastrointestinal system multiplex PCR panel positivity on the relapse of ulcerative colitis patients","M. Buyukkoruk|O. Guzel Tunccan|S. Yigit|A. Karatas|T. Karakan|M. Dizbay|G. Bozdayi|M. Arhan"
"3034","14/04 12:00","16","P2042","Paulo Jose MARTINS BISPO","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Highly multiplexed broad pathogen detection assay for diagnosis of intraocular infections","P. Martins Bispo|N. Belanger|R. Liu|E. Ferracioli-Oda|J. Yamamoto|K. Huynh|L. Sobrin"
"3037","14/04 12:00","17","P2043","Hae-Seong JEONG","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Rapid and accurate pathogen detection in joint infections: assessing the performance of the BioFire joint infection panel in Korean tertiary hospitals","J. Hae Seong|C. Su Mi|K. Yong Jun|L. Ah Rang|K. Min Ji|K. Sarah|S. Sung Un|K. Uh Jin|K. Seung Ji|J. Sook In|S. Jong Hee|W. Eun Jeong|K. Mi Na|P. Kyung Hwa"
"3058","14/04 12:00","18","P2044","Edison CANO CEVALLOS","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Microbial cell-free DNA NextGen sequencing diagnostics in solid organ transplant recipients","E. Acevedo Martinez|J. Rodriguez-Belen|J. Martinez Feshold|D. Melendez Lecca|B. Fernandez Lopez|N. Miller|P. Eckardt|E. Cano Cevallos"
"3080","14/04 12:00","19","P2045","Doria BENSERSA-NEDJAR","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Neuro-meningeal infections caused by enterovirus: epidemiological and microbiological profiles","D. Bensersa-Nedjar|N. Aggoune|F. Henniche|F. Yamouni|N. Benarfa|H. Sebahi|K. Boukorchi|M. Chabani|A. Zerouki"
"3152","14/04 12:00","20","P2046","Anis Farhanah ROSLEE","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Epidemiology and antibiotic resistance genotypes of respiratory pathogens in critical care units and non-critical care units in private chain hospitals","A. Roslee|Y. Neoh|J. Nagappan|M. Aziz|W. Ong|S. Fong|T. Ooi|A. Adnan|T. Kam|M. Muhammed"
"3190","14/04 12:00","21","P2047","Konstantina KONTOPOULOU","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Filmarray GI system for the diagnosis of gastrointestinal tract infections","M. Tsekoura|A. Lita|K. Kontopoulou"
"3198","14/04 12:00","22","P2048","Ijeoma OKOLIEGBE","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","The impact of targeted molecular ciprofloxacin resistance testing on positive gonorrhoea samples in NHS Grampian","I. Okoliegbe|N. Chithra|N. Ewen|G. Stuart|H. Callaby|D. Brawley|N. El Sakka"
"3213","14/04 12:00","23","P2049","Rebecca SMITH AGUASCA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Assessment of a qPCR syndromic device's C. difficile tcdA/tcdB assay with clinical relevance","R. Smith-Aguasca|N. Camenforte|L. Rodriguez|S. Herrera|K. Vara|D. Lueerssen|F. Van Deursen|C. Camprubi-Font|L. Penarrubia|O. Vidal"
"3273","14/04 12:00","24","P2050","Elizabeth MORREEL","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Promising novel molecular approaches compared to culture for detecting periprosthetic joint infections","E. Morreel|I. Van Loo|L. Van Alphen|R. Koeck|E. Beuken|P. Savelkoul"
"3460","14/04 12:00","25","P2051","Llanos SALAR-VIDAL","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of clinical usefulness of a commercial multiplex PCR for diagnosing mycobacterial infections: a multicentre study","M. Cano-Fernández|M. Ruiz-Serrano|H. Bermúdez-Marval|I. Diaz De La Torre|P. Lopez-Roa|C. Loras-Gallego|J. Esteban|L. Salar-Vidal"
"3470","14/04 12:00","26","P2052","Fernando PASTERAN","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","In silico evaluation of pilV-I PCR for identifying the hyperepidemic Klebsiella pneumoniae ST258 clone in contemporary isolates","F. Martino|M. Echegorry|S. Gomez|D. Faccone|J. De Mendieta|E. Albornoz|M. Rapoport|A. Petroni|F. Pasteran|A. Corso"
"3647","14/04 12:00","27","P2053","Daisuke KITAGAWA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Impact of multiplex polymerase chain reaction testing in patients with bacteraemia in Japan","D. Kitagawa|T. Kitano|S. Suzuki|T. Kasamatsu|Y. Suzuki|A. Nakano|R. Nakano|H. Yano|F. Nakamura|K. Maeda|M. Yasuda|M. Okada|N. Shiraishi"
"3728","14/04 12:00","28","P2054","Aida RAMIREZ MARINERO","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of a real-time polimerase chain reaction assay for the direct diagnosis and genital colonisation of Streptococcus agalactiae in pregnant women","C. Sanchez-La Fuente Doncel|P. Cardona|A. Ramirez Marinero|M. González Soler|N. Romani Rodes|T. Vela Lopez|E. Crespillo Galán|M. Carrasco Diaz"
"3768","14/04 12:00","29","P2055","Arturo MARTÍNEZ TREJO","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Development of a simple tool for the detection of pneumonia-causing bacteria in children","A. Martinez-Trejo|A. Vergara|J. Otero|A. Rull|O. Calavia|A. Sánchez|A. Papaleo|R. Farré|J. Vila"
"3877","14/04 12:00","30","P2056","Salma KODSI","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparison of three commercial nucleic amplification tests for CT and GC testing in urine and vaginal swabs","S. Kodsi|E. Torres-Chavolla|V. Parvu|B. Van Der Pol"
"4053","14/04 12:00","31","P2057","Colosimo CLAUDIA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Molecular assay of atypical community-acquired pneumonia from different matrices","C. Colosimo|L. Dionisi|G. Dirani|S. Zannoli|A. Scagliarini|M. Cricca|V. Sambri|M. Guerra|G. Gatti|M. Montanari|L. Grumiro|A. Marzucco|L. Ingletto|A. De Pascali|M. Brandolini"
"4220","14/04 12:00","32","P2058","Guillermo Carlos MARTÍNEZ CARRIÓN","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of PCR in saliva and stool for Whipple's disease diagnosis: a retrospective study from 2019 to 2024","L. Argente Colás|A. Navascues-Ortega|C. Ezpeleta Baquedano|G. Martinez Carrion"
"4275","14/04 12:00","33","P2059","Alexander LEPAK","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Urgent care (UC) clinician perceptions and identification of target populations for a novel point-of-care test (POCT) for pharyngitis","C. Hamer|S. Barlow|M. Goss|J. Temte|B. Lehrer|A. Lepak"
"4277","14/04 12:00","34","P2060","Lauren COOPER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparative analysis of workflow efficiency and safety in enteric bacterial pathogen detection methods","L. Cooper|K. Van Benten"
"4285","14/04 12:00","35","P2061","Eloïse LE BANNER","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Diagnostic value of PCR whipple: a retrospective multicentre study","E. Le Banner|F. Guérin|R. Nguyen Van|D. Luque Paz|M. Cailleaux|V. Cattoir|M. Revest|P. Tattevin"
"4304","14/04 12:00","36","P2062","Hiroki KITAGAWA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Clinical diagnostic performance of droplet digital PCR for pathogen detection in patients with Staphylococcus aureus bloodstream infections","H. Kitagawa|K. Tadera|K. Omori|T. Omoto|T. Nomura|N. Shigemoto|H. Ohge"
"4337","14/04 12:00","37","P2063","Colosimo CLAUDIA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparison of RHAM isothermal nucleic acid amplification technology and culture method: advancing screening for Streptococcus agalactiae","C. Colosimo|G. Gatti|L. Dionisi|M. Guerra|M. Montanari|A. Marzucco|L. Grumiro|L. Ingletto|A. De Pascali|M. Brandolini|G. Dirani|S. Zannoli|A. Scagliarini|M. Cricca|V. Sambri"
"4446","14/04 12:00","38","P2064","Benoit VISSEAUX","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of an innovative RT-PCR assay allowing detection of all respiratory viruses in a single classic PCR well","B. Visseaux|A. Lheude|E. Hedbaut|V. Dubois|L. Verdurme|C. Dhumieres|M. Roussel|S. Trombert-Paolantoni"
"4461","14/04 12:00","39","P2065","Füsun KIRCA","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Diagnosis of sexually transmitted infections with multiplex RT-PCR and analysis of symptoms","F. Kirca|F. Aslan|S. Aydogan|B. Dinç"
"4585","14/04 12:00","40","P2066","Nicolas VERGAUWE","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Validation of targeted next-generation nanopore sequencing for routine diagnosis of gastroenteritis","N. Vergauwe|G. Meersseman|S. Radoes|M. Molhoek|R. Van Der Veer|A. Riezebos-Brilman|J. Van De Bovenkamp"
"4598","14/04 12:00","41","P2067","Zain CHAUDHRY","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Molecular diagnostics for paediatric bone and joint infection","H. Brosnan|J. Brown|L. Atkinson|T. Best|Z. Chaudhry|S. De"
"4647","14/04 12:00","42","P2068","Jae Hyeon PARK","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of a laboratory-developed RT-PCR assay for the detection of Pneumocystis jirovecii using a high throughput system","J. Park|J. Lee|S. Cho|T. Kim|M. Seong"
"4778","14/04 12:00","43","P2069","Jeonghee KIM","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Automated high-throughput molecular diagnostic system for the simultaneous detection of four sexually transmitted infection pathogens in human urine and vaginal swab specimen","J. Kim|H. Park|C. Lee|J. Lee|T. Lim"
"4832","14/04 12:00","44","P2070","Sabrina ALBET","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Synergising PlexPlus chemistry, instrumentation and software: advancing multiplex PCR solutions","S. Bone|Y. Xu|R. Albu|D. Mansfield|H. Kumar|L. Nguyen|R. Kim|L. Smith|A. Todd"
"4877","14/04 12:00","45","P2071","Nicola BENVENUTO","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","BioFire joint infection panel for samples other than synovial fluid","N. Benvenuto|D. Luppino|J. Conti|V. Costantino|M. Di Santolo|M. Busetti|R. Luzzati|V. Zerbato|S. Di Bella|L. Principe"
"4929","14/04 12:00","46","P2072","Selin Gamze KILIC SINCI","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Etiologies and ophthalmological characteristics of infectious uveitis: insights from multiplex real-time PCR","S. Kilic Sinci|B. Kemer Atik|F. Aydin|A. Altan|A. Bakir|N. Karabulut|S. Alacam"
"5091","14/04 12:00","47","P2073","Mandar NAIK","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Transforming Salmonella detection via One-Pot CRISPR-Cas12-based assay","M. Naik|K. B. S.|A. Siji|R. Arora|V. Hegde|V. Gupta|V. Chandru"
"5126","14/04 12:00","48","P2074","Laura PASTOR-BERNAD","12","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Enhancing STI and UTI detection with a novel, versatile, fast and reliable tool for nucleic acid extraction","L. Pastor-Bernad|B. Santos Da Silveira|E. Lucia|M. Gil-Rodriguez|H. Alonso|C. Giménez-Rota"
"5130","14/04 12:00","1","P2075","Yosita LEEPROMMA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Colorimetric-loop mediated isothermal amplification assay for Helicobacter pylori detection","P. Sornsenee|Y. Leepromma|T. khonkhome|C. Romyasamit"
"5141","14/04 12:00","2","P2076","Run HUANG","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Accelerating molecular diagnostics: development of a novel rapid, integrated PCR system for acute respiratory infections detection","T. Zou|T. Ma|Z. Lv|Y. Li|R. Huang|F. Lu"
"5185","14/04 12:00","3","P2077","Flora Marzia LIOTTI","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance evaluation of the QIAstat-Dx meningitis/encephalitis panel: results from five studies","F. Liotti|B. Posteraro|M. Sanguinetti"
"5201","14/04 12:00","4","P2078","Lenka KRAMNA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Determination of bacteria and fungi by sequencing in clinical practise","L. Kramná|R. Dobias|J. Mrázek"
"5256","14/04 12:00","5","P2079","Melanie POLKE","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the co-morbidity of HPV, STIs and bacterial vaginosis","H. Wisplinghoff|A. Nowag|M. Polke|R. Grosser|M. Steinmetz|F. Mandraka"
"5303","14/04 12:00","6","P2080","Shoshanna MAY","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the BD COR automated random access system for the high-throughput testing of genital and non-genital samples for Chlamydia trachomatis and Neisseria gonorrhoeae with the BD CTGCTV2 assay","S. May|N. Drew|R. Lucic|C. Malone|M. Hassan-Ibrahim"
"5384","14/04 12:00","7","P2081","Florence DOUCET POPULAIRE","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance of two multiplex-real-time PCR kits detecting sexually transmitted pathogens","N. Bourgeois-Nicolaos|A. Braille|M. Mainardis|F. Carlot-Aujé|D. Wagne|F. Meunier|F. Caméléna|F. Doucet-Populaire|B. Berçot"
"5484","14/04 12:00","8","P2082","Jobin JACOB JOHN","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Development and evaluation of a rapid and sensitive RPA-assisted CRISPR/Cas12a assay for detecting Salmonella paratyphi and Salmonella paratyphi A","J. Jacob|P. Sathyanarayanan|P. Thilagan|S. Balasubramani|A. Velmurugan|M. Teekaraman|T. Thirumoorthy|J. John|.. Vikram|K. Walia|B. Veeraraghavan"
"5495","14/04 12:00","9","P2083","Ilaria TRIVA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Long-term preservation of bacterial DNA using a transport medium: evaluation across different storing temperatures and molecular assays","I. Triva|A. Franzoni|C. Sabelli"
"5547","14/04 12:00","10","P2084","Bhargava C N","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Rapid molecular detection of antibiotic resistance markers using PathCRISP test","B. C N|S. Patil|S. Hangekar|V. Hegde|V. Chandru|V. Gupta|R. Arora"
"5566","14/04 12:00","11","P2085","Friederike VON LOEWENICH","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","False positive pathogen detection in central nervous system infections by syndromic testing","F. Von Loewenich"
"5725","14/04 12:00","13","P2087","Matilde OUTEDA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Impact of molecular biology on the diagnosis of sexually transmitted infections at a public hospital in Montevideo, Uruguay","M. Outeda|L. Bornia|A. Goyeche|E. Flores|C. Rodrigeuz|M. Marina|B. Raquel"
"5731","14/04 12:00","14","P2088","Antonina Tindara FERRARA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Sepsis on critical patients: performance and evaluation of a new molecular test from direct whole blood","A. Ferrara|A. Mascarello|M. Merli|G. Casalicchio|A. Nava|S. Gianni|A. Bielli|M. Laratta|D. Fanti|A. Proto|V. Mancini|M. Puoti|G. Monti|C. Vismara"
"5834","14/04 12:00","15","P2089","Venere CORTAZZO","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Optimisation of microbiological diagnosis of suspected meningitis using an off-label syndromic molecular panel in paediatric cerebrospinal fluid samples","V. Cortazzo|C. Tripiciano|M. Pereyra Boza|G. Vrenna|M. Rossitto|B. Lucignano|M. Onori|M. Agosta|M. De Luca|L. Romani|F. Di Leva|V. Cetra|L. Lancella|C. Perno|P. Bernaschi"
"6216","14/04 12:00","16","P2090","Owen SPILLER","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evidence of phage as the source of unconfirmed positive Neisseria gonorrhoeae results in throat swabs","O. Spiller|I. Boostrom|A. Moore|J. Munoz Criollo|L. Jones|S. Jones|M. Perry"
"6228","14/04 12:00","17","P2091","Simone JETHA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Performance of a direct-from-sample next generation sequencing based pan-bacterial, pan-fungal assay on tissue samples","S. Jetha|M. Dasgupta|L. Shailesh|A. Zade|R. Moidu|S. Shah|S. Parimala Bhoojanath|A. Chatterjee"
"6257","14/04 12:00","18","P2092","Zafeirios TSINARIS","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Seasonal patterns of gastrointestinal pathogens in a tertiary-care hospital in northern Greece: a multi-pathogen surveillance study","Z. Tsinaris|A. Tychala|G. Meletis|A. Greco|T. Chatziantoniou|C. Chantzi|R. Dimitriadou|G. Kagkalou|O. Vasilaki|P. Mantzana|L. Skoura|E. Protonotariou|E. Keskilidou|A. Daviti"
"6344","14/04 12:00","19","P2093","Saeed SHAMS","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Fabrication of a sensitive surface plasmon resonance-based nanorods-shaped gold nanobiosensor for the specific detection of Vibrio cholerae","S. Zadeh-Hadad|B. Bakhshi|T. Tohodi-Moghadam|S. Shams"
"6358","14/04 12:00","20","P2094","Maria Leonor SANTOS","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","New microfluidic device with magnetic attraction for resistance genes","M. Santos|C. Bárbara|A. Duarte|R. Pinto|C. Caneiras|D. Caetano|M. Teixeira|D. Albuquerque"
"6374","14/04 12:00","21","P2095","Maria Antonella ZINGAROPOLI","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Rapid molecular diagnostics for respiratory infections: cycle thresholds and co-infections","M. Zingaropoli|R. Campagna|L. Caivano|M. Bernassola|D. Rodio|A. Pierangeli|G. Antonelli|O. Turriziani"
"6425","14/04 12:00","22","P2096","Emily BROWN","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Comparison of GP and central laboratory BioFire FilmArray point-of-care test performance as part of the RAPID-TEST RCT","E. Brown|A. Hay|P. Muir|G. Young|M. Lui|C. Metcalfe|S. Abbs|E. Bridgeman"
"6519","14/04 12:00","23","P2097","Heike ABICHT","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","New NAAT kits for rapid and accurate detection and differentiation of pathogenic E. coli","H. Abicht|C. Reichhuber|A. Slobodeniuk|M. Hofmann|E. Soutschek|M. Alberdi|A. Hiergeist|U. Reischl|F. Schwarzmann"
"6694","14/04 12:00","24","P2098","Stefan ZIMMERMANN","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Very rapid and accurate detection of acute bacterial meningitis in clinical samples","G. Graebe|S. Soprek Strugar|M. Tonkic|A. Tambic Andrasevic|S. Zimmermann"
"6991","14/04 12:00","25","P2099","Alicia GALAR","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Influence of rapid molecular testing in optimising clinical and therapeutic management of pneumonia","A. Galar|A. Alvarez-Uria|P. Martin-Rabadan|E. Cercenado|M. Sánchez Alegre|J. De La Torre Fernández|M. Ferris-Villanueva|L. Martin-Aguilera|M. Gil-Martinez|J. Garcia-Lopez|L. Puente|P. Munoz|E. Bouza|J. Serrano|L. Alcalá"
"7004","14/04 12:00","26","P2100","Vincenzo DI PILATO","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Application and performance of 16S/18S amplicon sequencing in diagnostic management of culture-negative infections","E. Willison|E. Costa|L. Calabrese|V. Di Pilato|A. Marchese"
"7052","14/04 12:00","27","P2101","Luis BRUSCA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluating the efficacy of a multiplex PCR sepsis panel for pathogen detection in non-blood neurosurgical samples","L. Brusca-Vidao|M. Xercavins-Valls|B. Dietl Gomez-Luengo|A. Boronat Munoz|J. Perez-Jove"
"7152","14/04 12:00","28","P2102","Onya OPOTA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the BioFire FilmArray RP2.1 panel for detection and quantification of viral and bacterial respiratory pathogens","A. Vitale|Z. Mahler|Z. Dance|G. Greub|O. Opota|V. Loup"
"7282","14/04 12:00","29","P2103","Wen-Tyng KANG","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Oropharyngeal swabs as a non-invasive alternative for diagnosis of lower respiratory tract infections in children","Q. Li|S. Zhou|W. Kang"
"7298","14/04 12:00","30","P2104","Zihan XIA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Culture-independent identification of microbial pathogens and antimicrobial resistance genes in intensive care units","Z. Xia|Q. Li|J. Song|H. Wang"
"7346","14/04 12:00","31","P2105","Tim T. SEVERS","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Evaluation of the EasySeq full-length 16S sequencing kit for bacterial identification in clinical samples: a multicentre study","T. Severs|J. Van De Bovenkamp|L. Van Alphen|L. Gard|J. Rossen|R. Yahiaoui|S. Matamoros|J. Dingemans|S. Pas|S. Boers"
"7410","14/04 12:00","32","P2106","Inês FONSECA COSTA","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Fast, thermostable and inhibitor-resistant: the future of reverse transcription in molecular diagnostics","I. Costa|P. Bule|V. Fernandes|C. Fontes"
"7442","14/04 12:00","33","P2107","Rita SIMÕES","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Bringing the heat: a new generation of thermophilic Bst polymerases mitigate non-specific LAMP","R. Simoes|J. Teodoro|P. Bule|C. Fontes"
"7452","14/04 12:00","34","P2108","Nadine THEISSEN","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Introduction and initial validation of a novel real time-PCR system for rapid identification of bacteria and resistance genes from positive blood cultures","N. Theissen|U. Reischl|A. Gessner"
"7487","14/04 12:00","35","P2109","Tomiwa ADESOJI","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Identification of Staphylococcus aureus by polymerase chain reaction using novel primers from heat shock protein","T. Adesoji|T. Adeyemo|H. Suleiman|O. Olatunji|A. Shittu"
"7511","14/04 12:00","36","P2110","Marie BLÜMEL","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Replacing stool culture with multiplex PCR in a primary care setting: a six months experience","J. Ebner-Suschitzky|M. Blumel|F. Mayer"
"7678","14/04 12:00","37","P2111","Sandrine BOISSET","13","B","04d. Molecular diagnostics (incl POCT and syndromic testing)","Interventional study to evaluate the impact of a rapid screening strategy in improving control of carbapenemase-producing organisms (CPOs) and vancomycin-resistant Enterococci (VREs)","C. Dinh|A. Hennebique|M. Veloso|N. Gonnet|I. Pelloux|S. David-Tchouda|C. Landelle|S. Boisset"
"750","14/04 12:00","38","P2112","Bingjie WANG","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","A longitudinal surveillance on molecular evolution of methicillin-resistant Staphylococcus aureus from children in Shanghai, China, 2013-2022","J. Zhang|B. Wang"
"801","14/04 12:00","39","P2113","Sudeshna DAS","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","The clinical spectrum of cutaneous nocardiosis using gene sequencing at tertiary care centre, India: an observational study","S. Das|S. Das|G. Rai|P. Singh"
"854","14/04 12:00","40","P2114","Ola SALACH","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Implementation of Fourier-transform infrared (FTIR) spectroscopy into clinical microbiology lab","O. Salah|L. Matanis|P. Shaked Mishan|R. Najjar-Debbiny|M. Baum"
"988","14/04 12:00","41","P2115","Mario RAMIREZ","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Two Group B Streptococci ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe","E. Martins|M. Forofontov|J. Mota-Freitas|J. Melo-Cristino|M. Ramirez"
"1047","14/04 12:00","42","P2116","Maria RIESGO","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Optimising IR-FTIR spectroscopy for epidemiological tracking Klebsiella pneumoniae ST512 strains","M. Riesgo Magana|E. Alvarado|S. Arnal|J. Bueno|H. Garcia|A. Achkir|C. Zumeta|M. Sarvisé|M. Batallon|C. Seral"
"1637","14/04 12:00","43","P2117","Sylvia BRUISTEN","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Molecular typing to discriminate between typhoid and nontyphoid Salmonella species","S. Bruisten|M. Fouraschen|S. Kuil|F. Bouwman|M. Admiraal|B. Westerhuis"
"1764","14/04 12:00","44","P2118","Pere-Joan CARDONA","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of Fourier-transform infrared spectroscopy as a method for rapid Streptococcus pneumoniae serotyping","M. Campos-Ruiz|J. Wang Wang|P. Pillado Alonso|M. Quesada|M. Giménez|P. Cardona|T. Vela Lopez"
"2070","14/04 12:00","45","P2119","Miriam CORDOVANA","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Application of Fourier-transform infrared spectroscopy to differentiate the Bacillus cereus group","M. Cordovana|H. Oberreuter|N. Mauder"
"2079","14/04 12:00","46","P2120","Miriam CORDOVANA","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Differentiation of Shigella spp. serotypes by FT-IR spectroscopy","P. Warnke|M. Cordovana|N. Mauder|A. Pranada|F. Pankok|U. Loderstaedt|S. Scheithauer|D. Dekker|A. Zautner|W. Geissdoerfer|J. Overhoff|M. Werner|A. Wille|T. Koeller|R. Hagen|U. Schotte|H. Frickmann"
"2229","14/04 12:00","47","P2121","Maria SÁNCHEZ CUETO","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Characterisation of an outbreak caused by vancomycin-resistant Enterococcus faecium and linezolid-resistant E. faecium using Fourier-transform infrared (FTIR) spectroscopy","E. Cercenado|P. Munoz|B. Rodriguez-Sanchez|D. Rodriguez-Temporal|M. Sánchez-Cueto|M. Blázquez-Sánchez|M. Marin"
"2233","14/04 12:00","48","P2122","Maria GORI","13","B","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Tackling invasive listeriosis outbreaks in northern Italy: the role of genomic surveillance","M. Gori|L. Bolzoni|E. Scaltriti|C. Fappani|S. Arnaboldi|V. Filipello|L. Vezzosi|E. Ammoni|A. Amendola|E. Tanzi|G. Finazzi|D. Cereda|S. Pongolini|S. Bianchi"
"3223","14/04 12:00","2","P2124","Natasia THORNVAL","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Optimisation of long-read whole-genome sequencing for surveillance of antibiotic resistance detection and typing in low-and-middle-income countries","N. Lacy-Roberts|R. Hendriksen|N. Thornval"
"3285","14/04 12:00","3","P2125","Federica MARINO","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of Fourier-transform infrared spectroscopy for typing of Klebsiella pneumoniae strains involved in hospital outbreaks","F. Marino|M. Cordovana|Y. Pfeifer|A. Zautner"
"3366","14/04 12:00","5","P2127","Marco Antonio ROLDÁN RUIZ","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Rapid outbreak detection of Raoultella bacteraemia in haemodialysis patients: evaluating the use of FTIR spectroscopy and whole-genome sequencing","M. Roldan Ruiz|L. Gozalo Álvarez|L. Perez Rodriguez|N. Chueca Porcuna|V. Garcia Casas|F. Garcia Garcia"
"3386","14/04 12:00","6","P2128","Nathaly LADINES REYES","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of Fourier-transform infrared spectroscopy as an alternative technique for typing Salmonella enterica","N. Ladines Reyes|B. Lopez Sanchez|P. Pillado Alonso|A. Fernandez Navarro|J. Wang Wang|P. Cardona|J. Cabré Torrents"
"3392","14/04 12:00","7","P2129","Konstantina KONTOPOULOU","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Study of the epidemiology of emm types of Group A Streptococcus strains","M. Tsekoura|A. Michos|E. Tatsi|V. Syriopoulou|K. Kontopoulou"
"3495","14/04 12:00","8","P2130","Miriam CORDOVANA","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of FT-IR for the differentiation of Campylobacter jejuni strains regarding their potential to induce Guillain-Barré syndrome","M. Cordovana|S. Freier|S. Kahlfuss|A. Zautner"
"4237","14/04 12:00","9","P2131","Juliana CAIERÃO","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of IR BIOTYPER performance for identification of Streptococcus pneumoniae serotypes","C. Romero|G. Cunha|N. Moreira|A. Barth|C. Dias|J. Caierao"
"4370","14/04 12:00","10","P2132","Stefanie VAN KLEEF VAN KOEVERINGE","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Emergence of emm3.93 Streptococcus pyogenes clone in iGAS infections: epidemiological insights from Belgium, May 2023-September 2024","S. Van Kleef-Van Koeveringe|S. De Koster|T. Van Der Spek|S. Vandamme|T. Demuyser|H. Jansens|M. Vanden Driessche|I. Mermans|P. Smeesters|S. Malhotra-Kumar|V. Matheeussen"
"4444","14/04 12:00","11","P2133","Zuzanna DRULIS-KAWA","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Phage-inspired rapid Klebsiella K-typing","Z. Drulis-Kawa|G. Majkowska-Skrobek|T. Olszak|J. Majewska|A. Otwinowska|R. Tournebize|V. Fontaine|C. Eckert|J. Bugert|J. Stender|M. Sabo|J. Hammerl"
"4570","14/04 12:00","12","P2134","Marcelo PILLONETTO","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Clonality of Acinetobacter baumannii blaOXA-24/40-like isolated from hospitals in southern Brazil using Fourier-transform infrared spectroscopy (FT-IR) methodology","G. Gonçalves|J. Da Cunha Neto|H. Salomé D'espindula|A. Santiago Chacon|L. Kraft|H. Faoro|M. Pillonetto"
"4958","14/04 12:00","13","P2135","Antoni ESCALAS BORDOY","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of FT-IR spectroscopy for vancomycin-resistant Enterococcus faecium outbreak delimitation","J. Wang-Wang|L. Soler|E. Martro|G. Clarà|J. Hidalgo|I. Casas|M. Garcia-Quesada|M. Giménez|V. Saludes|A. Bordoy|P. Cardona"
"5063","14/04 12:00","14","P2136","Sein PARK","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Enhancing infectious disease diagnostics: hierarchical strain typing from high to low resolution and genomic context-based language model for antibiotic resistance prediction","S. Park|K. Lee|H. Oh|J. Moon|M. Chalita|J. Chun"
"5202","14/04 12:00","15","P2137","Astrid RASMUSSEN","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Fourier transform infrared (FT-IR) spectroscopy for discrimination between global Escherichia coli ST131 subclades","A. Rasmussen|H. Hasman|A. Hammerum|L. Peixe|Â. Novais"
"5213","14/04 12:00","16","P2138","Miriam CORDOVANA","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Evaluation of FT-IR spectroscopy and machine learning for the serotyping of Streptococcus pneumoniae","T. Lazzarotto|C. Vocale|D. Guariglia|M. Cordovana|G. Blanco|D. Lombardo|S. Ambretti"
"5320","14/04 12:00","17","P2139","Kathrin LOOSLI","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Enhanced genomic relatedness determination of Group A Streptococcus isolates using whole-genome sequencing compared to emm typing in England","K. Loosli|N. Love|J. Coelho|K. Moganeradj|D. Ready|C. Beck"
"5371","14/04 12:00","18","P2140","Rita MARTINS","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Rapid differentiation of global multidrug-resistant and hypervirulent Klebsiella pneumoniae sublineages using FT-IR spectroscopy","R. Martins|S. Brisse|K. E. Holt|S. Saha|L. Peixe|Â. Novais"
"5668","14/04 12:00","20","P2142","Bedia DINC","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","An emm typing study performed in Turkey utilising the quadriplex real-time PCR assay","B. Saygin|F. Korukluoglu|N. Coplu|B. Dinç"
"5708","14/04 12:00","21","P2143","Sam VAN GOETHEM","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Fourier-transform infrared spectroscopy as a tool for clonal clustering in hospital-associated Serratia marcescens outbreaks","I. Passaris|S. Van Goethem|D. De Geyter|I. Wybo|Y. Glupczynski|H. Goossens|P. Ceyssens|S. Malhotra-Kumar"
"5717","14/04 12:00","22","P2144","Wei Yu HSU","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Application of IR technology for rapid typing and resistance prediction in carbapenem-resistant Klebsiella oxytoca complex","W. Hsu|T. Lee|Y. Huang"
"5733","14/04 12:00","23","P2145","Serena RAIMONDI","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Validation by whole-genome sequencing of the use of Fourier-transform infrared spectroscopy (FTIR) to rapidly assess Pseudomonas aeruginosa clonality in the microbiological management of patients with cystic fibrosis","S. Raimondi|M. Rossitto|G. Vrenna|V. Fox|V. Tuccio Guarna Assanti|N. Essa|M. Lepanto|V. Cortazzo|M. Pereyra Boza|V. Fini|A. Granaglia|K. Yu La Rosa|E. Montemitro|F. Alghisi|F. Majo|L. Cristiani|A. Boni|S. Bella|R. Cutrera|C. Perno|P. Bernaschi"
"5770","14/04 12:00","24","P2146","Jimmy JÖRGENSEN","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Long term Staphylococcus aureus carriage dynamics in people who inject drugs","J. Jörgensen|A. Gilland|A. Nilsson|M. Alanko Blomé|K. Riesbeck|D. Dahlman|H. Janson"
"5843","14/04 12:00","25","P2147","Johanna DABERNIG-HEINZ","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Bioinformatic updates addressing methylation-related basecalling issues of long-read sequencing data resolve typing issues in a multicentre performance study","J. Dabernig-Heinz|V. Galeone|M. Hölzer|M. Lipp|S. Fuchs|I. Steinmetz|C. Kohler|G. Wagner"
"5845","14/04 12:00","26","P2148","Thera HABBEN JANSEN","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Whole-genome analysis to establish genetic thresholds for excluding recent transmission of livestock-associated MRSA","T. Habben Jansen|P. Wever|A. Hendrickx|W. Van Den Bijllaardt|J. Verweij|M. Kristensen|J. Stohr"
"5897","14/04 12:00","27","P2149","Jae-Seok KIM","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Comparative genomic analysis of sequence type 72 (ST72), a successful community clone of Staphylococcus aureus strains","J. Kim|H. Kim|H. Kim|W. Song"
"5930","14/04 12:00","28","P2150","Michael BIGGEL","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Sequencing for Listeria monocytogenes outbreak detection and source attribution: latest advances","M. Biggel|N. Cernela|J. Horlbog|R. Stephan"
"5943","14/04 12:00","29","P2151","Eva MANNINO","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Unveiling the molecular epidemiology of invasive Group A Streptococcus in Bologna and Imola (2022–2024)","E. Mannino|C. Bonomo|E. Nicitra|G. Sangiorgio|D. Bongiorno|D. Bivona|G. Privitera|S. Ambretti|A. Amicucci|C. Vocale|D. Guariglia"
"6094","14/04 12:00","30","P2152","Philippe LEHOURS","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Impact of different whole-genome sequences production procedures and sequence analysis pipelines on genotyping and clustering of Campylobacter strains","Q. Jehanne|A. Felten|L. Ducret|G. Mourand|F. Tardy|M. Denis|M. Tasset|P. Lehours|A. Thépault"
"6161","14/04 12:00","31","P2153","Tom KORITNIK","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","A 12-year molecular surveillance and virulence determination of Listeria monocytogenes in Slovenia","T. Koritnik|J. Gregorcic|V. Mioc|I. Velimirovic|A. Krasevac Glaser|K. Eva|I. Strumbelj|I. Grmek Kosnik|A. Dodic Jurisevic|I. Piltaver|T. Stojoska|T. Janko|V. Vedlin|M. Boljesic|A. Steyer|J. Goncalves|T. Cerar Kisek|M. Trkov"
"6321","14/04 12:00","32","P2154","Asta LILI LAUGESEN","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Long-read sequencing: a standalone tool for Listeria monocytogenes outbreak investigations?","L. Vejrum|J. Møller|M. Kemp|A. Laugesen|S. Schjørring"
"6394","14/04 12:00","33","P2155","Tóth KINGA","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Molecular epidemiology of invasive Streptococcus pyogenes in Hungary, January 2023-May 2024","M. Käfer|Á. Toth|K. Toth|E. Ungvári|A. Mányoki-Vincze|T. Erdosi|K. Kovács|D. Elso|B. Gulyás|A. Lázár|G. Jakab|K. Tárkányi|K. Pintér"
"6451","14/04 12:00","34","P2156","Maria Francesca LIPORACE","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Multi locus sequence typing of Pseudomonas aeruginosa strains isolated from people with cystic fibrosis in elexacaftor/tezacaftor/ivacaftor treatment","L. Cariani|M. Liporace|B. Orena|D. Girelli|A. Teri|F. Salari|C. Alteri|A. Gramegna|V. Dacco|A. Callegaro|F. Blasi"
"6571","14/04 12:00","35","P2157","André RIO TINTO","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Is Group A Streptococcus emm1/ST28 a new threat in Brazil?","A. Rio-Tinto|E. Bressan|N. Costa|L. Oliveira|S. Fracalanzza|L. Teixeira|T. Pinto|V. Peloso|I. Martins|A. Almeida"
"6606","14/04 12:00","36","P2158","Irina TSVETKOVA","1","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Invasive Streptococcus pyogenes population in the Russian Federation","S. Sidorenko|I. Tsvetkova|D. Latypova|E. Danilenko|O. Kalinogorskaya|E. Nikitina|D. Rybalko|H. Alhaj|D. Polev|A. Saitova|S. Gordeeva|L. Kraeva|V. Gostev|A. Kruglov|N. Goncharov"
"6730","14/04 12:00","1","P2159","Mohamed Azzedine BACHTARZI","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Xpert Carba-R screening of digestive carriers of carbapenemase-producing GNB vs conventional techniques","M. Bachtarzi|C. Zerrouki|Z. Mahsas|S. Belahadid|S. Houacine|W. Amhis|S. Gourari"
"6762","14/04 12:00","2","P2160","Jane HAWKEY","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Developing a robust approach to determining plasmid transmission in the hospital setting","J. Hawkey|J. Wisniewski|N. Macesic|A. Peleg|N. Tagarino"
"7011","14/04 12:00","3","P2161","Leticia FONTÁN GARCÍA-RODRIGO","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Genotypic methods directly from epidemiological samples to detect resistance markers of Gram-negative bacilli: a reality?","L. Fontan Garcia-Rodrigo|V. Garcia Artiaga|N. Zurita Cruz|M. Diez Aguilar|M. Vargas Durán|L. Cardenoso Domingo"
"7122","14/04 12:00","4","P2162","Lucy LAMB","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Comprehensive comparative and pan-genome analysis of Staphylococcus lugdunensis isolates from the UK and globally","W. Nevin|Y. Li|Y. Wan|S. Pallett|J. Melhuish|R. Wakefield|K. Bhanot|M. Routledge|S. Sriskandan|A. Mason|N. Beeching|M. O'shea|T. Fletcher|L. Lamb|E. Jauneikaite"
"7136","14/04 12:00","5","P2163","Maira NAPOLEONI","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Discrimination of Salmonella serogroups and differentiation between typhoidal and non-typhoidal strains using ATR-FTIR spectroscopy","M. Napoleoni|S. Ceschia|E. Mitri|E. Benitez|V. Silenzi|M. Staffolani|E. Rocchegiani|G. Blasi|E. Gurian"
"7180","14/04 12:00","6","P2164","Kerstin LOCHER","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Fourier-transform infrared spectroscopy as a new tool to investigate Clostridioides difficile outbreaks","K. Locher|W. Chan|S. Chorlton|N. Gauthier|C. Belanger|B. Velapatino|A. Manges|A. Hadzic|A. Wilmer|M. Charles"
"7449","14/04 12:00","7","P2165","Stefan ZIMMERMANN","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Typing of food- and water-borne pathogens by Fourier transform infrared-spectroscopy (FT-IR)","T. Gaube|G. Graebe|N. Mauder|M. Cordovana|J. Kurz|S. Zimmermann"
"7514","14/04 12:00","8","P2166","Ignazio ARRIGO","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Discrimination of genus Legionella and serogroup of Legionella pneumophila strains using ATR-FTIR spectroscopy","I. Arrigo|T. Fasciana|L. Mariyam|M. Mirzajani Sarvandani|R. Santoro|M. Tricoli|O. Diquattro|N. Serra|M. Palermo|A. Giammanco"
"7612","14/04 12:00","9","P2167","Carlos DAVIÑA NUÑEZ","2","C","04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Local genomic surveillance of laboratory-confirmed human Salmonella isolates in Vigo-Galicia, Spain","D. Guzman Figueroa|C. Davina Nunez|A. De Malett Pintos-Fonseca|B. Montano Barrientos|C. Menendez Rodriguez|B. Fontan Silva|B. Villar Hernandez|S. Perez Castro"
"240","14/04 12:00","10","P2168","Jose ALEXANDER","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Culture vs next-generation sequencing for infective endocarditis: performance of the 16S/ITS NGS in cardiac valve samples as a rapid and direct diagnostic tool","J. Alexander|A. Charles"
"666","14/04 12:00","11","P2169","Jakub KANTOR","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Can be antimicrobial resistance predicted from metagenomic data of culture-negative 16S rDNA-positive synovial fluid samples?","J. Kantor|J. Tkadlec|M. Antuskova|P. Drevinek|M. Brajerová|J. Zikova|A. Gryndlerová|M. Krutova"
"777","14/04 12:00","12","P2170","Anna VILARÓ VIVES","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Antimicrobial resistance and molecular typing of Streptococcus suis causing systemic clinical cases in pig production in Spain","A. Vilaro|K. T. Karstensen|L. M. Cavaco|L. Serra|E. Solé|I. Sero|E. Novell|V. Enrique-Tarancon|N. Gonzalez-Escalona|L. Migura-Garcia|L. Fraile"
"1188","14/04 12:00","13","P2171","Wa Ode Dwi DANINGRAT","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Species clustering of the viridans group streptococci with whole-genome sequencing (WGS)","W. Daningrat|J. Caballero|Y. Corin|D. Sophia|C. Natacha|A. Nabil-Fareed|A. David"
"1315","14/04 12:00","14","P2172","Vaishnavi Vishram NAIK","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Genomic insights into Streptococcus pneumoniae in Indian paediatric carriage: serotype, virulence, and antimicrobial resistance profiles","V. Naik|V. Shamanna|R. Kl|G. Nagraj|S. Ar|T. Shaw"
"1685","14/04 12:00","15","P2173","Soraya HERRERA-ESPEJO","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Analysing uropathogenic Escherichia coli isolates with mutations conferring low-level resistance to quinolones and low-level resistance to fosfomycin","S. Herrera-Espejo|A. Rubio-Valle|L. Ceballos-Romero|J. Pachon|A. Pérez-Pulido|E. Cordero|M. Pachon-Ibanez"
"1809","14/04 12:00","16","P2174","Francisco FRANCO ÁLVAREZ DE LUNA","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Genome-based identification of Desulfovibrio strains from bacteraemia in Spain","M. Medina-Pascual|C. Garcia-Amil|G. Carrasco|J. Saavedra-Martin|S. Valdezate|F. Franco Álvarez De Luna"
"2456","14/04 12:00","17","P2175","Caroline SCHNEEBERGER-VAN DER LINDEN","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Whole-genome characterisation of Escherichia coli isolates from older women with urinary tract infection or asymptomatic bacteriuria: a pilot study","M. Mulder|M. Bilsen|M. Van Der Beek|A. Hendrickx|M. Lambregts|C. Schneeberger-Van Der Linden"
"2750","14/04 12:00","18","P2176","Marek Stefan","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Is there a difference between invasive and non-invasive Streptococcus pyogenes isolates?","M. Stefan|M. Brajerová|S. Prasad|E. Bébrová|J. Berousek|P. Pavlicek|J. Pozniak|S. Jarosciakova|I. Vitkova|E. Nycova|L. Ryskova|P. Kucova|L. Geigerová|D. Veselá|M. Balejová|N. Bartonikova|L. Havlinova|E. Czyzova|J. Kubele|B. Dratvová|M. Antuskova|J. Zikova|O. Nyc|M. Trojánek|P. Drevinek|M. Krutova"
"2768","14/04 12:00","19","P2177","Georgia CHASIOTI","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Application of whole-genome sequencing to investigate a collection of Elizabethkingia spp. isolates in a surgical and transplantation ICU","G. Chasioti|S. Vourli|O. Koutsopetra|G. Stravopodis|S. Hatzianastasiou|S. Dimopoulos|D. Tassi-Papatheou|G. Vrioni|J. Papaparaskevas"
"2919","14/04 12:00","20","P2178","Sheela Devi CHANDRAKESAN","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Molecular insights into Group B Streptococci from antenatal women attending a tertiary care centre in South India","S. Chandrakesan|R. Desdemona|M. Daniel"
"3243","14/04 12:00","21","P2179","Saskia PROUD","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Haemophilus influenzae genomes harbour novel prophages","S. Proud|F. Patel|M. Jansen Van Rensburg|K. Jolley|H. Zar|L. Ah Tow|M. Nicol|A. Brueggemann"
"3945","14/04 12:00","22","P2180","Javier LATORRE","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Double-zone-haemolysis in coagulase-positive staphylococci and in silico analysis of haemolysin (hlb) gene polymorphisms","J. Latorre-Fernández|C. Aspiroz|C. González-Azcona|A. Shittu|I. Abdullahi|M. Zarazaga|C. Lozano|C. Torres|A. Campana-Burguet"
"4083","14/04 12:00","23","P2181","Patricia SIMNER","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Optimised methods for bacterial whole-genome sequencing from positive blood culture broths","Y. Bergman|H. Harris|S. Lewis|J. Lu|P. Simner"
"4792","14/04 12:00","24","P2182","Nelly Carolina MENA","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Phenotypic and genotypic characterisation of Klebsiella pneumoniae isolates from ten Colombian hospitals using the EPISEQ CS","C. Pallares|B. Castro-Cardozo|E. De La Cadena|N. Restrepo Arbelaez|M. Uribe|N. Sánchez|K. Ordonez|L. Velásquez|L. Matta|J. Munoz|K. Ortega|L. Uribe|A. Marin|J. Zabala|L. Pescador|P. Hernandez|D. Padilla|M. Parga|Y. Rocha|L. Otero|G. Bergonzolli|D. Moreno|M. Villegas|N. Mena|J. Garcia-Betancur"
"4890","14/04 12:00","25","P2183","William STRIBLING","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Plasmidome analysis of the Klebsiella pneumoniae diversity panel collection","W. Stribling|F. Lebreton|T. Luo|A. Sapre|Z. Julie|B. Corey|R. Maybank|A. Ong|J. Bennett|P. Mcgann|M. Melissa"
"5187","14/04 12:00","26","P2184","Anurag Kumar BARI","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Evaluation of three commercial kits for Pseudomonas aeruginosa genomic DNA extraction: optimising yield and quality for long read sequencing","A. Bari|M. Cardoso|T. Severs|B. Xavier|B. Sinha|J. Rossen"
"5745","14/04 12:00","27","P2185","Martina ROSSITTO","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","From environmental to epidemic: how genomic surveillance allowed identification and characterisation of a new epidemic clone of Pseudomonas aeruginosa in our cystic fibrosis centre","M. Rossitto|G. Vrenna|V. Fox|V. Tuccio Guarna Assanti|N. Essa|M. Lepanto|S. Raimondi|V. Cortazzo|M. Agosta|M. Pereyra Boza|M. De Santis|V. Fini|A. Granaglia|K. Yu La Rosa|E. Montemitro|F. Alghisi|F. Majo|L. Cristiani|A. Boni|S. Bella|R. Cutrera|C. Perno|P. Bernaschi"
"5964","14/04 12:00","28","P2186","Mario ROMERO RIVERA","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","In vivo detection, isolation and genomic characterisation of predatory bacteria in human faecal samples","M. Romero Rivera|R. Barbero|J. Avendano|R. Del Campo|C. Herencias"
"5986","14/04 12:00","29","P2187","Julia STEGER","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Identification of Listeria monocytogenes persister types in the Austrian food chain","J. Steger|K. Kober-Rychli|L. Alteio|W. Ruppitsch|A. Pietzka"
"7205","14/04 12:00","30","P2188","Aditya Kumar LANKAPALLI","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","The explorative analysis of multiple copies of tigecycline resistance genes on bacterial genome assemblies","A. Lankapalli|N. Rakhi|P. Niumsup|K. Thomson|T. Walsh|K. Sands|J. Mathias"
"7244","14/04 12:00","31","P2189","Salamah Faisal UMMU","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Tiny patient, big challenge: decoding MDR Salmonella enterica Typhimurium ST29 with whole-genome sequencing","U. Faisal|U. Zainulabid|A. Kamarudin|H. Abdul Hakim Esa"
"7520","14/04 12:00","32","P2190","Phillipa BURNS","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Developing pipeline partnerships: the use of GenomeKey's genomic analysis pipeline to understand the epidemiology of Staphylococcus aureus (SA) isolates from a UK Teaching hospital with a high incidence of both blood stream infection (SABSI) and people who inject drugs (PWID)","P. Burns|M. Rudden|A. Richards|P. Lillie"
"7652","14/04 12:00","33","P2191","Mohammad Ridhuan MOHD ALI","2","C","04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Emergence of Vibrio paracholerae with co-occurrence of Vibrio cholerae and its diagnostic-public health implications","M. Mohd Ali|J. Mohamed Zahidi|N. Abd Hazis|M. Islam|P. Smith|M. Scribner|H. Carleton|R. Hashim|L. Judd"
"568","14/04 12:00","34","P2192","Jakub KANTOR","2","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Evaluation of a shotgun metagenomic NGS workflow for microbial pathogen detection from complex clinical samples using a host DNA depletion","J. Kantor|B. Abendroth|H. Muhl|M. Antuskova|P. Drevinek"
"879","14/04 12:00","35","P2193","Julio Cesar ORTEGA CAMBARA","2","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Analyses of hospital microbiomes revealed critical pathogens associated with HAIs","J. Ortega Cambara|O. Previtali|P. Cuber|A. Shanom|R. Misra|H. Mkrtchyan"
"1158","14/04 12:00","36","P2194","Teresa NASCIMENTO","2","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Skin microbiome in intensive care unit patients: temporal shifts in bacterial and fungal communities","J. Inácio|D. Guerreiro|P. Patricio|L. Proença|H. Barroso|T. Nascimento"
"1199","14/04 12:00","1","P2195","Elisa SOSA","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Culturomics insights into phenotypic antimicrobial resistance evolution in the gut microbiota of allogenic stem cell transplant patients","A. Monsalve|K. Haldimann|D. Albertos Torres|J. Halter|S. Mueller|E. Sosa|A. Egli"
"1219","14/04 12:00","2","P2196","Duncan NEWMAN","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Characterisation of the skin and oral microbiome in younger and older adults","D. Newman|T. Worthington|A. Hilton"
"1670","14/04 12:00","3","P2197","Edgar Igor CAMPOS-MADUENO","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Microbiota and resistome nanopore-based metagenomic analysis of Swiss expatriates living in Africa","E. Campos-Madueno|C. Aldeia|A. Endimiani"
"1780","14/04 12:00","4","P2198","Eefje SCHRAUWEN","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Rapid determination of the vaginal microbiome using nanopore sequencing at lowlands science","S. Boden|C. Waldekker|M. Kaijen-Lambers|C. De Bot|N. Van Den Braak|M. Van Gestel|D. Brackel|L. Wijnstroom-De Quartel|L. Pinheiro-Keulers|E. Klaassens|E. Schrauwen"
"1789","14/04 12:00","5","P2199","Sebastien BONTEMS","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Towards optimal endometrial microbiota sampling: a comparison of flush and biopsy using nanopore sequencing","S. Bontems|P. Kaluanga Bwanga|M. Timmermans|S. Ravet|P. Tremblay-Lemoine|M. Nisolle|M. Artesi|K. Durkin|K. El Moussaoui|M. Hayette|C. Meex|L. Henry"
"1962","14/04 12:00","6","P2200","Jan KEHRMANN","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Gut microbiota differences linked to weight gain and antiretroviral therapy in people living with HIV are enterotype specific but minor compared to those linked to sexual orientation","J. Kehrmann|A. Dostmohammadi|A. Stumpf|L. Best|L. Consten|H. Sievert|F. Maischack|S. Stefanie|S. Albayrak-Rena|A. Doerr|O. Von Velsen|I. Kraiselburd|C. Karsten|F. Farahpour|F. Meyer|S. Esser|J. Buer"
"2624","14/04 12:00","7","P2201","Guillem MACIP SANCHO","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Comparative analysis of two comercial sequencing platforms for 16S rRNA profiling of respiratory microbial communities","G. Macip|B. Llonch|A. Soler-Comas|A. Palomeque|J. Canseco-Ribas|L. Bueno-Freire|D. Calabretta|M. Ferrer|A. Torres|L. Fernandez-Barat|A. Motos"
"3252","14/04 12:00","8","P2202","Sara BELLALI","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Tips and tricks for microbiota investigation using SEM: sample preparation, imaging and landscape analysis correlated to multi-omics approach","M. Boukili|O. Zmerli|S. Fujii|H. Hattori|S. Bellali|J. Bou Khalil"
"3745","14/04 12:00","9","P2203","Giulia GATTI","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","The bile microbiota composition in pathological conditions: a pilot study","G. Gatti|G. Lucchi|C. Binda|G. Gibiino|B. Perini|P. Giuffrida|C. Coluccio|A. Cucchetti|G. Dirani|S. Zannoli|V. Sambri|C. Fabbri|M. Cricca"
"3965","14/04 12:00","10","P2204","Marielle Ezekielle DJUSSE","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Dietary habits and vaginal environment: can a beneficial impact be expected?","M. Djusse|S. Morselli|F. Prinelli|S. Conti|C. Consolandi|T. Camboni|C. Ceccarani|M. Severgnini|M. Dall' Asta|F. Curatolo|F. Danesi|L. Laghi|C. Foschi|A. Marangoni"
"4457","14/04 12:00","11","P2205","Chinenye AKPULU","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Effect of antibiotic use on the gut microbiome of neonates: a northern Nigeria cohort study","C. Akpulu|H. Sada Maikudi|H. Ahmad|H. Idris Babayo|R. Kalid Yakubu|A. Aminu|K. Iregbu|A. Lankapalli|K. Thomson|M. Stracy|T. Walsh|K. Sands"
"4964","14/04 12:00","12","P2206","Inderjit SINGH","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Exploration of urinary microbiome in patients at various stages of bladder cancer, India: association of Campylobacterales with muscle-invasive carcinoma","I. Singh|R. Chauhan|U. Mete|N. Taneja"
"5196","14/04 12:00","13","P2207","Sedreh NASSIRNIA","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Gut microbiota and hypothalamic inflammation as determinants of binge eating behavior prior to obesity","S. Nassirnia|N. Bouzourene|L. Aeschlimann|C. Chloé|M. Bangerter|G. Greub|B. Boutrel|C. Bertelli|C. Rossetti"
"5518","14/04 12:00","15","P2209","Anna FRANZONI","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Assessing potential bias introduced by sequential vaginal swab collection on microbiome profiling","A. Franzoni|C. Sabelli"
"5990","14/04 12:00","16","P2210","Anna FAGERSTRÖM","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Comparison of two 16S metagenomic protocols for high-throughput microbiome sequencing: library preparation and bioinformatics performance","A. Fagerström|O. Andersson|K. Dannenberg|J. Kekki|F. Wallin|C. Lindqvist|B. Stenmark"
"7406","14/04 12:00","17","P2211","Jasmin BAUMGARTNER","3","C","04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Microbial signatures of sexual contact: forensic and clinical implications","J. Baumgartner|N. Arora|M. Swayambhu|P. Resutik|A. Bratus-Neuenschwander"
"626","14/04 12:00","18","P2212","Molly HALES","3","C","04h. Clinical metagenomics","Benchmarking bacterial DNA extraction protocols to recover high molecular weight DNA from faecal reference material for long-read metagenomic sequencing","M. Hales|D. Berger|D. Grieg|H. Mkrtchyan|I. Olondale|C. Swift"
"702","14/04 12:00","19","P2213","Eline CAUWENBERGHS","3","C","04h. Clinical metagenomics","Improvement of pathogen detection using metagenomic shotgun sequencing in cystic fibrosis","E. Cauwenberghs|I. De Boeck|J. Bastiaenssen|I. Spacova|S. Verhulst|K. Van Hoorenbeeck|S. Lebeer"
"791","14/04 12:00","20","P2214","Samuel QUARTON","3","C","04h. Clinical metagenomics","Metagenomics in the diagnosis of pneumonia: a systematic review","S. Quarton|A. Livesey|C. Jeff|C. Hatton|C. Hsi Chen|A. Scott|D. Parekh|D. Thickett|A. Mcnally|E. Sapey"
"1328","14/04 12:00","21","P2215","Tiphaine ROUSSEL-GAILLARD","3","C","04h. Clinical metagenomics","A 16s turnkey pipeline at last! Routine evaluation of a commercial software","R. Fleury|T. Roussel-Gaillard|A. Souche|R. Chalvignac|M. Gautreau|O. Dauwalder|Y. Benito|H. Salord|F. Vandenesch|C. Bouchiat"
"1408","14/04 12:00","22","P2216","Aubin SOUCHE","3","C","04h. Clinical metagenomics","Partial V6-V8 or full 16SrRNA PCR + targeted-NGS for clinical diagnosis?","R. Fleury|A. Souche|T. Roussel-Gaillard|R. Chalvignac|M. Deleume|O. Dauwalder|Y. Benito|H. Salord|F. Vandenesch|C. Bouchiat"
"1572","14/04 12:00","23","P2217","Sun WENKUI","3","C","04h. Clinical metagenomics","Semi-quantitative targeted next-generation sequencing in pathogen diagnosis and drug resistance prediction in severe lower respiratory tract infection","J. Chuwei|W. Mingyue|P. Liangfei|S. Xuefei|W. Xiaodong|Q. Qian|D. Yuchen|Z. Ji|Y. Dongmei|H. Youming|S. Wenkui"
"2141","14/04 12:00","24","P2218","Amos ADLER","3","C","04h. Clinical metagenomics","Defining criteria for the distinction between infective versus non-infective in metagenomic analysis of CSF samples","K. Levytskyi|M. Slutzkin|A. Gadoth|Z. Habot-Wilner|R. Ben-Ami|Y. Paran|H. Goldshmidt|A. Adler"
"2983","14/04 12:00","25","P2219","Edwin VARGAS","3","C","04h. Clinical metagenomics","Impact of next generation sequencing (NGS) in culture negative infections coupled with infectious diseases consultation","E. Vargas|J. Weis|S. Dubey|S. Antonara"
"3072","14/04 12:00","26","P2220","Wei FEILI","3","C","04h. Clinical metagenomics","Pathogen detection and anti-microbial resistance prediction performance of mNGS and tNGS in HIV+ pulmonary infections","F. Wei|L. Zhang|X. Ma|S. Guo|M. Zhang|C. Guo|W. Wang|T. Zhang|Y. Zhang"
"3419","14/04 12:00","27","P2221","Kira WAAGNER BIRKELAND","3","C","04h. Clinical metagenomics","Exploring DNA and RNA plant viruses as internal controls for clinical metagenomic sequencing","K. Birkeland|K. Berger|H. Aamot"
"3851","14/04 12:00","28","P2222","Ander URIBARRI","3","C","04h. Clinical metagenomics","Refining 16S rRNA targeted NGS diagnostic criteria and thresholds for PJI diagnosis","A. Uribarri|L. Henriquez|I. Beguiristain|I. Rodriguez|A. Manuel|C. Ezpeleta|M. Portillo"
"3867","14/04 12:00","29","P2223","Ander URIBARRI","3","C","04h. Clinical metagenomics","25 vs 35 cycles of amplification of 16S rRNA gene for targeted NGS in PJI diagnosis: which does it better?","A. Uribarri|L. Henriquez|I. Beguiristain|I. Rodriguez|A. Manuel|C. Ezpeleta|M. Portillo"
"4971","14/04 12:00","30","P2224","Aubin SOUCHE","3","C","04h. Clinical metagenomics","When should targeted 16S-metagenomics be performed? A 15-months feedback","A. Souche|T. Roussel-Gaillard|R. Chalvignac|O. Dauwalder|Y. Benito|H. Salord|F. Vandenesch|C. Bouchiat"
"5143","14/04 12:00","31","P2225","Jannat Ara KHANOM","3","C","04h. Clinical metagenomics","Implementation of a rapid next-generation sequencing (NGS) based agnostic diagnostic for enhanced intensive care unit (ICU) care at a tertiary hospital in Dhaka, Bangladesh","J. Khanom|M. Nayem|M. Rabbi"
"5375","14/04 12:00","32","P2226","Richard CHALVIGNAC","3","C","04h. Clinical metagenomics","Optimisation of routine workflow for 16SrRNA and ITS-2 targeted-NGS in a clinical laboratory","R. Chalvignac|A. Souche|P. Tirard-Collet|J. Menotti|T. Roussel-Gaillard|C. Bouchiat"
"5478","14/04 12:00","33","P2227","Cécile ANGEBAULT","3","C","04h. Clinical metagenomics","Enhancing pathogen detection: shotgun metagenomics for tropical parasitic and fungal diagnostics","C. Angebault|L. Monpierre|S. Suyyagh-Albouz|F. Foulet|P. Cappy|F. Botterel"
"5619","14/04 12:00","34","P2228","Geetha NAGARAJ","3","C","04h. Clinical metagenomics","Diagnostic utility of nanopore full-length 16S rRNA gene sequencing for direct bacterial identification in chronic endometritis","G. Nagaraj|S. Varun|K. Ravikumar"
"5778","14/04 12:00","35","P2229","Charlotte DIXON","3","C","04h. Clinical metagenomics","Impact of saponin treatment on human mycoplasmas and implications for clinical metagenomics sequencing","C. Dixon|T. Rudman|H. Milton|R. Rowlands|O. Spiller|N. Couto|M. Beeton"
"5999","14/04 12:00","36","P2230","Claudia NGUYEN","3","C","04h. Clinical metagenomics","Proof-of-concept of a clinical metagenomics method for bacterial bloodstream infection detection using selective cell lysis and adaptive sampling","C. Nguyen|L. Borcard|S. Gempeler|M. Terrazos Miani|Y. Que|W. Hautz|A. Ramette|C. Casanova"
"6373","14/04 12:00","1","P2231","Ryan SHEAN","4","C","04h. Clinical metagenomics","Accurate and cost-effective metagenomic next-generation sequencing for meningitis and encephalitis on a novel sequencing platform","R. Shean|K. Tardif|A. Cruse|S. Hernandez|N. Iremadze|S. Pollock|D. Lipson|B. Benjamin"
"6381","14/04 12:00","2","P2232","Laura DI MURRO","4","C","04h. Clinical metagenomics","The use of metagenomics to evaluate different ESBL stool screening methods","L. Di Murro|L. Elton|S. Rofael|R. Lester|T. Mchugh"
"6488","14/04 12:00","3","P2233","Leysa FORREST","4","C","04h. Clinical metagenomics","Using metagenomics for pathogen screening in pregnancy complications","L. Forrest|T. Xenakis|Y. Sanchez-Corrales|J. Moreno Villena|S. Hillman|S. Castellano"
"6493","14/04 12:00","4","P2234","Torsten SCHROEDER","4","C","04h. Clinical metagenomics","Detection of pathogenic microorganisms usingmetagenomic next-generation sequencing in the emergency department","T. Schroeder|M. Eliwi Alsaffan|A. Dervishi|P. Kawaletz|H. Stäudle"
"6502","14/04 12:00","5","P2235","Virve Irene ENNE","4","C","04h. Clinical metagenomics","Correlation between nanopore respiratory metagenomics and quantitative respiratory culture","A. Alcolea-Medina|G. Humayun|V. Patel|L. Snell|D. Ward|A. Patel|R. Batra|J. Edgeworth|V. Enne"
"7356","14/04 12:00","6","P2236","Pugazhvanan CHIDAMBARAM RAJENDRAN","4","C","04h. Clinical metagenomics","Diagnostic utility of metagenomics next generation sequencing (mNGS) based on 16S rRNA sequencing in sterile samples","R. Gopalakrishnan|N. Sethuraman|P. Chidambaram Rajendran"
"1439","14/04 12:00","7","P2237","Kotaro AOKI","4","C","04i. Bioinformatics tools & pipelines","A validation and evaluation study of successive phylogenetic analysis by timely antimicrobial resistant organisms tracking (TAROT) for STEC","K. Aoki|I. Olonade|F. Tripodo|C. Swift|K. Tateda|C. Jenkins|D. Greig"
"2452","14/04 12:00","8","P2238","Marketa JAKUBICKOVA","4","C","04i. Bioinformatics tools & pipelines","Computational methylome analysis pipeline for uncovering DNA methylation sites in Klebsiella pneumoniae core genome","M. Jakubickova|K. Sabatova|M. Zbudilova|M. Bezdicek|M. Lengerová|H. Vitkova"
"2576","14/04 12:00","9","P2239","Fredrik DYRKELL","4","C","04i. Bioinformatics tools & pipelines","Bioinformatics analysis for low-frequency drug resistance mutations in HIV-1","F. Dyrkell|O. Aspelin|I. Gold Rodal"
"2728","14/04 12:00","10","P2240","Messiah ODEYALE","4","C","04i. Bioinformatics tools & pipelines","Comparing bacterial plasmid recovery in Hybracter vs Trycycler for long-read assemblies data","M. Odeyale|T. Luo|B. Corey|A. Ong|R. Maybank|L. Preston|J. Zelaya|F. Lebreton|J. Bennett|P. Mc Gann"
"3122","14/04 12:00","11","P2241","Hege Vangstein AAMOT","4","C","04i. Bioinformatics tools & pipelines","Comparative analysis of new bioinformatic pipelines for enhanced surveillance and outbreak investigation of Klebsiella pneumoniae","C. Sveen-Ekre|K. Helmersen|M. Wulf|H. Aamot"
"3325","14/04 12:00","12","P2242","Junko TAKATA","4","C","04i. Bioinformatics tools & pipelines","A rapidly adaptable platform for processing and analysing sequences of tiled amplicon-sequenced viruses to inform responses to future epidemics","J. Takata|J. Westhead|B. Young|T. Peto|D. Crook"
"4759","14/04 12:00","13","P2243","Juan Carlos GARCÍA-BETANCUR","4","C","04i. Bioinformatics tools & pipelines","A comprehensive tool for analysing Klebsiella pneumoniae genomes: the BGA pipeline","N. Forero-Pineda|J. Garcia-Betancur|B. Castro|N. Garcia Mena|E. De La Cadena|N. Restrepo Arbelaez|C. Pallares|M. Villegas"
"4777","14/04 12:00","14","P2244","H. Rogier VAN DOORN","4","C","04i. Bioinformatics tools & pipelines","Automated offline container with graphic user interface for genome assembly of both short-read and long-read","S. Trinh|J. Caballero|P. Shinde|A. Pragasam|N. Dagata|G. Lewis-Woodhouse|R. Acton|P. Turner|H. Van Doorn"
"4900","14/04 12:00","15","P2245","Jennifer LU","4","C","04i. Bioinformatics tools & pipelines","Kraken visualisation tool for clinical mNGS infectious disease diagnostics","J. Lu|P. Simner"
"5083","14/04 12:00","16","P2246","Sedreh NASSIRNIA","4","C","04i. Bioinformatics tools & pipelines","zAMPExplorer: a versatile shiny app for microbiota profiling in clinical microbiology","S. Nassirnia|V. Castelo-Szekely|F. Chaabane|V. Scherz|T. Pillonel|G. Greub|C. Bertelli"
"5225","14/04 12:00","17","P2247","Katerina SABATOVA","4","C","04i. Bioinformatics tools & pipelines","MethylomeMiner: a simple tool for processing and analysing DNA methylation data from sequencing","K. Sabatova|M. Jakubickova|M. Zbudilova|M. Bezdicek|H. Vitkova"
"5351","14/04 12:00","18","P2248","Alessia CARRARA","4","C","04i. Bioinformatics tools & pipelines","The PHAPRO toolbox: from phage characterisation to product quality assessment for phage therapy","A. Carrara|T. Pillonel|G. Resch|C. Bertelli"
"5548","14/04 12:00","20","P2250","Anargyros SKOULAKIS","4","C","04i. Bioinformatics tools & pipelines","AMRProfiler: a comprehensive tool for identifying antimicrobial resistance genes and mutations across species","A. Skoulakis|V. Kostoula|K. Daniilidis|C. Gkountinoudis|E. Petinaki|A. Hatzigeorgiou"
"5583","14/04 12:00","21","P2251","Janie OLVER","4","C","04i. Bioinformatics tools & pipelines","Visualising reference laboratory test results using dashboards: an aid to public health reporting and action","J. Olver|J. Warner|J. Osborne|M. Altidor|A. Belfield|T. Samuels|K. Skeats|H. Umpleby|C. Houlihan|C. Petridou|T. Rampling|C. Warrell|T. Brooks|N. Gordon|A. Semper"
"5842","14/04 12:00","22","P2252","Sam DIERICKX","4","C","04i. Bioinformatics tools & pipelines","Automated detection of antimicrobial resistance markers in next-generation sequencing data","S. Dierickx|W. Dumon|S. Cleemput|K. Dumon|K. Deforche"
"6689","14/04 12:00","23","P2253","Charbel AL BAYSSARI","4","C","04i. Bioinformatics tools & pipelines","Phylogenetic, serologic and sequence type analysis of 28,000 human and animal Escherichia coli genomes: on the lookout for the colibactin pks-island","A. Azour|C. Al-Bayssari|J. Rolain"
"7072","14/04 12:00","24","P2254","García García SAMUEL","4","C","04i. Bioinformatics tools & pipelines","Comparative analysis of a commercial platform and an in-house pipeline for processing whole genome sequencing data","S. Garcia Garcia|J. Rodriguez Grande|S. Garcia Fernandez|C. Sheppard|R. Palomino Cabrera|J. Calvo Montes|M. Roiz Mesones|J. Rodriguez Lozano"
"7336","14/04 12:00","25","P2255","Natacha COUTO","4","C","04i. Bioinformatics tools & pipelines","Enhancing AMR research and surveillance: introducing the AMRgen R package for gene and phenotypic resistance interpretation","M. Berends|N. Couto|J. Hawkey|K. Holt"
"375","14/04 12:00","26","P2256","Raksha KOCHI","4","C","04j. Artificial intelligence based tools and digital health","When ESCMID meets OpenAI over cups of coffee: brewing collaborative insights to streamline utility and interpretation of clinical guidelines with ChatGPT-4","R. Kochi"
"498","14/04 12:00","27","P2257","Han YU-LING","4","C","04j. Artificial intelligence based tools and digital health","Machine learning models incorporating virulence genes and serotype for identifying hypervirulent Klebsiella pneumoniae: a proof of concept study with 569 strains","H. Yu-Ling|Z. Wen-Qi|Z. Hong-Zhe|W. Xu-Hui|H. Zhi-De"
"531","14/04 12:00","28","P2258","Harry AKLIGOH","4","C","04j. Artificial intelligence based tools and digital health","MicroBIS A novel AI/ML based platform for bacterial and antimicrobial resistance identification and prediction","A. Kwakye|H. Akligoh|T. Lim|C. Huh"
"766","14/04 12:00","29","P2259","Mei-Hui LEE","4","C","04j. Artificial intelligence based tools and digital health","Predicted pathogens from blood culture with advanced pre-trained vision transformer models","R. Li|Y. Tsai|M. Lee"
"1038","14/04 12:00","30","P2260","Tochukwu AGBOEZE","4","C","04j. Artificial intelligence based tools and digital health","Application of machine learning models for prediction of AMR in Africa","T. Agboeze|O. Daramola|A. Akomolafe|R. Adedeji"
"1055","14/04 12:00","31","P2261","Sriram RADHAKRISHNAN","4","C","04j. Artificial intelligence based tools and digital health","Assessing the quality and appropriateness of artificial intelligence-generated outputs for sepsis management: a comparative study","V. Velmani|S. Dorairajan|S. K.|S. Kumar|L. Muppa|S. Radhakrishnan|S. Rajan"
"1312","14/04 12:00","32","P2262","Neha NITYADARSHINI","4","C","04j. Artificial intelligence based tools and digital health","Can artificial intelligence (AI) models be trusted? Determining the variables for building accurate prediction models for antimicrobial resistance","N. Nityadarshini|J. Biswas|T. Bordoloi"
"1724","14/04 12:00","33","P2263","Lucas OLIVEIRA DE MORAIS","4","C","04j. Artificial intelligence based tools and digital health","Enhancing antimicrobial prescription accuracy: an integrated evaluation of a clinical decision support system in a private hospital setting","L. Oliveira De Morais|P. Machado Mariano|R. Stradiotto Bernardelli|R. Miorando|R. Zagre Júnior|M. Castagnoli|M. Pillonetto"
"1938","14/04 12:00","34","P2264","Petrus VAN DER WALT","4","C","04j. Artificial intelligence based tools and digital health","Evaluation of the comercial urine culture application for automated urine culture analysis","P. Naidu|P. Van Der Walt|S. Avoledo|C. Mak|F. Starko"
"2084","14/04 12:00","35","P2265","Zahraa AL-SULTANI","4","C","04j. Artificial intelligence based tools and digital health","Using machine learning to identify factors associated with blood culture contamination in an Australian medical laboratory","Z. Al-Sultani|M. Reynolds|L. Thomas|T. Inglis"
"2298","14/04 12:00","36","P2266","Valêncio Siqueira ANDRÉ","4","C","04j. Artificial intelligence based tools and digital health","Machine learning-guided clustering: a new approach for KPC detection","A. Valêncio Siqueira|M. Silva|F. Santos|F. Kitamura|J. Polatto|M. Machado|R. Piazza|A. Gales"
"2529","14/04 12:00","1","P2267","Valeria FOX","5","C","04j. Artificial intelligence based tools and digital health","Fourier-transform infrared spectroscopy (FTIR) as a tool for predicting Group A Streptococcus (GAS) emm-type using a machine learning model","V. Fox|G. Vrenna|S. Raimondi|G. Foglietta|M. Rossitto|B. Lucignano|M. Onori|M. Cristiano|M. D'urbano|V. Fini|A. Granaglia|C. Perno|P. Bernaschi|V. Cortazzo|M. Agosta|M. Pereyra Boza"
"2599","14/04 12:00","2","P2268","Kenneth SMITH","5","C","04j. Artificial intelligence based tools and digital health","Digital holographic microscopy: use of AI to enable rapid slide digitisation and interpretation","E. Boulanger|K. Smith|A. Shamsheyeva|K. Spafford|R. Stahl|S. Cagina|O. Gusyatin"
"3087","14/04 12:00","3","P2269","Roshni MURALI","5","C","04j. Artificial intelligence based tools and digital health","Artificial intelligence vs clinical scores: evaluating mortality prediction in sepsis patients in a tertiary care hospital South India","R. Murali|D. Sureshkumar|S. Hassan"
"3138","14/04 12:00","4","P2270","Jinhan YU","5","C","04j. Artificial intelligence based tools and digital health","Automated species identification of clinically common Aspergillus using artificial intelligence based on colony morphology","J. Yu|X. Li|Y. Xu"
"3259","14/04 12:00","5","P2271","Albert MORENO-MINGORANCE","5","C","04j. Artificial intelligence based tools and digital health","ShigaMS: an artificial intelligence prediction tool for Shigella spp identification and serotyping from MALDI-TOF MS lipid profiles","R. Estévez|A. Moreno-Mingorance|P. Aja-Macaya|A. Candela|T. Blanco-Martin|S. Sánchez|J. Arca-Suárez|G. Bou|J. Gonzalez-Lopez|M. Oviano|M. Arroyo"
"3282","14/04 12:00","6","P2272","Tania BLANCO MARTÍN","5","C","04j. Artificial intelligence based tools and digital health","Artificial intelligence modelling prediction for rapid serotype prediction of Shiga-toxin Escherichia coli by lipid profiling mass spectrometry","T. Blanco-Martin|S. Sánchez|P. Aja-Macaya|R. Estévez|A. Candela|M. Arroyo|P. Guijarro-Sánchez|J. Arca-Suárez|A. Beceiro|G. Bou|M. Oviano"
"3609","14/04 12:00","7","P2273","Gemma STAITE","5","C","04j. Artificial intelligence based tools and digital health","Streamlining MRSA screens and urine cultures with AI-driven automatic release","G. Staite"
"3805","14/04 12:00","8","P2274","Fredrick MUTISYA","5","C","04j. Artificial intelligence based tools and digital health","Using artificial intelligence to integrate dynamic antibiograms and research into electronic medical record systems for enhanced antibiotic decision support","R. Kanguha|F. Mutisya"
"3873","14/04 12:00","9","P2275","Haseeb TARIQ","5","C","04j. Artificial intelligence based tools and digital health","Machine learning as a diagnostic tool for intestinal methanogen overgrowth and small intestinal bacterial overgrowth: a new frontier diagnosing","H. Tariq|A. Mariam|T. Muhammad Muneeb"
"4542","14/04 12:00","10","P2276","Po-Ren HSUEH","5","C","04j. Artificial intelligence based tools and digital health","AIM-GNB: an artificial intelligence-assisted monitor for early prediction of Gram-negative bacteraemia using machine learning and heamatological data in the emergency department","H. Po-Ren|Y. Chang|H. Shih"
"4553","14/04 12:00","11","P2277","Po-Ren HSUEH","5","C","04j. Artificial intelligence based tools and digital health","Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from raman spectra by artificial intelligent raman detection and identification system (AIRDIS) with machine learning","P. Hsueh|Y. Lin|H. Lln"
"4708","14/04 12:00","12","P2278",,"5","C","04j. Artificial intelligence based tools and digital health","Artificial intelligence (AI)-driven lab automation releases urine culture results without human intervention","R. Davidson|G. Patriquin|C. Porter|C. Heinstein"
"4720","14/04 12:00","13","P2279","Tze-Peng LIM","5","C","04j. Artificial intelligence based tools and digital health","Developing a mobile application for the delivery of personalised test-guided antibiotic combinations for difficult-to-treat bacterial infections: a user-centered design study","T. Lim|J. Teo|Y. Cai|A. Kwa"
"5116","14/04 12:00","14","P2280","Vincenzo DE LUCA","5","C","04j. Artificial intelligence based tools and digital health","Identification of unmet needs for design and procuring digital services to address antimicrobial resistance (AMR) in hospital settings","V. De Luca|G. Viceconte|A. Alvarez Fernandez|E. Limon Caceres|M. Pons Vizcarra|V. Valls Comamala|O. Elizondo Cordero|M. Virgolesi|L. Mercurio|I. Gentile|M. Catania|M. Illario"
"5127","14/04 12:00","15","P2281","Lee TAI FEN","5","C","04j. Artificial intelligence based tools and digital health","Integrating AI into microbiology laboratory automation (MLA) for screening of urine cultures","T. Lee|Y. Huang|H. Chiu"
"5584","14/04 12:00","16","P2282","Benjamin MCFADDEN","5","C","04j. Artificial intelligence based tools and digital health","How can large language models be used for clinical microbiology and infectious diseases: a tale of two applications","B. Mcfadden"
"5821","14/04 12:00","17","P2283","Galadriel PELLEJERO-SAGASTIZÁBAL","5","C","04j. Artificial intelligence based tools and digital health","Applying human-centred design (HCD) to develop an assisted microbiological order set: an innovative prototype from Aragon, Spain","Á. Abejez-Arrizabalaga|J. Sahagún-Pareja|C. Seral-Garcia|G. Pellejero-Sagastizábal|T. Serrano-Aullo|R. Sanz-Segura|J. Pano-Pardo|E. Pablo-Hernando|S. Loscos-Aranda|C. Toyas-Miazza"
"6026","14/04 12:00","18","P2284","Mariska OKKEMA-VAN DER LEI","5","C","04j. Artificial intelligence based tools and digital health","AI-powered innovations: enhancing accuracy in antibiotic susceptibility testing","D. Jacot|S. Gizha|M. Okkema-Van Der Lei|J. Lemstra|K. Van Benten|C. Orny|M. Fernandes|C. Tricoli|R. Marcelpoil"
"6206","14/04 12:00","19","P2285","Oliver SCHWENGERS","5","C","04j. Artificial intelligence based tools and digital health","BakRep: a searchable large-scale web repository for bacterial genomes, characterisations and metadata","L. Fenske|L. Jelonek|A. Goesmann|O. Schwengers"
"6432","14/04 12:00","20","P2286","Jason D WITTENBACH","5","C","04j. Artificial intelligence based tools and digital health","Machine learning for genomic AST prediction in metagenomic data from respiratory clinical samples","J. Wittenbach|L. Snell|D. Surujon|M. Sater|A. Alcolea-Medina|V. Enne|C. Maddux|D. Ward|R. Batra|J. Edgeworth|M. Huntley"
"6440","14/04 12:00","21","P2287","Monika BRZYCHCZY-WLOCH","5","C","04j. Artificial intelligence based tools and digital health","Revolutionising sepsis diagnosis: AI-powered pathogen identification from blood smears","M. Brzychczy-Wloch|K. Biegun-Drozdz|D. Ochonska|A. Olechowska-Jarzab|T. Gosiewski|A. Pardyl|D. Rymarczyk|M. Wronka|A. Borowa|M. Adamczyk|B. Zielinski|A. Sroka-Oleksiak"
"6441","14/04 12:00","22","P2288","Michelle BRESSAN","5","C","04j. Artificial intelligence based tools and digital health","Evaluation of six large language models answering pre-analytical questions in medical microbiology","M. Bressan|E. Meijer|O. Nolte|V. Hinic|G. Schneider|J. Goldman|T. Kew|T. Ellendorff|A. Egli"
"6666","14/04 12:00","23","P2289","Orcun ZORBOZAN","5","C","04j. Artificial intelligence based tools and digital health","Performance of Orienter-FA280 automated faeces analyser: preliminary evaluation","O. Zorbozan|R. Yis|G. Yaman|B. Özhak|M. Berktas"
"7385","14/04 12:00","24","P2290","Thunyapon PIPATTAWEEPON","5","C","04j. Artificial intelligence based tools and digital health","Integrating artificial intelligence to optimise STI PCR testing decisions: a data-driven approach to enhancing diagnostic microbiology","N. Chumpa|T. Pipattaweepon"
"181","14/04 12:00","25","P2291","Joanna Malgorzata BIVAND","5","C","04k. Other novel diagnostic technologies","Sequencing of bacterial rpoB and 16S rRNA gene amplicons for infectious disease diagnostics","J. Bivand|Ø. Kommedal|A. Sivertsen|M. Gjerde Tellevik"
"687","14/04 12:00","26","P2292","Jing HUANG","5","C","04k. Other novel diagnostic technologies","Rapid detection of carbapenem-resistant Klebsiella pneumoniae using CRISPR/Cas13a technology","J. Huang|F. Ren"
"1542","14/04 12:00","28","P2294","Ummu Afeera ZAINULABID","5","C","04k. Other novel diagnostic technologies","Rapid nanopore sequencing as a key diagnostic tool in adrenal histoplasmosis after a year of uncertainty","N. Zaidan|N. Ismail|H. Neoh|H. Gan|X. Cheong|N. Kori|P. Periyasamy|M. Abdul Muien|R. Musily|I. Mohamed Rose|U. Zainulabid"
"1648","14/04 12:00","29","P2295","Claudia ROTONDO","5","C","04k. Other novel diagnostic technologies","A newly developed method for rapidly and accurately detecting the hypervirulent genotype of Klebsiella pneumoniae","C. Rotondo|V. Dimartino|C. Fontana"
"1653","14/04 12:00","30","P2296","Rutuja H. PATIL","5","C","04k. Other novel diagnostic technologies","Metabolic profiling of Pseudomonas aeruginosa infection in cystic fibrosis","P. Drevinek|L. Fila|R. Patil|T. Pluhacek|H. Maresova|V. Havlicek|A. Palyzova|M. Antuskova"
"1994","14/04 12:00","31","P2297","Huong VU THI LAN","5","C","04k. Other novel diagnostic technologies","Feasibility of microbiology interventions for surveillance of antimicrobial resistance in district level hospitals in Vietnam","H. Nguyen Thi|H. Tran Thi|C. Dang Quang|H. Tran Thi Bich|H. Phan Quoc|M. Nguyen Duy|H. Nguyen Ba|H. Pham Van|T. Pham Le|G. Bui Thi Huong|T. Pham Thi Thanh|H. Nguyen Thi Thu|T. Nguyen Hai|D. Pham Minh|H. Dinh Xuan|L. To Duc|H. Nguyen Ngoc|T. Nguyen Thi|T. Van Dinh|H. Nguyen Thanh|Y. Nguyen Hai|P. Bui Bich|H. van Doorn|H. Vu Thi Lan|T. Kesteman"
"2192","14/04 12:00","32","P2298","Davinder KAUR","5","C","04k. Other novel diagnostic technologies","Loop mediated isothermal amplification assay: a reliable tool to detect SNPs in chloroquine resistance genes of Plasmodium falciparum in field settings","D. Kaur|U. Kaur|R. Sehgal"
"2323","14/04 12:00","33","P2299","Li ZHIDONG","5","C","04k. Other novel diagnostic technologies","Rapid detection of antimicrobial susceptibility based on holographic imaging system","Q. Zhang|C. Li|F. Chen|G. Fu|X. Li|L. Yang|Z. Li"
"2540","14/04 12:00","34","P2300","Arpita SAHOO","5","C","04k. Other novel diagnostic technologies","Harnessing synthetic nanobodies for characterisation and diagnosis of Staphylococcus aureus infections","A. Sahoo|A. Zinkernagel|M. Seeger|M. Sorgenfrei|F. Anderoni|S. Mairpady Shambat"
"2732","14/04 12:00","35","P2301","Alessandra SCAGLIARINI","5","C","04k. Other novel diagnostic technologies","PEDOT:PSS OECTs as versatile devices for real-time monitoring of monkeypox virus antiviral assays","M. Brandolini|A. Scagliarini|B. Fraboni|A. De Pascali|A. Guercio|S. Di Bella|V. Cannella|L. Ingletto|G. Gatti|L. Dionisi|C. Colosimo|S. Zannoli|G. Dirani|M. Guerra|M. Cricca|V. Sambri|F. Decataldo|G. Cortelli"
"3346","14/04 12:00","36","P2302","Marco Antonio ROLDÁN RUIZ","5","C","04k. Other novel diagnostic technologies","Improving blood culture interpretation: the role of IR biotyper for S. hominis","M. Roldan Ruiz|L. Gozalo Álvarez|N. Chueca Porcuna|F. Garcia Garcia"
"3542","14/04 12:00","1","P2303","Jürgen HELD","6","C","04k. Other novel diagnostic technologies","Ultrafast antibiotic susceptibility testing of 8 multidrug resistant Gramnegative rods with Raman single beam trapping using the Biospex platform","J. Träger|J. Esse|H. Yosef|A. Chenani|H. Nathwani|S. Kunchapudi|J. Held"
"4791","14/04 12:00","2","P2304","Carey-Ann BURNHAM","6","C","04k. Other novel diagnostic technologies","Multicentre evaluation of the pattern single-cell microbiology platform for microorganism identification and antimicrobial susceptibility testing directly from lower respiratory tract specimens","R. Chamberland|L. Sabharwal|C. Muenks|D. Bussian|M. Yarbrough|B. Buchan|N. Arab|M. Wallace|R. Johnson|J. Faucheaux|C. Burnham|D. Rhoads|E. Keskinen-Allen"
"4841","14/04 12:00","3","P2305","Sabrina ALBET","6","C","04k. Other novel diagnostic technologies","Viability assessment of Neisseria gonorrhoeae in male urine samples by a novel nucleic acid amplification test (NAAT)","N. Lima|A. Wong|R. Varma|K. Strojny|I. Aneman|T. Blair|T. Lonergan|H. Lowes|T. Applegate|C. Bradshaw|A. Todd"
"5114","14/04 12:00","4","P2306","Kelvin TO","6","C","04k. Other novel diagnostic technologies","Neural network prediction of bacterial pneumonia by host transcriptomic analysis of metagenomic data","K. To|D. Buhl|R. Leung|A. Chu|C. Wan-Mui"
"5309","14/04 12:00","5","P2307","Sofia SOMAJO","6","C","04k. Other novel diagnostic technologies","Quartz crystal microbalance as a diagnostic tool for Lyme borreliosis: a proof-of-concept study","S. Somajo|S. Hanna Elias|P. Anaspure|A. Jonsson Henningsson"
"5729","14/04 12:00","6","P2308","Blanca CABALLERO","6","C","04k. Other novel diagnostic technologies","Ultra-fast pathogen identification in sepsis diagnosis using an optomechanical sensor assisted by artificial intelligence","I. Colomar|A. Iregui|C. Munoz|A. Heras|D. Ramos|B. Caballero"
"6346","14/04 12:00","7","P2309","Gregorius Johannes SIPS","6","C","04k. Other novel diagnostic technologies","Sampling washing machine water to detect scabies (Sarcoptes scabiei)","G. Sips|W. Stolk|M. De Jong|R. Schilperoort|P. Bijkerk|A. Tjon-A-Tsien|M. De Graaf|J. Langeveld|E. Fanoy|G. Medema"
"6423","14/04 12:00","8","P2310","Robbie HAINES","6","C","04k. Other novel diagnostic technologies","Rapid, repeatable cell counting of bacteria using cytometric methods and FiSH","R. Haines|M. Kieran|K. Hammer|K. Ritika|M. Nicol"
"6803","14/04 12:00","9","P2311","Roberto DE LA RICA","6","C","04k. Other novel diagnostic technologies","Catalase-based sputum liquefaction for diagnosing respiratory infections caused by Pseudomonas aeruginosa at the point-of-care","R. De La Rica|A. Vaquer|A. Clemente"
"6881","14/04 12:00","10","P2312","Julia DOLEZEL","6","C","04k. Other novel diagnostic technologies","Agnostic sample preparation for bacteria, yeasts and viruses from blood, sputum and saliva","S. Reischl|J. Peham|K. Wassermann|K. Silberreis|K. Stoecker|A. Schilder|B. Posch|J. Dolezel|Z. Azizi|K. Dattler|D. Pittrich|S. Barratt|S. Gutierrez|S. Vasantham|T. Wimberger"
"7687","14/04 12:00","11","P2313","Sílvio SANTOS","6","C","04k. Other novel diagnostic technologies","A novel phage-derived receptor binding protein for rapid and specific detection of Escherichia coli O157:H7 and related Shiga toxin-producing strains","S. Santos|M. Costa|R. Mota|R. Monteiro"
"211","15/04 12:00","1","P3073","Arya KUMAR","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Reducing central line-associated bloodstream infection in intensive care units: an improvement project in a tertiary care centre in south India","A. Kumar|S. Singh|S. Sudhir|R. George|N. Mohan|R. Antony"
"382","15/04 12:00","2","P3074","Tjallie VAN DER KOOI","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Burden of phlebitis with peripheral catheters in Dutch hospitals","T. Van Der Kooi|S. Valk|C. Doodemont-Van Breen|S. Van Rooden|S. De Greeff"
"979","15/04 12:00","3","P3075","Mateja LOGAR","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Long-term success in the reduction of CRBSI rates at the university medical centre Ljubljana from 2010 to 2024","M. Logar|M. Mavric|N. Planinc Strunjas|S. Miklavcic"
"1094","15/04 12:00","4","P3076","Sandeep RAO KORDCAL","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Bacterial contamination of surfaces and central line-associated bloodstream infection in the medical intensive care unit","S. Rao Kordcal|P. Jorwal|N. Wig"
"1278","15/04 12:00","5","P3077","Vodianyk ARKADII","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Molecular characteristics of antimicrobial resistance and biofilm formation of bloodstream infection pathogens isolated from paediatric patients in Ukraine","A. Vodianyk|O. Holovnia|V. Poniatovskiy|V. Shyrobokov"
"1929","15/04 12:00","6","P3078","Mariem BEN HMIDA","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Incidence and risk factors of central venous catheter-associated infections in hemodialysis patients","G. Nasri|M. Ben Hmida|M. Trigui|B. Fandri|M. Baklouti|M. Ben Hmida|H. Ben Ayed|S. Yaich"
"2966","15/04 12:00","7","P3079","Cian LENIHAN","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Point prevalence survey of peripheral intravenous catheter utilisation and care bundle compliance in a tertiary hospital in Cork, Ireland","R. Barry|N. Mcdonnell|J. O'keefe|G. Kelleher|J. Crowley|A. Wallace|C. Hwei|K. Fitzmaurice|N. O'mara|C. Lenihan"
"3047","15/04 12:00","8","P3080","Nicolas FOURRÉ","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Factors associated with metastatic complications among patients with venous catheter-related bloodstream infections","N. Fourré|V. Zimmermann|B. Guery|M. Papadimitriou-Olivgeris|B. Grandbastien|L. Senn"
"4493","15/04 12:00","9","P3081","Giovanni SCAGLIONE","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","A novel one-class Bernoulli classifier for risk assessment of catheter-related (CRBSI), and catheter-associated (CABSI) bloodstream infections outside of the intensive care unit (ICU)","J. Leoni|G. Scaglione|M. Colaneri|F. Fassio|F. Borgonovo|R. Fattore|L. Galli|C. Genovese|M. Schiavini|A. Gori|V. Breschi|A. Foschi"
"4535","15/04 12:00","10","P3082","Rebecca FATTORE","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Assessing guideline adherence in vascular access device infection management: the ALIGN-VAD study","R. Fattore|L. Galli|M. Colaneri|M. Offer|F. Borgonovo|G. Scaglione|C. Genovese|M. Schiavini|G. De Capitani|M. Calloni|A. Bartoli|A. Gidaro|C. Cogliati|S. Antinori|A. Gori|A. Foschi"
"5260","15/04 12:00","11","P3083","Giovanni DE CAPITANI","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Effectiveness of vascular catheter removal vs retention in non-ICU patients with CRBSI or CABSI in a retrospective, single-centre study","G. De Capitani|M. Colaneri|M. Offer|F. Borgonovo|L. Galli|G. Scaglione|C. Genovese|R. Fattore|M. Schiavini|B. Caloni|A. Taino|A. Gidaro|M. Calloni|A. Bartoli|C. Cogliati|S. Antinori|A. Gori|A. Foschi"
"5900","15/04 12:00","12","P3084","Sawsan AL MUBARAK","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Epidemiological trends and multidrug-resistant patterns in central line-associated bloodstream infections among bone marrow transplant patients at comprehensive cancer centre in Jordan: five year retrospective study","S. Mubarak|H. Al Ghawrie|J. Jarrah|O. Khresat"
"6102","15/04 12:00","13","P3085","Beenish SYED","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Reducing the rates of phlebitis in a tertiary care hospital: an experience from a resource-limited setting","B. Syed|B. Ahmed|R. Shaheen|T. Ansari"
"7038","15/04 12:00","14","P3086","Gargee ANAND","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Surveillance of WHO's priority pathogens in ICU-associated CLABSI and CAUTI: antimicrobial susceptibility, epidemiology, and implications for stewardship","G. Anand|K. Priyadarshi|A. Sarfraz|B. Thakuria|P. K."
"7065","15/04 12:00","15","P3087","Pedro FLORIA BAQUERO","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Etiology of endovascular catheter infections based on cather type, sex, and age","P. Floria Vaquero|L. Andrés Eslava|L. Suarez Lopez|M. Guna Serrano|C. Gimeno Cardona"
"7443","15/04 12:00","16","P3088","Beate WEIKERT","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","Increased primary bloodstream infections associated with extracorporeal life support (ECLS) use during the COVID 19 pandemic in Germany","B. Weikert|F. Schwab|J. Busse|C. Geffers"
"7527","15/04 12:00","17","P3089","Nagham Léa KHANAFER","1","C","08a. Intravascular catheter-related infections (incl epidemiology, prevention)","An audit of central venous catheter insertion and management practices in 4 ICUs of a French university hospital","N. Khanafer|L. Argaud|E. Sola-Kuczewski|A. Malatray|A. De-La-Roque|B. Chabert|C. Marcelli|A. Pierron|S. Hadef|A. Lukaszewicz|P. Vanhems"
"146","15/04 12:00","18","P3090","Marta DÍAZ-NAVARRO","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","In vivo validation of sequential combination of antiseptic solutions for chemical debridement in periprosthetic joint infections","M. Diaz-Navarro|M. Marquez-Gomez|A. Visedo|L. Prats|P. Munoz|J. Vaquero|P. Sanz-Ruiz|M. Guembe"
"215","15/04 12:00","19","P3091","Jatin CHADHA","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Biomaterial modification of urinary catheters with cinnamaldehyde for long-term antimicrobial and antifouling activity against uropathogenic microorganisms","J. Chadha|G. Moudgil|L. Khullar|K. Harjai"
"1225","15/04 12:00","20","P3092","Eline SCHIPPERS","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","To change or not to change: clinical practice variation in catheter replacement for catheter-associated urinary tract infections","E. Schippers|M. Lambregts|J. Van Uhm|S. Geerlings"
"1228","15/04 12:00","21","P3093","Janneke MEIJER","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","A longer duration of intravenous antibiotic treatment for patients with early periprosthetic joint infections is not associated with a lower failure rate","J. Meijer|A. Soriano|W. Zijlstra|B. Ten Have|S. Tarabichi|P. Jutte|J. Parvizi|M. Wouthuyzen-Bakker"
"2157","15/04 12:00","22","P3094","Ana Maria ARNAIZ-GARCIA","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Clinical outcomes of delafloxacin in osteoarticular infections: a multicentre study in northern Spain","A. Arnaiz Garcia|J. Méndez Legaza|L. Perez-Perianez Orrillo|S. Velasco De La Fuente|R. Portilla Chocarro|J. De La Hera Fernández|R. Mazarrasa Alonso|R. Zarrabeitia Puente|I. Lopez Mirones|I. Cabezon Estevanez"
"2213","15/04 12:00","23","P3095","Iris CAZALI","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Effectiveness of a multifaceted educational bundle for CAUTI prevention in an intensive care unit","I. Cazali|A. Perez|D. Erdmenger|I. Hernandez"
"2466","15/04 12:00","24","P3096","Tomaso BERINGHELI","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Efficacy and safety of dalbavancin as suppressive therapy","T. Beringheli|C. Dupieux-Chabert|S. Goutelle|T. Roussel-Gaillard|C. Dhelens|P. Rascle|C. Doudet|S. Roux|C. Javaux|C. Triffault-Fillit|E. Braun|T. Ferry|F. Valour"
"2882","15/04 12:00","25","P3097","Lucía HENRÍQUEZ MEDEROS","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Prosthetic joint infection: analysis of epidemiology and resistance patterns during five years in a Spanish region","L. Henriquez|A. Uribarri|I. Beguiristain|I. Sancho|C. Ezpeleta|M. Portillo"
"3201","15/04 12:00","26","P3098","Yukino GÜTLIN","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Genomic insights into antimicrobial resistance and virulence in orthopaedic Gram-negative pathogens: a focus on Enterobacter cloacae complex and Klebsiella spp.","Y. Gutlin|S. Hartmann|F. Wegner|T. Roloff|E. Meijer|S. Berdalli|J. Hofstaetter|A. Egli"
"3233","15/04 12:00","27","P3099","Audrey JACOB","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","GLORIA, a global proof of concept study in prosthetic joint infection (PJI): presentation of the study design","P. Birman|A. Jacob|I. Soares|A. Kuhn"
"3826","15/04 12:00","28","P3100","Ander URIBARRI","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Assessment of the use of delafloxacin for the treatment of prosthetic joint infections caused by quinolone-resistant strains and anaerobes","A. Uribarri|L. Henriquez|I. Beguiristain|I. Sancho|C. Ezpeleta|M. Portillo"
"3928","15/04 12:00","29","P3101","Jessica ODONE","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Antibiotic stewardship and orthopaedic infection: do we need to wait for enriched culture results to target antibiotics?","J. Odone|D. Enoch|E. Nickerson|E. Moore|D. Greaves"
"4089","15/04 12:00","30","P3102","Manuela SANZ DE MENA","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Bone and joint infections by multidrug-resistant Pseudomonas aeruginosa: characteristics, outcome and efficacy of new beta-lactam/beta-lactamase inhibitor combinations in a Spanish multicentre study","M. Sanz-De Mena|D. Rodrigez-Pardo|M. Mancheno-Losa|P. González-De-La-Aleja|A. Ribera|R. Escudero-Sánchez|F. Martinez-Marcos|H. Mejide-Miguez|M. Oltra-Sempere|A. Rico-Nieto|E. Van Den Eynde|L. Sorli Redo|P. Hernández-Jiménez|J. Horcajada|J. Gomez-Junyent|M. Riera|J. Sellarés"
"4207","15/04 12:00","31","P3103","Kalliopi AVGOULEA","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","A retrospective study of neurosurgical device-related infections over a two-year period in a tertiary Hellenic hospital","K. Avgoulea|A. Spyrou|E. Kalogianni|A. Yiaskouri|A. Athanasopoulou|A. Tsakalos|M. Kamperogianni|M. Orfanidou"
"4248","15/04 12:00","32","P3104","Marta HERNÁNDEZ-MENESES","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Chronic antimicrobial suppression improves long-term outcomes in cardiac device infective endocarditis without complete device removal","M. Hernández-Meneses|E. Sandoval|J. Tolosana|G. Cuervo|C. Falces|A. Perissinotti|F. Marco|J. Llopis|A. Moreno|J. Miro"
"4312","15/04 12:00","33","P3105","Marcella NEGRI","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Impact of bacterobilia on postoperative bloodstream infections, complications, and survival in pancreaticoduodenectomy: a single-centre retrospective analysis","M. Negri|L. Provinciali|G. Ponta|T. Clemente|F. De Stefano|G. Guarneri|F. Gona|R. Lolatto|P. Reali|M. Ripa|V. Spagnuolo|C. Tassandin|P. Scarpellini|D. Tamburrino|A. Castagna|M. Falconi"
"4404","15/04 12:00","34","P3106","Iñaki BEGUIRISTAIN CALVO","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Genomic characterisation of Staphylococcus epidermidis strains causing prosthetic joint infections","I. Beguiristain|L. Henriquez|A. Uribarri|M. Alfaro|I. Rodriguez|M. Portillo|C. Ezpeleta"
"4576","15/04 12:00","35","P3107","Néstor LÓPEZ GUERRA","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Clinical and etiological insights into bacterial and fungal central nervous system infections: a decade of experience","N. Lopez Guerra|A. Vilalta|S. Anguera|B. Fidalgo|M. Alguacil|A. Rojas|G. Cabrera|M. Codes|L. Gomez|A. Mosteiro|G. Guizzardi|J. Torales|S. Herrera|I. Grafia|M. Bodro|G. Cuervo|C. Cardozo|L. Morata|A. Del Rio|J. Martinez|J. Bosch|A. Soriano|P. Puerta-Alcalde|A. Vergara"
"5049","15/04 12:00","36","P3108","Birgit KOCH","1","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Evaluation of local vancomycin delivery via hip and knee spacers: towards reducing intravenous antibiotics","M. Mehciz|P. Bos|J. Van Oldenrijk|E. Veltman|B. Koch"
"5079","15/04 12:00","1","P3109","Louise KELLY","2","C","08b. Other foreign-body and implant-associated infections (incl PJI)","A five-year review of external ventricular device infections in Ireland's national neurosurgical centre","L. Kelly|M. Russell|B. Dinesh|S. O' Donnell"
"5251","15/04 12:00","2","P3110","Renato PASCALE","2","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Risk factors for treatment failure of surgical site deep infections following spinal instrumentation: multicentre observational study (DeFEndO Study)","R. Pascale|M. Gallo|G. Fornaro|N. Regge Gianas|I. Grassi|M. Zagarrigo|A. Grechi|A. Zuppiroli|D. Santoro|E. Tenti|E. Zamparini|A. Gasbarrini|P. Viale|M. Giannella|S. Curti|S. Tedeschi"
"5317","15/04 12:00","3","P3111","Etienne RAPHAËL","2","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Surgical site infections following percutaneous fixation for vertebral fractures","E. Raphaël|H. Bouhali|P. Mai|F. Bert|V. Zarrouk|A. Lefort|M. Rousseau|B. Boukebous|V. De Lastours"
"5444","15/04 12:00","4","P3112","Riccardo BOLLINI","2","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Genomic characterisation of Pseudomonas aeruginosa isolates from implant-associated infections","R. Bollini|I. Rossomanno|D. Bavaro|Z. Asif|L. Peiretti|M. Casana|L. Bussini|C. Scuderi|R. Renzulli|G. Da Rin|S. Marchini|E. Casari|M. Bartoletti|S. Carloni|V. Cento"
"7537","15/04 12:00","5","P3113","Irene FERNÁNDEZ-LÓPEZ","2","C","08b. Other foreign-body and implant-associated infections (incl PJI)","Infections in patients with heart mate devices","I. Fernandez-Lopez|A. Pedraz|J. Castrodeza|D. Monzon|Z. Blazquez|G. Cuerpo|H. Rodriguez-Abella|M. Machado|P. Munoz|M. Valerio"
"183","15/04 12:00","6","P3114","Arya KUMAR","2","C","08c. Surgical site infections","Reducing caesarean section surgical site infection rate in a tertiary care hospital in India: a quality improvement initiative","A. Kumar|N. Mohan|G. Baby|S. Singh"
"242","15/04 12:00","7","P3115","Sruthi MENON","2","C","08c. Surgical site infections","Adherence to surgical antimicrobial prophylaxis and incidence of surgical-site infections at a tertiary care hospital in India","S. Menon|A. Udayakumar|M. Mylswamy|R. S. Kumar"
"535","15/04 12:00","8","P3116","Tamar HALPERIN","2","C","08c. Surgical site infections","Unmasking the source: post-craniotomy Cutibacterium acnes brain abscesses outbreak investigation","O. Yossepowitch|M. Shpriz|K. Levytskyi|T. Halperin|D. Ben-David|A. Adler"
"940","15/04 12:00","9","P3117","Christoph KLAUS","2","C","08c. Surgical site infections","Remanent antiseptics for preoperative skin preparation: an outcome-blinded, three-arm, randomised-clinical-trial under non-sterile operating room conditions in veterinary medicine","E. Marchionatti|C. Constant|C. Klaus|A. Steiner"
"1674","15/04 12:00","10","P3118","Daniele RICCUCCI","2","C","08c. Surgical site infections","Post-surgery infections in Crohn patients undergoing abdominal surgery: a single reference-centre experience","D. Riccucci|M. Rinaldi|M. Montironi|M. Giacomini|C. Gatto|L. Melotti|P. Gionchetti|M. Rottoli|G. Calini|G. Poggioli|P. Viale|M. Giannella"
"2489","15/04 12:00","11","P3119","Feyzullah Yavuz ATABAY","2","C","08c. Surgical site infections","The appropriateness of surgical antibiotic prophylaxis in spine surgery: a single-centre observational study from Turkey","F. Atabay|M. Çeli?k|A. Nazli|Z. Kuruuzum"
"2532","15/04 12:00","12","P3120","Maria GHEORGHE","2","C","08c. Surgical site infections","Feasibility assessment for indirect treatment comparisons (ITC) of aztreonam-avibactam (ATM-AVI) vs comparators for treating serious infections caused by Enterobacterales, including metallo-beta-lactamase (MBL)-producing pathogens","M. Falcone|M. Gheorghe|S. Kamat|C. Little|S. Panigrahi|E. Broughton|F. Rodriguez Santamaria|A. Paine"
"2835","15/04 12:00","13","P3121","Emanuele PONTALI","2","C","08c. Surgical site infections","Identifying weak points in the surgical pathway of hip and knee prosthetic surgery: use of data from surgical site infections surveillance","M. Porretto|S. Boni|M. Sartini|G. Adriano|S. Tigano|M. Santarsiero|G. Damiani|M. Nelli|D. Usiglio|L. Romano|A. Parisini|C. Mazzola|M. Cristina|E. Pontali"
"3817","15/04 12:00","14","P3122","Theresa PECHO","2","C","08c. Surgical site infections","Cefazolin pharmacokinetics in twin-pregnant women undergoing cesarean delivery","T. Pecho|M. Sanz Codina|A. Farr|C. Dorn|M. Zeitlinger"
"4044","15/04 12:00","15","P3123","Nour EL MESKI","2","C","08c. Surgical site infections","Surveillance of surgical site infections: ten year experience of a tertiary care centre in Beirut","N. El Meski|C. Challita|T. Abdallah|N. Kara Zahreddine|T. Boyajian|J. Hobbalah|N. Rizk|S. S. Kanj"
"4309","15/04 12:00","16","P3124","Rohan TEWARI","2","C","08c. Surgical site infections","Surgical site infections after breast cancer surgery: a review of microbiology and antibiotic treatment","R. Tewari|A. O'brien|M. Gilmartin|A. Byrne|A. Murray|S. Thomas|K. Schaffer"
"4395","15/04 12:00","17","P3125","Romain MANCHON","2","C","08c. Surgical site infections","Delayed antibiotic therapy (DAT) in postoperative meningitis following vestibular schwannoma surgery is safe","R. Manchon|L. Alciato|J. Robert|J. Destoop|M. Kalamarides|V. Degos|A. Bleibtreu"
"5680","15/04 12:00","18","P3126","Nicolas JACQUET","2","C","08c. Surgical site infections","The impact of air temperature and humidity in the operating room on surgical site infections: ancillary analysis from the ARIBO² cluster randomised trial","N. Jacquet|L. Grammatico-Guillon|E. Tavernier|C. Gaborit|T. Haudebourg|N. Mauduit|C. Leux|D. Lepelletier|J. Lucet|P. Castel|B. Giraudeau|G. Birgand"
"5902","15/04 12:00","19","P3127","Karin ODOJ","2","C","08c. Surgical site infections","Surgical site infection surveillance in Europe: variability and challenges in a multicountry analysis","K. Odoj|D. Ortiz|J. Garlasco|C. Magnabosco|F. Manco|M. Pezzani|F. Arieti|E. Addis|O. Awwad|E. Tacconelli"
"6672","15/04 12:00","20","P3128","Sixtine JEUFFIN","2","C","08c. Surgical site infections","Nosocomial peritonitis in intensive care units: adherence to recommendations and antibiotic stewardship","S. Jeuffin|P. Delannoy|A. Vachee|H. Georges|P. Herbecq|A. Meybeck|P. Bortolotti"
"7364","15/04 12:00","21","P3129","Pascal ASTAGNEAU","2","C","08c. Surgical site infections","Evaluation of surgical antimicrobial prophylaxis by observation of practices: feasibility, results, interest and limits","D. Verjat-Trannoy|I. Arnaud|J. Auraix|I. Raclot|L. Font|N. Osinski|A. Vagneur|C. Didon|F. Moreau-Baumer|N. Ourdjini|P. Astagneau"
"7383","15/04 12:00","22","P3130","Alberto BORTOLASO","2","C","08c. Surgical site infections","Surveillance of surgical site infections: first-year experience at IRCCS Ospedale Policlinico San Martino, Genoa, northwest Italy","A. Bortolaso|F. Stella|C. Trombetta|D. Bonassi|B. Guglielmi|S. Guccini|A. Battistini|G. Icardi|M. Ogliastro"
"7609","15/04 12:00","23","P3131","Caren CHALLITA","2","C","08c. Surgical site infections","Trends and dynamics of multi-drug resistant organisms in surgical site infections in a low/middle income country","C. Challita|N. El-Meski|T. Abdallah|N. Rizk|J. Hobbalah|N. Haddad|R. Youssef|N. Zahredine|S. Kanj"
"1091","15/04 12:00","24","P3132","Thomas LODISE","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Comparative effectiveness of early treatment with ceftolozane/tazobactam vs polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA)","T. Lodise|J. Min|B. Nathanson|E. Yucel"
"1129","15/04 12:00","25","P3133","Yusuke WATANABE","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Prognosis of hospital-associated Legionella pneumonia in Japan: a comparison with community-acquired Legionella pneumonia","Y. Watanabe|R. Kikuchi|Y. Miura|I. Nakamura|H. Watanabe"
"1140","15/04 12:00","26","P3134","José Pedro CIDADE","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Negative bronchoalveolar lavage in critically ill patients with suspected ventilator-associated pneumonia: insights into prevalence and predictive factors (NEBULA study)","J. Cidade|H. Moreira|J. Fustiga|I. Medeiros|M. Paes|D. Sousa|P. Povoa"
"1144","15/04 12:00","27","P3135","Vettakkara Kandy Muhammed NIYAS","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Diagnostic performance the BioFire FilmArray pneumonia plus panel in hospital-acquired pneumonia and its impact on antibiotic use: experience from south India","L. Sreekumari Nair|V. Niyas|R. Ananthanarayanan"
"1286","15/04 12:00","28","P3136","Ran LI","2","C","08d. Healthcare-associated pneumonia (incl VAP)","The effectiveness and safety of combination of colistimethate sodium aerosol and injection in the treatment of pulmonary infection caused by resistant carbapenem-resistant Gram-negative bacterial: a multicentre, retrospective study","R. Li|Z. Gao|Y. Fu|G. Mu|C. Cheng|X. Gu|Y. Gu|C. Zhang|Y. Tao"
"1335","15/04 12:00","29","P3137","María Inés STANELONI","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Multiplex pneumonia panel as part of a multimodal strategy to optimise antibiotic treatment in ventilator-associated pneumonia","M. Burokas|C. Nemirovsky|N. Zuljevic|L. Ibanez|S. Di Stefano|M. Venuti|M. Visús|M. Sanchez|V. Stanek|M. Staneloni|E. Huaier Arriazu"
"1391","15/04 12:00","30","P3138","Kasra KIAROSTAMI","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Inhaled amikacin disrupts biofilm viability in experimental Pseudomonas-induced ventilator-associated pneumonia","K. Kiarostami|L. Fernandez-Barat|A. Motos|G. Li Bassi|R. Cabrera|M. Rigol|A. Torres"
"1714","15/04 12:00","31","P3139","Anita NOVAK","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Phenotypic and whole-genome sequencing-based antimicrobial resistance in Pseudomonas aeruginosa isolated from patients with ventilator-associated pneumonia and ventilator-associated tracheobronchitis in a Croatian intensive care unit","A. Novak|M. Cavka|J. Marinovic|I. Goic-Barisic|Z. Rubic|M. Radic-Skelin|M. Tonkic|M. Dzelalija|A. Maravic|M. Kvesic-Ivankovic|K. Milanovic|A. Saskor"
"1752","15/04 12:00","32","P3140","Chutchawan UNGTHAMMAKHUN","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Comparison of dual vs additional tigecycline in colistin-sulbactam regimen for treatment of extensively drug-resistant Acinetobacter baumannii pneumonia","P. Luengwattanakit|D. Changpradub|C. Ungthammakhun"
"3136","15/04 12:00","33","P3141","Diego ERDMENGER","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Treatment efficacy and cost analysis of tigecycline- vs meropenem-based regimens for MDR Acinetobacter baumannii pneumonia","A. Rosales|A. Barrios|D. Erdmenger|L. Rodriguez|J. Orozco|S. Aguilar|C. Arango"
"3369","15/04 12:00","34","P3142","Holly JACKSON","2","C","08d. Healthcare-associated pneumonia (incl VAP)","ECRAID's perpetual observational study on ventilator-associated pneumonia (POS-VAP): empirical treatment practices across Europe","H. Jackson|A. Hernandez Padilla|L. Vintcent|A. Barac|D. Garot|O. Cremer|L. Forcelledo|S. Negoita|O. Barraud|S. Harbarth|M. Bonten|B. François|C. Van Werkhoven|M. De Kraker"
"3606","15/04 12:00","35","P3143","Roberta MONARDO","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Impact of targeted treatment on mortality in patients with Stenotrophomonas maltophilia isolation from the respiratory tract: a propensity score-adjusted analysis","R. Monardo|C. Maci|A. Di Napoli|S. Carletti|C. Tassandin|P. Scarpellini|A. Castagna|M. Ripa"
"3628","15/04 12:00","36","P3144","Holly JACKSON","2","C","08d. Healthcare-associated pneumonia (incl VAP)","Trial vs real life definitions: evaluating ventilator-associated pneumonia criteria for VAP diagnosis and cure","A. Hernandez Padilla|H. Jackson|L. Vintcent|A. Barac|D. Garot|O. Cremer|L. Forcelledo|S. Negoita|S. Harbarth|M. Bonten|C. Van Werkhoven|M. De Karker|B. François"
"3708","15/04 12:00","1","P3145","Sean VAN HELDEN","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Clinical use of meropenem-vaborbactam in carbapenem-resistant Enterobacterales or Pseudomonas aeruginosa pneumonia","S. Van Helden|K. Caniff|C. Judd|T. Eubank|K. Garey|W. Kufel|T. Krekel|K. Tan|E. Chandler|J. Aramburo|D. Chatterji|S. Walker|C. Yost|J. Muscat|J. Andrade|J. Cerenzio|R. Karan|M. Veve|M. Rybak"
"4204","15/04 12:00","2","P3146","Nicola DE PASQUALE","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Blind lung ultrasound sweeps: a performant approach to diagnose pneumonia in long-term care facilities","N. De Pasquale|A. Roux|T. Brokowski|J. Wolleb|J. Luder|D. Vu|E. Rubli|T. Bizzozzero|C. Bessat|V. Suttels|M. Hartley|V. Prendki|N. Boillat-Blanco"
"4384","15/04 12:00","3","P3147","Mohammed AL MUSAWA","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Race against time: unraveling the impact of early ceftazidime/avibactam administration","M. Al Musawa|A. Kunz Coyne|C. Judd|K. Lucas|D. Holger|A. Althubyani|C. Slaton|E. Shald|M. Cabanilla|W. Kufel|B. Callan|M. Biagi|C. Jankowski|B. White|K. Molina|R. Mynatt|T. Eubank|C. Rux|C. Deri|R. Wrenn|S. Vandorf|V. Venugopalan|C. Orzol|J. Sassine|K. Caniff|S. Kang-Birken|M. Davis|T. Morrisette|M. Veve|M. Rybak"
"5383","15/04 12:00","4","P3148","Victoria MADIGAN","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Impact of electronic medical record implementation on hospital coding for non-ventilator healthcare-associated pneumonia as a hospital-acquired complication","V. Madigan|E. Kindred|D. Ling"
"5718","15/04 12:00","5","P3149","Marta COLANERI","3","C","08d. Healthcare-associated pneumonia (incl VAP)","VIP-VAP study: ventilator-associated pneumonia, a very invasive peril with high mortality in the ICU","M. Colaneri|M. Offer|G. Tricella|F. Dore|C. Genovese|G. Scaglione|E. Palomba|G. Montrucchio|G. Monti|F. Agostini|A. Gori|S. Finazzi"
"5861","15/04 12:00","6","P3150","Raquel GIRARDELLO","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Impact of oral health on ventilator associated pneumonia incidence in patients hospitalised in intensive care units","A. Palazzi|N. Rocha|K. Russi|M. Assis|F. Marson|L. Mendes|R. Girardello"
"6298","15/04 12:00","7","P3151","Alexia ROUX","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Clinical signs and host inflammatory biomarkers to guide antibiotics among nursing home residents with lower respiratory tract infections","A. Roux|N. De Pasquale|J. Luder|D. Vu|A. Niquille|E. Rubli|T. Bizzozzero|J. Sauser|A. Cassini|E. Glampedakis|T. Snäkä|T. Roger|V. Prendki|N. Boillat-Blanco"
"6870","15/04 12:00","8","P3152","Virve Irene ENNE","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Post hoc analyses of INHALE WP3: clinical outcomes from of a multi-centre RCT (INHALE) testing the utility of rapid multiplex PCR for hospital-acquired and ventilator-associated pneumonia in critical care","S. Stirling|J. Barber|J. High|D. Livermore|V. Gant|V. Enne"
"7129","15/04 12:00","9","P3153","Loïse PIQUEMAL","3","C","08d. Healthcare-associated pneumonia (incl VAP)","Impact of respiratory mPCR FilmArray on deep respiratory samples from patients colonised with extended-spectrum beta-lactamase-producing Enterobacterales","L. Piquemal|S. Lo|J. Dessajan|I. Lolom|M. Doman|E. De Montmollin|L. Bouadma|R. Sonneville|N. Peiffer-Smadja|E. Rondinaud|S. Gera|S. Kernéis|J. Timsit|M. Thy"
"536","15/04 12:00","10","P3154","Se Yoon PARK","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Numerical simulation of contaminant dispersion to prevent airborne infectious disease transmission in hospital wards","S. Park|G. Kim|S. Minki|J. Park"
"570","15/04 12:00","11","P3155","Andrea BÜCHLER","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Retrospective evaluation and proposed follow-up strategy for carriers of carbapenemase-producing Pseudomonas aeruginosa","A. Buchler|C. Haanappel|I. De Goeij|C. Klaassen|M. Vos|A. Voor In 't Holt|J. Severin"
"745","15/04 12:00","12","P3156","María Verónica PAZ","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa with difficult-to-treat resistance: is it safe to discontinue surveillance?","M. Paz|R. Alzola|L. D'agostino|F. Garibaldi|R. Orellana|M. Paniagua|A. Santillan"
"756","15/04 12:00","13","P3157","Shariful Amin SUMON","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Trends in healthcare-associated infections and antibiotic use in four urban hospitals in Bangladesh: results from a point prevalence assessment","S. Sumon|S. Sarker|G. Harun"
"797","15/04 12:00","14","P3158","Stephen HUGHES","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Utilising culture-based methods to monitor three Irish hospitals for antimicrobial resistant pathogens","S. Hughes|S. Carter|M. O'reilly|M. Gaffney|C. Collins|J. Mccarthy|B. O'brien|N. O'connell|A. Kearney|F. Walsh|S. O'donnell"
"802","15/04 12:00","15","P3159","Antonio GALLARDO-PIZARRO","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Rectal colonisation by multidrug-resistant Gram-negative bacteria identified in a surveillance programme and subsequent bacteraemia in haematologic patients","A. Gallardo-Pizarro|C. Lopera|O. Peyrony|P. Monzo-Gallo|T. Aiello|A. Martinez-Urrea|S. Herrera|A. Del Rio|C. Teijon-Lumbreras|M. Chumbita|C. Jimenez-Vicente|A. Cortes|M. Bodro|C. Pitart|E. Rubio|J. Mensa|A. Soriano|J. Martinez|C. Garcia-Vidal"
"866","15/04 12:00","16","P3160","Andrea BÜCHLER","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Follow-up strategies for carbapenemase-producing Gram-negative carriers are very variable: results from an international scoping survey","A. Buchler|A. Voor In 't Holt|H. Humphreys|J. Severin|M. Vos"
"1039","15/04 12:00","17","P3161","David RODRIGUEZ-TEMPORAL","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Automatic surveillance of Escherichia coli bacteriological strains within clinical settings","R. Rodriguez-Palomo|A. Guerrero-Lopez|C. Sevilla-Salcedo|D. Rodriguez-Temporal|B. Rodriguez-Sanchez|V. Gomez-Verdejo"
"1122","15/04 12:00","18","P3162","Rujipas SIRIJATUPHAT","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prevalence, characteristics, and mortality impact of bacterial superinfection in hospitalided patients with COVID-19 in Thailand","R. Sirijatuphat|K. Aramkul"
"1332","15/04 12:00","19","P3163","Jérôme ORY","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Multidrug-resistant microorganisms and toxigenic Clostridioides difficile: threats in nursing homes?","J. Ory|E. Rodriguez|L. Roux|M. Richardoz|T. Pastre|F. Salipante|C. Garau|J. Lavigne|H. Marchandin|A. Pantel"
"1341","15/04 12:00","20","P3164","Monika CHAUDHARY","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","An explorative analysis on hospital acquired infections in intensive care unit of a tertiary care hospital in LMIC: determining antimicrobial resistance and outcome determinants","D. Kumar|M. Chaudhary|G. Bohra|N. Midha|V. Tak|P. Bhatia|M. Garg"
"1402","15/04 12:00","21","P3165","Giovanni LORENZIN","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","E. faecium: marker of AMR spread and evolution in HAIs: adaptability of a new successful clonality","G. Lorenzin|P. Fassan|M. Sandei|C. Scarparo|A. Casadei"
"1433","15/04 12:00","22","P3166","Dorottya NAGY","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Epidemiological, microbiological, and genomic risk factors for hospital-associated carbapenemase-producing Enterobacterales (CPE) outbreaks: a systematic review","C. Barton-Sargeant|J. Yang|S. Hopkins|A. Walker|W. Matlock|A. Ledda|J. Robotham|S. Lipworth|N. Stoesser|D. Nagy|A. Baker"
"1447","15/04 12:00","23","P3167","Jack POLLARD","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Cost and clinical impact of IPC measures for CPE in hospitals: a cost-effectiveness model","J. Pollard|E. Agnew|D. Pople|T. Whiteley|K. Pouwels|N. Salant|J. Robotham"
"1551","15/04 12:00","24","P3168","Uga DUMPIS","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in a multi-room general intensive care unit","I. Jansone|I. Drjagunovs|E. Langusa|A. Bistrova|B. Dejus|M. Strods|T. Juhna|J. Kibilds|A. Cirulis|J. Avsejenko|M. Streikisa|L. Labecka|A. Berzins|D. Fridmanis|D. Gudra|A. Roga|E. Liepa|N. Zrelovs|K. Liepina|R. Vangravs|J. Bodrenko|G. Skenders|U. Dumpis"
"1565","15/04 12:00","25","P3169","Jae Lim JO","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Analysis of carbapenem-resistant Enterobacterales (CRE) positive rate in hospital water systems","J. Jo|J. Lee|Y. Lim|E. Kim|J. Jung|Y. Chong"
"1604","15/04 12:00","26","P3170","Dijana VARDA BRKIC","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Specific temporal patterns of bacterial pathogens responsible for healthcare-associated bloodstream infections in the intensive care unit and lack of significant impact on mortality","D. Varda Brkic|L. Kanizaj|Z. Herljevic|R. Radonic|A. Budimir|T. Kulis|I. Marekovic"
"1605","15/04 12:00","27","P3171","Margreet C. VOS","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Predictive value of rectal screening for multidrug-resistant organisms in duodenal fluid as a risk of duodenoscope contamination","K. Van Der Ploeg|S. Renkens|M. Vos|B. Mason-Slingerland|C. Klaassen|H. Rughwani|N. Reddy|S. Veturi|M. Sasikala|M. Bruno|J. Severin|S. Memon"
"1612","15/04 12:00","28","P3172","Margreet C. VOS","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prevalence and risk factors for multidrug-resistant organism carriage in patients undergoing endoscopic retrograde cholangiopancreatography: implications for duodenoscope contamination risk","K. Van Der Ploeg|M. Vos|J. Severin|B. Mason-Slingerland|M. Bruno|H. Rughwani|N. Reddy|S. Veturi|M. Sasikala|S. Memon|A. Repici|M. Spadaccini|M. Colombo|M. Andreozzi|B. Stevens|R. Das|A. Slivka"
"1711","15/04 12:00","29","P3173","Federica MARINO","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Improving microbiological monitoring of hospital surfaces: loop-mediated isothermal amplification (LAMP) as a new approach for rapid nosocomial pathogens detection","F. Marino|C. Bonincontro|L. Girolamini|C. Derelitto|L. Caligaris|S. Paghera|S. Cristino"
"1768","15/04 12:00","30","P3174","Michael EISENMANN","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","External validation of a tool to predict vancomycin-resistant enterococci colonisation persistence","M. Eisenmann|V. Rauschenberger|I. Kafetzis|M. Hofmann-Chittka|M. Krone|C. Böing|S. Kampmeier"
"1793","15/04 12:00","31","P3175","Chiara MINOTTI","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Pool-testing strategies to guide antibiotic resistant colonisation surveillance in European neonatal units","C. Minotti|D. Bräm|A. Cook|M. Berkell|J. Bielicki"
"1899","15/04 12:00","32","P3176","Florence CÔTÉ","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Neglected acquired-resistant or intrinsically-resistant Gram-negative bacteria in nosocomial infections: narrative review of epidemiological characteristics","F. Côté|C. Rodrigues"
"1946","15/04 12:00","33","P3177","Kyaw Zaw LINN","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Results from the 2nd National Point Prevalence Survey (PPS) of healthcare-associated infections (HAIs) among adult patients in Singapore","K. Linn|A. Lim|P. Wu|X. Huan|C. Tay|R. Lin|S. Tan|M. Soon Margaret|L. Sun|S. Pada|K. Thoon|M. Ling|A. Ty|D. Fisher|K. Marimuthu"
"1976","15/04 12:00","34","P3178","Gurkirat KAUR","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Sinks as hidden reservoir for nosocomial infections in critical areas","G. Kaur|M. Biswal|I. Sehgal|M. Kumar H.|N. Sharma|S. Vij"
"2279","15/04 12:00","35","P3179","Carlos KIFFER","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Effect of the COVID-19 pandemic on carbapenem resistance in Gram-negative bacilli: a temporal analysis","T. Rezende|A. Marinonio|D. Costa-Nobre|C. Kiffer"
"2353","15/04 12:00","36","P3180","Domenica FLURY","3","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","National point-prevalence study on healthcare-associated infections and antibiotic consumption in Swiss long-term care facilities","D. Flury|N. Bloch|C. Gardiol|E. Glampedakis|F. Grässli|S. Kessler|J. Kuhn|S. Kuster|V. Piezzi|T. Kudrovsky|P. Kohler"
"2356","15/04 12:00","1","P3181","Nur Syaza Iwani BINTE HAIDI FITRI","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Comparison of skin swabs and stool samples for carbapenemase gene detection","N. Binte Haidi Fitri|J. Lee|Z. Tan|K. Linn|X. Huan|K. Govindaraju|M. Foo|I. Bin Sazali|J. Chua|H. Koh|S. Tan|N. Smitasin|S. Ooi|T. Tan|M. Ling|S. Vasoo|P. Tambyah|O. Ng|K. Marimuthu"
"2359","15/04 12:00","2","P3182","Shiomi YOSHIDA","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Indirect transmission of Mycobacterium abscessus subsp. massiliense associated with dry fomites between severely disabled patients under tracheostomy management","S. Yoshida|S. Mitarai|K. Takemoto|S. Nakamura|Y. Matsumoto|T. Arai|T. Kobayashi|Y. Kurahara|Y. Tanaka|K. Tsuyuguchi"
"2360","15/04 12:00","3","P3183","Haiqun BAN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Contamination and control of environmental surfaces and personal protective equipments in dental clinics: a multi-centre study","J. Ding|M. Huang|Y. Shen|H. Ban|Y. Yang|E. Lu"
"2365","15/04 12:00","4","P3184","Aleece MACPHAIL","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Epidemiology of hospital acquired bloodstream infections in haemato-oncology units","A. Macphail|M. Chraiti|A. Nguyen|G. Catho|M. Zanella|V. Camus|L. Fortchantre|S. Masouridi-Levrat|D. Neofytos|Z. Mcquilten|S. Harbarth|N. Buetti"
"2372","15/04 12:00","5","P3185","Anne MUTSAERS- VAN OUDHEUSDEN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Methicillin-resistant Staphylococcus aureus (MRSA) among healthcare workers (HCWs) in contact tracings in two Dutch teaching hospitals, 2017-2023, prevalence and genetic relatedness","A. Mutsaers-Van Oudheusden|V. Weterings|M. Van Rijen|W. Van Den Bijllaardt|J. Tjhie|J. Murk|J. Verweij|J. Stohr"
"2478","15/04 12:00","6","P3186","Lieven VAN DER VELDEN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","An automated surveillance system for hospital-onset bacteraemia (HOB) in a Dutch teaching hospital","E. Ruijters|A. Dirks|F. Stals|L. van der Velden"
"2519","15/04 12:00","7","P3187","Elena HIDALGO CARDEÑOSO","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Water systems as a source of colonisation and infection with multidrug-resistant Pseudomonas aeruginosa in ICU patients","I. Alia-Robledo|Á. Iniesta-Martinez|A. Miján-Pérez|B. Fernández-Pacheco González De Echavarri|M. Sayalero-Martin|J. Oteo-Iglesias|D. Arana|E. Hidalgo-Cardenoso|M. Pérez-Vázquez"
"2634","15/04 12:00","8","P3188","Esther SIB","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Genomic evolution of Pseudomonas aeruginosa: a One Health longitudinal analysis in Germany, 2012-2023","E. Sib|A. Bari|S. Engelhart|B. Xavier|A. Voss|J. Rossen|N. Mutters"
"2665","15/04 12:00","9","P3189","Rosslyn MAYBANK","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Effect of foaming bleach treatment and staff training on the incidence of Pseudomonas aeruginosa hospital-acquired infections","M. Lindsay|M. Bint|A. Powell|T. Luo|Y. Kwak|A. Ong|R. Maybank|P. Mc Gann"
"499","15/04 12:00",,"P3190","Ronza NAJJAR-DEBBINY",,,"08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Evaluating decontamination interventions to control CPE transmission from sinks: a retrospective analysis","R. Najjar-Debbiny|R. Abdo|R. Yasin|M. Amar|A. Arbel|S. Shehade|O. Saleh|P. Shaked|G. Weber"
"2872","15/04 12:00","11","P3191","Ferenc Darius RUETHER","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Feasibility of automated surveillance of healthcare-associated infections in European hospitals","F. Ruether|M. Guedes|M. Van Mourik|E. Presterl|D. Plachouras|C. Suetens|S. Van Rooden"
"2918","15/04 12:00","12","P3192","Jordan CHASE","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Economic evaluation of PCR screening for MRSA in hospital settings","H. Folse|A. Pisent|K. Winter|C. Martinaud|J. Chase"
"3002","15/04 12:00","13","P3193","Vasin VASIKASIN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Quantifying the effects of different antibiotics on the emergence of carbapenem-resistant organisms through deep learning on a 12-year university hospital database","V. Vasikasin|D. Ming|B. Hernandez-Perez|N. Zhu|W. Nasomsong|A. Myall|A. Holmes|T. Rawson"
"3014","15/04 12:00","14","P3194","Ben ALFORD","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Monitoring antimicrobial resistance in care homes through wastewater surveillance: a scoping review","B. Alford|C. Hughes|D. Gilpin|J. Mcgrath"
"3216","15/04 12:00","15","P3195","Spyros POURNARAS","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Rising prevalence of carbapenem-resistant organisms (CRO) and vancomycin-resistant Enterococci (VRE) rectal carriage at a Greek university hospital","P. Karakosta|K. Thomas|P. Georgiou|A. Tarpatzi|S. Damianidou|E. Kalogeropoulou|A. Vasilakopoulou|S. Louka|G. Baziotis|O. Koutsopetra|A. Demetriou|I. Kouva|M. Kostoula|I. Kliani|M. Tsakona|E. Poulianou|E. Parlitsi|I. Tzolas|N. Frantzi|S. Karanikolas|P. Kazakou|D. Kavatha|A. Papadopoulos|S. Tsiodras|S. Pournaras|M. Vargiami"
"3257","15/04 12:00","16","P3196","Cristina MAGNABOSCO","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","The role of national surveillance in reducing healthcare-associated infections: a European analysis","C. Magnabosco|J. Garlasco|K. Odoj|F. Manco|M. Pezzani|F. Arieti|E. Addis|O. Awwad|E. Tacconelli|D. Ortiz"
"3314","15/04 12:00","17","P3197","Spyros POURNARAS","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Screening rectal swabs for carbapenemase genes in the emergency department: the role of active surveillance at admission in controlling nosocomial transmission","P. Karakosta|P. Georgiou|P. Kazakou|G. Baziotis|S. Louka|O. Koutsopetra|A. Demetriou|E. Kalogeropoulou|A. Tarpatzi|A. Vasilakopoulou|S. Damianidou|P. Tsilikis|A. Spiliopoulou|I. Kliani|M. Kostoula|M. Tsakona|E. Poulianou|K. Thomas|D. Kavatha|A. Papadopoulos|S. Tsiodras|S. Pournaras|S. Grigoropoulou|M. Siopi"
"3671","15/04 12:00","18","P3198","Miriam LATORRE-MILLÁN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Comparative study on SARS-CoV-2, influenza and RSV circulation in hospital healthcare workers, hospital patients, and sentinel network","M. Latorre-Millán|L. Clusa|A. Tristancho-Baro|D. Martinez|M. Alejandre|I. Ezpeleta|N. Terren|A. Milagro"
"3700","15/04 12:00","19","P3199","Esther CALBO SEBASTIÁN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Validation of a semiautomated surveillance system for spinal arthrodesis infections","A. Domingo Casino|C. Porta Naharro|L. Boix Palop|O. Monistrol Ruano|S. Álvarez Viciana|E. Calbo|M. Lopez Sanchez"
"3701","15/04 12:00","20","P3200","Céline SAKR","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Transmission pathways and ability of Stenotrophomonas maltophilia in the hospital environment: experience from a French university hospital","C. Sakr|M. Darty-Mercier|M. Danjean|F. Cizeau|D. Ducellier|S. Romano-Bertrand|J. Decousser"
"3702","15/04 12:00","21","P3201","Jade Leigh VAN RHEENEN","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Is adiabatic humidification a safe alternative for current humidification systems in hospitals?","J. Van Rheenen|A. Voor In 't Holt|J. Severin|B. Mason-Slingerland|J. Immerzeel|R. Van Mansfeld|J. Van Der Vossen|K. Kompatscher|R. Traversari|W. De Groot"
"3726","15/04 12:00","22","P3202","Anna NIKOPOULOU","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Strict compliance with the protocols and sustained surveillance of Candida auris can prevent the colonisation of the hospital","A. Nikopoulou|P. Skalisti|A. Veleni|S. Tselenkidou|G. Papatzikas|S. Gkiti|H. Katsifa|D. Sotiropoulos"
"3776","15/04 12:00","23","P3203","Yueqin HONG","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prospective surveillance on MRSA colonisation in a new ICU of a tertiary teaching hospital: exploring origins and transmission dynamics","Y. Hong|Y. Chen"
"3983","15/04 12:00","24","P3204","Merve MERT VAHABI","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","As one pandemic ends and another emerges: a sepsis point prevalence study in a tertiary care hospital","M. Mert Vahabi|O. Acet|S. Dirik|B. Kenanoglu|B. Özkara|D. Akdag|H. Erdem|O. Sipahi|B. Arda"
"4009","15/04 12:00","25","P3205","Arthur PRANADA","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Evaluation of Fourier-transform infrared spectroscopy (FTIR) for regular screening and monitoring of Gram-negative bacilli in two neonatal intensive care units","C. Hess|M. Cordovana|A. Pranada"
"4067","15/04 12:00","26","P3206","Zizheng ZHANG","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Predicting mortality in the next 24-hours in hospital patients using machine learning and electronic health records","Z. Zhang|A. Walker|D. Eyre"
"4093","15/04 12:00","27","P3207","Geetha NAGARAJ","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Decade-long surveillance for Klebsiella pneumoniae reveals carbapenem-resistant hypervirulent superbugs with highly transmissible plasmid in India","N. Geetha|V. Shamanna|R. Kl"
"4152","15/04 12:00","28","P3208","Vittoria MATTIONI MARCHETTI","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Genetic plurality of carbapenemases-producing Citrobacter spp. in central Italy: a three-year of persistent nosocomial circulation","V. Mattioni Marchetti|I. Bitar|I. Venturelli|T. Cassetti|M. Meschiari|M. Sarti|R. Migliavacca"
"4161","15/04 12:00","29","P3209","Katherine DEVER","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","whole-genome sequence analysis of environmental and healthcare associated Pseudomonas aeruginosa","K. Dever|E. Brown|G. Rothwell-Kelly|C. Herra|K. Schaffer"
"4230","15/04 12:00","30","P3210","Laura CZEKSTER ANTOCHEVIS","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Emergence of CC5-ST105-SCCmecII methicillin-resistant Staphylococcus aureus in healthcare-associated bloodstream infections in Brazil: results from the ASCENSION study","L. Antochevis|D. Castro|C. Wilhelm|P. Barth|J. Santos|L. Lutz|L. Sudbrack|L. Guimaraes|J. Telles|R. Leao|A. Coelho|A. Martins|V. Rocha|E. Mendes|A. Barth|A. Zavascki"
"4294","15/04 12:00","31","P3211","Rozemarijn ROERINK","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Innovative dashboard for early detection of outbreaks in the neonatal intensive care unit (NICU)","R. Roerink|M. Van Dams|M. Van Den Bos-Kromhout|E. D' Haens|M. Hemels|M. Juurlink|S. Debast"
"4363","15/04 12:00","32","P3212","Vera BLASCHKE","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","From the gut to the blood: comparative analysis of clinical vancomycin-resistant Enterococcus faecium (VREfm) in colonisation and infection","S. Kampmeier|V. Blaschke|V. Rauschenberger"
"4429","15/04 12:00","33","P3213","Aislinn COOK","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Risk factors for resistant bacterial colonisation in 24 European neonatal units in the NeoIPC project","A. Cook|M. Berkell|S. Malhotra|J. Bielicki"
"4447","15/04 12:00","34","P3214","Amy COOKE","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prevalence of carbapenemase-producing Pseudomonas stutzeri colonising hospital surfaces in low- and middle-income countries","S. Pervin|R. Farzana|N. Tasnim|K. Thomson|K. Sands|M. Nieto Toboso|L. Wilson|S. Langhorne|R. Farzana|B. Hassan|J. Rzaska|Y. Mohammed|J. Abubkar|O. Oduyebo|B. Ogunsanya|A. Aminu|M. Yusuf Ahmad|N. Medugu|T. Akujobi|I. N. Nwafia|I. N. Orabueze|T. Walsh|K. Iregbu|A. Cooke|C. Achi|E. Rashid|A. Rehman|R. Tariq|A. Shoaib|R. Temur|M. Babar|A. Sajid|R. Razzaq|A. Shah|A. Mehboob|S. Riaz|M. Hamid|R. Zahra"
"4496","15/04 12:00","35","P3215","Sara ARNAL LEAL","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","PCR vs conventional cultures: should we prioritise speed or reliability? A case study of an Enterococcus faecium vanB outbreak","S. Arnal|E. Alvarado|M. Riesgo Magana|H. Garcia|M. Sarvisé|C. Zumeta|L. Ruiz-Roldán|A. Achkir|M. Batallon|C. Valiente-Mullor|J. Bueno|C. Seral|I. Hernandez|F. González-Candelas"
"4648","15/04 12:00","36","P3216","Sarah BROWNING","4","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Disinfectant induced pitting corrosion: a potential culprit reservoir in stainless steel sink grates","S. Browning|J. Jennings|B. Mitchell"
"4772","15/04 12:00","1","P3217","Adesola OLALEKAN","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Bacterial pathogens of hospital effluents and point prevalence survey of antibiotics utilisation from public healthcare facilities in Lagos, Nigeria","A. Olalekan|S. Adesida|M. Sangare|K. Adebisi|M. Mannie-Udoh|O. Ojurongbe|O. Ogunleye|F. Agomma"
"4910","15/04 12:00","2","P3218","Brendan KELLY","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Impact of time post-hospitalisation on carbapenem-resistance among Enterobacterales infections","S. Xie|L. Cressman|M. Ziegler|B. Kelly"
"4988","15/04 12:00","3","P3219","Lilla BUZGÓ","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Third generation sequencing methods for infection control: lessons from a pilot study","L. Buzgo|V. Nagy|C. Freytag|N. Orosz|F. Bodnár|R. Bokenyne-Toth|L. Laczko|G. Kardos|G. Gömöri"
"5002","15/04 12:00","4","P3220","Valentina MENOZZI","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Preliminary results of a pre-post intervention study evaluating the impact of the introduction of screening for rectal colonisation by Enterobacterales resistant to fluoroquinolones (FQR-E) and third-generation cephalosporins (3GCR-E) in heamatological patients admitted to hospital","A. Candoni|M. Luppi|V. Menozzi|V. Todisco|R. Vescovini|F. Bettelli|A. Gilioli|M. Meschiari|M. Sarti|C. Mussini|E. Franceschini"
"5080","15/04 12:00","5","P3221","George Alexander BAZIOTIS","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Trends in intestinal colonisation and bloodstream infections by carbapenem-resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in an ICU: impact of enhanced infection control measures","G. Baziotis|P. Karakosta|P. Georgiou|S. Louka|A. Demetriou|O. Koutsopetra|E. Poulianou|F. Frantzeskaki|I. Tsagkaris|S. Pournaras|K. Tarpatzi|S. Damianidou|E. Kalogeropoulou|A. Vasilakopoulou|M. Vargiami|S. Vourli"
"5087","15/04 12:00","6","P3222","Davide STANGALINI","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Monitoring microbiological cleanliness in operating rooms: a comprehensive environmental sampling approach","D. Stangalini|F. Stangalini|A. Ragni|V. De Simone|S. Paghera"
"5088","15/04 12:00","7","P3223","Yu FENG","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","From stealth to spotlight, a new guest knocking at the door: MDR Klebsiella pneumoniae ST101-KL17 in clinical settings","J. Qin|Y. Feng|Y. Yang|Z. Zong"
"5227","15/04 12:00","8","P3224","Riccardo BOLLINI","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Rapid MRSA/MSSA surveillance: a seven-years dual molecular-cultural approach","R. Bollini|F. De Fazio|D. Bavaro|L. Bussini|R. Renzulli|S. Locatelli|V. Ciorba|S. Carloni|Z. Asif|G. Da Rin|M. Bartoletti|E. Casari|V. Cento"
"5342","15/04 12:00","9","P3225","Cornelis H. VAN WERKHOVEN","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","A simulation study of antimicrobial resistance carriage in neonatal intensive care units: implications for cluster-randomised trials","H. Van Werkhoven|M. Berkell|A. Cook|E. Sieswerda|S. Malhotra|J. Bielicki"
"5434","15/04 12:00","10","P3226","Aikaterini MOUGKOU","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","The effect of COVID-19 pandemic on healthcare-associated infections acquired in European intensive care units","A. Mougkou|T. Kärki|P. Märtin|P. Mitt|A. Agodi|S. Nunes|A. Marques|X. Nuvials-Casals|D. Plachouras"
"5526","15/04 12:00","11","P3227","Xavier BERTRAND","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Evaluation of sampling strategies for aquatic environment surveillance of Gram-negative multi-drug-resistant organisms in hospitals","M. Sauget|N. Hassoun-Kheir|J. Riger|K. Van Hoorde|A. Peleg|M. Paul|S. Harbarth|D. Hocquet|M. De Kraker|X. Bertrand"
"5641","15/04 12:00","12","P3228","Aikaterini MICHELAKI","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Risk of bloodstream infection due to rectal colonisation by multidrug-resistant bacteria and Serratia marcescens among intensive care unit neonates","A. Michelaki|G. Paradeisis|K. Spyridopoulou|E. Petridou|A. Stathi|E. Papapetrou|M. Matsouka|A. Karavassilis|L. Zachariadou"
"5679","15/04 12:00","13","P3229","Victoria WILLIAMS","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Do shared washrooms pose similar risk to shared rooms in transmission of respiratory viruses? A 13-year retrospective case-control study in a long-term care home","V. Williams|K. Volpentesta|M. Avaness|C. Chan|A. Kiss|S. Brachvogel|J. Leis"
"5863","15/04 12:00","14","P3230","Gianluca VRENNA","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Integrating breakthrough technologies to detect Candida tropicalis outbreaks: using the Fourier-transform infrared (FTIR) spectroscopy and validation by whole-genome sequencing","G. Vrenna|V. Fox|S. Raimondi|G. Foglietta|M. Rossitto|B. Lucignano|V. Cortazzo|M. Agosta|M. Pereyra Boza|M. Onori|L. Mancinelli|M. Argentieri|M. Cristiano|M. D'urbano|G. Ferri|V. Fini|A. Granaglia|A. Sisto|C. Perno|P. Bernaschi"
"5874","15/04 12:00","15","P3231","Tiffany SCHAUMBURG","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Digital, semi-automated surveillance of urinary tract infections (UTI) on the intensive care unit (ICU)","T. Schaumburg|S. Kolbe-Busch|N. Köhler|D. Hasenclever"
"5973","15/04 12:00","16","P3232","Sandra REUTER","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Double Carbapenemases in Klebsiella pneumoniae blood isolates: dissemination in a single medical centre by multiple plasmids-multiple lineages","A. Afolayan|A. Rigatou|E. Tatsi|I. Deliolanis|A. Michos|S. Reuter|G. Daikos"
"5979","15/04 12:00","17","P3233","Callebaut CALLEBAUT","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Investigating the use of MRSA sampling kits for enhancing Candida auris growth","K. Callebaut|T. Chin|K. Floré|M. Reynders|A. Muyldermans"
"6035","15/04 12:00","18","P3234","Inês RODRIGUES","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","How long can MDR bacteria circulate within a veterinary hospital setting? Apparently, at least three years!","I. Rodrigues|J. Prata|J. Campos|J. Ribeiro|Â. Pista|P. Martins Da Costa"
"6129","15/04 12:00","19","P3235","Koos KORSTEN","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Keep the hospital clean: diagnostic performance of ten different molecular and culture-based methods to detect Candidozyma auris","K. Korsten|B. Gerrits Van Den Ende|R. Pique|F. Hagen|K. Van Dijk"
"6240","15/04 12:00","20","P3236","Nicole SCHMIDT","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Long-term care facilities in focus: results of a point-prevalence study for healthcare-associated infections and antimicrobial use, Germany, 2024","N. Schmidt|A. Meinen|M. Arvand|T. Eckmanns|V. Marujo"
"6251","15/04 12:00","21","P3237","Elke LOOTS","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Development and validation of HABSI surveillance: insights and outcomes within a healthcare network","E. Loots|S. Van Goethem|E. Bernaert|M. Mul|P. Willems|K. Hofkens|K. Callewaert|R. Naesens"
"6524","15/04 12:00","22","P3238","María Inés STANELONI","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Containment of carbapenemase-producing carbapenem resistant Enterobacterales via implementation of the global action in healthcare network antimicrobial resistance module: the experience of Argentina and Chile, March 2022-October 2024","L. Alonso|A. Colque|L. Barcelona|A. Corso|F. Pasteran|P. Marchetti|C. Echave|I. Pagano|R. Smith|M. Staneloni|O. Mcgovern|D. Lower|M. Orsini|A. Villamil|J. Hormazabal|F. Morales Lopez|C. Rodriguez Mora|G. Romero Thomas|M. Galas|F. Otaiza|P. Ramon-Pardo"
"6564","15/04 12:00","23","P3239","Michael DAVID","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Staphylococcus aureus nasal colonisation in inpatient healthcare workers over a ten-month period","M. Hiehle|K. Hofstetter|B. Talbot|T. Read|M. David"
"6589","15/04 12:00","24","P3240","Diego ORTIZ","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Disrupted surveillance: COVID-19's impact on HAI reporting in Europe","D. Ortiz|K. Odoj|C. Magnabosco|J. Garlasco|F. Manco|M. Pezzani|F. Arieti|E. Addis|O. Awwad|E. Tacconelli"
"6610","15/04 12:00","25","P3241","Adriana JIMENEZ","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Sink drain disinfection at an academic hospital in south Florida: what does not work or partially works","W. Lamar|O. Alfonzo|T. Ferreira|B. Shukla|A. Jimenez|S. Arenas|K. Mokoban|P. Pronty|A. Talati|M. Kakani|E. Zagaynova|R. Arely|A. Williams"
"6636","15/04 12:00","26","P3242","Andree FRIEDL","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Ambient cough levels predict respiratory infection burden in the hospital","P. Tinschert|M. Groh|M. Wertli|A. Friedl|B. Wiggli"
"6836","15/04 12:00","27","P3243","Zhou WANGXIAO","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Reshaping the Battlefield: A Decade of Clonal Wars Among Staphylococcus aureus in China","Z. Wangxiao"
"6854","15/04 12:00","28","P3244","Ahneez ABDUL HAMEED","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Impact of weekly and monthly screening for carbapenemase-producing Enterobacterales in a high-risk speciality unit in a tertiary acute care hospital","A. Abdul Hameed|R. Thannikkal|A. Verma"
"6882","15/04 12:00","29","P3245","Chidiebere NDUBUEZE","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Genotypic profiling of Staphylococcus aureus in hopitalised patients in a tertiary care centre in Enugu, Nigeria","C. Ndubueze|I. Nwafia|U. Ozumba|S. Ebede|I. Orabueze"
"6987","15/04 12:00","30","P3246","Gauthier PEAN DE PONFILLY","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prevalence of MDRO digestive colonisation in lung transplant patients (preliminary results of the PORTAGREFFE study)","G. Péan De Ponfilly|S. Snoussi|A. Gigandon|G. Dauriat|A. Mizrahi|B. Pilmis|A. Le Monnier"
"7024","15/04 12:00","31","P3247","Yolanda SAENZ","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Prevalence of emerging antimicrobial resistant pathogens in a hospital food service","R. Lopez De Dicastillo|P. Toledano|G. Ros|Y. Sáenz"
"7048","15/04 12:00","32","P3248","Brigitta SCHNEIDER-PATKÓ","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Dissemination of VIM-producing Pseudomonas aeruginosa controlled by eliminating the environmental reservoirs","B. Schneider-Patko|K. Kovács|E. Urbán|Z. Lutz|A. Nyul|H. Fenyvesi|C. Csontos|E. Rauth|Á. Sonnevend"
"7051","15/04 12:00","33","P3249","Edgar WELLINGTON","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Data for action; sharing and automated reporting of healthcare associated infection surveillance data using the data capture system mirror database","E. Wellington|A. Sharma|D. Chudasama|Z. Chowdhury|R. Hope"
"7094","15/04 12:00","34","P3250","Eleni KALOGEROPOULOU","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","A point prevalence study to estimate the rate of asymptomatic carriage of toxigenic Clostridioides difficile in a tertiary academic hospital","E. Kalogeropoulou|P. Karakosta|K. Thomas|P. Georgiou|S. Louka|G. Baziotis|A. Demetriou|O. Koutsopetra|S. Damianidou|M. Kostoula|E. Oikonomoula|M. Vargiami|A. Alvanidi|A. Tarpatzi|A. Vasilakopoulou|F. Kontos|I. Kliani|M. Tsakona|E. Poulianou|P. Tsilikis|L. Tsaroucha|E. Emmanouilidou|G. Terpo|S. Steris|P. Kazakou|J. Meletiadis|D. Kavatha|A. Papadopoulos|S. Tsiodras|S. Pournaras"
"7429","15/04 12:00","35","P3251","Monika CHAUDHARY","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","A comparative analysis of clinical features, antibiotic treatment, and mortality in ICU patients admitted in a tertiary care centre of LMIC with and without hospital acquired infections","N. Midha|D. Kumar|M. Chaudhary|D. Meena|G. Bohra"
"7447","15/04 12:00","36","P3252","Gordon RAMAGE","5","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Investigating environmental and biocide survival of Candida auris through transcriptional profiling","G. Ramage|A. Ware|C. Delaney|W. Johnston|J. Butcher|R. Kean"
"7480","15/04 12:00","1","P3253","Hester KORTHALS ALTES","6","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Visualising livestock-associated (LA)-MRSA clustering based on whole-genome MLST (wgMLST) in patients from ten hospitals in southeast Netherlands","H. Korthals Altes|T. Habben Jansen|W. Schuch|W. Van Den Bijllaardt|P. Wever|A. Jansz|A. Hendrickx|M. Hermans|H. Wertheim"
"7506","15/04 12:00","2","P3254","Nagham Léa KHANAFER","6","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Fungal and bacterial aerobiocontamination in a renovated intensive care unit: an unexpected source","A. Regard|E. Richard|A. Malatray|C. Frno|E. Marion|J. Crozon-Clauzel|J. Dumes|P. Cassier|P. Vanhems|M. Madjou|N. Khanafer"
"7597","15/04 12:00","3","P3255","Ahneez ABDUL HAMEED","6","C","08e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)","Hidden reservoir for silent dissemination of carbapenemase producing enterobactereaceae: outbreak linked to endoscopic retrograde cholangiopancreatography duodenoscope","A. Verma|A. Abdul Hameed|R. Ben Salem|D. Joshi"
"221","15/04 12:00","4","P3256","William FRASER","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Potency, selectivity, and cytotoxicity of inhibitors of Clostridioides difficile","B. Rateb|T. Worthington|W. Fraser"
"480","15/04 12:00","5","P3257","Muammer ÇELIK","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Investigation of a Ralstonia pickettii bloodstream infection outbreak in heamatology-oncology patients","M. Çeli?k|U. Uysal|A. Cinar|Ö. Akin Yilmaz|S. Sahin|M. Öktem|Z. Kuruuzum"
"943","15/04 12:00","6","P3258","Lucy BRODIE","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Implementing a revised pathway for management of Clostridium difficile infections in adult inpatients: Leeds quality improvement initiative","J. Martin|L. Brodie|K. Sethi|K. Freimane"
"1423","15/04 12:00","7","P3259","Daniela JAVORSKÁ","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","The new frontier of Clostridioides difficile: increasing rates of community-acquired infections throughout the years","M. Novotny|D. Javorská|I. Hockicková|J. Hockicko|Z. Paralicova"
"1624","15/04 12:00","8","P3260","Lengsea ENG","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Clostridioides difficile infection in children visiting the outpatient department, Angkor hospital for children, Cambodia","L. Eng|P. Turner|D. Collins|K. Alene|S. Lim|P. Tan|S. Soeng|A. Clements|T. Riley"
"2042","15/04 12:00","9","P3261","Connor PROSTY","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Global practice variation on the use of secondary prophylaxis for Clostridioides difficile infections","C. Prosty|É. Bortolussi-Courval|J. Lee|T. Lee|E. Mcdonald"
"2194","15/04 12:00","10","P3262","Aye Chan OO","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","An evaluation of Clostridioides difficile testing outcomes and antibiotic usage at Coventry and Warwickshire pathology service (CWPS) following the publication of NICE guideline NG199 (23rd July 2021)","A. Oo|S. Laird|G. Athukorala|B. Shin"
"2382","15/04 12:00","11","P3263","Dafna YAHAV","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Antibiotic use and the risk of hospital-onset Clostridioides difficile infection: a cohort study of carriers and non-carriers","M. Gilboa|G. Regev-Yochay|E. Meltzer|I. Cohen|Y. Peretz|T. Zilberman|S. Amit|D. Yahav|N. Barda"
"2582","15/04 12:00","12","P3264","Néstor LÓPEZ GUERRA","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Development of a prognostic score for predicting Clostridioides difficile infection recurrences: a retrospective cohort study","S. Anguera|M. Espasa|M. Alvarez-Martinez|S. Herrera|I. Grafia|N. Lopez Guerra|V. Rico|E. Rubio|M. Bodro|G. Cuervo|C. Cardozo|J. Martinez|C. Casals-Pascual|B. González-Suarez|A. Soriano|P. Puerta-Alcalde|A. Vilalta"
"2889","15/04 12:00","13","P3265","Antonio CASCIO","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Burden of Clostridioides difficile infection and risk factors for recurrences in an Italian tertiary care university hospital: a prospective observational study","M. Gagliano|A. Medaglia|L. Pipito|G. D'agati|B. Catania|A. Cascio|A. Tuttolomondo|B. Cefalù|N. Scichilone|C. Cammà|M. Barbagallo|A. Licata"
"2945","15/04 12:00","14","P3266","Noor ZAIDAN","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Assessing recurrence rate of Clostridioides difficile infection in patients treated with a sequential combination of oral vancomycin and fidaxomicin","K. Amin|S. Ferren|N. Zaidan|R. Britt|D. Reynoso"
"2947","15/04 12:00","15","P3267","Emma MCGUIRE","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Management and outcomes of Clostridiodes difficile infection in a UK academic hospital: can we justify fidaxomicin as first-line treatment?","E. Mcguire|T. Sullivan|A. Lima Soares"
"2981","15/04 12:00","16","P3268","Rocco COLLARINO","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Association between antidepressants and C. difficile infection in elderly hospital patients","R. Collarino|E. Gullo|N. Brunetti|E. Duron|E. Baudouin"
"3056","15/04 12:00","17","P3269","Jung JONGTAK","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Genomic epidemiological investigation and effectiveness of multidisciplinary interventions in a multidrug-resistant Acinetobacter baumannii outbreak in a university hospital ICU","J. Jung|H. Park|S. An|S. Oh|Y. Jeong|J. Kim|Y. Baek|J. Kim|L. Eunjung|T. Kim"
"3117","15/04 12:00","18","P3270","Silvia Noemi VAZQUEZ CUESTA","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Update on antimicrobial susceptibility of Clostridioides difficile isolates in a Spanish university hospital","S. Vázquez-Cuesta|L. Alcalá|S. De La Villa|A. Alvarez-Uria|M. Marin|P. Munoz|E. Bouza|E. Reigadas"
"3134","15/04 12:00","19","P3271","Neelam TANEJA","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Genomic insights into virulence factors and antimicrobial resistance: emergence of hypervirulent Clostridiodes difficile from haematopoietic stem cell transplant (HSCT) patient, India","N. Taneja|I. Singh|N. Singh|H. Kaur|A. Mittal|A. Khadwal"
"3163","15/04 12:00","20","P3272","Teppo SALMINEN","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Lateral flow immunoassay based on upconverting nanoparticles for the diagnosis of Clostridioides difficile toxins","T. Salminen|K. Korpi|S. Koskela|T. Laaksoaho|J. Pyylampi"
"3353","15/04 12:00","21","P3273","Jasmin S. KUTTER","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Unravelling GII.17[P17] norovirus transmission clusters in two consecutive outbreaks in a Spanish hospital: a retrospective whole-genome analysis with implications for infection prevention and control","M. Cabrerizo Sanz|J. Kutter|O. Cuevas Lobato|B. Fernández-Pacheco González De Echavarri|C. Moreno Gomila|N. Garcia Ibanez|J. Camacho|E. Ruiz De Pedro|J. Alos|M. Dolores Fernandez-Garcia"
"3530","15/04 12:00","22","P3274","Sofia DE LA VILLA MARTINEZ","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Is immunosuppression associated with risk of recurrences in Clostridioides difficile infection?","S. De La Villa|A. Alvarez-Uria|L. Alcalá|S. Vázquez|E. Reigadas|M. Marin|P. Munoz|M. Machado|M. Valerio|E. Bouza"
"3772","15/04 12:00","23","P3275","Taryn EUBANK","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","High Enterococcus colonisation burden associated with severe Clostridioides difficile disease severity","T. Eubank|K. Begum|E. Basseres|T. Horvath|K. Garey"
"3831","15/04 12:00","24","P3276","Sabine PETERSDORF","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Candida auris outbreak investigation by Fourier transform infrared spectroscopy (FTIR)","S. Petersdorf|C. Hess|M. Cordovana|A. Aldejohann|A. Pranada"
"3905","15/04 12:00","25","P3277","Silke HUBER","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Rapid and reliable strain typing in a CC17 ST80 vancomycin-resistant Enterococcus faecium cluster in healthcare facilities in Tyrol, Austria","S. Huber|C. Bruhwasser|M. Govrins|S. Fuchs|C. Lass-Flörl"
"3931","15/04 12:00","26","P3278","Sara ARNAL LEAL","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","The vanB Operon: the elusive gene making Enterococcus faecium a sequencing challenge in the analysis of a nosocomial outbreak","S. Arnal|C. Valiente-Mullor|L. Ruiz-Roldán|J. Bueno|E. Alvarado|M. Riesgo Magana|H. Garcia|A. Achkir|M. Sarvisé|C. Zumeta|M. Batallon|C. Seral|F. González-Candelas"
"4466","15/04 12:00","27","P3279","Itxasne CABEZON","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Profile of patients treated with fidaxomicin in a tertiary hospital","R. Parra|C. Farinas|I. Cabezon|M. Insua|S. Garcia-Fernandez|A. Rodriguez-Fernandez|C. Ruiz De Alegria-Puig|C. Arminanzas|F. Arnaiz De Las Revillas|M. Fernández-Sampedro|M. Gutierrez-Cuadra|P. Runza|I. Iribarren"
"5060","15/04 12:00","28","P3280","Twishi SHRIMALI","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a tertiary care centre of western Rajasthan","T. Shrimali|V. Jain|T. Nare|V. Tak|N. Kothari"
"5090","15/04 12:00","29","P3281","Mairead SKALLY","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Patient satisfaction with infection prevention control practices in acute hospitals: a narrative review","M. Skally|A. Kearney|S. Rajesh|J. Strawbridge|K. Benett|H. Humphreys|F. Fitzpatrick"
"5144","15/04 12:00","30","P3282","Agnese COMELLI","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Klebsiella pneumoniae ESBL (KP-ESBL) bloodstream infection outbreak in a neonatal intensive care unit (NICU) in Bangui, Central African Republic (CAR)","A. Comelli|M. Ebode Ela|E. Danwesse|S. Manirarora|S. Nazita|J. Mafuko|A. Isango|G. Yasselet|G. Ndrouma|B. Tombola|V. Baimi Tao|O. Ogundipe|I. Baluhe Muke|A. Sepou|R. Ngbalé|F. Gordillo Gomez|C. Martino|A. Farra|M. Khalife|P. Garcia-Vello"
"5195","15/04 12:00","31","P3283","Letizia OTTINO","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Carbapenem-resistant Acinetobacter baumannii outbreak in a neonatal intensive care unit in Khost, Afghanistan","L. Ottino|M. Shinwari|L. Rahman|K. Bibi|P. Garcia-Vello|A. Farra|M. Khalife"
"5232","15/04 12:00","32","P3284","Jane FREEMAN","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Antimicrobial resistance in commonly-isolated Clostridioides difficile PCR-ribotypes","E. Clark|K. Kaur|W. Fawley|D. Jeyaratnam|C. Brown|R. Hope|M. Wilcox|J. Freeman"
"5245","15/04 12:00","33","P3285","Adriana CABAL ROSEL","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Genomic epidemiology of linezolid-resistant Staphylococcus epidermidis isolated during an outbreak in Austria, 2023-2024","A. Cabal Rosel|H. Kerschner|J. Weinberger|A. Stoeger|B. Daza Prieto|K. Lippert|P. Apfalter|W. Ruppitsch|R. Hartl"
"5457","15/04 12:00","34","P3286","Youssra MIKRAT","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Genomic insights into Clostridium butyricum strains causing a necrotising enterocolitis outbreak in a southern French hospital","Y. Mikrat|A. Adjamian|B. La Scola|N. Cassir"
"5477","15/04 12:00","35","P3287","Anna Paola CALLEGARO","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","A multiclonal outbreak of carbapenem-non-susceptible Pseudomonas aeruginosa in neonatal intensive care unit","C. Alteri|A. Teri|L. Corneo|M. Liporace|F. Salari|A. Ronchi|D. Mangioni|C. Pietrasanta|L. Terranova|M. Carnevale Schianca|B. Orena|L. Cariani|M. Bernazzani|A. Muscatello|F. Gentiloni Silverj|A. Bandera|M. Fumagalli|A. Callegaro"
"5603","15/04 12:00","36","P3288","Jaroslava ZÍKOVÁ","6","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Can heme-dependent metronidazole resistance in currently circulating Clostridioides difficile isolates be reliably detected?","J. Zikova|P. Drevinek|M. Krutova"
"5673","15/04 12:00","1","P3289","Iffat KHANUM","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Comparison of risk factors and outcome of culture-positive and culture-negative nosocomial meningitis in patients with neurosurgical procedures","F. Muhammad Ilyas|N. Nasir|I. Khanum|S. Muhammad Sethi|S. Batool"
"5696","15/04 12:00","2","P3290","Giovanna TRAVI","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Vancomycin-resistant Enterococcus outbreak in neonatal intensive care unit: a real concern?","N. Bana|C. Del Curto|M. Puoti|F. Crippa|C. Vismara|G. Travi|F. Peracchi|E. Nicolini|A. Busni|L. Tartaglione|A. Bielli|A. Proto|L. Mezzadri"
"5703","15/04 12:00","3","P3291","Dorothy LING","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Inappropriate diagnosis of hospital-associated urinary tract infections","D. Ling|E. Kindred|M. Sajeva|V. Madigan"
"5851","15/04 12:00","4","P3292","Matteo CERCHIARO","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Understanding the impact of healthcare-associated infections in paediatric ECMO: insights from an eight-year cohort study","M. Cerchiaro|C. Russo Artimagnella|M. Mariani|A. Giardina|E. Caci|E. Tavella|C. Saffioti|C. Micalizzi|D. Contu|E. Ricci|F. Febbo|E. Ugolotti|R. Bandettini|A. Moscatelli|E. Castagnola|A. Mesini"
"6192","15/04 12:00","5","P3293","Fátima GALÁN-SÁNCHEZ","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Nosocomial outbreak caused by Serratia marcescens in a neonatal intensive care unit: prolonged carrier status and bacteraemia as the most frequent clinical presentation","F. De La Rubia|Á. Franco|A. Alcantara|L. Lopez-Cerero|P. Pérez-Palacios|E. Recacha|E. Gonzalez-Rodriguez|Á. Pascual|M. Rodriguez-Iglesias|F. Galán Sánchez"
"6707","15/04 12:00","6","P3294","Fabian STANGL","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Infectious complications after transrectal vs. transperineal prostate biopsy: a systematic review and meta-analysis","F. Stangl"
"6924","15/04 12:00","7","P3295","Pietro VITALE","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Pseudomonas Oryzihabitans contaminating galenic preparation bags:description of a cluster of bloodstream infections at an Italian hospital","I. Spalliera|P. Vitale|A. Crea|L. Campogiani|B. Massa|R. Iannazzo|A. Altieri|C. D'agostini|M. Iannetta|V. Malagnino|L. Sarmati"
"7050","15/04 12:00","8","P3296","José-Manuel RAMOS-RINCÓN","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","The evolving burden of Clostridioides difficile infection hospitalisations in Spain (1997-2022): a sex-stratified perspective","J. Ramos-Rincon|P. González-De-La-Aleja|R. Herrero-Del-Rio|M. Rodriguez-Fernandez|J. Rodriguez-Diaz|M. Valverde-Fredet-Ruiz|J. Sánchez-Paya|N. Merchante|E. Merino"
"7558","15/04 12:00","9","P3297","Fangfei LIU","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","First pseudobacteraemia outbreak of Achromobacter xylosoxidans in paediatric ward in China","F. Liu|W. Zingg|K. Lei|Y. Wu|J. Wang|C. Zhang"
"7634","15/04 12:00","10","P3298","Itxasne CABEZON","7","C","08f. Other healthcare associated infections (incl CDI, hospital outbreaks)","Evaluation of the management of Clostridioides difficile infection in a tertiary care hospital","M. Insua|I. Iribarren|I. Cabezon"
"516","15/04 12:00","11","P3299","Mohammad Naeem LAKANWALL","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","How Afghanistan is tackling infection control: an in-depth evaluation of practices and strategies","M. Lakanwall|P. Katyara|R. Rozina|S. Mahmood|R. Hareem|M. Karima|I. Heweidy|M. Hamuda"
"1268","15/04 12:00","12","P3300","Allie Yin LIM","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Assessing the impact of the COVID-19 pandemic on the implementation of transmission-based precautions across five acute care hospitals in Singapore","A. Lim|K. Linn|X. Huan|R. Lin|S. Tan|M. Soon|Margaret|L. Sun|S. Kaur|K. Thoon|M. Ling|D. Fisher|K. Marimuthu|A. Ty|P. Wu|C. Tay"
"1355","15/04 12:00","13","P3301","Cristina ORTEGA-PORTAS","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Polyurethane aerogels doped with modified SiO2 particles: advanced materials with antibacterial properties for healthcare applications","C. Ortega-Portas|E. Pinilla-Penalver|L. Sánchez-Silva|E. Torrecilla-Sádaba|L. Trallero-Calvo|J. Esteban|J. Aguilera-Correa"
"1559","15/04 12:00","14","P3302","Jae Lim JO","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Evaluation of effectiveness of enhanced environmental interventions in healthcare settings","J. Jo|H. Kim|M. Yun|Y. Lim|E. Kim|J. Jung|Y. Chong|J. Kim"
"1896","15/04 12:00","15","P3303","Florence CÔTÉ","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Infection prevention and control interventions for hospital-acquired infections by neglected Gram-negative bacteria: systematic review of the literature","F. Côté|C. Jeena|C. Rodrigues"
"2292","15/04 12:00","16","P3304","Jang Wook SOHN","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Effect of daily pillow-cover replacement on the incidence of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care units (MICU): a comparative study","J. Suh|K. Yang|J. Kim|Y. Yoon|J. Sohn"
"2294","15/04 12:00","17","P3305","Itaru NAKAMURA","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Reduction of bacteraemia in an intensive care unit using heating devices to mitigate sink drainpipe contamination","I. Nakamura|A. Okugawa|S. Tomihide|Y. Miura|T. Yamaguchi|H. Watanabe"
"2844","15/04 12:00","18","P3306","Ashlesha SONPAR","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Incidence of hospital acquired infections due to multidrug-resistant microorganisms: preliminary baseline results from REVERSE","A. Sonpar|G. Daikos|A. Hristea|J. Rodgriguez-Bano|E. Tacconelli|A. Sonpar|W. Zingg|E. Carrara|P. Retamar-Gentil"
"3121","15/04 12:00","19","P3307","Diego ERDMENGER","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Evaluating the effectiveness of cleaning and educational interventions on osteomyelitis rates in a high-risk unit","I. Cazali|D. Erdmenger|M. Sapon|I. Gudiel"
"3575","15/04 12:00","20","P3308","Matteo MORRA","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Enzymatic debridement with bromelain does not increase bloodstream infection risk in burn patients: a propensity score-matched cohort study","M. Pezzani|J. Minic|M. Morra|M. Governa|E. Tacconelli"
"3849","15/04 12:00","21","P3309","Nicholas ANGELINO","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Patient perspectives regarding the use of contact precautions and risk-based contact precaution policies for MRSA across two hospitals: patients are in favour of contact precautions","N. Angelino|L. O'hara|M. Bahr|M. Newman|L. Pineles|G. Schrank|A. Harris"
"3946","15/04 12:00","22","P3310","Jo MCEWEN","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Improving outcomes for people admitted to hospital with UTI/CAUTI: a quality improvement project","J. Mcewen|H. Kennedy|D. Shepherd|M. Steven|P. Davidson|O. Davidson|A. Davie|B. Parcell|B. Mooka|C. Marwick"
"4036","15/04 12:00","23","P3311","Vanessa WONG","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Artificial intelligence (AI) technology-based hand hygiene scanners introduced to improve hand hygiene at a tertiary healthcare centre in the United Kingdom","V. Wong|T. Bonnage|D. Enoch|C. Moody"
"4042","15/04 12:00","24","P3312","Chloé SCHLAEPPI","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Infection prevention and control interventions in neonatal and paediatric intensive care units to reduce nosocomial bacterial infections: a systematic review","C. Schlaeppi|C. Minotti|J. Bielicki"
"4362","15/04 12:00","25","P3313","Daiana GUEVARA-NUÑEZ","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Impact of lyophilisation on firmicutes/bacteroidota ratio for faecal microbiota transplantation","D. Guevara-Nunez|L. Saiz-Escobedo|A. Carrera-Salinas|L. Rodriguez|M. Bonilla|A. Gonzalez-Diaz|C. Arajol|J. Guardiola|M. Dominguez|S. Marti"
"4488","15/04 12:00","26","P3314","Maria Diletta PEZZANI","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Gaps in outbreak reporting: an analysis of infection prevention and control measures in European healthcare settings","M. Pezzani|F. Manco|F. Arieti|J. Garlasco|E. Cappelli|K. Odoj|D. Ortiz|C. Magnabosco|E. Addis|O. Awwad|E. Tacconelli"
"4819","15/04 12:00","27","P3315","Ili MARGALIT","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Impact of cohorting carbapenem-resistant Acinetobacter baumannii (CRAB) patients on CRAB BSI: a prospective surveillance-based study","I. Margalit|N. Pinas-Zade|A. Fridlin|B. Mechnik|Y. Peretz|H. Jaber|R. Rapaport|Y. Weiss-Ottolenghi|M. Brod|I. Ben-Zvi|S. Amit|Y. Levy|N. Barda|H. Yonath|G. Regev-Yochay"
"4892","15/04 12:00","28","P3316","Anna ERINGFÄLT","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Encapsulated faecal microbiota transplantation: a comparison of three preparation protocols","A. Eringfält|R. Persson|L. Arvidsson|M. Cassel Johansson|J. Undén|A. Kötz|E. Löfström"
"5374","15/04 12:00","29","P3317","Christoph SENGES","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Factors influencing hand hygiene quality in functional units","F. Oppenheimer|M. Laatzen|C. Herzer|H. Niesalla|S. Christoph"
"6040","15/04 12:00","30","P3318","Helena DUERING","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","UV-C LED irradiation to inactivate antibiotic resistance-conferring genes on mobile genetic elements","H. Duering|C. Stein|T. Westerhoff|F. Kipp"
"6059","15/04 12:00","31","P3319","Benjamin PARCELL","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Reducing the risk of spread of airborne and surface pathogens in healthcare practice","B. Parcell|C. Papadopoulou|R. Bacchetti|J. Sixsmith|W. Mackay|K. Cheesbrough"
"6637","15/04 12:00","32","P3320","Taweegrit SIRIPONGBOONSITTI","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Impact of culture-based active surveillance on carbapenem-resistant Enterobacteriaceae control among high-risk patients before hospital admission","T. Siripongboonsitti|M. Muadchimkaew|S. Wongpatcharawarakul|M. Harnphadungkit|P. Payoong|J. Buppanharun|C. Boonsankaew|K. Tawinprai|D. Jintanothaitavorn|K. Soonklang"
"6654","15/04 12:00","33","P3321","Ananth Ram K J","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Rising burden of Candida auris in LMICs: implementing a targeted bundle for infection prevention and control","A. K. J.|M. Moni|D. T. S.|P. Prasanna|P. B.|A. Venugopal"
"6966","15/04 12:00","34","P3322","Benjamin PARCELL","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Reduction in bacterial and fungal total viable counts by air purification across five sites in a large teaching hospital","S. Reid|E. Eadie|K. Bedair|K. Cheesbrough|B. Parcell"
"7576","15/04 12:00","35","P3323","Mahmoud HAMOUDA","7","C","08g. Infection control interventions and trials (incl microbiota transplantation)","Infection prevention and control (IPC) situation analysis during Marburg outbreak in Kigali, Rwanda 2024 using WHO IPC&WASH HERO checklist","M. Hamouda|A. Mukamunana|A. Rukundo|J. Ntihumbya|M. Tharcisse|C. Ndayisaba|I. Rugaravu|E. Rwagasore|H. Valois|B. Rwagitinywa|B. Chirombo|A. Baller|B. Hakizimana|C. Mukashema|B. Ndoye|W. Bakare|E. Hornsey|G. Rutayisire Karonkano|C. Philbert|A. Zimurinda"
"151","15/04 12:00","36","P3324","Marta DÍAZ-NAVARRO","7","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Management of healthcare-associated infections (HAI) caused by biofilm through UV-C irradiation","F. Palma|M. Diaz-Navarro|A. Visedo|G. Fiorella Schiavano|P. Munoz|P. Sanz-Ruiz|M. Guembe"
"886","15/04 12:00","1","P3325","Camila BRUNA","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Comparative microbiological analysis between different types of privacy curtains using three sampling methods","C. Bruna|C. Silva|K. Graziano"
"1182","15/04 12:00","2","P3326","Natalia Marta ZMARLAK-FEHER","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Tolerance of Candida auris biofilms to disinfectants","A. Richter|A. Finke|M. Arvand|N. Zmarlak-Feher|C. Schaudinn"
"1416","15/04 12:00","3","P3327","Valeria ALLIZOND","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Evaluating povidone-iodine irrigation as an intraoperative strategy to decrease bacterial contamination in shoulder arthroplasty: preliminary results","F. Menotti|F. Longo|E. Bellato|A. Bondi|C. Pagano|C. Costa|A. Curtoni|L. Cavallo|N. Mandras|F. Castoldi|D. Blonna|G. Vasario|G. Banche|V. Allizond"
"1856","15/04 12:00","4","P3328","Catarina GERALDES","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Influence of sub-MIC concentrations of chlorohexidine on enterococcal biofilms: a preliminary study","C. Geraldes|A. Pinheiro|G. Pereira|L. Chambel|S. Gil|L. Tavares|M. Oliveira"
"2515","15/04 12:00","5","P3329","Diana CERBU","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Octenidine-based antiseptics significantly reduce Candida auris burden on ex vivo human skin","D. Cerbu|S. Seiser|T. Phan-Canh|D. Moser|C. Freystätter|J. Matiasek|K. Kuchler|A. Elbe-Burger"
"2845","15/04 12:00","6","P3330","Becky SMITH","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Enhanced terminal room disinfection with UV-C: a post hoc analysis of outcomes from the BETR disinfection trial","B. Smith|D. Schaps|B. Warren|E. Sickbert-Bennett|D. Weber|Y. Lokhnygina|D. Anderson"
"4919","15/04 12:00","7","P3331","Andreea-Maria PÎNDARU","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Genetic basis of disinfectant tolerance and antimicrobial efficacy against clinical pathogenic strains","A. Pindaru|L. Marutescu|C. Chifiriuc|M. Popa|I. Barbu"
"5431","15/04 12:00","8","P3332","Heide NIESALLA","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Analysis of the material of ready-to-use disinfection wipes for surface disinfection and their impact on patient safety","M. Krewing|C. Noderer|C. Linke|H. Niesalla"
"6231","15/04 12:00","9","P3333","Caroline Lopes CIOFI-SILVA","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Qualify of cleaning in operating rooms: evaluating to improve","J. Munhoz|M. Donisete Pressato Junior|C. Quartim De Morais Bruna|F. Andrade De Oliveira|A. Zaninelli Schreiber|C. Lopes Ciofi-Silva"
"6290","15/04 12:00","10","P3334","Sophie LOEFFERT-FRÉMIOT","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Poliovirus on the sidelines! Who will be the replacement?","S. Loeffert-Frémiot|C. Pluchart"
"6864","15/04 12:00","11","P3335","Lukas BOUVIER-AZULA","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","The influence of floor heating on surface disinfectant's efficacy against clinical strains of Streptococcus pyogenes in comparison to reference bacteria","L. Bouvier-Azula|B. Leeb-Zatorska|M. Diab-El-Schahawi|J. Willesberger|E. Presterl"
"6915","15/04 12:00","12","P3336","Edit ZSOLDINÉ URBÁN","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","The antimicrobial effect of oral antiseptic solutions on the healthy and parodonthopatogenic oral microbiome","A. Nagy|Á. Bán|E. Urbán"
"7344","15/04 12:00","13","P3337","Katarina KOVAC","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","Is there correlation between high chlorhexidine digluconate MIC and high octenidine dihydrochloride MIC?","K. Kovac|D. Ribaric|J. Germ|M. Pirs"
"7565","15/04 12:00","14","P3338","Katrien VAN CROMBRUGGE","8","C","08h. Disinfection & sterilisation (incl medical device reprocessing)","The evaluation of a disinfection protocol for dental unit water lines contaminated with Mycobacterium abscessus and other nontuberculous mycobacteria","K. Van Crombrugge|I. Leroux-Roels|S. De Turck|T. Tesch|K. Claus|S. Verhofstede|K. Stevens"
"113","15/04 12:00","15","P3339","Lara PFUDERER","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","DNA for safety: using DNA loaded nanoparticles to evaluate doffing procedures for high-risk pathogens","L. Pfuderer|A. Luescher|A. Friedl|R. Grass|B. Wiggli"
"500","15/04 12:00","16","P3340","Fakhra IKHLAQ","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Burnout and hand hygiene: investigating the link among nurses at university teaching hospital, Birmingham U.K","F. Ikhlaq"
"4092","15/04 12:00",,"P3341","Netto MUNDADAN",,,"08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","A questionnaire-based approach for identification and labelling of multi-drug resistant Gram-negative bacilli (MDR-GNB) as colonisers in specimens from bone and joint infections: a clinical stewardship strategy","N. Mundadan|M. Rose|B. Fenn|K. S|A. Anslem|A. Gurudas|J. John|S. R|N. Babu|V. Mayan"
"1216","15/04 12:00","18","P3342","Marlies HULSCHER","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Moral tensions in MDRO care: a qualitative study on experiences of healthcare providers in hospitals and nursing homes","A. Oerlemans|M. Knippenberg|J. Van Gurp|M. Hulscher|J. Ten Oever|C. Damsté-Wijgman"
"1270","15/04 12:00","19","P3343","Xiaowei HUAN","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Non-medically trained executives (NMTEs) for device-associated infections (DAIs) surveillance in intensive care units (ICUs)","P. Wu|C. Tay|A. Ty|X. Huan|A. Lim|K. Linn|R. Lin|S. Tan|M. Soon|L. Sun|S. Kaur|K. Thoon|M. Ling|D. Fisher|K. Marimuthu"
"1901","15/04 12:00","20","P3344","Florence CÔTÉ","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","The main infection prevention and control guidelines on carbapenem-resistant-(CRE) and extended-spectrum-beta-lactamase-enterobacteriaceae (ESBL-E) overwhelmingly rely on limited Escherichia coli and Klebsiella pneumoniae evidence","F. Côté|C. Rodrigues"
"2116","15/04 12:00","21","P3345","Luigi DE MARIA","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Scabies outbreak among healthcare workers in a large Italian university hospital: from occupational risk management to the development of a public health prevention strategy","L. De Maria|G. Delvecchio|G. Sifanno|P. Danza|L. Vimercati"
"2409","15/04 12:00","22","P3346","Katerina FISEROVÁ","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among medical students","K. Fiserova|M. Htoutou Sedláková|K. Hricová|R. Karpiskova|M. Kolar|V. Pudová|K. Brodikova"
"2815","15/04 12:00","23","P3347","Roberta PAPAGNI","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Knowledge, practices, educational needs, and hospital engagement in Infection Prevention and Control (IPC) among Italian healthcare workers and students: results from a national multicentre survey","F. Di Gennaro|F. Segala|R. Papagni|E. De Vita|G. Guido|L. Frallonardo|A. Vigna|M. Fiorella|D. Capruzzi|M. Cibelli|A. Ritacco|F. De Palo|L. Pisani|P. Locantore|A. Tolin|F. Penco|M. Meschiari|R. Murri|M. Fantoni|C. Mussini|A. Saracino"
"2893","15/04 12:00","24","P3348","Max MAYERHÖFER","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","COVID-19 and influenza: a look at healthcare workers` vaccination intention ahead of the upcoming 2024/2025 winter season","M. Mayerhöfer|A. Gabel|M. Krone|I. Wagenhäuser|N. Petri|J. Mees|H. Muller|C. Lange|S. Kampmeier"
"3178","15/04 12:00","25","P3349","Kulakkattil ABDUL GHAFUR","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","I am responsible: a campaign for accountability in hand hygiene to contain infection outbreaks in critical care units","W. Mohammed|A. Ghafur|S. Avinash|V. Vasudevan|G. Sarlin"
"3713","15/04 12:00","26","P3350","Miriam LATORRE-MILLÁN","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","COVID-19 vaccination coverage in a Spanish hospital healthcare workers, 2021-2024","M. Latorre-Millán|L. Clusa|A. Tristancho-Baro|I. Ezpeleta|N. Terren|A. Rezusta|A. Milagro"
"3814","15/04 12:00","27","P3351","Miriam LATORRE-MILLÁN","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Pre-campaign assessment of reluctance and motivation to vaccinate against influenza in Spanish primary care healthcare worker","M. Latorre-Millán|I. Ezpeleta|J. Álvarez-Zárate|L. Clusa|M. Garcia-Vazquez|A. Cebollada|A. Rezusta|A. Milagro"
"7286","15/04 12:00",,"P3352","Leander PERZ",,,"08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Overall incidence and risk factors for SSI after CABG surgery: a retrospective data analysis","L. Perz|R. Ristl|E. Presterl"
"4540","15/04 12:00","29","P3353","Manuel KRONE","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Tracking SARS-CoV-2 immunity in healthcare workers throughout the COVID-19 pandemic","I. Wagenhäuser|J. Reusch|J. Mees|A. Gabel|N. Petri|M. Krone"
"5077","15/04 12:00","30","P3354","Keiko SUZUKI","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Trends in personal protective equipment usage among healthcare workers before, during, and after the COVID-19 pandemic: a multi-year survey in Japan","K. Suzuki|E. Pearson|N. Tetsuka"
"5380","15/04 12:00","31","P3355","Giulia BRIGADOI","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Healthcare workers' engagement and satisfaction with an online training for infection prevention and control and antimicrobial stewardship (the TEAM-COACH project)","M. Aboza|G. Tsopela|D. Donà|O. Neth|L. Cantarutti|C. Giaquinto|A. Gâchet|Á. Ballesteros|S. Dominguez|L. Manukyan|P. Rojo|C. Epalza|G. Brigadoi|I. Kopsidas|E. Barbieri|S. Villaverde|W. Goycoechea|M. Bason|D. Kousi|A. Arias"
"5386","15/04 12:00","32","P3356","Dr Nadia NOREEN","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Collaborative development of the national action plan for health security (NAPHS) in Pakistan: lessons learned post-joint external evaluation (JEE-2023)","N. Noreen"
"5563","15/04 12:00","33","P3357","Nneoma ENEKWA","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Aseptic technique in central line blood culture collection on the critical care unit reduces contamination: fact or fiction?","N. Enekwa|P. Jumaa|G. Bonnici|W. Tunnicliffe|I. Kilic"
"5735","15/04 12:00","34","P3358","Hannah HAMILTON HURWITZ","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Barriers and facilitators to quarantine and isolation measures for epidemic and pandemic-prone acute respiratory infections: a qualitative evidence synthesis","D. Arikpo|H. Hamilton Hurwitz|V. Gusmao|M. Padoveze|D. Dixit|A. Baller"
"5832","15/04 12:00","35","P3359","Sun Hee LEE","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Temporal trends in the incidence rate of occupational exposure to blood and body fluid during the COVID-19 pandemic in a tertiary care hospital in Korea","S. Lee|S. Lee|H. Jang|N. Park|J. Lee|S. Lee"
"5835","15/04 12:00","36","P3360","Elaine BELL","8","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","A curriculum of online education significantly improved physicians' knowledge, competence and confidence in prevention of respiratory infections throughout the life course continuum","E. Bell|S. Voorn|G. Kassianos"
"5910","15/04 12:00","1","P3361","Flora KONTOPIDOU","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","The impact of a hand hygiene (HH) programme on healthcare professionals' compliance in a Greek hospital","F. Kontopidou|M. Antonopoulou|O. Koutantelia|A. Votsi|A. Pyroti|Z. Chasapidou|E. Stathopoulou|V. Bereri|A. Pavli|G. Daikos"
"6265","15/04 12:00","2","P3362","S M Murshid HASAN","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Healthcare practitioners' infection prevention strategies and associated factors in primary healthcare facilities of Rohingya refugee camps in Bangladesh: a qualitative study","S. Hasan|S. Prema"
"6523","15/04 12:00","3","P3363","Chen CHII-SHYA","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Factors influencing COVID-19 infection stress levels and attitudes toward COVID-19 vaccination among hospital staff in the post-pandemic period","C. Chen|I. Chen"
"6591","15/04 12:00","4","P3364","Rabie Adel EL ARAB","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Advances in artificial intelligence for hospital-acquired infection control: an umbrella review","Z. Abdulaziz|R. El Arab"
"6794","15/04 12:00","5","P3365","Chen IAN-HORNG","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Comparing factors influencing hesitancy toward influenza vaccination and COVID-19 vaccination among hospital staff","I. Chen|C. Chen"
"6932","15/04 12:00","6","P3366","Deepti KC","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Experiences of nurses in implementing infection prevention and control guidelines during the COVID-19 pandemic in Nepal and Scotland","D. K.C.|V. Ness|J. Smith"
"7284","15/04 12:00","7","P3367","Nabeela MUGHAL","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Optimising training and concordance to alcohol-based hand rub hand-hygiene using digital health technology image analysis","N. Mughal|Z. Tzouros|M. Castillo|A. Heath|J. Flor|J. Lucas|S. Clarke|S. Pothen|M. Olivar|M. Dineen|S. Denny|L. Moore|H. Donaldson"
"7372","15/04 12:00","8","P3368","Nabeela MUGHAL","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","A qualitative review of infection prevention and control teaching in undergraduate medical students, perceptions, influences and behaviours","N. Mughal|J. Horsburgh"
"7376","15/04 12:00","9","P3369","Petros IOANNOU","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Mapping hand hygiene infrastructure in public hospitals in Crete, Greece","E. Astrinaki|E. Kritsotakis|D. Kofteridis|P. Ioannou"
"7413","15/04 12:00","10","P3370","Anna SCHWABE","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","The importance of personal protective equipment in dental treatments regarding airborne transmission","N. Zacharias|A. Schwabe|R. Cosgarea|S. Jepsen|N. Mutters"
"7481","15/04 12:00","11","P3371","Imran HASANOGLU","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Protecting the protectors: an evaluation of healthcare workers' preparedness against blood-borne pathogens","B. Kaplan|R. Guner|I. Hasanoglu|F. Eser|A. Kaya|B. Kayaaslan"
"7495","15/04 12:00","12","P3372","April BALLER","9","C","08i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)","Barriers and enablers for implementing infection prevention and control in the context of infectious disease outbreaks","M. Padoveze|L. Cordeiro|K. Shaw|S. Mearns|A. Coutinho-Rehse|A. Baller"
"4803","15/04 12:00","1","P3841","Haritha MADIGUBBA","1","A","12a. Professional affairs and career development","Building microbiology expertise: training laboratory technicians in a newly established hospital setting","H. Madigubba"
"5629","15/04 12:00","2","P3842","Rosy RAJU","1","A","12a. Professional affairs and career development","Impact of educational intervention on antimicrobial resistance awareness among community pharmacists","R. Raju|S. Malavalli Siddalingegowda|P. Tengginamath"
"5815","15/04 12:00","3","P3843","Bee Yean NG","1","A","12a. Professional affairs and career development","Increasing pharmacists' capacity in antimicrobial stewardship to strengthen practices at Kilifi County Referral hospital (KCRH), Kenya","E. Gathua|B. Ng|M. Shahada|A. Masha|F. Wetende|M. Maina|R. Wanjala|N. Aliyan|F. Garraghan|L. Dunsmure|M. Andersson"
"1174","15/04 12:00","4","P3844","Sean Wei Xiang ONG","1","A","12b. Publishing, ethics, other academic affairs","Sociodemographic characteristics of trial participants are under-reported in infectious diseases clinical trials: a systematic review","S. Ong|C. Blagojevic|A. Bryce|A. Ovadia|M. Slater|D. Pryal|R. Escobar|H. Moffroid|A. Yerramilli|E. Charani|N. Daneman|S. Tong"
"4170","15/04 12:00","5","P3845","Adrian Chapman YAN","1","A","12b. Publishing, ethics, other academic affairs","End-of-life antibiotic decisions: exploring physician perspectives","A. Yan|K. Fitzmaurice|K. Dennehy|M. O'leary|K. O'connor|C. Sadlier|R. Bambury"
"368","15/04 12:00","6","P3846","Shunkichi IKEGAKI","1","A","12c. Medical education for CM/ID","Evaluation of antibiollets, a serious educational game for learning about microbiology and antibiotics","S. Ikegaki|K. Ebisawa|G. Ohji|K. Iwata"
"442","15/04 12:00","7","P3847","Shanthi VOORN","1","A","12c. Medical education for CM/ID","Online education yields significant gains in physicians' knowledge of the burden of RSV in older adults","S. Voorn|A. Stan|P. Schoonheim|B. Graham|G. Kassianos|A. Barnard"
"459","15/04 12:00","8","P3848","Shanthi VOORN","1","A","12c. Medical education for CM/ID","Vaccinating travelers against dengue fever: impact of online medical education on physician knowledge and confidence","S. Voorn|A. Piazza|F. David|N. Petrosillo|T. Jelinek"
"639","15/04 12:00","9","P3849","Arash LETAFATI","1","A","12c. Medical education for CM/ID","Evaluating HPV knowledge in future health professionals: a survey of health science students","A. Letafati"
"913","15/04 12:00","10","P3850","Shanthi VOORN","1","A","12c. Medical education for CM/ID","Increasing understanding of the burden and diagnosis of RSV disease in older adults: effect of online education on physician knowledge and confidence","S. Voorn|G. Griffiths|T. Barras|T. Welte|T. Clark|S. Maggi"
"1203","15/04 12:00","11","P3851","Anna Simona RIEDER","1","A","12c. Medical education for CM/ID","Antibiotic resistance: the development of an e-learning browser based tool for high-school students","A. Rieder|A. Egli|L. Meyer Kurmann"
"1281","15/04 12:00","12","P3852","Garima KUMAR","1","A","12c. Medical education for CM/ID","Enhancing antimicrobial resistance stewardship: an implementation research study for healthcare providers in LMICs","G. Kumar|D. Kumar"
"1893","15/04 12:00","13","P3853","Geena KLUDJIAN","1","A","12c. Medical education for CM/ID","Creating a culture of stewardship: impact of an antimicrobial stewardship elective for internal medicine residents?","G. Kludjian|L. Pedroza|R. Nash|H. Fraimow|A. Hanretty"
"3770","15/04 12:00","14","P3854","Till KOCH","1","A","12c. Medical education for CM/ID","Infektiopod: improving podcasting as a teaching method for infectious diseases through listener's participation","T. Koch|T. Elena|H. Annette"
"7647","15/04 12:00","16","P3856","Iná Regina TALACIMON BARBOSA","1","A","12c. Medical education for CM/ID","Impact of COVID-19 and the Malaria Outbreak in the Amazonas Region of Brazil","I. Talacimon Barbosa"
"556","15/04 12:00","17","P3857","Digbijay KUNWAR","1","A","12d. Diversity and equality","Gender disparities among award and grant recipients in annual infectious disease society meetings","D. Kunwar|I. Margalit|E. Righi|A. Nasim|D. Yahav|N. Tau"
"4614","15/04 12:00","18","P3858","Qingfeng SHI","1","A","12d. Diversity and equality","Current status of post competency of nosocomial infection control personnel in different job category in Shanghai","Q. Shi"
"7528","15/04 12:00","19","P3859","Samkele MKUMBUZI","1","A","12d. Diversity and equality","Developing a communication strategy towards universal common language for antibiotic resistance: a consensus delphi study","S. Mkumbuzi|C. Bonaconsa|A. Kona|T. Makamu|E. Charani|M. Mendelson"
"529","15/04 12:00","20","P3860","Fahmeeda IDREES","1","A","12e. Advocacy and role of patients","Patient-centred advocacy in healthcare: shaping educational and professional approaches in Pakistan","F. Idrees"
"1250","15/04 12:00","21","P3861","Qasim ARAIN","1","A","12e. Advocacy and role of patients","Say AHHH to AMR! Public perceptions about toothache, antibiotics and resistance","Q. Arain|A. Amjad|W. Thompson"
"2902","15/04 12:00","22","P3862","Ermira TARTARI","1","A","12e. Advocacy and role of patients","Health literacy and antibiotic resistance: exploring public perceptions in Malta","G. Schranz|V. Camilleri|M. Sciortino|M. Borg|E. Tartari"
"3300","15/04 12:00","23","P3863","M HASSANZAI","1","A","12e. Advocacy and role of patients","Application of dried blood spot sampling for therapeutic drug monitoring of vancomycin and creatinine in the outpatient parenteral antimicrobial therapy service: a qualitative analysis of facilitators and barriers","M. Hassanzai|C. Schijff|B. Koch|B. De Winter|H. Van Onzenoort"
"3453","15/04 12:00","24","P3864","Sebastiaan MOGGRE","1","A","12e. Advocacy and role of patients","Meaningful involvement of patients in acute infectious disease studies: a qualitative interview study among clinical trial participants","S. Moggre|T. Ten Doesschate|A. Reuland|E. Sieswerda|M. Bonten|K. Romijnders"
"3688","15/04 12:00","25","P3865","Jayvee GUERRERO","1","A","12e. Advocacy and role of patients","Understanding isolation: educating families about antimicrobial-resistant organism (ARO) colonisation and infection, and Clostridioides difficile infection (CDI)","S. Paramalingam|J. Guerrero|S. Arefin|R. Baseanoo|S. Bhoite|A. Garga|J. Lerma|R. Leung|F. Lo|M. Pekelny|N. Pena|B. Rastgoo|R. Vasanthakumar|R. Lovinsky|A. Belhaj|F. Go"
"4134","15/04 12:00","26","P3866","Ruth REID","1","A","12e. Advocacy and role of patients","Co-designing diagnostics for children: integrating parent and public voices in infectious disease research","R. Reid|J. Herberg"
"4911","15/04 12:00","27","P3867","Goulia OHAN","1","A","12e. Advocacy and role of patients","HIV stigma, its impact on healthcare engagement: a study among people living with HIV in Armenia","E. Kabassakalian|M. Marashlian|S. Mikaelian|J. Mehrabian|C. Abboud|G. Ohan|M. Ter-Stepanyan"
"306","15/04 12:00","1","P3868","Mohammed VH","1","B","13a. Viral infections","Contrasting outcomes in Nipah virus infection: a case series of survival and fatality","A. AS|M. VH.|G. G.|V. V."
"391","15/04 12:00","2","P3869","Eirini CHRISTAKI","1","B","13a. Viral infections","Case series of West Nile virus encephalitis: an emerging public health concern","V. Samanidou|M. Christaki|F. Barkas|L. Athanasiou|R. Konstantopoulou|D. Lymperatou|D. Biros|M. Kourtidis|N. Velios|A. Liontos|E. Christaki|C. Milionis"
"514","15/04 12:00","3","P3870","Arjun MB","1","B","13a. Viral infections","HSV hepatitis as an emerging threat in immunocompetent young adults of low-income rural settings: a case series","A. Mallasandra Balakrishna"
"555","15/04 12:00","4","P3871","Elena SENDRA ÁLVAREZ DE CIENFUEGOS","1","B","13a. Viral infections","Dengue-induced macrophage activation syndrome and flow cytometry immunophenotypic findings: a case report","E. Sendra|A. Rial|X. Calvo-González|J. Villar-Garcia|D. Román|C. Palacios|N. Company|J. Poblet Florentin|S. Castaneda|E. Canas-Ruano|S. Gomez-Zorrilla|J. Horcajada"
"757","15/04 12:00","5","P3872","Nerice NGIAM","1","B","13a. Viral infections","Hantavirus haemorrhagic fever with renal syndrome in Singapore: a case report","E. Sng|N. Ngiam|H. Shafi|C. Chen|L. Cui|R. Lin|A. Yii"
"809","15/04 12:00","6","P3873","Daria SEMENOVOVÁ","1","B","13a. Viral infections","Crossed wires: navigating risks in concurrent nirmatrelvir/ritonavir and cyclosporine therapy for transplant patient","D. Semenovová|I. Hockicková|T. Baltesova|D. Javorská|P. Jarcuska"
"1024","15/04 12:00","7","P3874","Barbara Cariza BUENAFE","1","B","13a. Viral infections","Dolutegravir plus lopinavir/ritonavir as a second-line two-drug regimen in PLHIV: a case series of clinical success","B. Buenafe|M. Pasayan"
"1324","15/04 12:00","8","P3875","Raffaella GALLO","1","B","13a. Viral infections","A hidden threat: West Nile virus unveiled in a heart transplant recipient","R. Gallo|F. Patauner|L. Bertolino|N. Scarpulla|I. Cafarella|A. Delle Femine|D. Pinto|E. Durante-Mangoni|E. Tricarico"
"1366","15/04 12:00","9","P3876","Andronikos SPYROU","1","B","13a. Viral infections","When acyclovir goes rogue: a ganciclovir rescue story","A. Spyrou|E. Kalogianni|M. Ploumidis|G. Adamis|M. Astriti"
"1367","15/04 12:00","10","P3877","Andronikos SPYROU","1","B","13a. Viral infections","Erythema nodosum's secret CMV affair","A. Spyrou|E. Kalogianni|M. Ploumidis|M. Astriti"
"1753","15/04 12:00","11","P3878","Arthur Dessi ROMAN","1","B","13a. Viral infections","A rare gem: a case series on Epstein Barr virus smooth muscle tumor","H. Alfonso|A. Roman|K. Oliveros"
"1808","15/04 12:00","12","P3879","Claudia PAVIA","1","B","13a. Viral infections","Diagnostic work-up of an HHV-6 infection in a paediatric patient: a case report","C. Pavia|C. Pavia|R. Agistri|M. De Paschale|A. Nardella|L. Gabrielli|A. Balboni|R. Epifano"
"1819","15/04 12:00","13","P3880","Pothumarthy VENKATA SWATHI KIRAN","1","B","13a. Viral infections","Neurological involvement in two phases of Kyasanur forest disease","V. Pothumarthy|N. Gupta"
"1949","15/04 12:00","14","P3881","Jui ATHAVALE","1","B","13a. Viral infections","Disseminated adenovirus infection in solid organ transplant: a case series","J. Athavale|P. Balaguru|R. Gopalakrishnan|S. Karthik|M. Saravanan|N. Reddy|S. Jacob|E. Krishnan|K. Haribabu|M. Balasubramaniam"
"1979","15/04 12:00","15","P3882","Giulia QUARTINI","1","B","13a. Viral infections","Human immunodeficiency virus (HIV) associated eosinophilic folliculitis: a case of immune reconstitution inflammatory syndrome (IRIS)","G. Quartini|F. Del Nonno|D. Francisci|C. Di Giuli|A. Lavagna|L. Saraca|G. Proietti|L. Capogrossi|D. Colombo"
"2218","15/04 12:00","17","P3884","Manju SEBASTIAN","1","B","13a. Viral infections","Low-volume therapeutic plasma exchange in fulminant viral hepatitis: an effective alternative to liver transplantation in resource-limited settings","M. Sebastian|B. Fenn|A. A.|K. S.|N. Babu|V. M. C.|N. Mundadan|A. Gurudas|J. John|S. R."
"2264","15/04 12:00","18","P3885","Elena TRAN","1","B","13a. Viral infections","A severe case of RSV","E. Tran|D. Sepkowitz"
"2681","15/04 12:00","19","P3886","Kiana KETABI","1","B","13a. Viral infections","A rare case of ramsy-hunt syndrome associated with varicella meningitis","K. Ketabi|M. Haddad|F. Sheybani"
"2841","15/04 12:00","20","P3887","Ioannis MARKAKIS","1","B","13a. Viral infections","A serious case of EBV-positive mucocutaneous oral ulcer and HHV-6 and 7 co-infection in an immunocompromised patient","I. Markakis|E. Giannitsioti|P. Dimizas|E. Froukala|N. Spanakis|M. Koloutsou"
"3145","15/04 12:00","21","P3888","Mays ABU MUCH","1","B","13a. Viral infections","Transverse myelitis, a rare neurological sequela of mumps in an immunocompetent adult: a case report with MRI correlation","M. Abu Much|A. Yanovskay|C. Kasher|M. Landes|B. Chazan"
"3160","15/04 12:00","22","P3889","Risa YAWATA","1","B","13a. Viral infections","Acute retinal necrosis by acyclovir-resistant VZV in a post-allogeneic haematopoietic stem cell transplantation patient: a case report","R. Yawata|H. Nakagawa|K. Tsuda|C. Nitani|S. Yamada|S. Fukushi|M. Shirano"
"3577","15/04 12:00","25","P3892","Arianna LIPAROTI","1","B","13a. Viral infections","TDF/FTC levels in transgender woman on PrEP following gastric bypass surgery","A. Liparoti|V. Castelli|G. Bozzi|B. Mariani|A. Muscatello|A. De Nicolo|A. D'avolio|S. Bonora|A. Bandera"
"3583","15/04 12:00","26","P3893","Leyli GHAENI","1","B","13a. Viral infections","Pembrolizumab in patients with HIV-PML: a retrospective case series","L. Ghaeni|P. Migaud|D. Drauz|H. Stocker"
"3595","15/04 12:00","27","P3894","Miriam LATORRE-MILLÁN","1","B","13a. Viral infections","Complications associated with intranasal influenza vaccination in vulnerable children: a case report","M. Latorre-Millán|L. Clusa|F. Pozo|A. Milagro"
"3710","15/04 12:00","28","P3895","Alessandro CILLI","1","B","13a. Viral infections","A black friday: unusual manifestation of West Nile virus infection in an allogeneic haematopoietic stem cells transplant recipient","F. Medioli|A. Cilli|L. Bussini|F. Tordato|M. Bartoletti|S. Bramanti|D. Mannina|D. Taurino|I. Ciro"
"3744","15/04 12:00","29","P3896","Emma Ann DAVIES","1","B","13a. Viral infections","Adenovirus-associated bilateral panuveitis with retinitis in a post-bone marrow transplant patient: a case report","D. Haigh|S. Ahmad|B. Brown|C. Phillips|N. Machin|J. Wong|E. Davies"
"3803","15/04 12:00","30","P3897","Melania DEGLI ANTONI","1","B","13a. Viral infections","Parvovirus B19 encephalitis in immunocompetent patients: description of three cases","M. Degli Antoni|C. Colarossi|L. Zanichelli|F. Stragliati|R. Schiavo|A. Mancini|M. Bolzoni|G. Ratti|G. Tagliaferri|N. Rossi|L. Gerna|F. Paolillo|A. Ruggieri|G. Lo Cascio|F. Trapani|G. Priante|S. Vollaro|P. Immovilli"
"3932","15/04 12:00","31","P3898","Emanuela ZAPPULO","1","B","13a. Viral infections","Successful treatment of MDR HIV infection with lenacapavir plus fostemsavir-based background regimen","E. Zappulo|S. Mercinelli|G. Di Filippo|M. Cotugno|C. Carriero|N. Cuomo|C. Perno|I. Gentile"
"4166","15/04 12:00","32","P3899","Sanchita SHIROLE","1","B","13a. Viral infections","Quadriparesis due to spontaneous spinal haemorrhage as a rare manifestation of dengue haemorrhagic fever: a case report","S. Shirole|S. Ingawale"
"4223","15/04 12:00","33","P3900","Irina BULATA-POP","1","B","13a. Viral infections","Long-COVID symptoms in pediatric end-stage kidney disease patients","I. Bulata-Pop|B. Bulata|V. Briciu|M. Lupse"
"4505","15/04 12:00","34","P3901","Elena MARTINI","1","B","13a. Viral infections","RebUs(utu), a case of severe usutu virus encephalitis: steroid yes or no?","E. Martini|D. Lusetti|S. Casolari|C. Mussini"
"4715","15/04 12:00","35","P3902","Ryoon Wha KANG","1","B","13a. Viral infections","Cytomegalovirus as an independent risk factor for thrombosis in immunocompetent patients and its diagnostic challenge","R. Kang|S. Khalid"
"4742","15/04 12:00","36","P3903","Uh Jin KIM","1","B","13a. Viral infections","Direct transmission of severe fever with thrombocytopenia syndrome virus (SFTS) from SFTS infected dog to human","U. Kim|H. Jeong|A. Lee|M. Kim|S. Kim|S. Shin|S. Kang|S. Jung|W. Ro|D. Kim|K. Park"
"4797","15/04 12:00","37","P3904","Isabel Cristina RAMÍREZ-SÁNCHEZ","1","B","13a. Viral infections","Letermovir as secondary CMV prophylaxis in SOT, report of two cases","J. Lacouture Fierro|J. Marin Zuluaga|I. Ramirez-Sanchez"
"4886","15/04 12:00","38","P3905","Danilo Cesljarac","1","B","13a. Viral infections","Success of corticosteroid pulse therapy in a severe breakthrough tick-borne encephalitis","D. Cesljarac|T. Vovko"
"6122","15/04 12:00","39","P3906","Frantisek LAMI","1","B","13a. Viral infections","Case series of hepatitis A: eight fatalities linked to local epidemic in eastern Slovakia","F. Lami|I. Hockicková|J. Hockicko|D. Javorská|S. Zamba|M. Sevcik|D. Hudackova|P. Kristian"
"6128","15/04 12:00","40","P3907","Kiriam ESCOBAR LEE","1","B","13a. Viral infections","Congenital dengue in Panama: a case report","K. Escobar Lee|L. Rivera|A. Abouganem"
"6372","15/04 12:00","41","P3908","Anyeliria SUTANTO","1","B","13a. Viral infections","Post varicella infection and measles vaccine-related autoimmune encephalitis: a case report","A. Sutanto"
"6597","15/04 12:00","42","P3909","Filipa FERREIRA","1","B","13a. Viral infections","Parvovirus B19 infection: unusual clinical manifestation","F. Faria|F. Pinto Ferreira|F. Neto Novela|S. Almeida|A. Cipriano|A. Ludgero Vasconcelos"
"6632","15/04 12:00","43","P3910","Natalia Rosana PUJATO","1","B","13a. Viral infections","Donor-transmitted dengue in kidney transplant recipients: report of two cases","N. Pujato|S. Galian|L. Valinotto|C. Alvarez Lopez|S. Beltramino|A. Manchado|N. Nolis|G. Werber|M. Elencwajg|J. Walther|P. Lopez|A. Mistchenko"
"6756","15/04 12:00","44","P3911","Roberta ASTORRI","1","B","13a. Viral infections","Defining long-COVID: reflections in perspective, from an emblematic case of small fiber neuropathy","R. Astorri|M. Pisaturo|C. Ricozzi|N. Coppola"
"6761","15/04 12:00","45","P3912","Rafshanjani ADIL","1","B","13a. Viral infections","Concurrent cytomegalovirus (CMV) retinitis and neurosyphilis presenting as bilateral optic neuritis in a patient with HIV: a case report","R. Adil|S. Sala"
"6778","15/04 12:00","46","P3913","Ummu Afeera ZAINULABID","1","B","13a. Viral infections","When two worlds collide: acute HIV in the shadow of DADA2 deficiency","U. Zainulabid|X. Cheong|N. Kori|S. Othman|M. Nawawi|A. Ali|P. Periyasamy"
"6871","15/04 12:00","47","P3914","Líbia ZÉ-ZÉ","1","B","13a. Viral infections","Case report of a fatal case of Crimean-Congo haemorrhagic fever genotype III, Portugal 2024","L. Zé-Zé|C. Nunes|M. Sousa|R. De Sousa|C. Gomes|A. Santos|R. Terras Alexandre|F. Amaro|T. Loza|M. Blanco|M. Alves"
"7401","15/04 12:00","48","P3915","Maeve LEONARD","1","B","13a. Viral infections","New onset neutropaenia or worsening neutropaenia: consider parvovirus B19","M. Leonard|S. Gregg|P. Fitzpatrick|N. Keane|M. Cormican"
"7555","15/04 12:00","1","P3916","Clara BACELAR","2","B","13a. Viral infections","HBV and HCV co-infection: an interaction to keep in mind","C. Bacelar|S. Oliveira|F. Duarte|R. Correia Abreu|C. Batista"
"112","15/04 12:00","2","P3917","Nicola SARDI","2","B","13b. Bacterial infections","Fusobacterium nucleatum as a rare cause of lacrimal canaliculitis: a case report","N. Sardi|M. Leto|E. Vinai|F. Conte|M. Salvatico|M. Grillo"
"126","15/04 12:00","3","P3918","Ting LUO","2","B","13b. Bacterial infections","A case of Chlamydia psittaci pneumonia without bird contact: diagnosis and treatment via metagenomic next-generation sequencing","T. Luo|Y. Hong|J. Wu"
"127","15/04 12:00","4","P3919","Honey Jane BLANCO-LIMOS","2","B","13b. Bacterial infections","Melioidosis presenting as hepatosplenic abscesses in a diabetic patient misidentified as Burkholderia cepacia: a case report","H. Limos|M. Cordial"
"157","15/04 12:00","5","P3920","Maria MAZZITELLI","2","B","13b. Bacterial infections","Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae","M. Mazzitelli|M. Coppi|V. Scaglione|L. Paci|I. Castagliuolo|E. Franchin|G. Rossolini|A. Cattelan"
"251","15/04 12:00","6","P3921","Chidiogo IHEUKWUMERE","2","B","13b. Bacterial infections","Multiple antibiotic resistance indices of Vibrio cholerae isolated from boreholes from Awka metropolis","C. Iheukwumere|I. Iheukwumere|U. Okoli|C. Ugwu"
"312","15/04 12:00","7","P3922","David GOLDMEIER","2","B","13b. Bacterial infections","Disseminated nocardiosis in a patient with AIDS","D. Goldmeier|A. Umair|A. Ehinmisan|L. Streett"
"316","15/04 12:00","8","P3923","María Asunción PÉREZ-JACOISTE ASÍN","2","B","13b. Bacterial infections","When infection masquerades as malignancy","M. Perez-Jacoiste Asin|P. Branas|M. Gallego|F. Lopez-Medrano|J. Aguado|E. Revilla-Sánchez"
"321","15/04 12:00","9","P3924","Ishikawa KAZUHIRO","2","B","13b. Bacterial infections","Successful treatment of an intra-abdominal abscess caused by KPC-2-producing hypervirulent Klebsiella pneumoniae with imipenem/relebactam in a Japanese patient","K. Ishikawa|K. Shibutani|M. Yumiko|S. Harada|K. Komori|N. Mori"
"343","15/04 12:00","10","P3925","Suzan ALZEER","2","B","13b. Bacterial infections","Revealing co-infections in pneumonia: a case report on advancing diagnosis with metagenomic sequencing technologies","S. Alzeer|R. Almaghrabi|A. Alqasabi|A. Magrashi|T. Alzahrani|H. Tayeb"
"493","15/04 12:00","11","P3926","Lordieliza MELENDREZ","2","B","13b. Bacterial infections","An isolated case of Epididymo-orchitis tuberculosis in an immunocompetent patient: a case report","L. Melendrez|G. Zabat|A. Masbang"
"505","15/04 12:00","12","P3927","Sukoon AL HARTHI","2","B","13b. Bacterial infections","Cardiac manifestations of Q fever infection: case series in paediatric patients","H. Al Hashami|S. Al Harthi"
"523","15/04 12:00","13","P3928","Ramseena IBRAHIM","2","B","13b. Bacterial infections","Renal allograft tuberculosis: evolution of presentations and outcomes in five cases from an endemic region","R. Ibrahim|S. Balakrishnan|S. Narayanan|I. Naduvilaparambil|F. Aziz|A. Yadur|A. Balachandran"
"604","15/04 12:00","14","P3929","Azlina IBRAHIM","2","B","13b. Bacterial infections","Pyogenic spondylodiscitis secondary to Streptococcus dysgalactiae subsp. equisimillis in an immunocompetent patient","A. Ibrahim|M. Mohd Khalid|R. Mohd Noh"
"707","15/04 12:00","15","P3930","Guido GRANATA","2","B","13b. Bacterial infections","Combating metallo-beta-lactamase-producing Pseudomonas aeruginosa: the fractional inhibitory concentration index as a tool to evaluate antibiotic synergy","G. Granata|C. Venditti|C. Rotondo|G. Parisi|A. Capone|C. Fontana|S. Cicalini"
"743","15/04 12:00","16","P3931","Samadhi PATAMATAMKUL","2","B","13b. Bacterial infections","Melioidosis unveiled: a curious case of mediastinal, hepatosplenic, and eschar-like subcutaneous abscesses revealing adult-onset immunodeficiency with autoantibodies to interferon-gamma","S. Patamatamkul"
"765","15/04 12:00","17","P3932","Sergi RODRÍGUEZ MERCADER","2","B","13b. Bacterial infections","Tuberculosis, HIV and hyperinflammation: may the cure be worse than the disease?","F. Sanchez Martinez|S. Rodriguez Mercader|N. Jové Caballé|I. Pelegrin Senent|S. Esteban Cuco|A. Siverio Parés|L. Suaya Leiro|S. Castaneda Espinosa|M. Sanz De Mena|I. Lopez Montesinos|E. Sendra Alvarez De Cienfuego|J. Villar Garcia|I. Arrieta Aldea|H. Knobel Freud"
"821","15/04 12:00","18","P3933","Satyendra KHICHAR","2","B","13b. Bacterial infections","Global spotlight: tuberculosis unveiled through uncommon complication of peripheral gangrene","S. Bhat K S|S. Khichar|M. Rakesh Shah"
"976","15/04 12:00","19","P3934","Ales CHLOUBA","2","B","13b. Bacterial infections","Dalbavancin-resistant breakthrough bacteraemia due to S. epidermidis during consolidation treatment with dalbavancin in a patient with native infective endocarditis and spondylodiscitis","A. Chlouba|L. Boix Palop|M. Medina|G. Cuervo|M. Xercavins-Valls|B. Dietl|E. Calbo|J. Miro|M. Hernández-Meneses|C. Garcia-De-La-Maria|M. Canas-Pacheco|M. Brunet"
"980","15/04 12:00","20","P3935","Sharmathi DHANAPAL","2","B","13b. Bacterial infections","Tears of melioidosis: a rare presentation of lacrimal gland melioidosis with intracranial extension","S. Dhanapal|G. Rajahram|P. Pillai"
"989","15/04 12:00","21","P3936","Jane O'CONNOR","2","B","13b. Bacterial infections","A case of imported Burkholderia pseudomallei breast abscess in Ireland","J. O'connor|K. O'connell|O. O'donoghue"
"1022","15/04 12:00","22","P3937","Sabeen ZARA","2","B","13b. Bacterial infections","Genomic identification of Clostridium mangenotii bloodstream infection in an immunocompromised patient, an emerging pathogen","S. Zara|H. Abdelhadi|A. Al Bishawi|P. Coyle|F. Eltayeb|S. S.Abujarir|Y. Hamza"
"1070","15/04 12:00","23","P3938","Timothy HEALY","2","B","13b. Bacterial infections","Development of invasive meningococcal disease in a patient exposed to a household contact with primary meningococcal conjunctivitis","T. Healy|N. O' Mara|N. Reidy|S. Mcloughlin|S. Kenny|L. Susan|O. Ali|J. Stapleton|P. Barrett|K. Fitzmaurice|K. Fox"
"1073","15/04 12:00","24","P3939","Lorand MAGDO","2","B","13b. Bacterial infections","Legionella pneumophila: deadly trigger in a severely immunosuppressed patient","L. Magdo|R. Seiche|A. Dicea|L. Herbel|L. Damian|M. Lupse"
"1075","15/04 12:00","25","P3940","Yasemin ÇAKIR KIYMAZ","2","B","13b. Bacterial infections","Pleural empyema caused by Salmonella in a patient with chronic lymphocytic leukaemia","Y. Cakir Kiymaz|M. Özbey"
"1130","15/04 12:00","26","P3941","Elif Ozge DAMAR MIDIK","2","B","13b. Bacterial infections","A case of Brucella endocarditis complicated with ruptured cerebral mycotic aneurysm","E. Damar Midik|A. Batirel|E. Sargin Altunok|S. Bolukcu"
"1246","15/04 12:00","27","P3942","Beatrice WINKEL","2","B","13b. Bacterial infections","Fulminant Rothia mucilaginosa meningitis in immunocompromised patients: a case series","B. Winkel|B. Goemans|M. De Witte|I. Van Der Sluis|J. Stutterheim|L. Daenen|M. Van Der Flier|T. Wolfs|T. Van Der Bruggen"
"1284","15/04 12:00","28","P3943","Seong Geun HONG","2","B","13b. Bacterial infections","First report of KPC-2 producing Hafnia paralvei: evidence of horizontal gene transfer from Klebsiella pneumoniae","S. Cho|M. Kang|S. Hong"
"1329","15/04 12:00","29","P3944","Jerina BOELENS","2","B","13b. Bacterial infections","Rapid AST with ASTar: a Haemophilus influenzae case","E. De Muynck|L. De Bus|N. Verougstraete|D. Huis In 't Veld|S. Vandendriessche|A. Messiaen|J. De Waele|J. Boelens"
"1529","15/04 12:00","30","P3945","Noran AL-KOFAHI","2","B","13b. Bacterial infections","Macrolide-resistant mycoplasma septic arthritis in a patient with lymphoma on prophylactic azithromycin post immunotherapy: a diagnostic challenge","N. Al-Kofahi|J. Coleman|A. Johnson|N. Peters|A. Chue"
"1601","15/04 12:00","31","P3946","Nils WETZSTEIN","2","B","13b. Bacterial infections","Mycobacterium chelonae infection of a cardiovascular bioprosthesis linked to a recent outbreak","J. Kessel|A. Braner|M. Diricks|T. Walther|T. Holubec|M. Hogardt|T. Wichelhaus|S. Niemann|A. Moter|I. Friesen|N. Wetzstein"
"1619","15/04 12:00","32","P3947","Nadjat AGGOUNE KHINACHE","2","B","13b. Bacterial infections","Fatal bacteriemia involving an association of Stenotrophomonas maltophilia with an NDM and OXA-48 producing Proteus mirabilis","N. Aggoune|D. Bensersa|F. Henniche|S. Adjerad|N. Brihoum|S. Akbi|A. Zerouki"
"1623","15/04 12:00","33","P3948","Jesús Enrique GUEVARA OSORIO","2","B","13b. Bacterial infections","Chronic otitis media due to Auritidibacter ignavus","J. Guevara Osorio|T. Nebreda Mayoral|M. Cuervo Abarquero|A. Gomez Munoz|V. Cerpa Almenara|L. Tejedor Cantero|N. González Espinosa|B. Requejo Baruque|M. Uruena Garcia|S. Rojo Rello|J. Eiros Bouza"
"1644","15/04 12:00","34","P3949","Giorgia OLIVIERI","2","B","13b. Bacterial infections","Capnocytophaga canimorsus sepsis in heamodialysis patient","G. Olivieri|D. Fioriti|A. Gallo|R. Sperning|M. Aleandri|S. Di Clemente|E. Magini|M. Ciardullo|I. Canullo|F. Catini|M. Ippolito|R. Oliverio|G. Parisi"
"1679","15/04 12:00","35","P3950","Jose Luis CASTILLO","2","B","13b. Bacterial infections","Extrapulmonary tuberculosis mimicking cat-scratch disease in an immunosuppressed patient: a case of lymph node and bone involvement","G. Medina-Montano|E. Castro-Lopez|P. Castaneda-Mendez|C. Ortiz-Hidalgo|R. Olmedo-Reneaum|J. Castillo-Alvarez"
"1719","15/04 12:00","36","P3951","Nicole GEMIGNANI","2","B","13b. Bacterial infections","Tedizolid as oral step-down therapy for vancomycin-resistant Enterococcus faecium (VRE) prosthetic valve endocarditis and spondylodiscitis: a case report","N. Gemignani|V. Morena|A. Chiesa|C. Molteni|F. Conti|A. Consonni|S. Pontiggia|S. Piconi"
"1729","15/04 12:00","37","P3952","Mario KAROLYI","2","B","13b. Bacterial infections","Cefepime/enmetazobactam as treatment for extended-spectrum-betalactamase producing Escherichia coli bloodstream infection in a septic patient with liver cirrhosis: a case report","M. Karolyi|D. Stahl|F. Höllerl|E. Pawelka|C. Wenisch"
"1758","15/04 12:00","38","P3953","Natalia KAMAEVA","2","B","13b. Bacterial infections","Delamanid-containing chemotherapy of pre-XDR-TB patients 0-3 years old: case series","N. Kamaeva|N. Stepanov|G. Lysakov"
"1807","15/04 12:00","39","P3954","Lester Jun Long WONG","2","B","13b. Bacterial infections","Extensively drug-resistant Pseudomonas aeruginosa sternal osteomyelitis and the case for early bacteriophage therapy","N. Chua|L. Wong|S. Thong|D. Ng|J. Teo|S. Chung|A. Kwa"
"1844","15/04 12:00","40","P3955","Sreethish SASI","2","B","13b. Bacterial infections","A challenging case of partially treated bacterial meningitis due to Moraxella osloensis diagnosed by 16S rRNA sequencing","S. Sasi|M. Abukhattab|M. Hamed|J. Koleri|A. Mohamad|A. Prabhakaran Nair|M. Varghese|M. Al-Maslamani|A. Al-Khal"
"1937","15/04 12:00","41","P3956","Jishna SHRESTHA","2","B","13b. Bacterial infections","A case of recurrent multibacillary leprosy with type 2 reversal reaction: a newer approach to management","J. Shrestha|E. Clark|M. Kiener|K. Freemann"
"1943","15/04 12:00","42","P3957","Junhao, Ray LIN","2","B","13b. Bacterial infections","Disseminated ureaplasma urealyticum infection and hyperammonemia encephalopathy in a patient with activated phosphoinositide 3-kinase delta syndrome (APDS)","J. Lin|Y. Lai|X. Lim|H. Howe|M. Maiwald|T. Koh|R. Pooja|Z. Lim|S. Puah|T. Tan"
"1948","15/04 12:00","43","P3958","Thammarin KHAOROPPHAN","2","B","13b. Bacterial infections","A case report of Corynebacterium minutissimum?????? native valve endocarditis in the prisoner","T. Khaoropphan|P. Thaisiam"
"1977","15/04 12:00","44","P3959","Matteo PICCICA","2","B","13b. Bacterial infections","Intraoperative use of oritavancin in DAIR for periprosthetic joint infection (PJI)","M. Piccica|L. Attala|F. Raspanti|L. Zanna|N. Giabbani|G. Somma|M. Mugnaini|F. Bartalesi"
"1980","15/04 12:00","45","P3960","Pyrus BHELLUM","2","B","13b. Bacterial infections","Infective focus within a teratoma: a case of brucellosis complicating a mature cystic ovarian tumor","P. Bhellum|D. Meena|S. Khichar|N. Lodha|N. Kaur|S. Talreja|R. Goyal|A. Bazal|N. Sharma"
"1997","15/04 12:00","46","P3961","Warat USAWAKIDWIREE","2","B","13b. Bacterial infections","Chronic arthritis of left ankle caused by Mycobacterium intracellulare in a kidney transplant patient","W. Usawakidwiree|J. Vanichanan"
"2008","15/04 12:00","47","P3962","Teja VASIREDDY","2","B","13b. Bacterial infections","Tropical fevers: the unsolved mystery","T. Vasireddy"
"2019","15/04 12:00","48","P3963","Grace ROTHWELL-KELLY","2","B","13b. Bacterial infections","Cases of Bacillus cereus infection following breast reconstruction","G. Rothwell-Kelly|K. Dever|E. Brown|K. Schaffer|C. Egan|O. Donoghue"
"2054","15/04 12:00","1","P3964","Carmen PALACIOS CLAR","3","B","13b. Bacterial infections","Respiratory infection caused by Mycobacterium branderi in an HIV/AIDS patient","C. Palacios Clar|C. Hernández Carballo|C. Mateo Leon|D. Garcia Martinez De Artola|J. Alcoba Florez"
"2182","15/04 12:00","3","P3966","Anjely PULPARAMPIL SEBASTIAN","3","B","13b. Bacterial infections","Nocardia brain abscess in patients with immune thrombocytopenia: challenges in management","A. Pulparampil Sebastian|P. Tirlangi|M. Varma|N. Gupta"
"2206","15/04 12:00","4","P3967","Laura ANDRÉS ESLAVA","3","B","13b. Bacterial infections","Underdiagnosed brain abscess caused by Parvimonas micra in a immunocompetent host","L. Andrés Eslava|V. Artal Munoz|N. Talon Costa|M. Guna Serrano|C. Gimeno Cardona"
"2220","15/04 12:00","5","P3968","Diego ERDMENGER","3","B","13b. Bacterial infections","Infective endocarditis by Ochrobactrum anthropi in a heamodialysis patient with cor triatriatum dexter: a rare case report","D. Erdmenger|R. Luis|K. Algaba|F. Pezzarossi|M. Lopez|S. Aguilar|C. Arango|V. Chamale|K. Mejicanos|M. Ramos"
"2254","15/04 12:00","6","P3969","Bibek KOIRALA","3","B","13b. Bacterial infections","An unusual case of lepromatous leprosy in a Vietnamese immigrant presenting as diffuse rash during pregnancy","B. Koirala|S. Jubbal"
"2288","15/04 12:00","7","P3970","Hiroki KITAGAWA","3","B","13b. Bacterial infections","First human case of infected lymphocele with bloodstream infection caused by Staphylococcus coagulans transmitted from a pet dog: a case report","H. Kitagawa|K. Tadera|K. Omori|T. Nomura|N. Shigemoto|H. Ohge"
"2295","15/04 12:00","8","P3971","Yen Tsen SAW","3","B","13b. Bacterial infections","Fatigue: could the cause be Whipple's disease?","Y. Saw|M. Farroha|F. Dave"
"2398","15/04 12:00","9","P3972","Minggui LIN","3","B","13b. Bacterial infections","Contezolid for disseminated Bacillus Calmette-Guérin disease in a child with allogeneic haematopoietic stem cell transplantation","M. Lin|F. Jiang"
"2436","15/04 12:00","10","P3973","Dipu T S","3","B","13b. Bacterial infections","Clinical and microbiological profile of melioidosis in a tertiary care hospital in Kerala, India","D. Sathyapalan|D. Vijayakumar|H. Vikraman|P. Baby|A. Nambiar|A. Abdulla|A. Santhosh|G. Sreekumar|L. Biswas|H. Subhagan|C. Mukhopadhyay|H. Kaur|R. Biswas|A. Kumar"
"2447","15/04 12:00","11","P3974","Sara LO MENZO","3","B","13b. Bacterial infections","Prosthetic infection of the thoracic aorta by Salmonella enterica: a case report","S. Lo Menzo|M. Mazzitelli|V. Vecchiato|C. Passarella|A. Ballin|A. Celsan|M. Brundu|I. Tiberio|A. Cattelan"
"2457","15/04 12:00","12","P3975","Ramón PÉREZ TANOIRA","3","B","13b. Bacterial infections","Bacteraemia due to non-toxigenic Vibrio cholerae: a case report","T. Costales Lucia|G. Sánchez De Luis|R. Pérez-Tanoira|A. Rojas Diaz|C. Garcia Bertolin|H. Bermúdez-Marval|C. Rescalvo-Casas|M. Hernando Gozalo|P. Gomez Herruz|F. Perez-Garcia|A. González Sarria|M. Linares Rufo|J. Cuadros-González"
"2496","15/04 12:00","13","P3976","Deneeta SHANTHAKUMARA","3","B","13b. Bacterial infections","Multidrug-resistant Aeromonas hydrophila infection in an immunocompromised child with aplastic anaemia","D. Shanthakumara|N. Young|K. Sethi|J. Grinfeld|J. Nahl|M. Tavakoli|L. Brodie"
"2522","15/04 12:00","14","P3977","Rohan MEHRA","3","B","13b. Bacterial infections","LABouring the point: history taking, bias and a lab exposure","R. Mehra"
"2527","15/04 12:00","15","P3978","Ko IIDA","3","B","13b. Bacterial infections","Uninvited intruders: a 39-year-old man with brain abscess","K. Iida|R. Morita|R. Fukuoka|T. Asaoka|H. Nakagawa|T. Ishiguro|M. Shirano"
"2534","15/04 12:00","16","P3979","Jan Michael SOMBONG","3","B","13b. Bacterial infections","Cranial nerve mononeuropathy: an eye opener to neuro-ocular manifestation of leptospirosis","J. Sombong|J. Verona|J. Santos"
"2556","15/04 12:00","17","P3980","Javier DÍEZ DE LOS RÍOS","3","B","13b. Bacterial infections","Extensive pneumococcal aortitis complicated by multifocal spondylodiscitis: a case report","J. Diez De Los Rios|S. Molinos Abos|M. Hernández-Meneses|G. Cuervo|E. Quintana|V. Saludes|G. Pedemonte-Parramon|A. Perissinotti|J. Miro|L. Pedro-Botet|E. Reynaga"
"2562","15/04 12:00","18","P3981","Felix VOELK","3","B","13b. Bacterial infections","Successful treatment of relapsing enterococcal pacemaker-lead associated endocarditis including extended-duration dalbavancin: a case report","F. Völk|M. Sinner|S. Sadoni|U. Seybold"
"2611","15/04 12:00","19","P3982","Chaianant LEELABOORANASAK","3","B","13b. Bacterial infections","Leptospirosis-associated myocarditis masquerading acute myocardial infarction: a challenging case and diagnostic dilemma","C. Leelabooranasak|J. Vanichanan|C. Suankratay"
"7524","15/04 12:00",,"P3983","Carolina INÁCIO SANTOS",,,"13b. Bacterial infections","It might be syphilis: a case report and systematic review on syphilitic osteomielytis","C. Inácio Santos|A. Torcato Cartaxo|I. Sousa Miranda|S. Gomes Rocha|M. Teixeira Almeida|J. Vaz Alves|K. Kmansinho"
"2635","15/04 12:00","21","P3984","Edjola LULJA","3","B","13b. Bacterial infections","Urinary tract TB, don't forget the sterile pyuria: a case report","E. Lulja|A. Harxhi|N. Como|S. Kacori|E. Cuka"
"2653","15/04 12:00","22","P3985","Francesca CATANIA","3","B","13b. Bacterial infections","Exploring ""point-of-care"" ultrasound for early disseminated tuberculosis detection in patients treated with biologics","F. Catania|A. Cingolani|E. Tamburrini|P. Del Giacomo|R. Murri|I. Palucci|M. Sali|M. Sanguinetti|C. Torti|F. Taccari|F. Salvati|A. Frater|G. Scoppettuolo"
"2686","15/04 12:00","23","P3986","Akela Ahmed GHAZAWI","3","B","13b. Bacterial infections","Comprehensive genomic analysis of vancomycin- and daptomycin-resistant Enterococcus faecium bacteraemia in a high-risk patient","A. Ghazawi|A. Manzoor|M. Al Azri|N. Al Nuaimi|A. Al Hammadi|M. Khan"
"2693","15/04 12:00","24","P3987","Nerice NGIAM","3","B","13b. Bacterial infections","Fatal invasive Campylobacter rectus infection in two immunocompetent hosts from a tertiary hospital in Singapore","N. Ngiam|C. Wong|E. Sng|H. Shafi"
"2711","15/04 12:00","25","P3988","Kiana KETABI","3","B","13b. Bacterial infections","Meningitis caused by Listeria monocytogenes in a patient with inflammatory bowel disease: a case report","K. Ketabi|H. Mahboubeh|S. Fereshte"
"2715","15/04 12:00","26","P3989","Mushtaq KHAN","3","B","13b. Bacterial infections","Genomic analysis of carbapenem-resistant Klebsiella pneumoniae in a relapsed acute myelogenous leukemia patient: a case report","A. Ghazawi|A. Manzoor|M. Al Azri|N. Al Nuaimi|A. Al Hammadi|M. Khan"
"2774","15/04 12:00","27","P3990","Elena AGUILAR MOÑINO","3","B","13b. Bacterial infections","An exceptional case of meningoencephalitis caused by Campylobacter jejuni","E. Aguilar Monino|J. Baeza Ros|G. Valero Chazarra|M. Martinez Toldos|G. Yague Guirao|M. Méndez Miralles|J. Marin"
"2790","15/04 12:00","28","P3991","Punsita TANGKUM","3","B","13b. Bacterial infections","Chronic otomastoiditis complicated with deep neck spaces and intracranial abscesses caused by Mycobacterium abscessus: a case report","P. Tangkum|J. Vanichanan"
"2806","15/04 12:00","29","P3992","Ajithkumar ITTAMAN","3","B","13b. Bacterial infections","A rare presentation of tuberculous myocarditis as isolated ventricular tachycardia","A. Ittaman|M. Mohamad|M. Altayeb Alamin|S. Hamzeh Shaar|M. Al Maslamani"
"2812","15/04 12:00","30","P3993","André SILVA-PINTO","3","B","13b. Bacterial infections","Peritoneal tuberculosis in immunocompetent patients: a diagnostic and therapeutic challenge","M. Cunha|R. Almeida|P. Fernandes|C. Nunes-Silva|A. Silva-Pinto|A. Santos|P. Figueiredo|L. Santos"
"2820","15/04 12:00","31","P3994","Naresh Kumar MIDHA","3","B","13b. Bacterial infections","Pitting edema and proteinuria: a diagnostic clue to tuberculosis-associated granulomatous interstitial nephritis","M. Shah|N. Midha|S. Angirekula|V. Vishwajeet|R. Jhorawat"
"2856","15/04 12:00","32","P3995","Kateryna RUDNIEVA","3","B","13b. Bacterial infections","Azithromycin/meropenem combination therapy is effective in XDR GNB infection in immunocompromised patients: case series of UTI in kidney transplant recipients","K. Rudnieva|E. Svirzhevskyi|D. Puzikov|A. Oberniak|V. Potochilova|O. Iungin|O. Moshynets"
"2897","15/04 12:00","33","P3996","Erofili PAPATHANASIOU","3","B","13b. Bacterial infections","Double strike of Mycoplasma pneumoniae: from respiratory infection to RIME syndrome, a diagnosis not to be ignored","O. Vasilaki|E. Protonotariou|L. Skoura|C. Savopoulos|E. Papathanasiou|M. Kyziroglou|E. Keskilidou|G. Meletis|E. Ztriva|G. Polychronopoulos|P. Mantzana"
"2901","15/04 12:00","34","P3997","Lamiss MEJDOUBI","3","B","13b. Bacterial infections","Tuberculous endometritis: a rare cause of pyometra in a postmenopausal woman","L. Mejdoubi|A. Nader|R. Weichselbaum"
"2964","15/04 12:00","35","P3998","James Roderick GRIFFITHS","3","B","13b. Bacterial infections","Breaking ground: a rare case of Legionella longbeachae in a gardener","J. Griffiths|K. Bamford|G. Vanstone|A. Ainarozidou|T. De Beer|D. Cain"
"2973","15/04 12:00","36","P3999","Grazieli MABONI","3","B","13b. Bacterial infections","Whole genome sequencing-guided clinical management of fastidious bacterial infections","G. Maboni|A. Mackinney|I. Luo|B. Velayudhan"
"2988","15/04 12:00","37","P4000","Nirlep AGRAVEDI","3","B","13b. Bacterial infections","Ceftriaxone-induced severe agranulocytosis and neutropaenia leading to benzylpenicillin therapy in bacterial meningitis","N. Agravedi|J. Coleman|Y. Uraiby|A. Chue"
"3040","15/04 12:00","38","P4001","Azlina IBRAHIM","3","B","13b. Bacterial infections","Ocular bartonellosis in a virologically suppressed HIV patient","A. Ibrahim|A. Khamshah|R. Mohd Noh|N. Ahmad Tarmizi|C. Leong|I. Ismail"
"3045","15/04 12:00","39","P4002","Andrea COVINGTON","3","B","13b. Bacterial infections","A single centre review of sulbactam/durlobactam for the treatment of serious Acinetobacter baumannii infections","A. Covington|J. Hornak|S. Ferren|N. Zaidan"
"3059","15/04 12:00","40","P4003","Jaya BISWAS","3","B","13b. Bacterial infections","Chronic sexually acquired reactive arthritis, associated with extragenital Mycoplasma genitalium infection in an MSM: a case report","J. Biswas|A. Basu|R. Choudhary|B. Khaitan|B. Dhawan"
"3329","15/04 12:00","41","P4004","Till OTHMER","3","B","13b. Bacterial infections","Clearance of Mycobacterium abscessus with elexacaftor/tezacaftor/ivacaftor in a patient with cystic fibrosis","T. Othmer|L. Schaupp|Z. Syunyaeva|J. Roehmel|S. Thee|M. Stahl|M. Mall"
"3404","15/04 12:00","42","P4005","Romina KARDASHI","3","B","13b. Bacterial infections","Vascular endograft infection with Listeria monocytogenes: a case series","R. Kardashi|A. Frenz|A. Boiti|K. Schneider|S. Rössler|K. De With"
"3465","15/04 12:00","43","P4006","Jolene Shi En LOI","3","B","13b. Bacterial infections","Nodular secondary syphilis: a case report","J. Loi|D. Ren|H. Chia|Z. Thng|S. Ho"
"3467","15/04 12:00","44","P4007","Antonella POCOGNOLI","3","B","13b. Bacterial infections","Rifampicin resistance tuberculosis with phenotypic susceptibility rifampicin: a case report","A. Pocognoli|L. Teodori|S. Caucci|D. Trotta|G. Zeni|G. Morroni|A. Masucci|F. Orecchioni|M. Moretti|S. Staffolani|M. Tavio"
"3494","15/04 12:00","45","P4008","Elena BOTTAREL","3","B","13b. Bacterial infections","How did it catch the patient's eye?","E. Bottarel|M. Armellini|E. Tacconelli|M. Conti|F. Cioli Puviani"
"3527","15/04 12:00","46","P4009","Maria De Las Huertas GARCIA ATIENZA","3","B","13b. Bacterial infections","Mycobacterium tuberculosis in the hepatic hilum as a cause of erythema induratum of Bazin","M. Garcia Atienza|H. Gil Campesino|J. Alcoba Florez|J. Gonzalez Rodriguez|J. Rodriguez Gonzalez"
"3541","15/04 12:00","47","P4010","Chengmin SHENG","3","B","13b. Bacterial infections","Anti-tuberculosis therapy combined with ventriculoperitoneal shunt for tuberculous meningitis combined with hydrocephalus: a case report","C. Sheng|K. Xu"
"3573","15/04 12:00","48","P4011","Tajana JUZBASIC","3","B","13b. Bacterial infections","Molecular characterisation of multidrug-resistant Campylobacter jejuni in Croatia: insights from a case of recurrent infection","T. Juzbasic|N. Andrijasevic|I. Ferencak|D. Juric|S. Soprek|L. Zmak|V. Poje Janes|A. Tambic Andrasevic|A. Gveric Grginic"
"3593","15/04 12:00","1","P4012","Souvik CHAUDHURI","4","B","13b. Bacterial infections","Incidental hypervirulent Klebsiella pneumoniae pyogenic liver abscess in an elderly diabetic woman","D. Nagendra|V. Aditya|R. Neeraja|S. Chaudhuri|V. Shanbhag|M. Varma|K. Vandana|V. R. Bhat|P. Priya"
"3682","15/04 12:00","2","P4013","Federico FRONDIZI","4","B","13b. Bacterial infections","The role of molecular methods for blood culture-negative endocarditis due to Bartonella quintana complicated by ANCA-associated microscopic polyangiitis","F. Frondizi|G. Leanza|F. Giovannenze|F. Cammertoni|G. Scoppettuolo|M. Sanguinetti|M. Calabrese|R. Baccaro|N. Pavone|A. Lombardo|E. Taddei|R. Graffeo|M. La Sorda|G. Menchinelli|M. Lucia|C. De Vivo|C. Torti"
"3749","15/04 12:00","3","P4014","Giovanni DEL FABRO","4","B","13b. Bacterial infections","To shoot a basket: a challenging diagnosis of Whipple with respiratory involvement","G. Del Fabro|A. Scarda|E. Sigura|A. Baraggiotta|S. Venturini|I. Bramuzzo|A. Callegari|M. Crapis|F. Canal|U. Zuccon|P. Brosolo"
"3755","15/04 12:00","4","P4015","Lorenza ROMANI","4","B","13b. Bacterial infections","Cefiderocol use in critically ill children: targeted therapy through Therapeutic Drug Monitoring (TDM) application","L. Romani|S. Mercadante|S. Cairoli|R. Simeoli|C. Tripiciano|S. Chiurchiù|F. Calo Carducci|E. Tumbarello|M. Di Nardo|E. Manno|L. Dei Giudici|P. Bernaschi|L. Lancella|B. Goffredo|M. De Luca|L. Vallesi|T. Corsetti|M. Pereyra Boza|V. Cortazzo"
"3774","15/04 12:00","5","P4016","Samavia MEHMOOD","4","B","13b. Bacterial infections","Unexpected invasion: salmonella septic arthritis in an infant","S. Mehmood"
"3855","15/04 12:00","6","P4017","Olivia FUNK","4","B","13b. Bacterial infections","Non-faecium, non-faecalis endocarditis: a case report and in vitro analysis of Enterococcus casseliflavus","O. Funk|D. Cao|P. Saunders-Hao|T. Inzana|J. Cusumano|M. Epstein|B. Farber"
"3858","15/04 12:00","7","P4018","Na LI","4","B","13b. Bacterial infections","Personalised bacteriophage therapy for chronic biliary tract Pseudomonas aeruginosa infections","N. Li|L. Linlin|D. Tan|C. Zhou|R. Bao|S. Le|B. Hu"
"3899","15/04 12:00","8","P4019","Sara MEIRINHOS","4","B","13b. Bacterial infections","Emergent bacteraemia caused by Streptococcus sinensis in a case of possible endocarditis in a Portuguese hospital","M. Bragança|M. Gomes|S. Meirinhos|B. Carvalho|L. Almeida"
"3976","15/04 12:00","9","P4020","Jamilah SHUBEILAT","4","B","13b. Bacterial infections","A case of native valve endocarditis secondary to Micrococcus luteus","J. Shubeilat|S. Nagarakanti"
"3992","15/04 12:00","10","P4021","Casandra BULESCU","4","B","13b. Bacterial infections","Think outside the box for immunocompromised patients: unusual presentation of recurrent Ureaplasma urealyticum pelvic infection: diagnostic and therapeutic approach","C. Bulescu|C. Curtelin|C. Deyrolle|O. Aumont|C. Cazanave|S. Pereyre|E. Forestier|A. Bosch"
"3996","15/04 12:00","11","P4022","Federica CICCONE","4","B","13b. Bacterial infections","Subacute stroke secondary to tuberculous meningitis complicated by acute hydrocephalus and device-associated CNS Candida albicans infection","F. Ciccone|V. Petrone|F. Longo|V. Vola|E. Binetti|S. Covino|F. Nuti|S. Valeri|G. Savelloni|M. Candy|P. Pasculli|M. Zingaropoli|M. Bologna|C. Mastroianni|M. Ciardi"
"4005","15/04 12:00","12","P4023","Dominic SPARKES","4","B","13b. Bacterial infections","Lactococcus garviae endocarditis with associated vasculitis and aortic mycotic aneurysm: a case report","D. Sparkes|M. Routledge|D. Hulse|A. Stewart"
"4038","15/04 12:00","13","P4024","Arianna LIPPI","4","B","13b. Bacterial infections","Sternal osteomyelitis due to KPC-producing Klebsiella pneumoniae in a lung transplant recipient: successful treatment with meropenem/vaborbactam","A. Lippi|D. Bennett|A. Fossi|C. Catelli|M. Fabbiani|F. Franchi|E. Bargagli|L. Luzzi|M. Tumbarello|F. Montagnani"
"4060","15/04 12:00","14","P4025","Niamh REIDY","4","B","13b. Bacterial infections","""Hard to see, harder to treat"": Mycoplasma hominis causing complex postpartum infection","N. Reidy|M. O Donoghue|S. Kenny|S. Lapthorne|T. Healy|S. Mc Loughlin|N. Ahmed|F. Mc Carthy|K. Fitzmaurice|J. Walsh|A. Doherty|G. Corcoran|C. Hickey"
"4086","15/04 12:00","15","P4026","Giacomo STROFFOLINI","4","B","13b. Bacterial infections","Successful management of a complicated prosthetic sternal allograft infection in an oncologic patient","G. Stroffolini|A. Tedesco|R. Romano|G. Perroni|D. Gavezzoli|P. Orza|V. Montresor|A. Angheben"
"4133","15/04 12:00","16","P4027","Elena MATTEINI","4","B","13b. Bacterial infections","Cavernous sinus tuberculosis presenting as Tolosa-Hunt syndrome: a case report","E. Matteini|A. Carbone|L. Vahedi|G. Cucinotta|G. Maiuro|I. Izzi|A. Losito|A. Cingolani|C. Torti"
"4137","15/04 12:00","17","P4028","Mohamed TOORANI","4","B","13b. Bacterial infections","Rapidly-growing mycobacteria causing catheter-related bloodstream infections in paediatric haematology patients: a case series","M. Toorani|S. Rory Hicks|F. Aliyuda|A. Hawker|Z. Aiken"
"4140","15/04 12:00","18","P4029","Amani BOUABDALLAH","4","B","13b. Bacterial infections","Palatal and gingival tuberculosis: beware of the unusual localisations!","A. Bouabdallah|H. Ben Hmida|H. Ghorbel|H. Azzouzi|L. Zrelli|M. Gargouri"
"4155","15/04 12:00","19","P4030","Arianna LIPPI","4","B","13b. Bacterial infections","Dorsal necrotising fasciitis originating from lung abscess in a patient with multiple sclerosis","A. Lippi|M. Trezzi|I. Rancan|M. Fabbiani|P. D'onofrio|P. Paladini|T. Ligabue|L. Grimaldi|F. Roviello|R. Piagnarelli|S. Giannotti|G. Colasanti|M. Tumbarello|G. Giuliano|F. Montagnani"
"4199","15/04 12:00","20","P4031","Maria Luisa GURRUCHAGA YANES","4","B","13b. Bacterial infections","When nocardiosis spreads: multisystemic infection in a patient treated with ruxolitinib","M. Gurruchaga Yanes|M. Roche Matheus|M. Urrutikoetxea-Gutierrez|E. Ugalde Zárraga|M. Nieto Toboso|J. Diaz De Tuesta Del Arco|M. Unzaga Baranano|M. Elcano Garcia"
"4231","15/04 12:00","21","P4032","Vera SCHWIERZECK","4","B","13b. Bacterial infections","Plasmid-encoded AMR gene duplications during antibiotic therapy in Klebsiella pneumoniae isolates: two cases in clinical practise","V. Van Almsick|A. Sobkowiak|N. Scherff|F. Schuler|A. Mellmann|V. Schwierzeck"
"4247","15/04 12:00","22","P4033","Maria Soledad MARTINEZ","4","B","13b. Bacterial infections","Superinfection by Salmonella enteritidis in a tumoral lymphadenopathy due to lymphoma in an HIV patient: a rare presentation","M. Martinez|C. Royo-Cebrecos|J. Casal|O. Sarroca"
"4258","15/04 12:00","23","P4034","Stephen CONNOLLY","4","B","13b. Bacterial infections","Severe bullous skin rash likely precipitated by Mycoplasma pneumoniae infection","S. Connolly|R. Barry|A. White|T. Ramsbottom|B. Crowley|J. Gale|S. Clarke"
"4295","15/04 12:00","24","P4035","Christopher LOFTUS","4","B","13b. Bacterial infections","The bitter taste of Brucella: an illustrative case series","C. Loftus|J. Jervis|V. Owen|R. Fernando|T. Wingfield|R. Ball|W. Wong|C. Evans|C. Darlow|S. Batley|A. Gerada|S. Woolley"
"4393","15/04 12:00","25","P4036","Sena ISTANBULLU","4","B","13b. Bacterial infections","The overlooked cause of infective endocarditis: Brucella","S. Istanbullu|S. Ucer|C. Ataman Hatipoglu|E. Kaya Kilic|S. Altun Demircan|S. Senol|U. Öztoprak Siyah|Z. Seri|G. Tuncer Ertem|S. Kinikli"
"4458","15/04 12:00","26","P4037","Joan GOMEZ JUNYENT","4","B","13b. Bacterial infections","Caution with probiotics! A case report of Lacticaseibacillus casei bacteraemia associated with probiotic use in a patient with predisposing risk factors","J. Poblet Florentin|C. Iglesias|J. Gomez Junyent|M. Esplugas|M. Moreno|I. Pelegrin|E. Sendra|S. Castaneda|L. Sorli Redo|S. Gomez-Zorrilla|M. Montero|J. Horcajada"
"4462","15/04 12:00","27","P4038","Markus HELL","4","B","13b. Bacterial infections","A case of ulceroglandular tularemia with prolonged-relapsing course for a period of five years finally successfully treated with an oral combination therapy with delafloxacin and rifampicin for the first time","M. Hell|D. Schmid"
"4478","15/04 12:00","28","P4039","Chiara ALDIERI","4","B","13b. Bacterial infections","Emergence of a daptomycin-resistant MRSA strain following dalbavancin treatment for diabetic foot infection with osteomyelitis","C. Aldieri|F. Piana|E. Borgogno|D. Vitullo|V. Del Bono|R. Curetti"
"4486","15/04 12:00","29","P4040","Francesca CATANIA","4","B","13b. Bacterial infections","Ultrasound findings in patients with tuberculous epididymo-orchitis trigger microbiological diagnostic interventions","F. Catania|D. Hella|T. Kumwenda|D. Hodson|C. Wallrauch|T. Heller|F. Taccari|R. Murri|C. Torti"
"4490","15/04 12:00","30","P4041","Federico ROMANI","4","B","13b. Bacterial infections","A rare case of Listeria monocytogenes endophthalmitis: diagnosis and therapeutic approach","M. Albertini|F. Romani|I. Baldisserotto|A. Cervo|C. Mussini|A. Santoro"
"4503","15/04 12:00","31","P4042","Noran AL-KOFAHI","4","B","13b. Bacterial infections","Ureaplasma, less innocent than it seems: a case of polyarticular septic arthritis in an immunocompromised host","N. Al-Kofahi|E. Birkhamshaw|K. Kaur|S. Williams"
"4506","15/04 12:00","32","P4043","Ana Maria ARNAIZ-GARCIA","4","B","13b. Bacterial infections","Clinical experience with the use of ceftobiprole: study in two hospitals in northern Spain","A. Arnaiz Garcia|P. Hernández Hernández|J. Méndez Legaza|R. Zarrabeitia Puente|L. Perez-Perianez Orrillo|S. Fernandez Rubio|S. Velasco De La Fuente|S. Lopez Garrido|R. Portilla Chocarro|M. Anta Fernández"
"4526","15/04 12:00","33","P4044","Pilar GADEA","4","B","13b. Bacterial infections","Mycobacterium chelonae infection post aesthetic application of botulinum toxin","L. Bermúdez|M. Vola|M. Mansilla|P. Gadea"
"4557","15/04 12:00","34","P4045","Frantisek STEJSKAL","4","B","13b. Bacterial infections","Autochthonous spotted fever group rickettsiosis and human granulocytic anaplasmosis diagnosed in the Czech Republic","F. Stejskal|D. Labusova|J. Wnuk|S. Wnukova|N. Sojkova|K. Kybicová|M. Trojánek|M. Kracik|A. Vitous"
"4561","15/04 12:00","35","P4046","Jie TONG","4","B","13b. Bacterial infections","Case report: Yersinia pseudotuberculosis infection mimicking GI malignancy with liver metastases in a 63-year-old patient","J. Tong|H. El-Mugamar|S. Paget|A. Sivaramakrishnan"
"4571","15/04 12:00","36","P4047","María Fernanda MERCADO TORRES","4","B","13b. Bacterial infections","Disseminated infection due to Listeria monocytogenes in a patient treated with daratumumab: an emerging adverse effect","M. Mercado Torres|M. Calva Galván|S. Guzmán Tepetla|M. Viveros Terrazas|J. Garcia Méndez"
"4586","15/04 12:00","37","P4048","Pilar GADEA","4","B","13b. Bacterial infections","Buruli ulcer due to Mycobacterium ulcerans in a travel patient from Suriname, South America","P. Gadea|M. Vola|Z. Arteta|S. Tapia|M. Calgaro|E. Garcia"
"4639","15/04 12:00","38","P4049","Marcelo Victor RADISIC","4","B","13b. Bacterial infections","Surgical infection due to Rosenbergiella epipactidis","M. Radisic|C. Vay|C. Martinez|S. Haim|T. Poklepovich Caride|M. Almuzara|A. Terusi"
"4645","15/04 12:00","39","P4050","Isabel Cristina RAMÍREZ-SÁNCHEZ","4","B","13b. Bacterial infections","Pan-resistant Pseudomonas aeruginosa infection in a liver transplant recipient: case report","I. Ramirez-Sanchez|D. Oquendo Gaona"
"4655","15/04 12:00","40","P4051","Pilar GADEA","4","B","13b. Bacterial infections","Disseminated cutaneous nocardiosis: a clinical case report","V. Frantchez|P. Gadea|M. Breijo|M. Querejeta|Z. Arteta|I. Fernandez"
"4688","15/04 12:00","41","P4052","Rita Alexandra ROJAS FERMIN","4","B","13b. Bacterial infections","Spinal tuberculosis in an undetectable long term HIV patient: the role of early diagnosis and multidisciplinary management","Y. Reyes|J. Ledesma|R. Rojas|L. Chaddy"
"4723","15/04 12:00","42","P4053","Gabriela SEVILLANO","4","B","13b. Bacterial infections","Comparative genomics and molecular characterisation of probiotic Bacillus clausii isolated from a case of bacteraemia","S. Campos-Mino|G. Sevillano|A. Herrera|J. Ramirez|J. Zurita"
"4730","15/04 12:00","43","P4054","Laura MARTINS RANGEL","4","B","13b. Bacterial infections","A rare presentation of perianal tuberculosis abscess in a immunocompetent man: a case report","L. Martins Rangel|T. Areas Lisboa Netto|A. Figueiredo Accetta|B. Balzano De La Fuente Villar Zimmermann"
"4737","15/04 12:00","44","P4055","Karina Maria ESPAILLAT GENAO","4","B","13b. Bacterial infections","The perfect storm in an HIV patient: a case report","K. Espaillat|A. Fernández|J. Cruz|K. Rodriguez|A. Villegas|C. Blanco|X. Rodriguez|T. Flores"
"4758","15/04 12:00","45","P4056","Vildan AVKAN-OGUZ","4","B","13b. Bacterial infections","Prosthetic joint infections caused by Mycobacterium tuberculosis: single centre experience","A. Nazli|A. Ghaffari|V. Avkan-Oguz|N. Esen"
"4801","15/04 12:00","46","P4057","Seolah LEE","4","B","13b. Bacterial infections","Delayed diagnosis of tuberculosis meningoencephalitis finally identified by external ventricular drain PCR","S. Lee|H. Kim|S. Ahn|S. Ahn|K. Chu"
"4820","15/04 12:00","47","P4058","Ana Raquel FERNÁNDEZ","4","B","13b. Bacterial infections","An unusual cause of necrotising infection: Vibrio mimicus","A. Fernández|K. Espaillat|J. Cruz|K. Rodriguez|A. Villegas|X. Rodriguez|T. Flores"
"4842","15/04 12:00","48","P4059","Ana Raquel FERNÁNDEZ","4","B","13b. Bacterial infections","A confusing meningitis: Weissella confusa","A. Fernández|K. Espaillat|K. Rodriguez|J. Cruz|E. Medrano|G. Ferrara|X. Rodriguez|C. Blanco|T. Flores"
"4852","15/04 12:00","1","P4060","Julio CRUZ","5","B","13b. Bacterial infections","Double threat: cervical abscess caused by Enterococcus avium associated with community-acquired Burkholderia cepacia bacteraemia","J. Cruz|A. Fernández|K. Rodriguez|K. Espaillat|A. Villegas|X. Rodriguez|T. Flores"
"4879","15/04 12:00","2","P4061","Abhishek PATIL","5","B","13b. Bacterial infections","A series of three cases of Rickettsial fever complicating as symmetrical peripheral gangrene (SPG) and purpura fulminans","A. Patil|N. Limaye|K. Joshi"
"4920","15/04 12:00","3","P4062","Joana Marie MAGLINTE","5","B","13b. Bacterial infections","Disseminated Mycobacterium abscessus infection in a 24-year-old female: a case report","J. Maglinte"
"4976","15/04 12:00","4","P4063","Jiayang HUANG","5","B","13b. Bacterial infections","Guillain-Barré syndrome (GBS) associated with intravanous polymyxin E methanesulfonate","J. Huang|J. He"
"5025","15/04 12:00","5","P4064","Rajat GOYAL","5","B","13b. Bacterial infections","A case of multidrug-resistant disseminated nocardia otitidiscaviarum infection in an immunocompromised male patient","R. Goyal|D. Meena|N. Kaur|P. Bhellum|M. Dhaka|S. Kombade|S. Mehrotra|A. Bazal"
"5040","15/04 12:00","6","P4065","Diego ERDMENGER","5","B","13b. Bacterial infections","Bilateral neuroretinitis associated with Bartonella henselae: a rare case in Guatemala","K. Algaba|L. Rodriguez|D. Erdmenger|F. Pezzarossi|B. Lopez|M. Martinez|A. Davila"
"5042","15/04 12:00","7","P4066","Simone TOPPINO","5","B","13b. Bacterial infections","Neuroborreliosis presenting as meningoencephalitis with cerebral vasculitis","S. Toppino|J. Sumer|A. Lauber|T. Dittrich|G. Kägi|S. J. Albert"
"5146","15/04 12:00","8","P4067","Maria Katerina MALLARI-MALAYA","5","B","13b. Bacterial infections","Emerging opportunistic pathogen: a case series on Ralstonia mannitolilytica-associated infections","K. Oliveros|H. Alfonso|M. Mallari-Malaya|S. Bacolcol|C. Tibayan"
"5152","15/04 12:00","9","P4068","Shireen Yan Ling TAN","5","B","13b. Bacterial infections","Recurrent symptomatic infection with macrolide resistant Mycoplasma pneumoniae in an immunocompromised adult patient","S. Tan|H. Yingtaweesittikul|C. Suphavilai|K. Ko|N. Nagarajan|W. Ong|J. Yeo|K. Lim|K. Lim|P. Boonsimma|Y. Tan|K. Chan|B. Tan|T. Tan|L. Oon"
"5170","15/04 12:00","10","P4069","Marina DA RÓS MALACARNE","5","B","13b. Bacterial infections","First reported case of Streptococcus pluranimalium in Brazil","L. Seif Eddine|L. Brandao Carneiro|J. Von Doellinger Andrade Dos Santos|D. Borges Mielke|E. Toffoli Pandini|F. Dalapicula Amorim|R. Aguiar Gatti|M. Da Ros Malacarne"
"5171","15/04 12:00","11","P4070","Mahra ALMHEIRI","5","B","13b. Bacterial infections","Meningococcal bacteremia presenting as acute pericarditis, a rare clinical challenge","M. Almheiri|A. Zyara|M. Mohamad"
"5182","15/04 12:00","12","P4071","Twishi SHRIMALI","5","B","13b. Bacterial infections","An unusual source of Burkholderia cenocepacia outbreak in a neonatal intensive care unit","T. Shrimali|V. Tak|A. Singh|N. Gupta"
"5207","15/04 12:00","13","P4072","Sarah KENNY","5","B","13b. Bacterial infections","Cold-blooded culprit: a rare pulmonary pathogen","S. Kenny|N. Reidy|T. Healy|S. Mc Loughlin|A. Doherty|N. Mullane|J. Walsh|C. Hickey|J. Kiely|G. Corcoran|S. Lapthorne|A. O' Shea"
"5216","15/04 12:00","14","P4073","Maria João LOPES","5","B","13b. Bacterial infections","Diagnostic challenges in immunosupressed patients: post-pneumococcal meningitis vasculitis and unmasking IRIS with pulmonary aspergilloma","M. Alves|J. Batista|F. Peruzzu|M. Lopes"
"5250","15/04 12:00","15","P4074","Ummu Afeera ZAINULABID","5","B","13b. Bacterial infections","Brain abscess or meningeal myelomatosis? A case of Nocardia otitidiscaviarum in a post-transplant multiple myeloma patient","U. Zainulabid|X. Cheong|N. Kori|H. Wan Hanafi|S. Abdul Wahid|A. Basir|A. Zainudin|R. Ramli|P. Periyasamy"
"5273","15/04 12:00","16","P4075","Jordi RIERA","5","B","13b. Bacterial infections","Subtherapeutic exposure to linezolid in a critically ill patient on extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration: a case report","M. Sosa Garay|M. Negre González|S. Garcia Garcia|P. Lalueza Broto|M. Gorgas Torner|E. Gallart|X. Nuvials-Casals|A. Pau-Parra|M. Martinez Pla|L. Doménech Moral|J. Doménech Vila|A. Conto Asprilla|L. Castellote Belles|G. Marin Vivo|E. Del Barrio|J. Riera"
"5314","15/04 12:00","17","P4076","Francesca DI BARTOLOMEO","5","B","13b. Bacterial infections","Shewanella putrefaciens: an emerging foe from climate change","F. Di Bartolomeo|R. Ligresti|S. Pettenuzzo|T. Bini|C. Tincati|G. Marchetti"
"5333","15/04 12:00","18","P4077","Anette FRIEDRICHS","5","B","13b. Bacterial infections","Fuchs syndrom as first presentation of atypical pneumonia by M.pneumoniae","F. Hinrichsen|D. Pape|G. Heine|A. Fazel|E. Hansen|A. Friedrichs|C. Kujat"
"5405","15/04 12:00","19","P4078","Salomé GALLEMAERS","5","B","13b. Bacterial infections","Successful treatment of a brain abscess caused by Nocardia farcinica with ceftriaxone despite in vitro resistance: a case report highlighting diagnostic and therapeutic challenges","S. Gallemaers|E. Larranaga Lapique|D. Martiny|M. Hites"
"5464","15/04 12:00","20","P4079","Katrien TIMMERMANS","5","B","13b. Bacterial infections","Ureaplasma parvum septic arthritis in a patient with monogenic common variable immunodeficiency (LRBA Deficiency): diagnostic challenges in distinguishing infection from autoimmunity","K. Timmermans|L. Naesens|D. Huis In 't Veld|S. Callens|S. Vandendriessche"
"5537","15/04 12:00","21","P4080","Gemma VANSTONE","5","B","13b. Bacterial infections","A rare case of disseminated Bacillus Calmette-Guérin (BCG) following bladder cancer","G. Vanstone|V. Perks|A. Evans"
"5624","15/04 12:00","22","P4081","Mark CANITA","5","B","13b. Bacterial infections","Disseminated tuberculosis infection involving the thoracic spinal cord and GUT in PLHIV","M. Canita|E. Edrada|J. Arches|J. Verona"
"5642","15/04 12:00","23","P4082","Daniel PABLO MARCOS","5","B","13b. Bacterial infections","A challenge for clinical suspicion: abdominal pain in Lyme neuroborreliosis","L. Pérez Fernández|D. Pablo Marcos|I. De Benito Poblacion|A. Rodriguez-Fernandez|Z. Moure Garcia|G. Martinez de las Cuevas|M. Arsenio Polanco|L. Avert|M. Roiz Mesones"
"5699","15/04 12:00","24","P4083","Rosario CULTRERA","5","B","13b. Bacterial infections","Post-traumatic infection by Stenotrophomonas maltophilia in a one-year-old patient treated with cefiderocol: determination of the therapeutic dose","R. Cultrera|M. Gatti|M. Michelini|A. Marra|D. Segala|B. Quarta|D. Persichetti Proietti|S. Ambretti|C. Vella"
"5701","15/04 12:00","25","P4084","Lu SUN","5","B","13b. Bacterial infections","Healthcare-associated ST5 MRSA causing severe pseudomembranous enteritis in intensive care unit","L. Sun|F. Zhu|Y. Chen"
"5764","15/04 12:00","26","P4085","Fernanda UNDURRAGA SCHULER","5","B","13b. Bacterial infections","Impact of continuous infusion of ceftolozane/tazobactam in the treatment of extensively drug resistant Pseudomonas aeruginosa infections","F. Undurraga|N. Diaz|C. Conde|F. Zamora|C. Bravo"
"5798","15/04 12:00","27","P4086","Lisa-Marie WACKERNAGEL","5","B","13b. Bacterial infections","Biofilm-associated Achromobacter xylosoxidans prosthetic valve infective endocarditis","L. Wackernagel|A. Moter|T. Kruis|P. Menzel|L. Sander|F. Kurth|J. Kikhney|T. Lingscheid"
"5814","15/04 12:00","28","P4087","Navneet KAUR","5","B","13b. Bacterial infections","A young male with chest wall swellings and lymphadenopathy: actinomycosis mimicking lymphoproliferative disease","N. Kaur|T. Kanagiri|M. Shah|Y. Khatod|N. T. R.|S. Khichar|D. Kumar|D. Aggarwal|D. Datta|G. Bohra"
"5907","15/04 12:00","29","P4088","Siobhan O'REGAN","5","B","13b. Bacterial infections","Diagnostic complexity of a rare case of empyema necessitans due to Actinomyces israelli in Ireland","S. O' Regan|S. Fauzi|E. Newman|C. Moran|A. Almajrafi|I. O' Dea|J. O' Halloran|C. Mejia-Chew|S. Savinelli|P. Mallon|C. O' Broin|E. Feeney"
"6027","15/04 12:00","30","P4089","Martin VIDLICKA","5","B","13b. Bacterial infections","It's RIME time: mucocutaneous complications amidst the recent rise in incidence of Mycoplasma pneumoniae","M. Vidlick|V. Jegorova|O. Beranek|T. Ernestova|L. Kohout|G. Meseznikov|A. Nycova|R. Sindlerova|M. Tulach|Z. Uhrikova|B. Bizova|F. Rob|M. Trojánek|P. Drevinek|M. Stefan"
"6053","15/04 12:00","31","P4090","Cláudio SILVA-NUNES","5","B","13b. Bacterial infections","Management of a critically ill patient with refractory Clostridioides difficile infection: a case report on the role of tigecycline","C. Silva-Nunes|A. Martins|A. Silva-Pinto|A. Santos|A. Ferreira|S. Xerinda|P. Figueiredo|L. Santos"
"6057","15/04 12:00","32","P4091","Elena HERNÁNDEZ SÁNCHEZ","5","B","13b. Bacterial infections","In atypical cases... never stop striving for microbiological confirmation","E. Hernández-Sánchez|J. Gallego Peris|A. Blasco Claramunt|O. Pérez Olaso"
"6084","15/04 12:00","33","P4092","Ramakrishnan SIVASANKARAN","5","B","13b. Bacterial infections","A lump in the eye and a bump behind the knee with febrile neutropaenia","R. Sivasankaran|P. Rupali"
"6123","15/04 12:00","34","P4093","Izaskun ALEJO CANCHO","5","B","13b. Bacterial infections","Description of five tularemia cases detected in a tertiary hospital of the Basque country in Spain during 2024","A. Sanchez-Diaz|C. Gomez-Gonzalez|I. Sanjosé-Muniz|C. Garcia-Escudero|E. Saez De Adana|M. Gurrutxaga Olano|I. Alejo Cancho|Z. Ortiz De Zárate|S. Hernáez-Crespo|M. Lecaroz|J. Arribas|J. Ayensa|M. Fernández-Torres|M. Gomez-Ruiz De Arbulo|J. Gainzarain|A. Canut"
"6138","15/04 12:00","35","P4094","Lukas KOHOUT","5","B","13b. Bacterial infections","Q-fever as a surprising cause of a “doxycycline-deficiency syndrome”","L. Kohout|V. Grebenyuk|V. Jegorova|O. Beranek|G. Meseznikov|A. Nycova|B. Pisova|Z. Uhrikova|M. Vidlicka|M. Tulach|E. Nycova|M. Trojánek|M. Stefan"
"6170","15/04 12:00","36","P4095","Jonnel POBLETE","5","B","13b. Bacterial infections","Streptococcus suis bacteraemia presenting as acute meningitis and bilateral hearing loss in an adult Filipino male","J. Poblete|J. Santos|I. Ditan|C. Francisco"
"6199","15/04 12:00","37","P4096","Elena HERNÁNDEZ SÁNCHEZ","5","B","13b. Bacterial infections","A severe case of leptospirosis pulmonary haemorrhage","E. Hernández-Sánchez|N. Tornador Gaya|M. Escrivà Fornes|R. Álvaro Sánchez|M. Gil Fortuno|A. Blasco Claramunt|P. Monllor Taltavull|L. Mata Caudevilla"
"6259","15/04 12:00","38","P4097","Michael MCNAMARA","5","B","13b. Bacterial infections","An uncommon presentation of Clostridioides difficile bacteraemia in a young adult","M. Mcnamara|C. Mulrooney|G. Chan|E. Harkin"
"6288","15/04 12:00","39","P4098","Maria KAMPEROGIANNI","5","B","13b. Bacterial infections","A case of thrombotic microangiopathy/uraemic haemolytic syndrome (HUS) triggered by Campylobacter jejuni: gastroenteritis in a patient heterozygous for mutation in the CD4+6 gene","A. Poula|V. Karampali|E. Evangelou|A. Tsakalos|T. Poulli|A. Athanasopoulou|M. Orfanidou|A. Yiaskouri|A. Michelaki|M. Kamperogianni"
"6301","15/04 12:00","40","P4099","Leyla AKGUL","5","B","13b. Bacterial infections","The hidden threat of infliximab: atypical tuberculosis ileitis mimicking lymphoma","S. Gul Yurtsever|S. Emecen|L. Akgul|A. Sener|S. Akar"
"6318","15/04 12:00","41","P4100","Uchechika IROEGBU","5","B","13b. Bacterial infections","Utilising PCR for diagnosing challenging cases of Mycobacterium genavense infections in immunocompromised patients","U. Iroegbu|C. Hall|F. Mcgill"
"6459","15/04 12:00","42","P4101","Monprach HARNPHADUNGKIT","5","B","13b. Bacterial infections","Disseminated Mycobacterium abscessus infection presented with blur vision in patient with anti-interferon-gamma autoantibody","M. Harnphadungkit|P. Payoong"
"6474","15/04 12:00","43","P4102","Selene Rebecca BONCOMPAGNI","5","B","13b. Bacterial infections","First detection of a Stenotrophomonas acidaminiphila strain causing an infection in an immunocompromised patient in Europe","S. Boncompagni|L. Graziani|A. Bartoloni|S. De Chiara|T. Giani|G. Rossolini"
"6500","15/04 12:00","44","P4103","Emilie DE MUYNCK","5","B","13b. Bacterial infections","Campylobacter fetus endocarditis in an elderly patient with immunosuppression","E. De Muynck|S. Driezen|D. Schelfaut|K. Van Vaerenbergh|Y. Overmeire|L. Cattoir|A. Boel"
"6554","15/04 12:00","45","P4104","Vincent JEAN-PIERRE","5","B","13b. Bacterial infections","Identification of the emerging OXA-484 carbapenemase in a mother-to-child Escherichia coli infection and detection concerns","V. Jean-Pierre|P. Sorlin|M. Benyahia|F. Aujoulat|M. Morsli|M. Di Maio|C. Magnan|J. Lavigne|H. Marchandin|A. Pantel|M. Safarian"
"6605","15/04 12:00","46","P4105","Kohei SHIOTA","5","B","13b. Bacterial infections","Tuberculosis osteitis of the thumb in an immunocompetent adolescent with a suspected malignant tumor","K. Shiota"
"6650","15/04 12:00","47","P4106","Javier DE ARÍSTEGUI BENGOECHEA","5","B","13b. Bacterial infections","When imaging deceives: treatable metastases in an oncolgical pacient?","J. De Aristegui Bengoechea|I. Carmona Garcia|L. Garcia Lara|A. Tonda Selles|M. Sepúlveda|V. Cano Llorente"
"6669","15/04 12:00","48","P4107","José María LÓPEZ-PINTOR","5","B","13b. Bacterial infections","Peritonitis caused by Actinomyces meyeri in a patient with rectal cancer","M. Asencio|J. Sanchez-Lopez|M. Huertas|J. Gaitan|J. Lopez-Pintor"
"6710","15/04 12:00","1","P4108","Matteo SALA","6","B","13b. Bacterial infections","The role of ibrutinib as a risk factor in central nervous system nocardiosis: a case report","M. Sala|R. Pesare|M. Piazza|E. Maffezzini|M. Cerri|A. Copes|M. Fava|S. Rimoldi|A. Regazzetti|E. Segalini|S. Storti|G. Paioli|G. Pagani"
"6717","15/04 12:00","2","P4109","Vasileios ANGELOPOULOS","6","B","13b. Bacterial infections","A rare case of tuberculosis: immune reconstitution inflammatory syndrome (TB-IRIS) in an HIV-negative patient","V. Angelopoulos|A. Papanikolaou|A. Ladias|K. Kostikas|A. Konstantinidis|A. Assioura|C. Chronis|E. Salla"
"6729","15/04 12:00","3","P4110","Mary Paz ROCHE MATHEUS","6","B","13b. Bacterial infections","Actinomyces meyeri and pleural empyema: a diagnostic challenge","M. Roche Matheus|I. Pérez Ramos|M. Larrauri Garcia|D. Fernández Vecilla|M. Unzaga Baranano|J. Diaz De Tuesta Del Arco"
"6743","15/04 12:00","4","P4111","Mary Paz ROCHE MATHEUS","6","B","13b. Bacterial infections","Mycotic aortic aneurysm: a rare and severe complication of Bacillus Calmette-Guérin therapy","M. Roche Matheus|J. Aragon Diez|M. Larrauri Garcia|M. Unzaga Baranano|O. Ferrero Benitez|M. De La Pena Trigueros|S. Ibarra Ugarte|J. Diaz De Tuesta Del Arco"
"6754","15/04 12:00","5","P4112","Maeve LEONARD","6","B","13b. Bacterial infections","A case of carbapenemase-producing Enterobacterales (CPE) bloodstream infection in a high-risk obstetric patient in the post-natal period","M. Leonard|R. Waldron|R. Mulqueen|A. Taylor|M. Dempsey"
"6807","15/04 12:00","6","P4113","Maimuna MOHAMUD","6","B","13b. Bacterial infections","All the weil: Leptospira and Klebsiella co-infection","M. Mohamud|T. Mohamud|T. Kanitkar|M. Anil|S. Mubashir|A. Whittington"
"6834","15/04 12:00","7","P4114","Conor MULROONEY","6","B","13b. Bacterial infections","Verotoxigenic Escherichia coli bacteraemia: a paradigm of One Health","C. Mulrooney|S. Sarfraz|J. Britton|L. Moran|T. Teoh|M. Doyle|F. Zeb|G. Chan"
"6855","15/04 12:00","8","P4115","Costanza TRIPICIANO","6","B","13b. Bacterial infections","Spontaneous loss of antibiotic-resistant plasmid in a strain of KPC-producing Klebsiella pneumoniae responsible for multiple septic episodes in a paediatric patient","C. Tripiciano|M. De Luca|G. Vrenna|V. Fox|S. Raimondi|L. Romani|M. Di Giuseppe|L. Cursi|L. Lancella|P. Bernaschi"
"6948","15/04 12:00","9","P4116","Lorenz LISTA","6","B","13b. Bacterial infections","Conservative management of coronary artery mycotic aneurysm due to Salmonella enteritidis in a patient with immune thrombocytopenic purpura","L. Lista|M. Ariola-Ramos"
"6965","15/04 12:00","10","P4117","Sara BENEDETTI","6","B","13b. Bacterial infections","Missed opportunities: diagnostic delays in tuberculous salpingitis leading to irreversible infertility","S. Benedetti|A. Lippi|M. Tumbarello|A. Bailoni|M. Trezzi|M. Tumbarello"
"7039","15/04 12:00","11","P4118","Selma BOUHERAOUA","6","B","13b. Bacterial infections","First description of carbapenamase-producing hypervirulent Klebsiella pneumoniae in Algeria","F. Djedjig|F. Assaous|H. Ammari|S. Bouheraoua|J. Ifticen|D. Yala|S. Mahrane|H. Tali Maamar"
"7169","15/04 12:00","12","P4119","Rossana ROSA","6","B","13b. Bacterial infections","Primary peritonitis due to Streptococcus pyogenes in previously healthy woman","R. Rosa|P. Kolb|C. Black|R. Boisvert|Z. Aslam"
"7185","15/04 12:00","13","P4120","Tom WHITEHEAD","6","B","13b. Bacterial infections","It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria","T. Whitehead|H. Zaw|B. Angus|I. Elliott|M. Fry|K. Jeffery|N. Jones|J. Mccrae|N. Stoesser|M. Tsakok|T. Wangrangsimakul|M. Brook|X. Chan"
"7214","15/04 12:00","14","P4121","Carlos TARRAZO TARRAZO","6","B","13b. Bacterial infections","Combination therapy with cefazolin and ertapenem for the treatment of persistent methicillin-sensitive Staphylococcus aureus bacteraemia","C. Tarrazo Tarrazo|J. Valdés Bécares|N. Prado Alonso|S. Garcia Ledo"
"7226","15/04 12:00","15","P4122","Linda CHAN","6","B","13b. Bacterial infections","A case report and genomic analysis of a cefiderocol non-susceptible Escherichia coli strain in the absence of carbapenemase gene","L. Chan|C. Li|J. Li|W. Lee|K. Lai|M. Ip|C. Chow"
"7227","15/04 12:00","16","P4123","Xi CAO","6","B","13b. Bacterial infections","Probable doxycycline-induced acute pancreatitis: case report and literature review","X. Cao"
"7271","15/04 12:00","17","P4124","Natalia GONZÁLEZ ESPINOSA","6","B","13b. Bacterial infections","Genomic insights non carbapenemase-producing Klebsiella pneumoniae with high-level of resistance to carbapenems, ceftazidime/avibactam and cefiderocol: a new enemy?","N. González Espinosa|J. Gutiérrez Ballesteros|V. Cerpa Almenara|L. Tejedor Cantero|J. Guevara Osorio|B. Requejo Baruque|M. Gomez Diaz|M. Uruena Garcia|S. Rojo Rello|J. Eiros Bouza|T. Nebreda Mayoral|M. Cuervo Abarquero|M. Hernández Pérez|I. Lopez Mestanza"
"7296","15/04 12:00","18","P4125","Deniz ÖÇÇETIN","6","B","13b. Bacterial infections","Rare involvement of right-sided native valve endocarditis due to Corynebacterium striatum: a case report","D. Öççetin|E. Saricaoglu|I. Akdemir|G. Cinar|E. Gulten|S. Sezer|I. Akbulut Koyuncu|A. Heper|S. Eryilmaz|A. Azap"
"7311","15/04 12:00","19","P4126","Ana MUÑOZ GOMEZ","6","B","13b. Bacterial infections","The end of splenectomy: safety and efficacy of percutaneous CT-guided drainage in the management of Salmonella spp. splenic abscess","A. Guzmán Carreras|C. Olmos Mata|J. Pérez-Somarriba Moreno|M. Nunez Orantos|N. Cabello Clotet|M. Carralon Gonzalez|J. Barrado Cuchillo|V. Victor Palomares|Á. Nava Munoz|V. Estrada Pérez|A. Munoz Gomez"
"7333","15/04 12:00","20","P4127","Chloé DUPONT","6","B","13b. Bacterial infections","A ten-year history of disseminated Mycobacterium bovis infection following BCG therapy for non-invasive bladder cancer: a monocentric retrospective study with a literature review","P. Josuha|M. Nicolas|C. Guilhem|D. Chloé|G. Sylvain"
"7370","15/04 12:00","21","P4128","Asjad PERVEZ","6","B","13b. Bacterial infections","Development of neuroborellosis despite early antibiotic therapy for erythema migrans","A. Pervez|N. Ahmad|C. Sadlier|K. Fitzmaurice"
"7392","15/04 12:00","22","P4129","Anne-Marie DOLAN","6","B","13b. Bacterial infections","Clinical outcomes, epidemiology, and risk factors of Klebsiella liver abscesses: insights from an Irish tertiary hospital case series","A. Dolan|D. Persad|T. Hoban|R. Connolly|M. Trozs-Grzybowska"
"7451","15/04 12:00","23","P4130","Domingo FERNANDEZ VECILLA","6","B","13b. Bacterial infections","Genomic characterisation of isolates of the rare K2-ST66 sublineage within the hypervirulent Klebsiella pneumoniae (HvKp) pathotype","D. Fernández Vecilla|J. Rodriguez Grande|N. Fraile Valcárcel|D. Vallejo Iriarte|P. Bustamente De La Escalera|M. Roiz Mesones|J. Calvo Montes|A. Ocampo Sosa"
"7497","15/04 12:00","24","P4131","Kate JACKSON","6","B","13b. Bacterial infections","Mycobacterium tilburgii infection in an HIV-negative older male patient","K. Jackson|J. Hebert|E. De Barra"
"7503","15/04 12:00","25","P4132","Joannard BRUNE","6","B","13b. Bacterial infections","Emergence and reversion of rifampicin resistance during discontinuous treatment of tuberculosis in an HIV patient","B. Joannard|C. Genestet|O. Dumitrescu|S. Roux|L. Van-Den-Bogaart|S. Soueges|S. Landre|Q. Testard|F. Ader|E. Hodille"
"7509","15/04 12:00","26","P4133","Michelle ABBOTT","6","B","13b. Bacterial infections","Using dalbavancin and oritavancin for the treatment of acute skin and skin structure infection in the emergency department: our experience","M. Abbott|G. Ciusa|A. Mancuso|G. Pipitone|A. Ficalora|S. Agrenzano|F. Guida Marascia|A. Gizzi|C. Imburgia|A. D'alcamo|L. Moscarelli|P. Marrone|M. Geraci|A. Cascio|C. Iaria"
"7513","15/04 12:00","27","P4134","Domingo FERNANDEZ VECILLA","6","B","13b. Bacterial infections","Recurrent infection by a K30-ST198 hypervirulent Klebsiella pneumoniae (HvKp)","D. Fernández Vecilla|J. Rodriguez Grande|N. Fraile Valcárcel|D. Vallejo Iriarte|P. Bustamente De La Escalera|M. Roche Matheus|G. Iglesias Hidalgo|M. Roiz Mesones|J. Calvo Montes|A. Ocampo Sosa"
"7560","15/04 12:00","28","P4135","Stefano DE GIORGI","6","B","13b. Bacterial infections","Disseminated Mycobacterium genavense infection in immunocompromised patient","S. Torri|S. De Giorgi|S. Renica|N. Lo Re|A. Nava|D. Fanti|C. Vismara"
"7567","15/04 12:00","29","P4136","Claudia IMBURGIA","6","B","13b. Bacterial infections","Outpatient parenteral antimicrobial therapy (OPAT) using elastomeric pump: a stewardship programme","C. Imburgia|G. Ciusa|G. Pipitone|M. Abbott|F. Guida Marascia|A. Gizzi|R. Puccio|R. Ficalora|A. Sanfilippo|S. Agrenzano|P. Amari|M. Marsala|V. Mazzarese|C. Iaria"
"7622","15/04 12:00","30","P4137","Ghaydaa ABOU DAHER","6","B","13b. Bacterial infections","Bacillus cereus infection: an emerging pathogen in war injuries","G. Abou Daher|C. Challita|S. Kanj|N. Zahredine|R. Ahmadieh"
"173","15/04 12:00","32","P4139","Bonita VAN DER WESTHUIZEN","6","B","13c. Fungal infections","A case series: the distribution, patient characteristics, therapy and patient outcome in culture positive mold and dimorphic fungal infections in HIV positive patients in a tertiary hospital in the Free state province, South Africa","B. Van Der Westhuizen|S. Potgieter"
"512","15/04 12:00","33","P4140","Lordieliza MELENDREZ","6","B","13c. Fungal infections","Meningoradiculitis in a diabetic patient: a rare case of Cryptococcus neoformans infection","L. Melendrez|R. Llorin"
"883","15/04 12:00","34","P4141","Tarsila VIECELI","6","B","13c. Fungal infections","Long-term outcomes of two cases of COVID-19-associated mucormycosis","T. Vieceli|D. Falci|A. Pasqualotto"
"1025","15/04 12:00","35","P4142","Bonita VAN DER WESTHUIZEN","6","B","13c. Fungal infections","A case series: the distribution, patient characteristics, therapy and patient outcome in culture positive invasive mold infections in patients with heamatological conditions in a tertiary hospital in the Free state province, South Africa","S. Potgieter|B. Van Der Westhuizen"
"1113","15/04 12:00","36","P4143","Hugo BES BERLANDIER","6","B","13c. Fungal infections","Successful prolonged induction therapy resumption for probable disseminated cryptococcosis relapse during consolidation phase in patient with relapsing Hodgkin's lymphoma: a case report","H. Bes-Berlandier|J. Stellmann|S. Berro|J. Schiano|P. Berger|B. Choufi|C. Sohn|E. Menu|C. L'ollivier|P. Ramtohul|S. Ranque|J. Sevestre|A. Deschamps|G. Imbert|O. Marchand|Z. Sabouni|C. Solas|R. Guilhaumou"
"1139","15/04 12:00","37","P4144","Jose BAEZA ROS","6","B","13c. Fungal infections","An exceptional case of infective endocarditis caused by Exophiala dermatitidis","J. Baeza Ros|M. Martinez Toldos|G. Yague Guirao|E. Aguilar Monino|G. Valero Chazarra|A. Ortin Freire|J. Aguilar Jiménez|I. Garrido-Bravo|E. Escudero Moral"
"1265","15/04 12:00","38","P4145","Tse Hua Nicholas WONG","6","B","13c. Fungal infections","Hormographiella aspergillata elbow infection","J. Kang|S. Tan|M. Tan|T. Wong"
"1399","15/04 12:00","39","P4146","Sireethorn NIMITVILAI","6","B","13c. Fungal infections","Pneumocystis jirovecii diagnosed in the bone marrow of an HIV-infected patient: a case report and review of literature","S. Nimitvilai|W. Labsongsuk|K. Anankamart"
"1444","15/04 12:00","40","P4147","Nicolas LAVERDE-SUDUPE","6","B","13c. Fungal infections","Disseminated histoplasmosis and presumptive CNS toxoplasmosis-associated immune reconstitution inflammatory syndrome in a patient with HIV/AIDS: a case report","N. Laverde-Sudupe|E. Carr|B. Velit-Rios|M. Morel-Almonte|J. Castro"
"1550","15/04 12:00","41","P4148","Fernando CENTENO","6","B","13c. Fungal infections","Use of microbial cell-free DNA next-generation sequencing for the diagnosis of histoplasmosis in a quaternary healthcare centre","F. Centeno|T. Lasco|M. Al Mohajer"
"1655","15/04 12:00","42","P4149","Sandeep RAO KORDCAL","6","B","13c. Fungal infections","First case report of fungal periprosthetic joint infection caused by Candida viswanathii","S. Rao Kordcal|S. Sikdar|I. Xess|N. Nischal|M. Priyadarshi|S. Spalkit|G. Singh|T. Maula"
"1939","15/04 12:00","43","P4150","Kimberly Rose OLIVEROS","6","B","13c. Fungal infections","Invasive dermatophyte in the blood stream of an HIV positive patient","H. Alfonso|A. Roman|L. Cebrian|A. Rayos|K. Oliveros"
"2144","15/04 12:00","44","P4151","Pablo ÁVILA FRANCO","6","B","13c. Fungal infections","Rare invasive fungaemia by Saprochaete: an emerging life-threatening pathogen for oncoheamatological patients","P. Ávila|I. Merino Velasco|B. Lorenzo Vidal|S. Jimenez Álvarez|M. Dominguez Gil Gonzalez|L. Puente Fuertes|L. Iotti|Y. Martinez Oliveros|J. Eiros Bouza"
"2169","15/04 12:00","45","P4152","Angeliki STATHI","6","B","13c. Fungal infections","Mucormycosis following post-traumatic fusariosis in an immunocompetent adolescent after a pedestrian accident","E. Petridou|K. Spyridopoulou|A. Loupatatzi|A. Vardakastani|A. Milioni|S. Kritikou|M. Stefanou|N. Poniros|I. Anastasopoulos|A. Velegraki|L. Zachariadou|A. Stathi"
"2454","15/04 12:00","46","P4153","Princess Mae PETALLANA","6","B","13c. Fungal infections","A rare case of amphotericin B resistant disseminated Cryptococcosis in a non-HIV adult patient","P. Petallana|J. Verona"
"2555","15/04 12:00","47","P4154","Omayra CHINCHA","6","B","13c. Fungal infections","A case of chronic multifocal Paracoccidioidomycosis in a farmer from Peru????","C. Mcfarlane|O. Chincha|C. Seas"
"2691","15/04 12:00","48","P4155","Laudy RIVERO RODRÍGUEZ","6","B","13c. Fungal infections","Prevalence and clinical characteristics of Neoscytalidium spp. infections in a Canary Islands hospital: a ten-year retrospective analysis and literature review","L. Rivero Rodriguez|D. Adrados Ruiz|I. Hernandez Caceres|M. Hernandez Betancor|A. Alastruey Izquierdo|L. Alcazar Fuoli|I. De Miguel Martinez"
"2854","15/04 12:00","1","P4156","Carolina VEGA-RIVERA","7","B","13c. Fungal infections","Coccidiodal infection causing spinal arachnoiditis and longitudinally extensive transverse myelitis in an HIV-infected person","C. Vega-Rivera|J. Diaz-Vintimilla|A. Avalos-Arias|J. Garcia-Minamy|J. Casadiego-Durán|B. Callejas-Arroyo|K. Carillo-Loza|L. Ramirez-Gonzalez"
"2997","15/04 12:00","2","P4157","Sunish SHAH","7","B","13c. Fungal infections","Pharmacokinetic interaction between isavuconazole and rifabutin in a real-world setting","S. Shah|L. Clarke|L. Georgiades|R. Rivosecchi"
"3031","15/04 12:00","3","P4158","Hiroo MATSUO","7","B","13c. Fungal infections","A case of pulmonary infection caused by Trametes elegans and Peniophora incarnata in a patient with advanced AIDS","H. Matsuo|M. Niki|S. Kutsuna"
"3061","15/04 12:00","4","P4159","Diego ERDMENGER","7","B","13c. Fungal infections","Diagnostic challenges in fungal spine infections: a case of Pichia kudriavzevii","K. Algaba|L. Rodriguez|D. Erdmenger|B. Lopez|J. Carcamo|M. Lopez|V. Chamale"
"3104","15/04 12:00","5","P4160","Iriagbonse OSAIGBOVO","7","B","13c. Fungal infections","Paediatric cryptococcosis in a southern Nigerian tertiary hospital","I. Osaigbovo|M. Agun-Ebreme|A. Sadoh"
"3158","15/04 12:00","6","P4161","Anne MUST","7","B","13c. Fungal infections","Comparative evaluation of antifungal susceptibility testing and genomic analysis in Nakaseomyces glabratus isolates from an elderly patient with urosepsis","A. Must|K. Klaos|O. Karhu|L. Lilje|R. Russanova|S. Koljalg|K. Kermes|K. Loivukene|J. Pullat|A. Tamm"
"3358","15/04 12:00","7","P4162","Arianna BELLATI","7","B","13c. Fungal infections","Invasive aspergillosis in Cushing's syndrome: a case report and literature review","M. Fezzi|A. Bellati|E. Piccinno|A. Savoldi|D. Girelli|E. Tacconelli|A. Azzini"
"3533","15/04 12:00","8","P4163","Dongdong REN","7","B","13c. Fungal infections","A case of talaromycosis-associated haemophagocytic lymphohistiocytosis in human immunodeficiency virus","D. Ren|P. Rao|H. Teo|K. Lim|L. Chong|X. Ang"
"3564","15/04 12:00","9","P4164","Haran SCHLAMM","7","B","13c. Fungal infections","Fosmanogepix expanded access case series in patients with mucormycosis","A. Puing|A. Kaur|Y. Lee|P. Chang|A. Koff|D. Tyungu|M. Oldham|M. Shaughnessy|A. Tande|H. Schlamm|J. Maertens"
"3675","15/04 12:00","10","P4165","Nina GRASSELLI KMET","7","B","13c. Fungal infections","Successful use of rezafungin for treatment of Candida albicans spondylodiscitis","N. Grasselli Kmet|R. Luzzati|S. Babich|C. Jacopo|D. Stefano"
"3711","15/04 12:00","11","P4166","Patrick VAN DIJCK","7","B","13c. Fungal infections","Survival of the ""unfittest"": clinical emergence of hyper-multidrug-resistant Nakaseomyces (Candida) glabrata with nonfunctional Erg3 and Erg11 and severely impaired fitness","J. Vreys|V. Biriukov|C. Lobo Romero|J. Herrera Avila|D. Sofras|G. Vanreppelen|B. Xavier|T. Gabaldon|K. Lagrou|R. Naesens|P. Van Dijck|H. Carolus"
"3852","15/04 12:00","12","P4167","Satyendra KHICHAR","7","B","13c. Fungal infections","Unmasking the uncommon: histoplasmosis-induced HLH in an immunocompetent adult","S. Angirekula|M. Shah|K. Chowdary|N. Kumaran|S. Palekar|N. Jaine|S. Jagennath|S. Khichar|A. Purohit|G. Bohra"
"3885","15/04 12:00","13","P4168","Mohammadreza SALEHI","7","B","13c. Fungal infections","Posaconazole-induced gynecomastia: a case report","M. Salehi|H. Khalili|F. Zamani|A. Kazemzadeh|M. Alaei"
"4073","15/04 12:00","14","P4169","André SILVA-PINTO","7","B","13c. Fungal infections","Refractory bronchospasm in pulmonary mucormycosis: a therapeutic challenge in haematological patients","A. Silva-Pinto|C. Nunes-Silva|A. Martins|J. Bastos|J. Araujo|R. Pinto|A. Santos|P. Figueiredo|L. Santos"
"4123","15/04 12:00","15","P4170","Harsimran KAUR","7","B","13c. Fungal infections","Refractory mycotic keratitis by Cephalotheca foveolata: first report from India","H. Kaur|I. Jamir|D. Sharma|H. Ahmad|A. Gupta|A. Ghosh|S. Rudramurthy"
"4257","15/04 12:00","16","P4171","Gabriela Andrea MARTINEZ QUINTERO","7","B","13c. Fungal infections","Trichosporon inkin isolated from a pacemaker pocket infection","G. Martinez Quintero|M. Lopez Lomba"
"4274","15/04 12:00","17","P4172","Pedro LEAL","7","B","13c. Fungal infections","Post vacation blues: cerebral phaeohyphomycosis by two fungi in a traveller to Thailand","P. Leal|T. Baptista|K. Mansinho|C. Reizinho|S. Matos|C. Toscano"
"4305","15/04 12:00","18","P4173","Victoria CASTAÑO","7","B","13c. Fungal infections","Disseminated histoplasmosis and hemophagocytic syndrome: diagnostic and treatment challenges in a non-endemic setting","J. Merino|S. Casado|J. Silva|F. Castelbon|I. Munoz-Gallego|A. Pérez De Ayala|M. Castano-Amores"
"4468","15/04 12:00","19","P4174","Elizabeth ISKANDAR","7","B","13c. Fungal infections","Fungal keratitis caused by Scedosporium apiospermum in an immunocompetent patient: how challenging can treatment get?","E. Iskandar|N. Ferraro|F. Secchi|G. Ferrari|A. Pitrolo|P. Rama|F. Baldanti|C. Cavanna"
"4481","15/04 12:00","20","P4175","D. F GOMEZ BOADA","7","B","13c. Fungal infections","Osteoarticular mycoses caused by Geotrichum candidum: case report","D. Gomez Boada|J. Albarracin Reyes"
"4483","15/04 12:00","21","P4176","Filipe PROHASKA BATISTA","7","B","13c. Fungal infections","Efficacy of isavuconazole in the treatment of pulmonary fusariosis in a patient with acute promyelocytic leukemia: a case report","F. Prohaska Batista|C. Pires|L. Cavalcanti|L. Gueiros|E. Coelho"
"4512","15/04 12:00","22","P4177","Maria N. GAMALETSOU","7","B","13c. Fungal infections","Two separate invasive fungal infections post-CAR T-cell therapy with favorable outcome","P. Voutsinas|A. Anastasopoulou|K. Tsaprouni|A. Tsifi|M. Lefaki|P. Petsa|A. Benekou|O. Apostolou|A. Pantazatou|G. Siasou|I. Georgalas|M. Angelopoulou|M. Gamaletsou"
"4625","15/04 12:00","23","P4178","Weili ZHANG","7","B","13c. Fungal infections","mNGS combined with traditional microbiology identifies the first case of Candida auris in southwest China","W. Zhang|D. Zhou|M. Kang"
"4738","15/04 12:00","24","P4179","Diego ERDMENGER","7","B","13c. Fungal infections","A rare complication of spinal anesthesia: chronic meningitis due to Sporothrix schenckii","K. Algaba|L. Rodriguez|D. Erdmenger|S. Castro-Conde|B. Lopez|F. Pezzarossi|L. Alejandro|S. Aguilar|C. Arango|D. Posadas|C. Cosenza"
"4782","15/04 12:00","25","P4180","Ricardo TRIGUEROS","7","B","13c. Fungal infections","Isolated basal ganglia mucormycosis-antifungal salvage regimen for an uncommon presentation of an emerging life-threatening disease","J. Trigueros|T. Winstead"
"4785","15/04 12:00","26","P4181","Luis URIBE","7","B","13c. Fungal infections","Histoplasmosis in renal transplant patients: case series in a reference hospital in Colombia","L. Uribe|D. Barrera|S. Gelvez|L. Hernandez|S. Rincon"
"5142","15/04 12:00","27","P4182","Kim HENRY","7","B","13c. Fungal infections","Persistent undocumented meningoencephalitis due to histoplasmosis in an HIV-infected patient in Brazil","K. Henry|U. Françoise|C. Durand|C. Salloum|F. About|O. Lesens|S. Weber|F. Djossou|M. Zappa|L. Epelboin|P. Leturnier"
"5267","15/04 12:00","28","P4183","Vera TODISCO","7","B","13c. Fungal infections","Successful treatment of Cryptococcal meningitis with single-dose liposomal amphotericin B in Europe: report of two cases","T. Vera|S. Antonella|E. Sara|D. Martina|F. Beatrice|A. Cervo|C. Mussini|F. Casari"
"5300","15/04 12:00","29","P4184","Paolo PAVONE","7","B","13c. Fungal infections","Radiological evolution in central nervous system aspergillosis: a transient worsening is not associated with treatment failure","P. Pavone|E. Delmonte|C. Pavone|E. Salsi|E. Garlassi|C. Solera Horna|L. Facchini|A. Imovilli|F. Ilariucci|F. Merli|R. Pascarella|S. Mezzadri"
"5400","15/04 12:00","30","P4185","Jing LIU","7","B","13c. Fungal infections","Human pythiosis: a rare spondylitis caused by pythium insidiosum","G. Zeng|J. Liang|Z. Chen|T. Zhou|S. Chen|Z. Lei|L. Xu|J. Dong|J. Liu"
"5525","15/04 12:00","31","P4186","Wafa AL SARKHI","7","B","13c. Fungal infections","CNS phaeohyphomycosis in solid organ transplant recipients: two cases report","W. Al Sarkhi|A. Al Jabri"
"5610","15/04 12:00","32","P4187","Samavia MEHMOOD","7","B","13c. Fungal infections","Primary cutaneous Absidia infection in a premature newborn","S. Mehmood"
"5618","15/04 12:00","33","P4188","Ummu Afeera ZAINULABID","7","B","13c. Fungal infections","Emerging fungal threat: fatal invasive Candida lipolytica bloodstream infection in a postoperative patient","U. Zainulabid|X. Cheong|N. Kori|A. Zainudin|T. Khaithir|P. Periyasamy"
"5623","15/04 12:00","34","P4189","Elisa MATARAZZO","7","B","13c. Fungal infections","Talaromyces marneffei pneumonia diagnosed at Niguarda hospital, Milan, Italy","E. Matarazzo|L. Romeo|E. Di Gennaro|M. Chiamenti|A. Nava|D. Fanti|G. Lombardi|M. Puoti|C. Vismara"
"5627","15/04 12:00","35","P4190","Manan SHAH","7","B","13c. Fungal infections","Diabolic trinity: a rare coalescence of mucormycosis, aspergillosis, and tuberculosis in a young diabetic female","M. Shah|S. Angirekula|Z. Sanga|K. Choudhary|N. T. R.|S. Jagennath|D. Kumar|N. Midha|S. Tiwari|V. Jain|N. Roy|G. Bohra"
"5788","15/04 12:00","36","P4191","David Michael WELLER","7","B","13c. Fungal infections","Into thin air: limited therapeutic options in a hyperimmunoglobulin E syndrome patient with pulmonary aspergilloma","D. Weller|S. Brugger|S. Hillinger|I. Schmitt-Opitz|A. Zinkernagel"
"6197","15/04 12:00","37","P4192","Vienne PINLAC","7","B","13c. Fungal infections","Successful treatment of pulmonary mucormycosis with a lower dose of amphotericin B deoxycholate in a Filipino kidney transplant recipient: a case report","V. Pinlac|T. Lee|M. Rosario|M. Mendoza|G. Pamugas|P. Zamora"
"6241","15/04 12:00","38","P4193","Piao XU","7","B","13c. Fungal infections","A case of HIV-negative patient infected with disseminated cryptococcosis with necrotising fasciitis of both lower limbs","P. Xu|J. Li"
"6266","15/04 12:00","39","P4194","Sardar Mohammad SHARAR SAMINUL ISLAM","7","B","13c. Fungal infections","Exophiala dermatitidis endocarditis of prosthetic aortic valve in an immunocompetent patient","S. Sharar Saminul Islam|B. Su|M. Barerra Ruiz|C. Eades"
"6439","15/04 12:00","40","P4195","Amelia JOSEPH","7","B","13c. Fungal infections","A case series of severe urological infections with Nakaseomyces glabratus; the association between sodium-glucose co-transporter-2 (SGLT-2) inhibitors and fungal urinary tract infections","A. Joseph|A. Wild"
"6551","15/04 12:00","41","P4196","Arthur LEMSON","7","B","13c. Fungal infections","Navigating the therapeutic dilemma: treatment considerations in Aspergillus and non-tuberculous Mycobacterial co-infection","A. Lemson|L. Michon|J. Van Ingen|R. Bruggemann|R. Aarnoutse|M. Reijers|W. Hoefsloot"
"6585","15/04 12:00","42","P4197","Mauricio ARIAS","7","B","13c. Fungal infections","First report of Apiospora arundinis causing fungal keratitis following bamboo-stick penetrating ocular trauma","M. Arias|A. Sideri|S. Jones|E. Johnson|A. Borman|A. Abdolrasouli"
"6608","15/04 12:00","43","P4198","Alison BURGESS","7","B","13c. Fungal infections","All that glitters is not gold","J. Dickens|A. Borman|O. Williams|J. Colston|A. Burgess"
"6812","15/04 12:00","44","P4199","Xiong Khee CHEONG","7","B","13c. Fungal infections","Dual threat: Rhizopus and Staphylococcus hemolyticus in acute mediastinitis in an immunocompetent host","X. Cheong|U. Zainulabid|N. Kori|W. Chang|C. Ding|T. Khaithir|P. Periyasamy"
"7043","15/04 12:00","45","P4200","Dorarca LYNCH","7","B","13c. Fungal infections","Breaking barriers: a case of Curvularia hawaiiensis in an immunocompetent host","D. Gallagher|H. Tuite|A. Holmes|I. Zaghi|D. Lynch"
"7178","15/04 12:00","46","P4201","Marco BERRUTI","7","B","13c. Fungal infections","Two cases of probable invasive polmunary aspegillosis in heamatological patients treated with polatuzumab","M. Berruti|R. Pincino|K. Sciolé|S. Tita Farinella|N. Forni|D. Laurenda|M. Migliorati|G. Cenderello"
"7269","15/04 12:00","47","P4202","Rongchen DAI","7","B","13c. Fungal infections","Discovery of an emerging rare fungal species infection through national surveillance","R. Dai|J. Guan|Y. Ning|T. Kudinha|W. Zhang|X. Chen|G. Zhang|Y. Xu|M. Xiao"
"7586","15/04 12:00","48","P4203","Layan AKKIELAH","7","B","13c. Fungal infections","Complex kidney re-transplant candidate with history of donor-derived candidaemia, endocarditis and mucormycosis","L. Akkiela|D. Eskandarani|A. Bannan|R. Shahmirzadi"
"364","15/04 12:00","1","P4204","Lilit ARAKELYAN","8","B","13d. Parasitic infections","Challenges of treatment of the patient with visceral leishmaniasis and podagra in resource-limited settings","A. Hovhannisyan|M. Shmavonyan|T. Baghdasaryan|L. Arakelyan|A. Stepanyan|D. Sukiasyan|R. Poghosyan|V. Asoyan"
"519","15/04 12:00","2","P4205","Manasvin ONWAN","8","B","13d. Parasitic infections","A mimicker of lymphatic filariasis presented with unilateral leg edema in a filariasis endemic area","M. Onwan|K. Wattanawinitchai|S. Charoensakulchai"
"629","15/04 12:00","3","P4206","Joanne HASTINGS","8","B","13d. Parasitic infections","Hepatic alveolar echinococcus in pregnancy: a case report","J. Hastings|J. Allen|N. Ramalingam|K. Woods|L. Nabarro|Z. Amin"
"6560","15/04 12:00",,"P4207","Pugazhvanan CHIDAMBARAM RAJENDRAN",,,"13d. Parasitic infections","Novel ZNF341 deficiency causing hyper-IgE syndrome in a young Indian female","V. Krishna|P. Chidambaram Rajendran"
"1103","15/04 12:00","5","P4208","Laddarat SRIKHAM","8","B","13d. Parasitic infections","Successful treatment of pulmonary hemorrhage secondary to Strongyloides stercoralis hyperinfection and pulmonary nocardiosis","L. Srikham"
"1353","15/04 12:00","6","P4209","Sajanee LENADORA","8","B","13d. Parasitic infections","Strongyloides disseminated infection in a kidney transplant patient: implications for transplant protocols: a case report","S. Lenadora|M. Abeykoon|I. Samaraweera|S. Athauda|K. Ranatunga|R. Morel"
"1552","15/04 12:00","7","P4210","Nicolas LAVERDE-SUDUPE","8","B","13d. Parasitic infections","Visceral and cutaneous leishmaniasis in an HIV positive patient","N. Laverde-Sudupe|A. Giraldo-Serna|M. Vasquez-Amaya|F. Carrera-Patino"
"1795","15/04 12:00","8","P4211","Ye Qiong XU","8","B","13d. Parasitic infections","A case of hookworm disease combined with Angiostrongylus cantonensis infection in a child","Y. Xu|J. Deng|C. Li"
"1931","15/04 12:00","10","P4213","Misael PUJOL PEREZ","8","B","13d. Parasitic infections","First documented case of cutaneous leishmaniasis in Puerto Rico: unravelling a diagnostic and therapeutic challenge","M. Pujol Perez|H. Melendez Gonzalez|G. Oliveras Cordero|Y. Veras Vazquez"
"1990","15/04 12:00","11","P4214","Ambrogio CURTOLO","8","B","13d. Parasitic infections","Alveolar Echinococcosis: a neglected disease to be considered even in non-endemic countries","A. Curtolo|P. Puzzi|T. Kamal Eldin"
"2467","15/04 12:00","12","P4215","Paola BELLINI","8","B","13d. Parasitic infections","Lung cysts: unveiling the mystery of a multiorgan parasite","P. Bellini|E. Bernasconi|N. Ramponi|A. Valenti|M. Patella|L. Carnino|M. Bongiovanni"
"3018","15/04 12:00","13","P4216","Sangeeta NAIR-COLLINS","8","B","13d. Parasitic infections","A case series of Acanthamoeba endopthalmitis: evaluation and management","S. Nair-Collins|L. Brumble|D. Miller|M. Stewart|I. Wagner"
"3176","15/04 12:00","14","P4217","Therese BERGSTRAND","8","B","13d. Parasitic infections","Zoonotic Onchocerca, an emerging parasite in Sweden: a case report","T. Bergstrand|F. Bäckström|J. Forsell|Z. Rohan|L. Davidsson|T. Lier|D. Tappe|B. Mathison|B. Pritt|A. Pettke"
"3472","15/04 12:00","15","P4218","Marcus PRATT","8","B","13d. Parasitic infections","Alveolar Echinococcus transmission in the UK, Ireland or Spain","M. Pratt|K. Jackson|H. Bond|C. Culbert"
"3725","15/04 12:00","16","P4219","Melania DEGLI ANTONI","8","B","13d. Parasitic infections","A rare case of bilateral pulmonary echinococcosis: diagnostic, surgical and therapeutic management","M. Degli Antoni|C. Colarossi|F. Paolillo|L. Zanichelli|A. Ruggieri|G. Ratti|G. Tagliaferri|N. Rossi|L. Gerna|G. Tocci|C. Gorrini|R. Delfanti|A. Mancini|M. Bolzoni|R. Corso|G. Lo Cascio|F. Trapani|G. Priante"
"4026","15/04 12:00","17","P4220","Luis MARTINS","8","B","13d. Parasitic infections","Hyperinfection syndrome caused by Strongyloides stercoralis","M. Favila Menezes|L. Nogueira Martins|B. Miguel|P. Gomes|P. Borralho|T. Baptista|M. Rego De Sousa"
"4045","15/04 12:00","18","P4221","Manju SEBASTIAN","8","B","13d. Parasitic infections","Severe trichinellosis as a presenting manifestation in advanced HIV","M. Sebastian|B. Fenn|K. S.|A. A.|N. Babu|V. M. C.|N. Mundadan|A. Gurudas|J. John|S. R."
"4635","15/04 12:00","19","P4222","Martin VIDLICKA","8","B","13d. Parasitic infections","Eosinophilia and multiple liver lesions following travel to Vietnam: a diagnostic challenge","M. Vidlicka|V. Grebenyuk|I. Zicklerova|T. Ernestova|J. Zitova|O. Beranek|L. Kohout|G. Meseznikov|A. Nycova|R. Sindlerova|M. Tulach|Z. Uhrikova|M. Stefan|F. Stejskal|M. Trojánek"
"5067","15/04 12:00","20","P4223","Xiong Khee CHEONG","8","B","13d. Parasitic infections","A devastating duo: widespread toxoplasmosis in an immunocompromised host","X. Cheong|H. Tan|J. Tan|N. Amir Hamzah|N. Mohamad Kani|P. Periyasamy|N. Kori|U. Zainulabid"
"6361","15/04 12:00","21","P4224","Hande HAZIR KONYA","8","B","13d. Parasitic infections","Two cases of rare life-long hydatid cyst disease","H. Hazir Konya|S. Ozturk|A. Inan|H. Ertabaklar"
"6800","15/04 12:00","22","P4225","Xiong Khee CHEONG","8","B","13d. Parasitic infections","A deceptive enemy: unmasking toxoplasma encephalitis IRIS in HIV hepatitis B coinfection individual with tuberculosis","P. Periyasamy|X. Cheong|U. Zainulabid|N. Kori"
"6894","15/04 12:00","23","P4226","Armanda LEKA","8","B","13d. Parasitic infections","Echinococcal cyst recurrence after successful treatment: a case supporting prolonged follow-up","A. Leka|G. D'alessandro|S. Frattola|R. Lissandrin|M. Maestri"
"6911","15/04 12:00","24","P4227","Fabio BRIVIO","8","B","13d. Parasitic infections","AIDS-related cholangiopathy and gastric cryptosporidiosis in a patient with newly diagnosed HIV infection: back to the past?","F. Brivio|A. Covizzi|D. Bernasconi|G. Gubertini|M. Schiavini|S. Grosso|L. Carsana|M. Tonolini|M. Nebuloni|A. Gori|E. Palomba"
"6969","15/04 12:00","25","P4228","Donini VIRGINIA","8","B","13d. Parasitic infections","Managing a case of Chagas disease with megaesophagus: lessons learned and pitfalls from a non endemic country","D. Virginia|B. Anna|M. Fabio|V. Francesco|F. Costanza|B. Alessandro|S. Michele|Z. Lorenzo"
"7017","15/04 12:00","26","P4229","Fareeha FAISAL","8","B","13d. Parasitic infections","A case of new world cutaneous leishmaniasis after military travel: successful management at a UK tertiary hospital","F. Faisal|E. Rudd|E. Muhammad|G. Acuram|A. Geremias|M. Desales|T. Lampejo|M. Arias"
"7250","15/04 12:00","27","P4230","Jhongert ALZA ARCILA","8","B","13d. Parasitic infections","Trimethoprim-sulfamethoxazole desensitisation: a lifesaver in Toxoplasma encephalitis in an allergic woman","J. Alza-Arcila|L. Guevara Saldana"
"272","15/04 12:00","28","P4231","Ni Luh Putu Harta WEDARI","8","B","13e. Other unusual clinical situations","Clostridioides difficile infection by hypervirulent TW11-RT078 strain in an elderly male: a case report","N. Wedari"
"363","15/04 12:00","29","P4232","Marco VISICARO","8","B","13e. Other unusual clinical situations","A rare case of Clostridium saudiense bacteraemia and the first systematic review of Clostridium celatum group infections","M. Visicaro|C. Puzzolante|F. Calandra Buonaura|C. Mussini|I. Venturelli|A. Grottola|G. Franceschi|M. Sarti|G. Fregni Serpini"
"653","15/04 12:00","30","P4233","Lilit ARAKELYAN","8","B","13e. Other unusual clinical situations","Uncovering the hidden cause of fever with hepatitis","L. Arakelyan|T. Baghdasaryan|A. Stepanyan|D. Sukiasyan|R. Poghosyan|V. Asoyan|M. Shmavonyan|A. Hovhannisyan"
"853","15/04 12:00","31","P4234","Mariam VARDANYAN","8","B","13e. Other unusual clinical situations","Diagnostic challenges associated with oropharyngeal form of tularemia","M. Vardanyan|G. Ohan|A. Hovhannisyan|K. Mnukyan|V. Asoyan"
"1050","15/04 12:00","32","P4235","Sara Emanuela SALVAGGIO","8","B","13e. Other unusual clinical situations","Reversible acute adrenal insufficiency caused by fluconazole overdosage in a critically ill patient","S. Ragozzino|F. Pelloni|C. Marzolini|S. Salvaggio|A. Chiesa|M. Previsdomini|L. Elzi"
"1546","15/04 12:00","33","P4236","María Fernanda MERCADO TORRES","8","B","13e. Other unusual clinical situations","Skin deep: an unusual presentation of recurrent endocarditis","M. Mercado Torres|M. Sánchez Romero|R. Olmedo-Reneaum|P. Castaneda Mendez|G. Arteaga Cárdenas"
"1706","15/04 12:00","34","P4237","Anne Marie DE MAN","8","B","13e. Other unusual clinical situations","Fever, abdominal pain and bilateral adrenal haemorrhage as initial presentation of idiopathic multicentric castleman disease with TAFRO syndrome","A. De Man|J. Ten Oever|R. Arts|M. Verduin|L. Smits"
"1936","15/04 12:00","35","P4238","Nina AKBAR","8","B","13e. Other unusual clinical situations","Double trouble: bone marrow failure secondary to infiltrating Cryptococcus and Mycobacterium avium complex in a patient with HIV","E. Skrynnikova|B. Nicolalde|P. Mariuz|K. Sullivan|B. Khandpur|N. Akbar"
"2000","15/04 12:00","36","P4239","Zarifa ORTA","8","B","13e. Other unusual clinical situations","Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-infected patients with Kaposi sarcoma: the first case series from a single centre in Turkey","Z. Orta|A. Cagatay|A. Benli|S. Basaran|S. Erdem|S. Besisik"
"2111","15/04 12:00","37","P4240","Xiangyan LI","8","B","13e. Other unusual clinical situations","A case series of adult infective patients with ureaplasma parvum detected by metagenomic next-generation sequencing-based technique","H. Ma|Y. Wang|X. Li|N. Huo"
"2113","15/04 12:00","38","P4241","Chee Yew YONG","8","B","13e. Other unusual clinical situations","Dual pathologies: tuberculous myelitis presenting with transverse myelitis and anterior spinal artery infarct","C. Yong|C. Toh|P. Presaad Pillai|R. Giri Shan|Y. Chia"
"2136","15/04 12:00","39","P4242","Mala KANERIA","8","B","13e. Other unusual clinical situations","Granulomatous lesions: is it always tuberculosis?","M. Kaneria|K. Vaidya|R. Chhabria|P. Mashru|R. Deshpande|J. Dabhar|G. Vaswani|A. Patil|S. Bhandare"
"2406","15/04 12:00","40","P4243","Chiara ALDIERI","8","B","13e. Other unusual clinical situations","Daptomycin induced eosinophilic pneumonia (DIEP): a single-centre case series","C. Aldieri|R. Curetti|M. Mondini|F. Sordella|E. Monge|E. Borgogno|D. Vitullo|V. Del Bono"
"2593","15/04 12:00","41","P4244","Devesh JOSHI","8","B","13e. Other unusual clinical situations","From fever to aneurysms: unraveling a rare infantile diagnosis","N. Gor|D. Joshi"
"2614","15/04 12:00","42","P4245","Mohammadreza SHAFIEI","8","B","13e. Other unusual clinical situations","Clinical and immunological features in a Bach2-deficient patient with recurrent infections and normal laboratory and immunologic tests result","M. Shafiei|Z. Cavooshzadeh"
"2658","15/04 12:00","43","P4246","Peize ZHANG","8","B","13e. Other unusual clinical situations","Successful treatment with contezolid in a patient with renal allograft tuberculosis and intractable tuberculous meningitis","W. Liu|T. He|W. Li|H. Qin|P. Zhang"
"2667","15/04 12:00","44","P4247","Tomaso BERINGHELI","8","B","13e. Other unusual clinical situations","Peripheral neuropathy during long-term therapy with tedizolid","T. Beringheli|C. Javaux|S. Roux|E. Braun|P. Chauvelot|S. Goutelle|T. Briot|J. Cottin|C. Dupieux-Chabert|J. Boulant|A. Conrad|F. Ader|T. Ferry|F. Valour"
"2795","15/04 12:00","45","P4248","Lena LIPPERT","8","B","13e. Other unusual clinical situations","Infections in palliative patients: how and when to change standard treatment?","L. Lippert|J. Ahn|F. Pfäfflin"
"3082","15/04 12:00","46","P4249","Jhongert ALZA ARCILA","8","B","13e. Other unusual clinical situations","Longitudinally extensive transverse myelitis as a complication due to varicella zoster virus in a de novo HIV woman","J. Alza-Arcila|A. Mesa Márquez|J. Bedoya Sánchez|S. Castrillon Fernandez"
"3532","15/04 12:00","47","P4250","Jessica TAYLOR","8","B","13e. Other unusual clinical situations","5'-TTAGGG-3': you're it! A tale of telomeric respiratory disease","J. Taylor|M. Simonds"
"3698","15/04 12:00","48","P4251","Stephen WOOLLEY","8","B","13e. Other unusual clinical situations","The management of suspected high consequence infectious disease (HCID) patients on a maritime platform: a forgotten art?","S. Woolley|A. Wood|S. Marshall|M. Lasmarias|N. Wong|L. Ratcliffe|M. Hoyle|M. Beadsworth"
"4255","15/04 12:00","1","P4252","Suzanne ENGLISH","9","B","13e. Other unusual clinical situations","Scarred for life? An infection specialist's approach to drug reaction with eosinophilia and systemic symptoms","S. English|R. Sullivan"
"4532","15/04 12:00","2","P4253","Diego Alberto CONDE-GUTIÉRREZ","9","B","13e. Other unusual clinical situations","Mycobacterium bovis lymph node tuberculosis mimicking lymphoma recurrence in a cirrhotic patient: a diagnostic challenge","D. Conde-Gutiérrez|J. Castillo-Alvarez|L. Arias-Ruiz|L. Rojo-Gutierrez|R. Dorantes-Heredia|R. Valdez-Vázquez|D. Aguilar-Zapata"
"4656","15/04 12:00","3","P4254","Jhongert ALZA ARCILA","9","B","13e. Other unusual clinical situations","Meningeal and orbital cryptococcosis a rare presentation in a non-HIV elderly male complicated with long refractory hypokalemia post-amphotericin exposure","J. Alza-Arcila|S. Castrillon Fernandez|J. Bedoya Sánchez|F. Rodriguez Montufar"
"4926","15/04 12:00","4","P4255","Weili ZHANG","9","B","13e. Other unusual clinical situations","A case of Japanese spotted fever complicated by haemophagocytic syndrome was detected through metagenomic next-generation","W. Zhang|P. Xu"
"4992","15/04 12:00","5","P4256","Cagla SARIKAS","9","B","13e. Other unusual clinical situations","A case of resistant Tuberculosis spondylodiscitis and psoas abscess","E. Ates|N. Sari|N. Kurt|C. Sarikas|Ö. Kurt Azap"
"5504","15/04 12:00","6","P4257","Karthick Kumar VAITHEESWARAN","9","B","13e. Other unusual clinical situations","Nail the diagnosis: lamivudine-induced periungual pyogenic granulomas in HIV","K. Vaitheeswaran|N. Nischal|N. Bhari|S. Arava|N. Wig"
"6175","15/04 12:00","7","P4258","Martina VARGOVIC","9","B","13e. Other unusual clinical situations","Advanced HIV infection with M. genavense and CMV disease: a case report","A. Atelj|M. Vargovic|M. Santini"
"6238","15/04 12:00","8","P4259","Alin-Stefan VIZITIU","9","B","13e. Other unusual clinical situations","A revelatory disease: how can a severe infection create problems of differential diagnosis in brain cancer?","A. Vizitiu|D. Olteanu"
"6316","15/04 12:00","9","P4260","Mai AHMED","9","B","13e. Other unusual clinical situations","New beginnings and old diseases","S. Gupta|M. Ahmed|N. Weston|M. Dedicoat|A. Johnson|A. Dhaliwal|A. Chue"
"6426","15/04 12:00","10","P4261","Emmanuel JIMENEZ VILLANUEVA","9","B","13e. Other unusual clinical situations","Porphyria cutanea tarda as a presentation of late-stage HIV infection","E. Jimenez Villanueva|C. Martinez Perez|F. Zuniga Rodriguez|A. Molina Cruz"
"6570","15/04 12:00","11","P4262","Sreethish SASI","9","B","13e. Other unusual clinical situations","Navigating diagnostic quandaries: a case series of diagnostic dilemmas in central nervous system (CNS) infections resolved by molecular sequencing","S. Sasi|M. Abukhattab|F. Abid|M. Ali|J. Parengal|W. Awouda|M. Hamed|F. Eltayeb|M. Al-Maslamani|A. Al-Khal"
"6617","15/04 12:00","12","P4263","Marion MURPHY","9","B","13e. Other unusual clinical situations","Sepsis and acidosis: mind the gap","S. Al Lawati|C. Merry|M. Murphy"
"6646","15/04 12:00","13","P4264","Taweegrit SIRIPONGBOONSITTI","9","B","13e. Other unusual clinical situations","Isolated oropharyngeal syphilitic condyloma lata, an unrecognised form of secondary syphilis: a case report","T. Siripongboonsitti|S. Srisungsuk|N. Piyawannarat"
"6713","15/04 12:00","14","P4265","Imene DELMA","9","B","13e. Other unusual clinical situations","Urinary tract infections due to uncommon pathogens: case series","I. Delma|A. Naceri|F. Hamadouche|A. Rahmani"
"6990","15/04 12:00","15","P4266","Najoua EL HELALI","9","B","13e. Other unusual clinical situations","Therapeutic drug monitoring (TDM) benefits in non-tuberculosis mycobacteria (NTM) infections treatment","N. El Helali|J. Rebai|N. Leveque|A. Le Monnier|C. Mory"
"7028","15/04 12:00","16","P4267","Valeria BROGNA","9","B","13e. Other unusual clinical situations","Inflammatory response in a patient with disseminated BCG infection: a diagnostic challenge","V. Brogna|V. Cogliandro|S. Foresti|I. Caramma|E. Colella|P. Bonfanti"
"7215","15/04 12:00","17","P4268","Jhongert ALZA ARCILA","9","B","13e. Other unusual clinical situations","Prostatic Tuberculosis and addition of moxifloxacin as a cornerstone of antituberculous treatment","P. Chilito Zemanate|J. Alza-Arcila"
"7583","15/04 12:00","18","P4269","Aileen CONWAY","9","B","13e. Other unusual clinical situations","'The kiss of death; returns : two case reports of Corynebacterium diphtheriae in the Republic of Ireland","A. Conway|B. Boyle|C. Kerr|A. Lanigan|C. Brennan|C. Merry|S. Clarke|T. Teoh|K. Davenport"
"7721","15/04 12:00","3","P5002","Pierantonio GRIMALDI","2","A","22. Clinical trials","Validation of a proposed score for identifying critical patients at risk of failure in attaining aggressive PK/PD target attainment with piperaciilin/tazobactam and meropenem and relationship with clinical outcome: a 3-year retrospective cohort study","P. Grimaldi|M. Gatti|M. Rinaldi|T. Tonetti|A. Siniscalchi|P. Viale|F. Pea"
"7728","15/04 12:00","18","P5017","Benjamin LORENZ","2","A","22. Clinical trials","Long-term safety and immunogenicity of cytomegalovirus mRNA-1647 vaccine in healthy adults: 36-month results from a phase 2 extension trial","B. Lorenz|A. Iyer|S. Marsh|J. Lin|S. Kalidindi|J. Husson|L. Panther|R. Calheiros"
"7763","15/04 12:00","31","P5030","Selva ALA SELEK","2","A","22. Clinical trials","Prospective evaluation of the effect of SARS-CoV-2 vaccines on long Covid","H. Eraksoy|A. Benli|S. Ala Selek|S. Basaran|S. Simsek Yavuz|S. Mese|A. Cagatay|O. Oncul|H. Ozsut|M. Önel|A. Agacfidan"
"7784","15/04 12:00","32","P5031","Nasrallah GHEYATH","2","A","22. Clinical trials","Immunogenicity comparison of heterologous and homologous mRNA Covid-19 boosting: superior neutralising and IgA responses in homologous regimens","G. Nasrallah"
"7791","15/04 12:00","33","P5032","Jason A ROBERTS","2","A","22. Clinical trials","Meropenem and piperacillin/tazobactam optimised dosing regimens based on kidney replacement therapy settings and residual diuresis: findings from the SMARRT study","J. Roberts|S. The Sampling Antibiotics In Renal Replacement Therapy (smarrt) Study Group"
"7794","15/04 12:00","34","P5033","Besnik CULLHAJ","2","A","22. Clinical trials","Evaluation of toxoplasma IgM detection methods in 7,607 patients: a comparative study","B. Cullhaj|I. Marku"
"7802","15/04 12:00","35","P5034","Jose BRAVO FERRER COSTA","2","A","22. Clinical trials","Clinical failure in complicated urinary tract infection (cUTI): results of the ECRAID-base POS-cUTI observational cohort","J. Bravo-Ferrer|N. Maldonado|E. Rubio-Martin|P. Martinez-Aguado|F. Cogliati Dezza|R. Compagnone|M. Delgado-Valverde|A. Barac|P. Clevenbergh|F. Arieti|P. De Nardo|O. Awwad|Á. Cano|R. Espindola|E. Merino|E. Frangou|T. Lafon|P. Andrade|T. Ten Doesschate|A. Hernández-Torres|A. Bandera|L. Jacquin|M. Bokhari|A. Ternhag|O. Sandulescu|B. Koprivica|M. Samarkos|F. Patauner|J. Van Laethem|P. Munoz|J. Rupp|D. Viglino|A. Røder|L. Radulovic|G. Marchetti|D. Chadwick|E. Iosifidis|S. Tsiodras|M. David|A. Veiga-Ferraz|A. Bartoloni|J. Pano-Pardo|N. Catorze|I. Gentile|M. Tumbarello|C. Constantinou|C. Kirakli|M. Akova|J. Koepsell|M. Bonten|E. Tacconelli|J. Rodriguez-Bano"
"7821","15/04 12:00","36","P5035","Tristan FERRY","2","A","22. Clinical trials","Preliminary safety and efficacy 12 weeks results of PhagoDAIR-I, a pilot study of phage therapy in patients with hip or knee prosthetic joint infection (PJI) due to Staphylococcus aureus","T. Ferry|C. Batailler|M. Lacasse|A. Tizon|M. Châlons-Cottavoz|T. Briot|A. Kuhn|S. Rouanet|T. Roussel-Gaillard|F. Craighero|S. Lustig|P. Birman"
"7874","15/04 12:00","1","P5036","Xin LIU","3","A","22. Clinical trials","A semi-mechanistic population pharmacokinetic model of linezolid in renal impairment: optimising dosing for effective UTI treatment","X. Liu|A. Benitez-Cano Martinez|X. Zhu|S. Luque Pardos"
"7889","15/04 12:00","2","P5037","Francesco COGLIATI DEZZA","3","A","22. Clinical trials","International Delphi survey on priorities for clinical trials development in infections caused by antimicrobial-resistant pathogens: preliminary analysis of MePRAM project","F. Cogliati Dezza|P. Olivares Navarro|M. Caponcello|M. Salazar Moscoso|P. Cosano Perez|P. Retamar Gentil|J. Oteo-Iglesias|J. Torre-Cisneros|J. Horcajada Gallego|J. Rodriguez Bano"
"7902","15/04 12:00","3","P5038","Hana SLEPCANOVÁ","3","A","22. Clinical trials","Early diagnosis of invasive candidiasis in intensive care: evaluation of diagnostic biomarkers","H. Slepcanova|R. Dobias|A. Langer Sermeno|M. Kanova|P. Hamal"
"7911","15/04 12:00","4","P5039","Elena ALVAREZ","3","A","22. Clinical trials","Binding antibody threshold associated with optimal immune response Covid-19 booster vaccination in the EU-COVAT-2 BOOSTAVAC trial","V. Gautier|J. Cano Ochando|K. Loens|H. Hervius Askling|J. Jakobs|I. De Coster|E. Feeney|J. Lambert|E. De Barra|C. Bergin|C. Sadlier|C. Tondel|R. Cox|J. Rockstroh|O. Sophie|C. Stephan|M. Vehreschild|A. Borobia Perez|I. Vergara Mitxeltorena|C. Masuet Aumatell|P. Bruijning-Verhagen|M. Zeitlinger|J. Narro|P. Van Damme|S. Trelle|J. Demotes-Mainard|H. Goossens|P. Doran|O. Cornely|P. Mallon|E. Alvarez|L. Butikofer|A. Garcia-Leon"
"7928","15/04 12:00","5","P5040","Mihir DESAI","3","A","22. Clinical trials","Safety and immunogenicity of mRNA-1345 revaccination at 24 months in adults ≥60 years","M. Desai|E. Comstock|R. Rustomjee|S. Mehta|A. Kapoor|L. Wilson|C. Reuter|C. Lopez|L. Lan|H. Zhou|F. Priddy|R. Das"
"7940","15/04 12:00","6","P5041","Niklas Dyrby JOHANSEN","3","A","22. Clinical trials","A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among young and middle-aged adults with chronic disease: NUDGE-FLU-CHRONIC-2","N. Johansen|M. Vaduganathan|A. Bhatt|D. Modin|B. Claggett|K. Janstrup|C. Larsen|L. Larsen|L. Wiese|M. Dalager-Pedersen|L. Køber|S. Solomon|P. Sivapalan|J. Jensen|C. Martel|T. Krause|T. Biering-Sørensen"
"7943","15/04 12:00","7","P5042","Niklas Dyrby JOHANSEN","3","A","22. Clinical trials","Electronic nudges to increase influenza vaccination uptake among patients with heart failure: insights from 3 nationwide randomised trials enrolling > two million patients","N. Johansen|M. Vaduganathan|A. Bhatt|D. Modin|B. Claggett|K. Janstrup|C. Larsen|L. Larsen|L. Wiese|M. Dalager-Pedersen|E. Dueger|S. Samson|M. Loiacono|R. Harris|L. Køber|S. Solomon|P. Sivapalan|J. Jensen|T. Biering-Sørensen"
"7959","15/04 12:00","8","P5043","Cléa MELENOTTE","3","A","22. Clinical trials","Preliminary results of the COV-ID study: immunocompromised patients hospitalised for SARS-CoV-2 infection, treated with direct antiviral agents: a G2i study","C. De La Porte Des Vaux|O. Paccoud|R. Porcher|F. Lanternier|N. Peiffer-Smadja|G. Melica|L. Levi|K. Lacombe|H. Durand|C. Eldin|A. Schieber|V. Texier|F. Rivière|P. Loubet|S. Leautez|A. Chan Sui Ko|R. Cruchet|M. Hentzein|C. Aguilar|K. Diallo|B. Gaborit|L. Placais|M. Lahouati|R. Dhersin|V. Dubée|F. Givry|E. Faure|G. Martin-Blondel|C. Melenotte"
"7963","15/04 12:00","30","P5065","Louise CREMER","3","A","22. Clinical trials","Immunogenicity of Covid-19 vaccination in immunocompromised patients (Auto-COVID-VACC): interim analysis from a multicentre, prospective, non-interventional study","L. Cremer|U. Bethe|P. Borchmann|V. Di Cristanziano|L. Gieselmann|S. Grimm|M. Hellmich|J. Jakobs|J. Nacov|J. Neuhann|J. Prattes|M. Rabenstein|C. Scheid|R. Sprute|G. Steger|J. Stemler|S. Mellinghoff|O. Cornely"
"7983","15/04 12:00","2","P5073","Isabel LEROUX-ROELS","4","A","22. Clinical trials","Co-administration of the AS01E-adjuvanted respiratory syncytial virus (RSV) prefusion F protein vaccine (adjuvanted RSVPreF3) with the 20-valent pneumococcal conjugate vaccine (PCV20) in adults aged ≥60 years","L. Isabel|M. Lins|R. Surowitz|A. Pragalos|P. Jua|D. Wauters|A. Jayadev|J. Akite|A. Jastorff|V. Cárdenas|M. Van Der Wielen"
"8004","15/04 12:00","12","P5083","Victor CNOSSEN","4","A","22. Clinical trials","Using a randomised, placebo-controlled rhinovirus controlled human infection model to evaluate prophylactic antiviral effectiveness of intranasal 2-deoxy-D-glucose","V. Cnossen|S. Assil|I. Kamerling|L. Hell|V. Kovtunyk|S. Radivojev|F. Groiss|M. Roestenberg|R. Turner|A. Gorki|G. Gualdoni"
"7726","15/04 12:00","6","P5005","Mireia COSCOLLA","2","A","24. Outbreaks and public health emergencies","Genetic determinants behind a high persistent clone of Legionella pneumophila","I. Cancino-Munoz|J. González Rubio|F. González-Camacho|M. Coscolla"
"7727","15/04 12:00","11","P5010","Thierry WIRTH","2","A","24. Outbreaks and public health emergencies","Unraveling the epidemic success of Mycobacterium tuberculosis lineage 2: insights from evolutionary genomics, mutation rates, and socio-economic drivers","T. Wirth|N. Gharbi|E. Rousseau|M. Merker|S. Niemann"
"7750","15/04 12:00","21","P5020","Vittorio GUERRA","2","A","24. Outbreaks and public health emergencies","The role of frailty index laboratory in predicting clinical outcomes in patients with Clostridioides difficile infections: a 2020-2024 retrospective study","G. Patti|V. Guerra|N. Veronese|N. De Gennaro|E. De Vita|R. Papagni|C. Pellegrino|A. Amendolara|A. Vigna|V. Spada|M. Cormio|D. Cassano|G. Metrangolo|L. Ronga|M. Chironna|F. Di Gennaro|A. Saracino"
"7760","15/04 12:00","21","P5056","Stefano MUSUMECI","3","A","24. Outbreaks and public health emergencies","Role of viral coinfection in post-pandemic invasive group A streptococcal infections in adults, a nation-wide cohort study (iGASWISS)","S. Musumeci"
"7778","15/04 12:00","24","P5059","Shipra GUPTA","3","A","24. Outbreaks and public health emergencies","Breakthrough infections in rabies: a public health emergency","S. Gupta|S. Chandel|L. Lodha|A. M A|R. Mani"
"7806","15/04 12:00","27","P5062","José Guillermo PEREIRA BRUNELLI","3","A","24. Outbreaks and public health emergencies","Outbreak of Cutaneous Leishmaniasis in a previously unreported area of Paraguay","M. Gaona|M. Florentin|O. Aldama|V. Lezcano|M. Cardozo|G. Benitez|J. Pereira Brunelli"
"7849","15/04 12:00","29","P5064","Thinley DORJI","3","A","24. Outbreaks and public health emergencies","Genomics reveals extensive endemic transmission of a multi-drug-resistant tuberculosis clone in Bhutan","T. Dorji|K. Tshering|L. Adhikari|T. Jamtsho|P. Bhujel|P. Lhaden|S. Wangchuk|w. Wirth|K. Horan|J. Denholm|N. Sherry|M. Sait|T. Stinear|B. Howden|P. Andersson"
"7856","15/04 12:00","31","P5066","Jon SALMANTON-GARCIA","3","A","24. Outbreaks and public health emergencies","Matched cohort study comparing the impact of RSV, influenza, and SARS-CoV-2 infections in patients with haematologic malignancies","J. Salmanton-Garcia|M. Del Principe|J. Labrador|K. Piukovics|B. Weinbergerova|M. Cernan|M. Biernat|N. Fracchiola|A. Dabrowska-Iwanicka|M. Samarkos|B. Visek|V. Petzer|Y. Bilgin|A. Vena|I. Heras-Fernando|L. Drgona|O. Cornely|L. Pagano|F. Marchesi|M. Navratil|I. Falces-Romero"
"7857","15/04 12:00","32","P5067","Jon SALMANTON-GARCIA","3","A","24. Outbreaks and public health emergencies","Comparative outcomes of hMPV, influenza, and SARS-CoV-2 infections in haematologic malignancy patients: a matched cohort analysis","J. Salmanton-Garcia|F. Marchesi|E. Mackenzie|B. Weinbergerova|I. Falces-Romero|M. Cernan|K. Piukovics|A. Vena|Y. Bilgin|N. Erben|N. Sgherza|I. Heras-Fernando|G. Magliano|O. Cornely|L. Pagano"
"7879","15/04 12:00","33","P5068","Jay JONES","3","A","24. Outbreaks and public health emergencies","Mycoplasma Pneumonia rates were at an all time high in 2024: how well did we predict it?","J. Jones|B. Noble|S. Park|B. Grenfell"
"7909","15/04 12:00","34","P5069","Anika TRUDIC","3","A","24. Outbreaks and public health emergencies","Outbreak caused by VIM-producing Proteus mirabilis in a tertiary care hospital in Serbia","A. Trudic|F. Bozic|M. Hadnadev|M. Janjusevic|A. Andrijevic|J. Dekic Malbasa"
"7922","15/04 12:00","35","P5070","Klara SONDÉN","3","A","24. Outbreaks and public health emergencies","Intradermal MVA-BN vaccination generates neutralizing antibody response to MPXV clades Ib and IIb, suggesting cross-protective immunity","K. Sondén|C. Beck Eichler-Johansson|K. Johansen|A. Ekström|M. Herstad|J. Aarum|M. Keszei|V. Westergren|E. Storgärd|C. Treutiger"
"7930","15/04 12:00","36","P5071","Cléa MELENOTTE","3","A","24. Outbreaks and public health emergencies","Severe imported malaria in children in metropolitan France a retrospective cohort study, 2011-2023","L. Daneluzzo|M. Thellier|F. Gay|F. Sorge|J. Toubiana|L. Musset|O. Lortholary|S. Houze|P. Buffet|C. Melenotte"
"7931","15/04 12:00","1","P5072","Ben COOPER","4","A","24. Outbreaks and public health emergencies","The potential impact of substandard and falsified fluoroquinolones on clinical outcomes of typhoid fever","S. Cavany|L. Adipo|K. Van Assche|C. Caillet|C. Dolecek|C. Hauk|S. Nanyonga|N. Stoesser|P. Newton|C. Parry|B. Cooper"
"7937","15/04 12:00","3","P5074","Bhanasut HUNSAJARUPAN","4","A","24. Outbreaks and public health emergencies","Dengue outbreak among migrants from Myanmar in an immigration detention centre in Bangkok, Thailand: epidemiological investigation and public health response","C. Cheewa|B. Hunsajarupan|A. Keskesorn|R. Kompao|W. Guailee|K. Jinteng|S. Cheha|S. Nuanjaem|S. Prapaso|W. Chainontee|R. Buathong"
"7979","15/04 12:00","4","P5075","Adeline BOUTET-DUBOIS","4","A","24. Outbreaks and public health emergencies","Multiple environmental reservoirs involved in an outbreak of Enterobacter cloacae complex in a neonatal intensive care unit in Southern France","A. Boutet-Dubois|L. Bosc|B. Richaud-Morel|F. Compan|C. Dunyach-Remy|M. Di Maio|M. Safarian|J. Lavigne|A. Pantel|J. Ory"
"7980","15/04 12:00","5","P5076","Suttiporn PRAPASO","4","A","24. Outbreaks and public health emergencies","Mpox clade 1b screening at Thailand's points of entry: challenges in early detection","S. Prapaso|L. Wongkaew|S. Saosarn|T. Direkwutthikun|B. Hunsajarupan|R. Buathong"
"7981","15/04 12:00","6","P5077","Caspar GEENEN","4","A","24. Outbreaks and public health emergencies","Indoor air surveillance in a daycare centre detects emerging pneumococcal vaccine serotypes","C. Geenen|T. Nieuwenhuijsen|L. Cuypers|K. Beuselinck|K. Trzcinski|E. André|S. Desmet"
"7987","15/04 12:00","7","P5078","Vanlal TLUANPUII","4","A","24. Outbreaks and public health emergencies","Global first case series of Pseudomonas mendocina outbreak: from clinical insights to genomic analysis","V. Tluanpuii|M. Puraswani|N. Ahmed|M. Kirti|B. Das|P. Mathur"
"8007","15/04 12:00","8","P5079","Elif DOGAN","4","A","24. Outbreaks and public health emergencies","Chlorhexidine bath, vaporized hydrogen peroxide or all others; to stop a C. auris outbreak?","E. Dogan|C. Bulut|H. Yagmurdur|A. Cosar|G. Fidan"
"8008","15/04 12:00","9","P5080","Tetyana CHUMACHENKO","4","A","24. Outbreaks and public health emergencies","Measles outbreaks in wartime Ukraine: causes, impact, and mitigation strategies","T. Chumachenko|D. Chumachenko"
"8009","15/04 12:00","10","P5081","Corinna ERNST","4","A","24. Outbreaks and public health emergencies","Effectiveness of a mixed maternal and passive infant immunisation strategy to prevent RSV-related paediatric hospitalisations in Luxembourg","C. Ernst|D. Dookhun|N. Del Lero|G. Ketchiozo|R. Vaccaroli|A. Vergison|I. De La Fuente Garcia|J. Mossong"
"8017","15/04 12:00","11","P5082","Megan COFFEE","4","A","24. Outbreaks and public health emergencies","Assessing a vision-language model for Mpox diagnosis across clades, skin types, and real-world imaging challenges","W. Ye|C. Porter|C. Crews|K. Moise|A. Tabassum|M. Coffee|X. Cao"
"7700","15/04 12:00","1","P5000","Kei KAIMORI","2","A","21. New drugs and vaccines","Inhibitory effect of the quinolone-resistant mutant selection in gram-negative bacilli by new fluoroquinolone "" Lascufloxacin ""","K. Kaimori|T. Sato|Y. Tamura|M. Kawamura|S. Fujimura"
"7723","15/04 12:00","4","P5003","Afef NAJJARI","2","A","21. New drugs and vaccines","Antibacterial assessment and molecular docking of cuo nanoparticles by south Tunisian moringa alterniflora leaves against multidrug-resistant esbl-producing escherichia coli","A. Najjari|S. Raissi|H. Ouzari|S. Khemili-Talbi|A. merghni"
"7747","15/04 12:00","5","P5004","Xingchen BIAN","2","A","21. New drugs and vaccines","Pharmacokinetic and pulmonary tissue penetration simulation analysis of lefamulin in community-acquired bacterial pneumonia: insights from phase III study data","X. Bian|Y. Chen|J. Yu|J. Zhang|W. Yang"
"7761","15/04 12:00","7","P5006","Sang-Jin PARK","2","A","21. New drugs and vaccines","Evaluation of the 4-week repeated-dose toxicity of a plant-based SARS-CoV-2 S1 vaccine in Sprague-Dawley rats","S. Park|W. Kim|H. Kang|E. Sohn|M. Jang|W. Im|M. Yoo|Y. Kim"
"7762","15/04 12:00","8","P5007","Dariya TOKTYROVA","2","A","21. New drugs and vaccines","Assessment of safety and immunogenicity of an oral bait vaccine for rabies in wild carnivores using dog models","Y. Bulatov|Z. Koshemetov|R. Abitayev|A. Ussembai|D. Toktyrova"
"7773","15/04 12:00","9","P5008","Jan Naseer KAUR","2","A","21. New drugs and vaccines","Combine, combat, conquer: synergistic use of non-natural nucleosides in combination with antibiotics to tackle multidrug-resistant infections","J. Kaur|J. Klem|Y. Liu|A. Hanna|A. Chen|P. Holden|S. Kapoor|M. Sutton|A. Berdis|B. Tsuji"
"7815","15/04 12:00","10","P5009","Matthew ROUSCULP","2","A","21. New drugs and vaccines","Impact of reactogenicity of the 2024–2025 Covid-19 vaccines on health care workers and first responders in the United States","A. Phillips|G. Ellsworth|S. Calhoun|D. Odom|R. Zimiecki|B. Hahn|S. Yoon|M. Rousculp"
"7820","15/04 12:00","12","P5011","Balaji VEERARAGHAVAN","2","A","21. New drugs and vaccines","In vitro microbiological activity of aztreonam, cefepime and cefiderocol combined with nacubactam against NDM-harbouring Escherichia coli and Klebsiella pneumoniae clinical isolates","B. Veeraraghavan|Y. Bakathavatchalam|A. Shankar|H. Ragothaman|S. Krishnamoorthy|F. Abdullah|D. Srinivasan|S. Toyoda|H. Okade|K. Yanagihara"
"7839","15/04 12:00","13","P5012","Llorenç FERNÁNDEZ-COLL","2","A","21. New drugs and vaccines","Evaluation of the immunogenicity and protective efficacy of eight DNA vaccines targeting Klebsiella pneumoniae virulence factors","M. Vicente-Pazos|L. Fernández-Coll|A. Benito Mundet|C. Navarro Sánchez|J. Velasco Castillo|L. Quilez Agraz|L. Martin Ortega|J. Castro Gallegos|M. Mcconnell|M. Lopez-Siles"
"7865","15/04 12:00","14","P5013","Christina DESCHERMEIER","2","A","21. New drugs and vaccines","Nonstructural Protein 1 (NS1) - and Envelope Protein Domain III (EDIII) - specific antibody responses in QDENGA®-vaccinated Dengue virus (DENV)-naive and -preimmune individuals","C. Deschermeier|C. Ehmen|R. Ferraz|R. Von Possel|V. Zehner|M. Schmidt|L. Matthies|C. Klenk|M. Ramharter|P. Emmerich"
"7868","15/04 12:00","15","P5014","Elif AYDIN","2","A","21. New drugs and vaccines","Application of three-dimensional bacteriophage cocktail biogel on infected burn wounds in rats","E. Aydin|A. Kocak Sezgin|M. Koldemir Gunduz|G. Kaymak|F. Aslan|S. Ali|B. Bozdogan"
"7891","15/04 12:00","16","P5015","Masaya YAMATO","2","A","21. New drugs and vaccines","Ensitrelvir in hospitalised patients with SARS-CoV-2: a single-centre observational study","M. Yamato|M. Kinoshita|Y. Yoshida|Y. Yamamoto|R. Izuhara|T. Sonoyama"
"7892","15/04 12:00","17","P5016","Xinpeng YAO","2","A","21. New drugs and vaccines","Endoplasmic reticulum stress and KEAP1-Nrf2 activation in polymyxin-induced nephrotoxicity","X. Yao|J. Zhao|G. Siddiqui|D. Creek|K. Chen|F. Lin|Y. Wu|J. Lu|J. Li"
"7910","15/04 12:00","19","P5018","Anastasiia ROMANCHYSHYNA","2","A","21. New drugs and vaccines","New chemical compounds of 1-alkyl(aryl)oxy-3-amino-2-propanol group and their protistocidal activity","A. Romanchyshyna|V. Shyrobokov|V. Poniatovskyi|Y. Korotkyi"
"7912","15/04 12:00","20","P5019","Riham DAHER","2","A","21. New drugs and vaccines","Role of Adh2 isolated from Helcococcus kunzii in modulating the virulence of Staphylococcus aureus in a chronic wound model","R. Daher|R. Vincentelli|C. Dunyach-Remy|J. Lavigne"
"7915","15/04 12:00","22","P5021","Stephen HAWSER","2","A","21. New drugs and vaccines","Evaluation of the activity of the novel antibiotic combination Meropenem-ANT3310 against recent multidrug-resistant Enterobacterales and Acinetobacter baumannii clinical isolates","S. Hawser|F. Monti|I. Pittex|A. Llanos|M. Zalacain"
"7918","15/04 12:00","23","P5022","Hanne-Dorthe EMBORG","2","A","21. New drugs and vaccines","Enhanced influenza vaccines impact effectiveness in individuals aged ≥65 years","H. Emborg|P. Valentiner-Branth|R. Trebbien|T. Krause|B. Søborg"
"7920","15/04 12:00","24","P5023","Miao XU","2","A","21. New drugs and vaccines","Magetic probiotic vaccine therapy for periodontitis treatment","M. Xu"
"7923","15/04 12:00","25","P5024","Farah AL MARZOOQ","2","A","21. New drugs and vaccines","Emerging cefiderocol resistance in Escherichia coli from the United Arab Emirates: genomic insights and innovative approaches to counter resistance by novel beta-lactamase inhibitors","F. Al Marzooq|H. Ahli|R. Aldhaheri"
"7944","15/04 12:00","26","P5025","Kaja KASEMETS","2","A","21. New drugs and vaccines","Antifungal activity of silver-chitosan nanocomposites against Candida albicans and Candida parapsilosis","K. Kasemets|A. Kahru|L. Kaarma"
"7946","15/04 12:00","27","P5026","Beatriz CANO CASTAÑO","2","A","21. New drugs and vaccines","Immunogenicity of Klebsiella pneumoniae OmpA and OmpK36 decorating the outer-membrane of LPS-null Acinetobacter baumannii cells in the vaccine K-Vax","B. Cano-Castano|M. Cordero Alba|L. Del Pozo Acebo|M. Garcia|M. Ramiro|E. Gato|J. Infante|M. Mcconnell|A. Perez"
"7954","15/04 12:00","28","P5027","Esther WOHLFARTH","2","A","21. New drugs and vaccines","Genetic background of aztreonam-avibactam resistant Enterobacterales in Germany","E. Wohlfarth|F. Deuchert|S. Becker|S. Zimmermann|C. Hess|A. Serr|T. Wichelhaus|A. Anders|J. Eisfeld|P. Higgins"
"7970","15/04 12:00","29","P5028","Yuxin CHEN","2","A","21. New drugs and vaccines","Single-cell RNA sequencing reveals peripheral immune characteristics related to SARS-CoV-2 vaccination in populations of varying age demographics","Y. Chen"
"7972","15/04 12:00","30","P5029","Adrian EGLI","2","A","21. New drugs and vaccines","In vitro activity of zosurabalpin against carbapenem-resistant-A. baumannii (CRAB) clinical isolates from diverse origins","S. Mancini|K. Haldimann|J. Moran-Gilad|E. Aktas|O. Guenes|N. Kolensik-Goldmann|V. Hinic|O. Nolte|A. Egli"
"7990","15/04 12:00","11","P5046","Albert WAHL","3","A","21. New drugs and vaccines","Development of patient derived monoclonal antibodies to treat Candida infections","R. Sprute|F. Pley|A. Wahl|A. Kolovou|S. Mellinghoff|B. Hube|F. Klein|J. Rybniker|S. Singh|A. Ibrahim|A. Simonis|O. Cornely"
"7996","15/04 12:00","26","P5061","Andrea WESSELY","3","A","21. New drugs and vaccines","Seroconversion after application of a recombinant herpes zoster vaccine in VZV seronegative immunocompromised adults","A. Wessely|I. Zwazl|M. Poturica|U. Wiedermann|M. Kundi|A. Wagner"
"8005","15/04 12:00","28","P5063","Ioannis BALTAS","3","A","21. New drugs and vaccines","The INCREASE(ingly) difficult battle with carbapenem-resistant Klebsiella pneumoniae: insights into novel treatment options from Greek ICUs","I. Baltas|G. Vrioni|I. Skiadas|V. Grammelis|S. Vourli|N. Smyrni|J. Hatcher|A. Tsakris|L. Grandjean"
"7792","15/04 12:00",,"P55001","Jong Hyun SHIN",,,"21. New drugs and vaccines","Emergence of a structurally unique mcr-10 plasmid with host specific colistin resistance: a public health concern","J. Shin|K. Ko"
"7735","15/04 12:00","9","P5044","Sumeeta KHURANA","3","A","23. New and emerging pathogens","Evaluation of amoebicidal activity of miltefosine for Acanthamoeba Granulomatous amoebic encephalitis isolates in vitro","S. Khurana|C. Sharma"
"7746","15/04 12:00","10","P5045","Jingjing QUAN","3","A","23. New and emerging pathogens","Further enhancement of virulence related to polymyxin resistance caused by CrrB mutation in a KPC-2-producing KL2-ST65 hypervirulent Klebsiella pneumoniae clone","J. Quan|M. Zhou|W. Liao|D. Zhao"
"7752","15/04 12:00","12","P5047","Kamruddin AHMED","3","A","23. New and emerging pathogens","Serological evidences of severe fever with thrombocytopenia syndrome virus in the rural areas of Malaysian Borneo state of Sabah","D. Mori|J. John|M. Ngwe Tun|T. Yahiro|N. Ibrahim|A. Abd Aziz|S. Fong|K. Fornace|T. William|C. Drakeley|K. Morita|A. Nishizono|K. Ahmed"
"7767","15/04 12:00","13","P5048","Saeed KHAN","3","A","23. New and emerging pathogens","Emerging and re-emerging vector-borne diseases in Karachi Pakistan: a public health concern","S. Khan|M. Zahid|H. Faruqui"
"7772","15/04 12:00","14","P5049","Farhang JANET","3","A","23. New and emerging pathogens","Rapid and sensitive detection of Candida auris: clinical and analytical performance of a direct PCR assay","B. Bernier|L. Rubino|V. Tettamanzi|N. Carriglio|S. Brahmasandra|G. Minnucci|J. Farhang"
"7805","15/04 12:00","15","P5050","Andreas Friedrich WENDEL","3","A","23. New and emerging pathogens","First case of mpox clade Ib in Germany: results of in-hospital air and surface sampling","A. Wendel|F. Mattner|D. Peter|M. Krakau|H. Gruell|A. Nitsche|J. Michel"
"7825","15/04 12:00","16","P5051","Guido WERNER","3","A","23. New and emerging pathogens","Prevalence and population genomics of emerging linezolid-resistant enterococci: a multicentre study across 17 countries","J. Bender|A. Sundsfjord|K. Hegstad|G. Werner"
"7867","15/04 12:00","17","P5052","Luciana SARTORI","3","A","23. New and emerging pathogens","Identification and genomic profiling of multidrug-resistant Salmonella enterica serovars Minnesota and Sandiego infections in companion animals in Brazil","L. Sartori|J. Rueda Furlan|F. Parra Sellera|F. Borges Barbosa|B. Fuga|G. Batista Melocco|K. Sousa Dantas|A. Gales|N. Lincopan|T. Knöbl"
"7871","15/04 12:00","18","P5053","Erik WENDLANDT","3","A","23. New and emerging pathogens","Identification of highly pathogenic avian influenza Clade 2.3.4.4b","E. Wendlandt|E. Tretter|D. Tsang|A. Britten|G. Frandsen|C. Vakulskas"
"7890","15/04 12:00","19","P5054","Laura SOLDEVILA LANGA","3","A","23. New and emerging pathogens","Dengue: the rising threat of a re-emerging pathogen","L. Soldevila Langa|E. Fernández Pedregal|S. Roure Diez|L. Valerio Sallent|X. Vallès Casanova|G. Fernández Rivas"
"7947","15/04 12:00","20","P5055","Alexander JIMBO ZAPATA","3","A","23. New and emerging pathogens","Starmerella etchellsii and Hyphopichia burtonii: rare and emerging yeast species isolated from clinical samples of patients with onychomycosis","A. Zapata|P. Rodriguez|D. Carrillo-Cando|M. Arevalo|S. Paca-Torres"
"7992","15/04 12:00","22","P5057","Sabine WAGNER-LICHTENEGGER","3","A","23. New and emerging pathogens","Newly discovered paediatric melioidosis in Mali: the tip of an African iceberg?","S. Lichtenegger|I. Klugherz|J. Michel|M. Bastien|M. Koudika|Y. Sidibé|S. Traore|H. Kodo|R. Kanapathipillai|J. Ousley|I. Steinmetz|A. Sanogo|M. Diawara|M. Mbangui"
"8002","15/04 12:00","23","P5058","Nusrat Jahan SHALY","3","A","23. New and emerging pathogens","Epidemiology, antifungal resistance, and mortality of Candida auris in the tertiary care hospitals in Bangladesh","N. Shaly|S. Huq|F. Chowdhury|A. Faruque|F. Farzana|T. Shuvo|F. Jaby|A. Tasnim|M. Islam|S. Bhuiyan|M. Haque"
"8003","15/04 12:00","25","P5060","Danielle DIAS MUNHOZ","3","A","23. New and emerging pathogens","Toxicity and proinflammatory potential of Ruminococcus gnavus strains isolated from patients with inflammatory diseases","D. Dias Munhoz|M. Jacoutot|M. Beaufrère|P. Karpman|E. Frison|V. Robert|R. Said-Nahal|G. Gautreau|S. Glatigny|M. Breban|P. Langella|J. Chatel|L. Rizzo"
